-------

-------
                                          EPA/600/6-90/006F
                                          December 1992
      RESPIRATORY HEALTH EFFECTS
             OF PASSIVE SMOKING:
 LUNG CANCER AND OTHER DISORDERS
Major funding for this report has been provided by the Indoor Air Division,
          Office of Atmospheric and Indoor Air Programs
          Office of Health and Environmental Assessment
              Office of Research and Development
             U.S. Environmental Protection Agency
                    Washington, D.C.
                                            Printed on Recycled Paper

-------
                                      DISCLAIMER

       This document has been reviewed in accordance with U.S. Environmental Protection Agency
policy and approved for publication.  Mention of trade names or commercial products does not
constitute endorsement or recommendation for use.
                                            11

-------
                                  CONTENTS
Tables	 .	:............................    viii

Figures	.	 •    xiii

Foreword	,    xv

Preface	,	    xvi

Authors,  Contributors, and Reviewers  	'.	    xvii

1.  SUMMARY AND CONCLUSIONS	    1-1

   1.1. MAJOR CONCLUSIONS	    1-1
   1.2. BACKGROUND	    1-2
   1.3. PRIMARY FINDINGS	1	    1-4
       1.3.1.  ETS and Lung Cancer . '.	    1-6
             1.3.1.1.  Hazard Identification	 .	    1-6
             1.3.1.2.  Estimation of Population Risk	    1-11
       1.3.2.  ETS and Noncancer Respiratory Disorders	    1-12

2.  INTRODUCTION  	    2-1

   2.1. FINDINGS OF PREVIOUS REVIEWS	    2-2
   2.2. DEVELOPMENT OF EPA REPORT	    2-5
       2.2.1.  Scope	 .    2-5
       2.2.2.  Use of EPA's Guidelines	    2-6
       2.2.3.  Contents of This Report		 .    2-8

3.  ESTIMATION OF ENVIRONMENTAL TOBACCO SMOKE EXPOSURE  	   3-1

   3.1. INTRODUCTION	    3-1
   3.2. PHYSICAL AND CHEMICAL PROPERTIES	    3-2
   3.3. ASSESSING ETS EXPOSURE	    3-10
       3.3.1.  Environmental Concentrations of ETS	    3-12
             3.3.1.1.  Markers for Environmental Tobacco Smoke	   3-18
             3.3.1.2.  Measured Exposures to ETS-Associated Nicotine and RSP	   3-22
       3.3.2.  Biomarkers of ETS Exposure  .	 .	    3-40
       3.3.3.  Questionnaires for Assessing ETS Exposures	    3-48
   3.4. SUMMARY	    3-51

4.  HAZARD IDENTIFICATION I: LUNG CANCER IN ACTIVE SMOKERS,
   LONG-TERM ANIMAL BIOASSAYS, AND GENOTOXICITY STUDIES	   4-1

   4.1. INTRODUCTION		    4-1
                                       in

-------
                              CONTENTS (continued)
  4.2.  LUNG CANCER IN ACTIVE SMOKERS	.  . . . .	.	   4-2
       4.2.1.  Time Trends	. .   4-2
       4.2.2.  Dose-Response Relationships	   4-5
       4.2.3.  Histological Types of Lung Cancer and Associations With Smoking  	   4-10
       4.2.4.  Proportion of Risk Attributable to Active Smoking	  .   4-23
  4.3.  LIFETIME ANIMAL STUDIES	   4-23
       4.3.1.  Inhalation Studies	   4-25
       4.3.2.  .Intrapulmonary Implantations of Cigarette Smoke Condensates	   4-25
       4.3.3.  Mouse Skin Painting of Cigarette Smoke Condensates	   4-26
  4.4.  GENOTOXICITY	   4-27
  4.5.  SUMMARY AND CONCLUSIONS	,	   4-27

5. HAZARD IDENTIFICATION II: INTERPRETATION OF EPIDEMIOLOGIC
  STUDIES ON ENVIRONMENTAL TOBACCO SMOKE AND LUNG CANCER  ....   5-1

  5.1.  INTRODUCTION	   5-1
  5.2.  RELATIVE RISKS USED IN STATISTICAL INFERENCE  	   5-15
       5.2.1.  Selection of Relative Risks	   5-15
       5.2.2.  Downward Adjustment to Relative Risk for Smoker
             Misclassification Bias			   5-22
  5.3.  STATISTICAL INFERENCE	. .	   5-25
       5.3.1.  Introduction	   5-25
       5.3.2.  Analysis of Data by Study and Country	 . .	   5-31
             5.3.2.1.  Tests for Association	   5-31
             5.3.2.2.  Confidence Intervals	,  .	   5-34
       5.3.3  Analysis of Data by Exposure Level	   5-36
             5.3.3.1.  Introduction	  .   5-36
             5.3.3.2.  Analysis of High-Exposure Data	   5-37
             5.3.3.3.  Tests for Trend	  .   5-40
       5.3.4.  Conclusions	   5-51
   5.4. STUDY RESULTS ON FACTORS THAT MAY AFFECT
       LUNG CANCER RISK		,	   5-48
       5.4.1.  Introduction	•'.  .	   5-48
       5.4.2.  History of Lung Disease	.'....	   5-51
       5.4.3.  Family History of Lung Disease	   5-53
       5.4.4.  Heat Sources for Cooking or Heating	 . .	   5-53
       5.4.5.  Cooking With Oil			   5-54
       5.4.6.  Occupation	   5-54
       5.4.7. Dietary Factors		   5-55
       5.4.8. Summary on Potential Modifying Factors	   5-60
   5.5. ANALYSIS BY TIER AND COUNTRY	   5-60
   5.6. CONCLUSIONS FOR HAZARD IDENTIFICATION	   5-63
       5.6.1. Criteria for Causality	   5-63
       5.6.2. Assessment of Causality  	• • • •   5-67
       5.6.3. Conclusion	    5-68
                                        IV

-------
                               CONTENTS (continued)
6.  POPULATION RISK OF LUNG CANCER FROM PASSIVE SMOKING	    6-1

   6.1. INTRODUCTION	    6-1
   6.2. PRIOR APPROACHES TO ESTIMATION OF POPULATION RISK	    6-1
       6.2.1. Examples Using Epidemiologic Data	    6-2
       6.2.2. Examples Based on Cigarette-Equivalents	    6-5
   6.3. THIS REPORT'S ESTIMATES OF LUNG CANCER MORTALITY
       ATTRIBUTABLE TO ETS IN THE UNITED STATES	    6-8
       6.3.1. Introduction and Background	    6-8
       6.3.2. Parameters and Formulae for Attributable Risk 	, . . .	    6-10
       6.3.3. U.S. Lung Cancer Mortality Estimates Based on Results of
             Combined Estimates from 11 U.S. Studies  .	    6-16
             6.3.3.1.  U.S. Lung Cancer Mortality Estimates for Female
                      Never-Smokers	    6-17
             6.3.3.2.  U.S. Lung Cancer Mortality Estimates for Male
                      Never-Smokers	    6-17
             6.3.3.3.  U.S. Lung Cancer Mortality Estimates for Long-Term
                      (5+  Years) Former Smokers	    6-20
       6.3.4. U.S. Lung Cancer Mortality Estimates Based on Results of the
             Fontham et al. (1991) Study (FONT)  	,. .	    6-21
       6.3.5. Sensitivity to Parameter Values	    6-27
   6.4. SUMMARY AND CONCLUSIONS ON POPULATION RISK .	    6-29

7.  PASSIVE SMOKING AND RESPIRATORY DISORDERS
   OTHER THAN CANCER		    7-1

   7.1. INTRODUCTION	    7-1
   7.2. BIOLOGICAL MECHANISMS	    7-2
       7.2.1. Plausibility	    7-2
       7.2.2. Effects of Exposure In Utero and During the First
             Months of Life	 r .    7-3
       7.2.3. Long-Term Significance of Early Effects on
             Airway Function	    7-6
       7.2.4. Exposure to ETS and Bronchial Hyperresponsiveness  	,	    7-7
       7.2.5. ETS Exposure and Atopy	 .	    7-9
   7.3. EFFECT OF PASSIVE SMOKING ON ACUTE RESPIRATORY
       ILLNESSES IN CHILDREN	 .    7-10
       7.3.1. Recent Studies on Acute Lower Respiratory Illnesses	    7-11
       7.3.2. Summary and Discussion of Acute Respiratory Illnesses	 .    7-20
   7.4. PASSIVE SMOKING  AND ACUTE AND CHRONIC
       MIDDLE EAR DISEASES		    7-21
       7.4.1. Recent Studies on Acute and Chronic Middle Ear Diseases	    7-22
       7.4.2. Summary and Discussion of Middle Ear Diseases  .	 . .	    7-28

-------
                            CONTENTS (continued)
  7.5. EFFECT OF PASSIVE SMOKING ON COUGH, PHLEGM,
      AND WHEEZING	. .	    7-30
      7.5.1. Recent Studies on the Effect of Passive Smoking on Cough,
            Phlegm, and Wheezing	    7-30
      7.5.2. Summary and Discussion on Cough, Phlegm, and
            Wheezing	    7-41
  7.6. EFFECT OF PASSIVE SMOKING ON ASTHMA	    7-43
      7.6.1. Recent Studies on the Effect of Passive Smoking on
            Asthma in Children 	    7-44
      7.6.2. Summary and Discussion on Asthma	    7-50
  7.7. ETS EXPOSURE  AND SUDDEN INFANT DEATH SYNDROME	    7-51
  7.8. PASSIVE SMOKING AND LUNG FUNCTION IN CHILDREN  	    7-57
      7.8.1. Recent Studies on Passive Smoking and Lung Function
            in Children	    7-57
      7.8.2. Summary and Discussion on Pulmonary Function
            in Children	    7-63
  7.9. PASSIVE SMOKING AND RESPIRATORY SYMPTOMS AND
      LUNG FUNCTION IN ADULTS  	    7-64
      7.9.1. Recent Studies on Passive Smoking and Adult Respiratory
            Symptoms and Lung Function		    7-64
      7.9.2. Summary and Discussion on Respiratory Symptoms and
            Lung Function in Adults 	    7-68

8. ASSESSMENT OF INCREASED RISK FOR RESPIRATORY ILLNESSES IN
  CHILDREN FROM ENVIRONMENTAL TOBACCO SMOKE . .	    8-1

  8.1. POSSIBLE ROLE OF CONFOUNDING	    8-1
  8.2. MISCLASSIFICATION OF EXPOSED AND UNEXPOSED SUBJECTS  	    8-2
      8.2.1. Effect of Active Smoking in Children	    8-2
      8.2.2. Misreporting and Background Exposure	    8-3
  8.3. ADJUSTMENT FOR BACKGROUND EXPOSURE 	    8-5
  8.4. ASSESSMENT OF RISK	    8-9
      8.4.1. Asthma	    8-10
      8.4.2. Lower Respiratory Illness  	    8-13
      8.4.3. Sudden Infant Death Syndrome	    8-15
  8.5. CONCLUSIONS		    8-15

ADDENDUM: PERTINENT NEW STUDIES  .	ADD-1

APPENDIX A:  REVIEWS AND TIER ASSIGNMENTS FOR EPIDEMIOLOGIC
             STUDIES OF ETS AND LUNG CANCER	    A-l

APPENDIX B:  METHOD FOR CORRECTING RELATIVE RISK FOR
             SMOKER MISCLASSIFICATION	    B-l
                                     VI

-------
                          CONTENTS (continued)
APPENDIX C:  LUNG CANCER MORTALITY RATES ATTRIBUTABLE TO
            SPOUSAL ETS IN INDIVIDUAL EPIDEMIC-LOGIC STUDIES
APPENDIX D:  STATISTICAL FORMULAE

SELECTED BIBLIOGRAPHY .		
C-l

D-l

R-l
                                  VII

-------
                                          TABLES
3-1


3-2

3-3

3-4


3-5


3-6


3-7


4-1


4-2

4-3


4-4


4-5


4-6



4-7


4-8


4-9
Distribution of constituents in fresh, undiluted mainstream smoke and
diluted sidestream smoke from nonfilter cigarettes	
3-5
Example sidestream cigarette smoke deliveries	    3-8

Tobacco-specific N-nitrosamines in indoor air (ng/m3)	 .    3-17

Weekly average concentrations of each measure of exposure by parental
smoking status in the cross-sectional study, Minnesota, 1989	    3-36
Studies measuring personal exposure to airborne nicotine associated
with ETS for nonsmokers	
Studies measuring personal exposure to paniculate matter associated
with ETS for nonsmokers	
3-37.
3-38
Approximate relations of nicotine as the parameter between
nonsmokers, passive smokers, and active smokers	    3-43

Main characteristics of major cohort studies on the
relationship between smoking and cancer	    4-6

Lung cancer mortality ratios—prospective studies	,	    4-8

Lung cancer mortality ratios for men and women, by current
number of cigarettes smoked per day—prospective studies	    4-9

Relationship between risk of lung cancer and duration of smoking in
men, based on available information from cohort studies	    4-11

Lung cancer mortality ratios for males, by age of
smoking initiation—prospective studies	    4-12
Relationship between risk of lung cancer and number of years
since stopping smoking, in men, based on available information
from cohort studies	
4-13
Relative risks of lung cancer in some large cohort studies among
men smoking cigarettes and other types of tobacco	    4-15

Age-adjusted lung cancer mortality ratios for males and females,
by tar and nicotine (T/N) in cigarettes smoked  	    4-17

Relative risk for lung cancer by type of cigarette smoked (filter vs.
nonfilter), in men,  based on cohort and case-control studies	    4-17
                                             Vlll

-------
                                    TABLES (continued)

4-10   Main results of studies dealing with the relationship between
       smoking and different histological types of lung cancer	    4-18

4-11   Lung cancer deaths attributable to tobacco smoking in certain countries	    4-24

5-1    Epidemiologic studies on ETS and lung cancer in this report and
       tier ranking		    5-4

5-2    Studies by location, time, size, and ETS exposure	    5-6

5-3    Case-control studies of ETS:  characteristics  	    5-8

5-4    Diagnosis, confirmation, and exclusion of lung cancer cases	    5-12

5-5    Estimated relative risk of lung cancer from spousal ETS
       by epidemiologic study (crude and adjusted for cofactors)	;......    5-16

5-6    Effect of statistical adjustments for cofactors on risk estimates
       for passive smoking	 ; .........    5-20

5-7    Alternative estimates of lung cancer relative risks associated
       with active and passive smoking	  .    5-23

5-8    Estimated correction for smoker misclassification	    5-26

5-9    Statistical measures by individual study and pooled by country,
       corrected for smoker misclassification	  .    5-28

5-10   Statistical measures for highest exposure categories only	    5-39

5-11   Exposure response trends for females	    5-41

5-12   Reported p-values of trend tests for ETS exposure by study	    5-44

5-13   P-values of tests for effect and for trend by individual study  . . . .	    5-46

5-14   Other risk-related factors for lung cancer evaluated in selected studies .	    5-52

5-15   Dietary effects in passive smoking studies of lung cancer in females	    5-57

5-16   Classification of studies by tier	    5-62

5-17   Summary data interpretation by tiers within country	    5-64
                                             IX

-------
                                    TABLES (continued)

6-1    Definition and estimates of relative risk of lung cancer for 11 U.S. studies;
       combined for various exposure sources and baselines; population parameter
       definitions and estimates used to calculate U.S. population-attributable
       risk estimates for ETS	r ........ ... .....  ...•: <-: .    6-11

6-2    Estimated female lung cancer mortality by attributable sources
       for United States, 1985, using the pooled relative risk estimate
       from 11 U.S. studies  . . .	: .	    6-18

6-3    Female and'male lung cancer mortality estimates by attributable              :  ,    :
       ETS sources for United States, 1985, using 11 U.S. studies
       (never-smokers and former smokers who have quit 5+ years)	    6-22

6-4    Female lung cancer mortality estimates by attributable sources
       for United States, 1985, using both the relative risk estimates
       and Z values from the Fontham et al.  (1991) study  	:	    6-24

6-5    Female and male lung cancer mortality estimates by attributable
       ETS sources for United States, 1985, using the Fontham et al. (1991) study
       (never-smokers and former smokers who have quit 5+ years) .	    6-25

6-6    Effect of single parameter changes on lung cancer mortality due to
       ETS in never-smokers and former smokers who have quit 5+ years	    6-28

7-1    Studies on respiratory illness referenced in the Surgeon General's
       and National Research Council's reports of 1986	    7-11

7-2    Recent epidemiologic studies of effects of passive smoking on
       acute lower respiratory tract illnesses (LRIs)	 . .	 .    7-12

7-3    Studies on middle ear diseases referenced in the Surgeon
       General's report of 1986	    7-22

7-4    Recent epidemiologic studies of effects of passive smoking on
       acute and chronic middle ear diseases		 .    7-23

7-5    Studies on chronic respiratory symptoms referenced in the Surgeon
       General's and National Research Council's reports of 1986	   7-31

7-6    Recent epidemiologic studies of effects of passive smoking on
       cough, phlegm, and wheezing  	    7-32

7-7    Recent epidemiologic studies of effects of passive smoking on
       asthma in childhood	    7-45

-------
                                      TABLES (continued)

 7-8    Epidemiologic studies of effects of passive smoking on
        incidence of sudden infant death syndrome (SIDS) ;	         7.53

 7-9    Studies on pulmonary function referenced in the Surgeon General's
        and National Research Council's reports of 1986	              7.53

 7-10   Recent epidemiologic studies on the effects of passive smoking
        on lung function in children	                       7.59

 7-11   Recent epidemiologic studies on the effects of passive smoking
        on adult respiratory symptoms and lung function	 .	           7_65

 8-1    Adjusted relative risks for "exposed children."  Adjusted or background
        exposure based on body cotinine ratios between "exposed" and "unexposed"
        and equation 8-1	 .	                                g_g

 8-2    Behavior variations in adjusted relative risks from equation 8-1 when the
        observed relative risks and Z ratios are close together	           g_9

 8-3    Range of estimates of adjusted relative risk and attributable
        risk for asthma induction in children based on both threshold
        and nonthreshold models	               g_l j

 A-l    Study scores for tier assignments	    A-8

 A-2    Total scores  and tier assignment	            A-18

 B-l    Observed ratios of occasional smokers to current smokers
        (based on cotinine studies)	_  _      g_4

 B-2    Examples, using five U.S. studies, of differences in smoker misclassification
        bias between EPA estimates and those of P.N.  Lee regarding passive smoking
        relative risks for females	_         B_5

 B-3    Misclassification of female current smokers	        3.7

 B-4    Misclassification of female former smokers reported as never-smokers
        based on discordant answers   	               E-ll

 B-5    Misclassification of female lung cancer cases	                  E-12

B-6    Deletions from the "never" columns in Tables B-13 and B-16 and
        corrected elements	                 B_j3

B-7    Notation for distribution of reported female lung cancer cases and
        controls by husband's smoking status  .	                  B-15

                                              xi

-------
B-8

B-9


B-10



B-ll


B-12


B-13

B-14

B-15

B-16


B-17


C-l

C-2


C-3

C-4
                             TABLES (continued)

Notation for distribution of subjects by observed and true smoking status
Observed ratios of female former smokers to ever-smokers in the U.S., U.K.,
and Swedish studies: populations or controls (numbers or percentage)
Notation for observed lung cancer relative risks for exposed (k= 1) and
nonexposed (k=0) wives by the wife's smoking status, using average
never-smoking wives RR(a)0 as the reference category  	
Prevalences and estimates of lung cancer risk associated with active
and passive smoking  	
Observed ratios of current smoker lung cancer risk to ever-smoker
risk for females	
Observed smoking prevalence among the controls-Correa example

Observed relative risks-Correa example	

Crude case table, prevalence of cases by smoking status-Correa example
 Normalized case table, prevalence of cases by smoking status-
 Correa example  	
 Distribution of subjects by observed and true smoking status for wives
 in Correa example	
 Female lung cancer mortality from all causes in case-control studies

 Parameter values used to partition female lung cancer mortality
 into component sources	
 Female lung cancer mortality rates by attributable source
 Lung cancer mortality rates of female ever-smokers (ES) and never-smokers (NS)
 by exposure status	•	
B-15


B-16



B-18


B-19


B-23

B-26

B-27

B-27


B-27


B-28

C-2


C-4

C-6


C-8
                                              xn

-------
                                         FIGURES


3-1    Diagram for calculating the RSP mass from ETS emitted into any
       occupied space as a function of the smoking rate and removal rate (N)  .	 .    3-14

3-2    Diagram to calculate the ETS-associated RSP mass concentration in /ig/m3
       in a space as a function of total mass of ETS-generated RSP emitted in mg
       (determined from Figure 3-1) and the volume of a space  .	    3-15

3-3    Range of average indoor concentrations for notable ETS contaminants associated
       with smoking occupancy of different indoor environments	    3-16

3-4    Mean, standard deviation,  and maximum and minimum nicotine values measured
       in different indoor environments with smoking occupancy	    3-23

3-5    Mean, standard deviation,  and maximum and minimum concentrations
       of RSP mass measured in different indoor environments for smoking and
       nonsmoking occupancy	    3-26

3-6    Weeklong RSP mass and nicotine measurements in 96 residences
       with a mixture of sources	    3-27

3-7    Range of average nicotine  concentrations and range of maximum
       and minimum values measured by different indoor environments
       for smoking occupancy from studies shown hi Figure 3-4	    3-28

3-8    Range of average RSP mass concentrations and range of maximum
       and minimum values measured by different indoor environments
       for smoking occupancy from studies shown hi Figure 3-5	    3-29

3-9    Cumulative frequency distribution and arithmetic means of vapor-phase
       nicotine levels over a 1-week period in the main living area in residences
       in Onondaga and Suffolk Counties in New York State between January and
       April 1986	    3-31

3-10   Cumulative frequency distribution and arithmetic means of RSP mass levels by
       vapor-phase nicotine levels measured over a 1-week period in the main living
       area in residences in Onondaga and Suffolk Counties in New York State between
       January and April  1986	    3-31

3-11   Monthly mean RSP mass concentrations in six U.S. cities	    3-32

3-12a  Week-long nicotine concentrations measured in the main living area  of
       96 residences versus the number of questionnaire-reported cigarettes smoked
       during the air-sampling period  	    3-33
                                            Xlll

-------
                                     FIGURES (continued)

3-12b  Week-long RSP mass concentrations measured in the main living area
       of 96 residences versus the number of questionnaire-reported cigarettes
       smoked during the air-sampling period	     3-34

3-13   Cumulative frequency distribution of RSP mass concentrations from
       central site ambient and personal monitoring of smoke-exposed and
       nonsmoke-exposed individuals		     3-39

3-14   Average cotinine t,A by age groups	 .     3-41

3-15   Distribution of individual concentrations of urinary cotinine by degree
       of self-reported exposure to ETS	     3-44

3-16   Urinary cotinine concentrations by number of reported exposures to
       tobacco smoke in the past 4 days among 663 nonsmokers, Buffalo,
       New York, 1986	 .	     3-45

3-17   Average cotinine/creatinine levels for subgroups of nonsmoking
       women defined by sampling categories of exposure or by
       self-reporting exposure to ETS from different sources during
       the 4 days preceding collection of the urine sample	     3-47

4-1    Age-adjusted cancer death rates for selected sites, males,
       United States,  1930-1986	     4-3

4-2    Age-adjusted cancer death rates for selected sites, females,
       United States,  1930-1986	     4-4

4-3    Relative risk of lung cancer in ex-smokers, by number of years
       quit, women, Cancer Prevention Study II   	     4-14

5-1    Test statistics for hypothesis RR = 1, all studies	     5-32

5-2    Test statistics for hypothesis RR = 1, USA only	     5-32

5-3    Test statistics for hypothesis RR = 1, by country  	     5-33

5-4    Test statistics for hypothesis RR = 1, tiers 1-3 only	     5-33

5-5    90% confidence intervals, by country	     5-35

5-6    90% confidence intervals, by country, tiers 1-3 only	 . . .	     5-35
                                             xiv

-------
                         FOREWORD
                        1/19/93
     "Respiratory Health Effects of Passive Smoking:  Lung
Cancer and Other Disorders" is the most recent scientific
assessment of the health effects associated with exposure to
environmental tobacco smoke, and the first undertaken by the
U.S. Environmental Protection Agency (EPA).  It confirms and
strengthens the results of two 1986 reports by the U.S.
Surgeon General and the National Research Council, and
provides important new documentation of the emerging
scientific consensus that tobacco smoke is not just a health
risk for smokers.  It is, in fact, also a significant risk
for nonsmokers, particularly for children.

     This report demonstrates conclusively that
environmental tobacco smoke increases the risk of lung
cancer in healthy nonsmokers.  The report estimates, that
roughly 30 percent of all lung cancers caused by factors
other than smoking are attributable to exposure to
environmental tobacco smoke.  Put another way, a nonsmoker.
exposed to environmental tobacco smoke during everyday
activities faces an increased lifetime risk of lung cancer
of  roughly l-in-500 to l-in-1,000.  By comparison, EPA
generally sets  its standards or regulations so that
increased cancer risks are below l-in-10,000 to 1-in-a-
million.  In other words, estimated lung cancer risks
associated with environmental tobacco smoke are more than
ten times greater than the cancer risks which would normally
elicit an action by EPA.

     Perhaps as alarming are the report's  findings  on the
effects of environmental tobacco smoke on  infants and
children.  Children up to  18 months of age are at twice the
risk of bronchitis and pneumonia if their  parents smoke; the
report estimates that 150,000 to 300,000 cases per  year are
attributable to environmental tobacco smoke.  Environmental
tobacco smoke  also increases the risks of  fluid in  the
middle ear, asthmatic attacks,  respiratory tract  irritation,
and reduced lung  function.

     We hope that this report will prove a useful guide for
policy makers  and citizens everwhere.  Environmental tobacco
smoke  is  a  rarity among  the major  environmental health risks
we face today  in  so  far  as it  is  something we can personally
take  steps  to  prevent.   In the  end, responsibility
protecting  the safety of the indooiy environment belor
eve
 Louis W7 Sul"livan, M.D.
 Secretary
 U.S. Department of Health
   and Human Services
William  K. Reil
Administrator
U.S. Environmental
  Protection Agency
                             xv

-------
                                          PREFACE

       This assessment of the respiratory health effects associated with passive smoking has been
prepared by the Human Health Assessment Group, Office of Health and Environmental Assessment,  .
Office of Research and Development, which is responsible for the report's scientific accuracy and
conclusions. The assessment was prepared at the request of the Indoor Air Division, Office of
Atmospheric and Indoor Air Programs, Office of Air and Radiation, which defined the assessment's
scope and provided funding.
       The report has been developed under the authority of Title IV of Superfund (The Radon Gas
and Indoor Air Quality Research Act of 1986) to provide information  and guidance on the potential
hazards of indoor air pollutants.
       Two drafts of this report were made available for public review and comments, the first in June
1990 (reviewed by the Agency's Science Advisory Board [SAB] in December 1990) and a significantly
revised draft in May 1992  (reviewed by the SAB in July 1992). This  report reflects the comments
received from  those reviews.
       A comprehensive search of the scientific literature for this report is complete through
September  1991.  In addition, pertinent studies published through July 1992 have been included in the
aiialysis in  response to recommendations  made by reviewers.
       Due to both resource and time constraints, the scope of this report has been limited to  an
analysis of respiratory effects, primarily lung cancer in nonsmoking adults and noncancer respiratory
illnesses in children, with emphasis on the epidemiologic data.  Further, because two thorough reviews
on passive  smoking were completed in 1986 (by the U.S. Surgeon General and the National Research
Council), this document provides a summary of those reports with a more comprehensive analysis of
the literature appearing subsequent to those reports and an integration  of the results.
                                             xvi

-------
                      AUTHORS, CONTRIBUTORS, AND REVIEWERS

       This document was prepared by the Office of Health and Environmental Assessment (OHEA)
within the Office of Research and Development, with major contract funding provided by the Indoor
Air Division within the Office of Air and Radiation's Office of Atmospheric and Indoor Air Programs.
Steven P. Bayard1 was the OHEA project manager with overall responsibility for the contents of this
report and its conclusions. Other OHEA staff members responsible for the scientific content of sections
of this document are Jennifer Jinot1 and Aparna M. Koppikar.1 Jennifer Jinot and Steven Bayard were
the scientific editors.
AUTHORS
       Major portions of this revised report were prepared by ICF Incorporated, Fairfax, Virginia,
under EPA Contract No. 68-00-0102.  While OHEA staff provided technical editing and incorporated
reviewers' comments into each chapter in an attempt to develop a comprehensive and  consistent
document, the following people were the primary authors:
       Chapter 1:     Steven P. Bayard
       Chapter 2:     Jennifer Jinot
       Chapter 3:     Brian P. Leaderer2
       Chapter 4:     Jennifer Jinot
       Chapters 5/6:  Kenneth G. Brown3
       Chapter 7:     Fernando D. Martinez4
       Chapter 8:     Fernando D. Martinez and Steven P. Bayard
       Appendix A:   Kenneth G. Brown, Neal R. Simonsen,3 and A. Judson Wells3
       Appendix B:   A. Judson Wells
       Appendix C:   Kenneth G. Brown
       Appendix D:   Kenneth G. Brown and Neal R. Simonsen
        Health Assessment Group, Office of Health and Environmental Assessment, U.S. EPA,
Washington, DC 20460.
2J.B. Pierce Foundation Laboratory, Department of Epidemiology and Public Health, Yale
 University School of Medicine, New Haven, CT 06520.  Subcontractor to ICF, Inc.
3Kenneth G. Brown, Inc., P.O. Box 16608, Chapel Hill, NC 27516. Subcontractor to ICF, Inc.
"Division of Respiratory Sciences, University of Arizona Medical Center, Tucson, AZ 85724.
 Subcontractor to ICF,  Inc.

                                           xvii

-------
CONTRIBUTORS
       Numerous persons have provided helpful discussions or responded to requests for preprints,
data, and other material relevant to this report.  The authors are grateful to WJ. Blot, N. Britten, R.C.
Brownson, P.A. Buffler, T.L. Butler, D.B. Coultas, K.M. Cummings, J. Fleiss, E.T.H. Fontham,
Y.T. Gao, L. Garfinkel, S. Glantz, NJ. Haley, T. Hirayama, DJ. Hole, C. Humble, G.C. Rabat,
J.C. Kleinman, GJ. Knight, L.C. Koo, M. Layard, M.D. Lebowitz, P.N.  Lee, P. Macaskill, G.E.
Palomaki, J.P. Pierce, J. Repace, H. Shimizu, W.F. Stewart, D. Trichopoulos, R.W. Wilson, and A.
Wu-Williams.

REVIEWERS
       This final report was preceded by two earlier drafts:  an External Review Draft (EPA/600/6-
90/006A) published in May 1990, and an SAB Review Draft (EPA/600/6-90/006B) published in May
1992; The External Review Draft was released for public review and comment on June 25, 1990, and
was subsequently reviewed by the EPA Science Advisory Board (SAB) on December 4 and 5, 1990.
The SAB Review Draft incorporated many of the public comments and especially the valuable advice
presented in the SAB's April 19, 1991, report to the Agency.  In addition, many reviewers both within
and outside the Agency provided assistance at various internal review stages.
       The second Review Draft also was reviewed by the SAB on July 21 and 22, 1992, which
provided its report to the Agency on November 20, 1992. The authors wish to thank all those who
sought to improve the quality of this report with their comments and are particularly grateful to the
SAB for its advice.
       The following members of the SAB's Indoor Air Quality and Total  Human Exposure
Committee (IAQTHEC) participated in the reviews of the two Review Drafts.

Chairman
Dr. Morton Lippmann, Professor, Institute of Environmental Medicine, New York University
 Medical Center, Tuxedo, NY 10987
Vice Chairman
Dr. Jan AJ. Stolwijk, Professor, School of Medicine, Department of Epidemiology and Public
 Health, Yale University,  60 College Street,  New Haven, CT 06510
                                          xviu

-------
Members of the IAQTHEC

Dr. Joan Daisey, Senior Scientist, Indoor Environment Program, Lawrence Berkeley Laboratory,
   One Cyclotron Road, Berkeley, CA 94720

Dr. Timothy Larson, Environmental Science and Engineering Program, Department of Civil
  Engineering, University of Washington, Seattle, WA 98195 (1992 review only)

Dr. Victor G. Laties, Professor of Toxicology, Environmental Health Science Center,  Box EHSC,
  University of Rochester School of Medicine, Rochester, NY 14642

Dr. Paul Lioz, Department of Environmental and Community Medicine, Robert Wood Johnson
  School of Medicine, Piscataway, NJ 08854 (1992 review only)

Dr. Jonathan M. Samet, Professor of Medicine, Department of Medicine, University of New
  Mexico School of Medicine, and New Mexico Tumor Registry, 900 Camino De Salud, NE,
  Albuquerque, NM 87131

Dr. Jerome J. Wesolowski,  Chief, Air and Industrial Hygiene Laboratory, California Department
  of Health, Berkeley, CA 94704

Dr. James E. Woods, Jr., Professor of Building Construction, College of Architecture and Urban
  Studies,  117 Burress Hall, Virginia Polytechnic Institute and State University, Blacksburg VA
  24061-0156
Consultants to the IAQTHEC

Dr. Neal L. Benowitz, Professor of Medicine, Chief, Division of Clinical Pharmacology and
  Experimental Therapeutics, University of California-San Francisco, Building 30, Fifth Floor,
  San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110

Dr. William J. Blot, National Cancer Institute, 9000 Rockville Pike, Bethesda,  MD 20892 (Federal
  Liaison to the Committee)

Dr. David Burns, Associate Professor of Medicine, Department of Medicine, University of
  California, San Diego Medical Center, 225 Dickenson Street, San Diego, CA 92103-1990

Dr. Delbert Eatough, Professor of Chemistry, Brigham Young University, Provo, UT 84602

Dr. S. Katharine Hammond, Associate Professor, Environmental Health Sciences Program,
  Department of Family and Community Medicine, University of Massachusetts Medical School,
  55 Lake Avenue, North, Worcester, MA 06155

Dr. Geoffrey Kabat, Senior Epidemiologist, American Health Foundation, 320 East 43rd Street
  New York, NY 10017
                                            xix

-------
Dr. Michael D. Lebowitz, Professor of Internal Medicine, University of Arizona College of
 Medicine, Division of Respiratory Sciences, Tucson, AZ 85724
Dr. Howard Rockette, Professor of Biostatistics, School of Public Health, 318 Parran Hall,
 University of Pittsburgh, Pittsburgh, PA 15261
Dr. Scott T. Weiss, Charming Laboratory, Harvard University School of Medicine,
 Boston, MA 02115
Acknowledgments
       The authors would like to acknowledge the contributions of several people who have made this
report and the previous two drafts possible. Foremost is Robert Axelrad, Chief of the Indoor Air
Division, Office of Air and Radiation, who provided the foresight, funding, and perseverance that made
this effort possible.  We also would like to thank the following people:
       •    Individuals from the Office of Health and Environmental Assessment's Technical
             Information Staff who were responsible for the overall quality, coordination,
             organization, printing, and distribution of these reports:  Linda Bailey-Becht,
             Terri Konoza, Marie Pfaff, Michele Ranere, and Judy Theisen.  Also, Karen Sandidge
             from the Human Health Assessment Group for the typing support that she provided.
       •    Staff from R.O.W. Sciences, Inc., under the direction of Kay Marshall, who  were
             responsible for editing,  word processing, and proofreading the final report.
       •    Robert Flaak, Assistant Staff Director of the SAB, whose efforts and professionalism in
             organizing and coordinating the two SAB reviews led to an improved and  more useful
             product.
                                              xx

-------
                        1. SUMMARY AND CONCLUSIONS

1.1.  MAJOR CONCLUSIONS
       Based on the weight of the available scientific evidence, the U.S. Environmental
Protection Agency (EPA) has concluded that the widespread exposure to environmental
tobacco smoke (ETS) in the United States presents a serious and substantial public health
impact.

In adults:
       •   ETS is a human lung carcinogen,  responsible for approximately 3,000 lung
           cancer deaths annually in U.S. nonsmokers.
In children:
           ETS exposure is causally associated with an increased risk of lower
           respiratory tract infections (LRIs) such as bronchitis and pneumonia.  This
           report estimates that 150,000 to 300,000 cases annually in infants and young
           children up to 18 months of age are attributable to ETS.

           ETS exposure is causally associated with increased prevalence of fluid in the
           middle ear, symptoms of upper respiratory tract irritation, and a small but
           significant reduction in lung function.

           ETS exposure is causally associated with additional episodes and increased
           severity of symptoms in children with asthma. This report estimates that
           200,000 to 1,000,000 asthmatic children have their condition worsened by
           exposure to ETS.

           ETS exposure is a risk factor for new cases of asthma in children who have
           not previously displayed symptoms.
                                          l-l

-------
 1.2. BACKGROUND
       Tobacco smoking has long been recognized (e.g., U.S. Department of Health, Education,
 and Welfare [U.S. DHEW], 1964) as a major cause of mortality and morbidity, responsible for an
 estimated 434,000 deaths per year in the United States (Centers for Disease Control [CDC], 199la).
 Tobacco use is known to cause cancer at various sites, in particular the lung (U.S. Department of
 Health and Human Services [U.S. DHHS], 1982; International Agency for Research on Cancer
 [IARC],  1986). Smoking can also cause respiratory diseases (U.S. DHHS, 1984, 1989) and is a
 major risk factor for heart disease (U.S. DHHS, 1983).  In recent years, there  has been concern
 that nonsmokers may also be at risk for some of these health effects as a result of their exposure
 ("passive smoking") to the tobacco smoke that occurs in various environments  occupied by
 smokers.  Although this ETS is dilute compared with the mainstream smoke (MS) inhaled by
 active smokers, it is chemically similar, containing many of the same carcinogenic and toxic
 agents.
       In 1986, the National Research Council (NRC) and the Surgeon General of the U.S. Public
 Health Service independently assessed the health effects of exposure to ETS (NRC, 1986;
 U.S. DHHS, 1986). Both of the 1986 reports conclude that ETS can cause lung cancer in adult
 nonsmokers and that children of parents who smoke  have increased frequency of respiratory
 symptoms and acute lower respiratory tract infections, as well as evidence of reduced lung
 function.
       More recent epidemiologic studies of the potential associations between ETS and lung
 cancer in nonsmoking adults and between ETS and noncancer respiratory effects  more than
 double the size of the database available for analysis  from that of the 1986 reports.  This EPA
 report critically reviews the current database on the respiratory health effects  of passive smoking;
 these data are utilized to develop a hazard identification for ETS and to make quantitative
 estimates of the public health impacts of ETS for lung cancer and various other respiratory
 diseases.
       The weight-of-evidence analysis for the lung cancer hazard identification is developed in
 accordance with U.S. EPA's Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986a) and
 established principles for evaluating epidemiologic studies. The analysis considers animal
 bioassays and genotoxicity studies, as well as biological measurements of human uptake of tobacco
smoke components and epidemiologic data on active  and passive smoking. The availability of
abundant and consistent human data, especially human data at actual environmental levels of
exposure to the specific  agent (mixture) of concern, allows a hazard identification to be made with
a high degree of certainty.  The conclusive evidence  of the dose-related lung carcinogenicity of
                                            1-2

-------
 MS in active smokers (Chapter 4), coupled with information on the chemical similarities of MS
 and ETS and evidence of ETS uptake in nonsmokers (Chapter 3), is sufficient by itself to establish
 ETS as a known human lung carcinogen, or "Group A" carcinogen under U.S. EPA's carcinogen
 classification system. In addition, this document concludes that the overall results of 30
 epidemiologic studies on lung cancer and passive smoking (Chapter 5), using spousal smoking as a
 surrogate of ETS exposure for female never-smokers, similarly justify a Group A classification.
       The weight-of-evidence analyses for the noncancer respiratory effects are based primarily
 on a review of epidemiologic studies (Chapter 7).  Most of the endpoints examined are respiratory
 disorders in children, where parental smoking is used as a surrogate of ETS exposure.  For the
 noncancer respiratory effects in nonsmoking adults, most studies used spousal smoking as an
 exposure surrogate.  A causal association was concluded to exist for a number of respiratory
 disorders where there was sufficient consistent evidence for a biologically plausible association
 with ETS that could not be explained by bias, confounding, or chance.  The fact that the database
 consists of human evidence from actual environmental exposure levels gives a high degree of
 confidence in this conclusion. Where there was suggestive but inconclusive evidence of causality,
 as was the case for asthma induction in children, ETS was concluded to be a risk factor for that
 endpoint. Where data were inconsistent or inadequate for evaluation of an association, as for
 acute upper respiratory tract infections and acute middle ear infections in children, no conclusions
 were drawn.
       This report also has attempted to provide estimates of the extent of the public health
 impact, where appropriate, in terms of numbers of ETS-attributable cases in nonsmoking
 subpopulations.  Unlike for qualitative hazard identification assessments, where information from
 many sources adds to the confidence in a weight-of-evidence conclusion, for quantitative risk
 assessments, the usefulness of studies usually depends on how closely the study population
 resembles nonsmoking segments of the general population.  For lung cancer estimates among U.S.
 nonsmokers, the substantial epidemiology database of ETS and lung cancer among U.S. female
 never-smokers was considered to provide the most appropriate information.  From  these U.S.
 epidemiology studies, a pooled relative risk estimate was calculated and used in the derivation of
 the population risk estimates. The large number of studies available, the generally consistent
 results, and the condition of actual  environmental levels of exposure increase the confidence in
 these estimates.  Even under these circumstances, however, uncertainties remain, such as in the
 use of questionnaires and current biomarker measurements to estimate past exposure, assumptions
 of exposure-response linearity, and extrapolation to male never-smokers and to ex-smokers. Still,
given the strength of the evidence for the lung carcinogenicity of tobacco smoke and the extensive
human database from actual environmental exposure levels, fewer assumptions are necessary than
                                            1-3

-------
is usual in EPA quantitative risk assessments, and confidence in these estimates is rated medium to
high.
       Population estimates of ETS health impacts are also made for certain noncancer respiratory
endpoints in children, specifically lower respiratory tract infections (i.e., pneumonia* bronchitis,
and bronchiolitis) and episodes and severity of attacks of asthma.  Estimates of ETS-attributable
cases of LRI in infants and young children are thought to have a high degree of confidence
because of the consistent study findings and the appropriateness of parental smoking as a
surrogate measure of exposure in very young children. Estimates of the number of asthmatic
children  whose condition is aggravated by exposure to ETS are less certain than those for LRIs
because of different measures of outcome in various studies and because of increased
extraparental exposure to ETS in older children. Estimates of the number of new cases of asthma
in previously asymptomatic children also have less confidence because at this time the weight of
evidence for asthma induction, while suggestive of a causal association, is not conclusive.
       Most of the ETS population impact estimates are presented in terms of ranges, which are
thought to reflect reasonable assumptions about the estimates of parameters and variables required
for the extrapolation models.  The validity of the ranges is also dependent on the appropriateness
of the  extrapolation models themselves.
       While this report focuses only on the respiratory health effects of passive smoking, there
also may be other health effects of concern. Recent analyses of more than a dozen epidemiology
and toxicology studies (e.g., Steenland, 1992; National Institute for Occupational Safety and Health
[NIOSH], 1991) suggest that ETS exposure may be a risk factor for cardiovascular disease. In
addition, a few studies in the literature link ETS exposure to cancers of other sites; at this time,
that database appears inadequate for any conclusion.  This report does not develop an analysis of
either  the nonrespiratory cancer or the heart disease data and takes no position on whether ETS is
a risk factor for these diseases.  If it is, the total public health impact from ETS will be greater
than that discussed here.
1.3. PRIMARY FINDINGS
       A.   Lung Cancer in Nonsmoking Adults
            1.   Passive smoking is causally associated with lung cancer in adults, and ETS, by the
                total weight of evidence, belongs in the category of compounds classified by EPA
                as Group A (known human) carcinogens.
            2.   Approximately 3,000 lung cancer deaths per year among nonsmokers (never-
                smokers and former smokers) of both sexes are estimated to be attributable to
                ETS in the United States.  While there are statistical and modeling uncertainties
                                             1-4

-------
         in this estimate, and the true number may be higher or lower, the assumptions
         used in this analysis would tend to underestimate the actual population risk.  The
         overall confidence in this estimate is medium to high.
B.  Noncancer Respiratory Diseases and Disorders
    1.   Exposure of children to ETS from parental smoking is causally associated with:
         a.   increased prevalence of respiratory symptoms of irritation (cough,
             sputum, and wheeze),
         b.   increased prevalence of middle ear effusion (a sign of middle ear
             disease), and
         c.   a small but statistically significant reduction iri luiig function as tested
             by objective measures of lung capacity.
    2.   ETS exposure of young children and particularly infants from parental (and
         especially mother's) smoking is causally associated  with an increased risk of LRIs
         (pneumonia, bronchitis, and bronchiolitis). This report estimates  that  exposure to
         ETS contributes 150,000 to 300,000 LRIs annually  in infants and children less
         than 18 months of age, resulting in 7,500 to 15,000 hospitalizations.  The
         confidence in the estimates of LRIs is high; Increased risks for LRIs continue,
         but are lower in magnitude, for children until about age 3; however, no estimates
         are derived for children over 18 months.
    3.   a.   Exposure to ETS is causally associated with additional episodes and
             increased severity of asthma in children who already have the disease.  This
             report estimates that ETS exposure exacerbates symptoms in approximately
             20°7
-------
                     asthma annually. The confidence in this range is medium and is dependent
                     on the conclusion that ETS is a risk factor for asthma induction.
            4.   Passive smoking has subtle but significant effects on the respiratory health of
                nonsmoking adults, including coughing, phlegm production, chest discomfort,
                and reduced lung function.
       This report also has reviewed data on the relationship of maternal smoking and sudden
 infant death syndrome (SIDS),  which is thought to involve some unknown respiratory
 pathogenesis.  The report concludes that while there is strong evidence that infants whose mothers
 smoke are at an increased risk  of dying from SIDS, available studies do not allow us to
 differentiate whether and to what extent this increase is related to in utero versus postnatal
 exposure to tobacco smoke products.  Consequently, this report is unable to assert whether or not
 ETS exposure by itself is a risk factor for SIDS independent of smoking during pregnancy.
       Regarding an association of parental smoking with either upper respiratory tract infections
 (colds and sore throats) or acute middle ear infections in children, this report finds the evidence
 inconclusive.

 1.3.1. ETS and Lung Cancer
 1.3.1.1. Hazard Identification
       The Surgeon General (U.S. DHHS, 1989) estimated that smoking was responsible for more
 than one of every six deaths in the United States and that it accounted for about 90% of the lung
 cancer deaths in males and about 80% in females in 1985. Smokers,  however, are not the only
 ones exposed to tobacco smoke. The sidestream smoke (SS) emitted from a smoldering cigarette
 between puffs (the main component of ETS) has been documented to contain virtually all of the
 same carcinogenic compounds (known and suspected human and animal carcinogens) that have
 been identified in the mainstream smoke (MS) inhaled by smokers (Chapter 3).  Exposure
 concentrations of these carcinogens to passive  smokers are variable but much lower than for active
 smokers. An excess cancer risk from pas_sive smoking, however, is biologically plausible.
       Based on the firmly established causal association of lung cancer with active smoking with
 a dose-response relationship down to low doses (Chapter 4), passive smoking is considered likely
 to affect the lung similarly. The widespread presence of ETS in both home and workplace and its
 absorption by nonsmokers in the  general population have been well documented by air sampling
and by body measurement of biomarkers such as nicotine and cotinine (Chapter 3).  This raises the
question of whether any direct  evidence exists for the relationship between ETS exposure and
lung cancer in the general population and what its implications may be for public health. This
                                           1-6

-------
report addresses that question by reviewing and analyzing the evidence from 30 epidemiologic
studies of effects from normally occurring environmental levels of ETS (Chapter 5). Because
there is widespread exposure and it is difficult to construct a truly unexposed subgroup of the
general population, these studies attempt to compare individuals with higher ETS exposure to
those with lower exposures.  Typically, female never-smokers who are married to a smoker are
compared with female never-smokers who are married to a nonsmoker. Some studies also
consider ETS exposure of other subjects (i.e., male never-smokers and long-term former smokers
of either sex) and from other sources (e.g., workplace and home exposure during childhood), but
these studies are fewer and represent fewer cases, and they are generally excluded from the
analysis presented here. Use of the female never-smoker studies provides the largest, most
homogeneous database for analysis to determine whether an ETS effect on lung cancer is present.
This report assumes that the results for female never-smokers are generalizable to all nonsmokers.
       Given  that ETS exposures are at actual environmental levels and that the comparison
groups are both exposed to appreciable background (i.e., nonspousal) ETS, any excess risk for lung
cancer from exposure to spousal smoke would be expected to be small. Furthermore, the risk of
lung cancer  is  relatively low in nonsmokers, and most studies have a small sample size, resulting in
a very low statistical power (probability of detecting a real effect if it exists). Besides small
sample size and low incremental exposures, other problems inherent in several of the studies may
also limit their ability to detect a possible effect. Therefore, this report examines the data in
several different ways. After downward adjustment of the relative risks for smoker
misclassification bias, the studies are individually assessed for strength of association, both for the
overall data  and for the highest exposure group when exposure-level data are available, and for
exposure-response trend. Then the study results are pooled by country using statistical techniques
for combining data, including both positive and nonpositive results, to increase the ability to
determine whether or not there  is an association between ETS and lung cancer. Finally, in
addition to the previous statistical analyses that weight the studies only by size, regardless of
design and conduct, the studies  are qualitatively evaluated for potential confounding, bias, and
likely utility to provide information about any lung carcinogenicity of ETS.   Based on these
qualitative considerations, the studies are categorized into one of four tiers and then statistically
analyzed successively by tier.
       Results from all of the analyses described above strongly support a causal association
between lung cancer ETS exposure. The overall proportion (9/30) of individual studies found  to
show an association between lung cancer and spousal ETS exposure at all levels combined is
unlikely to occur by chance (p < 10"4).  When the analysis focuses on higher  levels of spousal
exposure, every one of the 17 studies with exposure-level data shows increased risk in the highest
                                            1-7

-------
exposure group; 9 of these are significant at the p < 0.05 level, despite most having low power,
another result highly unlikely to occur by chance (p < 10'7).  Similarly, the proportion (10/14;
p < 10"9) showing a statistically significant exposure-response trend is highly supportive of a
causal association.
       Combined results by country showed statistically significant associations for Greece
(2 studies), Hong Kong (4 studies), Japan (5 studies), and the United States (11 studies), and in
that order of strength of relative risk. Pooled results of the four Western European studies (three
countries) actually showed a slightly stronger association than that of the United States, but it was
not statistically significant, probably due to the smaller sample size.  The combined results of the
Chinese studies do not show an association  between ETS and lung cancer; however, two of the
four Chinese studies were designed mainly to determine the lung cancer effects of high levels of
other indoor air pollutants indigenous to those areas, which would obscure a smaller ETS effect.
These two Chinese studies do, however, provide very strong evidence on the lung carcinogenicity
of these other indoor air pollutants, which contain many of the same components as ETS.  When
results are combined only for the other two Chinese studies, they demonstrate a statistically
significant association for ETS and lung cancer.
       The heterogeneity of observed relative risk estimates among countries could result from
several factors.  For example,  the observed differences may reflect true  differences in lung cancer
rates for never-smokers, in ETS exposure  levels from nonspousal sources, or in related  lifestyle
characteristics in different countries. For the time period in which ETS exposure was of interest
for these studies, spousal smoking is considered to be a better surrogate for ETS exposure in more
"traditional" societies, such as  Japan and Greece, than in the United States.  In the United States,
other sources of ETS exposure (e.g., work and public places) are generally higher, which obscures
the effects of spousal smoking and may explain the lower relative risks observed in the United
States. Nevertheless, despite observed differences between countries, all showed evidence of
increased risk.
       Based on these analyses and following the U.S. EPA's Guidelines for Carcinogen Risk
Assessment (U.S. EPA, 1986a), EPA concludes that environmental tobacco smoke is a Group A
(known human) carcinogen. This conclusion is based on a total weight of evidence, principally:
        •   Biological plausibility.  ETS is taken up by the lungs, and components are distributed
            throughout the body.  The presence of the same carcinogens in ETS and MS, along
            with the established causal relationship between lung  cancer and active smoking with
            the dose-response relationships exhibited down to low doses, establishes the
            plausibility that ETS is also a lung carcinogen.
                                             1-8

-------
Supporting evidence from animal bioassays and genotoxicity experiments. The
carcinogenicity of tobacco smoke has been demonstrated in lifetime inhalation studies
in the hamster, intrapulmonary implantations in the rat, and skin painting in the
mouse.  There are no lifetime animal inhalation studies of ETS; however, the
carcinogenicity of SS condensates has been shown in intrapulmonary implantations
and skin painting experiments.  Positive results of genotoxicity testing for both MS
and ETS provide corroborative evidence for  their carcinogenic potential.
Consistency of response. All 4 of the cohort studies and 20 of the 26 case-control
studies observed a higher risk of lung cancer among the female never-smokers
classified as ever exposed to any level of spousal  ETS. Furthermore, every one of the
17 studies with response categorized by exposure level demonstrated increased risk for
the highest exposure group.  When assessment was restricted to the 19 studies judged
to be of higher utility based on study design, execution, and analysis (Appendix A),
17 observed higher  risks, and 6 of these increases were statistically significant,  despite
most having low statistical power.  Evaluation of the total study evidence from several
perspectives leads to the conclusion that the  observed association between ETS
exposure and increased lung cancer occurrence is not attributable to chance.
Broad-based evidence.  These  30 studies provide data from 8  different countries,
employ a wide variety of study designs and protocols, and are conducted by many
different research teams.  Results from all countries, with  the possible exception of
two areas of China  where high levels of other indoor air lung carcinogens were
present, show small to modest increases  in lung cancer associated with spousal ETS
exposure. No alternative explanatory variables for the observed association between
ETS and lung cancer have been indicated that  would be broadly applicable across
studies.
Upward trend in exposure-response. Both the largest of the cohort studies—the
Japanese study of Hirayama with 200 lung cancer cases—and the largest of  the
case-control studies—the U.S. study by  Fontham and associates (1991) with 420 lung
cancer cases and two sets of controls—demonstrate a strong exposure-related
statistical association between  passive smoking and lung cancer.  This upward trend is
well supported by the preponderance of epidemiology studies. Of the 14 studies that
provide sufficient data for a trend test by exposure level, 10 were statistically
significant despite most having low statistical power.
Detectable association at environmental exposure levels. Within the population of
married women who are lifelong nonsmokers,  the excess lung cancer risk from
                                 1-9

-------
 exposure to their smoking husbands' ETS is large enough to be observed, even for all
 levels of their spousal exposure combined. Carcinogenic responses are usually
 detectable only in high-exposure circumstances, such as occupational settings, or in
 experimental animals receiving very high doses. In addition, effects are harder to
 observe when there is substantial background exposure in the comparison groups, as is
 the case here.
 Effects remain after adjustment for potential upward bias.  Current and ex-smokers
 may be misreported as never-smokers, thus inflating the apparent cancer risk for ETS
 exposure.  The evidence remains statistically significant and conclusive, however,
 after adjustments for smoker misclassification. For the United States, the summary
 estimate  of relative risk from nine case-control plus two cohort studies is 1.19 (90%
 confidence interval [C.I.] =  1.04,  1.35; p < 0.05) after adjustment for smoker
 misclassification.  For Greece,  2.00 (1.42, 2.83), Hong Kong, 1.61 (1.25, 2.06), and
 Japan, 1.44 (1.13,  1.85), the estimated relative risks are higher than those of the
 United States and  more highly  significant after adjusting for the  potential bias.
 Strong associations for highest  exposure groups. Examining the groups with the
 highest exposure levels increases the ability to detect an effect, if it exists. Nine  of
 the sixteen studies worldwide for which there are sufficient exposure-level data are
 statistically significant for the highest exposure group, despite most having low
 statistical power. The overall pooled estimate of 1.81 for the highest exposure groups
 is highly statistically significant (90% C.I. = 1.60, 2.05; p < 10"6).  For the United
 States, the overall pooled estimate of 1.38 (seven studies, corrected for smoker
 misclassification bias) is also highly statistically significant (90% CI. = 1.13, 1.70;
 p - 0.005).
 Confounding cannot explain the association.  The broad-based evidence for an
 association found by independent investigators across several countries, as well as the
 positive exposure-response trends observed in most of the studies that analyzed for
 them, make any single confounder highly unlikely as an explanation for the results.
In addition, this report examined potential confounding factors (history of lung
disease, home heat sources, diet, occupation) and concluded that none of these factors
could account for the observed  association between lung cancer and ETS.
                                 1-10

-------
 1.3.1.2. Estimation of Population Risk
        The individual risk of lung cancer from exposure to ETS does not have to be very large to
 translate into a significant health hazard to the U.S. population because of the large number of
 smokers and the widespread presence of ETS.  Current smokers comprise approximately 26% of
 the U.S. adult population and consume more than one-half trillion cigarettes annually (1.5 packs
 per day, on average), causing nearly universal exposure to at least some ETS.  As a biomarker of
 tobacco smoke uptake, cotinine, a metabolite of the tobacco-specific compound nicotine, is
 detectable in the blood, saliva, and urine of persons recently exposed to tobacco smoke.  Cotinine
 has typically been detected in 50% to 75% of reported nonsmokers tested  (50% equates to
 63 million U.S. nonsmokers age 18 or older).
        The best estimate of approximately 3,000 lung cancer deaths per year in U.S. nonsmokers
 age 35 and over attributable to ETS  (Chapter 6) is based on data pooled from all 11 U.S.
 epidemiologic studies of never-smoking women married to smoking spouses.  Use of U.S. studies
 should increase the confidence in these estimates. Some mathematical modeling is required to
 adjust for expected bias from misclassification of smoking status and to account for ETS exposure
 from sources other than spousal smoking.   The overall relative  risk estimate of 1.19 for the
 United States, already adjusted for smoker misclassification bias, becomes 1.59 after adjusting for
 background ETS sources (1.34 for nonspousal exposures only).  Assumptions are also needed to
 relate responses in female never-smokers to those in male never-smokers and ex-smokers of both
 sexes, and to estimate the proportion of the nonsmoking population exposed to various levels of
 ETS.  Overall, however, the assumptions necessary for estimating risk add far less uncertainty
 than other EPA quantitative assessments.  This  is because the extrapolation for ETS is based on a
 large  database of human studies, all at levels  actually expected  to be encountered  by much of the
 U.S. population.
       The components of the 3,000 lung cancer deaths figure include approximately 1,500
 female never-smokers, 500 male never-smokers, and 1,000 former smokers of both sexes. More
 females are estimated to be affected  because  there are more female than male nonsmokers.  These
 component estimates have varying degrees  of confidence; the estimate of 1,500 deaths for female
 never-smokers has the highest confidence because of the extensive  database.  The estimate of 500
 for male never-smokers is less certain because it is based on the female never-smoker response
 and is thought to be low because males are  generally subject to higher background ETS exposures
 than females. Adjustment for this higher background exposure would lead to higher risk
estimates.  The estimate of 1,000 lung cancer deaths for former smokers of both sexes is
                                           1-11

-------
considered to have the lowest confidence, and the assumptions used are thought to make this
estimate low as well.
       Workplace ETS levels are generally comparable with home ETS levels, and studies using
body cotinine measures as biomarkers demonstrate that nonspousal exposures to ETS are often
greater than exposure from spousal smoking. Thus, this report presents an alternative breakdown
of the  estimated 3,000 ETS-attributable lung cancer deaths between spousal and nonspousal
exposures. By extension of the results from spousal smoking studies, coupled with biological
measurements of exposure, more lung cancer deaths are estimated to be attributable to ETS from
combined nonspousal exposures—2,200 of both sexes—than from spousal exposure—800 of both
sexes.  This spouse-versus-other-sources partitioning depends on current exposure estimates that
may or may not be applicable to the exposure period of interest. Thus, this breakdown contains
this element of uncertainty in addition  to those discussed above with respect to the previous
breakdown.
       An alternative analysis, based on the large Fontham et al. (1991) study, which is the only
study  that provides biomarker estimates of both relative risk and ETS exposure, yields population
risk point estimates of 2,700 and 3,600. These population risk estimates are highly consistent with
the estimate of 3,000 based on the combined U.S. studies.
       While there is statistical variance around all of the parameters used in the quantitative
assessment, the two largest areas of uncertainty are probably associated with the relative risk
estimate for spousal ETS exposure and the parameter estimate for the background ETS exposure
adjustment.  A sensitivity analysis that independently varies these two estimates yields population
risk estimates as low as 400 and as high as 7,000.  These extremes, however, are considered
unlikely; the more probable range is narrower, and the generally conservative assumptions
 employed suggest that the actual population risk number may be greater than  3,000. Overall,
 considering the multitude, consistency, and quality of all these studies, the weight-of-evidence
 conclusion that ETS is a known human lung carcinogen, and the limited amount of extrapolation
 necessary, the confidence in the estimate of'approximately 3,000 lung cancer  deaths is medium to
 high.

 1.3.2. ETS and Noncancer Respiratory Disorders
        Exposure to ETS  from parental smoking has been previously linked with increased
 respiratory disorders in children, particularly in infants. Several studies have confirmed the
 exposure and uptake of ETS in children by assaying saliva, serum, or urine for cotinine. These
 cotinine concentrations were highly correlated with smoking (especially by  the mother) in the
 child's presence. Nine to twelve million American children under 5 years of age, or one-half to

-------
two-thirds of all children in this age group, may be exposed to cigarette smoke in the home
(American Academy of Pediatrics, 1986; Overpeck and Moss,  1991).
       With regard to the noncancer respiratory effects of passive smoking, this report focuses on
epidemiologic evidence appearing since the two major reports of 1986 (NRC and U.S. DHHS) that
bears on the potential association of parental smoking with detrimental respiratory effects in their
children.  These effects include symptoms of respiratory irritation (cough, sputum production, or
wheeze); acute diseases of the lower respiratory tract (pneumonia, bronchitis, and bronchiolitis);
acute middle ear infections and indications of chronic  middle ear infections (predominantly
middle ear effusion); reduced lung function (from forced expiratory volume and flow-rate
measurements); incidence and prevalence of asthma and exacerbation of symptoms in asthmatics;
and acute  upper respiratory tract infections (colds and sore throats).  The more than 50 recently
published  studies reviewed  here essentially corroborate the previous conclusions of the 1986
reports of the NRC and Surgeon General regarding respiratory symptoms, respiratory illnesses,
and pulmonary function, and they strengthen support for those conclusions by the additional
weight of  evidence (Chapter 7).  For example, new data on middle ear effusion strengthen
previous evidence to warrant the stronger conclusion in this report of a causal association with
parental smoking.  Furthermore, recent studies establish associations between parental smoking
and increased incidence of  childhood asthma. Additional research also supports the hypotheses
that in utero exposure to mother's smoke  and postnatal exposure to ETS alter lung function and
structure,  increase bronchial responsiveness, and enhance the process of allergic sensitization,
changes that are known to predispose children to early respiratory illness.  Early respiratory illness
can lead to long-term pulmonary effects (reduced lung function  and increased risk of chronic
obstructive lung disease).
       This report also summarizes the evidence for an association between parental smoking and
SIDS, which was not addressed in the 1986 reports of the NRC or Surgeon General. SIDS is the
most common cause of death in infants ages 1 month to 1  year. The cause (or causes) of SIDS is
unknown; however, it is widely believed that some form of respiratory pathogenesis is generally
involved.  The current evidence strongly suggests that  infants whose mothers smoke are at an
increased risk of dying of SIDS, independent of other known risk factors for SIDS, including low
birthweight and low gestational age, which are specifically associated with active smoking during
pregnancy. However, available studies do not allow this report to conclude whether that increased
risk is related to in utero versus postnatal exposure to tobacco smoke products, or to both.
       The 1986 reports of the NRC and Surgeon General conclude that both the prevalence of
respiratory symptoms of irritation and the incidence of lower respiratory tract infections are
higher  in children of smoking parents.  In the 18 studies of respiratory symptoms subsequent to
                                            1-13

-------
the 2 reports, increased symptoms (cough, phlegm production, and wheezing) were observed in a
range of ages from birth to midteens, particularly in infants and preschool children.  In addition
to the studies on symptoms of respiratory irritation,  10 new studies have addressed the topic of
parental smoking and acute lower respiratory tract illness in children, and 9 have reported
statistically significant associations.  The cumulative evidence is conclusive that parental smoking,
especially the mother's, causes an increased incidence of respiratory illnesses from birth up to the
first 18 months to 3 years of life, particularly for bronchitis, bronchiolitis, and pneumonia.
Overall, the evidence confirms and strengthens the previous conclusions of the NRC and Surgeon
General.
       Recent studies also solidify the evidence for  the conclusion of a causal association between
parental smoking and increased middle ear effusion  in young children. Middle ear effusion is the
most common reason for hospitalization of young children  for an operation.
       At the time of the Surgeon General's report on passive smoking (U.S. DHHS, 1986), data
were sufficient to conclude only that maternal smoking may influence the severity of asthma in
children.  The recent studies reviewed here strengthen and confirm these exacerbation effects.
The new evidence is also conclusive that ETS exposure increases the number of episodes of asthma
in children who already have the disease. In addition, the evidence is suggestive that ETS
exposure increases the number of new cases of asthma in children who have not previously
exhibited symptoms, although the results are statistically significant only with children whose
mothers smoke 10 or more cigarettes per day. While the evidence for new cases of asthma itself is
not conclusive of a causal association, the consistently strong association of ETS both with
increased frequency and severity of the asthmatic symptoms and with the established ETS effects
on the immune system and airway hyperresponsiveness lead to the conclusion that ETS is a risk
factor for induction of asthma in previously asymptomatic children.
        Regarding the effects of passive smoking on lung function in children, the 1986 NRC and
Surgeon General reports both conclude that children of parents who  smoke have small decreases in
tests of pulmonary output function of both the larger and smaller air passages when compared
with the children of nonsmokers. As noted in the NRC report, if ETS exposure is the cause of the
observed decrease in lung function, the effect could be due to the direct action of agents in ETS
or an indirect consequence of increased occurrence of acute respiratory illness related to ETS.
        Results from eight studies on ETS and lung function in children that have appeared since
those reports add some additional confirmatory evidence suggesting a causal rather than an
indirect relationship. For the population as a whole, the reductions are small relative to the
interindividual variability of each lung function parameter. However, groups of particularly
susceptible or heavily exposed children have shown  larger decrements. The studies reviewed
                                            1-14

-------
 suggest that a continuum of exposures to tobacco products starting in fetal life may contribute to
 the decrements in lung function found in older children.  Exposure to tobacco smoke products
 inhaled by the mother during pregnancy may contribute significantly to these changes, but there
 is strong evidence indicating that postnatal exposure to ETS is an important part of the causal
 pathway.
        With respect to lung function effects in adults exposed to ETS, the 1986 NRC and Surgeon
 General reports found the data at that time inconclusive, due to high interindividual variability
 and the existence of a large number of other risk factors, but compatible with subtle deficits in
 lung function.  Recent studies confirm the association of passive smoking with small reductions in
 lung function.  Furthermore, new evidence also has emerged suggesting a subtle association
 between exposure to ETS and increased respiratory symptoms in adults.
       Some evidence suggests that the incidence of acute upper respiratory tract illnesses and
 acute middle ear infections may be more common in children exposed to  ETS.  However, several
 studies failed to find any effect. In addition, the possible role of confounding  factors, the lack of
 studies showing clear dose-response relationships, and the absence of a plausible biological
 mechanism preclude more definitive conclusions.
       In reviewing the available evidence indicating an association (or lack thereof) between
 ETS exposure and the different noncancer respiratory disorders analyzed  in this report, the
 possible role of several potential confounding factors was considered. These include other indoor
 air pollutants; socioeconomic status; effect of parental symptoms; and characteristics of the
 exposed child, such as low birthweight or active smoking.  No single or combined confounding
 factors can explain the observed respiratory effects of passive smoking in children.
       For diseases for which ETS has been either causally associated (LRIs) or indicated as a risk
 factor (asthma cases in previously asymptomatic children), estimates of population-attributable
 risk can be calculated.  A population risk assessment (Chapter 8) provides a probable range of
 estimates that 8,000 to 26,000 cases  of childhood asthma per year are attributable to ETS exposure
 from mothers who smoke 10 or more cigarettes per day.  The confidence in this range of estimates
 is medium and  is dependent on the suggestive evidence of the database. While the data show an
 effect only for children of these heavily smoking mothers, additional cases due to lesser ETS
 exposure also are a possibility. If the effect of this lesser exposure is considered, the range of
 estimates of new cases presented above increases to 13,000 to 60,000.  Furthermore, this report
estimates that the additional public health impact of ETS on asthmatic children includes more than
200,000 children whose symptoms are significantly aggravated and as many as 1,000,000 children
who are affected to some degree.
                                           1-15

-------
       This report estimates that ETS exposure contributes 150,000 to 300,000 cases annually of
lower respiratory tract illness in infants and children younger than 18 months of age and that
7,500 to 15,000 of these will require hospitalization.  The strong evidence linking ETS exposure to
increased incidence of bronchitis, bronchiolitis, and pneumonia in young children gives these
estimates a high degree of confidence. There is also evidence suggesting a smaller ETS effect on
children between the ages of 18 months and 3 years, but no additional estimates have been
computed for this age group. Whether or not these illnesses result in death has not been addressed
here.
       In the United States, more than 5,000 infants die of SIDS annually. It is the major cause
of death in infants between the ages of 1 month and 1 year, and the linkage with maternal
smoking is well established.  The Surgeon General and the World Health Organization estimate
that more than 700 U.S. infant deaths per year from SIDS are attributable to  maternal smoking
(CDC, 199la, 1992b). However, this report concludes that at present there is not enough direct
evidence supporting the contribution of ETS exposure to declare it a risk factor or to estimate its
population impact on SIDS.
                                            1-16

-------
                                     2. INTRODUCTION

         An estimated 434,000 deaths per year in the United States, or more than one of every six
  deaths, are attributable to tobacco use, in particular cigarette smoking (CDC, 1991 a; figures for
  1988).  Approximately 112,000 of these smoking-related deaths are from lung cancer, accounting
  for an estimated 87% of U.S. lung cancer mortality (U.S. DHHS, 1989).  Cigarette smoking is also
  causally related to cancer at various other sites, such as the bladder, renal pelvis, pancreas, and
  upper respiratory and digestive tracts (IARC, 1986). Roughly 30,000 deaths per year from cancers
  at these sites are attributable to smoking (CDC, 1991a).  Furthermore, smoking is the major cause
  of chronic obstructive pulmonary disease (COPD), which includes emphysema, and is thought to
  be responsible for approximately 61,000 COPD deaths yearly, or about 82% of COPD deaths
  (U.S. DHHS, 1989).  Tobacco use is also a major risk factor for cardiovascular diseases, the
  leading cause of death in the United States.  It is estimated that each year 156,000 heart disease
  deaths and 26,000 deaths from stroke are attributable to smoking (CDC,  1991a). In addition to
  this substantial  mortality, the association of smoking with these conditions also involves
 significant morbidity.
        Smoking also is a risk factor for various respiratory infections, such as influenza,
 bronchitis, and  pneumonia. An estimated 20,000 influenza and pneumonia deaths per year are
 attributable to smoking (CDC, 1991a).  Smokers also suffer from lung function impairment and
 numerous  other respiratory symptoms, such as cough, phlegm production, wheezing, and shortness
 of breath.  In addition, smokers are at increased risk for a variety of other conditions, including
 pregnancy complications and ulcers.
       Although the exact mechanisms and tobacco smoke components associated with these
 health effects are not known  with certainty, more than 40 known or suspected human carcinogens
 have been  identified in tobacco smoke.  These include, for example, benzene, nickel,
 polonium-210, 2-napthylamine, 4-aminobiphenyl, formaldehyde, various AT-nitrosamines,
 benz[a]anthracene, and benzo[a]pyrene.  Many other toxic agents, such as  carbon monoxide,
 nitrogen oxides,  ammonia, and hydrogen cyanide, are also found in tobacco smoke.
       Smokers, however, are not the only ones at risk  from exposure to these tobacco smoke
 toxicants. In utero exposure from maternal smoking during pregnancy is known to be associated
 with low birth weight and increased risk of fetal and infant death (U.S. DHHS, 1989).
Furthermore, nonsmokers might be at risk for smoking-associated health effects from "passive
smoking," or exposure to environmental tobacco smoke (ETS).
                                           2-1

-------
       When a cigarette is smoked, approximately one-half of the smoke generated is sidestream
smoke (SS) emitted from the smoldering cigarette between puffs.  This SS contains essentially all
of the same carcinogenic and toxic agents that have been identified in the mainstream smoke (MS)
inhaled by the smoker (see Chapter 3). SS and exhaled MS are the major components of ETS.
Environmental monitoring and measurements of biomarkers for ETS in the biological fluids of
nonsmokers demonstrate that ETS constituents can be found at elevated levels in indoor
environments where smoking occurs and that these constituents are inhaled and absorbed by
nonsmokers (see Chapter 3).
       Twenty-six percent of the U.S. adult population (CDC, 1992b), or about 50 million
Americans, are smokers, and so virtually all Americans are likely to be exposed to some amount of
ETS in the home, at work, or in public places.  Measurements of biomarkers for ETS in
nonsmokers confirm that nearly all Americans are exposed to ETS (see Chapter 3).
       In view of the high levels of mortality and morbidity associated with smoking, the
chemical similarity between ETS and MS, and the considerable likelihood for exposure of
nonsmokers to ETS, passive smoking is potentially a substantial public health concern.  The
objectives of this report are to assess the risk to nonsmokers for respiratory health effects from
exposure to ETS (hazard identification) and to estimate the population impact (quantitative
 population risk assessment) of any such ETS-attributable respiratory effects.

 2.1.  FINDINGS OF PREVIOUS REVIEWS
        The first epidemiologic results associating passive smoking with lung cancer appeared in
 the early 1980's. Since then, two major comprehensive reviews of the health effects of passive
 smoking and several less extensive ones have been published.  One of the major reviews was
 conducted by the National Research Council (NRC) in 1986. At the request of two Federal
 agencies, the U.S. Environmental Protection Agency and the U.S. Department of Health and
 Human Services, the NRC formed a committee on passive smoking to evaluate the methods for
 assessing exposure to ETS and to review the literature on all of the potential health consequences
 of exposure.  The committee's report (NRC, 1986) addresses the issue of lung cancer risk in
 considerable detail and includes summary analyses from 10 case-control studies and 3  cohort
 (prospective) studies. The report concludes that "considering the evidence as a whole, exposure  to
 ETS increases the incidence of lung cancer in nonsmokers." Combining the data from all the
 studies, the committee calculated an overall observed relative risk estimate of 1.34 (95%  C.I. =
  1.18, 1.53).
                                             2-2

-------
       The NRC committee was concerned about potential bias in the study results caused by
current and former smokers incorrectly self-reported as lifelong nonsmokers (never-smokers).
Using plausible assumptions for misreported smoking habits, the committee determined that
smoker misclassification cannot account for all of the increased risk observed in the epidemiologic
studies. Furthermore, the .upward bias on the relative risk of lung cancer caused by smoker
misclassification is counterbalanced by the downward bias from background ETS exposure to the
supposedly unexposed group.  Correcting for smoker misclassification and background ETS
exposure, the committee calculated an overall adjusted relative risk estimate of 1.42 (range of
1.24 to 1.61) for lung cancer in nonsmokers from exposure to ETS from spousal smoking plus
background sources.
       The NRC committee also found evidence for noncancer respiratory effects in children
exposed to ETS. It recommended that "in view of the weight of the scientific evidence that ETS
exposure in children increases the frequency of pulmonary symptoms and respiratory infections, it
is prudent to eliminate smoking and resultant ETS from the environments of small children."
Furthermore, the committee concluded that "household exposure to ETS is linked with increased
rates of chronic ear infections and middle ear effusions in young children." The NRC report also
notes that "evidence has accumulated  indicating that nonsmoking pregnant women  exposed to ETS
on a daily basis for several hours are at increased risk for producing low-birthweight babies,
through mechanisms which are, as yet, unknown."
       The second major review, the Surgeon General's report on the health consequences of
passive smoking, also appeared in 1986 (U.S. DHHS, 1986). This review covers ETS chemistry,
exposure, and various health effects, primarily lung cancer and childhood respiratory diseases.  On
the subject of lung cancer, the report concludes:
       The absence of a threshold for respiratory carcinogenesis in active smoking, the
       presence of the same carcinogens in mainstream and sidestream smoke, the
       demonstrated uptake of tobacco smoke constituents by involuntary smokers, and
       the demonstration of an increased lung cancer risk in some populations with
       exposures to ETS leads to the  conclusion that involuntary smoking is a cause of
       lung cancer.
With respect to  respiratory disorders in children, the Surgeon General's report determined that
"the children of parents who smoke, compared with the children of nonsmoking parents, have an
increased frequency of respiratory infections, increased respiratory symptoms, and slightly smaller
rates of increase in lung function as the lung matures."
       In 1987, a committee of the International Agency  for Research on Cancer (IARC) issued a
report  on methods of analysis  and exposure measurement  related to passive smoking (IARC,
                                           2-3

-------
1987a).  The committee reviewed the physicochemical properties of ETS, the toxicological basis
for lung cancer, and methods of assessing and monitoring exposure to ETS. The report borrows
the summary statement on passive smoking from a previous IARC document that dealt mainly
with tobacco smoking (IARC, 1986). The working group that produced the 1986 report had found
that the epidemiologic evidence then available on passive smoking was compatible with either the
presence or the absence of a lung cancer risk; however, based on other considerations related to
biological plausibility, it concluded that passive smoking gives rise to some risk of cancer.
Specifically, the 1986 IARC report states:
       Knowledge of the nature of sidestream and mainstream smoke, of the materials
       absorbed during "passive smoking," and of the quantitative relationships between
       dose and effect that are commonly observed from exposure to carcinogens . . .
       leads to the conclusion  that passive smoking gives rise to some risk of lung cancer.
       More recently, the Working Group on Passive Smoking, an independent international panel
of scientists supported in part by RJR Reynolds Nabisco, reported the findings of its
comprehensive "best-evidence  synthesis" of over 2,900 articles on the health effects of passive
smoking (Spitzer et al., 1990).  The group concluded that "the weight of evidence is compatible
with a positive association between residential exposure to environmental tobacco smoke
(primarily from spousal smoking) and the risk of  lung cancer." It also found "strong evidence that
children exposed in the home to environmental tobacco smoke have higher rates of hospitalization
(50% to 100%) for severe respiratory illness" and that the "evidence strongly supports a
relationship between exposure  to environmental tobacco smoke and asthma among children." In
addition, the working group reported that there is evidence for associations between home ETS
exposure and many chronic and acute respiratory illnesses, as well as small decreases in
physiologic measures of respiratory function, in both children and adults. Evidence
demonstrating an increased prevalence of otitis media (inflammation  of the middle ear) in
children exposed to ETS at home was also noted.  With respect to in utero exposure, the group
concluded that active maternal smoking is associated with reduced birthweight and with increased
infant mortality.
       A recent review of the  health effects associated with adult workplace exposure to  ETS
conducted by the National Institute for Occupational Safety and Health (NIOSH, 1991) determined
that "the collective weight of evidence (i.e., that from the Surgeon General's reports, the
similarities in composition of MS and ETS, and the recent epidemiologic  studies) is sufficient to
conclude that ETS poses an increased risk of lung cancer and possibly heart disease to
occupationally exposed workers."  Furthermore:
                                            2-4

-------
        Although these data were not gathered in an occupational setting, ETS meets the
        criteria of the Occupational Safety and Health Administration (OSHA) for
        classification as a potential occupational carcinogen [Title 29 of the Code of
        Federal Regulations, Part 1990].  NIOSH therefore recommends that exposures be
        reduced to the lowest feasible concentration.
 The classification of "potential occupational carcinogen" is NIOSH's category of strongest evidence
 for carcinogenicity.

 2.2.  DEVELOPMENT OF EPA REPORT
 2.2.1. Scope
        Due to the serious health concerns that have arisen regarding ETS, a virtually ubiquitous
 indoor air pollutant, and the wealth of new information that has become available since the
 extensive 1986 reviews, the EPA has performed its own analytical hazard identification and
 population risk assessment for the respiratory health effects of passive smoking, based on a critical
 review of the data currently available, with an emphasis on the abundant epidemiologic evidence.
 The number of lung cancer studies analyzed in this document is more than double the number
 reviewed in 1986 (31 vs. 13), with a total of about 3,000 lung cancer cases in female nonsmokers
 now reported in case-control studies and almost 300,000 female nonsmokers followed by cohort
 studies. Furthermore, the database on passive smoking and respiratory disorders in  children
 contains more than  50 new studies, including 9 additional studies on acute lower respiratory tract
 illnesses, 10 on acute and chronic middle ear diseases,  18 on respiratory symptoms, 10 on asthma,
 and 8 on lung function. This report also discusses six recent studies of the effects of passive
 smoking on adult respiratory symptoms and lung function. Finally, eight studies of maternal
 smoking and sudden infant death syndrome (SIDS), which was not addressed in the NRC report or
 the Surgeon General's report, are reviewed. (Although the cause of SIDS is unknown, the most
 widely accepted hypotheses suggest that some form of  respiratory pathogenesis is usually
 involved.)
       First, this report reviews information on the  nature of ETS and human exposures. Then,
 in accordance with the Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986a), it critically
 analyzes human, animal, and genotoxicity data to establish the weight of evidence for the hazard
 identification of ETS as a human lung carcinogen and to characterize the  U.S. population risk.
Similarly, it reviews studies of passive smoking and noncancer respiratory disorders, particularly
in children, and provides both hazard identification and population risk estimates  for some of
these effects.
                                           2-5

-------
       While this report restricts analysis to ETS-associated respiratory effects because of time
and resource considerations, several recent studies have also linked passive smoking with an
increased risk of heart disease or cancers at sites other than the lung. For cancers of other sites,
the available evidence is quite limited (e.g., Hirayama, 1984; Sandier et al.,  1985), but three recent
analyses, examining over 15 epidemiologic studies and various supporting mechanistic studies,
suggest that ETS is an important risk factor for heart disease, accounting for as many as 35,000 to
40,000 deaths annually (Wells, 1988; Glantz and Parmley, 1991; Steenland, 1992).  This report
takes no  position on ETS and heart disease.
       Other health effects of active smoking may also have passive smoking correlates of public
health concern. Maternal smoking during pregnancy, for example, is known to affect fetal
development. Studies on passive smoking during pregnancy are far fewer but have demonstrated
an apparent association with low birthweight (e.g., Martin and Bracken,  1986).  Furthermore,
passive exposure to tobacco smoke products both in utero (during pregnancy) and postnatally
(after birth) may result in other nonrespiratory developmental effects in children—for example,
decrements in neurological development (Makin et al., 1991). Again, this report takes no position
on these potential nonrespiratory effects.

2.2.2. Use of EPA's Guidelines
       The lung cancer hazard identification and risk characterization for ETS are conducted in
accordance with the EPA's  Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986a).  In fact,
tobacco  smoke is a mixture of more than 4,000 compounds  and could be evaluated according to
the Guidelines for the Health Risk Assessment of Chemical  Mixtures (U.S. EPA, 1986b). Such a
highly complex mixture, however, is not easily characterized with respect to chemical
 composition, levels of exposure, and toxicity of constituents. Furthermore, the effects and
 mechanisms of interactions among chemicals are insufficiently understood.
        The Guidelines for the Health Risk Assessment of Chemical Mixtures acknowledges these
 inherent uncertainties and recommends various assessment  approaches, depending on the nature
 and quality of the data.  When adequate data are available on health effects and exposure for the
 actual mixture of concern,  as is the case with both MS and ETS, the preferred approach,
 according to the mixtures guidelines, is to adopt the procedures used for single compounds
 described by the Guidelines for Carcinogen Risk Assessment, as is done here. The EPA also has
 used this strategy for assessments of diesel exhausts, PCBs, and unleaded gasoline.  The
 compilation of health effects and exposure information for all the mixture components of interest
 is considered optional. In the case of tobacco smoke, compiling this information would be highly
                                             2-6

-------
impractical due to the large number of components and the highly complex and changing nature
of this mixture. It is also considered unnecessary, given the abundant epidemiologic data on ETS
and lung cancer.
       The Guidelines for Carcinogen Risk Assessment provide a general framework for the
analysis of carcinogenic risk, while permitting "sufficient flexibility to accommodate new
knowledge and new assessment methods as they emerge" (U.S. EPA, 1986a). According to the
guidelines, a qualitative risk assessment, or hazard identification, is performed by evaluating all of
the relevant data to determine if a compound has carcinogenic potential. Then, a dose-response
assessment is made by using mathematical models to extrapolate from high experimental or
occupational exposures, where risks are usually detected, to lower environmental exposure levels.
Finally, the dose-response assessment and an exposure assessment are integrated into a risk
characterization, providing risk estimates for exposed populations.  The risk characterization also
describes the assumptions and uncertainties in the estimate.
       The enormous databases on active and passive smoking provide more than sufficient
human evidence on which to base a hazard identification of ETS. The use  of human evidence
eliminates the uncertainties that normally arise when one has to base hazard identification on the
results of high-dose animal experiments.  Furthermore, the epidemiologic data on passive smoking
provide direct evidence from environmental exposure levels, obviating the  need for a dose-
response extrapolation from high to low doses. These low-level environmental exposures,
however, are associated with low relative risks that can only be detected in well-designed studies
of sufficiently large size. For this  reason, new assessment methods are used to categorize studies
on the basis of quality criteria and to combine studies to increase the statistical power.  Combining
studies also provides a means for incorporating both positive and nonpositive study results into the
statistical analysis.
       As an alternative to using actual epidemiologic data on ETS, an ETS risk assessment could
have used "cigarette-equivalents" to correlate ETS exposure with lung cancer risk based on
dose-response models from active smoking.  This would have involved using measures such as
cotinine or respirable suspended particles to compare smoke uptake between smokers and
ETS-exposed nonsmokers in order to equate  passive smoking to the active smoking of some
quantity of a cigarette(s). Then the carcinogenic response associated with that exposure level
would be estimated from extrapolation models based on the dose-response relationships observed
for active smoking. This procedure was not used for several reasons.  Although MS and ETS are
qualitatively similar with respect to chemical composition (i.e., they contain most, if not all, of the
same toxicants and carcinogens), the absolute and proportional quantities of the components, as
                                            2-7

-------
well as their physical state, can differ substantially. Many tobacco smoke compounds partition
preferentially into the MS component of smoke emissions; others, however, such as certain highly
carcinogenic W-nitrosamines, are preferentially produced at lower temperatures and appear in
much greater amounts in the ETS fraction. In addition, active and passive smokers have different
breathing patterns, and particles in ETS are smaller than those in MS.  Therefore, the distribution
and deposition of smoke constituents in the respiratory tracts of active and passive smokers will
not be identical.  Furthermore, it is not known which of the chemicals in tobacco smoke are
responsible for its carcinogenicity.  Clearly, the comparison of a small number of biomarker
measures cannot adequately quantify differential distributions of unknown carcinogenic
compounds.
       Another area of uncertainty in the "cigarette-equivalents" approach relates to potential
metabolic differences between active and passive smokers.  Active smoking is known to induce
chemical- and drug-metabolizing enzymes in various tissues to levels that significantly exceed
those found in nonsmokers.  Thus,  the dose-response relationships for tobacco smoke-associated
health effects are likely to be nonlinear.  In fact, evidence suggests that a linear dose-response
extrapolation might underestimate the  risk of adverse health effects from low doses of tobacco
smoke (Remmer, 1987). Because of these uncertainties, the data from active smoking are more
appropriate for qualitative hazard identification than for  quantitative dose-response assessment.
Furthermore, at least for lung cancer and other respiratory effects, we have substantial
epidemiologic  data from actual exposure of nonsmokers to environmental levels of genuine ETS,
which constitute a superior database from which to derive quantitative risk estimates for passive
smoking, without the need for low-dose extrapolation.

2.2.3. Contents of This Report
       ETS is chemically similar to MS, containing most, if not all, of the same toxicants and
known or suspected human carcinogens. A major  difference, however, is that ETS is rapidly
diluted into the environment, and consequently, passive smokers are exposed to much lower
concentrations of these agents than are active smokers.  Therefore, in assessing potential health
risks attributable to ETS, it is important to be able to measure ETS levels in the many
environments where it is found and to quantify actual human ETS exposure. The physical and
chemical nature of ETS and  issues related to human exposure are discussed in Chapter 3. The use
of marker compounds and various methods for assessing ambient ETS concentrations, as well as
the use of biomarkers and questionnaires to determine human exposure,  is described.
Furthermore, measurements  of ETS components in various indoor environments and of ETS
                                            2-8

-------
 constituents and their metabolites in nonsmokers are presented, providing evidence of actual
 nonsmoker exposure and uptake.
        Chapter 4 reviews the major evidence that conclusively establishes that the tobacco smoke
 inhaled from active smoking is a human lung carcinogen.  Unequivocal dose-response
 relationships exist between tobacco smoking and lung cancer, with no evidence of a threshold
 level of exposure.  Supporting evidence for the carcinogenicity of tobacco smoke from animal
 bioassays and genotoxicity experiments is also summarized, including data from the limited animal
 and mutagenicity studies pertaining specifically to ETS or SS.
        The chemical similarity between MS and ETS and the measurable uptake of ETS
 constituents  by nonsmokers (Chapter 3), as well as the causal dose-related association between
 tobacco smoking and lung cancer in humans, extending to the lowest observed doses, and the
 corroborative evidence for the carcinogenicity of both MS and ETS provided by animal bioassays
 and genotoxicity studies (Chapter 4), clearly establish the biological plausibility that ETS is also a
 human lung carcinogen.  In fact, this evidence is sufficient in its own right to establish the weight
 of evidence for ETS as a Group A (known human) carcinogen under EPA guidelines.
        In addition to the evidence of human carcinogenicity from high exposures to tobacco
 smoke from active smoking, there are now more than 30 epidemiologic studies investigating lung
 cancer in nonsmokers exposed to actual ambient levels of ETS. The majority of these studies
 examine never-smoking women, with spousal smoking used as a surrogate for ETS exposure.
 Female exposure from spousal smoking is considered to be the single surrogate measure that is the
 most stable and best represents ETS exposure.  Spousal smoking is, however, a crude surrogate,
 subject to exposure misclassification in both directions, since it actually constitutes only a varying
 portion of total exposure.
       For the purposes of the hazard identification analysis in Chapter 5, which is based
 primarily on  the epidemiologic studies of ETS, this document extensively and critically evaluates
 31 epidemiologic studies from 8 different countries, including 11  studies from the United States
 (Appendix A).  More than half of these studies have appeared since the NRC and Surgeon
 General's reviews were issued in  1986.  Two U.S. studies are of particular interest.  The recently
 published five-center study of Fontham et al. (1991) is a well-designed and well-conducted
 case-control study with 429 never-smoking female lung cancer cases and two separate  sets of
 controls. This is the largest case-control study to date, and it has a high statistical power to detect
 the small increases in lung cancer risk that might be expected from ambient exposures.
Furthermore, the Fontham et al. study is the only lung cancer study that also measured urinary
cotinine levels as a biomarker of exposure. Another large U.S. case-control study was the recent
                                           2-9

-------
study by Janerich et al. (1990), with 191 cases. Both of these studies were supported by the
National Cancer Institute.
       In evaluating epidemiologic studies, potential sources of bias and confounding also must be
addressed. Smoker misclassification of current and former smokers as never-smokers is the one
identified source of systematic upward bias to the relative risk estimates.  Therefore, prior to the
analyses of the epidemiologic data that are conducted in Chapters 5 and 6, the relative risk
estimates from each study are adjusted for smoker misclassification using the methodology
described in Appendix B. Other potential sources  of bias and confounding are discussed in
Chapters.
        Chapter 5 quantitatively and qualitatively analyzes the epidemiologic data to determine the
weight of evidence for the hazard identification of ETS. First, the individual studies are
statistically assessed using tests for effect (i.e., association between lung cancer and ETS) and tests
for exposure-response trend.  In addition, the high-exposure data are analyzed alone to help
minimize the effects of exposure misclassification resulting from the use of spousal smoking as a
surrogate for ETS exposure. Various combining analyses also are performed to examine and
compare the epidemiologic results for separate countries.  Then several potential confounders and
modifying factors are evaluated to determine if they affect the results. Finally, the studies are
analyzed based on  qualitative criteria. The studies are categorized into four tiers according to the
 utility of the study in terms of its likely ability to detect a possible effect, using  specific criteria
 for evaluating the  design and conduct as described in Appendix A. These tiers are integrated one
 at a time into statistical analyses, as an alternative method for evaluating the epidemiologic data
 that  also takes into account qualitative considerations.  Chapter 5 concludes with  an overall
 weight-of-evidence determination for lung cancer based on the analyses in Chapters 3, 4, and 5.
         In Chapter 6, the population risk for U.S.  nonsmokers is characterized by estimating the
 annual number of lung cancer deaths that are attributable to exposure from all sources of ETS.
 The overall relative risk estimate from 11 U.S. epidemiological studies of passive smoking and
 lung cancer in female never-smokers is adjusted upward, based on body cotinine measurements
 from different U.S. population studies,  to correct for the systematic downward bias caused by
 background exposure to ETS from sources other than spousal smoke.  Additional assumptions are
 used to extend the results from female never-smokers to male never-smokers and long-term
 former smokers of both sexes.  Separate estimates are calculated for background (workplace and
 other ndnhome exposures) and spousal (home) exposures, as well as for female and male
 never-smokers and former smokers. An alternative analysis of the population risk is performed
 based solely on the Fontham et al. (1991) study, the only study that provides exposure-level
                                              2-10

-------
  measurements.  Chapter 6 also discusses the sources of uncertainty and sensitivity in the lung
  cancer estimates.
         The final two chapters address passive smoking and noncancer respiratory disorders. Both
  the NRC and Surgeon General's reports concluded that children exposed to ETS from parental
  smoking are at greater risk for various respiratory illnesses and symptoms.  This report confirms
  and extends those conclusions with analyses of more recent studies.  New evidence for an
  association between ETS and middle ear effusion, and for a role of ETS in the cause as well as the
  prevalence and severity of childhood asthma, is reviewed. In addition, the evidence for an
  association between maternal smoking and SIDS is examined.
        Chapter 7 reviews and analyzes epidemiologic studies of passive smoking and noncancer
  respiratory disorders, mainly in children. Possible biological mechanisms, additional risk factors
  and modifiers, and the potential long-term significance of early effects on lung function are
  discussed. Then, the evidence indicating relationships between childhood exposure to ETS and
 acute  respiratory illnesses, middle ear disease, chronic respiratory symptoms, asthma, and lung
 function impairment, as well as between maternal smoking and SIDS, is evaluated.
        Passive smoking as a risk factor for noncancer respiratory health effects in adults is also
 analyzed in Chapter 7.  The NRC and Surgeon General's reports concluded that adults exposed to
 ETS may exhibit small deficits in lung function but noted that  it is difficult to determine the
 extent to which ETS impairs respiration because so many other factors can similarly affect lung
 function.  More recent evidence and new statistical techniques allow the demonstration of subtle
 effects of ETS on lung function and respiratory health in adults.
        Chapter 8 discusses potential confounding factors and possible sources of bias in the ETS
 studies that might affect the conclusions of Chapter 7.  Chapter 8 also describes methodological
 and data considerations that limit quantitative estimation of noncancer respiratory health effects
 attributable to ETS exposure.  Finally, the chapter develops population impact assessments for
 ETS-attributable childhood asthma and for infant/toddler bronchitis and pneumonia.  Acute
 respiratory illnesses are one of the leading causes of morbidity and mortality during infancy and
 early childhood, and an estimated 2 to 5 million children under  age 18 are afflicted with asthma.
 Therefore, even small increases in individual risk for these illnesses can result in a substantial
public  health impact.
                                           2-11

-------

-------
          3.  ESTIMATION OF ENVIRONMENTAL TOBACCO SMOKE EXPOSURE

 3.1. INTRODUCTION
       Environmental tobacco smoke (ETS) is composed of exhaled mainstream smoke (MS) from
 the smoker, sidestream smoke (SS) emitted from the smoldering tobacco between puffs,
 contaminants emitted into the air during the puff, and contaminants that diffuse through the
 cigarette paper and mouth end between puffs (NRC, 1986; U.S. DHHS, 1986; Guerin et-al., 1992).
 These emissions contain both vapor phase and particulate contaminants. SS is the major
 component of ETS, contributing nearly all of the vapor phase constituents and over half of the
 particulate matter.
       Overall, ETS is a complex mix of over 4,000 compounds.  This  mix contains many known
 or suspected human carcinogens and toxic agents. The information necessary to evaluate human
 exposures to each of the compounds of human health interest in ETS does not exist.
       Recognizing that it is impractical to characterize the many individual compounds that
 make up ETS and to  then assess exposures to those compounds, this chapter focuses on the
 characterization of the complex ETS contaminant mix and exposure to  it by nonsmokers.
 Available data on the physical and chemical properties of sidestream and mainstream  smoke are
 compared to assess the potential for the release of known or suspected human carcinogens and
 toxic agents into indoor environments where human exposures occur. The available published
 data are reviewed to determine whether ETS constituents exist in  elevated levels in various indoor
 environments where smoking occurs and whether human exposures ensue. Particular  attention is
 focused upon environmental and biological marker compounds that serve as proxies for the
 complex ETS mix and the compounds of human health interest.
       The available biomarker data for ETS clearly show that levels of ETS contaminants
 encountered indoors by nonsmokers are of sufficient magnitude to be absorbed and to result in
 measurable doses. Chapters 6 and 8 and Appendix B use such biomarker data for estimating
 relative residential and nonresidential ETS exposures in calculating the  associated risks for lung
 cancer and various noncancer respiratory effects.
       Epidemiologic studies relating exposure to ETS with lung cancer (Chapter 5) and
 respiratory disorders other than cancer (Chapter 7) frequently rely on questionnaires to assess level
of exposure. This chapter reviews the limited number of studies that have attempted to validate
questionnaires with objective measures  of exposure.  All of these are population surveys and not
epidemiologic disease studies. The few studies that compare body cotinine levels with childhood
respiratory disease occurrences are discussed in Chapters 7 and 8.
                                           3-1

-------
       This chapter concludes that (1) MS, SS, and ETS are chemically similar and contain a
number of known or suspected human carcinogens and toxic compounds; (2) marker compounds
for ETS are  measurable in a variety of indoor environments; (3) exposure to ETS is extensive; and
(4) there is a measurable uptake of ETS by nonsmokers.

3.2.  PHYSICAL AND CHEMICAL PROPERTIES
       Over the past several years, there have been a number of reviews of the physical and
chemical properties of mainstream and sidestream cigarette smoke (NRC, 1986; U.S. DHHS, 1986;
Guerin et al., 1992).  A particularly detailed review is contained in the recent book by Guerin et
al. (1992). This section summarizes the findings of these reviews to identify the similarities and
differences in mainstream and sidestream emissions and to establish that known and suspected
human carcinogens and toxic agents are released into occupied spaces from tobacco combustion.
Data contained in these reviews, as well as recently published material, are also presented to
document that sidestream emissions of notable air contaminants result in measurable increases of
these contaminants in indoor locations where individuals spend time.
       The  physical and chemical characterization of MS air contaminant emissions from
cigarettes, cigars, or pipes is derived from laboratory^based studies that have typically utilized
standardized testing protocols (FTC, 1990; Guerin et al., 1992). The data available are primarily
for tobacco  combustion in cigarettes and provide a substantial database on the nature of MS.
These protocols employ smoking machines, set puff volumes and frequencies, and standardized air
contaminant collection protocols (small chambers, Cambridge filters, chamber air flow rates, etc.).
Existing standardized protocols reflect conditions representative of human smoking practices of
over 30 years ago for nonfiltered cigarettes and may not reflect current human smoking
parameters for today's filtered low-tar cigarettes (NRC,  1986; U.S. DHHS, 1986; Guerin et al.,
1992). It has been suggested that  current standardized protocols, particularly for filter cigarettes,
may underestimate MS deliveries (Guerin et al., 1992).  MS air contaminant emission rates
determined  in these studies using  standardized protocols can be affected by a number of factors,
such as puff volume,  air dilution rate, paper porosity, filter ventilation air flow around the
cigarette, and moisture content of the tobacco. Actual smoking habits of individuals can also
dramatically alter the MS deliveries.  Variability in any of the factors can affect the nature and
quantity of  the MS emissions.
       Standardized testing protocols for assessing the physical and chemical nature of SS
emissions from cigarette smoke do not exist, and data on SS are not as extensive as those for MS
emissions. Protocols used for the generation and collection of SS emissions typically use
standardized MS protocols (smoking machines, puff volumes, etc.) with modifications in the test
                                            3-2

-------
  devices (use of small chambers) that allow for the simultaneous collection of SS emissions for
  analysis (Dube and Green, 1982; McRae,  1990; Rickert et al., 1984).
         The protocols for the collection of SS emissions are such that results can be directly
  compared to MS emissions and thus provide valuable insights into the physical and chemical
  nature of ETS.  It should be noted, however, that the SS emissions collected under these protocols
  may be somewhat different from ETS emissions.  ETS  also contains exhaled MS, which has not yet
  been characterized.  Exhaled MS can contribute from 15% to 43% of the particulate matter in
  ETS, though little of the gas phase contaminants (Baker and Proctor,  1990). In addition, SS
  samples are not collected under conditions where the emissions are  diluted and "aged," as is ETS.
  The aging and dilution of the SS emissions can produce changes in phase distribution  of the
  contaminants.
        Results of laboratory evaluations have indicated substantial  similarities and some
  differences between MS and SS emissions from cigarettes (NRC, 1986; U.S. DHHS, 1986; Guerin
  et al., 1992).  Differences in SS and MS emissions are due to differences in the temperature of
  combustion of the  tobacco, Ph, and degree of dilution with air, which is accompanied by a
  corresponding rapid decrease  in temperature. SS is generated at a lower temperature
  (approximately 600°C between puffs vs. 800-900°C for MS during puffs) and at a higher Ph (6.7-
  7.5 vs.  6.0-6.7)  than MS.  Being slightly more alkaline, SS contains more ammonia,  is depleted of
 acids, contains greater quantities of organic bases, and contains less  hydrogen cyanide  than MS.
 Differences in MS and SS are also ascribable  to differences in the oxygen concentration (16% in
 MS vs.  2% in SS). SS contaminants are generated in a more reducing environment than those in
 MS, which will affect the distribution of some compounds-nitrosamines, for example, are  .
 present in greater concentrations  in SS than in MS.
        SS is rapidly diluted in air, which results in a SS  particle size distribution smaller than that
 for MS and in the potential for changes in phase distribution for several constituents. Nicotine,
 for example, while  predominantly in the particle phase in MS, is found predominantly in the gas
 phase in ETS (Eudy et al.,  J985).  The shift to gas phase  is due to the rapid dilution in  SS. SS
 particle size is typically in the  range of 0.01-1.0 /un, while MS particle size is 0.1-1.0 pm.  The SS
 size distribution shifts to small sizes with increasing dilution (NRC, 1986;  U.S. DHHS,  1986;
 Guerin et al.,  1992; Ingebrethsen and Sears, 1985).  The differences in  size distribution for MS
 and SS particles, as well as the  different  breathing patterns of smokers and nonsmokers, have
 implications for deposition of the produced particle contaminants in  various regions of the
 respiratory tract.  Estimates of from 47% to more than 90% deposition  for MS and of 10%
deposition for SS have been reported (U.S. DHHS, 1986).
                                            3-3

-------
       Despite quantitative differences and potential differences in phase distributions, the air
contaminants emitted in MS and SS are qualitatively very similar in their chemical composition
because they are produced by the same process. Over 4,000 compounds have been identified in
laboratory-based studies of MS (Dube and Green, 1982; Roberts, 1988). In a 1986 IARG
monograph evaluating the carcinogenic risk of tobacco smoke to humans (IARC, 1986), 42
individual MS components were identified as carcinogenic in bioassays with laboratory animals,
with many of these either known or suspected human carcinogens. Many additional compounds in
MS have been identified as toxic compounds.  Although SS emissions have not been chemically
characterized as completely as MS emissions, many of the compounds found in MS emissions,
including a host of carcinogenic agents, are found in SS emissions  (NRC, 1986; U.S. DHHS, 1986;
Guerin et al., 1992; Dube and Green, 1982; Roberts, 1988) and at emission rates considerably
higher than for MS.
        Part of the data available from studies of MS and SS emissions is  shown in Table 3-1
(extracted from NRC, 1986). These data are for nonfilter cigarettes and represent a summary of
data from several sources. It is immediately obvious from Table 3-1 that SS and MS contain many
of the same notable air contaminants, including several known or  suspected human toxic and
 carcinogenic agents, and that SS emissions are often considerably higher than MS emissions.  For
 the compounds shown in Table 3-1, all of the five known human  carcinogens, nine probable
 human carcinogens, and three animal carcinogens are emitted at higher levels in SS than in MS,
 several by an order of magnitude or more.  For example, Ar-nitrosodimethylamine, a potent  animal
 carcinogen, is emitted in quantities 20 to 100 times higher in SS than in MS.  Table 3-1 similarly
 shows that several toxic  compounds found in MS are also found in SS (carbon monoxide,
 ammonia, nitrogen oxides, nicotine, acrolein, acetone, etc.). Again, for many of these
 compounds, SS emissions are higher than MS emissions-in some  cases by an order of magnitude
 or higher.
        The SS/MS emission ratios shown in Table  3-1 can be highly variable and potentially
 misleading because, as noted earlier, a number of factors can have a substantial impact on MS
 emissions.  A filtered cigarette, for example, can substantially reduce MS  of total mass well below
 that shown in Table 3-1, thus resulting in a much higher SS/MS ratio. A  number of recent studies
 (Adams et al., 1987; Guerin, 1987; Higgins et al.,  1987; Chortyk and Schlotzhauer, 1989; Browne
 et al., 1980; Guerin et aL, 1992) indicate that, quantitatively, SS emissions show little variability as
 a function of a number of variables (puff volume, filter vs. nonfilter cigarette, and filter
  ventilation). The lack of substantial variability in SS emissions is related to the fact that
  sidestream emissions are primarily related  to the weight of tobacco and paper consumed during
                                             3-4

-------
Table 3-1. Distribution of constituents in fresh, undiluted mainstream smoke, and diluted
sidestream smoke from nonfilter cigarettes1
Constituent
Vapor phase:2
Carbon monoxide
Carbon dioxide
Carbonyl sulfide
Benzene3
Toluene
Formaldehyde4
Acrolein
Acetone
Pyridine
3 -Methylpyridine
3-Vinylpyridine
Hydrogen cyanide
Hydrazine4
Ammonia
Methylamine
Dimethylamine
Nitrogen oxides
AT-Nitrosodimethylamine4
Af-Nitrosodiethylamine4
W-Nitrosopyrrolidine4
Formic acid
Acetic acid
MethCyl chloride
1,3-Butadiene4'6
Amount in MS

10-23 mg
20-40 mg
12-42 Mg
12-48 ng
100-200 /tg
70-100 /tg
60-1 00 /tg
100-250 /tg
16-40 jig
12-36 /tg
11-30 /tg
400-500 ng
32 ng
50-130 /tg
11. 5-28.7 /tg
7.8-10 /tg
100-600 fig
10-40 ng
ND-25 ng
6-30 ng
210-490 /tg
330-810 /tg
150-600 /tg
69.2 /tg
Range in SS/MS

2.5-4.7
8-1 1
0.03-0.13
5-10
5.6-8.3
0,1 — 50
8-15
2-5
6.5-20
3-13
20-40
0.1-0.25
3
3.7-5.1
4.2-6.4
3.7-5.1
4-10
20-100
<40
6-30
1.4-1.6
1.9-3.6
1.7-3.3
3-6
                                                           (continued on the following page)
                                           3-5

-------
Table 3-1. (continued)
Constituent \ s
Particulate phase:2
Particulate matter7
Nicotine
Anatabine
Phenol '
Catechol
Hydroquinone
Aniline4
2-Toluidine
2-Naphthylamine3
4-Aminobiphenyls
Benz[a]anthracene5
Benzo[a]pyrene4
Cholesterol
7-Butyrolactone6
Quinoline
Harman8
W-Nitrosonornicotine5
NNK9
Af-Nitrosodiethanolamine4
Cadmium4
Nickel3
Zinc
Polonium-2103
Benzoic acid
Lactic acid
Glycolic acid
Succinic acid
PCDDs and PCDFs10
Amount in MS

15-40 mg
l-2.5mg
2-20 Mg
60-140 Mg
100-360 fig
1 10-300 /tg
360 ng
160 ng
1.7 ng
4.6 ng
20-70 ng
20-40 ng
22 Mg
10-22 n§
0.5-2 /tg
1.7-3.1 /tg
200-3,000 ng
100-1, 000 ng
20-70 ng
HOng
20-80 ng
60 ng
0.04-0.1 pCi
14-28 Mg
63-1 74 Mg
37-1 26 Mg
110- 140 Mg
1 Pg
' Range in SS/MS

1.3-1.9
2.6-3.3
<0.1-0.5
1.6-3.0
0.6-0.9
0.7-0.9
30
19
30
31
2-4
2.5-3.5
0.9
3.6-5.0
3-11
0.7-1.7
0.5-3
1-4
1.2
7.2
13-30
6.7
1.0-4.0
0.67-0.95
0.5-0.7
0.6-0.95
0.43-0.62
2
                                                            (continued on the following page)
                                            3-6

-------
Table 3-1. (continued)

 *Data in this table come from the NRC report (1986), except where noted, which compiled data
 from Elliot and Rowe, 1975; Schmeltz et al., 1979; Hoffman et al., 1983; Klus and Kuhn, 1982;
 Sakuma et al., 1983, 1984a, 1984b; and Hiller et al., 1982.  Full references are given in NRC,
 1986. Diluted SS is collected with airflow of 25 mL/s, which is passed over the burning cone; as
 presented in the NRC report on passive smoking (1986).
 Reparation into vapor and particulate phases reflects conditions prevailing in MS and does not
 necessarily imply same separation in SS.
 3Known human carcinogen, according to U.S. EPA or IARC.
 4Probable human carcinogen, according to U.S. EPA or IARC.
 6Animal carcinogen (Vainio et al., 1985).
 6Data from Brunnemann et al., 1990.
 PCDDs = polychlorinated dibenzo-p-dioxins;
 PCDFs = polychlorinated dibenzofurans.
 7Contains di- and polycyclic aromatic hydrocarbons, some of which are known animal
 carcinogens.
 8l-methyl-9#-pyrido[3,4-6]-indole.
 9NNK = 4-(Af-methyl-Af-nitrosamino)-l-(3-pyridyl)-l-butanone.
10Data from Lofroth and Zebiihr,  1992. Amount is given as International Toxic Equivalent Factor
 (I-TEF).


the smoldering period, with little influence exerted by cigarette design (Guerin et al., 1992).
More recent summary data on SS emission rates from filtered test cigarettes and commercial

cigarettes for many compounds of human health interest are presented by Guerin et al. (1992) and

shown, with modifications, in Table 3-2. Much of the data in Table 3-2 is extracted  from
detailed data presented in an R.J. Reynolds (1988) report. Table 3-2, like Table 3-1, documents
that appreciable quantities of important air contaminants are emitted into the air from SS
emissions resulting from tobacco combustion. The table demonstrates that SS emissions are
reasonably similar across different brands of cigarettes, varying by only a factor of 2-3.  So, while

MS emissions can vary considerably (Table 3-1), SS emissions are relatively constant (Table  3-2).

       In summary, the available data indicate that tobacco combustion results in  the emission of
a large number of known toxic compounds and that many of these will be released at rates that are
higher in SS than in MS.  Emphasis in characterizing SS emissions has been  placed upon those
carcinogens and toxic compounds found in MS. Although not all of the SS emissions have been
characterized,  the available data showing SS to be enriched in many of the same carcinogens and
toxic agents found in MS lead to the conclusion that ETS will contain the same hazardous

compounds. This conclusion provides the basis for the toxicological comparison of these complex
mixtures in Chapter 4. The enrichment of several known or suspected carcinogens in SS  relative

to MS suggests that the SS contaminant mix may be even more carcinogenic than the MS  mix, per
                                           3-7


-------
Table 3-2. Example sidestream cigarette smoke deliveries1
  Constituent
Kentucky reference2
                                                                       Commercial
   Condensate
   Total particulate matter
   Nicotine
   Carbon monoxide
   Carbon dioxide
   Nitrogen oxides
   Ammonia
   Formaldehyde
   Acetaldehyde
   Acrolein
   Propionaldehyde
   Benzene
   Toluene
   Styrene
   Pyrrole
   Pyridine
   3-Vinylpyridine
   3-Hydroxypyridine
   Limonene
   Neophytadiene
   Isoprene
   nC27-nCS3
   Acetonitrile
   Acrylonitrile
            Milligrams per cigarette
                               36-67
      16.9
       5.6
      54
     474
       0.9
       9.1
       0.7
       4.2
       1.3, 1.4
       0.9
                               0.3-0.5
0.3, 0.4, 0.7
0.8, 1.3

0.4
0.3
        0.3

        2.5, 6.1
        0.2-0.8
        1.0, 0.83
        0.2
                        16-36, 20-23
                        5.7-11.2,2.7-6.1
                        41-67
                        0.7-1.0
                               0.8-1.1
                        <0.1-0.4
                        0.1-0.2
                        4.4-6.5
                                                             (continued on the following page)
                                             3-8

-------
Table 3-2. (continued)
Constituent

Hydrogen cyanide
Phenol
o-Cresol
m + p-Cresol
Catechol
Hydroquinone
Naphthalene
Phenanthrene
Anthracene
Fluoranthene
Pyrene
Benz[a]anthracene
Benzo[a]pyrene
NNN4
NNK4
NAT4
NAB4
DMNA4
EMNA4
DENA4
NPYR4
2-Naphthylamine
4-Aminobiphenyl
Nickel
Cadmium
Lead
Chromium
Kentucky reference2 Commercial
Micrograms per cigarette
53, 173
44-371 :
24-98
59-299
46-189
26-256
53-177
2.4
0.7
0.7
0.5
0.2 0.2
0.1 0.1
0.2 1.7
0.4 0.4
0.1
<0.1
0.3 0.7-1.0
<0.1
<0. 1-0.1
0.2 0.2-0.4
<0.1-15
<0.1-0.25




                                                           (continued on the following page)
                                           3-9

-------
Table 3-2. (continued)
^able reprinted from Guerin et al. 1992, who compiled data from Browne et al., 1990;
 Brunnemann et al., 1977, 1978, and 1990; Chortyk and Schlotzhauer, 1989; Grimmer et al., 1987;
 Guerin, 1991; Higgins et al., 1987; Johnson et al., 1973; O'Neill et al., 1987; R.J. Reynolds, 1988;
 Rickert et al., 1984; Sakuma et al., 1983, 1984a, 1984b; and Norman et al., 1983. Full references
 are given in Guerin et al., 1992.
2Filter 1R4F unless otherwise specified.
3Nonfilter 1R1.
4AT-nitrosonornicotine (NNN), 4-methylnitrosoamino-l-(3-pyridinyl)-l-butanone (NNK),
 W-nitrosoanatabine (NAT), AT-nitrosoanabasine (NAB), dimethylnitrosamine (DMNA),
 ethylmethylnitrosamine (EMNA), diethylnitrosamine (DENA), Af-nitrosopyrrolidine (NPYR).
Calculated from NRC, 1986, SS/MS ratio.
unit tobacco burned. The mouse skin painting bioassays of organic extracts of MS and SS
reviewed in Chapter 4 add support to the suggestion that SS is a more potent carcinogen than MS.
Furthermore, the incomplete chemical characterization of SS emissions means that there may be
additional, as yet unidentified compounds in SS of human health interest.
       Detailed chemical characterizations of ETS emissions under conditions more typical of
actual smoking conditions (e.g., using smokers rather than smoking machines) are limited.  As a
result, the impact on ETS of factors, such as the rapid dilution of SS emissions, adsorption and
remission of contaminants, and exhaled MS is not well understood. Several studies conducted in
chambers or controlled environments and using smokers (e.g., Benner et al.,  1989; Due and
Huynh, 1989; Leaderer and Hammond,  1991; R.J. Reynolds, 1988; NRC, 1986; U.S. DHHS, 1986;
Guerin et al., 1992) have characterized some of the ETS components (total mass, carbon
monoxide, nicotine and other selected compounds, including known carcinogenic and toxic
substances). These studies indicate that many of the contaminants of interest in SS are measurable
in ETS (NRC, 1986; U.S. DHHS, 1986; Guerin et al., 1992) and that several SS contaminants (e.g.,
total mass, carbon  monoxide, nicotine) are easily measurable in ETS.  It is not known how the MS
and SS air contaminant emission data for specific compounds, generated by the standardized
testing protocols utilized, compare to data gathered under conditions more representative of actual
smoking in occupied spaces.

3.3.  ASSESSING ETS EXPOSURE
       In the course of a typical day, an individual spends varying amounts of time in a variety
of environments (residences, industrial and nonindustrial workplaces, automobiles, public access
buildings, outdoors, etc.). While in these different environments,  individuals are exposed to a
                                           3-10

-------
 broad and complex spectrum of organic and inorganic chemicals in gaseous and particle forms, as
 well as a range of viable particles.
        ETS is a major source of indoor air contamination because of the large, though decreasing,
 number of smokers in the population and the quantity and quality of the contaminants emitted
 into the environment from tobacco combustion (NRC, 1981, 1986). In a 1990 self-reported
 smoking survey of a representative sample of the U.S. civilian, noninstitutionalized population, it
 was reported that 50.1% (89.9 million) of the adult population  were ever-smokers and 25.5% were
 current smokers (CDC,  1992). The reported average number of cigarettes smoked per day was
 19.1, with 22.9% of smokers reporting smoking 25 or more cigarettes per day. From 1965 through
 1985, the overall smoking prevalence among U.S. adults declined 0.5% annually, with a 1.1%
 annual decline between 1987 and  1990.
       In another recent survey (CDC, 1991b), 40.3% (46 million) of employed adults (>  18 years
 old) in 1988 (who reported that their workplace was not in their home) worked in locations where
 smoking was allowed in designated or other areas.  Of the nonsmokers (79.2 million), 36.5% (28.5
 million)  worked at places that permitted smoking in designated (if any) and other areas. Of these
 nonsmokers, 59.2% (16.9 million)  reported that exposure to ETS in their  workplace caused them
 discomfort. The survey highlighted the importance of the workplace as a major source of ETS
 exposure in addition to the home.
       The available data on ETS exposure  to children in the home are limited.  However, based
 on the 1988 National Health Interview Survey on Child Health, 42% of children 5 years of age  and
 under are estimated to live in households with current smokers (Overpeck and Moss, 1991).  The
 home environment is clearly an important source of ETS exposure for children.
       Nationally based survey data needed to make direct estimates of the frequency, magnitude,
 and duration of ETS exposure for  nonsmoking adults and children and  the different indoor
 environments in which those exposures occur are not available. The survey data available,
 however, do indicate that due to the ubiquitous nature of ETS in indoor environments, some
 unintentional inhalation  of ETS by nonsmokers is unavoidable.
       The combustion of tobacco results in the emission of a particularly complex array of air
 contaminants into indoor microenvironments.  Data on the chemical composition of mainstream
 and sidestream cigarette  emissions  as well as measurements in indoor spaces where smoking occurs
 indicate that exposure to ETS will  result in exposure to toxic and carcinogenic agents (Section 3.2).
The nature of the ETS contaminant mix and eventual human exposure is the product of the
interaction of several interrelated factors associated with the source, transport, chemical
transformation, dispersal, removal, and remission from surfaces, as well as human activities.
Efforts to determine adverse health effects of ETS must address the issue of exposure to a
                                           3-11

-------
complex mixture, which can occur in a number of environments. Assessing exposure to ETS, as
with any complex air contaminant mix, is inherently complicated in epidemiologic studies
(Leaderer et al., 1992).
       Because of the many potentially toxic agents in ETS and the various possible toxicological
endpoints of interest, it is neither feasible nor desirable to focus on any one contaminant.  Rather,
the focus is on gathering information on marker or proxy compounds or other indicators of ETS
exposure.  In assessing these exposures, both direct and indirect methods can be employed. Direct
methods include personal monitoring and measurement of biological markers. Indirect methods
employ models to estimate exposures.  The modeling approach generally makes use of stationary
monitoring and questionnaire data.
       Stationary monitoring is used to measure concentrations of air contaminants in different
environments. These  measured concentrations are then combined with time-activity patterns
(time budgets) to determine the average  exposure of an individual as the sum of the
concentrations in each environment weighed by the time spent in that environment. Monitoring
of contaminants might also be supplemented with the monitoring of factors in the environment
that affect the contaminant levels measured (meteorological variables, primary compounds,
ventilation, etc.). Measurement of these factors, in a  carefully chosen set of conditions, can lead
to models that predict concentrations in the absence of measured concentrations and provide a
means of assessing the impact of efforts to reduce or eliminate exposures.  Questionnaires are used
to determine time-activity patterns of individuals, to  provide a simple categorization of potential
exposure, and to obtain information on the. properties of the environment affecting the measured
levels (number of smokers, amounts smoked, etc.).
        ETS exposure measurements, whether conducted to support epidemiological studies or to
determine the extent  of exposure in nonsmoking individuals, have typically employed air
monitoring of indoor spaces, personal monitoring, and questionnaires.  Modeling of ETS
exposures, while useful in estimating, from measured data, the level of exposure in a variety of
 indoor spaces under varying conditions, is beyond the scope of this report.

 3.3.1. Environmental Concentrations of ETS
        The SS emission data discussed in Section 3.2  and  shown in Tables 3-1 and 3-2  clearly
 indicate that tobacco combustion will result in the release of thousands of air contaminants  into
 the environments in which smoking occurs.  The concentrations of the known and unidentified
 contaminants in the ETS complex mix in an enclosed space can exhibit a pronounced spatial and
 temporal distribution. The concentration is the result of a complex interaction of several
 important variables, including (1) the generation rate of the contaminant(s) from the tobacco
                                            3-12

-------
(including both SS and exhaled MS emissions), (2) location in the space that smoking occurs, (3)
the rate of tobacco consumption, (4) the ventilation or infiltration rate, (5) the concentration of
the contaminant(s) in the ventilation or infiltration air, (6) air mixing in the space, (7) removal of
contaminants by surfaces or chemical reactions, (8) re-emission of contaminants by surfaces, and
(9) the effectiveness of any air cleaners that may be present. Additional considerations relate to
the location at which contaminant measurements are made, the time of sample collection, the
duration of sampling, and method of sampling.
       Variations in any one of the above factors related to introduction, dispersal, and removal  ,
of ETS contaminants can have a marked impact on the resultant indoor ETS constituent
concentrations. Any one of these parameters can vary by an order of magnitude or more.  For
example, infiltration rates in residences can range from 0.1 to over 2.0 air changes per hour, and
house volumes can range from 100 to over 700 m3 (Grimsrud et al., 1982; Grot and Clark, 1979;
Billick et al., 1988; Koutrakis et al.,  1992).  Smoking rates and mixing within and between rooms
can also show considerable variability. The potential impact on indoor ETS-related respirable
suspended particle (RSP) mass concentrations due to variations in these parameters is
demonstrated in Figures 3-1  and 3-2 (these figures were taken directly from Figures 5-4 and 5-5
in NRC, 1986). Figures 3-1  and 3-2 are based on the mass balance model for ETS (NRC, 1986)
for a typical range of input parameters encountered in indoor spaces. These figures demonstrate
that  ETS-generated RSP concentrations in indoor environments can range from less than 20 /ig/m3
to over 1 mg/m3 depending upon the location and conditions of smoking.
       Numerous field studies in "natural" environments have been conducted to assess the
contribution of smoking occupancy to indoor air quality. These studies, summarized in a number
of reviews (e.g., NRC, 1986; U.S. DHHS, 1986; Guerin et al., 1992), have measured several ETS-
related contaminants of human health concern (e.g., particle mass, carbon monoxide, benzene,
nicotine, polycyclic aromatic hydrocarbons, W-nitrosamines), in a number of enclosed
environments (e.g., residential, office, transportation) and under a variety of smoking and
ventilation rates.  These studies demonstrate that (1) many of the contaminants of health interest
found in SS are also found in ETS; (2) ETS contaminants are found above background level in a
wide range of indoor environments in which smoking occurs; and (3) the concentrations of ETS
contaminants indoors can be highly variable. These findings can be demonstrated for selected
ETS-related compounds presented in Figure 3-3 and in Table 3-3.
        Figure 3-3 principally utilizes data summaries presented in reviews of indoor
measurements of  ETS-related compounds in a variety of indoor spaces (NRC, 1986; U.S. DHHS,
1986; and particularly Guerin et al., 1992).  Only the range of average concentrations measured in
                                           3-13

-------
                              02 0.3
                                  N
0.50.7 I     2   3   5 7  10
 (air changes per hour)
Figure 3-1. Diagram for calculating the respirable suspended particle mass (RSP) from ETS
emitted into any occupied space as a function of the smoking rate and removal rate (N). The
removal rate is equal to the sum of the ventilation or infiltration rate (nv) and the removal rate by
surfaces (na) times the mixing factor.  The calculated ETS-related RSP mass determined from this
figure serves as an input to Figure 3-2 to determine the ETS-related RSP mass concentration in
any space in /tg/m3.  Smoking rates (diagonal lines) are given as cigarettes smoked per hour.
Mixing is determined as a fraction, and nv and na are in air changes per hour (ach). All three
parameters have to be estimated or measured. Calculations were made using the equilibrium form
of the mass-balance equation and assume a fixed emission rate of 26 mg/m3 of RSP.

Shaded area shows the range of RSP emissions that could  be expected for a residence with one
smoker smoking at a rate  of either 1 or 2 cigarettes per hour for the range of mixing, ventilation,
and removal rates occurring in residences under steady-state conditions.
Source:  NRC, 1986.
                                           3-14

-------
  10000
   7000
   5000
                           10   20     50   100  200   500  1000
                               Total RSP Emitted (mg)
3000    10000
Figure 3-2. Diagram to calculate the ETS-associated respirable suspended particle mass (RSP)
concentration in /tg/m3 in a space as a function of total mass of ETS-generated RSP emitted in mg
(determined from Figure 3-1) and the volume of a space (diagonal lines).  The concentrations
shown assume a background level of zero in the space. The particle concentrations shown are
estimates during smoking occupancy. The dashed horizontal lines (A, B, C, and D) refer to
National Ambient Air Quality Standards (health-related) for total suspended particulates
established by the U.S. Environmental Protection Agency.  A is the annual geometric mean. B is
the 24-hour value not to be exceeded more than once a year.  C is the 24-hour air pollution
emergency level. D is the 24-hour significant harm level.  Shaded area shows the range of
concentrations expected (from Figure 3-1) for a range of typical volumes of U.S. residences and
rooms in these residences.
Source:  NRC, 1986.
                                          3-15

-------
          Range of Average Indoor Concentrations of Noteable ETS Contaminants
                            Associated with Smoking Occupancy
Figure 3-3. Range of average indoor concentrations for notable ETS contaminants associated with
smoking occupancy for different indoor environments.  Ranges of averages are principally from
tables presented in Guerin et al. (1992), although other sources were used (NRC, 1986; U.S.
DHHS, 1986; Turk et al., 1987). Background levels are subtracted.  Maximum recorded values are
typically orders of magnitude higher than averages shown.
                                        3-16

-------
Table 3-3. Tobacco-specific W-nitrosamines in indoor air (ng/m3)1
Site
Bar I
Bar II
Bar III
Restaurant3
Restaurant3
Car4
Train I
Train II
Office
Smoker's Home
Apptox.
#of
cigarettes
smoked
25-35
10-15
10-15
$5-30
40-50
13
50-60
50-60
25
30
Collection
time
{hours)
3
3
3
6
8
3.3
5.5
6
6.5
3.5
Flow
rate
(liters/
min.)
3.2
3.2
3.2
2.15
2.1
2.15
3.3
3.3
3.3
3.3
Tobacco-specific
jy-nitrosamines
NNN2 NAT2 NNK2
22.8
8.3
4.3
1.8
ND
5.7
ND
ND
ND
ND
9.2
6.2
3.7
1.5
ND
9.5
ND
ND
ND
ND
23.8
9.6
11.3
1.4
3.3
29.3
4.9
5.2
26.1
1.9
*Data corrected for recovery.
2NNN = NNN-AT-nitrosonornicotine; NAT = NAT-W-nitrosoanataline;
 NNK = NNK-4-methylInitrosoamino-l-(3 pyridinyl)-l-butanone.
3Smoking section.
4Windows partially open.
 ND = not detected (in some cases due to chromatographic interference).
Source:  Brunnemann et al., 1992.
different environments is shown. Maximum values, which can range up to two or more orders of
magnitude above the averages, are not shown in Figure 3r3.  Background levels for nonsmoking
conditions have been subtracted.  When smoking occurs, concentrations of total polycyclic
aromatic hydrocarbons, benzo[a]pyrene, benzene, formaldehyde, toluene, and carbon monoxide
will be elevated above background levels in a variety of indoor environments.  Figures 3-7 and
3-8 present a similar summary with the same conclusions for two other ETS-related
contaminants—respirable suspended particle mass and nicotine.
       AT-nitrosamines are important  constituents of SS because they are considered to be
carcinogenic, because they are emitted in much larger quantities in SS than in MS (Table 3-1), and,
because tobacco combustion is the only identified air source in the nonoccupational indoor
environment. Guerin et al. (1992) reviewed the available data on indoor levels of W-nitrosamines
                                           3-17

-------
related to smoking occupancy.  They concluded that levels associated with smoking can range
from less than detectable to as high as 100 ng/m3 for nitrosodimethylamine (NDMA) under
conditions of heavy smoking.  A more typical range of concentrations of NDMA were
< 10-40 ng/ms. In a recent paper, Brunnemann et al. (1992) demonstrated that exposure to
tobacco specific W-nitrosamines can occur in a variety of indoor spaces under a range of smoking
conditions (Table 3-3).
       The potential for high exposures of nonsmokers to carcinogenic components found
enriched in SS can be demonstrated in the case of 4-aminobiphenyl (4-ABP). Tables 3-1 and 3-2
show 4-ABP emissions in SS to be approximately 30 times higher than in MS (100-200 /tg/cig).
Despite the fact that SS emissions of 4-ABP are diluted rapidly in the indoor environment,
presumably resulting in considerably less exposure than to smokers, 4-ABP Hb adduct levels in
nonsmokers have been found to be  10% to 20% of those in smokers (see Section  3.3.2).
       There are important circumstances where concentrations of ETS-related contaminants in
indoor spaces may considerably underestimate potential levels of exposure.  These circumstances
occur when the SS emissions or exhaled MS emissions are in direct proximity to a nonsmoker (e.g.,
an infant held by a smoking mother or father, or when a nonsmoker is directly downwind of the
plume of a smoldering cigarette). While there are no measurements to assess the impact on the
nonsmoker's exposure  under these conditions, it is an important exposure and will be much higher
than would be predicted from existing  environmental measurements of more diluted SS and
exhaled MS emissions.
       The data discussed above represent concentrations measured in selected indoor
environments and indicate that exposure will occur for individuals in those spaces. Estimating the
actual level of exposure (concentration x time) requires knowledge of the actual time spent in
those environments.

3.3.1.1. Markers for Environmental Tobacco Smoke
       Although ETS  is a major source of indoor air contaminants, the actual contribution of ETS
to indoor air is difficult to assess due to the background levels of many contaminants contributed
from a variety of other indoor and outdoor sources.  Relatively few of the individual constituents
of the ETS mix have been identified and characterized. In addition, little is known about the role
of individual ETS constituents in eliciting the adverse health and nuisance effects  observed.
However, the issue is not how to fully characterize the exposure to each ETS-related contaminant,
but rather how to obtain accurate quantitative measures of exposure to the entire ETS mixture.
The measurement of all components in ETS is not feasible, practical, or even desirable due to
                                           3-18

-------
limitations in knowledge of the mixture components related to the effects of interest, as well as
the feasibility and cost of sampling. It is necessary then to identify a marker (also referred to as a
tracer, proxy, indicator, or surrogate) for ETS that will, when measured, accurately represent the
frequency, duration, and magnitude of exposure to ETS. These markers can be chemicals
measured in the air, biomarkers, models, or simple questionnaires.
       There are important issues related to the measurement of a given marker compound to
represent exposure to ETS. Ideally, an air contaminant marker for ETS should (1) vary with
source strength, (2) be unique to the source, (3) be easily detected in air at low concentrations, (4)
be similar in emission rates for a variety of tobacco products, (5) occur in a consistent ratio in air
to other ETS components in the complex mix, and (6) be easily, accurately, and cost effectively
measured (Leaderer, 1990). The marker can be a specific compound (e.g., nicotine) or much less
specific (e.g., respirable suspended particle mass). These criteria for selecting a suitable marker
compound are the ideal criteria.  In practice, no single contaminant  or class of contaminants has
been identified that would meet all the criteria.  Selection of a suitable marker for ETS is reduced
to satisfying as  many of the criteria for judging a marker as is practical.  In using a  marker, it is
important to state clearly the role of the marker and to note its limitations.
       A number of marker or proxy compounds have been used to represent ETS concentrations
in both field and chamber studies.  Nicotine, carbon monoxide, 3-ethenylpyridine, nitrogen
dioxide, pyridine, aldehydes, nitrous acid, acrolein, benzene, toluene, myosmine, and several
other compounds have been used or suggested for use as markers or proxies for the vapor phase
constituents of ETS (NRG, 1986; U.S. DHHS,  1986; Hammond et al., 1987; Eatough et al., 1986;
Lofroth et al., 1989; Leaderer and Hammond, 1991; Guerin et al., 1992). Tobacco-specific
nitrosamines, particle phase nicotine and cotinine, solanesol, polonium-210, benzo[a]pyrene,
potassium, chromium, and respirable suspended particle mass (RSP—particle mass < 2.5 /an) are
among the air contaminants used or suggested for use as markers for particle phase constituents of
ETS (NRC, 1986; U.S. DHHS, 1986; Leaderer and Hammond, 1991; Benner et al., 1989; Hammond
et al., 1987; Rickert, 1984; Guerin et al., 1992). All the markers employed to date have some
problems associated with their use. For example, carbon monoxide, nitrogen oxides, benzene, and
RSP have many indoor and outdoor sources other than the combustion of tobacco, while other
compounds such as nitrosamines and benzo[a]pyrene are sufficiently difficult to measure (e.g.,
concentrations in smoking environments are low and the cost of collection and analysis of samples
is high) that their use is very limited.
       At the present time, vapor phase nicotine and respirable suspended particulate matter are
widely and most commonly used  as markers of the presence and concentration of ETS for a
                                           3-19

-------
variety of reasons associated with their ease of measurement, existing knowledge of their emission
rates from tobacco combustion, and their relationship to other ETS contaminants.
       Vapor phase nicotine, the dominant form of nicotine in ETS (Eudy et al.,  1985; NRC,
1986; U.S. DHHS,  1986; Hammond et al., 1987; Eatough et al., 1986; Guerin et aL, 1992) accounts
for approximately 95% of the nicotine in ETS and is a good marker air contaminant for ETS. It is
specific to tobacco combustion and is emitted in large quantities in ETS (NRC, 1981, 1986; U.S.
DHHS, 1986; Rickert et al., 1984; Eatough et al., 1990;  Guerin et al., 1992). Chamber
measurements have shown that nicotine concentrations  vary with source strength (Rickert et al.,
1984; Hammond et al., 1987; Hammond and Leaderer, 1987; Leaderer and Hammond, 1991) and
show little variability among brands of cigarettes, despite variations in MS emissions (Rickert et
al., 1984; Leaderer and Hammond,  1991). Field studies have shown that weekly nicotine
concentrations are  highly correlated with the number of cigarettes smoked (Hammond et al., 1987;
Mumford et al., 1989; Thompson et al., 1989; Leaderer and Hammond, 1991).  One large field
study (Leaderer and Hammond, 1991) showed that weekly nicotine concentrations were strongly
correlated with measured RSP levels, as well as with reported number of cigarettes smoked. In
this study, the slope of the regression line was 10.8 (standard error of ± 0.72), similar to the
RSP/nicotine level seen in chamber studies. Also, the RSP intercept was equal to background
levels in homes without smoking (17.9 A*g/m3 ±  1.63) (Leaderer et al., 1990). A comparable study
by Miesner et al. (1989) of particulate matter and nicotine in workplaces found a similar ratio
between RSP and nicotine.  The utility of nicotine as an ETS marker is enhanced by the fact that
recent advances in air sampling have resulted in the development of a variety of validated and
inexpensive passive and active monitoring methods for measuring nicotine in indoor air
environments and for personal monitoring (Hammond et al., 1987; Hammond and Leaderer, 1987;
Eatough et al.,  1989a; Koutrakis et al., 1989; Muramatsu et al., 1984; Oldaker and Conrad,  1987).
       Nicotine is also an attractive marker for the complex ETS air contaminant mix because it
and its metabolites, principally cotinine, can serve as biomarkers of ETS exposure.  Nicotine and
cotinine have long served as markers for active smoking. Over the past several years,
measurements of nicotine and cotinine in blood, urine, and saliva have been used extensively as
reasonably sensitive biomarkers indicative of exposure  to ETS (see Section 3.3.2).
       Nicotine is, however, not an ideal ETS marker.  One of the potential drawbacks is that
vapor-phase nicotine has a high affinity for indoor surfaces.  The high adsorption rate of nicotine
could decrease  its concentration relative to other ETS constituents, particularly ETS-associated
particle mass (Eudy et al., 1986; Rickert et al.,  1990; Eatough et al., 1989b). This relative decrease
in concentration could lead to an underestimation of ETS exposures. The ratio of nicotine to RSP
and possibly other ETS constituents would be expected to be most dynamic as the ETS
                                           3-20

-------
contaminant mix ages (Eatough et al., 1989a).  An additional potential problem is that nicotine
may be re-emitted from interior surfaces, resulting in measurable concentrations in the absence of
active smoking. There have, however, been a number of field studies (see above and Figures 3-4
and 3-7) where nicotine has been used successfully as an ETS marker.  These studies  would    •.-.-,
indicate that the uncertainties associated with nicotine in typical indoor environments under
normally encountered smoking rates are relatively small. Levels of nicotine in smoking
environments have been measured over several orders of magnitude (Figures 3-4 and 3-7),
suggesting that the uncertainty associated with its high adsorption rate is small compared to the
concentration range.  It should also  be noted that other gas phase ETS contaminants may exhibit  ,
adsorption and reemission properties similar to that of nicotine.  Use of nicotine or any other ETS
marker must consider the limitations associated with its use.                ,             .
       The combustion of tobacco results in substantial emissions of RSP. One small chamber
study using a smoking machine found the average particle emission rate for 15 Canadian cigarettes
to be 24.1 mg/cigarette with a range of 15.8-36.0 mg/cigarette (Rickert et al., 1984).  A large
chamber study using  smokers reported an average particle emission rate of 17.1  mg for 12 brands
of American cigarettes (Leaderer and Hammond, 1991).  This study noted that emission rates  .    ;
among brands are similar.  Included in the RSP are a number of compounds of direct health
concern, e.g., many of the polycyclic aromatic hydrocarbons and tobacco-specific A^-nitrosamines
(NRC, 1986; U.S. DHHS, 1986; Guerin et al., 1992; Tables 3-1 and 3-3, Figure 3-3).  There are a
number of accepted methods to measure personal RSP exposures and concentrations in indoor
environments (Ogden et al., 1990).  The available methods permit the accurate measurement of.
RSP for sampling times ranging from seconds to several days.     ,
       Numerous studies of personal exposures to RSP and of RSP levels in indoor environments
have shown elevated  levels of RSP in environments where smoking was reported (NRC, 1986; U.S.
DHHS, 1986; Guerin  et al., 1992; Leaderer and Hammond, 1991; Turk et al.,  1987). One study
found a strong correlation between  weekly residential RSP levels and reported number of
cigarettes smoked (Leaderer and Hammond, 1991). At low smoking and high ventilation rates,
however, it may be difficult to separate out the ETS-associated RSP  in a background of RSP from
other indoor sources (e.g., kerosene heaters) or even from outdoor sources. In using RSP as a
marker for ETS, it is  important to account for the background RSP level related to other sources
before ascertaining the contribution from ETS. Efforts to model ETS exposures for the purpose
of assessing risks and the impact of various mitigation measures  have often focused on predicting
ETS-associated RSP concentrations (e.g., Repace and Lowrey, 1980).
                                           3-21

-------
3.3.1.2. Measured Exposures to ETS-Associated Nicotine and RSP
3.3.1.2.1. Measurements using stationary monitors. In the past several years, numerous studies have
been conducted in a variety of indoor environments to determine the impact of tobacco
combustion on levels of nicotine and RSP.  These studies have employed a variety of protocols
that used a diversity of air sampling techniques (passive, active, continuous  integrative, etc.),
sampled over highly varying timeframes (from minutes to several days), and collected highly
variable information on factors affecting the measured concentrations (number of cigarettes
smoked, volume of building, ventilation rates, etc.).  In an attempt to present an overall view of
the contribution of ETS to indoor air quality, only the summary results of the measured
concentrations of ETS-associated nicotine and RSP will be discussed here.  Several reviews of the
studies evaluating the impact of ETS on indoor RSP levels have been conducted over the past few
years, and a number of recent reports have discussed measured indoor levels of nicotine (e.g.,
NRC, 1986;  U.S. DHHS, 1986; Guerin et al., 1992; Leaderer and Hammond, 1991).  Only the
indoor levels measured are discussed and summarized. In order to assess exposures, the time in
contact with the concentrations would have to be estimated or measured.  The reader is referred to
those reports and to the individual study reports to acquire more detailed information.
       Measured nicotine concentrations in various indoor environments where smoking was
noted are summarized in Figure 3-4.  The mean concentration, standard deviation, and the
maximum and minimum values recorded are presented. Also given in Figure  3-4 are the number
of locations  in which the measurements were taken and the references in which the data were
reported.  Elevated nicotine levels were measured in all microenvironments  in which smoking was
reported.  Measured nicotine levels, as would be expected, were highly variable, covering several
orders of magnitude.
       The home and workplace may represent the most important environments for exposure to
ETS because of the amount of time individuals spend there. For the five studies  reporting
residential levels, average nicotine concentrations in homes where smoking occurs ranged from
less than 1 jig/m3 (Leaderer and Hammond, 1991) to over 14 /*g/m3 (Muramatsu et al., 1984).  For
two of the studies (Leaderer and Hammond, 1991; Marbury et al., 1990) nicotine concentrations
represent weekly averages.  Actual concentrations in the homes during nonsleeping occupancy
(i.e., while smoking would be occurring) would be considerably higher than the levels presented in
the table (a factor of 3 or more higher).  Workplace nicotine also demonstrated a  wide range of
concentrations, from near zero to over 33 /ig/m3. In other environments, nicotine concentrations
also demonstrated considerable variability.  It is important to note that short-term concentrations
                                           3-22

-------
K*	m
    I?
B--S-V--


 8*-N-

 E*v-
S d'i
S ? cf
£
X
                                                           2
                                                             V

                                                           o S
                                                           ~ 

>p X) cr> „ CO Og cc 10 I c « ± O s T I CMO 5 to en 0= CM O I O 00 g CM !-• J; o ~ P a «• g 5? evi •§ in ro in CM £ '* d £2 S o ea '? § e cs


-------
                        REFERENCES FOR FIGURES 3-4 AND 3-5
        Figure 3-4

 1.   Leaderer and Hammond, 1991
 2.   Mumford et al., 1989
 3.   Marbury et al., 1990
 4.   Muramatsu et al., 1984
 5.   Coultas et al., 1990b
 6.   Weber and Fischer, 1980
 7.   Vaughan and Hammond, 1990
 8.   Leaderer, 1989
 9.   Miesner et al., 1989
10.   Hinds and First, 1975
11.   Oldaker et al., 1990
12.   Coghlin et al., 1989
13.   Badre et al., 1978
14.   Higgins, 1987
15.   Nagda et al., 1990
16.   Eatough et al., 1990
17.   Mattson et al., 1989
18.   Harmsden and Effenberger, 1957
19.   Cano et al., 1970
        Figure 3-5

 1.   Brunekreef and Boleij, 1982
 2.   Hawthorne et al., 1984
 3.   Moschandreas, 1981
 4.   Nitschke et al., 1985
 5.   Parker et al., 1984
 6.   Spengler et al., 1981
 7.   Spengler et al., 1985
 8.   Leaderer et al., 1990
 9.   Lebret et al., 1990
10.   Coultas et al., 1990b
11.   Turketal., 1987
12.   Weber and Fischer, 1980
13.   Sterling and Sterling, 1983
14.   Nelson et al., 1982
15.   Quant et al.,  1982
16.   Repace and Lowery, 1980
17.   Repace and Lowery, 1982
18.   Leaderer, 1989
19.   First, 1984
20.   Oldaker et al., 1990
21.   Ishizu, 1980
22.   Husgafvel-Pursiainen et al., 1986
23.   Eatough et al., 1990
24.   Nealetal., 1978
25.   Nagda et al., 1990
26.   U.S. Department of Transportation, 1971
27.   Elliot and Rowe, 1975
                                           3-24

-------
(on the order of minutes) are likely to show considerably more variability, resulting in
considerably higher short-term peak exposures.
       A substantial number of studies examining the impact of tobacco combustion on
concentrations of RSP in various indoor environments have been reported. Many of these studies
have reported outdoor RSP concentrations and indoor RSP levels without smoking as well as
concentrations when smoking occurs. These studies are summarized in Figure 3-5. Outdoor and
indoor RSP levels for each of the studies as well as the  smoking-associated RSP measurements are
shown.  The sampling time for the presented data ranged from one minute to over several days. A
major portion of the data is for the residential indoor environment. Where smoking is reported,
RSP levels are considerably higher than RSP levels outdoors or indoors without smoking. RSP
levels associated with smoking, like those for nicotine,  demonstrated considerable variability
ranging from a few |tg/m3 to over 1  mg/m3. Workplace RSP levels associated with smoking
occupancy are comparable to residential RSP levels.
       In one large residential study, both ETS-associated nicotine and RSP levels were found to
be highly correlated (r = 0.84; p < 10"5) with reported number of cigarettes smoked (Leaderer and
Hammond, 1991).  This study found that, consistent with chamber data, measured nicotine
concentrations predicted the contribution to residential RSP levels from tobacco combustion
(Figure  3-6). The  data in Figure 3-6 might be used to  estimate the RSP levels associated with
tobacco combustion from the nicotine levels shown in Figure 3-4.  The predictive equation, along
with the standard errors,  is given in  the figure and figure legend. In a study of the impact of
smoking on residential levels of RSP and nicotine and of urinary cotinine levels in nonsmoking
occupants involving 10 homes, a correlation of 0.54 between residential levels of RSP and nicotine
was found (Coultas et al., 1990b).
       Indoor levels of nicotine and RSP associated with the combustion of tobacco are a function
of several factors related  to the generation, dispersal, and removal of ETS in enclosed
environments (see Section 3.3.1). Thus, measured levels of these air contaminants indicate a wide
range of concentrations (Figures 3-1 and 3-2).  Figures 3-7 and 3-8 present a summary of the
range of nicotine and ETS-associated particle concentrations measured by type of environment.
The figures present the range of average values reported for each study and the minimum and
maximum values reported.  Only studies reporting sampling times over 4 hours were  included in
the residential and office summaries in  Figures 3-7 and 3-8, because the averaging time is more
likely to represent  the exposures associated with occupancy time (this included most of the studies
for residential spaces shown in Figures 3-4 and 3-5). Since occupancy time in other environments
(e.g., restaurants) is likely to be much shorter, averaging times on the order of minutes or greater
were considered for the other indoor environments presented in the figures.  Indoor particulate
                                           3-25

-------
in


Si \.


IO
si — *=
s 1^
10 i*
2 ~«..v.



tr
!•
H •*= e>
g E 1
§ c g
0 ^ ™
0 0 0
S o o
M "c: 1=
0 O •

IO
Eo

K




a
1-0 	 D



D
— — a —
	 -o 	
	 D~
* D
• o
i 	 - • a '
o
• tCH
KX
1 > 1
HH
O

D


O


— H>~~
Su> o 10 o to C
_ cj o r- m evi
1
".& 1

3
8!S ?

^•S- «>!
to c3 fl> c/a
§ *> 'o. • •§
ffs fg
«UL
.*i
i O-
W o
' =F
ot cu • -
il~ 1

;.af

-'- 1
•> *"~ a>
~ - '
"• E
ra .§
as g
^ «u
ff =
i 0>
1 ro
s" *° S
«T a*
.oS
"" «
rf-. ^
1
«T ro
fW CM

- —

5 "1
fL,
m
 c
"o o
« e
t-i o
•o o a-

s § *o
111
S'" « S
T3 5
•O S3 C
C rt 4)
rt eorS
Sc ^
•S -o
S "2 «

» V 
"2 o «
Ctf «fl *~
*2 S
« S *j3
v C c
*$ * *^i o
iX -s g
t t3 o
**.» d> e
3-26

-------
      200
   ^  150
   10
    W
    O
    E
   Q.
   cn
   o:
       100
        50
RSP* 17.9 + 10.8 Nicotine
N*96
r.2-0.71-
S.E. intercept = 1.63
S.E. slope-0.72
                                  4          6
                               Nicotine   (/ig/m3)
                                            8
10
Figure 3-6.  Week-long respirable suspended particle mass (RSP) and nicotine measurements in 96
residences with a mixture of sources.  Numbers 1-9 refer to the number of observations at the
same concentration.

Source: Leaderer and Hammond, 1991.
                                   3-27

-------
CO
 t

     24
     20
      "
      12
       *
               i Max. Value

                 Range of
                 Average
                  Values
               1 Min. Value
           Residential       Offices       Restaurants   Transportation

                            Occupied Spaces with Smoking
                                                                           25


                                                                          Others
Figure 3-7. Range of average nicotine concentrations and range of maximum and minimum
values measured by different indoor environments for smoking occupancy from studies shown in
Figure 3-4. Only those studies with sampling times of 4 hours or greater are included in the
residential and office indoor environment summaries.
                                        3^28

-------
g  120
I
C2)  100

I
I
I
I
I
80
     60
     40
20
              560
                         i Max. value
                      Range of
                      Average
                       Values
                    1 Min. value

                                          986
                                                                            140
           Residential        Office       Restaurants    Transportation

                             Occupied  Spaces  with Smoking
                                                                      Other
Figure 3-8.  Range of average respirable suspended particle mass (RSP) concentrations and range
of maximum and minimum values measured by different indoor environments for smoking
occupancy from studies shown in Figure 3-5.  RSP values represent the contribution to
background  levels without smoking.  Background levels were determined by subtracting reported
indoor concentrations without smoking. Only those studies with sampling times of 4 hours or
greater are included in the residential and office indoor environment summaries.
                                         3-29

-------
levels associated with smoking occupancy (Figure 3-8) were calculated by subtracting particle
levels for nonsmoking occupancy (presented in the studies) from the smoking occupancy levels.
Thus, the increase in particle mass concentrations associated with ETS is presented in Figure 3-8.
Indoor RSP levels in residences without smokers are typically in the range of 10-25 /tg/m3, while
background office levels are somewhat lower (Figure 3-5).
       The summary nicotine data (Figure 3-7) suggest that average nicotine values in residences
with smoking occupancy will range from 2 to approximately 10 /tg/m3, with high values up to  14
/tg/m3 and  low values down to 0.1 /tg/m3. Offices with smoking occupancy show a range of
average nicotine concentrations similar to that of residences, but with considerably higher
maximum values. The data from other indoor spaces suggest considerable variability, particularly
in the range of maximum values. The cumulative distribution of weekly nicotine measured in  one
study (Leaderer and Hammond, 1991) for a sample of 96 homes, with the levels for smoking
occupancy  emphasized, is shown in Figure  3-9.
       Particle mass concentrations in smoker-occupied residences show average increases of
from 18 to  95 /ig/m3, while the individual increases can be as high as 560 /tg/m3 or as low as
5 /tg/ms (Figure 3-8). Figure 3-10 (Leaderer and Hammond, 1991) highlights the distribution  of
weekly RSP concentrations for residences with smoking occupancy.  In that study, smoking
residences had RSP concentrations approximately 29 /tg/m3 higher than nonsmoking homes.
Concentrations in offices with smoking occupancy will be  on average about the same as those in
residences.  Interestingly, in a large and possibly the most comprehensive study of particle mass
concentrations associated with smoking and nonsmoking sites in office buildings (Turk et al.,
1987), the geometric mean concentration for RSP in 32 smoking sites was 44 /ig/m3 while the
geometric mean for  35 nonsmoking sites was 15 /tg/m3. The difference of 29 /tg/m3 is the same as
that found  for smoking and nonsmoking residences (Figure 3-10). Restaurants, transportation,
and other indoor spaces with smoking occupancy will result in a considerably wider range of
average, minimum, and maximum increases in particle concentrations than the residential or
office environments.
       As noted earlier, indoor air contaminant concentrations are the result of the interaction of
a number of factors related to the generation, dispersal, and elimination of the contaminants.
Source use  is no doubt the  most important factor. Few studies have measured contaminant
concentrations as a function of the smoking rate  in residences or offices, but some data are
available. One study estimated an average weekly contribution to residential RSP of 2-5 /ig/m3
per cigarette (Leaderer et al., 1990), while another study estimated that a pack-a-day smoker
would add 20 /tg/m3 to residential levels (Spengler et al., 1981).  Coultas et al. (1990b) estimated
                                           3-30

-------
          iOOr
                                                                      x (/ig/m3)
                                                                      .I (2.0)
                                                                      0
                                                                     2.17 (2.43)
                                               • All data (N=96)
                                               a Nicotine «0.0 (N=49)
                                                 Nicotine>0.0 (N=47)
                                3      4     5      6      78
                           Vapor Phase Nicotine  (/ig/m3)

Figure 3-9. Cumulative frequency distribution and arithmetic means of vapor-phase nicotine
levels measured over a 1-week period in the main living area in residences in Onondaga and
Suffolk Counties in New York State between January and April 1986.
Source: Leaderer and Hammond, 1991.
              IOOr
                                           • All data (N = 96)
                                           n NicotineO.O (N=49)
                                             Nicotine>0.0(N=47)
                                                                  x (/tg/m3)
                                                                 29.4 (25.9)
                                                                 15.2(7.4)
                                                                 44.1 (29.9)

                        20    40    60     80    100    120   140    160
                      Respirable Particle Mass

Figure 3-10. Cumulative frequency distribution and arithmetic means of respirable suspended
particle mass levels by vapor-phase nicotine levels measured over a 1-week period in the main
living area in residences in  Onondaga and Suffolk Counties in New York State between January
and April 1986.

Source: Leaderer and Hammond, 1991.
                                       3-31

-------
that one or more smokers in a home added approximately 17 Mg/m3 to the residential RSP level.
Variations in residential RSP levels as a function of the number of smokers and over a period of
several months are demonstrated in Figure 3-11 (Spengler et al., 1981).  An association between
the reported number of cigarettes and weekly residential nicotine and RSP levels for a sample of
96 homes (Leaderer and Hammond, 1991) is shown in Figure 3-12a and 3-12b. Smoking clearly
increases indoor concentrations of both nicotine and particle mass, and residential levels of both
nicotine and particle mass increase with increasing levels of smoking. Since nicotine and particle
mass are proxies for the complex ETS contaminant mix, other ETS air contaminants, including the
toxic and carcinogenic contaminants, should, similarly, be elevated with smoking occupancy. This
elevation for selected contaminants is shown in Figure 3-3 and Table 3-3, and for a wider range
of contaminants in other publications (NRC, 1986; U.S. DHHS, 1986; Guerin et al., 1992; Turk et
al., 1987; Brunnemann et al.,  1992).
       Children have been identified as a particularly sensitive group at health risk from exposure
to ETS in the residential indoor environment (NRC, 1986; U.S. DHHS,  1986). One study has
measured smoking status of the parents and weekly nicotine concentrations in the activity rooms
and bedrooms of 48 children  under the age of 2 years (Marbury et al., 1990).  The results, shown
                                         » fridccr; no smokers
                                         » Indasr, I smoicw    .-»
                                                  i imcfcer /  \
                                                                   1278
 Figure 3-11. Monthly mean respirable suspended particle mass (RSP) concentrations in six U.S.
 cities.
 Source: Spengler et al., 1981.
                                            3-32

-------
          10
          8
      to
       O
       o
               Nicotine =0.065+0.0281
r2 = 0.67
S.E. intercept = 0.014
S.E. slope = 0.003
                       50       100       150      200      250      300
                          Total  number  of  cigarettes
Figure 3-12a. Week-long nicotine concentrations measured in the main living area of 96
residences versus the number of questionnaire-reported cigarettes smoked during the air-sampling
period. Numbers 1-9 refer to the number of observations at the same concentrations. Closed
circles indicate that cigar or pipe smoking was reported in the houses, with each cigar or pipe
smoked set equal to a cigarette.  Data from residences in Onondaga and Suffolk Counties in New
York State between January and April 1986. For panel (a), the standard errors for the intercept
and slope are 0.014 and 0.002, respectively.  For panel (b), the standard errors for the intercept :
and slope are 2.1 and 0.03, respectively.

Source: Leaderer and Hammond, 1991.
                                        3-33

-------
      200
       150
  to
   E
       100
   CA
   O
   E
        50
         0
RSP=I7.7+0.322T
N = 96
r2«0.55
S.E. intercept* 2.1
S.E. slope = 0.03
                      50       100        150       200      250

                         Total  number of  cigarettes (T)
                                                            300
Figure 3-12b.  Week-long respirable suspended particle mass (RSP) concentrations measured in
the main living area of 96 residences versus the number of questionnaire-reported cigarettes
smoked during the air-sampling period. Numbers 1 -9 refer to the number of observations at the
same concentrations. Closed circles indicate that cigar or pipe smoking was reported in the
houses, with each cigar or pipe smoked set equal to a cigarette. Data from residences in Onondaga
and Suffolk Counties in New York State between January and April 1986. For panel (a), the
standard errors for the intercept and slope are 0.014 and 0.002, respectively.  For panel (b), the
standard errors for the intercept and slope are 2.1 and 0.03, respectively.

Source: Leaderer and Hammond, 1991.
                                       3-34

-------
 in Table 3-4, indicate that activity and bedroom concentrations of nicotine in the children's homes
 increase with the number of cigarettes reported smoked in the home by parents.  Concentrations
 also increased with the number of reported smokers in the household. Correlation coefficients
 over 0.7 were calculated between nicotine concentrations and number of cigarettes smoked.
 Exposure of children to ETS is covered in greater detail in Chapter 8.
        It is important to note that while measurements of nicotine and ETS-associated RSP are
 good indicators of the contribution of ETS to air contaminant levels in  indoor environments, their
 measurement does not directly constitute a measure of total exposure.  The concentrations
 measured in all indoor environments have to be combined with time-activity patterns in order to
 determine average exposure of an individual as the sum of the concentrations in each environment
 weighted by the time spent in that environment.  Both the home and the work environment (those
 without policies restricting smoking) have highly variable ETS concentrations, with the  ranges
 largely overlapping. Which environment is most important in determining total exposure will vary
 with individual circumstances (e.g., a person who lives in a nonsmoking home but works in an
 office with smokers will receive most ETS exposure at work, but for those exposed both at home
 and  at work, the home may be more important because, over the course of a week, more time is
 generally spent at home).
        An additional issue to be considered is how well the general indoor concentrations
 represent exposures of individuals who may be  directly exposed to the SS plume of ETS. Small
 children, particularly infants, held by smoking parents may receive exposures considerably higher
 than those predicted from concentrations reported for indoor spaces.  Special consideration must
 be given to these significant subpopulations.

 3.3.1.2.2. Personal monitors.  Personal monitoring allows for a direct integrated measure  of an
 individual's exposure. Personal air monitoring employs samplers (worn  by  individuals) that record
 the integrated concentration of a contaminant to which individuals are exposed in the course of
 their normal activity for time periods of several hours to several days.  The monitors  can be active
 (employing pumps to collect and concentrate the air contaminant) or passive (working on the
 principal of diffusion).  As with biomarkers, personal monitoring provides  an integrated measure
of exposure to air contaminants across a number of environments where an individual spends time
but does not provide direct information on concentrations of the air contaminant of interest in
individual environments or on the level of exposure  in each environment unless samples  are taken
in only one environment or are changed with each change of environment.  Supplemental
                                           3-35

-------
Table 3-4. Weekly average concentrations of each measure of exposure by parental smoking
status in the cross-sectional study, Minnesota, 1989
f Smoking status ,, 	
Number
Non-
M^MHBMMHB^^^MP^^HiM^^^^^^^^^^^^^^^^^^^^^^^^^^^^
of subjects 23
Total cigarettes (no./week) 0.9
Activity
room nicotine (/tg/ms) 0.15
Bedroom nicotine (/tg/m3)
Light
smokers
4
28.8
0.32
0.30
Father
only
8
68.6
2.45
1.21
Mother
only
6
58.8
5.50
2.66
Both
parents
•••••••••
7
227.6
12.11
5.32
 information (air monitoring of spaces, time-activity patterns, etc.) is needed to determine the
 contribution of each microenvironment to total exposure.
        Relatively few studies have measured personal exposures to ETS-associated nicotine and
 RSP for nonsmoking individuals. The few reported studies of personal exposure to nicotine are
 summarized in Table 3-5.  Personal exposures associated with specific indoor environments are
 presented. Indoor environments include the nonindustrial workplace, homes, restaurants, public
 buildings, and transportation-related indoor spaces. Table 3-5 highlights the wide range of indoor
 environments in which ETS exposures take place and the wide  range of personal exposures
 encountered in those environments. It is important to note, however, that relatively few
 observations are available and that observations for nonworkplace nicotine exposures are
 dominated by the Japanese data (Muramatsu), which may not be representative of personal
 exposures in the United States. Because the data are limited, specific conclusions about the
 contribution of different indoor environments to personal nicotine exposures associated with
 passive smoking cannot be drawn. The data do indicate, however, that a wide range of exposures
 to ETS takes place in a variety of indoor environments where smoking is permitted.  The data also
 indicate that occupational and residential environments are important sources of exposure to ETS
 because of the levels encountered, which are comparable, and the amount of time individuals
 spend in them.
        Studies of personal exposure to RSP of nonsmoking individuals that have attempted to
 stratify the collected data by ETS exposure are shown in Table 3-6. Three of the five studies
 represent exposures integrated over several different microenvironments (residential, public

                                            3-36

-------
Table 3-5. Studies measuring personal exposure to airborne nicotine associated with ETS for
nonsmokers
Study
Mattson et
al., 1989

Schenker
et al.,
1990

Coultas et
al., 1990a
Muramatsu
etal., 1984






Muramatsu
et al., 1984




Setting Subject
Airplane Attendants


Railroad Clerks



Workplace Nonindus-
trial
Office Volunteers
Laboratory
Conference room
Home
Hospital lobby
Hotel lobby
Restaurant
Transportation
Office Volunteers
Home
Restaurant
Car
Public
transportation
N
16


40



15

10
8
5
3
1
4
15
22
3
7
15
7
1

Nicotine, ng/m*
X(±SD) Range
4.7 (±4.0) 0.1-10.5


6.9



20.4 (±20.6)

21.1
5.8
38.7
11.2
3.0
11.2
26.0
21.7
6.9
7.0
28.2
40.0
11.4

Comments
4 atten-
dants on 4
flights
Samples
collected
over work
shifts


Calculated
from data
presented





Calculated
from data
presented



                                          3-37

-------
r
!
8
I
                  1
                   ^
                   (D
                   0>
                   4_*
                   C3
                   «
                   
                        E
                         2
                        I
                         in
                         1
           1
                         1
                         I
                         i2
            ca
                              -H
                              S-'

                              X
                              w
                              00
                              t/3
                a)
                O
O
CO
                                0
                                                        oo
                                                             00
                                «-< O
                                                        VO
                                                             -H
                                           00
                                              VO
                                              00
                                           00
                                           JN
                                       1
                                                 4-S
                                                 CN
                                     rt     IT)
                                     OO     OO
                 Q> ccj   
                C/O 
                                               4>
                                               So
                                               •^ s^
                                               a £)
                                               <  —"
                                                   CT\
                                                           o\
                                                    \
                                                   -H     CJ -H
                                                                    ot
                                                         . a\
                                                        ~2
                                                        ON -^
                                                        E-a
                                                        •si
                                                                             ffi
                                                                          a
                                                           a
                                                         S 55
                                                         03 ii
                                                         1-1 a>
                                                         , o o
                                                                         ^> l-c tc
                                                                         ,O «*H «1H

                                                       o> aj 
-------
 buildings, occupational, etc.), while two studies report exposures for the workplace only.
 Individuals reporting exposure to ETS have substantially higher integrated exposures to RSP than
 those reporting no exposure.  Passive smoke exposure resulted in increases in personal RSP
 exposures of 18-64 /tg/ms. It is difficult to assess the ETS contribution to personal RSP levels for
 each indoor environment for the 24-hour RSP personal exposures.  The contribution of each
 indoor environment must be substantially higher than the 24-hour averages presented, because
 exposures presumably did not occur during sleeping hours or in all microenvironments. Table 3-6
 demonstrates that the contribution of ETS-related RSP in the work environment to personal
 exposure is important and variable.
       The most extensive study of personal exposure to RSP clearly demonstrates the impact on
 RSP levels from ETS (Spengler et al., 1985).  In this study, outdoor, indoor, and personal 24-hour
 concentrations of RSP (particle diameter <  3.5 |tm) were obtained for a sample of 101  nonsmoking
 individuals. Of the 101 nonsmokers, 28 persons reported some exposure to ETS in either the home
 or workplace, while 73 reported no ETS exposure. The cumulative frequency distributions of RSP
 for the ETS-exposed and non-ETS-exposed individuals and measured outdoor levels are shown in
 Figure 3-13. Those reporting ETS exposure had mean personal RSP levels 28 ng/ms higher than
 those reporting no ETS exposure (Table 3-6).  A larger variation in RSP concentrations was also
 seen for  those reporting ETS exposure.

Ill
G

H
UI
U
e
IU
I
5
3
2
a
U
100


80


60

40

20


0

/•' ..." 	 	 «•" ' • *
' ..• . — 	 * — —
"~ / .** X
i« •
, .* J •• AmenM
•• ' •* •
j ^ / ........ ?»TIOi«t
- / / /-/ N-o-Sm.^&.x,..,,
iff ' v^^-r- — i
- / / r'
1 .•/-
* • •
_^^ 	 1 	 [_._ ! ! 1 1
 40        80       120      160      200
RESPIRAHLE PAHTICULATE CONCENTRATION
                                                                     240
Figure 3-13.  Cumulative frequency distribution of respirable suspended particle mass (RSP)
concentrations from central site ambient and personal monitoring of smoke-exposed and
nonsmoke-exposed individuals.
Source:  Spengler et al., 1985.
                                           3-39

-------
3.3.2.  Biomarkers of ETS Exposure
       Biomarkers of exposure are actually measures of dose or uptake and hence indicators that
an exposure has taken place. Biomarkers, within the context of assessing exposure to air
contaminants, refer to cellular, biochemical, or molecular measures obtained from biological
media such as human tissues, cells, or fluids that are indicative of human exposure to air
contaminants (NRC and Committee on Biological Markers, 1986; NRC, 1986; Hulka et al., 1990).
The relationship between the biomarker and exposure, however, is complex and varies as a
function of several factors, including environmental factors and the uptake, distribution,
metabolism, and site and mode of action of the compound or compounds of interest.
       Ideally, a biomarker of exposure for a specific air contaminant should be chemically
specific, have a long half-life  in the body, be detectable in trace quantities with high precision, be
measurable in samples easily collected by noninvasive techniques, be inexpensive to assay, be
either the agent associated with the effects or strongly associated with the agent of interest, and be
quantitatively relatable to a prior exposure regimen.  Ideal biomarkers for air contaminants, like
markers for complex mixtures, do not exist.
        Numerous biomarkers  have  been proposed as indicators for ETS (e.g., thiocyanate,
carboxyhemoglobin, nicotine and cotinine, TV-nitrosoproline, aromatic amines, protein or DNA
adducts) (NRC, 1986; U.S. DHHS, 1986). While these biomarkers demonstrate that an exposure
has taken place, they may not be directly related to the potential for developing the adverse effect
under study (i.e., not the contaminant directly implicated in the effect of interest), they can show
considerable variability from individual to individual, and they represent only fairly recent
exposure (potentially inadequate for chronic outcomes). Furthermore, some of these markers may
not be specific to ETS exposure (e.g., carboxyhemoglobin) while others (e.g., thiocyanate) may not
be sensitive enough for ETS exposures.
        Nicotine and its metabolite, cotinine,  in the saliva, blood, and urine are widely used as
biomarkers of active smoking and exposure to ETS and are valuable in determining total or
integrated short-term dose to.  ETS across all environments (NRC,  1986; U.S. DHHS, 1986).
Nicotine and cotinine are specific to tobacco  and are accurately measured by gas chromatography,
radioimmunoassay, or high pressure liquid  chromatography in concentrations down to 1 ng/mL.
Nicotine has a half-life of about 2 hours in the blood and is metabolized to cotinine and excreted
in the urine. The short half-life of nicotine makes it a better indicator of very recent exposures
than of integrated exposure.
        Cotinine in saliva,  blood, and urine is the most widely accepted biomarker for integrated
exposure to active smoking or ETS (NRC,  1986; U.S. DHHS, 1986), Cotinine is the major
                                            3-40

-------
metabolite of nicotine, is specific to tobacco, and has a longer half-life for elimination from the
body. The elimination half-life in smokers is approximately 20 hours (range of 10 to 37 hours),
but it is typically longer in nonsmokers with ETS exposure, particularly in children (Figure 3-14)
(Collier et al., 1990; Elliot and Rowe, 1975; Goldstein et al., 1987; Etzel et al., 1985; Greenberg et
al., 1984). The half-life of cotinine makes it a good indicator of integrated ETS exposure over the
previous day or two. Laboratory studies of nonsmokers exposed to acute high levels of ETS over
varying times have shown significant uptake of nicotine by the nonsmokers and increases in their
cotinine levels (NRC, 1986; U.S. DHHS, 1986; Hoffman et al., 1984; Russell and Feyerabend,
1975).
       Cotinine, however, is not an ideal biomarker for ETS, and caution in its use has been
suggested (Idle, 1990).  Cotinine is only one of the metabolites of nicotine (trans-3'-
hydroxycotinine has recently been identified as the major metabolite [Neurath et al., 1988]), and it
shows considerable intersubject variability in controlled nicotine exposure studies (Idle, 1990).
The assumption that nicotine is specific to tobacco has recently been questioned (Idle, 1990;
Sheen, 1988; Castro and Monji, 1986; Davis et al., 1991). Plant sources other than tobacco,
primarily from the Solanaceae family, which are common dietary components have been suggested
as sources (e.g., eggplant, tomato, and green pepper).  It has been suggested that nicotine  in food
is a natural defense against bacteria,  fungi, insects, and animals (Ames, 1983).
                 ific-
                 140-.
                 120- •
             •«•  too- -
             1*0+
                 20"
                        N«onot«       Under 18 mo.      Ov«r 18 mo.
                                            Age Group
Adult
Figure 3-14. Average cotinine tj/j by age groups.
Source: Collier et al., 1990.
                                            3-41

-------
       Tea has been identified as a particularly high source of dietary nicotine (Sheen, 1988).
The impact of dietary nicotine, particularly tea, on cotinine levels of nonsmokers was evaluated in
a study of 3,383 men and women 40-59 years of age as part of the Scottish Heart Health Study
(Tunstall-Pedoe et al., 1991).  The study found a small but inconsistent effect on serum cotinine
levels with consumption of 10 or more cups of tea per day with no effect for consumption rates at
fewer than 10 cups per day.  The authors concluded that "cotinine levels  in true nonsmokers
reflect far more the nicotine in inhaled ambient tobacco smoke than they do nicotine in tea."
       In the most detailed evaluation of nicotine in food, Davis et al. (1991) measured nicotine
in a number of teas  and foods. They found nicotine levels ranging from less than detectable to
285 ng/g wet weight.  The authors calculated that with consuming average quantities of tomatoes,
potatoes, cauliflower, and black tea, the average contribution to urinary cotinine levels would be
0.6 ng/mL.  High consumption of the foods and tea might result in a maximum urinary cotinine
level of 6.2 ng/mL.  The average contribution of dietary nicotine intake to urinary cotinine levels
might be expected to be below 1 ng/mL and somewhat higher under conditions of high
consumption of nicotine-containing foods.
       Several population-based studies examined cotinine levels in smokers, nonsmokers
reporting passive smoke exposure, and nonsmokers reporting no passive smoke  exposure (NRC,
1986; U.S. DHHS, 1986; Greenberg et al.,  1984; Wald et al., 1984; Wald and Ritchie, 1984; Jarvis
et al., 1985; Coultas et al., 1987; Riboli et al., 1990; Cummings et al., 1990; Tunstall-Pedoe et al.,
1991). These studies found that exposure  to ETS is highly prevalent even among those living with
a nonsmoker (e.g., Cummings et al., 1990). Saliva, serum, and urine cotinine levels in ETS-
exposed nonsmokers are generally higher than those in nonsmokers reporting no ETS exposure,
and levels of cotinine are considerably higher in smokers than those  in nonsmokers passively
exposed (e.g., Table 3-7).  Cotinine levels in nonsmokers exposed to ETS are approximately 1%  of
the levels in active smokers.  Cotinine levels of nonsmokers have been found  to increase with self-
reported  ETS exposure (e.g., Figures 3-15 and 3-16).
       In a  10-country study of ETS exposure of 1,369 nonsmoking women (Riboli et al., 1990),
average urinary levels of cotinine/creatinine by country ranged from approximately 2.5 ng/mg for
Shanghai to approximately 14 ng/mg for Trieste.  Eighty percent of  those sampled had a
detectable level of cotinine.  Statistically significant differences were observed between centers
with lowest values observed in Honolulu, Shanghai, and Chandigarh and the highest values in
Trieste, Los Angeles, and Athens. This study also found an increase in cotinine/creatinine levels
from the group of women reporting no ETS exposure either at home or work (lowest exposure) to
the group reporting ETS exposure both at home and at work, the highest exposure group
                                           3-42

-------
12
^ ^^
§ **
ll
*
1
1
p^
W v?
"|i
I
w
a
o
JK
|
w1
pi
'fe <*>
5* •«
J| "
|~
1
§
i

1
I
I
1
II
I
*&
#
1
a
S
2 ,
l|
id ^
8-
o
^

-
1
§
1
 o o o



oo *o «™^ o *o t^
o >X M  4)


   O O
   2 2
   o o
   e s

   Ii
  •b TJ
   £ £
   ca cti
   a a
     S
     8
8
on co
H H
     °
     en
     O
     2
   O O

   d d
   §§
   d d
   4) 4>
  X) X!
   en en


   ii
   eu 4>
   l-l tM
   a> eu
        00
        o\
Di

Di
         O
         1/3
3-43

-------
                             2S

                         01
                          o
                          I
                          cc
                             10
                                     :--!-    I
                                  HOHC   A UTTLE    SOUS     A LOT
                                  AT AU.
Figure 3-15. Distribution of individual concentrations of urinary cotinine by degree of self-
reported exposure to ETS. Horizontal bars indicate median values.
Source:  Jarvis and Russell, 1985.
                                            3-44

-------
                    O
                    o
 non«    1 or 2.
n=162   n=2O8
                                                 3 to 5  6 or more
                        Number of Exposures in the Past 4 Days
Figure 3-16. Urinary cotinine concentrations by number of reported exposures to tobacco smoke
in the past 4 days among 663 nonsmokers, Buffalo, New York, 1986.
Source: Cummings et al., 1990.
                                        3-45

-------
(Figure 3-17). The group of women reporting ETS exposure only at home had cotinine/creatinine
levels approximately 60% of those who reported exposure both at home and at work.
       Urinary cotinine levels also were found to increase with the number of questionnaire-
reported ETS exposures in a group of 663 never-smokers and ex-smokers (Cummings et al., 1990).
In that study, 76% of the subjects reported passive smoke exposure in the 4-day period preceding
the sampling.  Of the total sample, 91% had detectable cotinine levels.  Among the 76% reporting
ETS exposure, 28% reported exposure at work, 27% at home, 16%  in restaurants, 11% at social
gatherings, 10% in a car or airplane, and 8% in public buildings. Cotinine levels in this study
were also found to vary by month, with the winter months being associated with higher levels and
corresponding to higher reported exposures.
       Cotinine values in smokers and nonsmokers measured in both the laboratory or field
setting show considerable variability due to individual differences in the uptake, distribution,
metabolism, and elimination of nicotine.  Another issue to be considered in interpreting the field
data is that exposure status is determined by respondent self-reporting. This can lead to a
misclassification error, which tends to reduce the differences in cotinine levels  measured in the
ETS-exposed versus non-ETS-exposed groups and to increase the  variability in the levels within
any exposure category.  Within the exposed group, this misclassification error could either
increase or decrease the average cotinine levels measured.
       It is important to recognize that nicotine and  eotinine are actually proxy biomarkers. They
may not be the active agents  in eliciting the adverse effect under study but merely indicative of
the level of passive smoke exposure. Using these measures to estimate cigarette equivalents or
determine equivalent active smoking exposure could  result in over- or underestimating exposure
to individual or classes of compounds that may be more directly related to the health or nuisance
effect of concern.  Use of different biomarker proxies (e.g., protein adducts) could result in
estimates of much larger cigarette equivalent doses.
        Nevertheless, nicotine and cotinine levels in ETS-exposed  nonsmokers measured in
laboratory and field studies have been used to estimate cigarette equivalent exposures and to
equate ETS exposures with active smoker exposures (NRC, 1986; U.Sf DHHS, 1986; Jarvis, 1989).
On an equivalent cigarette basis, an upper-bound estimate of nicotine dose of 2.5  mg/day for a
passive smoke exposure has been proposed (Jarvis, 1989).  This would translate into the
equivalent of about one-fifth of a cigarette per day or about 0.7% of the average smoker's dose of
nicotine (cigarette equivalent dose of other toxins or carcinogens would be different—see above).
Comparisons of cotinine values in ETS-exposed nonsmokers with  those measured  in smokers
 ranged from 0.1% to 2%. One analysis proposed that, on average, nonsmokers' cotinine levels are
 0.5%-0.7% of those found in cigarette smokers (Jarvis, 1989).  It should  be noted that these
                                            3-46

-------
       a) Sampling categories of
          exposure


           loot > 0
                    b) Self-reported exposure
                   20
                                    15
                                    10
                                      0
                                              c) Self-reported
                                                 extreme patterns
                                                 of exposure

                                              20              -i 20
                                                    15
                                                    10
                                                                 15
                                                                                             z
                                                                                             r
                                                                 10
                                                                                            z
                                                                                            z
                                                                                          5I
                                                                    tj   0
                                                         NO      EXPOSURE
                                                         EXPOSURE FROM ALL
                                                         REPORTED SOURCES
 ALL
N°.   405
MEAN  3.1
                 350
                        270 N°.  271
      MEAN 5.0
268
6.1
 2M5
10.6
 269
11.0
1)29
5.6
172
7.8
                                                   335
                                                  10.8
 117
12.6
209
"t.S
 36
18.5
Figure 3-17.  Average cotinine/creatinine levels for subgroups of nonsmoking women defined by
sampling categories of exposure or by self-reporting exposure to ETS from different sources
during the 4 days preceding collection of the urine sample.

Source: Riboli et al., 1990.
                                             3-47

-------
estimations are based on a number of assumptions that may not hold (e.g., the half-life of nicotine
and cotinine in smokers and nonsmokers being the same).
       One of the protein adducts used as a biomarker of active and passive smoking is the 4-
aminobiphenyl adduct of hemoglobin.  One advantage of hemoglobin adducts is that their half-
life is quite long and they will persist through the life of a red blood cell, which is approximately
120 days.  Therefore, levels of 4-ABP-Hb adducts reflect exposures over the past several weeks,
rather than the day or two of exposure integration reflected by cotinine measurements.
       Tobacco smoke is the primary environmental source of 4-aminobiphenyl (its use in the dye
industry was discontinued decades ago), and smokers have between 5 and 8 times as much
4-ABP-Hb adducts as nonsmokers (Hammond et al.,  1990; Perera et al.,  1987; Maclure et al.,
1989).  That nonsmokers appear to have approximately 10-20% the adduct level as smokers may at
first appear to be contradictory to the urinary cotinine ratios of about 1%, but in fact both results
are quite consistent with our knowledge of the emissions of various contaminants in mainstream
and sidestream smoke.  Approximately twice as much nicotine is emitted in sidestream as in
mainstream smoke, but about 31 times as much 4-ABP is emitted in SS as in  MS. Thus, compared
to MS, SS is 15 times more enriched in 4-ABP than in nicotine. Similarly, the ratio of biomarkers
in those exposed to ETS compared with smokers is roughly 15 times greater for the biomarker 4-
ABP-Hb adducts than for the biomarker cotinine, a metabolite of nicotine.
        The above discussions indicate that the cigarette equivalent dose of those exposed to ETS
varies with the compound, so that a passive smoker may receive  1% as much  nicotine as an active
smoker but 15% as much 4-ABP. These examples demonstrate the importance  of careful
interpretation of biomarkers in estimating doses.

3.3.3.  Questionnaires for Assessing ETS Exposures
        Questionnaires are the most commonly used method to assess exposure to ETS in both
retrospective and prospective studies of acute and chronic effects. They are  the least expensive
method to obtain ETS exposure information for large populations. They can be used to provide a
simple categorization of ETS exposure, to determine  time-activity patterns of individuals (e.g.,
how much time is spent in environments .where smoking occurs), and to acquire information on
the factors or properties of the environment affecting ETS concentrations (e.g., number of
cigarettes smoked, size of indoor environments, subjective evaluation of level of smokiness).  The
time-activity pattern information is combined with measured or estimated concentrations of ETS
in each environment to provide an estimate of total exposure. Information on  the factors
affecting ETS concentrations is used to model or predict ETS levels in those  environments.
                                           3-48

-------
        Questionnaires are used most extensively to provide a simple categorization of potential
 ETS exposure (e.g., do you live with a smoker?, are you exposed to ETS at your place of work?,
 how many hours a week are you exposed to ETS?) and to obtain information on possible
 confounders (e.g., occupational history, socioeconomic status).  When used simply to determine a
 dichotomous exposure (ETS-exposed vs. unexposed), any misclassification tends to bias measures
 of association toward the null.  Thus, any effect that may be present will be underestimated or
 even may not be detectable.  If there are more than two exposure categories (e.g, light, medium,
 or heavy exposure), the intermediate categories of exposure may be biased either away from or
 toward the null.  Misclassification errors may arise from respondents' (1) lack of knowledge, (2)
 biased recall, (3) memory failure, and (4) intentional alteration of information.  Additionally,
 there are investigator-based sources of misclassification.  Errors may arise if semiquantitative
 levels are incorrectly imputed to answers; e.g., even if house exposures are higher than
 occupational exposures on average, for any given  individual the ranking may well be reversed
 from that of the average.
        In using questionnaires to assess exposure  categories to ETS, to determine time-activity
 patterns, and to acquire information on the factors affecting concentrations, it is important to
 minimize the uncertainty associated with the estimate and to characterize the direction and
 magnitude of the error.
        Unlike for active smoking assessment, standardized questionnaires for assessing ETS
 exposures in prospective or retrospective studies of acute or chronic health or nuisance effects do
 not exist.  Lebowitz et al. (1989) reported on an effort to develop a standardized questionnaire to
 assess ETS exposure in various indoor environments. This questionnaire, however, has not yet
 been validated.  Questionnaires used to assess ETS exposure typically have been developed, for
 specific studies and have not been validated for general use. There is no "gold standard" with
 which to validate the questionnaires. Various strategies, however, have been used to assess the
 validity of diverse types of questionnaires used to assess ETS exposure. Efforts  to validate
 questionnaires have used survey data, air monitoring of nicotine in various microenvironments,
 and nicotine or cotinine in body fluid samples.
        A recent study (Leaderer and Hammond, 1991)  of 96 homes using a questionnaire to assess
 residential smoking and a passive nicotine air monitor found that 13% of the residences reporting
 no smoking had measurable levels of nicotine while 28% of the residences reporting smoking had
 nondetectable levels of nicotine. A good level of agreement between questionnaire-reported
 number of cigarettes smoked and residential levels of ETS-related RSP and nicotine was observed
in this study (Figures 3-12a and 3-12b).
                                            3-49

-------
       Studies (Marbury et al., 1990; Coghlin et al., 1989; Coultas et al., 1987, 1990a, 1990b;
Riboli et al., 1990; Cummings et al., 1990) comparing various measures of ETS exposure (location
of exposure, intensity of exposure, duration of exposure, number of cigarettes smoked, etc.) with
cotinine levels measured in physiological fluids generally meet with only moderate success
(explained variations on the order of 40% or less).  The largest such study (Riboli et al., 1990) was
a collaborative effort conducted in 10 countries; correlations in the range of 0.3  to 0.51  (p < 0.01)
were found  between urinary cotinine levels and various measures of exposure derived from
questionnaire data. Using cotinine as a biomarker of exposure, studies indicated that a substantial
percentage of those reporting no ETS exposure by questionnaire do have measurable exposure.
Differences in the uptake, metabolism, and excretion of nicotine among individuals make it
difficult to use this measure as a "gold standard" in validating questionnaires^  Also, the recent
exposure (previous 1-2 days) that is measured by  cotinine may differ from usual exposure.
       In a study involving 10 homes with 20 nonsmoking and 11 homes with smoking residents,
the variability of four markers of ETS exposure (questionnaires,  cotinine in saliva and urine,
respirable suspended particle mass in air, and nicotine in air) was assessed (Coultas et al., 1990b).
Questionnaire-reported exposures explained less than 10% of the variability in air concentrations
of suspended particle mass and nicotine, 8% of the variability in urinary cotinine, and 23%  of the
variability in saliva cotinine. The authors concluded that multiple  exposure assessment
measurement tools were needed to assess ETS exposure in the home.
       In one effort to develop a validated questionnaire (Coghlin et al., 1989), 53 subjects were
asked detailed questions about their exposures to  ETS,  including location of exposures, number of
smokers, ventilation characteristics, number of hours exposed, proximity of smokers, and intensity
of ETS. They then wore a passive sampler for nicotine for 7 days and recorded  the same
information regarding each exposure episode in daily diaries.  Formulae were developed to  score
the exposures on both the questionnaire and the diary, and these scores were then correlated to the
average nicotine concentrations measured over the 7-day period.  Excellent correlation was found
(r* - 0.83 for the questionnaire and 0.90 for the diary). However,  the simple questions that have
been used most frequently in epidemiologic studies, such as  whether a subject lived with a  smoker
or the number of hours the subject was exposed,  were  not nearly as well correlated with the
measured exposures.  These results indicate that reliable  questionnaires can be developed, but that
those used in most studies in the past will lead to some random misclassification of exposure, and,
hence, underestimation of any effect that may be present.
       More recently, epidemiologic studies of acute and chronic respiratory effects in children
associated with ETS exposure have utilized questionnaires in combination with  measurements of
cotinine levels in physiologic fluids (Ehrlich et al., 1992; Reese et al., 1992; Etzel et al., 1992).
                                             3-50

-------
  The studies provide more of a direct link between questionnaire-assessed exposures and objective
  measures of exposure and disease. Such studies, discussed in Chapter 8, not only provide a means
  of validating questionnaires but also provide data to establish validation of the risk models used in
  Chapter 8.
         ETS exposures take place across a number of environments, with an individual's total
  exposure being a function of the amount of time spent in each environment and the concentration
  in that environment. Questionnaires need to assess exposures across indoor environments.
  Personal air monitoring provides a method  to validate  ETS exposure assessment questionnaires and
  to assess the contribution of each environment to total current exposure.
        Personal air monitoring and cotinine measurements in combination with questionnaires   ,
  have highlighted the importance of obtaining information on spouses' smoking status, smoking at
  home, smoking at work, smoking in various other indoor environments (social settings, vehicles,
  public places, etc.), amount of time in environments where smoking occurs, and the intensity of
 the exposure (Marbury et al., 1990; Coghlin et al., 1989; Coultas et al., 1987, 1990a, 1990b; Riboli
 et al., 1990; Cummings et al., 1990).

 3.4.  SUMMARY
        ETS is a major source of indoor air  contaminants.  The ubiquitous nature of ETS in indoor
 environments indicates that some unintentional inhalation of ETS by nonsmokers is virtually
 unavoidable. ETS is a dynamic complex mixture of over 4,000 chemicals found in both vapor and
 particle phases.  Efforts to characterize the physical and chemical properties of SS emissions,  the
 principal component of ETS, have found that: (1) MS and SS emissions are qualitatively very
 similar in their chemical composition, containing many of the same carcinogenic and toxic
 compounds, (2) several of these compounds, including five known human carcinogens, nine
 probable human carcinogens, three animal carcinogens, and several toxic agents, are emitted at
 higher levels in SS than MS smoke (sometimes by an order of magnitude  or more); (3) SS emissions
 of these notable air contaminants demonstrate little variability among brands of cigarettes. The
 enrichment of several known or suspected carcinogens in SS relative to MS smoke suggests that, the
 SS contaminant mix may be even more carcinogenic than the MS mix, per unit of tobacco burned.
       Sidestream emissions, while enriched in several  notable air contaminants, are quickly
 diluted into the environment where ETS exposures take place. Air sampling conducted in a
 variety of indoor environments has shown that nonsmoker exposure to ETS-related toxic and
 carcinogenic substances will occur in indoor spaces where there is  smoking occupancy.
Individuals close to smokers (e.g., an infant in a smoking parent's arms) may be directly exposed
                                          3-51

-------
to the plume of SS or exhaled MS, and thus be more heavily exposed than indoor measurements
from stationary air monitors might indicate.
       Given the complex nature of ETS, it is necessary to identify marker or proxy compounds
that when measured will allow for the quantification of exposure to ETS.  Vapor phase nicotine
and respirable suspended particle mass are two such markers that are suitable indicators of
exposure to ETS. Nicotine and RSP have been measured in personal monitoring studies and in
studies of a variety of indoor environments. The results of these studies clearly demonstrate that
reported exposure to ETS, even under the conditions of low frequency, duration, and magnitude,
will result in RSP and nicotine values above background.  These studies indicate that ETS
exposures take place in a wide range of environments (residences, workplaces, restaurants,
airplanes, etc.,) where smoking occurs.  Indoor levels of RSP and vapor phase nicotine have been
shown to vary in a linear fashion with reported tobacco consumption.  Nicotine levels measured
indoors have ranged from less than 1 ,*g/m3 to over 500 Mg/m3, while RSP levels have ranged
from less than 5 /ig/m3 to over 1 mg/m3. Nicotine exposures greater than  100 jig/m3 are
exceedingly rare; most environments measured have ranged from less than 0.3 (smoke free) to 30
/jg/m3; bars and smoking sections of planes may reach 50-75 ,*g/m3.  Thus, the normal range of
 ETS exposures is approximately 100-fold: 0.3 to 30 Mg/m3 for nicotine and from 5 to 500 /*g/m3
 for RSP.
        In residences with smoking occupancy, average daily or weekly nicotine values might
 typically range from less than 1  to 10 /ig/m3, varying principally as a function of number of
 smokers or number of cigarettes smoked.  Average daily or weekly residential concentrations of
 ETS-associated RSP could be expected to increase from 18 to 95 /.g/m3 (added to background
 levels) in homes where smoking occurs. Like nicotine, ETS-associated RSP increases with
 increased smoking.  Average levels of nicotine and RSP in offices with smoking occupancy are
 roughly comparable to those in homes.
        Cotinine in saliva, blood, and urine, while not an ideal biomarker, is the most widely
  accepted biomarker of ETS exposure.  Cotinine is an excellent indicator that ETS exposure has
  taken place.  It also establishes the link between exposure and uptake. Studies show that cotinine
  levels correlate with levels of ETS exposure. The available data also indicate that as many as 80%
  of nonsmokers are exposed to ETS and that there is variability in average exposure levels among
  nonsmokers in different geographical regions.
         Although average cotinine levels are a useful indicator of relative doses of ETS among
  different groups of nonsmokers, the ratio of cotinine levels in nonsmokers versus smokers may not
  be indicative of the exposure ratio for the active agents in ETS and MS responsible for the adverse
  effects. For example, while comparisons of cotinine levels in smokers and nonsmokers  have led to
                                             3-52

-------
 estimates that ETS-exposed nonsmokers receive from 0.1 to 0.7% of the dos.e of nicotine of an
 average smoker, ETS-exposed nonsmokers may receive 10-20% of the dose of 4-ABP that
 smokers inhale.
       Questionnaires are the most commonly used method to assess exposure to ETS in both
 retrospective and prospective studies of acute and chronic effects. They have been used not only
 to establish simple categories  of ETS exposure but also to obtain information on activity patterns
 of exposed individuals and on environmental factors affecting concentrations in different indoor
 environments. No standardized or validated questionnaires have yet been developed for assessing
 ETS exposure. A number of studies have compared questionnaire responses to measured air
 concentrations of nicotine and RSP and to cotinine levels. These efforts have indicated that a
 significant percentage of individuals  reporting no exposure had actually been exposed. In general,
questionnaires had moderate success in assessing exposure status and level of exposure.
Misclassification errors must be addressed when using questionnaires to assess ETS exposure.
       In summary, ETS represents an important source of toxic and carcinogenic indoor air
contaminants. The available data suggest that exposure  to ETS is widespread, with a wide range
of exposure levels.
                                          3-53

-------

-------
           4.  HAZARD IDENTIFICATION I:  LUNG CANCER IN ACTIVE SMOKERS,
             LONG-TERM ANIMAL BIOASSAYS, AND GENOTOXICITY STUDIES

  4.1. INTRODUCTION
         Numerous epidemiologic studies have conclusively established that the tobacco smoke
  inhaled from active smoking is a human lung carcinogen (U.S. DHHS, 1982; IARC, 1986). A clear
  dose-response relationship exists between lung cancer and amount of exposure, without any
  evidence of a threshold level. It is, therefore, reasonable to theorize that exposure to
  environmental tobacco smoke (ETS) might also increase the risk of lung cancer in both smokers
  and nonsmokers.
        As documented in the previous chapter, the chemical compositions of mainstream smoke
  (MS) and ETS are qualitatively similar, and both contain numerous known or suspected human
  carcinogens.  In fact, ETS contains essentially all of the same carcinogens identified in MS, and
  many of these appear in greater amounts in sidestream smoke (SS), the primary component of
  ETS, than in MS, per unit tobacco burned (Table 3-1). In addition,  both MS and SS have been
 shown to be carcinogenic in animal bioassays (Wynder and Hoffman, 1967; Grimmer et al., 1988),
 and MS, SS, and ETS have all been found to be genotoxic in in vitro systems (IARC, 1986).
 Furthermore,  as the previous chapter also describes, exposure assessments of indoor air and
 measurements of nicotine and cotinine levels  in nonsmokers confirm that passive smokers are
 exposed to and absorb appreciable amounts of ETS that might result in elevated lung cancer risk.
       This chapter reviews the major evidence for the lung carcinogenicity of tobacco smoke
 derived from human studies of active smoking and the key supporting evidence from animal
 bioassays and in vitro experiments.  The evidence from the few animal and mutagenicity studies
 pertaining specifically to ETS is also presented. The majority of this information has already been
 well documented by the U.S. Department of Health and Human Services (U.S. DHHS) (1982) and
 the International Agency for Research on Cancer (IARC) (1986).  The current discussion mainly
 extracts and summarizes some of the important issues and principal studies described in those
 comprehensive reports.
       In view of the abundant and consistent human evidence establishing the carcinogenic
 potential of active smoking to the lung, the bulk of this chapter focuses on the human data.
 Although EPA's carcinogen risk assessment guidelines (U.S. EPA, 1986a) suggest an extensive
 review of all evidence pertaining to carcinogenicity,  we believe that the large quantity of human
 cancer studies on both MS and ETS provide the most appropriate database from which to evaluate
 the lung cancer potential of ETS.  Thus, the animal evidence and genotoxicity results are given
only limited attention here. Similarly, a discussion of the mutagenicity data for individual smoke
                                          4-1

-------
components would be superfluous in the context of the overwhelming evidence from other, more
pertinent sources and is not included.  Extensive reviews of these data can be found in the
U.S. DHHS (1982) and IARC (1986) publications.  Claxton et al. (1989) provide an assessment of
the genotoxicity of various ETS constituents.

4.2. LUNG CANCER IN ACTIVE SMOKERS
       Studies of active smoking in human populations from many countries provide direct and
incontrovertible evidence for a dose-related, causal association between cigarette smoking and
lung cancer.  This evidence includes time trends in lung cancer mortality rates associated with
increasing cigarette consumption, high relative risks for lung cancer mortality in smokers of both
sexes observed consistently in numerous independent retrospective and prospective studies, and
dose-response relationships demonstrated with respect to smoking intensity and  duration and for
all four major histological types of lung cancer.

4.2.1. Time Trends
        While the overall cancer death rate in the United States has been fairly stable since 1950,
 the lung cancer death rate has increased drastically for both males and females (Figures 4-1 and
 4-2).  Age-adjusted lung cancer mortality rates in men have increased from  11  per 100,000 in
 1940 to 73 per 100,000 in 1982, leveling slightly to 74 per 100,000 in 1987 (Garfinkel and
 Silverberg, 1991). In women, lung cancer mortality rates have risen from 6 per 100,000 in the
 early 1960's to 28 per 100,000 in 1987 (Garfinkel and Silverberg, 1991).
        The striking time trends and sex differences seen in lung cancer mortality rates correlate
 with historical smoking patterns. Increases in lung cancer death rates parallel increases in
 cigarette consumption with a roughly 20-year lag  time, accounting for the latency period for the
 development of smoking-induced lung cancer. Males started smoking cigarettes in large numbers
 during the years around World  War I, whereas females did not begin smoking in appreciable
 numbers until World War II.  Cigarette consumption per capita (based on the total population age
  18 and older) in the United States rose from 1,085 in 1925 to a high of 4,148 in 1973. In the past
 two decades, cigarette consumption has decreased to 2,888 in 1989 (Garfinkel and Silverberg,
  1991). This decline correlates with the leveling off of lung cancer mortality rates in recent years.
                                              4-2

-------
              Rite per 100,000 mate population
eu
70
60
50
40
30
20
10
0
19,
Aj
DE
Se
Ui
1<


v'^
f-
/
-^.-^
I II
je-Adjusted Cancer
lath Rates* for
ilected Sites, Males,
lited States,
30-1986


^"\.
/"
/'
§


\.
-\ /
s
— • — -.•



-A
f
'*' "



^

	




/
	
\
.._--•
— .-.-



/


\ 	
-•._.-
-•-."."-


/


—
••^.
—
-:---:-

i



	 v,./-

3»— s

x





r^r.rz.7
^T~




__• —

^rr."
/




/

\
30 1940 1950 1960 1970 1980 199
	 Esophagus 	 Prostate • 	 Colon & Rectum
	 	 Lung 	 ••-. Bladder 	 Leukemia
Figure 4-1. Age-adjusted cancer death rates* for selected sites, males, United States, 1930-1986.



*Adjusted to the age distribution of the 1970 U.S. census population.



Source: U.S. DHHS, 1989.




                                             4-3

-------
            fiat* p«r 100,000 famafe population
80
70
60
50
40
30
20,
10
0
19

AI
Di
Oi
ol
u
11



^
--...


I
I
36-Adjusted Cancer
wth Rates* for
elected Sites, Female
nited States,
)30-1



"\
•...
	

30 19
	
986



-^=«
"V






s:
^
,---





\
V
..— •.-••^



IS,




-"-_'.
— v

^ZTZZ,







~\s
x-~ -

Jp**

40 1950 1960
Lung 	 fjyjry
Breast 	 Uterus
Psnrr*** ^^— — — — — Ctnm*f>h








vv.^
/
^-_,









/
'-
5=
1970







-^
^
"^sX.

19f
	 LJU
	 _ 1 tu.







	 s~

^••=;^







J>
*
>
w -
•M
\



JO 1990
n& Rectum
kemia
Figure 4-2. Age-adjusted cancer death rates* for selected sites, females, United States, 1930-
1986.

* Ad justed to the age distribution of the 1970  U.S. census population.

Source: U.S. DHHS, 1989.

                                             4-4

-------
 4.2.2. Dose-Response Relationships
        More than 50 independent retrospective studies have consistently found a dose-related
 association between smoking and lung cancer (U.S. DHHS, 1982). Eight major prospective studies
 from five countries corroborate this association:
        •   American Cancer Society (ACS) Nine-State Study (white males) (Hammond and Horn,
            1958a,b)
        •   Canadian War Veterans Study (Best et al., 1961; Lossing et al., 1966)
        •   British Doctors Study (Doll and Hill,  1964a,b; Doll and Peto, 1976; Doll et al., 1980)
        •   American Cancer Society 25-State Study (Hammond, 1966; Hammond and Seidman,
            1980)
        •   U.S. Veterans Study (Kahn, 1966; Rogot and  Murray, 1980)
        •   California Labor Union Study (Weir and Dunn, 1970)
        •   Swedish Study (sample of census population)  (Cederlof et al., 1975)
        •   Japanese Study (total population of 29 health  districts) (Hirayama, 1967, 1975a,b,
            1977, 1978, 1982, 1985).
        Details of the designs of these studies are summarized in Table 4-1. These eight studies
 together represent more than 17 million person-years and more than 330,000 deaths.  Lung cancer
 mortality ratios from the prospective studies are presented in Table 4-2.  Combining the data from
 the prospective studies results in a lung cancer mortality ratio of about 10 for male cigarette
 smokers compared with nonsmokers. (Note that these lung cancer mortality ratios underestimate
 the relative risk of lung cancer to smokers compared with a non-tobacco-smoke-related
 background risk to nonsmokers [see Chapter 6],  given the  causal association between ETS exposure
 and lung cancer in nonsmokers documented in this report.)
       This strong association between smoking and lung  cancer is further enhanced by very
 strong and consistent dose-response relationships.  A gradient of increasing risk for lung cancer
 mortality with increasing numbers of cigarettes smoked per day was established in every one of
 the prospective studies (Table 4-3).  Lung cancer mortality ratios for male smokers who smoked
 more than 20 cigarettes daily were generally 15 to  25 times greater than those for nonsmokers.
 Marked increases in lung cancer mortality ratios were also seen in all the lowest dose categories.
 Males who smoked fewer than 10 cigarettes per day had lung cancer mortality ratios 3 to 10 times
 greater than those for nonsmokers. There is no evidence of a threshold level for the development
 of smoking-induced lung cancer in any of the studies.
       Dose-response relationships with respect to the duration of smoking also have been well
established. From the British male physicians study, Peto and Doll (1984) calculated that the
                                           4-5

-------
Table 4-1. Main characteristics of major cohort studies on the relationship between smoking and
cancer
(Study.

 ACS
 9-state
 study

 Canadian
 veterans
 study
 British
 doctors
 study
Year of
enrollment


1952
1955-1956
 1951
Sample size;  ..
initial samples;
In brackets,
population for
followup
•MMBHB

204,547  men
[187,783]
 207,397
 subjects
 (aged 30+)
 [92,000]
 34,440 men
 (aged 20+)
                         6,194 women
                         (aged 20+)
  ACS
  25-state
  study
 1959-1960
  U.S.
  veterans
  study
 1954
  1,078,894
  subjects,
  first followup:
  440,558 men,
  562,671 women
  (aged 35-84);
  second followup:
  358,422 men,
  483,519 women

  293,958 men
  (aged 31-84)
  [248,046]
Source of
information on
smoking
(proportion of
respondents)
         of
followup
and no. of
deaths
Self-administered 44 months
questionnaire     11,870 deaths
Self-administered  6 years
questionnaire      9,491 deaths
(57%
respondents)
                                               in men;
                                               1,794 deaths
                                               in women
Self-administered  20 years
questionnaire      10,072 deaths
(69%
respondents)
                              Self-administered
                              questionnaire
                              (60%
                              respondents)
                                    22 years
                                    1,094 deaths
Completeness
of followup
for mortality^

98.9%
                                                              NA
 Self-administered 4.5 + 5 years
 questionnaire     26,448 deaths
                  in men;
                  16,773 deaths
                  in women
 Self-administered 16 years
 questionnaire     107,563 deaths
 (85%
 respondents)
 llCalifornia   1954-1957  68,153 men       Self-administered  5-8 years
  study                   (aged 35-64)      questionnaire      4,706 deaths
                                                                           99.7%
                                                                            99%
                97.4% in
                women
                97.9% in men
                in first
                followup
                 Almost 100%
                 ascertainment
                 of vital status;
                 97.6% of death
                 certificates
                 retrieved

                 NA
                                                            (continued on the following page)
                                             4-6

-------
Table 4-1. (continued)
Sample size;
initial samples;
In brackets*
Year of population for
Study enrollment followup
Swedish 1963
study
Japanese 1965
study
27,342 men,
27,732 women
(aged 18-69)
122,261 men,
142,857 women
(aged 40+)
Source of
information on
smoking
(proportioa of
respondents)
Self-administered
questionnaire
(89%
respondents)
Interview
(95% of
population in
area)
Duration of
followup
and no. of
deaths
10 years
5,655 deaths
(2,968
autopsies)
16 years
51,422 deaths
Completeness
of followup
for mortality
NA
Total
NA = not available.
Source:  IARC, 1986.
                                            4-7

-------
Table 4-2. Lung cancer mortality ratios—prospective studies
Population
British
doctors study
Swedish
study
Japanese
study
ACS 25-state
study
U.S. veterans study
Canadian
veterans study
ACS 9-state
study
California males
in 9 occupations
•• •> '
Size
34,000 males
6,194 females
27,000 males
28,000 females
122,000 males
143,000 females
358,000 males
483,000 females
290,000 males
78,000 males
188,000 males
68,000 males
Numbet
of deaths
441
27
55
8
940
304
2,018
439
3,126
331
448
368
Nonsmokers
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
Cigarette
smokers
14.0
5.0
7.0
4.5
3.76
2.03
8.53
3.58
11.28
14.2
10.73
7.61
Source:  U.S. DHHS, 1982.
                                            4-8

-------
Table 4-3. Lung cancer mortality ratios for men and women, by current number of cigarettes
smoked per day—prospective studies
Men
Population
ACS 25-state
study



British
doctors
study

Swedish study



Japanese study
(all ages)


U.S. veterans
study



ACS 9-state
study


Canadian
veterans study


California
males
in 9
occupations
Cigarettes
smoked pet day
Nonsmoker
1-9
10-19
20-39
40+
Nonsmoker
1-.14
15-24
25+
Nonsmoker
1-7
8-15
16+
Nonsmoker
1-19
20-39
40+
Nonsmoker
1-9
10-20
21-39
:>40
Nonsmoker
1-9
10-20
20+
Nonsmoker
1-9
10-20
20+
Nonsmoker
about i pk
about 1 pk
about 11 pk
Mortality
ratios
1.00
4.62
8.62
14.69
18.71
1.00
7.80
12.70
25.10
1.00
2.30
8.80
13.70
1.00
3.49
5.69
6.45
1.00
3.89
9.63
16.70
23.70
1.00
8.00
10.50
23.40
1.00
9.50
15.80
17.30
1.00
3J2
9.05
9.56
Women
Cigarettes
smoked per day
Nonsmoker
1-9
10-19
20-39
40+
Nonsmoker
1-14
15-24
25+
Nonsmoker
1-7
8-15
16+
Nonsmoker
<20
20-29


















Mortality
ratios .
1.00
1.30
2.40
4.90
7.50
1.00
1,28
6.41
29.71
1.00
1.80
11.30
'' •'
1.00
1.90
4.20


















Source:  U.S. DHHS, 1982.
                                          4-9

-------
excess annual incidence rates of lung cancer after 45, 30, and 15 years of cigarette smoking were
in the approximate ratio of 100:20:1 to each other. The California and Swedish studies also
demonstrated an increasing risk of lung cancer in men  with longer smoking duration (Table 4-4).
       Four of the prospective studies examined lung cancer mortality in males by age at
initiation of smoking and found increasing risk with younger age (Table 4-5). Some of the studies
also investigated smoking cessation in men and observed a decrease in lung cancer risk with
increasing number of years since quitting smoking (Table 4-6). The Cancer Prevention Study II, a
study of 1,200,000 people in all 50 states, reveals a similar trend for women who quit smoking
(Figure 4-3). The occurrence of higher lung cancer mortality ratios in the groups with only a few
years since cessation as compared with current smokers (Table 4-6 and Figure 4-3) is attributable
to the inclusion of recent ex-smokers who were forced to stop smoking because they already had
smoking-related symptoms or illness (U.S. DHHS, 1990a). The increased lung cancer risks seen in
people who started smoking at a younger age and the decreased risks seen with time since smoking
cessation suggest both initiation and promotion capabilities of tobacco smoke components.
        Additional dose-response relationships have been derived from consideration of the types
of tobacco products used.  Pipe and cigar smokers, who inhale less deeply than cigarette smokers,
have lower risks of lung cancer than cigarette smokers (Table 4-7).  Furthermore, the American
Cancer Society 25-state study found decreased risks for lung cancer in males and females who
smoked cigarettes with lower tar and nicotine content compared with those who smoked cigarettes
with higher tar and nicotine content (Table 4-8), although these decreased risks are still
substantially higher than the risk to nonsmokers. Similarly, it has been established that smokers of
filtered cigarettes have relatively lower lung cancer risks than smokers of nonfiltered cigarettes
(Table 4-9).  Filters reduce the amount of tars, and hence a portion of the carcinogenic agents, in
the MS inhaled by the smoker.  Passive smokers, however, do not share in any benefit derived
from cigarette filters (see Chapter 3) and may, in fact, be exposed to greater amounts of ETS if
smokers of filtered cigarettes smoke a greater number  of cigarettes to compensate for any
reduction in nicotine uptake resulting from the filters (U.S. DHHS, 1986).

4.2.3. Histological Types of Lung Cancer and Associations With Smoking
        A number of epidemiologic studies have also examined the association between various
histological types of lung cancer and smoking. The results of some of these investigations are
summarized in Table 4-10.  Problems in interpreting the results of such studies include
differences in the nomenclature, criteria, and verification of tumor classification; inadequacy of
some specimens; and the small size of many of the patient groups, resulting in unstable risk
                                            4-10

-------
 Table 4-4. Relationship between risk of lung cancer and duration of smoking in men, based on
 available information from cohort studies
f

Reference
Weir and Dunn
(1970)


Cederlof et al.
(1975)



Duration of smoking
(years)
1-9
10-19
20+
Nonsmokers
1-29
>30
Nonsmokers
Standardized
mortality ratio
(no. of observed
deaths)
1.13
6.45
8.66
1.0
1.8 (5)
7.4 (23)
1.0(7)

Approximate annual
excess death rate
\ /V f
0.002(0.001)
0.09 (0.05)
0.12 (0.08)
0
0.01 (0.008)
0.1 (0.06)
0 • .. .
 The mortality ratio among nonsmokers was assumed to be 15.6 per 100,000 per year, as in the
 American Cancer Society 25-state study. Figures in parentheses were computed by the IARC
 working group, applying the British doctors' mortality rate among nonsmokers (10.0/100,000
 per year).                                                                           ,

Source:  IARC, 1986.
                                         4-11

-------
Table 4-5. Lung cancer mortality ratios for males, by age of smoking initiation—prospective
studies
v. ••' '
•.
Study " s \ ^ :
ACS 25-state
study


Japanese
study

U.S. veterans study




Swedish
study

Age of \
smoking initiation
in years
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^g^^M«|^aMM|HMM
^^H^^^^^B^^^^^HI^^^^^^^^^^^^^^™^^^^^^^^^^^^^^^^^"
Nonsmoker
25+
20-24
15-19
Under 15
Nonsmoker
25+
20-24
Under 20
Nonsmoker
25+
20-24
15-19
Under 15
Nonsmoker
19+
17-18
Under 16
X tA •" f •>
""^ ' ' ^Mortality
r ' ' "'f ratio
JMB^^HHIi^^^HMI^^^M^^^^^^^^^^^^^^^^^^^^^^^^^
1.00
4.08
10.08
19.69
16.77
1.00
2.87
3.85
4.44
1.00
5.20
9.50
14.40
18.70
1.00
6.50
9.80
6.40
 Source:  U.S. DHHS, 1982.
                                             4-12

-------
 Table 4-6.  Relationship between risk of lung cancer and number of years since stopping
 smoking, in men, based on available information from cohort studies
  Reference
 No, of years since
 stopping smoking
     Mortality ratio
(no. of observed deaths)
  ACS
  25-state study
  (Hammond, 1966)
  Swedish study
  (Cederlof et al.,
  1975)


  British doctors
  study (Doll and Peto,
  1976)
  Rogot and Murray (1980)
 1-19 cig./day
 Current smokers

 1-4
 5-9
 10+
 Nonsmokers

 20+ cig./day
 Current smokers

 1-4
 5-9
 10+
 Nonsmokers
Nonsmokers


Current smokers
1-4
5-9
10-14
15+
Nonsmokers


Current smokers
<5
5-9
10-14
15-19
20+
Nonsmokers
        6.5 (80)
        7.2 (3)
        4.6 (5)
        1.0(1)
        0.4 (1)
        1.0(32)
       13.7 (351)
       19.1 (33)
       12.0 (33)
        7.2 (32)
        1.1 (5)
        1.0(32)


        6.1 (12)
        1.1 (3)
        1.0(7)


       15.8 (123)
       16.0(15)
        5.9 (12)
        5.3 (9)
        2.0 (7)
        1.0(7)


       11.3(2,609)
       18.8 (47)
      -7.5 (86)
      -5.0 (100)
      -5.0(115)
        2.1 (123)
        1.0 NA
NA = not available.

Source:  IARC, 1986.
                                          4-13

-------
                                                               32.4
                                                         21.2
                       13.6
                 10.3   •




           .Illll-   .
                                                                    20.3
                                                                          11.4
           Never  Current  s2    3-5   6-10  11-15   16+   Never  Current  s2   3-5  6-10   11-15  16 +
          Smoked Smokers                             Smoked Smokers
                              Years of Cessation
                                                                      Years of Cessation
                   Smoked 1-20 Cigarettes a Day
Smoked 21 or More Cigarettes a Day
Figure 4-3.  Relative risk of lung cancer in ex-smokers, by number of years quit, women, Cancer
Prevention Study II.

Source:  Garfinkel and Silverberg, 1991.
                                                4-14

-------
Table 4-7.  Relative risks of lung cancer in some large cohort studies among men smoking
cigarettes and other types of tobacco
Study
ACS 9-state
study1





Canadian
veterans
study


ACS 25-state
study1




Swedish study1





Smoking category
Never smoked
Occasionally only
Cigarettes only
Cigars only
Pipes only
Cigarettes + other
Cigars + pipes
Nonsmokers
Cigarettes only
Cigars only
Pipe only
Ex-smokers
Never smoked
Cigarettes only
Cigars only
Pipes only
Cigarettes + other
Cigars + pipes
Nonsmokers
Cigarettes only
Cigarettes + pipe
Pipe only
Cigars only
Ex-smokers
Relative
risk
1.0
1.5
9.9
1.0
3.0
7.6
0.6
1.0
14.9
2.9
4.4
6.1
1.0
9.2
1.9
2.2
7.4
0.9
1.0
7.0
10.9
7.1
9.2
6.1
Death rate
per 100^000
12.8
19.2
27.2
13.1
38.5
97.7
7.3





12
111
22
27
89
11






No. of
cases
15
8
249
7
18
148
3
7
325
2
18
18
49
719
23
21
336
11
7
28
27
31
.6
12
                                                         (continued on the following page)
                                          4-15

-------
Table 4-7. (continued)
Study
British doctors
study




U.S. veterans
study1




Norwegian
study1



"S" ~
Smoking category
Nonsmokers
Current smokers
Cigarettes only
Pipes and/or cigars only
Cigarettes + other
Ex-smokers
Nonsmokers
Cigarettes
Cigarettes only
Cigars only
Pipes only
Ex-cigarette smokers
Nonsmokers
Cigarettes
Cigarettes only
Pipes or cigars only
Ex-smokers
, Relative
risk
1.0
10.4
14.0
5.8
8.2
4.3
1.0
11.3
12.1
1.7
2.1
4.0
1.0
9.7
9.5
2.6
2.8
Death rate
per 100,000
10
104
140
58
82
43











- No. of
cases






2,609
1,095
41
32
517

7
88
70
12
11
 JFigures given in original report.



 Source: IARC, 1986.
                                            4-16

-------
 Table 4-8. Age-adjusted lung cancer mortality ratios for males and females, by tar and nicotine
 (T/N) in cigarettes smoked

High T/N1
Medium T/N
Low T/N
Males
1.00
0.95
0.81
Females
1.00
0.79
0.60
 *The mortality rate for the category with highest risk was made 1.00 so that the relative reductions
 in risk with the use of lower T/N cigarettes could be visualized.

 Source: U.S. DHHS, 1982.
Table 4-9.  Relative risk for lung cancer by type of cigarette smoked (filter vs. nonfilter), in men,
based on cohort and case-control studies
Reference ,,„ ,
Hawthorne and
Fry (1978)
Rimington(1981)
Bross and Gibson (1968)
Wynder et al. (1970)
Dean et al. (1977)
Type of Study
Cohort
Cohort
Case-control
Case-control
Case-control
Relative risk
0.8
0.7
0.6
0.6
0.5
Source:  IARC, 1986.
                                           4-17

-------
                                                                                           CM
                                                       OO
 a
 n «

                         Tj- •-( O —<
                           cM oo oo
                                                                  CM
                                            I

                                                                  CM
                      o a  —••
                                         CCJ
                                   I
                                   
                                         O CN
                                         CM -+
                                         o co
                                         _i O

                                         o c>
                                                    CM
                                                                               C5 O
•a
      1
       00
     i—<


oo   oo
V-.    l-i
(U    >
              o **
                                                    
-------
•o
a>
§
o

I
g

*5
u















£
"•3
§>
flrf










n
S

®
a
S
S
N<
o-

"3 ® ' ®
(3 w •« 2 "H
4) ^ *CS Q!
S *"* o* ?3
O § 0 *3 <
££ g 2 !
CO ^%
JS "°
2 j2"
1 3
W &
t! ~H
>
'3 rt
5 5
Q 3 O
•ri oo cj
s i9 a
^ PS »—H
^* V

2 § C B
c o u a>
•5 'SS-S
S 8 2? g
••3 o'3 "
13
73
i OT
55 , «
«I
a>


AS
I|
•7 s
^-< ^

1


O 00
r~* oo




r- ON
. •
^^ fNj




V.O \f\
•* -J
CN —<




>O CN
 (H
N /— s
C3 si ^"
Q^ dl ^O
c& rt ^
ffiHC^
f
a
a>
g
1







73
g
rt *v_
co 0)
O TO
g g
CO V
§ "

*• z
^^
»
g
.
O
3 "g
73
I g
c a

\"
S8








/— N — ' ~+Jr >«^v«^
^^ ^' CS V>
CN *"*











P ^












<*\ y^V
•^- rsij CNI ^-^
>— ' >J' >— ' _.
.
OO O>


•o
1
d ° t) *


>>
3 ^^
* "*
fS SO
cd Os
53 C,
«r^


Squamous-cell
carcinoma
Adenocarcinoma








                                                                            0>

                                                                            I


                                                                           I
                                                                           J2
                                                                           "3
                                                                            §




                                                                           1
                                                                            o
                                           4-19

-------
 s
I
         O
         S
         W

        i
         00
I

I
O O IO  O Ol^




IN O rrt  O Ol «">


O CN O  O Ol «N



IN fN o  O Ol ^3"


o 
                                                    3
                                                    oo
                                                   •«-i
                                                    o
                                                            I
                                                                      e
                                                                             O —J Op
                                                                         ON
                                                                     4>
                                                                     §>
                                                                     .8.
                                                                    I
                                                                     o
                                                                                             I
                                                                                             §
                                                                                             •d
                                                                                             I
                                                                                           ir>
                                              eo|
                                                                  X
                                                                                ON •— i
                            ~* oo
                                       ivo
                                       |vo
                         o rt  ^T TT

                                                                 "^ TT  »-H •—(  .ON co
                                                                 ON r\|  vo tN  ON 10
                   rt
                                 ON r-
                                  cti

"3
.a
 oo


                                                                          8?
                                                                          
-------
•o


I
 o
 o
{3
O
U







tn
IB








^

;1
s
.9
0
c
18
: »




o^o
52 2^2
 >_^>^.*— '
Q O f*"l ON
1 "~

's
,0 52 o ON ON
a § *~
s S
£2



^L tn
Jj g O O4  <^
-<" -S, M A o o o o
if?"
i ^Ot-vOO OO1*
•o
.Q'
fl> *$•
O ^" ^ *o V* ro ^H
s - • •
tn
go
w T^
c3 J OQ i^ ^j
W ^-v
4-. t-
S c\
0 O
> "3
                                                                                                          CD

                                                                                                          g?
                                                                                                          Q.


                                                                                                          a*
                                                                                                          
-------
T)
d)
O
o
I


V

13
C
I
U



















"S
1

i
P*
+-•
*3
.2
DO
_o
"o
*•*
CO
a
,
t§
DO
IS
O

^j
0
1«
>S 3
•^ *•

S
1
O

1*8
IB

«— ;
<
0
ll
52
eu
W C-g
Is
l<^ CO

rr -J

vq vq
CN -<


01 00



.CO -4

•^t "^f
CO «

vq cr\
CO -^

o o
1
73 2
Hi
sll
3SS
° JL °
SsJ
0-133
OQ <

•fa» "v
CO ^*
e3 O
A •
CJ-rt
c>
•— '-
to"
O
g
CO
C
o
Z


"F
C3
00

^
O
CO
C4~t
O
C
O
• fH
•o
>>
2
•s
1
•s





(D
S
0
^








1



o

C7\
0
•T
ON
CO
1
O
CO


0\
+
o
>r»
T
o.
o
CO
0
CO
o\
O\ o co -*
— ,*• oo co'
UO ^  CM' «•» r-'



. ^* — < O\ CM
•*' « co 1-; oo
ON  CO VO t~
-H CM
c> o C3 -^;
wi CM" vd vd
-« CM
•o
- 11 1
"S 2-2 £
V « -3 d a* c2 ca
|1||1||


*^-s
>. — ' 00
« * o\
H, « O
                                                                        U
                                                                        CO
                                                                        U
                                                                        3
                                                                        O
                                         4-22

-------
estimates, particularly in women.  There are four major histological types' of lung cancer:
squamous-cell carcinoma, small-cell carcinoma, adenocarcinoma, and large-cell undifferentiated
carcinoma. Sometimes two broad categories—Kreyberg Group I, containing squamous-cell and
small-cell carcinomas, and Kreyberg Group II, containing all other epithelial lung cancers,
including adenocarcinomas and large-cell undifferentiated carcinomas—are used for classification.
The majority of the studies demonstrate an increase in the risk for lung cancer with increasing
amount smoked for all four major histological groups in both males  and females. The slope of the
gradient for adenocarcinomas, however, is shallower than the slopes for the other types.

4.2.4.  Proportion of Risk Attributable to Active Smoking
       Table 4-11 presents data on the proportion of lung cancer deaths attributable to smoking
in various countries.  Differences by sex and between countries largely correlate with differences
in the proportion of smokers within these populations and the duration and intensity of cigarette
usage.  In the early 1960s, 50% of U.S. men and 30% of U.S. women smoked, although these
proportions have been declining in recent years (Garfinkel and Silverberg, 1991).
       In the United States, deaths from lung cancer currently represent one-quarter of all cancer
deaths.  The American Cancer Society predicted there would be 143,000 lung cancer deaths in
1991 (Garfinkel and Silverberg, 1991).  Over 85% of this lung cancer mortality is estimated to be
attributable to tobacco smoking. In other words, the overwhelming majority of lung cancer
deaths, which are a significant portion of all cancer deaths, result from smoking. The strong
association between smoking and lung cancer and the dose-response relationships, with effects
observable at low doses and no evidence of a threshold, make it highly plausible that passive
smoking also causes lung cancer in humans.

4.3. LIFETIME ANIMAL STUDIES
       The human evidence for the carcinogenicity of tobacco smoke is corroborated in
experimental animal bioassays.  The main animal evidence is obtained from inhalation studies in
the hamster, intrapulmonary implantations in the rat, and skin painting in the mouse. There are
no lifetime animal inhalation studies of ETS;  however, the carcinogenicity of SS condensates has
been demonstrated in intrapulmonary implantations and skin painting experiments.
       Negative responses in short-term animal studies (e.g., 60 to 90 days) are not reliable
indicators of the carcinogenic potential of a compound because of the long latency period for
cancer development.  Long-term animal studies at or near the maximum tolerated dose level are
used to ensure an adequate power for the detection of carcinogenic activity (U.S. EPA, 1986a).
                                           4-23

-------
Table 4-11. Lung cancer deaths attributable to tobacco smoking in certain.countries

Country
Canada
Men
Women
England and Wales
Men
Women
Japan
Men
Women
Sweden
Men
Women
USA
Men
Women
•, '
'Year ''
1978
1978
1981
1981
1981
1981
1981
1981
1979
1979

NO, of
deaths1 M
6,435
1,681
26,297
8,430
16,638
6,161
1,777
654
72,803
25,648
, 7 •'
Expected
deaths in
556
487
1,576
1,663
2,868
2,593
301
281
5,778
5,736
. Crude
persons
Observed
142.8
34.0
228.5
63.3
64.8
21.0
85.0
28.0
166.7
50.0
rate in
aged 35-f
, , In non-
smokers
11.8
9.9
13.3
12.4
10.7
8.9
14.0
12.3
12.7
11.1

" "AC3 AJ>*
5,762 0.9
1,194 0.71
24,720 0.94 /
6,767 0.80
13,184 0.83
3,568 0.58
1,476 0.83
373 0.57
67,024 0.92
19,912 0.78
       the Global Epidemiological Surveillance and Health Situation Assessment data bank of
 WHO.
Calculated by IARC, 1986.  Slightly overestimates number of expected deaths.
3AC, number of cases attributable to smoking.
4AP, proportion of cases attributable to smoking.

Source: IARC, 1986.
                                           4-24

-------
4.3.1.  Inhalation Studies
       Although evidence of the carcinogenicity of cigarette smoke originated in humans,
attempts were made to develop an inhalation model for smoking in experimental animals in order
to study the carcinogenicity of various tobacco products. Such inhalation studies are difficult to
conduct, however, because  laboratory animals are reluctant to inhale cigarette smoke and will
adopt shallow breathing patterns in response to aerosols and irritants.  Furthermore, rodents are
obligatory nose-breathers, and the anatomy and physiology of the respiratory tract and the
biochemistry of the lung differ between rodents and humans. Because of these distinctions,
laboratory animals and humans are likely to have different deposition  and exposure patterns for
the various cigarette smoke components in the respiratory system. For example, rodents have
extensive and complex nasal turbinates where significant particle deposition could occur,
decreasing exposure to the lung.
       The Syrian golden hamster has been the most useful animal inhalation model found so far
for studying smoking-induced carcinogenesis.  It is more tolerant of tobacco smoke than mice and
rats and is relatively resistant to respiratory infections. The hamster also has a low background
incidence of spontaneous pulmonary tumors and is, in fact, refractory to the induction of lung
cancers by known carcinogenic agents.  The inhalation of tobacco smoke by the hamster does,
however, induce carcinomas of the larynx.  In one study (Dontenwill et al., 1973), three groups of
80 male and 80 female Syrian golden  hamsters were exposed for 10 minutes to air-diluted
cigarette smoke (1:15) once, twice, or three times daily, 5 days per week, for their lifetimes.
Preinvasive carcinomas of the upper larynx were detected in 11.3%, 30%, and 30.6% of the
animals, respectively,  and invasive carcinomas were found in 0.6%, 10.6%, and 6.9%, respectively.
No laryngeal tumors were observed in control animals. In another experiment, exposure for 59 to
80 weeks to an 11% or 22% cigarette smoke aerosol twice daily for 12 minutes resulted in
laryngeal carcinomas in 3 of 44 and 27 of 57 animals, respectively, providing some evidence of a
dose-response relationship for the induction of carcinoma of the larynx by cigarette smoke
(Bernfeld et al., 1979). Bernfeld et al. suggest that the greater deposition of tar per unit of surface
area in the larynx compared to the lung may explain the high yield of  laryngeal cancers and lack
of lung tumors in this  animal model.

4.3.2.  Intrapulmonary Implantations of Cigarette Smoke Condensates
       Because of the difficulties with inhalation studies of cigarette smoke, some in vivo studies
examine the carcinogenicity of cigarette smoke condensate (CSC) collected from smoking
machines. CSC assays may  not, however, reveal all of the carcinogenic activity of actual cigarette
smoke, because these condensates lack most of the volatile and semivolatile components of whole
                                           4-25

-------
smoke.  In lifetime rat studies, intrapulmonary implants of MS condensate in a lipid vehicle cause
a dose-dependent increase in the incidence of lung carcinomas (Stanton et al., 1972; Dagle et al.,
1978).
       SS condensates have also demonstrated carcinogenicity when implanted into rat lungs
(Grimmer et al., 1988). SS emitted by a smoking machine was separated into condensate fractions
containing the semivolatiles, the polycyclic aromatic hydrocarbon (PAH)-free particulates and the
PAHs with two or three rings, or the PAHs with four or more rings. These fractions were
implanted into female Osborne-Mendel rats, following the procedure of Stanton et al. (1972), at a
dose level of one cigarette per animal. At the end of the lifetime study, none of the 35 rats in
each of the untreated control, vehicle control, or semivolatile-exposed groups had lung
carcinomas. In the group exposed to the fraction containing PAH-free particulates and PAHs
with 2 or 3 rings, there was 1 lung carcinoma in 35 animals. In the group exposed to the fraction
comprising PAHs with 4 or more rings, there were 5 lung carcinomas in 35 rats. An additional
group that was exposed to a dose of 0.03 mg benzo[a]pyrene (BaP) per rat exhibited  3 lung
carcinomas in 35 animals.  The condensate fraction containing BaP and the other PAHs with four
or more rings from the SS generated by a single cigarette contains about 100 ng of BaP. Assuming
a linear, nonsynergistic dose-response relationship, this would suggest that less than 1% of the
total carcinogenicity of that condensate fraction can be attributed to the BaP present in the smoke.

4.3.3.  Mouse Skin Painting of Cigarette Smoke Condensates
       In addition,  numerous studies have shown that when MS condensate suspended in acetone
is chronically applied to mouse skin, significant numbers of the mice develop papillomas or
carcinomas at the site of application (e.g., Wynder et al., 1957; Davies and Day, 1969). Mouse
skin studies have also demonstrated that MS condensate has both tumor-initiating and tumor-
promoting capabilities (Hoffman and Wynder, 1971).
       One mouse skin painting study examined the carcinogenicity of SS condensate (Wynder
and Hoffman, 1967). Cigarette tar from SS deposited on the funnel of a smoking machine was
suspended in acetone and administered to mouse skin. Fourteen of thirty mice  developed skin
papillomas, and 3 of 30 developed carcinomas.  In a parallel assay in the same study, a suspension
of MS condensate applied to deliver a comparable amount of condensate to the skin of 100 mice
yielded benign skin tumors in 24 and malignant tumors in 6 of the mice.  This suggests that the
condensate of SS has greater mouse skin tumorigenicity per unit weight than that of MS.
                                           4-26

-------
 4.4. GENOTOXICITY
        Supportive evidence for the carcinogenicity of tobacco smoke is provided by the
 demonstration of genotoxicity in numerous short-term assays. Extensive reviews of these studies
 can be found in IARC (1986) and DeMarini (1983); only the highlights are presented here. A few
 studies  deal with whole smoke, but most examine CSC. Tobacco smoke is genotoxic in virtually
 every in vitro system tested, providing overwhelming supportive evidence for its carcinogenic
 potential.
        In Salmonella typhimurium, for example, Basrur et al. (1978) found that both whole MS
 and MS condensates from various types of tobacco were mutagenic in the presence of a metabolic
 activating system. SS (Ong et al.,  1984) and extracts of ETS collected from indoor air (Lofroth et
 al., 1983; Alfheim and Ramdahl, 1984; Lewtas et al., 1987; Ling et al., 1987; Lofroth et al., 1988)
 also exhibit mutagenic activity in  this bacterium. Claxton et al. (1989) found that SS accounted
 for approximately 60% of the total S. typhimurium mutagenicity per cigarette—-40% from the SS
 particulates and 20% from the semivolatiles.  The highly volatile fraction, from either MS or SS,
 was not mutagenic.
       Similarly, cigarette smoke  produced mitotic gene conversion, reverse mutation, and
 reciprocal mitotic recombination in fungi (Gairola, 1982). In addition,  CSC's induce mutations,
 sister chromatid exchanges, and cell transformation in various mammalian cells in culture.
 Putnam et al. (1985) demonstrated dose-dependent increases in sister chromatid exchange
 frequencies in bone-marrow cells  of mice exposed to cigarette smoke for 2 weeks.

 4.5. SUMMARY AND CONCLUSIONS
       Lung cancer mortality rates have increased dramatically over the past 60 years in males,
 and, more recently,  in females, with increasing cigarette consumption.  High relative risks for
 lung cancer, associated with the number of cigarettes smoked  per day, have been demonstrated in
 countless studies, with no evidence of a threshold level of exposure. Active smoking induces  all
 four major histological types of human lung cancer—squamous-cell carcinomas, small-cell
 carcinomas, large-cell carcinomas, and adenocarcinomas~all in a dose-related manner. Dose-
 response relationships have also been established with respect  to duration of smoking.
 Furthermore, lung cancer risk increases with the younger the age at initiation of smoking and
decreases with the longer the time since cessation of smoking. These latter trends, coupled with
evidence from mouse skin painting studies, suggest that tobacco smoke has both tumor-initiating
and tumor-promoting capabilities.
                                           4-27

-------
       Inhalation studies in hamsters confirm that MS is carcinogenic to the respiratory tract. In
addition, mouse skin painting experiments and intrapulmonary implantations in rats have
demonstrated the carcinogenicity of condensates from both MS and SS (the primary component of
ETS), with SS condensate having a greater potency than MS condensate in mouse skin painting
studies. Numerous genotoxicity tests contribute supporting evidence for the carcinogenic
potential of MS and SS smoke and smoke condensates.  The mutagenicity of ETS and its extracts
has also been established.  One study found that SS accounted for 60% of the total mutagenicity
per cigarette.
       As discussed in Chapter 3, MS and ETS are qualitatively similar in composition, and both
contain numerous known or suspected human carcinogens. ETS constituents include  essentially all
of the same carcinogens found in MS, and many of these appear in greater amounts in SS, and
hence, in ETS, than in MS, per unit of tobacco burned. This quantitative comparison is  consistent
with the observation noted above that SS condensates apparently have even greater carcinogenic
potential than MS condensates.
       The unequivocal causal association between tobacco smoking and lung cancer in humans
with dose-response relationships extending down to the lowest exposure categories, as well as the
corroborative evidence of the carcinogenicity of both MS and ETS provided by animal bioassays
and in vitro studies and the chemical similarity between MS and ETS (Chapter 3), clearly establish
the plausibility that ETS is also a human lung carcinogen. In addition, biomarker studies verify
that passive smoking results in detectable uptake of tobacco smoke constituents by nonsmokers,
affirming that ETS exposure is a public health concern (Chapter 3).
        In fact, these observations are sufficient in their own right to establish the carcinogenicity
of ETS to humans.  According to EPA's Guidelines for Carcinogen Risk Assessment (U.S. EPA,
 1986a), a Group A (known human) carcinogen designation is used "when there is sufficient
evidence from epidemiologic studies to support a causal association between exposure to the
agents and cancer."  The Guidelines establish "three  criteria (that) must be met before a causal
association can be inferred between exposure and cancer in humans:
        1.  There is no identified bias that could explain the association.
        2.  The possibility of confounding has been considered and ruled out as explaining the
            association.
        3.  The association is unlikely to be due to chance."
        Given  the strong dose-related associations, with high relative risks consistently observed
 across numerous independent studies from several countries, and the biological plausibility
 provided by ancillary evidence of the genotoxicity and animal carcinogenicity of MS and by
                                            4-28

-------
 knowledge of the existence of many specific carcinogenic components within MS, confounding,
 bias, and chance can all be ruled out as possible explanations for the observed association between
 active smoking and lung cancer. Therefore, under the EPA carcinogen classification system, MS
 would be categorized as a Group A (known human) carcinogen.  Furthermore, the extensive
 chemical and toxicological similarities between SS and MS, detailed in Sections 3.2, 4.3, and 4.4,
 strongly infer that SS is also capable of causing lung cancer in humans, as was documented for MS
 in Section 4.2.  Thus, under EPA's carcinogen classification system, SS also belongs in Group A.
 Finally, because ETS is composed of SS and exhaled MS, and because ETS is known to be inhaled
 and absorbed into the body (Section 3.3.2), ETS would similarly be categorized as a Group  A
 carcinogen.
       In addition, there exists a vast body of epidemiologic data dealing specifically with lung
 cancer and exposure to ETS.  These data should also be examined in the interest of weighing all
 the available evidence, as recommended by EPA's carcinogen risk assessment guidelines (U.S.
 EPA, 1986a), both for hazard identification and exposure-response assessment.  The rapid dilution
 of both  SS and exhaled MS into the environment and changing phase distributions of ETS
 components over time raise some questions about the carcinogenic potential of ETS under actual
 environmental exposure conditions.  Furthermore, while MS and ETS may be qualitatively
 comparable, active smoking data do not constitute a good basis for quantitative estimation of the
 health effects of passive smoking because the relative uptake and deposition between active and
 passive smokers of the agent(s) responsible for these effects are not known (see Chapters 2 and 6).
 Provided the epidemiologic studies are of sufficient power and adequate study design, this
 database can offer unique information on the actual lung cancer risk to nonsmokers from exposure
 to true ambient levels of ETS.  The epidemiologic evidence for the human  lung carcinogenicity
 associated specifically with ETS is the subject of Chapter 5.  These epidemiologic data are then
 used as the basis for the calculation of population risk estimates for lung cancer from passive
smoking in Chapter 6.
                                           4-29

-------

-------
        S. HAZARD IDENTIFICATION II: INTERPRETATION OF EPIDEMIOLOGIC
         STUDIES ON ENVIRONMENTAL TOBACCO SMOKE AND LUNG CANCER

 5.1. INTRODUCTION
       The Centers for Disease Control attributed 434,000 U.S. deaths in 1988 to smoking (CDC,
 199la). Major disease groups related to smoking mortality include lung cancer, chronic
 obstructive pulmonary disease, coronary heart disease, and stroke, with smoking accountable for
 an estimated 87%, 82%, 21%, and 18% of total deaths, respectively. Lung cancer alone accounted
 for about 25% to 30% of the total smoking mortality, with some 100,000 deaths.  The age-
 standardized annual lung cancer mortality rates for 1985 are estimated at 12 per 100,000  for
 females and 15 per 100,000 for males who never smoked but 130 per 100,000 for female  cigarette
 smokers and 268 per 100,000 for male cigarette smokers, a relative risk of 10.8 and 17.4,
 respectively (Garfinkel and Silverberg, 1991).
       Chapter 4 discusses the biological plausibility that passive smoking also may be a  risk
 factor for lung cancer because of the qualitative similarity of the chemical constituency of
 sidestream smoke, the principal source of environmental tobacco smoke (ETS), and mainstream
 smoke taken in during the act of "puffing" on a cigarette, and because of the apparent
 nonthreshold nature of the dose-response relationship observed between active smoking and lung
 cancer.  Although the relative risk of lung cancer from passive smoking would undoubtedly be
 much smaller than that for active smoking, the ubiquity of ETS exposure (Chapter 3) makes
 potential health risks worth -investigating.
       This chapter analyzes the data from the large number of epidemiologic studies on ETS and
 lung cancer that contain data on the effects of ETS on never-smoking women.  Although some of
 the studies involve male nonsmokers and former smokers of both sexes, the female never-smokers
 comprise the large majority of the database—more than 3,000 cases and 6,000 controls in the 27
 case-control studies and almost 300,000 female never-smokers followed in the 4 cohort studies.
 Whenever study data are separated by sex and smoking status, women never-smoker results are
 used. The use of a more homogeneous group allows more confidence in the results of combined
 study analyses. All of the studies used provide data on adult home exposure to ETS. Some also
 provide information on childhood and/or workplace exposure, but there is far less information on
 these exposures; therefore, in order to develop one large database for analysis, only the female
 exposures from spousal smoking are considered. The exposure surrogate used is a report of the
husband's smoking status.  Wherever a measure of the amount of exposure to husband's smoking is
available, additional analyses are performed to examine effects in  the highest exposure groups
(Section 5.3.3.2) and dose-response relationships (Section 5.3.3.3).  Virtually all of the 31 studies
                                           5-1

-------
available classify never-smoking women as "exposed" or "unexposed" to ETS based on self- or
proxy-reported smoking in the subject's environment, usually according to whether or not a
woman is married to a smoker.  In addition, 17 studies provide sufficient information for highest
exposure group and exposure-response analyses. Other analyses of the data include adjusting for
the potential upward bias of smoker misclassification (Section 5.2.2); examining confounders,
effect modifiers, and sources of potential bias (Section 5.4); and pooling qualitatively higher
ranked studies (Section 5.5).  It  is hoped that by analyzing the data in several different ways, a
clear picture will emerge (Section 5.6).
       Throughout this chapter, one-tailed tests of significance (p = 0.05) are used, which
increases the statistical ability (power) to detect an effect. The 90% confidence intervals used for
the analyses performed are consistent with the use of the one-tailed test. The justification for this
usage is based on the a priori hypothesis (from the plausibility of a lung cancer effect documented
in Chapters 3 and 4) that a positive association exists between exposure to ETS and lung cancer.
       Epidemiologic evidence of an association between passive smoking and lung cancer first
appeared 10 years ago in a prospective cohort study in Japan (Hirayama, 198la) and a case-control
study in Greece (Trichopoulos et al., 1983). Both studies concluded that the lung cancer incidence
and mortality in nonsmoking women was higher for women married to smokers than for those
married to nonsmokers. Although there are other sources of exposure to ETS,  particularly outside
the home, the assumption  is that women married to smokers are exposed to more tobacco smoke,
on average, than women married to  nonsmokers.  These two studies, particularly the cohort study
from Japan, evoked considerable critical response.  They also aroused the interest of public health
epidemiologists, who initiated additional studies.
       At the request of two Federal agencies—the U.S. Environmental Protection Agency
(Office of Air and Radiation) and the U.S. Department of Health and Human Services (Office of
Smoking and Health)—the National Research Council (NRC) formed a committee on passive
smoking to evaluate the methods for assessing exposure to ETS and to review the literature on the
health consequences. The committee's report (NRC, 1986) addresses the issue  of lung cancer risk
in considerable detail and  includes summary analyses of the evidence from  10 case-control and 3
cohort (prospective) studies. It concludes, "Considering the evidence as a whole, exposure to ETS
increases the incidence of lung  cancer in nonsmokers."
       The NRC committee was particularly concerned about the potential bias in the study
results caused by the fact  that current and former smokers may have incorrectly reported
themselves as lifelong nonsmokers (never-smokers). Using reasonable assumptions for
misreported smoking habits, the committee determined that a plausible range for the true relative
                                            5-2

-------
risk is 1.15 to 1.35, with 1.25 the most likely value. When these relative risks also are corrected
for background exposure to ETS to make the risk relative to a baseline of zero ETS exposure, the
resultant estimate is 1.42, with a plausible range of 1.24 to 1.61.
        Two other major reports on passive smoking have appeared:  the Surgeon General's report
on the health consequences of passive smoking (U.S. DHHS, 1986) and the report on methods of
analysis and exposure measurement related to  passive smoking by the International Agency for
Research on Cancer (IARC,  1987a).  The Surgeon General's report concludes:
       The absence of a threshold for respiratory carcinogenesis in active smoking, the
       presence of the same carcinogens in mainstream and sidestream smoke, the
       demonstrated uptake of tobacco smoke constituents by involuntary smokers, and
       the demonstration of an increased lung cancer risk in some populations with
       exposures to ETS lead to the conclusion that involuntary smoking is a cause of lung
       cancer.                                                   '
       The IARC committee emphasized issues related to the physicochemical properties of ETS,
the toxicological basis for lung cancer, and methods of assessing and monitoring exposure to ETS.
Included in the 1987 IARC report is a citation from the summary statement on passive smoking of
a previous IARC report that the epidemiologic evidence available at that time (1985) was
compatible with either the presence or absence of lung cancer risk. Based on other considerations
related to biological plausibility, however, it concludes that passive smoking gives rise to some risk
of cancer.  Specifically, the report (IARC,  1986) states:
       Knowledge of the nature of sidestream and mainstream smoke, of the materials
       absorbed during "passive smoking," and of  the quantitative relationships between
       dose and effect that are commonly observed from exposure to carcinogens . . .
       leads to the conclusion  that passive  smoking gives rise to some risk of cancer.
       In the years since those reports, the number of studies available for analysis has more than
doubled. There are now 31 epidemiologic studies available from eight different countries, listed
in Table 5-1. Twenty-seven studies employ case-control designs, denoted by the first four letters
of the first author's  name for convenient reference, and four are prospective cohort studies,
distinguished by the designation "(Coh)." Six case-control studies, FONT (USA), JANE (USA),
KALA (Greece), LIU (China), SOBU (Japan), and WUWI (China), have been published as
recently as 1990.  The small cohort study from Scotland (Gillis et al.,  1984) has been updated and
is now included under the name HOLE(Coh);  another small cohort study on Seventh-Day
Adventists in the United States, an unpublished dissertation, is included as BUTL(Coh).  The
abstracts for a second case-control study by Kabat and Wynder and a new one by Stockwell and
colleagues are included in Section A.4, but  insufficient information is available to include their
results.

                                           5-3

-------
Table 5-1. Epidemiologic studies on ETS and lung cancer in this report and tier ranking
Study
AKIB
BROW
BUFF
CHAN
CORR
FONT
GAO
GARF
GENG
HUMB
INOU
JANE
KABA
KALA
KATA2
KOO
LAMT
LAMW
LEE
LIU
PERS
SHIM
SOBU
SVEN
Tier1
2
3
3
4
2
1
3
2
4
2
4
2
2
1

1
2
3
2
4
1
2
2
2
Country
Japan
United States
United States
Hong Kong
United States
United States
China
United States
China
United States
Japan
United States
United States
Greece
Japan
Hong Kong
Hong Kong
Hong Kong
England
China
Sweden
Japan
Japan
Sweden
Within country
Hiroshima
Colorado
Texas

Louisiana
Five metro areas
Shanghai
New Jersey, Ohio
Tianjin
New Mexico
Kanajawa
New York
New York
Athens





Xuanwei

Nagoya
Osaka
Stockholm
References
Akiba et al. (1986)
Brownson et al. (1987)
Buffleretal. (1984)
Chan and Fung (1982)
Correaetal. (1983)
Fontham et al. (1991)
Gao et al. (1987)
Garfinkel et al. (1985)
Geng et al. (1988)
Humble et al. (1987)
Inoue and Hirayama (1988)
Janerich et al. (1990)
Kabat and Wynder (1984)
Kalandidi et al. (1990)
Katada et al. (1988)
Koo et al. (1987)
Lam et al. (1987)
Lam (1985)
Lee et al. (1986)
Liu etal. (1991)
Pershagen et al. (1987)
Shimizu et al. (1988)
Sobue (1990)
Svenson et al. (1989)
                                                          (continued on the following page)
                                            5-4

-------
Table 5-1. (continued)
Study
TRIG
WU
WUWI
BUTL(Coh)
GARF(Coh)
HIRA(Coh)
HOLE(Coh)
Tier
3
2
4
2
3
2
1
Country
Greece
United States
China
United States
United States
Japan
Scotland
Within country
Athens
California

California


Paisley Renfrew
References
Tfichopoulos et al.
(1981, 1983)
Wu et al. (1985)
Wu- Williams and
Samet (1990)
Butler (1988)
Garfinkel (1981)
Hirayama(1984)
Hole et al. (1989)
 Tier rankings refer to this report's ratings of studies for utility of studying the association of ETS
 and lung cancer, where "1" is highest (see Section 5.5 and Section A.3).
2KATA has no tier number because the odds ratio cannot be calculated.
       Because of coincidental timing, the 1986 reports of the Surgeon General and the NRC
review approximately the same epidemiologic studies. More specifically, the NRC report includes
nine of the studies shown in Table 5-1:  AKIB, CHAN, CORR, GARF, KABA, KOO, LEE,
PERS, and TRIG; WU was available but not included because the crude data were not reported.
(Crude data consist of the number of exposed and unexposed subjects among lung cancer cases
and controls, where a subject is typically classified as exposed to ETS if married to a smoker.)
The NRC also excluded an earlier version of the KOO study and the studies by Knoth et al. (1983)
(no reference population was given), Miller (1984) (did not report on lung cancers separately), and
Sandier et al. (1985) (included very few lung cancers). Aside from WU, these studies also are
omitted from this report for the same reasons.
       Tables 5-2 and 5-3 provide an overview of some descriptive features of the individual
ETS  studies included in this report. The studies are grouped by country in Table 5-2, which
indicates the time period of data collection in each study, sample size, and prevalence of ETS
exposure for each study. The geographical distribution of the current epidemiologic evidence is
diverse. By country, the number of studies and its percentage of the total number of studies over
all countries is as follows: China  (4, 13%), England (1, 3%), Greece (2, 6%), Hong Kong (4, 13%),
Japan (6, 19%),  Scotland (1, 3%),  Sweden (2, 6%), and United States (11, 35%).  (One of the
                                           5-5

-------
Table 5-2. Studies by location, time, size, and ETS exposure
Country
Greece
Greece
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Japan
Japan
Japan
Japan
Japan
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
W. Europe
Scotland
England
Study
KALA
TRIG
CHAN
KOO
LAMT
LAMW
AKIB
HIRA(Coh)
INOU
SHIM
SOBU
BROW
BUFF
BUTL(Coh)
CORR
FONT
GARF
GARF(Coh)
HUMS
JANE
KABA
WU
HOLE(Coh)
LEE
Accrual1
period
1987-89
1978-80
1976-77
1981-83
1983-86
1981-84
1971-80
1965-81
1973-83
1982-85
1986-88
1979-82
1976-80
1976-82
1979-82
1985-88
1971-81
1959-72
1980-84
1982-84
1961-80
1981-82
1972-85
1979-82

Cases
90
40
84
86
199
604
94
22
90
144
19
41
22
420
134
20
191
24
298
32
Size2
Controls
116
149
139
136
335
1444
270
47
163
731
47
196
,207
133
7806
402
176,739 -
162
191
25
628
1*79 A
,/o4
66
' ' ETS
Cases
71
73
60
59
58
624
78
82
58
56
21
80
64
70
67
75
*7
54
*
69
exoosure f%)s
Controls
60
52
53
49
45
444
70
64
56
54
15
84
46
636
61
7**
56
60r
60
*
71
68
                                                          (continued on the following page)
                                            5-6

-------
Table 5-2. (continued)
Country
W. Eurooe
(continued)
Sweden
Sweden
China
China
China
China
Study

PERS
SVEN
GAO
GENG
LIU
WUWI
Accrual1
period

1961-80
1983-85
1984-86
1983
1985-86
1985-87
Size2
Cases

.67
34
246
54
54
417
Controls

*
174
375
93
202
602
ETS exoosure (%f
Cases

49
71
77
63
83
49
Controls

*
66
74
44
87
55
1Time during which cases occurred.
2Number of subjects included in ETS analyses; where numbers differ for spousal smoking and
 other exposures, those for spousal smoking are given.
3Spousal smoking unless otherwise noted.
4Adenocarcinoma only. Data for all cell types were available only for general passive smoke
 exposure, which showed 77% of 75 cases and 56% of 144 controls exposed.
5Figure pertains to "spouse pairs" cohort, which is of principal interest regarding ETS; a subgroup
 of this cohort comprised the "ASHMOG" cohort.
6Figure is for population controls; study also included 351 colon cancer controls (66% exposed).
7ORs but no exposure prevalences are presented for spousal smoking in the source.  The value
 shown for controls is taken from KABA, as closest to JANE in time and location; no exposure
 percentage is assumed for cases.
8Adenocarcinoma only. Analyses for other cell types included smokers while adjusting for
 smoking status.

*Data not available.
                                           5-7

-------
Table 5-3. Case-control studies of ETS: characteristics
Study
AKIB



BROW
BUFF
CHAN


CORR

FONT


GAO

GARF

GENG


HUMB

INOU



JANE



Percentage
proxy
response1
Ca Co
90 88



69 39
82 76
* *


* *

34 0-108


0 *

88 *

0 0


* *

* *



33io 3310



Female age3
Source of
Ca Co controls
70.2 * Atomic bomb
35-95 * survivor
population

66.3 68.2 Cancer cases4
30-79 30-79 Cancer cases6
39-70 39-70 Orthopedic
patients

* * Hospital
patients7
20-79 20-79 Cancer cases;
general
population
35-69 35-69 General
population
S:40 S:40 Cancer cases9

£65 £65 *


£85 £85 General
population
* * Cerebrovas-
cular disease
deaths

67. 110 68. 110 New York
State Dept. of
Motor
Vehicles
Matched
variables
Age, sex,
residence,
vital status,
med. subject3
Age, sex
Age, sex
Matched but
variables
unspecified
Age (±5),
sex, race
Age, (for
cancer
controls) race
Age (+ 5)

Age (±5),
hospital
Age (± 2),
sex, race,
marital status
Age(± 10),
sex, ethnicity
Age, year
of death
(± 2.5),
district
Age, sex,
county,
smoking
history
ETS
sample
matched
No



No5
No5
No5


No5

Yes


No6

Yes

No5


No5

No5



Yes



                                                             (continued on the following page)
                                             5-8

-------
Table 5-3. (continued)
Percentage
proxy
response1 Female age2 •;
$t«dy Ca
KABA 0


KALA 0

KATA 0

KOO 0


LAMT 0

LAMW *



LEE 3815



LIU 0

PERS *18

SHIM 0



SOBU 0
SVEN 0

Source of
Co Ca Co controls
0 61.6 53.9 Patients11


0 S35 ^35 Orthopedic
patients
0 67.8 * Noncancer
patients
0 .. * * "Healthy"12


0 *.'.'* "Healthy"13

* 67.5 66 Hospitalized
orthopedic
patients

38 35-74 35-74 Patients16



0 52 52 General
population?
* *19 * *20

0 59 58 Patients21
35-81 35-81


0 60 56 Patients
0 66.3 General
population
Matched
variables
Age (± 5),
sex, race,
hospital
Sex

Age (± 2),
sex
Age (±5),
residence,
housing
Age (± 5),
residence
Age, socio-
economic
status,
residence14
Age, sex,
hospital
location, time
of interview
Age (±2),
sex, village
Age(± 1),
sex
Age(± 1),
hospital,
admission
date
None
Age

ETS
sample
matched
Yes


Yes '

Yes

: No5


No5

No6



No5-17



Yes

Yes

Yes



No '
No5

                                                           (continued on the following page)
                                           5-9

-------
Table 5-3. (continued)
Percentage
proxy
response1


Study
TRIG


WU

WUWI



Ca
0


0

0



Go
0


0

0

-. \ ' ' f
Female age2
• ••

Ga
62.8


<76

55.922



Co
62.3


<76

55.422

•"
Source of
controls
Hospitalized
orthopedic
patients
Neighbor-
hood13
General
population
<" •""' •>
Matched _
variables
Age,
occupation,
education14
Age (± 5),
sex, race
Sex, age23

ETS
sample
matched.
No5


No6

No5

 lnCa" and "Co" stand for "cases" and "controls," respectively.
 2Single values are the average or median.  Paired values are the range.
 Participation in RERF biennial medical examination program.
 ^Persons with cancers of bone marrow or colon in Colorado Control Cancer Registry.
 5Not matched on personal smoking status (e.g., smoker/nonsmoker).
 6Population-based and decedent comparison subjects selected from state and Federal records.
 7Assorted ailments.
 80% for general population and 10% for colon cancer controls.
 9Colorectal cancer.
"includes males and females and long-term ex-smokers.
"Diseases not related to smoking.
12Selected from a healthy population.
13Living in neighborhood of matched case.
""Similar" but not actually matched.
15Applies only to the 143 patients in the followup study.
16Excluding lung cancer, chronic bronchitis, ischemic heart disease, and stroke.
17Ongoing study modified for passive smoking.
18No overall percentages given.
19Two control groups:  15 to 65 and 35  to 85 for both cases and controls in groups 1 and 2,
  respectively.
20Two control groups were randomly chosen from the cohort under study.
21Patients in the same or adjacent wards with other diseases.
22Entire study population, including smokers.
23Frequency matched by 5-year age group to age distribution of cases reported in study area
  2 years prior to initiation of study.

*Data not available.
                                            5-10

-------
studies from Japan, KATA, does not appear in most of the tables because the odds ratio cannot be
calculated.) The studies differ by size, however, which has to be taken into account in analysis.
There are two large cohort studies, GARF(Coh) and HIRA(Coh), conducted in the United States
and Japan, respectively, and two very small ones, BUTL(Coh) and HOLE(Coh), from the United
States and Scotland, respectively. There are two exceptionally large case-control studies—FONT
and WUWI of the United States and China; the first was designed specifically to assess the
association between ETS and lung cancer, whereas the second has broader exploratory objectives.
       The accrual periods of the case-control studies are typically 2 to 4 years in length
(exceptions  with longer periods are AKIB [9 years], INOU [10 years], GARF [10 years], KABA
[19 years], and PERS [9 years]) and occur between the early 1970s and late 1980s (exceptions are
KABA [1961-1980] and PERS [1961-1980]). The two large cohort studies were conducted
relatively early (GARF(Coh), 1959-72; HIRA(Coh), 1965-81).  Differences in study duration or
accrual period should not be consequential for hazard identification, which is the topic addressed
in this chapter, but both factors affect the estimation of population risk (Chapter 6). Earlier study
results are more uncertain for projection of current risk, and parameter values used for modeling
are more uncertain when based on extended study periods.  Table 5-2 also demonstrates
variability across studies in the percentages of cases and controls classified as exposed to ETS.  For
example, at the extremes for U.S. studies alone, BUFF and  BROW classify 84% and 15% of
controls as exposed to ETS, respectively.  Statistical variability and differences across
subpopulations sampled are partially explanatory, but a major factor is differences between
researchers' criteria for classification of subjects as exposed to ETS.  This issue affects study
comparability and observed values of relative risks, which affect both hazard identification and
characterization of population risk.
       Another example of a study feature of broad consequences in both case-control and cohort
studies is the method of diagnosis or confirmation of lung cancer and exclusion of secondary lung
cancers in subjects classified as having lung cancer, as shown in Table 5-4. Accurate
classification of subjects vis-a-vis the presence or absence of primary lung cancer is essential to
the validity  of results; inaccurate classification can reduce the chance of detecting a positive
association between ETS exposure and  lung cancer, if it exists, by biasing the observed relative
risk toward  unity. (Note. "Relative risk"  is used to mean the estimate of the true [but unknown]
relative risk. For case-control studies,  the estimate used is the odds ratio. For editorial
convenience, "relative risk" is used for both case-control and cohort studies.)
       The  large majority of the studies (27 of 31  total) are of the case-control type, which are
subject to more potential sources of bias than the cohort studies (see discussion in Section 5.4.1).
                                            5-11

-------
Table 5-4. Diagnosis, confirmation, and exclusion of lung cancer cases
.> A.
Study / V
AKIB8
BROW
BUFF8'4
CHAN8'4
CORR8
FONT
GAO8-5
GARF5
GENG8
HUMS6'7
INOU
JANE8
KABA
KALA
KATA
KOO
LAMT
LAMW
LEE
LIU8
PERS
SHIM
SOBU
SVEN8
TRIG8
WU
WUWI8
BUTL(Coh)9
GARF(Coh)
; ss» s 	 j^a
;: ^Histology
53
inn
1UU
inn
	 iuu
82
97
100
43
100
85
O-5
	 oJ
*
99
100
48
100
94
inn
IUU
inn
	 IUU
*
n'

83
100
100
70
28
100
42
100
*
gnosis/Confirmatioal^1
Radio./
Cytology clinical
4 43







38 19

4


* *
1

38






* *
Q-*
	 o j
16


29
37 35

32 26

* *
Other/
uisspec.
0


18
3

10

11
17
*


14

6


*
0
1


1





Excluded
secondary
LC*
Y
Y
Y
N
Y
Y
Y
Y
N
Y
N
Y
Y
Y
N
Y
Y
Y
N
N
Y
Y
Y
Y
N
Y
Y
Y
. N
                                                            (continued on the following page)
                                           5-12

-------
 Table 5-4.  (continued)
Diagnosis/Confirmation (%)*
Study Hi$tology
HIRA(Coh) *
HOLE(Coh)10 *
Radio./
Cytology clinical
* *
* *
Excluded
Other/ secondary
utt$pe>& ' LC*
N
N
 figures apply to confirmation of original diagnosis when conducted.
 2Y (for "yes") if specifically indicated; otherwise, N (for "no").
 3Not restricted to never-smokers (contains former smokers or ever-smokers).
 Inconsistency in article. May be 100% histology.
 5Diagnostic information was reviewed for study.
 6Includes males.
 7Available  histologic specimens (17 cases) reviewed by pathologists. Poor agreement between
  review diagnoses and original cancer registry diagnoses (8 of 17 cases).  Only reviewed cases,
  however, are presented in article.
 Includes male ever- and never-smokers and one female ever-smoker (control).
 Includes one former smoker.
10Death certificate diagnosis checked against Scottish cancer registry records.
*Data not available.
To continue the overview depicting some basic similarities and differences between studies that
may affect analysis of their results, some additional characteristics of the case-control studies
alone are summarized in Table 5-3. The percentage of proxy response is high for some studies,
but there is little basis for assessing the direction or magnitude of potential bias from this source,.
The age range of subjects differs across studies, but there is insufficient information on age
distributions within studies to evaluate the effect of age or to adjust for differences between
studies. The source of control subjects is a potential source of bias in some studies.
       The table heading "ETS sample matched" refers to whether design matching applies to the
ETS subjects (the never-smokers used for ETS/lung cancer analysis). As indicated under
"matched variables," controls are virtually always matched (or at least similar) to cases on age and
usually on several other variables as well that the researcher suspects may affect comparability of
cases and controls.  The matching often refers to a larger data set than the ETS subjects only,
however, because many studies included smokers and investigated a number of issues in addition
to whether passive smoking is associated with lung cancer.  When the data on ETS subjects are
                                            5-13

-------
extracted from the larger data set, matching is not retained unless smoking status was one of the
matching variables.
       Although matching is commonly used as a method to reduce potential confounding,
effective techniques also may be implemented during analysis of the data (e.g., the use of
poststratification or logistic regression adjustment for unmatched, stratified, or frequency-
matched samples). Use of a method of analysis that adjusts for known or suspected confounders
and factors that may interact with ETS exposure to affect risk of lung cancer is particularly
important for studies that are not designated as "ETS sample matched" in Table 5-3.  Even with
matched data, a method of analysis that controls for confounding, such as the use of matched
pairs or regression techniques, is preferable.  In fact, Breslow and Day (1980,  p. 32) describe the
main purpose of matching in a case-control study as permitting use of efficient analytical methods
to control confounding by the factors used for matching.
       The analysis for hazard identification in this report follows two approaches.  The first
approach (Section 5.3) treats all  studies equally, i.e., statistical methods are applied to all studies
without regard to differences in study utility for the task of hazard identification. Differences in
study size, of course, are taken into account by the statistical methods. Statistical inference
includes estimation, with confidence intervals, and hypothesis testing for an effect (an increased
relative risk in ETS-exposed subjects) and for an upward trend (an increase in relative risk as
some measure of ETS exposure  increases). The second approach (Section 5.5) is motivated by the
heterogeneity of the study evidence, as described above. Study size aside,  some studies have
higher utility than others far assessing questions related to ETS and lung cancer and thus should
be given more weight.  To implement this extended data interpretation, all studies are first
reviewed individually for sources of bias and confounding that might affect interpretation of
results for assessing ETS and lung cancer and then assigned a tier number from 1 to 4 accordingly.
 Tier 1 contains those studies of greatest utility for investigating a potential association between
ETS and lung cancer. Other studies are assigned to Tiers 2, 3, and 4 as confidence in their utility
diminishes. (Note: Study utility does not mean study quality.  Utility is evaluated with respect to
the research objectives of this report, while the objectives of individual studies often differ.)
Pooled estimates of relative risk by country are then recalculated by tiers,  beginning with the
studies of  highest utility (Tier 1) and adding studies from Tiers  2, 3, and 4 successively to see
what effect a judgment of utility has on the overall outcome in each country. The criteria used in
evaluating studies and the procedure for assigning  them to tiers are described in Appendix A,
which also contains the individual study reviews.
                                             5-14

-------
       The selection of the most appropriate relative risk estimate to be used from each study is
addressed in Section 5.2.1.  In Section 5.2.2, each chosen relative risk estimate is adjusted
downward to account for bias expected from some smokers misrepresenting themselves as
nonsmokers.  This topic has been a contentious issue in the literature for several years, with claims >
that this one source of systematic upward bias may account entirely for the excess risk observed in
epidemiologic studies. Recent detailed investigation of this topic by Wells and Stewart
(unpublished) make that claim unlikely (Appendix B). They found that a reasonable correction
for bias, calculated on a study-by-study basis, is positive but small.  Following this methodology,
this report makes reductions in the relative risk estimates at the outset for each study individually
before statistical inference or pooling estimates from studies of the same country.  This is in
contrast to the NRC report (1986), which makes the same downward adjustment to all studies
(applied to an overall  estimate of relative risk obtained after pooling all study estimates).
       The estimates  adjusted for smoker misclassification bias are the  basis for statistical
inference  in Sections 5.3 (without regard to tier classification) and 5.5 (analysis by tier
classification). Section 5.4 reviews the study results on potential modifying factors. Conclusions
are then drawn for hazard identification (i.e., whether ETS is causally associated with increased
lung cancer mortality) based on the total weight of evidence. Chapter 6 of this report addresses
the upward adjustment on the U.S. relative risk estimate for background ETS exposures and the
U.S. population risk of lung cancer from ETS.

5.2. RELATIVE RISKS USED IN STATISTICAL INFERENCE
5.2.1.  Selection of Relative Risks
       Two considerations largely affect the choice of relative risk (RR):  (1) whether other
relevant cofactors are  taken into account (namely, potential confounders and risk modifiers that
may be correlated with ETS exposure), and (2) the source and place of ETS exposure used.  The
alternatives (not yet adjusted for smoker misclassification) are shown by study in Tables 5-5 and
5-6, with  the ones selected for analysis in this report in boldface type. Table 5-5 lists the RRs
and their confidence intervals, along  with explanatory footnotes, and Table 5-6 provides
information on source and place of exposure and on the adjusted analysis. Because most .studies
include spousal smoking, and  interstudy comparisons may be useful, spousal smoking was the
preferred  ETS surrogate in all except for LAMW and SOBU. In LAMW, spousal smoking data are
limited to  cases with adenoCarcinoma; in SOBU, the data for cohabitants are separate from data
for spousal smoking, and much of the ETS exposure appears  to result from the cohabitants. Only
data for broader exposure to ETS than spousal smoking alone were collected in BUFF, CHAN,
SVEN, and HOLE(Coh).
                                           5-15

-------
Table 5-5. Estimated relative risk of lung cancer from spousal ETS by epidemiologic study
(crude and adjusted for cofactors)
"^ •."• •.
Case-control
AKIB
BROW
BUFF
CHAN
CORR
FONT9
GAO
GARF
GENG
HIRA1S
HUMB
INOU
JANE
,',/"„" •. '
Crude RR1'*
1.52
(0.96, 2.41)
1.52^
(0.49, 4.79)
1.824'6
(0.45, 7.36)6
0.817
(0.39, 1.66)
0.75s
(0.48, 1.19)
2.078
(0.94, 4.52)
1.37
(1.10, 1.69)
1.21
(0.94, 1.56)
1.32
(1.08, 1.61)
1.19
(0.87, 1.63)
1.31
(0.93, 1.85)
2.16
(1.21, 3.84)
1.5310
(1.10, 2.13)
2.34
(0.96, 5.69)
2.5514
(0.90, 7.20)
0.86
(0.57, 1.29)
Never-Sttlokers
V "' ' Aa /,
1.5
(1.0,2.5)
*
1.684'6
(0.39, 6.90)6
*
*
* _ . .
1.29
(1.03, 1.62)
1 28
(0.98', 1.66)
1.3410-11
1.7012
(0.98, 2.94)6
*
1.6410
*
2.2
(0.9, 5.5)
2.5410-15
*
0.93/0.4416
                                                          (continued on the following page)
                                           5-16

-------
Table 5-5. (continued)
Case-control
KABA17
KALA
KATA
KOO
LAMT
LAMW
LEE
LIU
PERS
SHIM
SOBU
SVEN
TRIG
WU
WUWI
Never-smokers
Crude RR1'2,
J . . X . . . X
0.79
(0.30, 2.04)
1.6218
(0.99, 2.65)
1.41
(0.78,2.55)
*19
1.55
(0.98, 2.44)
1.65
(1.22, 2.22)
2.5120
(1.49,4.23)
1.03
(0.48, 2.20)
0.74
(0.37, 1.48)
1.28
(0.82, 1.98)
1.0822
(0.70, 1.68)
1.0618
(0.79, 1.44)
1.77
(1.29,2.43)
1.265
(0.65, 2.48)
2.0823
(1.31, 3.29)
1.4124
(0.63,3.15)
0.79
(0.64, 0.98)

Aifi UR1*8*5
/VUj* JVR.
* . '• •
1.92
(1.02, 3.S9)6
*
*
1.64
*
*
0.75/1. 6021
0.77
(0.35, 1.68)
1.2
(0.7, 2.1)6
*
1.1318
(0.78, 1.63)6
1.57
(1.07, 2.31)6
1.45
*
1.2
(0.6, 2.5)6
0.7
                                                         (continued on the following page)
                                          5-17

-------
Table 5-5. (continued)
                                                   Never-smokers
  Case-control
Crude RR1*21
  BUTL(Coh)


  GARF(Coh)


  HIRA(Coh)


  HOLE(Coh)26
   2.45
                                          25
    2.02
(0.48, 8.S6)6

   1.1710
(0.85, 1.61)6
    1.38
(1.03, 1.87)

    2.27
(0.40, 12.7)
    1.61
     *
    1.99
(0.24, 16.7)6
 Parentheses contain 90% confidence limits, unless noted otherwise.  When not represented in the
 original studies, the crude ORs and their confidence limits were calculated (or verified) by the
 reviewers wherever possible.  Boldface indicates values used for analysis in text of this report.
 Odds ratios are shown for case-control studies; relative risks are shown for cohort studies.
 2ORs for never-smokers apply to exposure from spousal smoking, unless indicated otherwise.
 Calculated by a statistical method that adjusts for other factors (see Table 5-3), but not
 corrected for smoker misclassification.
 4Adenocarcinoma only. Data for crude OR values communicated from author (Brownson).
 EExposure at home and/or at work.
 695% confidence interval.
 7Exposure to regularly smoking household member(s). Differs slightly from published value of
 0.78,  wherein 0.5 was added to all exposure cells.
 8Excludes bronchioalveolar carcinoma. Crude OR with bronchioalveolar carcinoma included is
 reported to be 1.77, but raw data for calculation of confidence interval are not provided.
 ^he first, second, and third entries are calculated for population controls, colon cancer controls,
 and both control groups combined, respectively.  For adenocarcinoma alone, the corresponding
 ORs,  both crude and adjusted, are higher by 0.15-0.18.
10Composite measure formed from categorical data at different exposure levels.
uFor GAO, data are given as (number of years lived with a smoker, adjusted  odds ratio [OR]):
 (<20,  1.0), (20-29, 1.1), (30-39, 1.3), (40+, 1.7).
"Estimate for husband smoking 20 cig./day.
"Case-control study nested in  the cohort study of Hirayama.  OR for ever-smokers is taken from
 cohort study.  This case-control study is not counted in any summary results where HIRA(Coh)
 is included.
MOR reported in study is 2.25, in contrast to the value shown that was reconstructed from the
 confidence intervals reported in the study; no reply to inquiry addressed to author had been
 received by press time.
1EFor INOU, data are given as  (number of cig./day smoked by husband, adj. OR): (<19,  1.58),
 (20+,  3.09).
16From subject responses/from proxy responses.

                                                            (continued on the following page)
                                           5-18

-------
 Table 5-5.  (continued)

 17For second KABA study (see addendum in study description of KABA in Appendix A),
  preliminary unpublished data and analysis based on ETS exposure in adulthood indicate 68% of
  never-smokers are exposed and OR = 0.90 (90% C.I. = 0.51, 1.58), not dissimilar from the table
  entry shown.
 18For the first value, "ETS.-exposed" means the spouse smokes; for the second value, "ETS-
 jjxposed" means a member of the household other than the spouse smokes.
 2flOR is not defined because number of unexposed subjects is zero for cases or controls.
  Table entry is for exposure to smoking spouse, cohabitants, and/or coworkers; includes lung
  cancers of all cell types. OR for spousal smoking alone is for adenocarcinoma only: 2.01 (90%
  C.I. = 1.20, 3.37).
 21From subject responses/from spouse responses.
 22From crude data, estimated to be: exposed cases 52, exposed controls 91, unexposed cases 38
  unexposed controls 72.                                                               '
 23Known adenocarcinomas and alveolar carcinomas were excluded, but histological diagnosis was
  not available for many cases. Data are from Trichopoulos et al. (1983).
  Raw data for WU are from Table 11 of Surgeon General's report (U.S. DHHS, 1986).  Data
  apply to adenocarcinoma only.
 2*RR is based on person-years of exposure to spousal smoking. "Prevalence" in those units is 20%
  RR values under never-smoker are for  lung cancer mortality. For lung cancer incidence crude
  RR is 1.51 (90% C.I. = 0.41, 5.48) and adjusted RR is 1.39 (95% C.I.  = 0.29, 6.61).

*Data not available.
                                         5-19

-------
Table 5-6.  Effect of statistical adjustments for cofactors on risk estimates for passive smoking1
                                                            Adjustment      Adj.
                                                             &ctor(s)5     technique®
Case-control
study
Source2  Place8
   AKIB

   BROW
   BUFF

   CHAN

   CORR
                                                             A,E,I,L>R
                                                             A,E,I,L,R
                                                            A,SES,H,Yd
    GARF

    GENG

    HIRA
    HUMB

    INOU

    JANE
                                             0.93/0.4411
                                             1.09/2.0712
    KABA

    KALA-
                                                              A,E,B,Yc
                                                              A,E,B,Yc
                                                        (continued on the following page)
                                           5-20

-------
Table 5-6. (continued)
Case-control
study
LAMW
LEE

LIU
PERS
SHIM
SOBU
SVEN
TRIG
WU
WUWI
BUTL (Coh)
GARF (Coh)
HIRA (Coh)
HOLE (Coh)
Exposure
Source2
Sp
A
Sp
Co
Co
Sp
Sp
Sp
Sp
oc
A
Sp
Sp
Sp
Co
Sp
Sp
Sp
Co
Place5
*
*
A
H
A
A
A
H
A
A
H,W
A
A
P
P
A
A
A
A
Crude
RR4,
2.01 1S
2.5114
1.315
0.75
[1.03
0.80
0.74
1.28
1.28
1.08
1.06
1.77
1.1/1.816
(1.26)
2.08
1.4117
0.79
0.78
2.45
*
1.38
2.27
Adj.
RR4 ,
*
*
1.6015
0.75
1.001
0.8710
0.77
1.2
1.4710
*
1.13
1.57
1.2/2. 116
(1.4)
*
1.2
0.7
0.7
2.02
1.27/1.1018
1.17
1.37/1.0418
1.61
1.99
Adjustment
jfactor(s)*
* •
*
A
A
C
A,V
A
*
A,E
A,E
A
*
A,L
As
A,E,L
A,E,L
A
A
A,E,L,R,Oh
Ah
A,SES
Adj.
technique6
*
*
S
S
LR
M
S
*
S
S
S
*
M
LR
LR
LR
S
S
S
S
S
Values used for inference in this report are shown in boldface.
2Source: A = anyone; (C) = childhood; Co = cohabitant(s); M = mother; OC = cohabitant(s) other
 than spouse; Sp = spouse.
3Place:  A = anywhere; H = home/household; P = proximity of subjects; W = workplace.
4OR for case-control studies; RR for cohort studies.

                                                            (continued on the following page)
                                            5-21

-------
Table 5-6. (continued)

 6Adjustment factors: A = age of subject; Ah = age of husband; As = age started smoking; B =
 number of live births; C - cooking habits; E = education; F = fish consumption; H = hospital; I =
 income; Ir = interviewer; L = location; O = occupation of subject; Oh = occupation of husband;
 R « racial or ethnic group; SES = socioeconomic status; Sm = active smoking; V = vital status;
 Yc - years since exposure ceased; Yd = year of diagnosis.
 6LR - logistic regression; R = regression; M = matched analysis; S =  stratified.
 7Bronchioalveolar carcinoma excluded.  Spousal smoking  OR = 1.77  with bronchioalveolar
 carcinoma excluded; no corresponding value reported for maternal smoking.
 Population controls, all cell types (crude and adjusted ORs for adenocarcinoma alone are 1.52
 and 1.47, respectively).
 9Colon cancer controls, all cell types (crude and adjusted  ORs for adenocarcinoma alone are 1.35
 and 1.44, respectively).
10Composite measure formed from categorical data at different exposure levels.
11Cases and controls matched on A, L, and N; first value is from subject; second value is from
 proxy sources.
121-24 smoker-years/> 25 smoker-years.
13Adenocarcinoma only.
14A11 cell types.
15First value is for smoking information provided by patient's spouse; second value is for
 information provided by patient herself; third value (in brackets) utilizes available data from
 either source with subject classified as exposed if either  source so indicates.
16Exposed at home but not at work or vice versa/exposed  both at  home and at work followed by
 weighted average of exposed strata.
17Crude OR from Table 11 of Surgeon General's report (U.S. DHHS  1986); note that adjusted OR
 from WU is not restricted to never-smokers and analysis includes only adenocarcinoma.
18Spouse smokes 1-20 cig. per day/spouse smokes > 20 cig. per day.  The composite RR is 1.17.

*Data not available.
       After exposure source and place are taken into account in the choice of RR values in

Table 5-6, an adjusted RR is considered preferable to a crude RR unless the study review in

Section A.4 indicates a problem with the adjustment procedure.  Of the 31 studies, 20 provide

both an adjusted and crude RR, where the "adjusted estimate" is based on the author's use of a

statistical procedure that takes potential confounding factors into account, usually by stratification

or logistic regression.  Based on the decision rule just described,  our choice  of RR is the smaller

of the crude and adjusted values in 14 of the 20 studies providing both estimates.  In several

studies, RR values in addition to those shown in Table 5-6 might be considered (see Table 5-7).

They were not found to  be the best choices, however, for comparison between studies.


5.2.2.  Downward Adjustment to Relative Risk for Smoker Misclassification Bias

       There is ample evidence that some percentage of smokers, which differs for current and

former smokers, misrepresent themselves as never-smokers (sometimes the wording of a

                                           5-22

-------
Table 5-7. Alternative estimates of lung cancer relative risks associated with active and passive
smoking
Active/
Study passive
BUFF2 Passive


FONT3 Passive


HUMB7 Passive
KOO8 Passive
PERS9 Active
SHIM12 Passive
BUTL Active
(Coh)
HIRA14 Active
(Coh)
HOLE16 Active
(Coh)
BTS exposure
Household members
regularly smoking for 33+
years
Spousal smoking,
all types


Spousal cigarette smoking7
Home and/or workplace
exposure over lifetime8
N.A.10
Total household ETS
exposure12
N.A.10
N.A.10
N.A.10
Controls
exp. (%)
71


63
66
64

57
64
3711
77
1411
4411
5611
Alternative Comparison
estimate estimate1
Crude OR 0.95
(0.38, 2.40)

Crude OR 1.524
(1.19, 1.96)
Adj. OR 1.47
Crude OR 1.356
(1.02, 1.80)
Adj. OR 1.44
Crude OR 1.476
(1.15, 1.87)
No adj. OR
Crude OR 1.8
(0.6, 5.4)
adj. OR 1.7
Crude OR 1.36
(0.83, 2.21)
Adj. OR 1.86
Crude OR 4.2
Crude OR 1.36
Adj. RR 4.013
Adj. RR 3.79
Adj. RR 4.2
0.81


1.37
1.29
1.21
1.28
1.32
*
2.3
2.2
1.34
1.64
*
1.08
*
2.67
*
1Nearest equivalent from Tables 5-5 or 5-6.
2Values in Tables 5-5 and 5-6 include household smoking for any duration.  Lung cancer may
 have a long latency period, however, so the extended exposure may be of interest.
3As in  Table 5-5 except for adenocarcinoma alone.
Population controls only.
5Colon cancer controls only.
6Control groups combined.
7Values in Tables 5-5 and 5-6 include spousal smoking of cigars and pipes.
8Value in Table 5-6 is for household cohabitant smoke exposure during adulthood.

                                                           (continued on the following page)
                                           5-23

-------
Table 5-7. (continued)
 9Estimate is based on papers by Cederlof et al. (1975) and Floderus et al. (1988) describing larger
 populations on which Pershagen study was based.
10Not applicable because alternative estimate is for active smoking.
"Percentage ever-smokers.
"Composite estimate from crude ORs for exposure from husband, parents, and father-in-law.
 Values in Tables 5-5 and 5-6 consider only spousal smoke exposure.
13Rough estimate based on data in Fraser et al. (1991). The prevalence of female ever-smoking is
 estimated from KALA and TRIG studies, which were conducted in similar conservative
 societies.
^Compares active smokers with never-smokers unexposed to ETS, thus providing a reference
 group more truly unexposed to tobacco smoke.  The value in Table 5-5 is the more conventional
 comparison of ever-smokers with never-smokers, regardless of passive smoking status.
15Estimate is from adjusted RR for both sexes combined with assumption that female RR is 75%
 of male RR.
*Data not available.

questionnaire may not be  explicit enough to distinguish former smokers from never-smokers) (see
Appendix B). It has been argued that the resultant misclassification of some smokers as
nonsmokers produces an upward bias in the observed relative risk for lung cancer from ETS
exposure (i.e., the observed RR is  too large).  The essence of the supporting argument is based on
smoking concordance between husband and wife—a smoker is more likely than a nonsmoker to
have been married to a smoker.  Consequently, the smoker misclassified as a nonsmoker is more
likely to be in the ETS-exposed classification as well.  Because smoking causes lung cancer, a
misclassified smoker has a greater chance of being a lung cancer case than a nonsmoker. The net
effect is that an observed association between ETS exposure and lung cancer among people who
claim to be never-smokers may be partially explainable by current or former active smoking by
some subjects.
       The potential for bias  due to  misreported smoking habits appears to have been noted first
by Lee (see discussion in Lehnert, 1984), and he emphasizes it in several articles (e.g., Lee, 1986,
1987a,b).  In Lee, 1987b,  it is argued that smoker misclassification may explain the entire excess
lung cancer risk observed in self-reported never-smokers in epidemiologic studies. Lee's
estimates of bias due to smoker misclassification appear to be overstated, however, for reasons
discussed in Appendix B.
       The NRC report on ETS (1986) devotes considerable attention to the type of adjustment
for smoker misclassification bias.  It  follows the construct of Wald and  coworkers, as described in
Wald et al., 1986; Wald was the author of this section in the 1986 NRC  report.  An illustrative
diagram for the implicit true relative risk of lung cancer from exposure to ETS in women from
                                           5-24

-------
spousal smoking is shown in Figure 2 of Wald et al. (1986). A similar example is in Table 12-5 of
the NRC report.
       Both Lee's and Wald's work adjust an overall relative risk estimate, pooled over several
studies, downward, rather than address each individual study, with its own peculiarities,
separately. Furthermore, statistical analysis over the studies as a whole is conducted first, and
then an adjustment is made to the overall relative risk estimate.  The recent work of Wells and
Stewart (Appendix B) on this subject makes an adjustment to each individual study separately.
Consequently, the pertinent adjustment factors that vary by study and type of society can be
tailored to each study and then applied to the observed data before any statistical analysis.  The
latter procedure is applied in this report.
       The methodology to adjust for bias due to smoker misclassification and the details of its
application to the ETS studies  are provided in Appendix B. The results of the adjustment and
estimate of bias are given in Table 5-8. In general, the biases are low in East Asia, or in any
traditional society such as Greece,  where female smoking prevalence is low and the female smoker
risk is low. Some of the calculated biases are slightly less than unity when carried to three decimal
places. This may result from the assumption in the calculations that there is  no passive smoking
effect on current smokers.

5.3. STATISTICAL INFERENCE
5.3.1. Introduction
       Table 5-9 lists the values of several statistical measures for the effect of spousal smoking
by study (see boldface entries  in Table 5-6 for details).  Their meanings will be described before
proceeding to interpretation of the data, even though the concepts discussed  may be familiar to
most readers. The p-values refer to a test for effect and a test for trend. In the former, the null
hypothesis of no association (referred to as "no effect" of ETS exposure on lung cancer risk) is
tested against the alternative of a positive association. The test for trend applies to a null
hypothesis of no association between RR and exposure level against the alternative of a positive
association.  When data are available on more than two levels  of intensity or  duration of ETS
exposure, typically  in terms of the husband's smoking habit (e.g., cig./day or years of smoking),
then a test for trend is a useful supplement in testing for an effect, as well as indicating whether a
dose-response relationship is likely.
       The entries  under "power" in Table 5-9 are calculated for the study's ability to detect a
true relative risk of 1.5 and a decision rule to reject the null hypothesis of no effect when p < 0.05
(see Dupont and Plummer [1990] for methods to calculate power). The power is the estimated
probability that the null hypothesis would be rejected if the true relative risk is 1.5 (i.e., that the
                                            5-25

-------
Table 5-8. Estimated correction for smoker misclassification
Case
control
AKIB
BROW

BUFF

CHAN

CORR

FONT
GAO
GARF
GENG
HIRA

HUMB
INOU
JANE

KABA
KALA
KATA
KOO

LAMT

..
; " Uncorrected2
V a)


1.52
(0.49, 4.79)
0.81
(0.39, 1.66)
0.75
(0.48, 1.19)
2.07
(0.94, 4.52)
1.29
(1.03, 1.62)

1.31
(0.93, 1.85)

1.53
(1.10, 2.13)
2.2
(0.9, 5.5)

0.86
(0.57, 1.29)
0.79
(0.30, 2.04)

*
1.55
(0.98, 2.44)
1.65
(1.21,2.21)
Never-smokers RR1 ui
Corrected* ,„„
" - , (2) -
1.5
(1.0, 2.5)
1.50
(0.48, 4.72)
0.68
(0.32, 1.41)
0.74
(0.47, 1.17)
1.89
(0.85, 4.14)
1.28
(1.03, 1.60)
1.19
(0.87, 1.63)
1.27
(0.91, 1.79)
2.16
(1.21, 3.84)
1.52
(1.10,2.12)
2.00
(0.83, 4.97)
2.55
(0.90, 7.20)
0.79
(0.52, 1.17)
0.73
(0.27, 1.89)
1.92
(1.13, 3.23)
*
1.54
(0.98, 2.43)
1.64
(1.21,2.21)

,Bias4
0)7(2)
1.00
1.01

1.20

1.01

1.10

1.01
1.00
1.03
1.00
(0.995)
1.01

1.10
1.00
(0.996)
1.09

1.08
1.00
*
1.01

1.01

Ever-smokers
ORtised6
2.38
4.30

7.06

3.48

12.40

8.0
2.54
6.0
2.77
3.20

16.3
1.66
8.0

5.90
3.32
*
2.77

3.77

                                                          (continued on the following page)
                                           5-26

-------
Table 5-8. (continued)
Case
control
LAMW
LEE
LIU
PERS
SHIM
SOBU
SVEN
TRIG
WU
WUWI
BUTL
(Coh)
GARF
(Coh)
HIRA
(Coh)
HOLE
(Coh)
'
Uncorrected2
(I)


1.03
(0.48, 2.20)


1.2
(0.7, 2.1)6
1.08
(0.70, 1.68)

1.26
(0.65, 2.48)

1.41
(0.63, 3.15)
0.79
(0.64,0.98)
2.027
(0.48, 8.56)6
1.177
(0.85, 1.61)6
1.38
(1.03, 1.87)
1.997
(0.24, 16.7)6
Never-smokers RRX
Corrected* ,
(2)
2.51
(1.49, 4.23)
1.01
(0.47, 2.15)
0.77
(0.35, 1.68)
1.17
(0.75, 1.87)
1.07
(0.7,1.67)
1.57
(1.13,2.15)
1.20
(0.63,2.36)
2.08
(1.31, 3.29)
1.32
(0.59, 2.93)
0.78
(0.63,0.96)
2.01
(0.61,6.73)
1.16
(0.89, 1.52)
1.37
(1.02, 1.86)
1.97
(0.34, 11.67)
'
(J)/(2)
1.00
(0.996)
1.02
1.00
1.03
1.01
1.00
1.05
1.00
1.07
1.01
1.00
1.01
1.01
1.01
Ever-smokers
OR usedf
4.12
4161
*
4.2
2.8
2.81
6.00
2.81
4.38
2.24 '
4.0
3.58
3.20
4.2
     for case-control studies; RR for cohort studies.
'Adjusted OR in Table 5-5 is used unless the confidence interval is unknown or the study review
 (Appendix A) is critical of the method(s) used.
3Corrected (2) (estimate and confidence interval) equals uncorrected (1) times ratio [(2)/(l)].  All
 corrected 95% confidence intervals have been converted to 90% confidence intervals.
4Values shown are the lower of (calculated ratio, 1). Calculated ratios less than 1 are shown in
 parentheses.
 The crude OR for ever-smokers in Table 5-5 is used in the calculations for the corrected value
 (Appendix B), when available. Ever-smoker ORs for GARF, JANE, PERS, and SHIM are
 approximated from the data of other studies for suitable location and time period. The ever-
 smoker ORs for BUTL(Coh) and (LEE) are based on data in Fraser et al. (1991) and Alderson et
 al. (1985), respectively.
i95% confidence interval.
7Adjusted RR value in Table 5-5.
                                           5-27

-------
Table 5-9. Statistical measures by individual study and pooled by country, corrected for smoker
misclassification1
Location
Greece
Greece
Greece
HK
HK
HK
HK
HK
Japan
Japan
Japan
Japan
Japan
Japan
USA
USA
USA

USA
USA
USA
Study
KALA
TRIG
ALL
CHAN
KOO
LAMT
LAMW
ALL
AKIB '
HIRA
(Coh)
INOU
SHIM
SOBU
ALL
BROW
BUFF
BUTL
(Coh)
CORR
FONT8
GARF
Relative"
weight2
43
57
5
20
20
45
15
14
15
35
3
16
30
19
1
3
1

3
35
15
Power*
0.39
0.45

0.43
0.43
0.73
0.39

0.42
0.75
0.17
0.377
0.66

0.15
0.17
0.18

0.22
0.93
0.607
P-vai
Effect*
0.02
<0.01
<0.01
>0.5
0,06
<0.01
<0.01
<0.01
0.05
0.04
0.07
0.38
0.01
<0.01
0.28
>0.5
0.17

0.10
0.03
0.12
lie
Tread8
0.04
<0.01

*
0.16
<0.01
*

0.03
<0.01
<0.03
* -
*

*
*
*

0.01
0.04
<0.02
«
1.92
2.08
2.01
0.74
1.54
1.64
2.51
1.48
1.50
1.37
2.55
1.07
1.57
1.41
1.50
0.68
2.01

1.89
1.28
1.27
Confidence
interval
90%
(1.13,3.23)
(1.31, 3.29)
(1.42, 2.84)
(0.47, 1.17)
(0.98, 2.43)
(1.21,2.21)
(1.49,4.23)
(1.21, 1.81)
(1.00,2.50)
(1.02, 1.86)
(0.90, 7.20)
(0.70, 1.67)
(1.13,2.15)
(1.18, 1.69)
(0.48, 4.72)
(0.32, 1.41)
(0.61,6.73)

(0.85, 4.14)
(1.03, 1.60)
(0.91, 1.79)
                                                            (continued on the following page)
                                            5-28

-------
Table 5-9.  (continued)
Location
USA
USA
USA
USA
USA
USA
Scotland
Eng./Wales
Sweden
Sweden
W. Europe
China
China
China
China
China
Relative
weight2
Study (%}
GARF
(Con)
HUMS
JANE
KABA
WU
ALL
HOLE
(Coh)
LEE
PERS
SVEN
ALL
GAO
GENG
LIU
WUWI
ALL
25
2
10
2
3
34
100
100
68
32
5
28
8
4
60
22
v "" s ""*
P- value
Power3
0.92
0.20
0.447
0.177
0.21

0.09
0.20
0.457
0.24

0.66
0.32
0.18
0.897

Effect4
0.18
0.10
>0.5
>0.5
0.29
0.02
0.26
0.50
0.27
0.31
0.22
0.18
0.01
>0.5
>0.5
>0.5
Trend5 RR*
* 1.16
* 2.00
* 0.79
* 0.73
* 1.32
1.19.
* 1.97
* 1.01
0.12 1.17
* 1.20
1.17
0.29 1.19
<0.05 2.16
* 0.77
* 0.78
0.95
Confidence
interval
90% ,
(0.89, 1.52)
(0.83, 4.97)
(0.52, 1.17)
(0.27, 1.89)
(0.59,2.93)
(1.04, 1.35)
(0.34, 11.67)
(0.47, 2.15)
(0.75, 1.87)
(0.63, 2.36)
(0.84, 1.62)
(0.87, 1.62)
(1.21,3.84)
(0.35, 1.68)
(0.63,0.96)
(0.81, 1.12)
 ^isclassification is discussed in Section 5.2.2 and Appendix B.
 2A study's relative weight (wt) is 1/var (log(OR)), divided by the sum of those terms for all studies
 included, times  100 (to express as a percentage).
 3A priori probability of significant (p < 0.05) test of effect when true relative risk is 1.5.
 4One-sided p-value for test of RR = 1 versus RR > 1.
 5P-value for upward trend. P-values from studies reporting only the significance level for trend were
 halved to reflect a one-sided alternative, i.e., upward trend.
 6Adiusted for smoker misclassification.  OR used for case-control studies; RR for cohort studies.
 Calculated for matched study design.
 8For population control group only, all cases.

 *Data not available;  ns = not significant.
                                               5-29

-------
 correct decision would result; the power would be larger if the true relative risk exceeds 1.5). If
 the estimates of power for the U.S. studies in Table 5-9 are used for illustration, it can be seen
 that the estimated probability that a study would fail to detect a true relative risk of 1.5 (equal to
 1 - Power, the probability of a Type II error [discussed in the next paragraph] when the true
 relative  risk is 1.5) is as follows: FONT, 0.07; GARF(Coh), 0.08; GARF, 0.40; JANE, 0.56;
 BUFF, 0.83; CORK, 0.78; WU, 0.79; HUMB, 0.80; KABA, 0.83; BUTL(Coh), 0.82; and BROW,
 0.85. Thus,  7 of the 11 U.S. studies have only about a 20% chance of detecting a true relative risk
 as low as 1.5 when taken alone. Sources of bias effectively alter the power in the same direction
 as the bias (e.g., a downward bias in RR decreases the power). Of the potential sources of bias
 discussed by study in Section A.4, the predominant direction of influence on the observed RR,
 when identifiable, appears to be in the direction of unity, thus affecting power adversely. The
 RRs already have been reduced to adjust for smoker misclassification, the only systematic source
 of upward bias that has been established.
       Studies of all sizes, large and small, are equally likely to make a false conclusion if ETS is
 not associated with lung cancer risk (Type I error). However, smaller studies are less likely to
 detect a  real association when there is one (Type II error).  This imbalance comes from using the
 significance level of the test statistic to determine whether to reject the null hypothesis.  If the
 decision rule is to reject the hypothesis when the p-value is smaller than some prescribed value
 (e.g., 0.05), then the Type I error rate is 0.05,  but the Type II error rate increases as study size
 decreases.  When a study with low power fails to reject the null hypothesis of no effect, it is not
 very informative because that outcome may be nearly as likely when the null hypothesis is false as
 when it is true.  When detection of a small relative risk is consequential, pooling informational
 content of suitably chosen studies empowers the application of statistical methods.
       The heading in Table 5-9 that remains to be addressed is "relative weight," to be referred
 to simply as "weight."  When the estimates of relative risk from selected studies are combined, as
 for studies within the same country as shown in the table, the logarithms of the RRs are weighted
 inversely proportional to their variances (see Appendix D and footnote 2 of Table 5-9). These
 relative weights  are expressed as percentages summing to 100 for each country in Table 5-9.
 Study weight and power are positively associated, which is explained by the significant role of
study size to both. Consequently, studies weighted most heavily (because the standard errors of
the RRs are low) also tend to be the ones with the highest power (most likely to detect an effect
when present).
                                            5-30

-------
 5.3.2.  Analysis of Data by Study and Country
 5.3.2.1.  Tests for Association
        The p-values of the test statistics for the hypothesis of no effect (i.e., RR = 1) are shown
 in Table  5-9. Values of the test statistics (the standardized log odds ratio; see Appendix D) are
 plotted in Figure 5-1.  Also shown in Figure 5-1 for reference are the points on the horizontal
 axis corresponding to p-values of 0.5, 0.2, 0.1, 0.05, 0.01, and 0.001. For example, the area under
 the curve to the right of the vertical line labeled p = 0.01 is 0.01 (1%), so it is apparent from
 Figure 5-1 that three studies had significance levels p < 0.01 (more specifically, 0.001 < p < 0.01).
 The size of the symbol (inverted triangle) used for a study is proportional in area  to the relative
 weight of that individual study, but of current interest is the location and not the  size of  the
 symbol. If the null hypothesis is true, then the plotted values would arise from a standard normal
 distribution, shown in the figure (points to  the left of zero indicate that the RR is less than 1, and
 points to  the right of zero indicate that RR is greater than 1). If the points lie more toward the
 right side of the normal curve than would be likely to occur by chance alone, then the hypothesis
 of no effect is rejected in favor of a positive association between ETS exposure and lung  cancer.
 If one constructs five intervals of equal probability (i.e., intervals  of equal area under the standard
 normal curve), the expected number of observations in each interval is six (these five intervals are
 not shown on Figure 5-1). The observed numbers in these intervals, however, from left to right
 are 3, 3, 1, 7, and 16, an outcome that is significant at p < 0.005, by the chi-square goodness-of-
 fit test. At the points on  the standard normal curve corresponding to p-values 0.5, 0.4, 0.3, 0.2,
 0.1, and 0.05, the probability that a number of outcomes as large as that actually observed would
 occur by chance is less than 0.005 at all points. Consequently, the hypothesis of no effect is
 rejected on statistical grounds,  and that conclusion is not attributable to a few extreme outcomes
 that might be aberrant in  some way.
        Figure 5-2 displays the U.S. studies  alone (see Appendix D for calculation  of the test
 statistics). Figure 5-3 corresponds to Figure 5-1  except that the test statistics for the hypothesis
 of no effect (i.e., RR = 1) for the significance levels shown apply to a single overall estimate of
 RR for each country, formed by statistically pooling the outcomes from the studies within each
 country.  The areas of the symbols for countries are also in proportion to statistical weight as
 given in Table 5-9. It is implicitly assumed that studies within a country, and the  subpopulations
 sampled, are sufficiently homogeneous to warrant combining their statistical results into a single
estimate for the country (see Greenland [1987] for a discussion of applications of meta-analysis to
epidemiology). The calculational method employed weights the observed RR from each study
within a country inversely proportional to its estimated variance (see Appendix D). The relative
                                            5-31

-------
                                TESTS OF THE HYPOTHESIS THAT RR = 1
                                              BY STUDY
                                                  p-0.5
                                                       p-0.2
                                                                  p = 0.01
                                                                       p - 0.001
Figure 5-1.  Test statistics for hypothesis RR = 1, all studies.
                                TESTS OF THE HYPOTHESIS THAT RR = 1
                                                 USA
                                                  p-0.5
                                                        p-0.2
                                                           p-0.1
                                                                  p - 0.01
                                                                        p - 0.001
                                           JWE KABA 0    WU   MUUB
                                            BUFF       BROW  COflR
                                                        CUtr(Coh)
                                                         BUIl(Coh)
                                                              TOMT
Figure 5-2. Test statistics for hypothesis RR = 1, USA only.


                                                5-32

-------
                              TESTS OF THE HYPOTHESIS THAT RR = 1
                                          BYCOUNTRY
                                              p-0.5
                                                    p-0.2
                                                      p-0.1
                                                         p - 0.05
                                                         v   p-0.01
                                                         x   '     p - 0.001
                                           CHINA
W.EUR     USA    JAPAN
                GREECE
               HK
Figure 5-3.  Test statistics for hypothesis RR = 1, by country.
                           TESTS OF THE HYPOTHESIS THAT RR = 1
                             BY COUNTRY (STUDIES IN TIERS 1 -3 ONLY)
                                              p = 0.5
                                                     = 0.2
                                                                     0.001

                                                   	v
                                                   W.EUR         JAPAN
                                                    CHINA   USA    GREECE
                                                                        HK
Figure 5-4. Test statistics for hypothesis RR = 1, tiers 1-3 only.


                                            5-33

-------
study weights are shown in Table 5-9.  Each symbol in Figures 5-1, 5-2, 5-3, and 5-4 has been
scaled so that its area is proportional to the weight of the outcome represented, relative to all other
outcomes shown in the same figure.
       Greece, Hong Kong, and Japan, which together comprise a total weight of 39%, are  each
statistically significant at p < 0.01 against the null hypothesis of no increase in relative risk
(RR =1). When the United States is included, the total weight is 73%, and each of the four
countries is significant at p < 0.02. The four studies combined into the group called Western
Europe are not large. Together they represent 5% of the total weight, and their combined odds
ratio (1.17) is slightly above 1 but not statistically significant (p = 0.21). In contrast, China is
weighted quite high (22%), the p-value is large (0.66), and the odds ratio is less than 1 (0.95),
strongly indicating no evidence of an increase in RR due to ETS.  This is largely because China is
very heavily  influenced by WUWI (relative weight of 60%  of China), which is a very large case-
control study. However, this apparent inconsistency in WUWI may be due to the presence of
indoor smoke from cooking and heating, which may mask  any effect from passive smoking. A
similar but more extreme situation is found in LIU, conducted in a locale where indoor heating
with smoky coal (an established risk factor for lung cancer) and inadequate venting are common.
Both WUWI and LIU were conducted primarily to assess the hazardous potential of these
pollutants.  The indoor environments of the populations sampled in WUWI and LIU make
detection of any carcinogenic hazard from ETS unlikely, and thus render these studies to be of
little value for that purpose (see discussions of WUWI and  LIU in Section A.4). Without WUWI or
LIU, the combined results of the two remaining studies in  China, GAO and GENG, are
significant at p = 0.03.
       Such  qualitative considerations about the  likely utility of a study to detect an ETS effect,
if one exists, are taken into account in Section 5.5. In that section, studies are ranked into one of
four tiers based on their likely utility. Studies such as WUWI and LIU would be placed into Tier
4, the grouping with the least likelihood of providing useful information on the effects of ETS.
Figure 5-4 is similar to Figure 5-3 displaying the distribution of test statistics for the pooled
estimates by country, but includes only the studies in Tiers 1,  2, and 3; it is shown here for
comparison purposes (see Section 5.5 for a detailed discussion  of the analysis based on tiers).

5.3.2.2.  Confidence Intervals
       Confidence intervals for relative risk are  displayed by study and by country in Table 5-9
(see Appendix D for method of calculation). The 90% confidence intervals by  country are
illustrated in Figure 5-5. (Note: 90% confidence intervals  are used for correspondence to a  right-
                                            5-34

-------
                              902 CONFIDENCE INTERVALS FOR RR
                                         BY COUNTRY
                       GREECE


                       HONGKONG

                       JAPAN

                       USA


                       W. EUROPE

                       CHINA


                      J-
I	•     I

I   •	1
                      0.0      0.5     1.0      13      2.0
                                                                  3.0
 Figure 5-5. 90% confidence intervals, by country.
                           90% CONFIDENCE INTERVALS FOR RR
                           BY COUNTRY (STUDIES IN TIERS 1 -3 ONLY)
                  GREECE


                  HONG KONG

                  JAPAN

                  USA


                  W. EUROPE

                  CHINA
                 0.0      0.5      1.0       1.5      2.0       2.5       3.0
Figure 5-6.  90% confidence intervals, by country, tiers 1-3 only.


                                          5-35

-------
tailed test of the hypothesis of no effect at a 5% level of significance.)  The area of the symbol
(solid circle) locating the point estimate of relative risk within the confidence interval is
proportional to study weight. Symbol size is used as a device to draw attention to the shorter
confidence intervals, which tend to be based on more data than the longer ones. The confidence
intervals for countries jointly labeled as Western Europe are in Table 5-9, except for Sweden
which contains two studies, PERS and SVEN. For those two studies combined, the odds ratio
(OR) is 1.19 (90% C.I. = 0.81, 1.74). The  confidence intervals for the pooled relative risk
estimates by country for studies in Tiers 1, 2, and 3  only (see previous paragraph and Section 5.5)
are displayed in  Figure 5-6.
       In descending order, the relative risks in Figure 5-6 are for Greece, Hong Kong, Japan,
the United States, and Western Europe. (China is being excluded from this summary because it
contains only one study in Tiers 1-3 [GAO], which is unlikely to  be representative of such a vast
country. The relative risk estimate for that study, 1.19, is similar to the overall relative risks for
the United States and Western Europe.) The estimated relative risks from exposure to spousal
smoking differ between countries, with Greece, Hong Kong, and Japan at the high end of the
scale and the United States and Western Europe at the low end. These differences suggest that
combining studies from different countries should be done with caution. The relative risks
pertain only to ETS exposure from spousal smoking, which may be a higher proportion of total
ETS exposure in some countries than in others.  This also emphasizes the importance of taking
into account exposure and background (nonspousal) ETS, which is considered in the estimation of
population risk for the United States in Chapter 6.

5.3.3. Analysis  of Data by Exposure Level
5.3.3.1. Introduction
        In Section 5.3.2, analyses are conducted by individual study and by studies pooled within
countries, using the dichotomous data on spousal smoking (i.e., any level of spousal smoking
versus no spousal smoking) as a surrogate for ETS exposure. This section examines the response
data from all of the studies that provide data analysis by exposure-level categories.  Exposure
level, for these studies, refers to the amount of spousal smoking.  In different studies, exposure is
measured by intensity (e.g., cig./day smoked by the husband), duration (e.g., number of years
married to a smoker), or a combination of both (e.g., number of pack-years—packs per day
 x years of smoking by the husband).  The data are analyzed by calculating RR estimates for the
highest exposure groups only (Section 5.3.3.2) and then by testing for an upward trend in RR
across exposure  groups within studies as ETS exposure increases (Section 5.3.3.3).
                                            5-36

-------
       An evaluation of the highest exposure group or a test for exposure-related trend may be
able to detect an association that would be masked in a test for effect using only dichotomous
data.  This masking is especially likely to occur when dealing with a weak association or a crude
surrogate measure for exposure that is widespread (i.e., greater potential for exposure
misclassification), both of which are difficulties in studies of ETS and lung cancer.
       As  discussed in Chapter 3, ETS is a dilute mixture,  and, consequently, any association
observed between environmental levels of ETS exposure and lung cancer is likely to be weak (i.e.,
have a low RR).  Furthermore, questionnaire-based assessment of exposure to ETS is a crude
indicator of actual lifetime exposure, and spousal smoking is an incomplete surrogate for exposure
because it does not consider ETS from other sources, such as the workplace. Therefore, exposure
misclassification in both directions is inevitable. For example, there will be women whose
husbands do not smoke but who are exposed to substantial levels of ETS from other sources, and
there will be women whose husbands smoke but who are not actually exposed to appreciable levels
of ETS. This latter scenario is most likely if the level of spousal smoking is low.  Comparing the
highest exposure  group with the "unexposed" group will help reduce the effect of this latter type
of exposure misclassification bias.
       In addition, the detection of an exposure-response relationship (trend) across exposure
groups increases support for a causal association by diminishing the likelihood that the results can
be explained by confounding, because any potential confounder would have to be associated with
both lung cancer and ETS exposure in a dose-related manner.  However, the potential for
exposure misclassification is compounded when the exposed group is further divided into
level-of-exposure categories  and the sample sizes become small. This is especially problematic in
small studies.  These inherent difficulties with the ETS database tend to diminish the possibility of
detecting exposure-response  relationships. Therefore, the inability to demonstrate an exposure-
response trend is not considered evidence against causality; rather, if a statistically significant
trend can be detected despite these potential obstacles, it provides evidential support for a causal
association.

5.3.3.2.  Analysis of High-Exposure Data
       In  this section, analyses will be conducted for the highest exposure groups by study and by
studies pooled within countries.  As described in Section 5.3.3.1, analyzing only the data from the
highest exposure group of each study increases the sensitivity for detecting an association and
reduces the effects of exposure misclassification. Fractionating the data, however, does decrease
the power to observe statistical significance.
                                             5-37

-------
        The results of statistical inference using only data from the highest exposure categories are
 displayed in Table 5-10.  As indicated in the table, exposure-level data are available in 17 studies.
 The definitions of highest exposure category, shown next to the study name in the table, vary
 widely between studies. Crude RR estimates adjusted for smoker misclassification (see Section 5.2
 and Appendix B) are used in this section rather than the estimates adjusted for modifying factors
 within the studies, because the latter are available by exposure level for only a limited number of
 studies.
        Several observations are apparent from Table 5-10. First, every one of the 17 individual
 studies shows increased risk at the highest exposure level, even after adjusting for smoker
 misclassification. Second, 9 of the 16 comparisons for which sufficient data are available are
 statistically significant (p <; 0.05), despite most having very low statistical power. Third, the RR
 estimates pooled within countries are each statistically significant with p ^ 0.02.  Although the
 RR estimates within a country are pooled across different definitions of highest exposure, which
 somewhat limits  their interpretation and practical value, it is apparent that these RRs are
 considerably higher than the values observed for the dichotomous data (Table 5-9). The RR
 estimates pooled by country vary from a low of 1.38 (p = 0.005) for  the United States to a high of
 3.11 (p = 0.02) for Western Europe, which contains only one study.  Finally, the overall pooled
 estimate of 1.81 for the highest exposure  groups from all 17 studies is highly statistically
 significant (p < 0.000001).
        These results are consistent with the statistical evidence presented in Section 5.3.2 for an
 association between ETS exposure and lung cancer.  In fact, increased risks are found for the
 highest exposure groups without exception.  Furthermore, the RR estimates pooled within
 countries are all statistically significant and  range from  1.38 to 3.11, even after adjustment for
 smoker misclassification.  The consistency of these highest exposure results cannot be accounted
 for by chance, and the stronger associations detected for the highest exposure  groups across all
 countries further reduce the likelihood that  bias or confounding could explain the observed
 relationship between ETS and lung cancer.
        In addition, with the exception of Western Europe, which contains only one low-power
 study in this analysis, the pooled RR estimates from other, more "traditional" countries are all
 appreciably higher than that from the United States. It is likely that these differences are at least
 partially a result of higher background (nonspousal) ETS exposures to the allegedly "unexposed"
 group in the United States. Again, this highlights the importance of accounting for ETS exposures
from sources other than spousal smoking. An adjustment for background ETS exposures is made
in Chapter 6, for the estimation of population risk for the United States.
                                            5-38

-------
Table 5-10. Statistical measures for highest exposure categories only1
Location
Greece
Greece
Greece
Hong Kong
Hong Kong
Hong Kong
Japan
Japan
Japan
Japan
United States
United States
United States
United States
United States
United States
United States
United States
W. Europe
W. Europe
China
China
China
All
Study
KALA
TRIG
All
KOO
LAMT
AH
AKIB
HIRA
(Coh)
INOU
AD
CORE
FONT
GARF
GARF
(Coh)
HUMB
JANE
WU
AH
PERS
AH
GAO
GENG
AD
AH
Highest
exposure
level
( 2:41 cig./day)
(2:21 cig./day)
High
(2:21 cig./day)
(2:21 cig./day)
High
(2:30 cig./day)
( 2:20 cig./day)
(2: 20 cig./day)
High
( 2:41 pack-yrs)
(2:80 pack-yrs)
(S 20 cig./day)
(2:20 cig./day)
(2:21 cig./day)
(2:50 pack-yrs)
(2:31 years)
High
(2: 16 cig./day)
High
(2:40 years)
(2: 20 cig./day)
High
High
Relative
weight2
{%)
35
65
8
36
64
8
6
89
4
22
8
14
15
45
2
8
8"
36
100
2
35
65
24

P~vahte
Power3 Effect4
0.06 0.16
0.11 0.003
0.002
0.11 0.36
0.16 0.02
0.03
0.10 0.13
0.13 0.00015
* 0.05
<0.00004
0.06 0.005
* 0.21
0.21 0.01
* 0.33
* 0.46
* 0.50
* *
0.005
* 0.02
0.02
0.33 0.02
* <0.00001
<0.000001
< 0.000001
RR5*
1.67
2.55
2.15
1.18
2.05
1.68
2.1
1.91
3.09
1.96
3.20
1.327
2.05
1.09
1.09
1.01
1.87
1.38
3.11
3.11
1.7
2.76
2.32
1.81
Confidence
interval6
80%
(0.74, 3.32)
(1.46, 4.42)
(1.38,3.35)
(0.58, 2.55)
(1.18, 3.57)
(1.08, 2.62)
(0.7, 2.5)
(1.42, 2.56)
(1.0, 11.8)
(1.49,2.60)
(1.53, 6.74)
(0.75, 2.29)
(1.19, 3.49)
(0.81, 1.49)
(0.27, 4.73)
(0.50, 2.04)
*
(1.13, 1.70)
(1.18, 7.71)
(1.18, 7.71)
(1.09, 2.65)
(2.02, 3.84)
(1.78, 3.03)
(1.60, 2.05)
                                                          (continued on the following page)
                                            5-39

-------
Table 5-10.  (continued)
Similar to Table 5-9 except entries apply to highest exposure category only in each study.  Only
 studies with data available for categorized measures of exposure are included. Relative risks and
 confidence bounds are corrected for smoker misclassification.
2A study's relative weight (wt) is 1/var (log(OR)), divided by the sum of those terms for all  ,
 studies included, times 100 (to express as a percentage).
SA priori probability of significant (p < 0.05) test of effect when true relative risk is 1.5.
4One-sided p-value for test of RR = 1 versus RR > 1.
5Adjusted for smoker misclassification.  OR used for case-control studies; RR for cohort studies.
6Values may differ from those of Table 5-11, where confidence intervals are shown as they
 appear in the source.  In Table 5-11, the RR and confidence interval are not corrected for smoker
 misclassification, as in this table, and most of the confidence intervals are 95% instead of 90%.
7Value shown is for all cell types with the two control groups combined. For adenocarcinoma
 cases only, the RR is 1.68 with C.I. = 0.81, 3.46.
8Relative  weight assumed to be the same as for CORR, based on the outcome in Table 5-9.
*Data not available.
5.3.3.3.  Tests for Trend
       In this section, exposure-response data from the studies providing data by exposure level
are tested for upward trend.  An exposure-response relationship provides strong support for a
causal association (see Section 5.3.3.1).
       Table 5-11 presents the female exposure-response data and trend test results from the
studies of ETS and lung cancer discussed in this report. The p-values reported in the table are for
a test of no trend against the one-sided alternative of an upward trend (i.e., increasing RR with
increasing exposure). (Note:  The results for tests of trend are taken from the study reports.
Unless the report specified that a one-sided alternative was used, the reported p-value was halved
to reflect the outcome for the one-sided alternative of RR increasing with exposure.  Where the
data are available, the p-values reported by the individual study's authors have been  verified here
by application of the Mantel, Haenszel test [Mantel, 1963].)
       Wu-Williams and Samet (1990) previously reviewed the exposure-response relationships
from the epidemiologic studies on ETS then available.  They determined that 12 of 15 studies
were statistically significant for the trend test for at least one exposure measure.  The probability
of this proportion of statistically significant results occurring by chance in this number of studies
is virtually zero  (p < 10"13).  Intensity of spousal smoking was the most consistent index of ETS
exposure for the demonstration of an exposure-response relationship.
       Our assessment of the exposure-response data is similar and provides essentially the same
results for a slightly  different set of studies. Table 5-12 summarizes the p-values of  the trend
                                            5-40

-------
Table 5-11. Exposure response trends for females
Study
AKIB
(cig./day)


AKIB
(years)


CORR
(pack-yrs.)

FONT6
(years)


FONT7
(years)


FONT6
(pack-yrs.)



FONT7
(pack-yrs.)



GAO
(tot. yrs.)8


GARF
(cig./day)


GENG
(cig./day)


Case
21
29
22
12
21
20
29
22
8
5
9
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
99
93
107
76
44
29
17
26
*
*
*
*
Coat.
82
90
54
23
82
30
81
59
72
38
23
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
57
63
78
48
157
90
56
44
*
*
*
*
Exposure1

1-19
20-29
£30
0
1-9
20-39
£40
0
1-40
£41
0
1-15
16-30
>30
0
1-15
16-30
>30

0<15
15-39
40-79
£80

0<15
15-39
40-79
£80
0-19
20-29
30-39
£40
0
1-9
10-19
£20
0
1-9
10-19
£20
RR4
1.0
1.3
1.5
2.1
1.0
2.1
1.5
1.3
1.00
1.18
3.52
1.00
1.19
1.14
1.25
1.00
1.33
1.40
1.43
1.00
0.96
1.13
1.25
1.33
1.00
1.03
1.26
1.49
1.70
1.0
1.1
1.3
1.7
1.00
1.15
1.08
2.11
1.00
1.40
1.97
2.76
c.iA3

(0.7, 2.3)\
(0.8,2.8)^
(0.7, 2.5)5

(1.0,4.3)1;
(0.8,2.7)5
(0.7, 2.5)5

(0.44, 3.20)
(1.45, 8.59)

(0.88, 1.61)
(0.82, 1.59)
(0.91, 1.72)

(0.93, 1.89)
(0.96, 2.05)
(0.99, 2.09)

(0.72, 1.29)
(0.81, 1.59)
(0.86, 1.81)
(0.68, 2.58)

(0.73, 1.46)
(0.85, 1.87)
(0.98, 2.27)
(0.82, 3.49)

(0.7, 1.8)
(0.8, 2.1)
(1.0,2.9)

(0.8, 1.6)
(0.8, 1.5)
(1.1,4.0)

(1.1,1.8)
(1.4,2.7)
(1.9,4.1)
F-jrenxf*
0.03



0.24



0.01


0.07



0.02



0.04




0.01




0.29



<0.02



<0.059



                                                           (continued on the following page)
                                           5-41

-------
Table 5-11. (continued)
Study
GENG
(years)


HUMB
(cig./day)

INOU
(cig./day)

JANE10
(pack-yrs.)


KALA
(cig./day)


KALA
(years)



KOO
(cig./day)


LAMT6
(cig./day)


LAMT7
(cig./day)


**« ' »<














26
34
22
8
26
15
15
17
17
32
17
25
12
84
22
56
20
53
17
37
15
Cpnt:
*
*
*
*
*
*
*
*
*
*
*
*
*
*
46
39
22
9
46
21
20
15
16
67
15
35
19
183
22
66
21
92
12
28
9
Exposure1
0
<20
20-39
S»40
0
1-20
;>21
0-4
5-19
s»20
0
1-24
25-49
;>50
0
1-20
21-40
41+
0
<20
20-29
30-39
>40
0
1-10
11-20
£•21
0
1-10
11-20
S»21
0
1-10
11-20
3:21
x**/ *"
1.00
1.49
2.23
3.32
.0
.8
.2
.00
.58
3.09
1.00
0.71
0.98
1.10
.00
.54
.77
.57
.00
.26
1.33
2.01
1.88
1.00
2.33
1.74
1.19
1.00
2.18
1.85
2.07
1.00
2.46
2.29
2.89
cxw

(1.15, 1.94)
(1.54, 3.22)
(2.11,5.22)

(0.6, 5.6)5
(0.3, 5.2)B

(0.4, 5.7)6
(1.0, 11.8)6

(0.37, 1.35)
(0.47, 2.05)
(0.47, 2.56)

(0.88, 2.70)
(0.93, 3.35)
(0.64, 3.85)

(0.56, 2.87)
(0.58, 3.03)
(0.86, 4.67)
(0.82, 4.33)

(0.9, 5.9)
(0.8, 3.8)
(0.5, 3.0)

(1.14,4.15)
(1.19, 2.87)
(1.07,4.03)

(1.09, 5.54)
(1.26, 4.16)
(1.18, 7.07)
P-trend4
<0.059



ns


<0.03


*



0.08



0.04




0.16



0.01



0.01



                                                         (continued on the following page)
                                           5-42

-------
Table 5-11. (continued)
Study
PERS11
(cig./day)

TRIG12
(cig./day)

WU13
(years
exposed as
adult)
gARF(Coh)
(cig./day)
j|IRA(Coh)
(cig./day)
Case
34
26
7
24
24
14
*
*
*

65
39
49
37
99
64
Cont
*
*
*
109
56
25
*
*
*

*
*
21,895
44,184
25,461
Exposure1
0
1-15
£16
0
1-20
£21
0
1-30
£31

0
1-19
£20
0
1-1916
£20
KR*
1.0
1.0
3.2
1.00
1.95
2.55
1.0
1.2
2.0

1.00
1.27
1.10
1.00
1.41
1.93
CIV

(0.6, 1.8)
(1.0, 9.5)

(1.13, 3.36)
(1.31, 4.93)

*
*

(0.85, 1.89)
(0.77, 1.61)
(1.03, 1.94)
(1.35, 2.74)
P-trend4
0.12


0.01


*



*

0.01

 ^Smoking by spouse unless otherwise specified.
 2See footnote 6 in Table 5-10.
 ^Confidence intervals are 95% unless noted otherwise.
  P-value for upward trend. P-values from studies reporting only the significance level for trend
  were halved to reflect a one-sided alternative (i.e., upward trend).  Values below 0.01 are shown
  as 0.01.
 ~90% confidence interval.
 6A11 histologies.
 'Adenocarcinomas only.
  Years lived with a smoking husband.
 9Neither crude data nor a test for trend is included in reference articles.  The relative risk at each
  exposure category is significant alone, however, at p < 0.05.
10Data are from subject responses in Table 3 of the source.
"Low exposure level is for husband smoking up to 15 cigarettes per day or one pack (50 g) of
  pipe tobacco per week, or smoking any amount during less than 30 years of marriage.  High
  exposure level is for husband smoking more than 15 cigarettes per day or one pack of pipe
•  tobacco per week during 30 years of marriage or more.
"Data from Trichopoulos et al. (1983), with RRs corrected (personal communication from
  Trichopoulos, 1984).
13Years of exposure to spousal smoke plus years of exposure to workplace smoke; adenocarcinomas
  only.
1 Value under "RR" is mortality ratio of observed to expected lung cancer deaths.  Value under
  "Case" is number of observed lung cancer deaths.
"Standardized for age of subject (Hirayama, 1984). Values under "case" are numbers of lung
  cancer deaths; values under "cont." are total population.
  Includes former smokers of any exposure level.

*Data not available;  ns = not significant.
                                           5-43

-------
Table 5-12. Reported p-values of trend tests for ETS exposure by study1'

AKIB
CORR
FONT
GAO
GARF
GENG
HUMB
INOU
JANE
KALA
KOO
LAMT
PERS
TRIG
WU
GARF(Coh)
HIRA(Coh)
s ,-, -
, -, -: *> Intensity
' s (cig./day)
0.03
*
*
*
*
<0.02
<0.056
ns
<0.03
*6
0.08
0.16
<0.01
<0.014
0.12
<0.01
*
*6
<0.01
~ AV Trend test results
Duration
{total years)
0.24
*
0.07s
<0.024
0.29
*
<0.055
*
*
*
0.04
*
*
*
*
*6
*
*

Cumutative,
(t>ack~yearsr
*
0.01
0.04
<0.01
*
*
*
*
*
*
*
*
*
*
*
*
*
*
 JDetailed data presented in Table 5-11.
 2A "pack-year" is equivalent to one pack/day for 1 year.
 SA11 cell types.
 4Adenocarcinoma only.
 ESee footnote 9 in Table 5-11.
 ^Trend results presented without p-values or raw data—see Table 5-11.

 *Data not available; ns » not significant.
                                            5-44

-------
 tests for the various ETS exposure measures from the studies presented in Table 5-11.  The
 exposure measure most commonly used was intensity of spousal smoking.  Eight of the twelve
 studies that reported exposure-response data based on cigarettes per day showed statistical       "~"
 significance at the p < 0.05 level for the trend test.  Again, the probability of this many
 statistically significant results occurring by chance in this number of studies is negligible
 (p < 10-7).  The trend test results for the other exposure measures were consistent, in general, with
 those based on cigarettes per day (three of six studies using total years of exposure were
 significant, as were two of two studies using pack-years).
        Overall, 10 of the 14 studies with sufficient exposure-response data show statistically
 significant trends for one or more exposure measures. No possible confounder has been
 hypothesized that could explain the increasing incidence of lung cancer with increasing exposure
 to ETS in so many independent studies from different countries.
        By country, the number of studies with significant results for upward trend is as follows:
 China,  1 of 2; Greece,  2 of 2; Hong Kong, 1 of 2; Japan, 3 of 3; Sweden, 0 of 1; and United
 States, 3 of 4. Of particular interest, two of the U.S. studies, GARF and CORR, are statistically
 significant for a test of trend, providing evidence for an association between ETS exposure and
 lung cancer even though neither was significant in a test for effect. In both cases, this  occurs
 because the data supporting an increase in RR are largely at the highest exposure level. It appears
 that relatively high exposure levels are necessary to observe an effect in  the United States, as
 would be expected if spousal smoking is a weaker surrogate for total ETS exposure in this country.
        The U.S. study by Fontham et al. (1991), a well-conducted study and the largest case-
 control study of ETS and lung cancer to date, with the greatest power of all the U.S. studies to
 detect an effect, was statistically significant  with a p-value of 0.04 for the trend test with pack-
 years as the exposure measure. When the analysis was restricted to adenocarcinomas (the majority
 of the cases), tests for trend were statistically significant by both years (p = 0.02) and pack-years
 (p = 0.01).

 5.3.4.  Conclusions
       Two types of tests have been conducted:  (1) a test for effect, wherein subjects must be
classified as exposed or unexposed to ETS, generally according to whether the husband  is a
smoker or not, and (2) a trend test, for which exposed subjects are further categorized by some
level of exposure, such as the number of cigarettes smoked per day by the  husband, duration of
smoking, or total number of packs smoked. Results are summarized in Table 5-13, with countries
in the same order as in  Table  5-9. Studies are noted in boldface if the test of effect or the trend
                                            5-45

-------
Table 5-13. P-values of tests for effect and for trend by individual study1
Country
Greece
Greece
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Japan
Japan
Japan
Japan
Japan
United States
United States
United States
United States
United States
United States
United States
Study
KALA
TRIC
CHAN
KOO
LAMT
LAMW
AKIB
HIRA(Coh)
INOU
SHIM
SOBU
BROW
BUFF
BUTL(Coh)
CORR
FONT
GARF
GARF(Coh)
' / Power ,,
0.39
0.45
0.43
0.43
0.73
0.39
0.42
0.75
0.17
0.37
0.66
0.15
0.17
0.18
0.22
0.93
0.60
0.92
'"""test
Effect
Trend
Effect
Trend
Effect
Effect
Trend
Effect
Trend
Effect
Effect
Trend
Effect
Trend
Effect
Trend
Effect
Effect
Effect
Effect
Effect
Effect
Trend
Effect
Trend
Effect
Trend
Effect
P-vaiae2
0.02
0.04
<0.01
<0.01
>0.50
0.06
0.16
<0.01
<0.01
<0.01
0.05
0.03
0.04
<0.01
0.07(0.05)3
0.03
0.38
0.01
0.28
>0.50
0.17
O.IO(O.OOS)3
0.01
0.034
0.044
0.1 2(0.0 1)3
<0.02
0.18
                                                           (continued on the following page)
                                            5-46

-------
 Table 5-13.  (continued)
Country
United States
United States
United States
United States
W. Eurooe
Scotland
England
Sweden
Sweden
China
China
China
China
Study
HUMB
JANE
KABA
WU
Hole(Coh)
LEE
PERS
SVEN
GAO
GENG
LIU
WUWI
Power
0.20
0.44
0.17
0.21
0.09
0.20
0.45
0.24
0.66
0.32
0.18
0.89
Test
Effect
Trend
Effect
Effect
Effect
Effect
Effect
Effect
Trend
Effect
Effect
Trend
Effect
Trend
Effect
Effect
P~val«e*
0.10
ns
>0.50
>0.50
0.29
0,26
0.50
0.27(0.02)3
0.12
0.31
0.18(0.02)3
0.29
0.01
<0.05
>0.50
>0.50
 Test for effect—H0: no increase in lung cancer incidence in never-smokers exposed to spousal
 ETS; HA:  an increase.  Test for trend—H0: no increase in lung cancer incidence as exposure to
 spousal ETS increases; HA:  an increase. P-values less than 0.05 are in boldface.
 Smallest p-value is used when there is more than one test for trend; ns = not significant.
 P-value in parentheses applies to test for effect at highest exposure only (see text).
 For all cell types. P-values for adenocarcinoma alone were smaller.


test is significant at 0.05 (one-tailed) or if, as in PERS and GAO, only the odds ratio at the

highest exposure is significant. In 8 of the  11 studies in Greece, Hong Kong, or Japan, at least

one of the tests is significant at 0.05. For the United States and Western Europe, 4 of the  15

studies are significant at 0.05 for at least one test. For the studies within the first group of

countries (Greece, Hong Kong, and Japan), the median power is 0.43, and only 1 of  the 10 studies

(10%) has power less than 0.25 (INOU).  In contrast, the median power for the United States and

Western Europe together is 0.21, and 10 of the 15 studies (67%) have power less than 0.25. In a

                                            5-47

-------
small study, significance is meaningful, but nonsignificance is not very informative because there
is little chance of detecting an effect when there is one.  Consequently, there are several studies in
the United States-Western Europe group that provide very little information.  Two of the four
studies in China are significant at the 0.05 level for at least one test. The two nonsignificant
studies in China (LIU and WUWI) are not very informative on ETS for reasons previously
described (see Section 5.3.2.1).
       For the U.S. and Western Europe studies, 3 of the 5 with power greater than 0.25 are
shown in boldface (FONT, GARF, and PERS), indicating at least suggestive evidence of an
association between ETS and lung cancer, compared with only 1 of 10 with power under 0.25
(CORR).  All three of the higher power studies are significant for effect (PERS and GARF are
significant at the highest exposure only) and two (FONT and GARF) are also significant for
trend.  CORR is significant for trend and for effect at the highest exposure level.  Overall, the
evidence of an association in the United States and Western Europe is  strengthened by the tests at
the highest exposure levels and by the tests for trend.
       To summarize, the results of the several different analyses in this section provide
substantial evidence that exposure to ETS from spousal smoking is associated with increased lung
cancer mortality.  The evidence is strongest in Greece, Hong Kong, Japan, and the United States.
The evidence for Western Europe appears similar to that in the United States, but there are far
fewer studies.  (The usefulness of statistical information from studies  in China is quite limited, so
no conclusions are drawn from the studies there.)
       The evidence from the individual studies, without pooling within each country, is also
conclusive of an association. Adjustment, on  an individual study basis, for potential bias due to
smoker misclassification results in slightly lower relative risk estimates but does not affect the
overall conclusions.  The results based on either the test for  effect or the test for trend cannot be
attributed to chance alone.  Tests for effect, tests at the highest exposure levels, and tests for trend
jointly support the conclusion of an association between ETS and lung cancer in never-smokers.

5.4. STUDY RESULTS ON FACTORS THAT MAY AFFECT LUNG CANCER RISK
5.4.1. Introduction
        The possibility of chance accounting for the observed associations between ETS and lung
 cancer has been virtually ruled out by the statistical methods previously applied.  Potential sources
 of bias and confounding must still be considered to determine whether they can explain the
 observed increases.  While the exposure-response relationships reviewed  in Section 5.3.3.3
 generally reduce the likelihood of bias and confounding accounting for the observed associations,
 this section focuses  on specific factors that may bias or modify the lung cancer results.
                                             5-48

-------
       Validity is the most relevant concern for hazard identification.  Generalizability of results
to the national population (depending on "representativeness" of the sample population, treated in
the text) is important for the characterization of population risk, but no more so than validity. As
stated by Breslow and Day (1980), "In an analysis, the basic questions to consider are the degree of
association between risk for disease and the factors under study, the extent to which the observed
associations may result from bias, confounding and/or chance, and the extent to which they may
be described as causal."
       Whereas Section 5.3 examined the epidemiologic data by individual study and by pooling
results by country, this section considers potential sources of bias and confounding and their
implications for interpretation of study results. As indicated in the brief review of the meanings
of bias and confounding at the end of this section, confounding arises from the characteristics of
the sample population, whereas bias is the result of individual study features involving design,
data collection, or data analysis. Section 5.4.2 briefly reviews the evidence on non-ETS risk
factors and modifiers of lung cancer incidence that appears in the 30 epidemiologic studies (not
counting KATA) reviewed for this report.  None of the factors has been established as a
confounder of ETS, which would require demonstrating that the factor causes lung  cancer and is
correlated with ETS exposure (specifically, spousal smoking to affect the analysis in this report).
       Our objective is to consider the influence of sources of uncertainty on the statistical
measures summarized in Table 5-13, although there are limitations to such an endeavor. For
example, not controlling for a factor such as age in the statistical analysis, which should be done
whether or not the study design is matched on age, may require reanalyzing data not included in
the study report.  Potential sources of bias are just that—potential—and their actual effect may be
impossible to evaluate (e.g., selection bias in case-control studies). Although numerous questions
of interest cannot be answered unequivocally, or even without a measure of subjective judgment,
it is nevertheless worthwhile to consider issues that may affect interpretation of the quantitative
results.  The issues of concern are largely those of epidemiologic investigations in general that
motivate the conscientious investigator to implement sound methodology.  Statistical uncertainty
aside, the outcomes of studies that fare well under! clos^e examination inspire more confidence and
thus deserve greater emphasis than those that do poorly.
       Preliminary to the next sections, some relevant notes on epidemiologic concepts are
excerpted from two IARC volumes entitled Statistical Methods in Cancer Research (Breslow and
Day, 1980, 1987), dealing with case-control and cohort studies, respectively, which are excellent
references. In the interest of brevity, an assortment of relevant passages is simply quoted directly
from several locations in the references (page numbers and quotation marks have been omitted to
                                            5-49

-------
improve readability). Some readers may wish to skip to the next section; those interested in a
more fluid, cogent, and thorough presentation are referred to the references.

       •   Bias and confounding. The concepts of bias and confounding are most easily
           understood in the context of cohort studies, and how case-control studies relate to
           them.  Confounding is intimately connected to the concept of causality. In a cohort
           study, if some exposure E is associated with disease status, then the incidence of the
           disease varies among the strata defined by different levels of E.  If these differences
           in incidence are caused (partially) by some other factor C, then we say that C has
           (partially) confounded the association between E and the disease. If C is not causally
           related to disease, then the differences in incidence cannot be caused by C, thus C
           does not confound the disease/exposure association.

           Confounding in a case-control study has the same basis as in a cohort study . . . and
           cannot normally be removed by appropriate study design alone.  An essential part of
           the analysis is an examination of possible confounding effects and how they may be
           controlled.

           Bias in a case-control study, by contrast, [generally] arises from the differences in
           design between case-control and cohort studies.  In a cohort study, information is
           obtained on exposures before disease status is determined, and all cases of disease
           arising in a given time period should be ascertained.  Information on exposure from
           cases and controls is therefore comparable, and unbiased estimates of the incidence
           rates in the different subpopulations can be constructed.  In case-control studies,
           however, information on exposure is normally obtained after disease status is
           established, and the cases and controls represent samples  from the total. Biased
           estimates of incidence ratios will result if the selection processes leading to inclusion
           of cases and controls in the study are different (selection bias) or if exposure
           information is not obtained in a comparable manner from the two groups,  for
           example, because of differences in response to a questionnaire (recall bias).  Bias is
           thus a consequence of the study design, and the design should be directed  towards
           eliminating it.  The effects of bias are often difficult to control in the analysis,
           although they will sometimes resemble confounding effects and can be treated
           accordingly.

           To summarize, confounding reflects the causal association between variables in the
           population under study, and will manifest itself similarly in both cohort and case-
           control studies.  Bias, by contrast, is not a property of the underlying population.  It
           results from inadequacies in the design of case-control studies, either in the selection
           of cases or controls or from the manner in which the data are acquired.

       •   On prospective cohort studies.  One of the advantages of cohort studies over case-
           control studies is that information on exposure is obtained before disease status is
           ascertained. One can therefore have considerable confidence that errors in
           measurement are the same for individuals who become cases of the disease of interest,
           and the remainder of the cohort.  The complexities possible in retrospective case-
           control studies because of differences in recall between cases and controls  do not
           apply. [Regarding the success of a cohort study, the] follow-up over time  ... is the
           essential feature. . . .  The success with which the follow-up is achieved is probably
           the basic measure of the quality of the  study.  If a substantial proportion of the cohort
                                            5-50

-------
           is lost to follow-up, the validity of the study's conclusions is seriously called into
           question.

       «   On case-control studies.  Despite its practicality, the case-control study is not
           simplistic and it cannot be done well without considerable planning.  Indeed, a case-
           control study is perhaps the most challenging to design and conduct in such a way that
           bias is avoided. Our limited understanding of this difficult study design and its many
           subtleties should serve as a warning—these studies must be designed and analyzed
           carefully with a thorough appreciation of their difficulties. This warning should also
           be heeded by the many critics of the case-control design.  General  criticisms of the
           design itself too often reflect a lack  of appreciation of the same complexities which
           make these studies difficult to perform properly.

           The two major areas where a case-control study presents difficulties  are in the
           selection of a control group, and in dealing with confounding and interaction as part
           of the analysis. . . these studies are highly susceptible to bias, especially selection bias
           which creates non-comparability between  cases and controls. The problem of
           selection bias is the most serious potential  problem in case-control studies. .  . .  Other
           kinds of bias, especially that resulting from non-comparable information from cases
           and controls are also potentially serious; the most common of these is recall  . . . bias
           which may result because cases  tend to consider more carefully than do controls the
           questions they are asked or because  the cases have been considering what might have
           caused their cancer.

       In addition to standard demographic factors (e.g., age) that are usually controlled for in a
study, a number of other variables have been considered as potential risk factors  (including risk

modifiers) for lung cancer.  If a factor increases the risk of lung cancer and its presence is
correlated with exposure to spousal ETS, then it could be a confoiinder of ETS if not controlled

for in a study's analysis. In .general, factors that may affect risk of lung cancer and also may be

correlated with ETS exposure are of interest as possible explanatory variables.  Findings from the

ETS studies are reviewed for six general categories: (1) personal history of lung disease,
(2) family history  of lung disease, (3) heat sources,  (4) cooking with oil, (5) occupation, and
(6) diet.  Table 5-14 provides an overview of results in these categories.  Two shortcomings are
common in the studies where these factors appear:  failure to evaluate the correlation of exposure
to the factor and to ETS, and then to adjust the analysis accordingly; and failure  to adjust

significance levels for multiple comparisons. Multiple tests on the same data increase the chance
of a false positive (i.e., outcomes appear to be more significant than warranted due to the multiple

comparisons being made on the same data).


5.4.2. History of Lung Disease
       Results regarding history of lung disease have  been reported in eight of the reviewed ETS
studies, but with little consistency.  Tuberculosis (TB), for example, is significantly associated
with lung cancer in GAO (OR = 1.7; 95% C.I. = 1.1, 2.4) but not in SHIM (OR =  1.1, no other

                                            5-51

-------
Table 5-14. Other risk-related factors for lung cancer evaluated in selected studies
  Category  ""*•
Possible risk factor     Mixed outcome
                      No evidence
  Personal or family
  history

  Heat source for
  cooking or heating
  Cooking with oil

  Diet

  /3-carotene

  Occupation
WU (US)
GENG (Ch)
LIU (Ch)
WU (US)
WUWI (Ch)
GENG (Ch)
GAO (Ch)
LIU (Ch)
WUWI (Ch)
GAO (Ch)
WU (US)
WUWI (Ch)
SHIM (Jap)
GENG (Ch)
BUTL (US)
BUFF (US)
SHIM (Jap)
GAO (Ch)

SOBU (Jap)
KALA (Gr)
HIRA (Jap)
LAMW(HK)
SHIM (Jap)

WUWI(Ch)
KALA (Gr)
GAO (Ch)-harmful
WU (US)
GAO (Ch)
statistics), LIU or WU (no ORs provided). Chronic bronchitis, on the other hand, is
nonsignificant in GAO (OR = 1.2; 95% C.I. = 0.8, 1.7), SHIM (OR = 0.8), KABA, and WU, but it
is highly significant in LIU (OR = 7.37; 95% C.I. = 2.40, 22.66 for females; OR = 7.32; 95% C.I. =
2.66, 20.18 for males) and mildly so in WUWI (OR = 1.4; 95% C.I. = 1.2, 1.8). (Notably, the
populations of WUWI, LIU, and GENG were exposed to non-ETS sources of household smoke.)
Consideration of each lung disease separately, as presented, ignores the effect of multiple
comparisons described above. For example,  GAO looked at five categories of lung disease.  If
that were taken into account, TB would no longer be significant. No discussion of the multiple
comparisons effect was found in any of the references, which might at least be acknowledged.
       Broadening our focus to examine the relationship of lung cancer to history of lung disease
in general does little to improve consistency. GENG reports an adjusted OR of 2.12 (95% C.I. =
1.23, 3.63) for history of lung disease, GAO's disease-specific findings are consistently positive,
and WUWI reports three positive  associations out of an unknown number assessed.  SHIM and
                                           5-52

-------
WU, however, consistently found no effect except marginally for silicosis (perhaps better
construed as an occupational exposure surrogate) in SHIM and for childhood pneumonia in WU.
LIU found a significant association only for chronic bronchitis and KABA only for pneumonia.
Interpretation is hampered by the lack of numerical data for factors that were not statistically
significant in KABA, LIU, and WU. Even with such data, however, interpretation is hampered
by the absence of control for key potential confounders in many of the studies (e.g., age in GENG
and LIU).  Only one study (WU) attempted to control for a history variable (childhood
pneumonia), which reportedly did not alter the ETS results.  The importance of prior lung disease
as a factor in studies of ETS is thus unclear, but it does not appear to distort results one way or
the other.

5.4.3.  Family History of Lung Disease
       Only a few of the studies addressed family history of lung disease. GAO found no
significant association between family history of lung cancer and subjects' disease status (e.g.,
parental lung cancer OR = 1.1; 95% C.I. = 0.6, 2.3), and positive family histories were very rare
(e.g., 1.0% among mothers of either cases or controls). In contrast, WUWI reports a significant
association with history of lung cancer in first-degree relatives (OR =  1.8; 95% C.I. = 1.1, 3.0),
which occurred in about 4.5% of the cases.  The presence of TB in a household member (OR = 1.6;
95% C.I. = 1.2, 2.1) is also significant, even after adjustment for personal smoking and TB status.
The  rarity of family-linked lung cancer in these populations makes accurate  assessment difficult
and also reduces the potential impact on results of any effect it may have. Its study in populations
where such cancer is more common would be more appropriate. The household TB outcome may
be the result of multiple comparisons and/or confounding, particularly in view of the weaker
(nonsignificant) outcome noted for personal TB status.

5.4.4. Heat Sources for Cooking or Heating
       Household heating and cooking technologies have received considerable  attention as
potential lung cancer risk factors in Asian ETS studies. Most studies have focused on fuel type.
Kerosene was specifically examined in three studies.  All three found positive associations—
CHAN and LAMW for kerosene cooking, and SHIM for kerosene heating—but  none of the
associations were statistically significant, and the SHIM relationship held only for adult and not
for childhood exposure. Five studies specifically examined coal.  GENG evaluated use of coal for
cooking and found a significant positive association.  Use of coal for household cooking or heating
prior to adulthood is significantly associated with lung cancer in WU's study of  U.S. residents, but
                                            5-53

-------
 no results for adulthood are mentioned. Recent charcoal stove use showed a positive (OR = 1.7)
 but not significant association in SHIM. Separate analyses of five coal-burning devices and two
 non-coal-burning devices by WUWI found positive although not always significant associations
 for the coal burners.  In contrast, SOBU found no association between use of unventilated heating
 devices—including mostly kerosene and coal-fueled types but also some wood and gas burners—
 and lung cancer (OR - 0.94 for use at age 15, 1.09 at age 30, 1.07 at present). Results for wood or
 straw cooking were specifically reported in three studies.  SOBU found a significant association
 for use of wood or straw at age 30 (OR = 1.89; 95% C.I. = 1.16, 3.06) but only a weak relationship
 at age 15.  GAO found no association with current use of wood for cooking (OR = 1.0; 95% C.I. =
 0.6, 1.8), and WUWI mentions that years of household heating with wood, central heating, and
 coal showed nonsignificant trends (negative, negative, and positive, respectively).
       Overall, studies that examined heating and cooking fuels generally found evidence of an
 association with lung cancer for at least one fuel, which was usually but not always statistically
 significant. Such relationships appeared most consistently for use of coal and most prominently in
 WUWI and LIU.  Neither study found a significant association between ETS and lung cancer, nor
 did either address whether coal use was associated with ETS exposure.  The presence  of non-ETS
 sources of smoke within households, however, may effectively mask  detection of any effect due to
 ETS (as noted by the authors of WUWI).  Evidence of effects of other fuel types and  devices is
 more difficult to evaluate, particularly because many studies do not report results for these
 factors, but kerosene-fueled devices seem worthy of further investigation.

 5.4.5.  Cooking With Oil
       Cooking with oil was examined by GAO and WUWI, both conducted in China, with
 positive associations for deep-frying (OR ranges of 1.5-1.9 and 1.2-2.1, respectively,  both
 increasing with frequency of cooking with oil). GAO also reports positive findings for stir-
 frying, boiling (which  in this population often entails addition of oil  to the water), and smokiness
 during cooking and found that most of these effects seemed  specific for users of rapeseed oil.
 These results may apply to other populations where stir-frying and certain other methods of
 cooking with oil are common. Neither study, however, addressed whether use of cooking with oil
is correlated with ETS  exposure.

5.4.6.  Occupation
       Seven studies investigated selected occupational factors,  with five reporting positive
outcomes for one or more occupational variables.  The outcomes, however, are somewhat
inconsistent.  SHIM found a strong and significant relationship with occupational metal exposure
                                            5-54

-------
 (OR = 4.8) and a nonsignificant one with coal, stone, cement, asbestos, or ceramic exposure, while
 WUWI found significant positive relationships for metal smelters (OR = 1.5), occupational coal
 dust (OR = 1.5), and fuel smoke (OR = 1.6) exposure. Textile work is positively associated with
 lung cancer in KABA and negatively associated with lung cancer in WUWI. BUFF divided
 occupations into nine categories plus housewife and found eight positive and one negative
 associations relative to housewives, but only one ("clerical") is significant. GAO, on the other
 hand, found no association with any of six occupational categories, while GENG found a
 significant association for an occupational exposure variable that encompassed textiles, asbestos,
 benzene, and unnamed other substances (OR = 3.1; 95% G.I. = 1.58, 6.02). WU reported "no
 association between any occupation or occupational category," although there was a nonsignificant
 excess among cooks and beauticians.  Finally, BUTL(Coh) found an increased RR for wives whose
 husbands worked in blue collar jobs (> 4; never-smoker).  HIRA(Coh) did not present findings for
 husband's occupation as a risk factor independently but reported that adjustment for this factor
 did not alter the study's ETS results. Few studies attempted to adjust ETS findings for
 occupational factors—SHIM found only modest effects of such adjustment  for occupational metal
 exposure, despite an apparent strong independent effect for this factor, and GENG found only
 minimal effect of occupational exposure  on active smoking results but did no adjustment of ETS
 results. Overall, multiple comparisons, other factors (e.g., socioeconomic status, age), and the
 rarity of most specific occupational exposure sources probably account for the inconsistent role of
 occupation in these studies.

 5.4.7.  Dietary Factors
       Investigations related to diet have been reported in nine of the ETS  studies, with mixed
 outcomes.  The fundamental difficulty lies in obtaining accurate individual values for key
 nutrients of interest, such as 0-carotene.  The relatively modest size of most ETS study
 populations adds further uncertainty in attempts to detect and assess any dietary effect that, if
 present, is likely to be small. In those studies where dietary data were collected and adjusted for
 in the analysis of ETS, diet has had no significant effect. Nevertheless, diet has received attention
 in the literature as a possible explanatory factor in the observed association  between ETS exposure
 and lung cancer occurrence (e.g., Koo, 1988; Koo et al., 1988; Sidney et al., 1989;  Butler, 1990,
 1991; Marchand et al., 1991); therefore, a more detailed and specific discussion is provided in this
section.
       Diet is of interest for a potential protective effect against lung cancer. If nonsmokers
unexposed to passive smoke  have a lower incidence of spontaneous (unrelated to tobacco smoke)
lung cancer incidence due to a protective diet, then the effect would be upward bias in the RR for
                                           5-55

-------
ETS.  However, for diet to explain fully the significant association of ETS exposure in Greece,
Hong Kong, Japan, and the United States, which differ by diet as well as other lifestyle
characteristics, it would need to be shown that in each country:  (1) there is a diet protective
against lung cancer from ETS exposure, (2) diet is inversely associated with ETS exposure, and (3)
the association is strong enough to produce the observed relationship between ETS and lung
cancer.  Diet may modify the magnitude of any lung cancer risk from ETS (conceivably increase
or decrease risk, depending on dietary components), but that would not affect whether ETS is a
lung carcinogen.
       The literature on the effect of diet on lung cancer is not consistent or conclusive, but
taken altogether there may be a protective effect from a diet high in 0-carotene, vegetables, and
possibly fruits.  Also, there is some evidence that low consumption of these substances may
correlate with increased ETS exposure, although not necessarily for all study areas. The
calculations made by Marchand et al. (1991) and Butler (1990, 1991) are largely conjectural, being
based only on assumed data. Therefore, we examined the passive smoking studies themselves for
empirical evidence on the effect of diet and whether it may affect ETS results.
       It was found  that nine of the studies have data on diet, although only five of them use a
form of analysis that assesses the impact of diet on the ETS association.  None of those five
studies—CORR, HIRA(Coh), KALA, SHIM, and SVEN—found that diet made a significant
difference.  In the four studies where data on diet were collected but not controlled for in the
analysis of ETS, three (GAO, KOO, and WUWI) are from East Asia and one (WU.) is from  the
United States. Koo (1988), who found strong protective effects for a number of foods, has been
one of the main proponents of the idea that diet may explain the passive smoking lung cancer
effect.  To our knowledge, however, she has not published a calculation examining that conjecture
in her own study where data were collected on ETS subjects. In WU, a protective effect of
/3-carotene was found, but the data include a high percentage of smokers (80% of the cases for
adenocarcinoma, 86% for squamous cell), and the number of never-smokers is small.  In recent
correspondence  concerning the large FONT study, its authors state that "mean daily intake of
beta-carotene does not significantly differ between study subjects whose spouse smoked and  those
whose spouse never smoked" (Fontham et al., 1992).
        The equivocal state of the literature regarding the effect of diet on lung cancer is also
apparent in the  nine ETS studies that include dietary factors, summarized in Table 5-15.  Note
that GAO found an adverse effect from /3-carotene. HIRA and KOO found opposite effects from
fish while SHIM found no effect.  Fruit was found to be protective by KALA and KOO but
adverse by SHIM and WUWI.  Retinol (based on consumption of eggs and dairy products) was
 found to be protective by KOO but adverse by GAO and WUWI.
                                            5-56

-------
V)
1-H

in
 o>


I

-
en
tt>
+C!
'B m
i »i S|
— jad A ££j
*« *2 j?3 ^
If,! 3
1 S v 4,
^

s j>
** ^
T3
3
V5

Never-smokers. Carotene and total vitamin A were
examined. "Except for gender, age, and study area,
no confounding was detected."



d ri
V CU
'eo'ob
ea ei
+•» +••
OJ Gt
•O 73
O O





<
Carotene
Vitamin

r-
o
IN
7.
£\
U

Patterns were similar for smokers and nonsmokers.
Passive RR was not adjusted for diet, possibly
because the trends were the opposite of those in the
literature.
o~^
IN — «S
«0«
^^ ^ ^^

O -H'VO
— — —

O O O


V
*o
0 JH .S
'c.a<
83 In •
d-d
« d i
s|l
e4 cU .«
U ft5 >

Os

••*
O
•^
o
. o\ :>.
Never-smokers. Lung cancer risks for wives whose
husbands were former smokers plus 1-19 cig./day
smokers and 20+ cig./day smokers relative to never-
smokers were 1.50 and 1.79 when adjusted for wives
age (Hirayama, 1984). They ranged from 1.53 to 1.6
and 1.66 to 1.91 when adjusted for wives' age,
husband's occupation, and each of the various dietar
factors.
to e£
VO r- tN O r*»
oo oo vo f> O\
0-0-0
1 1 1 1 1


o o o o o


1 1 I 1 1

CO
> • •
:> O-
1 §

« 1
o E s 5i M

fo
v>
"^
^
M '
a

Never-smokers. Controlled for age, years of
schooling, interviewer, and total energy intake. No
confounding was observed between the passive
smoking effect and the effect of fruits, or between
that of fruits and that of vegetables. Passive risk
increased to 2.11 when adjusted for fruit
consumption.
O O CO vo m
— — O 0 —

1 1 1 1 1


1 III).

o o o o o




"•If
dj co r ^ 2
Hcolol
{g « .** d _d w


-------
g
 I

a>

I
1
1
k*2 »*H

1 »y
** % 3 -si
8 '£, ]j ill
g .
•v-4
a
CD
S
1
c/j ftl
(2 pi
^
1
en ci ^
Never-smokers. Values are adjusted for age, number
of live births, and schooling. Diet items are selected
to compare with those in other studies. No calculatio
is shown of confounding effect of diet on the passive
smoking risk either in Koo et al. (1987), Koo (1988),
Koo et al. (1988), or Koo (1989). Fresh fruit, vitamil
C, fresh fish, and retinol showed statistically
significant trends.

Tf i-O r** ^3" ^3" CO ON ON ^f
OOOOOO OOO
^^ CO ^^ OO i^l *^" OO ^D **^
^5 ^>H ^^ ^^ ^^ ^^ . ^5 ^^ *O*
OOOOOO OOO


1 1 1 1 1 1 III


oo
c S 5
CD CO .t} (J j-j ,g "3
I"1 gj j~ ^ ,^1 ~— . O
eo*2oe*H'SCM'S'§ *®
^ 1 "l.^ll ® «'l

Vi
—
*6
Io
Ui

Never-smokers. No dose response was found. No
difference between cases and controls was found
regarding intake of green-yellow vegetables.
00
o\ ri o o r-
O -4 — « -HO


°o o o o o


iii ii

00
>
1 °
« -a
>> 0 (3
C3 *^ _^/
« *J jrf -- g o
£ g --S "S S £
r< t« M ..H — H ^
O Pu ^H PH V..
00
0
— '
s •.
K
on

Adjusted for age, smoking, cumulative Rn exposure
and municipality. The inclusion of carrot
consumption in the regression model "had only a
slight effect on the risk estimates of the other
exposure variables." See Svensson (1988).
r4
rH
VO
0
I
0
iH
r--
o
o
-H






•t-t
o
t,
s
VO

-------
^S
       :

I

                «
                O rr>
                •*• 00

                O O
           es o
           rrt VI

           d d
           "1 °i
           d d
           o
                 eo
                 r^
                       n

                       *o
                       d
                       oo
                       d
                          o g   e .8:
                         •« s .a » a
                          S .s ^ « I
                                  **
                          «   rt    o
                          eo oo w ««  **
                          e8 •« >• -r  -«
                          i~ W « rt  g
                              •* >

                                  •
                                'C  e
d d —* cs
                              O O
                                 poop
                                  g S   -s
                                S 2 I -ts 2
                               JJ c5 i- 9 a
                               •° ° 51 tS —

                                Mill
                          D
                                                oo
                                  5-59

-------
        In view of the results summarized in Tables 5-14 and 5-15, the actual data of ETS studies
 do not support the suspicion that diet introduces a systematic bias in the ETS results. Indeed, it
 would be difficult to show otherwise. Dietary intake is difficult to assess; dietary habits vary
 within countries and enormously between countries, making it difficult to attribute any effect on
 lung cancer to a particular food group; lifestyle characteristics and consumption of food and
 beverage with possibly an adverse effect may be associated, either positively or negatively, with
 the food group under consideration.  It would, of course, be helpful to identify dietary factors
 that may affect lung cancer, positively or negatively, because that information could usefully
 contribute to public health. To affect interpretation of ETS results, however, it would  need to be
 established also that consumption of the dietary factor of interest is highly correlated with ETS
 exposure in study populations where  ETS exposure is linked with increased incidence of lung
 cancer.

 5.4.8. Summary on Potential Modifying Factors
       In summary, an examination of six non-ETS factors that may affect lung cancer risk finds
 none that explains the association between lung cancer and ETS exposure as observed by
 independent investigators across several countries that vary in social and cultural behavior, diet,
 and other characteristics. On the other hand, the high levels of indoor air pollution from other
 sources (e.g., smoky coal) that occur in some parts of China and show statistical associations with
 lung cancer in the studies of GENG,  LIU, and WUWI may mask any ETS effects in those studies.

 5.5. ANALYSIS BY TIER AND COUNTRY
       In this section, attention is directed to properties of individual studies, including potential
 sources of bias,  that may affect their  utility for the assessment of ETS and lung cancer.  Studies
 are assessed based on qualitative as well as statistical evaluation.  The studies are qualitatively
 reviewed in Appendix A and categorized into "tiers" within country. Studies are individually
 scored according to items in eight categories.  Study scores are  then implemented in a numerical
 scheme to classify each study into one of four tiers according to that study's assessed utility for
 hazard identification of ETS.  Tier  1 studies are those of greatest utility for investigating a
 potential association between ETS and lung cancer. Other studies are assigned to Tiers 2, 3, and 4
 as confidence in their utility diminishes.  Tier 4 is reserved for studies we would exclude from
analysis for ETS, for various reasons specified in the text.  In the statistical analysis presented in
 this section, the summary RR for each country is recalculated for studies  in Tier 1 alone and for
Tiers 1-2,.1-3, and 1-4 (the last category corresponds to  the combined analysis shown in
                                            5-60

-------
 Table 5-9) by country.  This exercise provides some idea of the extent to which the summary RR
 for a country depends on the choice of studies.
        The assignment of studies to tiers is shown in Table 5-16.  Overall, 5 studies are in the
 highest tier, while 15, 5, and 5 studies are in Tiers 2, 3, and 4, respectively (KATA was not
 assigned  to a tier). Studies in Tier 4 are not recommended for the objectives of this report. The
 statistical weight for Tiers  1, 2, and 3 pooled together for each country is shown in Table 5-9 as a
 percentage of the total for corresponding tiers over all countries.  Emphasis on studies through
 Tier 2 or through Tier 3 is  somewhat arbitrary. Although studies in Tier 1 are judged to be of the
 highest utility, exclusive attention to Tier 1 would eliminate considerable epidemiologic data
 because only 16% of the studies are in Tier 1. Excluding Tier 4 leaves the choices to either all
 studies through Tier 2 or through Tier 3. GAO is the only study in China that was not placed in
 Tier 4, but there is little basis to assume that  this single study from Shanghai should be
 representative of a vast country like China.
        Table 5-17 presents adjusted relative  risk estimates, 90% confidence intervals, and
 significance levels (one-sided) from studies pooled by country and by tier. The  pooled relative
 risks do not decrease as the results from studies in Tier 2 and Tier  3 are combined with those from
 Tier 1, with two exceptions: In the United States, the pooled estimate changes from 1.28 to 1.22
 to 1.19 when Tier 2 and Tier 3 studies are added, respectively, and in  Western Europe, the pooled
 estimate changes from 1.21  to 1.17 when Tier 2 studies are added.  The pooled estimates for
 studies through Tier 2 are statistically significant at p = 0.02 (one-tailed) in Greece, Hong Kong,
 Japan, and the United States; Western Europe is the exception (p = 0.22).  The same statement
 holds with Tier 2 replaced by Tier 3, except that China includes one study at p = 0.18. The
 relative risk results from all four Western European studies (RR = 1.17) is virtually the same for
 all U.S. studies (RR =1.19), but with less power that value is not significant for Western Europe.
 The similarity of outcomes is also interesting, however, because Western Europe is probably more
 similar to the United States  than the other countries.
       Analysis, by tiers provides a methodology for weighting studies according to their utility
 for hazard identification of  ETS. It allows one to emphasize those studies thought to provide
 better data for analysis of an ETS effect.  The addition of studies of lower utility to the analysis,
 such as inclusion of Tier 3 studies with those from Tiers  1 and 2, has a small effect on the relative
 risk estimate but both increases its statistical significance and narrows  its confidence interval. In
 view of that outcome and the results and discussion in Section 5.4, this analysis finds little to
indicate confounding or bias in studies through Tier 3 (which include all studies in the United
States).  In summary,  it is concluded that the association of ETS and lung cancer observed from
                                            5-61

-------
Table 5-16.  Classification of studies by tier
Country
Greece
Greece
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Japan
Japan
Japan
Japan
Japan
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
Study * fieri
KALA X
TRIG
KOO X
LAMT
LAMW
CHAN
AKIB
HIRA(Coh)
SHIM
SOBU
INOU
FONT X
BUTL(Coh)
GARF
HUMB
JANE
WU
BROW
BUFF
CORR
GARF(Coh)
KABA
, Tier 2 ' ' ' "" Jlet 3 /" T«er 4 	

X

X
X
X
X
X
X
X
X

X
X
X
X
X
X
x
x
x
XII
•-; _ II
                                                              (continued on the following page)
                                             5-62

-------
Table 5-16.  (continued)
Country
W. Eurooe
Scotland
Sweden
Sweden
England
China
China
China
China
Study Tier 1 Tier 2 Tier 3 Tier 4

HOLE(Cbh) X
PERS X
SVEN X
LEE X
GAO X
GENG X
LIU X
WUWI X
the analysis of 30 epidemiologic studies in eight different countries is not due to chance alone and
is not attributable to bias or confounding.

5.6. CONCLUSIONS FOR HAZARD IDENTIFICATION
5.6.1.  Criteria for Causality
       According to EPA's Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986a), a
Group A (known human) carcinogen designation is used "when there is sufficient evidence from
epidemiologic studies to support a causal  association between exposure to the agents and cancer."
The Guidelines establish "three criteria [that] must be met before a causal association can be
inferred between exposure and cancer in  humans:
       1.   There is no identified bias that could explain the association.
       2.   The possibility of confounding has been considered and ruled out as explaining the
           association.
       3.   The association is unlikely to be due to chance."
As demonstrated in the preceding sections, the overall results observed in the 30 epidemiologic
studies are not attributable to chance and the  association between ETS and lung cancer is not
explained  by bias or confounding.
                                            5-63

-------
        »
                               oo
£
£*"
(M


                                                                        I
                                                                        oo
                                                                        a

                                                                       1
I
                     ^    ^°

                                vo
                                         *> 00  , .
                                         ^H _  O
                                                                  vo
                                                      JC •«
                                                      OO OO
                                                                                  O

                                                                                 1
                                                                                  o
                                         T-t^H  -H 1-H   ^H -H  O O O O
                                                                          o o
                 o\
                                         0\ —.
                                                      ^^   •  i S
                                                                          i-l O
                                                 feg?
                                                 <  .0
                                                            u


4)
               Ui b  b Ui
               oooo
                         00 M bfi M
                         CHOC
                         oooo
                         oooo
                                   98
                                  rt rt   * rt

                                 oo c/5   C/D oo


                            S qj   
                                                     O.
                                                            o p p
                                                            VH *" *«
                                                       ft D.

                                                               g
                                                                           rt cd
                                                             S .S .5 .S
a
s
      4>
      fti
                           VO
                                                                        o r-
        Jl
        HH
                                      5-64

-------
    I
    I
    .a
    H
    1



    I
    o
          00
     ***  •  s"'
    <~ "2 £
    *s *o  *"!
    .2-a*
     O co S fo




     o 2 — a


     ff eo W "O
     co ** 3  rt

     1-5 ?t
     (s
    .43
          -SD «

          « .S
T3

S    S ±3  •* S

•S    2 co -3 O
3    S S  S «
CS   •£ -S3  o at
O   " $  S «

^^      j3 «*-c o
      CO Q  O IH
V)
     f"1 .« 2 es

     o "^ 
-------
       Below, the evidence for a causal association between ETS and lung cancer is evaluated

according to seven specific criteria for causality developed by an EPA workshop to supplement

the Guidelines (U.S. EPA, 1989). These criteria are similar to the original and classical

recommendations of Hill (1953, 1965).  The seven recommended (but not official) criteria from

the EPA workshop, which vary between essential and desirable, are listed below (U.S. EPA, 1989).

       A causal interpretation is enhanced for studies to the extent that they meet the
       criteria described below. None of these actually establishes causality; actual proof
       is rarely attainable when dealing with environmental carcinogens. The absence of
       any one or even several of the others does not prevent a causal interpretation.
       Only the first criterion (temporal relationship) is essential to a causal relationship:
       with that exception, none of the criteria should be considered as either necessary or
       sufficient in itself. The first six criteria apply to an individual study.  The last
       criterion (coherence) applies to a consideration of all evidence in the entire body of
       knowledge.

       1. Temporal relationship:  The disease occurs within a biologically reasonable
          timeframe after the initial exposure to account for the specific health effect.

       2. Consistency: When compared to several independent studies of a similar exposure
          in different populations, the study in question demonstrates a similar association
          which persists despite differing circumstances. This usually constitutes strong
          evidence for a causal interpretation (assuming the same bias or confounding is not
          also duplicated across studies).

       3. Strength of association:  The greater the estimate of risk and the more precise, the
          more credible the causal association.

       4. Dose-response -or biologic gradient:  An increase in the measure of effect is
          correlated positively with an increase in the exposure or estimated dose. If present,
          this characteristic should be weighted heavily in considering causality.  However,
          the absence of a dose-response relationship should not be construed by itself as
          evidence of a lack of a causal relationship.

       5. Specificity of the association: In the study in question, if a single exposure is
          associated with an excess risk of one or more cancers also found in other studies, it
          increases the likelihood of a causal interpretation.

       6. Biological plausibility: The association  makes sense in terms of biological
          knowledge. Information from toxicology, pharmacokinetics, genotoxicity, and in
          vitro studies should be considered.

       7. Coherence:  Coherence exists when a cause-and-effect interpretation is in logical
          agreement with what is known about the natural history and biology of the disease.
          A proposed association that conflicted with existing knowledge would have to be
          examined with particular care. (This criterion has been called "collateral evidence"
          previously.)
                                            5-66

-------
5.6.2.  Assessment of Causality
       We consider the extent to which the criteria for causality are satisfied for the ETS studies.
Regarding temporal relationship, ETS exposure classification is typically based on the marital
history of a subject, which varies, or on the status at the beginning of a prospective cohort study.
Very few studies up through Tier 3 considered current exposure status only (see Appendix A), so
some history of ETS exposure is largely the rule for ETS-exposed subjects. Analysis of data by
exposure level in Section 5.3.3 indicates increased relative risk with exposure level, which supports
the temporal relationship.
       If ETS causes  lung cancer, then the true relative risk is small for detection by
epidemiologic standards and may differ between countries as well. However, by considering the
totality of the evidence, it is determined that the large accumulation of epidemiologic evidence
from independent sources in different locales and circumstances, under actual exposure
conditions, is adequate for conclusiveness.  Having accounted for variable study size, adjusted for
a possible systematic spousal bias due to smoker misclassification, and considered potential bias,
confounding, and other sources of uncertainty on a study-by-study basis, consistency of a
significant association is clearly evident for the summary statistical measures for Tiers  1 through 2
and 1 through 3  in Greece, Hong Kong, Japan, and the United States.  The combined countries
from Western Europe are similar in outcome  to the United States, although significance is not
attained.  There  is too much obscurity and  uncertainty attached to  the studies in China for
adequate data interpretation.
       The relative risks for each country  are obtained by pooling estimates from the
epidemiologic studies conducted in the country. The strength of association is limited by the true
value of the relative risk, which is small. Statistical significance is attained, however, for the
pooled studies of the United States and most  other countries. The  data were obtained from actual
conditions of environmental exposure; therefore, imprecision is not increased by extrapolation of
results from atypically high exposure  concentrations, a common situation in risk analysis.
Additionally, all studies were individually corrected for systematic bias from smoker
misclassification at the outset, and qualitative characteristics of the studies were carefully
reviewed  to emphasize the results from the studies with higher utility for the objectives of this
report.  The outcome  for the United States  is heavily influenced by the large National Cancer
Institute study (FONT) that was specifically designed and executed to avoid methodological
problems  that might undermine the accuracy or precision of the results.
       Of the 14 studies reporting a test for upward trend, 10 are statistically significant at 0.05
(see Table 5-12) which would occur by chance alone with probability less than 10"9.  This
                                            5-67

-------
evidence of dose response is very supportive of a causal interpretation because it would be an
unlikely result of any operative sources of bias or confounding.
       Specificity does not apply to ETS. Although ETS has been assessed for the same endpoint
(lung cancer) in all studies, the occurrence of lung cancer is not specific to ETS exposure.  Data
on histological cell type are not conclusive.  The study by Fontham and colleagues (1991) suggests
that adenocarcinoma may be more strongly related to ETS exposure than other cell types.
Adenocarcinoma, however, does not appear to be etiologically specific to ETS.
       Biomarkers such as cotinine/creatinine levels clearly indicate that ETS is taken up by the
lungs of nonsmokers (see Chapter 3). The similarity of carcinogens identified in sidestream and
mainstream smoke, along with the established causal relationship between lung cancer and
smoking in humans with high relative risks and dose-response relationships in four different lung
cell types down to  low  exposure levels, provide biological plausibility that ETS is also a lung
carcinogen (Chapter 4). In addition, animal models and genotoxicity assays provide corroborating
evidence for the carcinogenic potential of ETS (Chapter 4).  The epidemiologic data provide
independent empirical  verification of the anticipated risk of lung cancer from passive smoking
and also an estimate of the increased risk of lung cancer to never-smoking women.  The coherence
of results from these three approaches and the lack of significant arguments to the contrary
strongly support causality as an explanation of the observed association between ETS exposure and
lung cancer.

5.6.3.  Conclusion
       Based on the assessment of all the evidence considered in Chapters 3, 4, and 5 of this
report and in accordance with the EPA Guidelines and the causality criteria above for
interpretation of human data, this report concludes that ETS is a Group A human carcinogen, the
EPA classification "used only when there is  sufficient evidence from epidemiologic studies to
support a causal association between exposure to the agents and cancer"  (U.S. EPA, 1986a).
                                            5-68

-------
          6.  POPULATION RISK OF LUNG CANCER FROM PASSIVE SMOKING

6.1.  INTRODUCTION
       The preceding chapter addressed the topic of hazard identification and concluded that
environmental tobacco smoke (ETS) exposure is causally associated with lung cancer. If an effect
is large enough to detect in epidemiologic studies investigating the consequences of ETS exposure
at common exposure levels, the individual risk associated with exposure is considered to be high
compared with most environmental contaminants assessed. Of course, the number of lung cancer
deaths attributable to ETS exposure for a whole population, such as the United States, depends on
the number of persons exposed as well as the individual risk. Studies of cotinine/creatinine
concentrations in nonsmokers indicate that ETS is virtually ubiquitous. For example, in urinary
bioassays of 663 nonsmokers, Cummings et al. (1990) found that over 90% had detectable levels of
cotinine.  Among the 161 subjects who reported no recent exposure to ETS, the prevalence of
detectable cotinine was still about 80%. Although the average cotinine level for all those tested
may be below the average for subjects exposed to spousal ETS, as studied in this report, it
indicates uptake of ETS to some extent by a large majority of nonsmokers (see also Chapter 3).
Consequently, exposure to ETS is a public health issue that needs to be considered from a national
perspective.
       This chapter derives U.S. lung cancer mortality estimates for female and male never-
smokers and long-term (5+ years) former smokers.  Section 6.2 discusses prior approaches to
estimating U.S. population risk. Section 6.3 presents this report's estimates.  First, the parameters
and formulae used are defined (Section 6.3.2), and then lung cancer mortality estimates are
calculated from two different data sets and confidence and sources of uncertainty in the estimates
are discussed. Section 6.3.3 derives estimates based on the combined relative risk estimates of the
11 U.S. studies from Chapter 5. Section 6.3.4 bases its estimates on the data from the single
largest U.S. study, that of Fontham et al. (1991).  Finally, Section 6.3.5 discusses the sensitivity of
the estimates to changes in various parameter values. ETS-attributable lung cancer mortality rates
(LCMR) for each of the individual studies from Chapter 5 are presented in Appendix C.
6.2. PRIOR APPROACHES TO ESTIMATION OF POPULATION RISK
        Several authors have estimated the population risk of lung cancer from exposure to ETS.
Two approaches have been used almost exclusively.  One approach analyzes the overall
epidemiologic evidence available from case-control and cohort studies, as done in this report; the
other estimates a dose-response relationship for ETS exposure extrapolated from active smoking,
based on "cigarette-equivalents" determined from a surrogate measure of exposure common to
                                            6-1

-------
passive and active smoking. A recent review of risk assessment methodologies in passive smoking
may be found in Repace and Lowrey (1990).
6.2.1.  Examples Using Epidemiologic Data
       The National Research Council report (NRC, 1986) is a good example of the epidemiologic
approach. An overall estimate of relative risk (RR) of lung cancer for never-smokers exposed to
both spousal smoking and background ETS versus those exposed only to background ETS is
obtained by statistical summary across all available studies.  Two "corrections" are then made to
the estimate of RR to correct for the two sources of systematic bias. The first correction accounts
for expected upward bias from former smokers and current smokers who may be misclassified as
never-smokers; this correction results in a decrease in the RR estimate. The second correction is
an upward adjustment to the RR taking into account the risk from background exposure to ETS
(experienced by a never-smoker whether married to a smoker or not) to obtain  estimates of the
excess  lung cancer risk from all sources of ETS exposure (spousal smoking and background ETS)
relative to the risk in an ETS-free environment. Population  risk can then be characterized by
estimating the annual number of lung cancer deaths among never-smokers attributable to all
sources of ETS exposure. This calculation requires the final  corrected estimates of RR (one for
background ETS only and one for background plus spousal smoking), the annual number of lung
cancer deaths (LCDs) from all causes in the population assessed (e.g., never-smokers of age 35 and
over), and the proportion of that population exposed to spousal smoking. The entire population is
assumed to be exposed to some average background level of ETS; although, in fact, the population
contains some individuals with high exposure and others with virtually no exposure.
       The NRC report combines data for female and male never-smokers to obtain an  overall
observed RR estimate of 1.34 (95% confidence interval [C.I.] = 1.18, 1.53), but this estimate is
most heavily influenced  by the abundant female data. (The female data alone generate a
combined RR estimate of 1.32 [95% C.I. = 1.18, 1.52], while the male data produce an RR estimate
of 1.62 [95% C.I. = 0.99, 2.64].) To adjust for potential misclassification bias, the NRC uses the
construct of Wald and coworkers.  The technical details of the adjustment are contained  in Wald et
al. (1986) and to a lesser degree in the NRC report.  After correcting the overall observed RR
estimate of 1.34 downward for an expected positive (upward) bias from smoker misclassification,
the NRC concludes that  the relative risk is about 1.25, and probably lies between 1.15 and 1.35.
Correction for background sources (i.e., nonspousal sources of ETS) increases the NRC estimate of
RR for an "exposed" person (i.e., exposed to ETS from spousal smoking) to  1.42 (range of 1.24 to
1.61); the change is due only to implicit redefinition of RR to mean risk relative to zero-ETS
exposure instead of relative to nonspousal sources of ETS.  Under  this redefinition, the RR for an
                                           6-2

-------
"unexposed" person (i.e., unexposed to spousal ETS) versus a truly unexposed person (i.e., in a
zero-ETS environment) becomes 1.14 (range of 1.08 to 1.21). The NRC report further estimates
that about 21% of the lung cancers in nonsmoking women and 20% in nonsmoking men may be
attributable to exposure to ETS (NRC, 1986, Appendix C); these estimates, however, are based on
RRs corrected for background ETS but not for smoker misclassification. Applying these
percentages to estimates of 6,500 LCDs in never-smoking women and 3,000 LCDs in never-
smoking men in 1988 (American Cancer Society, personal communication), the number
attributable to ETS exposure is 1,365 and 600, respectively, for a total of about 2,000 LCDs
among never-smokers of both sexes.
       Robins (NRC, 1986, Appendix D [included in the NRC report but neither endorsed nor
rejected by the committee]) explores three approaches to assessment of lung cancer risk from
exposure to ETS, each with attendant assumptions clearly stated. A related article by Robins et al.
(1989) contains most of the same information.  Method 1 is based solely on evaluation of the
epidemiologic data applying two assumptions: (1) correction of relative risk for background
exposure to ETS independent of age, and (2) the excess relative risk in a nonsmoker is
proportional to the lifetime dose of ETS. In this method, Robins uses a weighted average RR of
1.3.  After correcting this RR for background ETS exposure, age-adjusted population-attributable
risks are calculated for females and males separately. Adjusting Robins' results  to 6,500 annual
LCDs in female never-smokers and 3,000 LCDs in male  never-smokers, for comparison purposes,
yields estimates of 1,870 female LCDs and  470 male LCDs attributable to ETS.  Method 2 uses an
overall relative risk value based on epidemiologic data, but also makes some assumptions to appeal
to results of Day and Brown (1980) and Brown and Chu  (1987) on lung cancer risk in active
smokers.  Again, adjusting Robins' estimates to 6,500 female LCDs and 3,000 male LCDs, the
range of excess LCDs attributable to ETS is 1,650 to 2,990 for never-smoking females and 420 to
 1,120 for  never-smoking males. Method 3  is a "cigarette-equivalents" approach and is discussed in
Section 6.2.2.
       The Centers for Disease Control (CDC) has published an estimate of 3,825 (2,495 female
and 1,330 male) deaths in nonsmokers from lung cancer  attributable to passive smoking for the
year 1988 (CDC,  1991a), with reference to  the NRC report of 1986. Those figures are the
midrange of values for males and females from method 2 of Robins in Appendix D of the NRC
 report (NRC, 1986).
        Blot and Fraumeni (1986) published a review and discussion of the available epidemiologic
 studies about the  same time that the reports of the Surgeon General and NRC appeared. The set
 of studies considered by Blot and Fraumeni are almost identical to those included in the NRC
 report, except for omission of one cohort study (Gillis et al., 1984), and inclusion of Wu et al.
                                            6-3

-------
 (1985), the case-control study excluded by the NRG because the raw data were unpublished.  An
 overall relative risk estimate calculated from the raw data for females yields 1.3 (95% C.I. = 1.1,
 1.5). When the results are combined for high-exposure categories, the overall relative risk
 estimate is 1.7(1.4,2.1).
        Wells (1988) provides a quantitative risk assessment that includes several epidemiologic
 studies subsequent to the NRC and Surgeon General's reports of 1986 (NRC,  1986; U.S. DHHS,
 1986).  Like the NRC report, the epidemiologic data for both women and  men are considered, for
 which Wells provides separate estimates of overall relative risk and attributable risk.  Wells
 calculates an overall relative risk of 1.44 (95% C.I. = 1.26, 1.66) for females and 2.1 (1.3, 3.2) for
 males.  Following the general approach of Wald et al. (1986), the misclassification percentage for
 ever-smokers is assumed to  be 5%  (compared to 7% for Wald et al.). Rates are corrected for
 background exposure to ETS, except in studies from Greece, Japan, and Hong Kong, where the
 older nonsmoking women are assumed to experience very little exposure to ETS outside the home.
 A refinement in the estimation of population-attributable risk is provided by adjusting for age at
 death (which also appears in the calculations of Robins, NRC, Appendix D).  The calculation of
 population-attributable risk applies to former smokers as well as never-smokers, which is a
 departure from Wald et al. and the NRC report. The  annual number of LCDs attributable to ETS
 in the United States is estimated to be 1,232 (females) and 2,499 (males) for a total of 3,731.
 About 3,000, however, is thought to be the best current estimate (Wells, 1988).  (In addition to the
 estimates of ETS-attributable LCDs,  Wells uses the epidemiological approach to derive estimates
 of ETS-attributable deaths from other cancers—1 l,000~and from heart disease—32,000.)
       Saracci and Riboli (1989), of the International Agency for Research on Cancer (IARC),
 review the evidence from the 3 cohort studies and 11  of the case-control studies (Table 4-1). The
 authors follow the example of the NRC and Wald et al. with respect to the exclusion of studies,
 and add only one additional  case-control study (Humble et al., 1987).  The overall observed
 relative risk for the studies,  1.35 (95% C.I. = 1.20, 1.53), is about the same  as that reported by the
 NRC, 1.34 (1.18,  1.53). It is not reported how the overall relative risk was calculated.
       Repace and Lowrey (1985) suggest two methods to quantify lung cancer risk associated
 with ETS.  One method is based on epidemiologic data, but, unlike the previous examples, Repace
 and Lowrey use a study comparing  Seventh-Day Adventists (SDAs) (Phillips et al., 1980a,b) with
 a demographically and educationally matched group of non-SDAs who are also never-smokers to
 obtain estimates of the relative risk of lung cancer mortality, in what they describe as a
"phenomenological" approach. The SDA/non-SDA comparison provides a basis for assessing lung
cancer risk from ETS in a broader environment, particularly outside the home, than the other
epidemiologic studies. It also serves as an independent source of data and an alternative approach
                                           6-4

-------
for comparison.  Information regarding the number of age-specific LCDs and person-years at risk
for the two cohorts is obtained from the study.  The basis for comparison of the two groups is the
premise that the non-SDA cohort is more likely to be exposed to ETS than the SDA group due to
differences in lifestyle.  Relatively few SDAs smoke, so an SDA never-smoker is probably less
likely to be exposed at home by a smoking spouse, in the workplace, or elsewhere, if associations
are predominantly with other SDAs. One of the virtues of this novel approach is that it
contributes to the variety of evidence for evaluation and provides a new perspective on the topic.
       Phillips et al. (1980 a,b) reported that the non-SDA cohort experienced an average LCMR
equal to 2.4 times that of the SDA cohort.  Using  1974 U.S. Life Tables, Repace and Lowrey
calculate the difference in LCMR for the two cohorts by 5-year age intervals and then apply this
value to an estimated 62 million never-smokers in the United States in 1979 to obtain the number
of LCDs attributable to ETS annually.  The result, 4,665, corresponds to a risk rate of about 7.4
LCDs per 100,000 person-years. In an average lifespan of 75 years,  that  value equates to 5.5
deaths per 1,000 people exposed. The second method described by Repace and  Lowrey is a
"cigarette-equivalents" approach and is discussed in Section 6.2.2.
       Wigle et al. (1987) apply the epidemiologic evidence from the SDA/non-SDA study
(Phillips et al., 1980a,b) to obtain estimates of the number of LCDs in never-smokers due to ETS
in the population of Canada. The estimated number of deaths from lung  cancer attributable to
passive smoking  is calculated separately for males and females, using age-specific population
figures for Canada and the age-specific rates of death from lung cancer attributable to ETS
estimated  by Repace and Lowrey (1985). A total of 50  to 60  LCDs per year is attributed to
spousal smoking  alone, with 90% of them in women. Overall, involuntary exposure to tobacco
smoke at home, work, and elsewhere may cause about 330 LCDs annually.

6.2.2. Examples Based on Cigarette-Equivalents
       The cigarette-equivalents approach assumes that the dose-response curve for lung cancer
risk from  active smoking also applies to passive smoking, after extrapolation of  the curve to lower
doses and  conversion of ETS exposure into an "equivalent" exposure from active smoking,
determined from a surrogate measure of exposure common to passive and active smoking.
Relative cotinine concentrations in body fluids (urine, blood, or saliva) of smokers versus
nonsmokers and tobacco smoke particulates in sidestream smoke (SS) and  mainstream smoke (MS)
have commonly been used for this purpose. The lung cancer  risk of ETS  is assumed to equal the
risk from  active smoking at the rate determined by the cigarette-equivalents.  For example,
suppose the average cotinine concentration in exposed never-smokers is 1% of the average value
found in people who smoke 30 cigarettes per day.  The lung cancer risk for a smoker of (0.01)30 =
                                           6-5

-------
0.3 cigarettes per day is estimated by low-dose extrapolation from a dose-response curve for
active smoking, and that value is used to describe the lung cancer risk for ETS exposure. This
general explanation describes the nature of the approach; however, authors vary in their
constructed solutions and level of detail. The basic assumption of cigarette-equivalents
procedures is that the lung cancer risks in passive and active smokers are equivalently indexed by
the common measure of exposure to tobacco smoke, i.e., a common value of the surrogate measure
of exposure in an active and a passive smoker would imply the same lung cancer risk in both.
This assumption may not be tenable, however, as MS and SS differ in the relative composition of
carcinogens and other components identified in tobacco smoke and in their physicochemical
properties in general; the lung and systemic distribution of chemical agents common to MS and SS
are affected by their relative distribution between the vapor and particle phases, which differs
between MS and SS and changes with SS as it ages. Active and passive smoking also differ in
characteristics of intake; for example, intermittent (possibly deep) puffing in contrast to normal
(shallow) inhalation, which may affect deposition and systemic distribution of various tobacco
smoke components as well (see Sections 3.2 and 3.3.2).
       Several authors have taken issue with the validity of the cigarette-equivalents approach.
For example, Hoffmann et al. (1989), in discussing the  longer clearance times of cotinine from
passive smokers than from active smokers, conclude that "the differences in the elimination time
of cotinine from urine preclude a direct extrapolation of cigarette-equivalents to smoke uptake by
involuntary smokers."  A recent consensus report of an  IARC panel of experts (Saracci, 1989)
states, "Lacking knowledge of which substances are responsible for the well-established
carcinogenic effect of MS, it is impossible to accurately gauge the degree of its similarity to ETS
in respect to carcinogenic potential." The Surgeon General's report devotes a three-page section to
the concept of cigarette-equivalents, quantitatively demonstrating how they can vary as a measure
of exposure (U.S. DHHS, 1986). It concludes that "these limitations make extrapolation from
atmospheric measures to cigarette-equivalents  units  of disease risk a complex  and potentially
meaningless process." (On a lesser note, it has  generally been assumed that the dose-response
relationship for active smokers  is reasonably welLcharacterized. - Recent literature raises some
questions on this issue [Moolgavkar et al.,  1989; Gaffney and Altshuler, 1988; Freedman and
Navidi, 1987a,b; Whittemore, 1988].)
       Citing cigarette-equivalents calculated  in other  sources, Vutuc (1984) assumes a range of
0.1 to 1.0 cigarettes per day for ETS exposure.  Relative risks for nonsmokers are calculated for
10-year age intervals (40 to  80) based on the reported relationships of dose, time, and lung cancer
incidence in Doll and Peto (1978).  Relative  risks for smokers of 0.1 to 1.0 cigarettes per day give
a range in relative risk from 1.03 to 1.36.  The author concludes that "as it applies to passive
                                             6-6

-------
 smokers, this range of exposures may be neglected because it has no major effect on lung cancer
 incidence."  Vutuc assumes that his figures apply to both males and females.  If an exposure
 fraction of 75% is assumed for both males and females, the range of relative risks given
 correspond to a range for population-attributable risk. If the number of LCDs among never-
 smokers in the  United States in 1988 is about 6,500 females and 3,000 males (personal
 communication from the American Cancer Society), then the number of LCDs in never-smokers
 attributable to ETS is estimated to range from 240 to 2,020 (140 to 1,380 for females alone). So
 Vutuc's figures are consistent with several hundred excess LCDs among never-smokers in the
 United States.  These estimates are from our extension of Vutuc's analysis, however, and are not
 the claim of the author.
       Repace  and Lowrey (1985) describe a cigarette-equivalents approach as an alternative to
 their "phenomenological" approach discussed in Section 6.2.1. One objective is to provide an
 assessment of exposure to ETS from all sources  that is more inclusive and quantitative than might
 be available from studies based on spousal smoking. They consider exposure to ETS both at home
 and in the workplace, using a probability-weighted average of exposure to respirable suspended
 particulates (RSP) in the two environments.  Exposure values are derived from their basic
 equilibrium model relating ambient concentration of particulates to the number of burning
 cigarettes per unit volume of air space and to the air change  rate. From 1982 statistics of lung
 cancer mortality rates among smokers and their own previous estimates of daily tar intake by
 smokers, the authors calculate a lung cancer risk for active smokers of 5.8 x 10"6 LCDs/year per
 mg tar/day per  smoker of lung cancer age.  The essential assumption linking lung cancer risk in
 passive and active smokers is that inhaled tobacco tar poses the same risk to either on a per unit
 basis.  Extrapolation of risk from exposure levels for active smokers to values calculated for
 passive smokers is accomplished by assuming that dose-response follows the one-hit model for
 carcinogenesis.  An estimated 555 LCDs per year in U.S. nonsmokers (never-smokers and former
 smokers) are attributed to ETS exposure (for 1980). The ratio of total LCDs in 1988 to 1980 is
 approximately 1.37 (Repace, 1989).  With that population adjustment factor, the approximate
 number of LCDs attributable to ETS among nonsmokers is closer to 760 for 1988 (including
 former smokers).
       Method  3 of Robins (NRC, 1986, Appendix D—again, included in the NRC report but not
specifically endorsed by the committee) extrapolates from data on active smoking, along with
several assumptions.  Applying his results to 6,500 females and 3,000 males, the range of excess
LCDs in never-smokers due to ETS is 550 to 2,940 for females and 153 to 1,090 for males.
       Russell and coworkers (1986) use data on urinary nicotine concentrations in smokers and •
nonsmokers to estimate exposure and risk from  passive smoking. The risk of premature death
                                           6-7

-------
from passive smoking is presumed to be in the same ratio to premature death in active smokers as
the ratio of concentrations of urinary nicotine in passive to active smokers (about 0.007).
Calculations are made using vital statistics for Great Britain and then extrapolated to the United
States. The latter estimate, 4,000+ deaths per year due to passive smoking, is for all causes of
death, not just LCDs.
       Arundel et al. (1987) attributes only five LCDs among female never-smokers to  ETS
exposure.  The corresponding figure for males is seven (both figures are adjusted to 6,500 females
and 3,000 males). The  expected lung cancer risk for never-smokers is estimated by downward
extrapolation of the lung cancer risk per mg of particulate ETS exposure for current smokers.
The authors' premise is that the lung carcinogenicity of ETS is entirely attributable to the
particulate phase of ETS, and the consequent risk in  passive smoking is comparable to active
smoking on a per mg basis of particulate ETS retained in the lung. If the vapor phase of ETS
were also considered, the number of LCDs attributable to ETS would likely increase (e.g., see
Wells, 1991).

6.3.   THIS REPORT'S ESTIMATES OF LUNG CANCER MORTALITY ATTRIBUTABLE TO
      ETS IN THE UNITED STATES
6.3.1. Introduction and Background
        This report uses the epidemiologic approach because of the abundance of human data from
actual environmental exposures.  Furthermore, the assumptions are fewer and more valid than for
the cigarette-equivalents approach.  The report generally follows the epidemiologic methodology
used by the NRC (NRC, 1986) and others (Section 6.2.1), with three important differences.  The
first difference is that  the NRC combined the data on females and males for its summary relative
risk estimate.  This report uses only the data on females because there are likely to be true sex-
based differences in relative risk due to differences in exposure  to background ETS and
differences in background (i.e., non-tobacco-smoke-related) lung cancer risk. Furthermore, the
vast majority of the  data are for females.  The second difference is that the NRC combined study
estimates of relative risk across countries for its summary relative risk estimate; this report
combines relative risk  estimates only within countries, and then  bases the U.S. population risk
assessment on the U.S. estimate only.  As discussed in Chapter 5, there are apparently true
differences in the observed relative risk estimates from different countries, which might reflect
lifestyle differences, differences in background lung cancer rates in females, exposure  to other
indoor  air pollutants, and differences in exposure to background levels of ETS. Therefore, for the
purposes of U.S.  population risk assessment, it is appropriate to  use the  U.S. studies; in addition,
far more studies are currently available so there is less need to combine across countries. The
                                            6-8

-------
third difference is that the NRC corrected its overall estimate of relative risk downward for
smoker misclassification bias.  In this report, the individual study estimates are corrected for
smoker misclassification bias at the outset, i.e., prior to any analysis, using the particular
parameters appropriate for each separate study (Appendix B).
       The basic NRC model is defined as
                                      = (1 + Z * /JdN)/(l + 0dN)
where RR(dE) is the relative risk for the group of never-smokers identified as "exposed" to spousal
ETS (plus background ETS) compared with the group identified as "unexposed" (but actually
exposed to background ETS); Z is the ratio between the operative mean dose level in the exposed
group, dE, and the mean dose level in the unexposed group, dN; and 0 is the amount of increased
risk per unit dose. The equation is only defined for Z > RR(dE) > 1 (see Section 8.3).
        The method used here is based on several assumptions: (1) that body cotinine levels in
never-smokers are linearly related to ETS exposure; (2) that current ETS exposure is
representative of past exposures; and (3) that the excess risk of lung cancer in nonsmokers exposed
to ETS  is linearly related to the dose absorbed.
        Estimates of RR(dE) for female never-smokers were derived in Chapter 5, where they
were corrected for smoker misclassification bias; these are redefined in Section 6.3.2 as RR2. The
relative risk estimates are then adjusted to be applicable to different baseline exposure groups in
order to calculate population risks for never-smoking women. In order to extend the analyses to
female  former smokers and male never- and  former smokers, the relative risks are converted to
excess or additive risks. The use of additive  risks is more appropriate for these groups  because of
the different baseline lung cancer mortality rates by sex and smoking status (former vs. never).
        More specifically, estimates of ETS-attributable population mortality are calculated from
female lung cancer mortality rates, which are themselves derived from summary relative risk
estimates either from the 1 1 U.S. studies combined (Section 6.3.3) or from the  Fontham et al.
(1991)  study alone (Section 6.3.4), along with other  parameter estimates from prominent sources
(Section 6.3.2).  The LCMRs in this instance  are defined as the number of LCDs in 1985 per
 100,000 of the population at risk.  The LCMR in U.S.  women under age 35 is minuscule, so only
 persons of age 35 and above are considered at risk.   Although these LCMRs are expressed as a
 mortality rate per 100,000 of the population  at risk, as derived they are applicable only to the
 entire population at risk and not to any fraction thereof that might, for example, have a different
 average exposure or age distribution.                                      '  .   \
                                             6-9

-------
        The LCMR for the subpopulation and exposure scenario to which the epidemiologic
 studies apply most directly—never-smoking females exposed to spousal ETS--is estimated first.
 That estimate is then incremented to include exposure to nonspousal ETS for all never-smoking
 females.  For the ETS-attributable population mortality estimates, these LCMRs are applied to
 never-smoking males and former smokers at risk, as well as to the females at risk for which the
 rates were specifically  derived. The most reliable component of the total estimate constructed for
 the United States is the estimate for the female never-smokers exposed to spousal ETS. The other
 components require additional assumptions, which are described. As the number of assumptions
 increases, so does the uncertainty of the estimates. Thus, the total estimate of lung cancer risk to
 U.S. nonsmokers of both sexes is composed of component estimates of varying degrees of
 certainty.
        One might argue that smokers are among those most heavily exposed to ETS, since they
 are in close proximity to sidestream smoke (the main component of ETS) from their own
 cigarettes and are also more likely than never-smokers to be exposed to ETS from other smokers.
 The purpose of this report, however, is to address respiratory health risks from ETS exposure in
 nonsmokers.  In current smokers, the added risk from passive smoking is relatively insignificant
 compared to  the self-inflicted risk from active smoking.

 6.3.2. Parameters and Formulae for Attributable Risk
       Several parameters and formulae are needed to calculate attributable risk.  These are
 presented in Table 6-1, with the derivations explained below.
       The size of the  target population, in this case the number of women in the United States of
 age 35+ in 1985, is denoted by N, with N = N, + N2, where N1 - the number of ever-smokers and
 N2 = the number of never-smokers.  The total number of LCDs from all sources, T, is apportioned
 into components from four attributable sources: (1) non-tobacco-smoke-related causes, the
 background causes that would persist in an environment free of tobacco smoke; (2) background
 ETS, which refers to all ETS exposure other than that from spousal smoking; (3) spousal ETS; and
 (4) ever-smoking.  The risk from non-tobacco-smoke-related causes (source  1) is a baseline risk
 (discussed below) assumed to apply equally to the entire target population (never-smokers and
 ever-smokers alike).  The ever-smoking component of attributable risk (source 4) refers to the
incremental risk above the baseline  in ever-smokers (this report does not partition the incremental
risk in ever-smokers further into components due to background ETS and spousal ETS, except for
long-term [5+ years] former smokers).  The background ETS component (source 2) is the
incremental risk above the baseline in all never-smokers from exposure to nonspousal sources of
                                          6-10

-------
I.




^
CO
*|H
CU
1
CU
IH
CM
O
O
H
P4
w
^H
D
Z











MINATOR
O
Z
w
Q
urrent and former
smokers
u





2 eu
Q) in
-*J 9
il
fc£
* Is
£







1
o
2
cu
Q.

^
I
"3
S



Active smoking
[nt]+[ETS]+[ACT]

I g
S r* W
W W T

d CO CO
3 3 H
2 a a
OO CO T
1 I
n

co
w ^
•o 2
d H
3 W
1 S
^ c
o •— •
Rt
CQ
"0 3
s s
?- a

§
§ C n
W M
Q. <->. O
ic adjustment for background ex]
led value from 1 1 U.S. studies fo
j = a weighted average of 11.94 f
6%) = 9.26.
J3 2 p4 vd
m fi r"1 
^^ CN CO
jver-smokers) + N2 (never-smokers) =
+ = 0.443.
1 ETS (plus background ETS) = 0.6.
to background ETS plus spousal ETS)
75.
ed 35+ = 38,000.
v.,- *rt yi . tSD
ter Values
n Paramel
c
nitions and Estimates of Pooulati
cH
0.
f en co "^ »•* j^
Z «> o « II d
- „ g" o- 2 •— 2
n «t co a >> g
+ 2 S S « |
S ^ S S ° ^
I I •§ •§ ^ f
f~* fl IH O" S *rt H
•rt o cu cu co e *
oo -J3 > o d § in
2 — , « 3 o § 
-------
ETS.  The spousal ETS component (source 3) is the additional incremental risk in never-smokers
exposed to spousal smoking.
       The calculational formulae also require values for the parameters Pl (prevalence of ever-
smokers), P2 (proportion of never-smokers exposed to spousal smoking), RRt (average lung cancer
risk for ever-smokers relative to the average risk for never-smokers in the population), and RR2
(lung cancer risk of never-smokers exposed to spousal ETS relative to never-smokers not exposed
to spousal ETS).  Additional parameters (RRn, Z, RR0i, RRo2> and RRos) are introduced or
developed below.
       The "baseline" risk is defined as the term in the denominator of a risk ratio.  For example,
in RRj the baseline risk is the lung cancer risk in a population of never-smokers with P2 exposed
to spousal ETS and 1  - P2 not exposed to spousal ETS. The conversion of RRj to the same
baseline risk as RR2 (the risk of never-smokers not exposed to spousal ETS but still exposed to
non-tobacco-smoke-related causes and to background ETS), is given by
RR
                               n
                                                 - P2).
(6-D
To convert relative risks to the baseline risk of lung cancer from non-tobacco-smoke-related
causes only (i.e., excluding background ETS in the baseline) requires some assumptions.  Let RR<)2
denote the conversion of RR2 to this new baseline. It is assumed that: (1) the excess risk of lung
cancer from ETS exposure is proportional to ETS exposure; and (2) the ratio of ETS exposure
from spousal smoking plus other sources to exposure from other sources alone, denoted by Z,.is
known and Z > RR2 > 1.  (For the values used in this report, this relation is true. See also the
discussion in Section 8.3.) Under these assumptions, RRoa = 1 + 0ZdN (from Section 6.3.1), or
                                                       (6-2)
                           RR02=(Z-1)/(Z/RR2-1).
Determination of a value for Z from data on cotinine concentrations (or cotinine/creatinine) is
discussed below. The conversion of RRj to the same zero-ETS baseline risk as RR02 follows from
multiplying expression (6-1) by RR^RR^ i.e.,
RR
                              0l
                                                  - P2)RR02/RR2).
(6-3)
The terms RRoi and RR^^ are the lung cancer risks for ever-smokers and for never-smokers
exposed to spousal ETS, respectively, relative to the risk for never-smokers in a zero-ETS
                                           6-12

-------
environment. The risk of never-smokers not exposed to spousal ETS (but exposed to background^
ETS and nonsmoking causes) relative to the zero-ETS baseline risk is
                                                                                  (6-4)
       The population-attributable risk of lung cancer in the total population for a source .(risk
factor) is a ratio.  The numerators of the ratios for sources of tobacco smoke are:
             current/former active smoking in ever-smokers,
             P!(RROI - 1);

             background ETS plus spousal ETS in never-smokers exposed to both,
                                                                                   (6-5)
                                                                                   (6-6)
              background ETS in never-smokers not exposed to spousal ETS,
              (1 - P!)(! - P2)(RR02/RR2 - 1).

The denominator for each term is their sum plus one, i.e.,

              Ex(6-5) + Ex(6-6) + Ex(6-7) + 1
                                                                                   (6-8)
 where Ex(6-5) refers to expression (6-5), etc. The population-attributable risk for remaining
 causes of lung cancer (non-tobacco-smoke-related background causes) is
                                         l/Ex(6-8).
                                                                                   (6-9)
        Multiplying the population-attributable risk for a source by the total number of LCDs
 yields the number of LCDs attributable to that source. An alternative and equivalent derivation
 of the source-attributable LCD estimates can be performed by first calculating LCMRs.  LCMRs
 are obtained for each source as follows:
        non-tobacco-smoke-related causes:  LCMRnt =  105Ex(6-9)T/N.
        ever-smoking:                     LCMRnt(RR01 - 1).               '
        spousal ETS:                       LCMRnt(RR02 - RR03)-
        background ETS:                   LCMRnt(RR03 - 1)-
 Then the number of LCDs attributable to a source is estimated by multiplying the LCMR for that
 source by the total population at risk from that source.
                                            6-13

-------
        We now consider parameter values for N, T, Pj, P2, RRb and Z to be used with the value
 1.19 for RR2, the pooled estimate of RR2 from the 1 1 U.S. studies (Table 5-17), for the
 population risk assessment in Section 6.3.3. The value used for RR2 is then changed to 1.28, the
 estimate from the Fontham et al. (1991) study in the United States, and a new value of Z is
 constructed from the cotinine data in that study for the alternative population risk assessment
 calculations in Section 6.3.4.  The female population in 1985 of age 18+ years of age is
 approximately 92 million (U.S. DHHS, 1989, Chapter 3).  Detailed census data by age for 1988
 indicate that the proportion of women 35+ years of age in the female population of age 18+ is 0.63
 (U.S. Bureau of the Census, 1990).  Applying that proportion to the 1985 population gives
 approximately 58 million women of aged 35+ in 1985, the value used for N.  There were
 approximately 38,000 female LCDs in the United States in 1985 (U.S. DHHS, 1989), which is used
 as the value for T.              •         .        •
        Using figures from the Bureau of the Census and the  1979/80 National Health Interview
 Survey, Arundel  et al. (1987) estimate the number of women of age 35+ by smoking status,
 obtaining a value of 0.443 as the fraction of ever-smokers. The National Center for Health
 Statistics (as reported in U.S. DHHS, 1989) provides the proportion of the female population by
 smoking status (never, former, current) for 1987.  When applied to figures from the Bureau of the
 Census (1990) for the female population by age group available for 1988, the same fractional value
 (0.443) is obtained. These sources suggest that the proportion of ever-smokers in the female
 population has been fairly constant between 1980 and 1987, so Pj will be given the value 0.443.
 Multiplying N by Pl gives a,n estimate of Nj = 25.7 million ever-smokers, leaving N2 .= 32.3
 million never-smokers.
        RRj applies to ever-smokers, which consist of current and former smokers. The relative
 risks of current and former female smokers of age 35+ for the period 1982-1986 are estimated at
 11.94 and 4.69, respectively, from data in the American Cancer Society's Cancer Prevention Study
 II (CPS-II; as reported in U.S. DHHS, 1989).  For 1985, the composition of ever-smokers is 63.4%
 current smokers and 36.6% former smokers (CDC,  1989a).  Using  those percentages to weight the
 relative risks for ever-smokers and former smokers gives 9.26, which will be used as the value of
       The proportion of never-smokers exposed to spousal ETS in epidemiologic studies
typically refers to married persons, so we need to consider how to treat unmarried persons as well
in order to set a value for P2.  The American Cancer Society's CPS-II (reported in Stellman and
Garfinkel, 1986) percentages for marital status of all women surveyed (not just never-smokers)
are:  married, 75.3; divorced, 5.1; widowed, 14.6; separated, 0.8; and single, 4.2. Our estimates of
risk apply to married female never-smokers, which comprise about 75% of female never-smokers,
                                           6-14

-------
so it is necessary to consider exposure to ETS in the remaining 25% of unmarried female never-
smokers.
       Cummings (1990) obtained urinary cotinine levels on a total of 663 self-reported never-
smokers and former smokers.  The cotinine levels were slightly higher in males than in females
(9.6 and 8.2 ng/mL, respectively), and slightly more than one-half of the subjects were females.
The average cotinine level was 10.7 ng/mL for married subjects if the spouse smoked and 7.6
ng/mL otherwise.  The average cotinine levels reported by marital status are:  married, 8.3 ng/mL;
never married, 10.3 ng/mL; separated, 11.8 ng/mL; widowed, 10.4 ng/mL; and divorced, 9.2
ng/mL. The study, in which 7% of the subjects were of age 18 to 29, and 47% were of age 60 to
84, does not claim to be representative.  Nevertheless, the results suggest that in terms of ETS
exposure, an unmarried never-smoker is probably closer, on average, to a never-smoker married
to a smoker (an exposed person) than to a  never-smoker married to a nonsmoker (an unexposed
person).  This observation is also consistent with the findings of Friedman et al. (1983).
       The proportion of never-smoking controls exposed to spousal smoking varies among
studies in the United States. If we exclude studies of uncertain representativeness, the median
value for the remaining studies is 0.6. From the evidence on ETS exposure to unmarried female
never-smokers, it is reasonable to assume that their exposure to ETS, on average, is at least as
large as the average background level plus 60% of the average exposure from spousal smoking.
For the calculations needed from these figures, this assumption is equivalent to treating unmarried
and married female never-smokers alike in terms of exposure to ETS (i.e., 60% exposed at a level
equivalent to spousal smoking plus background and 40% exposed at the background level only).
Consequently, the value P2 = 0.6 is assumed to apply equally to married and unmarried female
never-smokers.
       The NRC report of 1986 uses Z = 3 for the ratio  of ETS exposure from spousal smoking
plus other sources to ETS exposure from nonspousal sources alone.  That value was primarily
based on data from Wald and Ritchie (1984), for men in  Great Britain, although Lee (1987b) had
reported a value of 3.3 for women in Great Britain.  The results of Coultas et al. (1987) also were
considered, wherein a value of 2.35 was observed for saliva cotinine levels in a population-based
survey of Hispanic subjects in New Mexico. More recent data suggest that a lower value of Z
may be more accurate for the United States. The study of 663 volunteers in Buffalo, New York,
reported by Cummings et al. (1990),  observed a value of 1.55 based  on mean urinary cotinine
levels among married females (n = 225; Cummings, 1990).  A study by Wall et al. (1988)
containing 48 nonsmokers observed a ratio of mean cotinine levels of 1.53. A survey of municipal
workers at a health fair found a cotinine ratio of 2.48 for the 112 women surveyed, but the
comparison is between women who shared living quarters with a smoker and those who did not
                                          6-15

-------
(Haley et al., 1989). The 10-country collaborative cotinine study conducted by IARC (Riboli et
al., 1990) collected urinary cotinine samples from nonsmoking women in four groups totaling
about 100 each—married to a smoker (yes, no) and employed (yes, no)—including two locations,
Los Angeles and New Orleans, in the continental United States. The ratios of average
cotinine/creatinine concentrations for women married to a smoker to women not married to a
smoker range from 1.75 to 1.89 in New Orleans, when the percentage of women employed is
assumed to be between 25% and 75%. The data from Los Angeles contain an abnormally high
mean for women who are employed  and also married to a smoker (a mean of 14.6 based on only
13 observations, compared to the other three means for Los Angeles of 2.1, 4.5, and 6.6), so only
the two means for unemployed women (married to a smoker and married to a nonsmoker) were
used. The resultant ratio of cotinine/creatinine concentrations is 1.45. Data from the Fontham et
al. (1991) study of lung cancer and ETS exposure in five U.S. cities yield a Z of 2.0 based on mean
urinary cotinine levels in 239 never-smoking women (data provided by Dr. Elizabeth Fontham).
       Cotinine data exhibit variability both within and between subjects, as  well as between
studies due to different experimental designs, protocols, and geographical locations (see also
Chapter 3).  Most of the Z values from recent U.S. studies range between 1.55 and 2.0.  A value of
1.75 for Z appears reasonable based  on the available  U.S. data and will be used in Section 6.3.3
along with the combined RR estimate from 11 U.S. studies (Chapter 5) to calculate ETS-
attributable lung cancer mortality estimates.  Z = 2.0 and Z = 2.6,  which are based on median
cotinine levels, will be used in Section 6.3.4 for alternative calculations of lung cancer mortality
based on the results of the Fontham  et al. (1991) study.  The sensitivity of the lung cancer
mortality estimates to changes in Z and other parameters is discussed in Section 6.3.5.

6.3.3.  U.S. Lung Cancer Mortality Estimates Based on Results of Combined Estimates from
       11 U.S. Studies
       This section calculates ETS-attributable U.S. lung cancer mortality estimates based on the
combined relative risk estimate (RR2 =1.19) derived in Chapter 5 for the 11 U.S. studies.
Alternatively, the estimate from just the combined Tier 1  and Tier 2 studies (RR2 = 1.22 from 8
of the 11; see Table 5-17) could have been used because these eight studies were assessed as
having the greater utility in terms of evaluating  the lung cancer risks from ETS; however, the
results would be virtually the same because the relative risk estimates are so similar. It  was
therefore decided to use the  data from all the U.S. studies for the purposes of the population risk
assessment.
                                           6-16

-------
6.3.3.1. U.S. Lung Cancer Mortality Estimates for Female Never-Smokers
       The parameter values presented in Section 6.3.2 are assumed along with RR2 = 1.19.  For
Z = 1.75, RR02 = 1-59 (from expression 6-2, denoted hereafter as Ex(6-2); see also Table 6-1).
Given those parameter values, the formulae in Section 6.3.2 yield the estimated lung cancer
mortality for U.S. women in 1985 by smoking status (ever-smoker, never-smoker exposed to
spousal ETS, and never-smoker not exposed to spousal ETS) and source (non-tobacco-smoke-
related causes, background ETS in never-smokers, spousal ETS in never-smokers, and ever-
smoking), as displayed in Table 6-2. The LCMR from non-tobacco-smoke-related causes
(LCMRnt) is estimated to be 9.4 per 100,000 and is assumed to apply equally to all persons in the
target population, regardless of smoking status. The excess LCMR in never-smokers from
exposure to  background ETS is 3.2, with  an additional 2.4 if exposed to spousal ETS. The excess
LCMR in ever-smokers, which includes whatever effect exposure to  ETS has on ever-smokers as
well as the effect from active smoking, is 120.8.
       In rounded figures, 5,470 (14.4%) of the 38,000 LCDs in U.S. women age 35 and over in
1985 are unrelated to smoking (active or passive). The remaining 32,530 LCDs (85.6% of the
total) are attributable to tobacco smoke: 31,030 in 25.7 million ever-smokers and  1,500 in 32.3
million never-smokers.  These 1,500 ETS-attributable LCDs in never-smokers account for about
one-third of all LCDs in female never-smokers.  Of the 1,500 LCDs, about 1,030 (69%) are due to
background ETS, and 470 (31%) are from spousal ETS.  In summary, the total 38,000 LCDs from
all causes  is due to non-tobacco-smoke-related causes, 5,470 (14.4%), occurring in ever-smokers
and never-smokers;  ever-smoking, i.e., the effects of past and current active smoking as well as
ETS exposure, 31,030  (81.7%), occurring in ever-smokers; and background ETS,  1,030 (2.7%), and
spousal ETS, 470 (1.2%), occurring in never-smokers. In other words, ever-smoking causes about
81.7% of the lung cancers in women age  35 and over; exposure to ETS from all sources accounts
for some 3.9%; and causes unrelated to tobacco smoke are responsible for the remaining 14.4%.
The LCDs in never-smokers attributable to ETS equal about 5% (1,500/31,030) of the total
attributable to ever-smoking. Part of the mortality attributed to ever-smoking here, however, is
due to ETS  exposure in former smokers,  to be taken into account in Section 6.3.3.3.

6.3.3.2.  U.S. Lung Cancer Mortality Estimates for Male Never-Smokers
       There are 11 studies worldwide of exposure to ETS and lung  cancer in males.  The studies
and their  respective relative risks are AKIB, 1.8; BROW, 2.2; BUFF, 33+ years' exposure, 1.6;
CORR, 2.0; HUMB, 4.2; KABA, 1.0; LEE, 1.3; HIRA(Coh), 2.25; HOLE(Coh), 3.5; plus the data
in Rabat (1990), 1.2; and Varela (1987, Table 13 scaled  down to 50 years of exposure), 1.2. (Data
                                           6-17

-------
CO
•8
H
•o
03
"3
0
A
^
•°
_|?
"3
ti
Q
S
(I
 1
H w
v






c^
*-*
rt
1
«
0
§
O
bo
c
taj













:,. '-• I ".
00
S s , .S
•• ^j
0
w>
C? S"
sJ R

" •' 1
M"
J^V " g
v»_x •• tO.
, X
•.""O
' 1
ed
•*$N ^(S
5?" » ^™*
V^> 0Q ji£j[
••


< T)
§ -S
o- ™
^ £
o * *r
t Js w
, e o 53
***v O^ C3 ^f
pj >7 B R
O >& « o
'

co

wt C
^» ^^
t-l f






(S OO CT\
o\ m vo
oi o\ in



O cU
z . >*.

g s s
o
o
o_
oo"
en

C-;

oo
0
8.
f<>

c^
T™\
0
^f


f~"
o
CO

^^




X— V
^^
It
o
t~-
V?






§
oo'
in





2

?ij ob
« 1
8- -g
o S "
sl I
e8 o >
43 o V
2 00 2
i a ^
Q 'tH flj
§1 2
So -g
8 "
0*0 «'•>
1" S • • -S
o „ °

5 ^ 0
a . °
^ ^ S 53
^< o a> o
•" ° S v
^ « « a
«> •" P o
3 -^ -ss «
a -8 g-o
P j_, S3 c<
f^ crt P
•r1 CO o
** fe H ^

ti ' f i
co c O i*
— p t. S
2 S s *
•O CO _, 2
•-< -C ra *3
> •!-• (-
'•3 ^ "1 >
C ^^ • O
»*H ^3  _Q
_, o .-H e3
go ^ TO
TO ** CO
«*- ° 8 S>
r* ** •> d O
g3 0 00 B fl
« s >n « B
^ "o o 8 "

I* H 2 cs
O. " •— ' a> .5
»j ». . '^

^^ rt so « g a> o
8^ § P? f « §
§•2.3 -«- fe.g-"
00 S « | , , > •& g>

^ZT^a SSSn«5
•a .« « 52" '« j§
|| !§§§§! 11
'o'cfiCJUUCJ ?.£<*
If! i HI
jS^- § s £••$$?
6-18

-------
for BROW, BUFF, and HUMB were supplied via personal communication from Drs. Brownson,
Buffler, and Humble.)  A weighted average of the passive smoking risk (RR2) from these 11
studies is about 1.6. For the seven U.S. studies, BROW, BUFF, CORR, HUMB, KABA, Kabat
(1990), and Varela (1987), the weighted average RR is about 1.4, but this value is heavily
weighted (about 66%) by the Kabat (1990) and Varela (1987) studies, neither of which was used in
the analysis of the female data.  The combined risk for the five U.S. studies not including  Kabat
(1990) and Varela (1987) is about 1.8, but they are all small, low-weight studies. In any case, the
observed relative  risks for males appear to be at least as great as those for females.
       When an attempt is made to correct the observed male risks for smoker misclassification,
however, using the procedures outlined in Appendix B and the community survey-based
misclassification factors for males (1.6% for current regular smokers, 15% for current occasional
smokers, and 5.9% for former smokers), it is found that for most of these cohorts, the number of
smokers misclassified as never-smokers either exceeds  the relatively small number of observed
never-smokers or is so great as to drive the corrected relative risk substantially below unity. This
implies that the misclassification factors from the community surveys are too high to accurately
correct the risks in the epidemiologic studies.  Until better misclassification data on males are
available, no real sense can be made of the male passive smoking relative risks.
        Given the greater stability of the more extensive database on females, it was decided to
apply the incremental LCMRs for spousal and nonspousal ETS exposure in female never-smokers
to male never-smokers. The incremental LCMRs were used instead of the relative risk estimates
because relative risk depends on the background  risk of lung cancer (from non-tobacco-related
causes) as well as the risk from ETS, and background lung cancer risk may differ between females
and males. From Section 6.3.3.1, the LCMR from spousal ETS exposure was 2.4 per 100,000 at
risk, and the LCMR from nonspousal ETS exposure  was  3.2 per  100,000.  The 1985 male
population age 35 and over is 48 million (U.S. DHHS,  1989), of whom 27.2% (private
communication from Dr. Ronald W. Wilson of the U.S. National Center for Health Statistics), or
 13.06 million, were never-smokers. Of these, 24% (Wells, 1988), or 3.13 million, were spousally
exposed.  Applying the female ETS LCMRs, 3.13 million x 2.4/100,000 = 80 deaths in males from
spousal ETS exposure and 13.06 million x 3.2/100,000 = 420 deaths from nonspousal exposure,
 for  a total of 500 ETS-attributable LCDs among  never-smoking males. These estimates based on
 female LCMRs are believed to be conservatively low because males generally have higher
 exposure to background ETS than females.  This would lead to lower Z values and subsequently
 higher estimates  of deaths attributable to background (nonspousal) ETS sources.  In conclusion,
 confidence in these estimates for male never-smokers is  not as high as  those for female never-
 smokers.
                                            6-19

-------
6.3.3.3.  U.S. Lung Cancer Mortality Estimates for Long-Term (5+ Years) Former Smokers
       Because the risk of lung cancer from active smoking decreases with the number of years
since smoking cessation (Section 4.2.2), passive smoking may be a significant source of lung
cancer risk in long-term former smokers. There is, however, a scarcity of data on the relative
risks of lung cancer for former smokers exposed to ETS. With former smokers, it is unknown how
much of the observed lung cancer mortality is attributable to non-tobacco-smoke-related causes,
how much is due to ETS exposure, and how much is accounted for by prior smoking.
Consequently, neither the observational data on the number of lung cancers in the former smokers
nor the relative risk data from never-smoking females are utilized. Instead, long-term former
smokers are assumed  to have the same LCMR from exposure to ETS as never-smoking females, as
was assumed above for  never-smoking males. In this manner, the lung cancer risk from ETS
exposure can be calculated as an additional risk, supplemental to any remaining risk from previous
active smoking. There  is some uncertainty in the application of this assumption because the
additional risk to long-term former smokers from ETS exposure may  not, in fact, be the same as
the risk to never-smokers.  For example, ETS may have a greater promotional effect on former
smokers because of their previous exposures to high concentrations of carcinogens from active
smoking.
       Female ever-smokers comprise about 44.3%, or 25.7 million, of the total U.S. female
population age 35 and over of 58 million. Long-term (5+ years) former smokers comprise about
34%  of these ever-smokers (U.S. DHHS, 1990b), or about 8.7 million women.  Using a 2.2
concordance factor for former smokers married to ever-smokers versus never-smokers married to
never-smokers (see Appendix B), it is estimated that about 77% of the former smokers, or about
6.7 million, would be spousally exposed compared with the 60% for the never-smokers. Thus,
based on the LCMRs  derived for female never-smokers, the expected number of ETS-attributable
LCDs for female long-term former smokers would be 6.7 million x 2.40/100,000 = 160 deaths
from spousal exposure and 8.7 million x 3.20/100,000 = 280 deaths from nonspousal exposure, for
a total of 440.
       Male ever-smokers comprise 72.8% of the U.S; male population, age 35 and over, of 48
million, equal to 35 million; of these, about 43% (derived from data in U.S. DHHS, 1990b, page
60, Table 5), or about 15 million, are 5+ year quitters. Of the never-smoking males, 24% were
married to smokers (Section 6.3.3.2). Again using  a 2.2 concordance factor for former smokers, it
is estimated that 41%  of the 15 million former smoking males, or 6.2 million, would  be married to
ever-smokers.  Applying the female neyer-smoker LCMRs from Section 6.3.3.1, 6.2 million x
2.40/100,000 = 150 deaths from spousal ETS exposure and 15 million  x  3.20/100,000 = 480 deaths
                                          6-20

-------
from nonspousal ETS exposure for a total of 630 ETS-attributable LCDs among male long-term
former smokers.
       Table 6-3 displays the resultant estimates for LCDs attributable to background ETS and
spousal ETS by sex for never-smokers and for former smokers who have quit for at least 5 years.
The LCMRs for background ETS and spousal ETS, assumed to be independent of smoking status
and sex, are the same as derived in Section 6.3.3.1 for female never-smokers (3.2 and 2.4,
respectively).  Background ETS accounts for about 2,200 (72%) and spousal ETS for 860 (28%) of
the total due to ETS. Of the 3,060 ETS-attributable LCDs, about two-thirds are in females
(1,930, 63%) and one-third in males (1,130, 37%).  More females are estimated to be affected
because there are more female than male never-smokers.  By smoking status, two-thirds are in
never-smokers (2,000, 65%) and one-third in former smokers who have quit for at least 5 years
(1,060,35%).
       The numbers shown in Table 6-3 depend, of course, on the parameter values assumed for
the calculations. The sensitivity of the totals in Table 6-3 to alternative parameter values is
addressed in Section 6.3.5. First, however, tables equivalent to Tables 6-2 and 6-3 are developed
based on the FONT study alone for comparison.

6.3.4.  U.S. Lung Cancer Mortality Estimates Based on Results of the Fontham et al. (1991)
       Study (FONT)
       The estimate of RR2 (1.19), the risk of lung cancer to female never-smokers with spousal
ETS exposure relative to the risk for female never-smokers without spousal ETS exposure, used in
Section 6.3.3, is based on the combined outcomes of the 11 U.S. epidemiologic studies from
Chapter 5 (see Table 5-17).  In this section, the quantitative population impact assessment is
repeated with FONT, the single U.S. study with Tier 1  classification (Section 5.4.4), as the source
of the estimates of RR2 and Z (constructed from  urine cotinine measures), with the remaining
parameter values left unchanged.  While a single study  has lower power and larger confidence
intervals on the relative risk estimate than can be obtained by combining the various U.S. studies,
using the specific data from a single study decreases the uncertainties inherent in combining
results from studies that are not fully comparable. FONT is the only study of passive smoking
and lung cancer that collected cotinine measurements, thus providing estimates for RR2 and Z
from a single study population. The total number of lung cancers attributable to total ETS
exposure is particularly sensitive to those two parameters (discussed in Section 6.3.5).
        The NCI-funded Fontham et al. study (1991) is a large, well-conducted study designed
specifically to investigate lung cancer risks from  ETS exposure (see also the critical review in
                                            6-21

-------
s
1
CO*
13
«-H
^H
'§
S3
oo
•*
CO
2
a
CO
aj
2
1
5
O
CO
1

.•S
I
jj?
S?

|&
CO +
£'3
TO ^*
II
o -g
§
I!
1 *
73 o

CO "**
« -a
is
li
* a
ve T
l-l
M *^
»O ?T
§2 e







;3
I
e
1
1
CO































p
>° eP
B I -
- 1-5
;£§

fi
w
15* Is
7"v ^;-
-
1
s li
% *

*o
o
Ul
sfg

-
'to
' «l

c? 11
^ Zo


•« w
; ' "* *e5
- ||



vx
' JS
^ '
'J3C£J
o
S^tf
^«
»




ofe t sr f
II -I §| §g

2 | g § § £ 28'
^


0 O O
t~ o >o >r>
Tl- OO -H —i




oooooooo
^f ^O CO ^H f>| fNl CN





OJ OO CO CO
O\ CO ON ^^ CO t^ OO Oi





o So S o So S
2 >* 2 K« 2 >• ' 2 >^




b fc . .S S h h S S



W5 t/3 ty3 C/5 ^s **
*2L *7 *7 *7 LL LL LL S

6-22




I

o
s
CO


O 00




CX^-^*
tN ^^




C>
S













3

2
















CO
CU
CO
1
g 0
c M
o >*
^.^

co 9
at cu
?!
8 °
si
5 o
ja 1
"rt "-1
rt II
W gP

W jo
0 0
oo |
C C
CU ii
o II
« on
-£<£


-------
Appendix A).  It addresses some of the methodological issues that have :been of concern in the
interpretation of results regarding lung cancer and passive smoking:  smoker misclassification, use
of surrogate respondents, potential recall bias, histopathology of the lung tumors, and possible
confounding by other factors (see also Sections 5.3, 5.4.2, and 5.4.3). Cases and controls were
drawn from five major cities across  the United States (Atlanta, New Orleans, Houston, Los
Angeles, and San Francisco) and, hence, should be fairly representative of the general U.S.
population, at least of urban areas with moderate climates.  Furthermore, the results of the study
are consistent across the five cities.
       In spite of  the care incorporated into the FONT design to avoid smoker misclassification
bias, some might still exist; thus, the adjusted relative risk of 1.29 reported in FONT is "corrected"
slightly to 1.28 in this report. The parameter P2, the proportion of never-smokers exposed to
spousal ETS, was assigned the value 0.60 in the preceding section.  In FONT, the observed
proportion of spousal-exposed controls is 0.60 (0.66) for spousal use of cigarettes only (any type of
tobacco) among colon-cancer controls and 0.56 (0.63) in population controls.  Consequently,  the
previous value of 0.60 is retained. Of the 669 FONT population controls, whose current cotinine
levels are considered the most representative of typical ETS exposure, there were 59  living with a
current smoker and 239 whose spouses never smoked. (The other 371 were nonsmoking women
who either no longer lived with a smoking spouse or whose spouse was a former smoker.)  The
mean cotinine level for never-smoking women with spouses who are current smokers (n = 59) is
15.90 ± 16.46; the mean level for the other 239 was 7.97 (± 11.03).  The ratio is 15.90/7.97,  giving
Z = 2.0 (data provided by Dr. Elizabeth Fontham).  The median is a measure of central tendency
that is less sensitive to extremes, so  the ratio of median  cotinine levels is also considered
(Z = 11.4/4.4 = 2.6). Results for both values of Z are displayed in Tables 6-4 and 6-5, which
correspond to Tables 6-2 and 6-3, respectively, of the previous sections for direct comparison.
        The results of Section 6.3.2 are based on RR2 =1.19 (combined U.S. study results) and
Z = 1.75 (from studies on cotinine levels). In this section, RR2 and Z are both increased (RR2 to
1.28 and Z to 2.0 and 2.6).  Correcting RR2 = 1.28 for background ETS exposure yields estimates
of RRoa = 1-78 (i.e., the relative risk from spousal and background ETS) for Z = 2.0, and RR02 =
1.55 for Z = 2.6.  The relative risk estimate from exposure to background ETS only becomes
RR03 = 1.39 for Z = 2.0, and RR03 = 1.21 for Z = 2.6.  The change in RR2, from 1.19 to 1.28,
increases the estimated number of LCDs from background and spousal ETS, whereas increasing Z
decreases the figure for background ETS and has no effect on the number for spousal ETS (see
Tables 6-2 and 6-4).  Relative to the total ETS-attributable LCD estimate in the last section
                                            6-23

-------

.CO
*c
• F*
£
Sii
a>
1
*O
oo
a
'w
vT
oo
i-H
8
•#-*
TJ
'a
t~
Ut
tS
(/)
s
s
9
O
CO
Q>
1
ft
« %
>>/-^
CO §^
rt *— '
•fj 13
CO <->
£s
"3 w
Si
0 0
gfe
si
g g
o o
Ifs
•5
1 >
IN
MH -O
II








<*jl
&
3
VH
2
fi
Ue
O
00
5
14






















" 2 "
$


O
E £
*- ' >
w




t
s §fH
%
1
O
toe
t>
-—» « H
5^. J*Q (J^



1 T*
O <&
o ti
O ^"
ra ^S
JO I-H
| »^
^ W 0

s
^-v
s: |
• | i
**v* t^ WJ^ €5
<< VH V
§s
3
&0
& e



,_,
^»
2S"
11^
^* ^^ Q^:
CO V 	



_^
P tx
^•H "**<
0 0
VO ^O
VO vo

—V -N
cT tx f^ ^
-^* O ~1 ^
"***S V_ Vi—*' ^N*—
0 C5 00
T tx VO *~i
^ *N vo "^





5^ ^-^ 5^-^
o o o o o o
n*.. *« ^iL rt •.
^H ***H ^^ **"< C^l f*^




CN oo O\
c7\ co vq
CN O\ V^
— < -H (S
O cS
z ><
CO &0 c/3
Z !z; w
0
o
ob"
CO

Ol *^O
00 00
0 0
  '5
rt O
S s
S. <-•
*^N fl>

o S *"
1 2 ^
S « '§ £
<« O d i
o us «> i
g'd W g
^H,— , CO
e^ d ^ o
* & o3 o
|| .13 nj !5
' CO TO ^
N « .S3

?P cd r c
9 y^^v fl5 O
'a ~ vi- "
C 
5 .3 "> 0
9 d o •=>
0 -fl 0 cS
3§ is
• • S ' 3-g
w ti_i e
S "« o 1
Sflrf 8 i
g *o -S g >
i|l|l.g
S***, Vrt *^ S *^ ^
^5 . rt wj ^ C
*-^* r\i i .s TO
Percentage of grand total (38,0(
typeface. Outcomes using Z = :
2See Table 6-2 for formulae for
3NS = never-smokers; ES = ever
4Baseline lung cancer mortality i
5This figure attributes all lung c
6-24

-------
+-*
> o1
•0 a>
P
•if
BJ !*
* 2
-8
11
O w
Sfe
11
0 73
S «
3 52
1!
•o f
a t-i
a s>
jj »

§ >>
iS-S
. «
"> x-^
1 ^.J1
*> ON
q> ON
3 ^
^•d

••





&
*s
*•»
o
s
fcj
V


HO
>-)
































23«
"2-?«
» ** o B
^J&li



^ %
^ H W






tS
S ^P
""^ MW




1

0
«<
S f |2
mrt





ts f
J5 )g
**** g *S
C ilt§



||
ll


>*
Si
CO



2?

S ^^
n

<=>=*? s e f
t^ r?5 S VO O\ Ep ^^C/f ^^C/f
-:<^ «^^_ "»„_ «-«ofe



o o o o o o o o o o o o o o o o
-J1^







OO OO OO OO
VO^o -H»»I CSfN 




2 ! i 0 2 ! £ £



.. ^. ^^ ^^
tu b 2 2 b PL, IS S






K^ K K eo so c«oo

0 0
>n \o
^"^



® ^
r^fN



<-~>"^v
O\ "^
rr» "S
^^"^^^
00
-H »«r




^H^t^
VO ^»
jr i^T
0 0
VO vo
Cvf-M






r-
o
vo
















2
(2

1
•3
1
<«
o
o
•o
vo
ci
11
N
00
a
'i
p«»
CO
I
§
^
o

aJ
o
j™ «"
q^ 03
^V flj
? f
13 aj
43 •-
!? a

C2 — ^ Q
•*H o OO
CN ^ ^*
£ rsT *2
O ^ 03

co O >^
£ ^
c3 f^
co co J3
ci " wG or
« ts o
§ js1*
"3 S^
•^^ J2 fe
8 S^
2S^
SQ
S «g
!.0 (ratio of
/n in italics.
-attributabll
1 = former s:
o^tu

[sj eoW Zo"
dj ***^ S
J3 £3 *2^j
'OT^~-*J fi
«:'3tO f
M. aj 
-------
(3,060), the net effect is an increase of 12% to 3,570 at Z = 2.0, and a decrease of 13% to 2,670
when Z » 2.6.  (FONT is the largest study and therefore  the dominant influence in the combined
relative risk from the 11 U.S. studies [RR2 = 1.19], so the outcomes being compared here with
those in Section 6.3.3 are not independent. Similarly, the Z-value of 1.75 used with RR2 = 1.19 in
the first analysis is subjectively based on the outcomes of several U.S. cotinine studies, including
the FONT cotinine results.) Overall, these two analyses support an estimate in the neighborhood
of 3,000 total lung cancer deaths in never-smokers and former smokers (quitters of 5+ years) from
exposure to ETS in the United States for 1985.
       The 3,000 figure is a composite value from estimates of varying degrees of uncertainty.
The confidence for the female never-smoker estimates is highest. The lung cancer estimates for
never-smoking females from exposure to spousal ETS (470 to 660; from Tables 6-2 and  6-4) are
based on the direct evidence from epidemiologic studies and require the fewest assumptions.
Adding in a figure for exposure to background ETS in never-smoking females (680 to 1,100) is
subject to the assumptions and other uncertainties attached to the estimate of the parameter Z.
The relative risk from ETS exposure, which depends on the risk from background sources of lung
cancer as well as the risk from ETS, may differ in females and males.  Consequently, the absolute
risk (LCMR) in never-smoking females was assumed to  apply to never-smoking males, adding
390 to 560 to the total (80 to 110 for spousal ETS and 280 to 450 for background ETS; Tables 6-3
and 6-5). Males, however, are thought to have higher background exposures to ETS than females,
so this assumption is likely to underestimate the  ETS-attributable lung cancer mortality  in males.
       The confidence in the estimates for former smokers is less than in those for never-
smokers.  These estimates also are probably low because they assume that ETS-attributable rates in
never-smokers and former smokers are the same. Figures for lung cancer mortality from ETS in
former smokers, for the same categories as never-smokers (i.e., females and males, background
and spousal ETS), account for an additional 940  to 1,250 (totals of 310 to 440 for spousal ETS and
500 to 810 for background ETS, for both sexes). These  figures for former smokers are summed
from appropriate entries in Tables 6-3 and 6-5 (Tables 6-2 and 6-4 do not make them explicit;
they are accounted for in the entry for lung cancer attributable to ever-smoking).
        Finally, there is statistical uncertainty in each of the LCD estimates resulting from
sampling variations around all of the  parameter estimates that were used in the calculations.  It  is
already apparent that the estimate of total lung cancer mortality attributable to ETS is sensitive to
the values of Z and RR2.  Uncertainties associated with the parameter values assumed and the
sensitivity of the estimated total ETS-attributable LCDs to various parameter values are examined
next.
                                           6-26

-------
6.3.5.  Sensitivity to Parameter Values
       The estimates for ETS-attributable lung cancer mortality are clearly sensitive to the
studies, methodology, and choice of models used, and previous methodologies have been presented
in Section 6.2. Even for this current model, however, estimates will vary with different input
values.  Specifically, the estimates depend on the parameter values assumed for the total number
of lung cancer deaths from all sources (T), the population size (N), the proportion of ever-smokers
in the population (Pt), the proportion of never-smokers exposed to spousal ETS (P^, the risk of
ever-smokers relative to never-smokers (RRj), the risk of never-smokers exposed to spousal ETS
relative to unexposed never-smokers (RR2), and the ratio of ETS exposure from spousal smoking
and background (i.e., nonspousal) sources to background sources alone (Z).
       The effects of changing several of the parameters is readily discernible. A change in T/N
produces a proportional change in the same direction for all estimates of attributable mortality.  A
change in P1 creates a proportional change in the same direction in all mortality figures for ever-
smokers and a change in the opposite direction proportional to 1 - Pj in all estimates for never-
smokers. The parameter values assumed for these three parameters are from the sources described
in the preceding text and are assumed to be acceptably accurate.  The value of P2 is assumed to be
0.6, but values between 0.5 and 0.7 are easily credible.  At either of those extremes, there is a 17%
change in the lung cancer mortality due to spousal smoking, which only amounts to  80 for the first
analysis (Table 6-2) and 100 for the second one (Table 6-4).  The impact of changing RRl5 RR2,
or Z on the total lung cancer mortality attributable to ETS from the first analysis is  displayed in
Table 6-6 for  RRt from 8 to 11, for RR2 between 1.04 and 1.35 (extremes of the 90% confidence
intervals for the 11  U.S. studies; Table 5-17), and  for Z in the range 1.5 to 3.0.
       For RRt in the interval (8,11), the total lung cancer mortality from ETS ranges from about
2,600 to 3,500, a 14% change in either direction relative to the comparison total of 3,060.  The
extremes are much greater over the range of values considered for RR2 (1.04 to 1.35). At the low
end, where the excess relative risk from spousal ETS is only 4%, there is a 77% decrease in the
total lung cancer mortality to 700.  The percentage change is  roughly equivalent in the opposite
direction when the excess relative risk is at the maximum value 35%, for a total of 5,190.  The
total is also highly sensitive to the value  of Z. A decrease of only 0.25 from the comparison value
of Z = 1.75 increases the total by 36% to 4,160.  A 36% decrease in  ETS-attributable mortality
occurs at Z = 2.5, leaving a corresponding estimate of 1,950.  At Z = 3.0, the total drops further to
1,680, a 45% decrease.
        Varying  more than one parameter value simultaneously may have a compounding or
canceling effect on  the total lung cancer mortality due to ETS. For example, at the  following
                                            6-27

-------
Table 6-6. Effect of single parameter changes on lung cancer mortality due to ETS in never-
smokers and former smokers who have quit 5+ years
Parame
change
None4
Z =






RR2s








RRi-







ter

1.50
1.75
2.00
2.25
2.50
2.75
3.00
1.04
1.05
1.10
1.15
1.19
1.20
1.25
1.30
1,35
8.00
8.50
9.00
9.26
9.50
10.00
10.50
11.00
Background1
2,210
3,310
2,210
1,660
1,320
1,100
950
830
510
630
1,220
1,780
2,210
2,310
2,820
3,290
3,750
2,510
2,380
2,260-
2,210
2,160
2,060
2,020
1,890
LCM due to ETS
Spousal2
850
850
850
850
850
850
850
850
190
•240
470
690
850
890
1,080
1,270
1,440
970
920
870
850
830
800
780
730
Total
3,060
4,160
3,060
2,510
2,170
1,950
1,800
1,680
700
870
1,690
2,470
3,060
3,200
3,900
4,560
5,190
3,480
3,300
3,130
3,060
2,990
2,860
2,800
2,620
Percentage of
change3
0
+36
0
-18
-29
-36
-41
-45
-77
-72
-45
-19
0
+5
+27
+49
+70
+14
+8
+3
0
-2
-7
-9
-14
'69,100,000 at risk.
235,400,000 at risk.
Percentage of change from total shown in boldface (the outcome from Tables 6-2 and 6-3,
 using the 11 U.S. studies).
4Z - 1.75, RR2 =1.19, RRj = 9.26.
                                          6-28

-------
values of RR2, the range of percentage changes from the total of 3,060 ETS-attributable lung
cancer deaths for values of Z in the interval 1.50 to 3.0 are shown in parentheses:  RR2 = 1.04
(-69%, -88%), RR2 = 1.15 (+10%, -56%), RR2 = 1.25 (+73%, -30%), and RR2 = 1.35 (+131%, -7%).
The total ETS-attributable LCD estimates range from 380 (at RR2 = 1.04, Z = 3.0) to 7,060 (at
RR2 = 1.35, Z = 1.5).  Without considering the additional variability that other parameters might
add, it is apparent that the estimated lung cancer mortality from ETS is very sensitive to the
parameters RR2 and Z and that the uncertainty in these parameters  alone leaves a fairly wide
range of possibilities for the true population risk.
        While various extreme values of these parameters can lead to the large range of estimates
noted, the extremities of this range are less likely possibilities for the true population risk because
the parameters RR2 and Z are not actually independent and would be expected to co-vary in the
same direction, not in the  opposite direction as expressed by the extreme values.  For example, if
the contributions of background to total  ETS exposure decrease, Z would increase, and the
observable relative risk from spousal exposure, RR2, would be expected to increase as well. In
addition, most of the evidence presented in this report suggests that a narrower range of both RR2
and Z are appropriate. Thus, while substantially higher or lower values are conceivable, this
report concludes that the estimate of approximately 3,000 ETS-attributable LCDs based on the 11
U.S. studies is a reasonable one. Furthermore, this estimate is well corroborated by the estimates
of 2,700 and 3,600 calculated by analyzing the FONT data alone, the only study dataset from
which estimates of both RR2 and Z are obtainable.

6.4.  SUMMARY AND CONCLUSIONS ON POPULATION RISK
        Having concluded in the previous chapter that ETS is causally associated  with lung cancer
in humans and belongs in EPA Group A of known human carcinogens, this chapter assesses the
magnitude of that health impact in the U.S. population. The  ubiquity of ETS in a typical
individual's living environment results in the respiratory uptake of tobacco  smoke to some degree
in a very high percentage of the adult population, conservatively upwards of 75%  based on the
outcome of urinary cotinine/creatinine studies in nonsmokers.  Compared with observations on
active smokers, body cotinine levels in nonsmokers are low, on the order of a few percent, and
there is  considerable variability in interindividual metabolism of nicotine to cotinine.  Some
authors  have used the relative cotinine levels in active and passive smokers  to estimate the
probability of lung cancer in nonsmokers by extrapolating downward on a dose-response curve for
active smokers. This "cigarette-equivalents" approach requires several assumptions, e.g., that the
dose-response curve used for active smokers is reasonably accurate and low-dose extrapolation of
risk for active smokers is credible, that cotinine  is proportional (and hence a substitute for)
                                           6-29

-------
whatever is used for "dose" in the dose-response curve, and that the risk calculated in this way
applies equally to active and passive smokers with equivalent cotinine measures.  The effect of
differences in physico-chemical properties of mainstream smoke and sidestream smoke (the
principal component of ETS), in lung dosimetry between active and passive smoking, and in
exposure patterns (related to concentration and duration of exposure) are not fully understood,  but
the current state of knowledge casts doubts on the validity of these assumptions.
        The remaining approach to population risk extrapolates to the general population from
the epidemiologic evidence of increased relative risk of lung cancer in never-smoking women
married to smokers.  To extrapolate exposure and consequent risk to other sources of ETS
exposure, cotinine levels of never-smokers exposed to spousal ETS are compared with those of
never-smokers exposed only to other sources of ETS (background), and it is assumed that excess
risks of lung cancer from ETS exposures, using cotinine levels as a surrogate measure, are
proportional to current ETS exposure levels.  (Here, cotinine levels are used to gauge relative
levels of ETS exposure, not to extrapolate between active  and passive smoking as in the
"cigarette-equivalents" approach.) The use of current cotinine data to estimate ETS exposure in
nonsmokers seems reasonable because cotinine levels correlate quite well with questionnaire
response on ETS exposure. However, the total estimate of population risk is sensitive to
uncertainty in making these assumptions and variability in the use of cotinine measures.
        This report uses the modeling approach based on  direct ETS epidemiologic evidence
because the assumptions are fewer and more valid than for the "cigarette-equivalents" approach,
and the abundance of human data from actual environmental exposures makes this preferred
approach feasible.  The total number of lung cancer deaths in U.S. females from all causes is
partitioned into components attributable to non-tobacco-smoke-related causes (background causes
unrelated to active or passive smoking), background ETS (also called nonspousal ETS), spousal
ETS, and ever-smoking.  Two sets of calculations are made for the U.S. female population age 35
and over in 1985 based on parameter values from national statistics and estimates from the
epidemiologic  studies on ETS and lung cancer. They differ in the values assumed for two
parameters in the formulae for attributable risk: RR2, the relative risk of lung cancer for never-
smokers exposed to spousal smoke, and Z, the ratio of cotinine concentrations in never-smokers
exposed to spousal ETS to those exposed to background ETS only. The first analysis uses the
pooled estimate of RR2 from the 11 U.S. studies from Chapter 5, and a subjective value of Z
based on the outcomes of independent U.S. cotinine studies (RR2 = 1.19 and Z = 1.75).  The
second analysis uses the estimates of RR2 and Z from the large, high-quality Fontham et al. study
                                           6-30

-------
(1991), the sole U.S. study that collected cotinine data for its study population (RR2 = 1.28 with
mean Z = 2.0 and with median Z = 2.6).
        The estimated lung cancer mortality in never-smoking women from ETS (background and
spousal ETS) is 1,500 in the first analysis and 1,760 (1,340) in  the second analysis for Z = 2.0 (2.6).
When estimates for never-smoking males and former smokers  (5+ year quitters) of both sexes are
added, the corresponding totals are 3,060 and 3,570 (2,670). All of these figures are based on
calculations in which unknown parameter values are replaced with numerical estimates that are
subject to uncertainty, and departures in either direction cannot be precluded as unrealistic
possibilities for the correct population risks.  Nonetheless, because of the large database utilized
and the extensive analysis performed, there is a high degree of confidence in the estimates derived
for female never-smokers. The figures for male never-smokers and  former smokers of both sexes
are subject to more uncertainty because more assumptions were necessary for extrapolation from
the epidemiologic results.  The estimates for male never-smokers, in  particular, may be on the low
side because males generally are exposed to higher levels of background ETS  than females.  In
summary, our analyses support a total of approximately 3,000  as an estimate for the annual U.S.
lung cancer deaths in nonsmokers attributable to ETS exposure.
        A quantitative estimate of the variance associated with the 3,000 estimate is not possible
without many assumptions, both  about the model and the accuracy of the parameters used to
derive the population estimates.  As exhibited in Tabje 6-6, we believe the  largest variability to be
associated with RR2 and Z.  Based on the statistical variations, estimates as  low as 400 and as high
as 7,000 are possible.  However, where specific assumptions were made, we believe that they are
generally conservative, and we expect that the actual number may be greater  than 3,000.
        A feature of variability not addressed in the range presented above is the correlation
between RR2 and Z.  The greater the correlation, the smaller will be the expected variance of
RR02, resulting in a narrower range of lung cancer estimates.  Because only one lung cancer study,
FONT, allows RR2 and Z to be jointly estimated, no assessment of this correlation is possible.
However, the two point estimates derived from the FONT data--2,700 and 3,600—provide
additional reassurance in the 3,000 estimate.
        In conclusion, despite some unavoidable uncertainties, we believe these estimates of ETS-
attributable lung cancer mortality to be fairly reliable, if not conservatively low, especially with
respect to the male nonsmoker component. First, the weight of evidence that ETS is a human lung
carcinogen is very strong. Second, the estimates are based on a large amount  of data from various
studies of human exposures to actual environmental  levels of ETS. They do not suffer from a
need to extrapolate from an animal species to humans or from high to low exposures, as is nearly
always the case in environmental quantitative health risk assessment.  Thus, the confidence in
                                           6-31

-------
these estimates is judged to be medium to high. In summary, the evidence demonstrates thjat ETS
has a very substantial and serious public health impact.
                                           6-32

-------
     7. PASSIVE SMOKING AND RESPIRATORY DISORDERS OTHER THAN CANCER

7.1.  INTRODUCTION
       In 1984, a report of the Surgeon General identified cigarette smoking as the major cause
of chronic obstructive lung disease in the United States (U.S. DHHS, 1984). The same report
stated that there is conclusive evidence showing that smokers are at increased risk of developing
respiratory symptoms such as chronic cough, chronic phlegm production, and wheezing (U.S.
DHHS;, 1984). More recently, longitudinal studies have demonstrated accelerated decline in lung
function in smoking adults (Camilli et al., 1987). In children and adolescents who have recently
taken up smoking, several cross-sectional studies have found statistically significant increases in
the prevalence of respiratory symptoms (cough, phlegm production, and dyspnea [i.e., shortness of
breath]) (Seely et al., 1971; Bewley et al., 1973). Longitudinal studies also have demonstrated that,
among young teenagers, functional impairment attributable to smoking may be found after as
little as 1 year of smoking 10 or more cigarettes per week (Woolcock  et al., 1984).
       From a pathophysiologic point of view, smoking is associated with significant structural
changes in both the airways and the pulmonary parenchyma (U.S. DHHS, 1984). These changes
include hypertrophy and hyperplasia of the upper  airway mucus glands, leading to an increase in
mucus production, with an accompanying increased prevalence  of cough and phlegm.  Chronic
inflammation of the smaller airways leads to bronchial obstruction.  However, airway narrowing
also may be due to the destruction of the alveolar walls and the  consequent decrease in lung
elasticity and development of centrilobular emphysema (Bellofiore et al., 1989). Smoking also may
increase mucosal permeability to allergens. This may result in increased total and specific IgE
levels (Zetterstrom et al., 1981) and increased blood eosinophil counts (Halonen et al., 1982).
       The ascertained consequences of active  smoking on respiratory health, and the fact that
significant effects have been observed at relatively low-dose exposures, lead to an examination for
similar effects with environmental  tobacco smoke (ETS).  Unlike active smoking, involuntary
exposure to ETS (or "passive smoking") affects individuals of all ages, particularly infants and
children. An extensive analysis of respiratory effects of  ETS in children suggests that the lung of
the young child may be particularly susceptible to  environmental insults (NRC, 1986). Exposures
in early periods of life during which the lung is undergoing significant growth and remodeling
may alter the pattern of lung development and  increase the risk for both acute  and chronic
respiratory illnesses.
       Acute respiratory illnesses are one of the leading  causes  of morbidity and mortality during
infancy and childhood.  One-third of all infants have at least one lower respiratory tract illness
(bronchitis, bronchiolitis, croup, or pneumonia) during the first year of life (Wright et al., 1989),
                                            7-1

-------
whereas approximately one-fourth have these same illnesses during the second and third years of
life (Gwinn et al., 1991).  The high incidence of these potentially severe illnesses has an important
consequence from a public health viewpoint:  Even small increases in risk due to passive exposure
to ETS would considerably increase the absolute number of cases in the first 3  years of life (see
Chapter 8). In addition, several studies have shown that lower respiratory tract illnesses occurring
early in life are associated, with a significantly higher prevalence of asthma and other chronic
respiratory diseases and with lower levels of respiratory function later in life (reviewed
extensively by Samet and  collaborators [1983]).
       This chapter reviews and analyzes epidemiologic studies of noncancer respiratory system
effects of passive smoking, starting with possible biological mechanisms (Section 7.2).  The
evidence indicating a relationship between exposure to ETS during childhood and acute
respiratory illnesses (Section 7.3), middle ear diseases (Section 7.4), chronic respiratory symptoms
(Section 7.5), asthma (Section 7.6), sudden infant death syndrome (Section 7.7), and lung function
impairment (Section 7.8) is evaluated.  Passive smoking as a risk factor for noncancer respiratory
illnesses and lower lung function in adults also is analyzed (Section 7.9). A health hazard
assessment and population impact is presented in the next chapter.

7.2.  BIOLOGICAL MECHANISMS
7.2.1.  Plausibility
       It is plausible that  passive smoking may produce effects similar to those known to be
elicited by active smoking. However, several differences both between active and passive forms
of exposure and among the individuals exposed to them need to be considered.
       The concentration  of smoke components inhaled by subjects exposed to ETS is small
compared with that from active smoking.  Therefore, effect will be highly dependent on the
nature of the dose-response curve (NRC, 1986). It is likely that there is a distribution of
susceptibility to  the effects of ETS that may depend on, among other factors, age, gender,  genetic
predisposition, respiratory history, and concomitant exposure to other risk factors for the
particular outcome being studied. The ability to ascertain responses to very low concentrations
also depends on the reliability and sensitivity of the instruments utilized.
       Breathing patterns for the inhalation of mainstream smoke (MS) and ETS differ
considerably; active smokers inhale intensely and intermittently and usually hold their breath for
some time at the end of inspiration. This increases the amount of smoke components that are
deposited and absorbed (U.S. DHHS, 1986).  Passive smokers inhale with tidal breaths  and
continuously.  Therefore,  patterns of particle deposition and gas diffusion and  absorption differ
considerably for these two types of inhalation.
                                             7-2

-------
       There are also important differences in the physicochemical properties of ETS and MS (see
Chapter 3). These have been extensively reviewed earlier by the National Research Council
(NRC, 1986) and the Surgeon General (U.S. DHHS, 1986). ETS is a combination of exhaled MS,
sidestream smoke (that is, the aerosol that is emitted from the burning cone between puffs), smoke
emitted from the burning side of the cigarette during puffs, and gases that diffuse through the
cigarette paper into the environment.  This  mixture may be modified by reactions that occur in
the air before involuntary inhalation.  This  "aging" process includes volatilization of nicotine,
which is present in the particulate phase in  MS but is almost exclusively a component of the vapor
phase of ETS.  Aging of ETS also entails a decrease in the mean diameter of its particles from 0.32
/un to 0.1-0.14  /tm, compared to a mean particle diameter for MS of 0.4 /on (NRC, 1986).
       Individual and socioeconomic susceptibility may be important determinants of possible
effects of ETS on respiratory health. A self-selection process almost certainly occurs among
subjects who experiment with cigarettes, whereby those more susceptible to the irritant or
sensitizing effects of tobacco smoke either never start or quit smoking (the so-called "healthy
smoker" effect). Infants, children, and nonsmoking adults thus may include a disproportionate
number of susceptible subjects when compared with smoking adults. In addition, recent studies
clearly have shown that, as incidence and prevalence of cigarette smoking has decreased, the
socioeconomic characteristics of smokers also have changed. Among smokers, the proportion of
subjects of lower educational level  has increased in the past 20 years (Pierce et al., 1989). The
female-to-male ratio also has increased (Fiore et al.,  1989), and this is particularly true for young,
poor women, in whom incidence and prevalence of smoking has increased (Williamson et al.,
1989).  It is thus possible that exposure to ETS may be most prevalent today among precisely those
infants and children who are known to be at a high risk of developing respiratory illnesses early in
life.

7.2.2. Effects of Exposure In Utero and During the  First Months of Life
       A factor that may significantly modify the effect of passive smoking (particularly in
children) is exposure to tobacco smoke components by the fetus during pregnancy.  This type of
exposure differs considerably from passive smoking;  in fact, the fetus (including  its lungs) is
exposed to components of tobacco smoke that are absorbed by the mother and that cross the
placental barrier, whereas passive smoking directly affects the bronchial mucosa and the alveolus.
It is difficult to distinguish between the possible effects of smoking during pregnancy and those
of ETS exposure after birth.  Some  women may quit smoking during pregnancy, only to resume
after pregnancy is over.  Most mothers who  smoke during pregnancy continue smoking after the
birth of their child (Wright et al., 1991), and among those who stop smoking after birth, the
                                           7-3

-------
influence on that decision of events occurring shortly after birth (such as respiratory illnesses in
their child) cannot be excluded. Recall bias also may influence the results of retrospective studies
claiming differential effects on lung function of prenatal and postnatal maternal smoking habits
(Yarnell and St. Leger, 1979).
       To attempt to circumvent these problems, researchers have studied infant lung function
shortly after birth (the youngest group of infants reported was 2 weeks old [Neddenriep et al.,
1990]), with the  implication that subsequent changes encountered could be attributed mainly to
ETS exposure. However, the possibility that even brief exposure to ETS may affect the lungs at a
highly susceptible age may  not be discarded. Maternal smoking during pregnancy needs to be
considered, therefore, as a potential modifier of the effect of passive smoking on respiratory
health, particularly in children.
       Exposure to compounds present in tobacco smoke may affect the fetal and neonatal lung
and alter lung structure much like these  same compounds do in smoking adults.  Neddenriep and
coworkers (1990) studied 31 newborns and reported that those whose mothers smoked during
pregnancy had significant increases in specific lung compliance (i.e., lung compliance/lung
volume) at 2 weeks of age when compared with infants of nonsmoking mothers. The authors
concluded that exposure to  tobacco products detrimentally affects the elastic properties of the
fetal lung.  Although these  effects also could be attributed to postnatal  exposure to ETS, it is
unlikely that such a brief period of postnatal exposure would be responsible for these changes
affecting the lung parenchyma (U.S. DHHS, 1986).
       There is  evidence for similar effects of prenatal lung development in animal models.
Collins and associates (1985) exposed pregnant rats to MS during day 5 to day 20 of gestation.
They found that pups of exposed rats showed reduced lung volume, reduced number of lung
saccules, and reduced length of elastin fibers in the lung interstitium. This apparently resulted in
a decrease in lung elasticity: For the same inflation pressure, pups of exposed mothers had
significantly higher weight-corrected lung volumes than did pups of unexposed mothers. Vidic
and coworkers (1989) exposed female  rats for 6 months (including mating and gestation) to MS.
They found that lungs of their 15-day-old pups had less parenchymal tissue, less extracellular
matrix, less collagen, and less elastin than found in lungs of control animals. This may explain the
increased lung compliance  observed by Collins et al. (1985) in pups exposed to tobacco smoke
products in utero.
        Hanrahan and coworkers (1990)  reported that infants born to smoking mothers had
significantly reduced levels of forced expiratory flows. The researchers studied 80 mother/child
pairs and found significant correlations  between the cotinine/creatinine ratio in urine specimens
obtained during pregnancy in the mother and maximal expiratory flows and tidal volumes at a
                                            7-4^

-------
 postconceptional age of 50 weeks or younger in their children.  The investigators concluded that
 exposure due to prenatal smoking diminishes infant pulmonary function at birth and, by
 inference, airway size. These authors also measured maximal flows during tidal breathing in their
 subjects. At rather low lung volumes, such as those present during tidal breathing, airway size
 and maximal flows are both a function of lung elasticity. These results thus may be due to both a
 specific alteration of the infant's airways and an increased lung compliance in infants whose lungs
 are small relative to the infant's length.
        It also has been suggested that the increased IgE levels observed in adult smokers also may
 be present in fetuses whose mothers smoke during pregnancy.  Magnusson (1986) reported that
 cord serum levels of IgE and IgD were significantly higher for neonates whose mothers smoked
 during pregnancy, particularly if the  neonates had no parental history of allergic disorders.  Cord
 serum levels of IgD (but not of IgE) were increased for neonates whose fathers smoked, and this
 effect was independent of maternal smoking. A more recent study on a larger sample (more than
 1,000 neonates) failed to find any significant difference in cord serum IgE levels between infants
 (N = 193) of mothers who smoked during pregnancy and those (N = 881) of mothers who did not
 (Halonen et al., 1991).
        It also has been reported recently that the pulmonary neuroendocrine system may be
 altered in infants whose mothers smoke during pregnancy. The pulmonary neuroendocrine
 system, located in the tracheobronchial tree, consists of specialized cells (isolated or in clusters
 called "neuroepithelial bodies")  that are closely related to nerves.  In humans, these cells increase
 in number significantly during intrauterine development, reach a maximum around birth,  and
 then rapidly decline during the first 2 years of life. Their function is not well understood, but the
 presence of potent growth factors and bronchoconstrictive substances in their granules suggests
 that they play an important role in growth regulation  and airway tone control during this period,
 of lung development (Stahlman and Gray, 1984). Chen and coworkers (1987) reported that
 maternal smoking during pregnancy increases the size of infant lung neuroepithelial bodies and
 decreases the amount of core granules present in them. Wang and coworkers (1984) had reported
 previously that mother mice receiving tap water with  nicotine during pregnancy and during
 lactation had offspring with increased numbers of neuroepithelial bodies at 5 days of age when
 compared with baby mice whose mothers were not exposed.  Baby  mice exposed to nicotine only
 during pregnancy had neuroepithelial bodies of intermediate size with respect to these two groups,
whereas those exposed only during lactation had neuroepithelial bodies of normal size. By age 30
days, only baby mice exposed to nicotine  during both pregnancy and lactation had neuroepithelial
bodies that were larger than those of control animals.
                                            7-5

-------
       Activation of the pulmonary neuroendocrine system is not limited to ETS exposure; it is
activated by active smoking as well. Aguayo and collaborators (1989) reported that
bronchoalveolar lavage fluids obtained from healthy smokers have increased levels of
bombesin-like peptides, which are a normal component and a secretion product of human lung
neuroendocrine cells (Cutz et al., 1981).
       In summary, effects of maternal smoking during pregnancy on the fetus are difficult to
distinguish from those elicited by early postnatal exposure to ETS.  Animal studies suggest that
postnatal exposure to tobacco products enhances the effects of in utero exposure to these same
products.

7.2.3. Long-Term  Significance of Early Effects on Airway Function
       By altering  the structural and functional properties of the lung, prenatal exposure to
tobacco smoke products and early postnatal exposure to ETS increase the likelihood of more
severe complications during viral respiratory infections early in life.  Martinez and collaborators
(1988a) measured lung function before 6 months of age and before any lower respiratory illness in
 124 infants.  They found that infants with  the lowest levels for various indices of airway size were
three to nine times more likely to develop wheezing respiratory illnesses during the first year of
 life than the rest of the population. The same authors (Martinez et al., 1991) subsequently showed
 that, in these same infants with lower initial levels of lung function, recurrent wheezing illnesses
 also were more likely to occur during the first 3 years of life. A similar study performed in
 Australia (Young et aL, 1990) confirmed that infants who present episodes of coughing and
 wheezing during the first 6 months of life  have lower maximal expiratory flows before any such
 illnesses develop.
        The increased likelihood of pulmonary complications during viral respiratory infections in
 infants of smoking parents has important long-term consequences for the affected individual.
 There is considerable evidence suggesting that subjects with chronic obstructive lung diseases have
 a history of childhood respiratory illnesses more often than subjects without such diseases
 (reviewed by Samet and coworkers [1983]). Burrows and collaborators (1988) found that active
 smokers without asthma (N = 41) who had a history of respiratory troubles before age 16 years
 showed significantly steeper declines in FEV1 (as a percentage of predicted) after the age of 40
 than did  nonasthmatic smokers without such a history (N = 396). Although these results may have
 been influenced by recall bias, they suggest that lower respiratory tract illnesses during a period of
 rapid lung development may damage the lung and increase the susceptibility to potentially
 harmful environmental stimuli.
                                             7-6

-------
        There is no information available on the degree of reversibility of changes induced by
 exposure to ETS during early life.  Longitudinal studies of lung function in older children have
 shown, however, that diminished levels of lung function are found in children of smoking parents
 at least until the adolescent years.

 7.2.4. Exposure to ETS and Bronchial Hyperresponsiveness
        Bronchial hyperresponsiveness consists of an enhanced sensitivity of the airways to
 pharmacologic or physical stimuli that normally produce no changes or only small decreases  in
 lung function in normal individuals. Subjects with bronchial hyperresponsiveness have significant
 drops in airway conductance and maximal expiratory flows after inhalation of stimuli such as cold
 air, hypertonic saline, nebulized distilled water, methacholine, or histamine.  Bronchial
 hyperresponsiveness is regarded as characteristic of asthma (O'Connor et al.,  1989) and may
 precede the development of this disease in children (Hopp et al.,  1990). It has also been
 considered as a predisposing factor  for chronic airflow limitation in adult life (O'Connor et al.,
 1989).
       Recent studies of large population samples have shown that active smokers have increased
 prevalence of bronchial hyperresponsiveness (Woolcock et al., 1987; Sparrow et al., 1987;  Burney
 et al., 1987) when compared with nonsmokers. This relationship seems  to be  independent of other
 possible determinants of bronchial hyperresponsiveness (O'Connor et al., 1989).  However, one
 large study of almost 2,000 subjects from a general population sample failed to find a significant
 relationship between smoking  and prevalence of bronchial hyperresponsiveness (Rijcken et al.,
 1987). The subjects involved in the latter study were younger and were therefore exposed to a
 smaller average cumulative pack-years of smoking than were the  subjects of studies in  which a
 positive relationship was found.  This suggests that the relationship may be evident only among
 individuals with a high cumulative exposure.
       Epidemiologic studies have demonstrated that exposure to ETS is associated with an
 increased prevalence of bronchial hyperresponsiveness in children.  Murray and Morrison (1986),
 in a cross-sectional study, reported that asthmatic children of smoking mothers were four times
 more likely to show increased responsiveness to histamine than were asthmatic children of
 nonsmoking mothers.  O'Connor and coworkers (1987),  in a study of a general population sample,
 found a significant association between maternal smoking and bronchial hyperresponsiveness (as
assessed with eucapnic hyperpnea with subfreezing air)  among asthmatic children, but not among
nonasthmatic children (Weiss et al., 1985).  Martinez and coworkers (1988b) reported a fourfold
increase in bronchial responsiveness  to carbachol among male children of smoking parents when
compared with male children of parents who were both  nonsmokers.  A smaller (and statistically
                                           7-7

-------
not significant) increase in bronchial responsiveness was reported in girls. These authors also
found that the effect of parental smoking was stronger in asthmatic children, and results were still
significant after controlling for this factor in a multivariable analysis.  Because only a small
proportion of mothers in this population smoked during pregnancy, the effect was considered to
be associated mainly with exposure to ETS in these children. Lebowitz and Quackenboss (1990)
showed that odds of having bronchial reactivity (as assessed by the diurnal variability in maximal
expiratory flow rate) were 3.6 times as high among 18 children aged 15 years and younger who
lived with persons who smoked more than 20 cigarettes per day than among 62 children of the
same age who lived with nonsmokers (95% C.I. = 1.2, 10.6).  Children living with smokers of 1 to
20 cigarettes per day had a prevalence of bronchial reactivity that was similar to that of children
living with nonsmokers.
        Therefore, there is evidence indicating that parental smoking enhances bronchial
responsiveness in children. The mechanism for this effect and the possible role of atopy in it are
unknown. The doses required to enhance bronchial responsiveness in children exposed to ETS are
apparently much lower than those required to elicit similar effects among adult active  smokers.  A
process of self-selection, by which adults who are more sensitive to the effects of tobacco smoke
do not start smoking or quit smoking earlier, may explain this finding. Variations in bronchial
responsiveness with age also may be involved (Hopp et al.,  1985).
        Increased bronchial responsiveness may be an important predisposing factor for the
development of asthma in childhood (Hopp et al., 1990). Moreover, it has been suggested that
bronchial hyperresponsiveness may have effects on the developing respiratory system that
predispose to chronic obstructive lung disease in later life (O'Connor et al., 1989). Redline et al.
(1989)  examined bronchial responsiveness to hyperventilation with cold air and its association with
growth of lung function over a 12-year period in 184 children and young adults (aged 8 to 23
years) over a maximum span of 12 years. Among subjects with persistenfpositive responses to
 cold air during followup, forced vital capacity grew faster, but forced expiratory flows grew more
slowly, than among subjects who consistently did not respond to cold air.  Among subjects with
 intermittently positive cold air responses, forced expiratory flows also grew more slowly than in
 controls, but growth of forced vital capacity was not changed. Although this study needs
 confirmation, its results suggest that bronchial hyperresponsiveness may have significant effects
 on the rate of growth of airway function and lung size in children.
                                             7-8

-------
  7.2.5. ETS Exposure and Atopy
         Atopy has been defined epidemiologically as the presence of immediate hypersensitivity to
  at least one potential allergen administered by skin prick test.  Atopy is an immediate form of
  hypersensitivity to antigens (called allergens) that is mediated by IgE immunoglobulin. Allergy (as
  indicated by positive skin test reactivity to allergens, high levels of circulating IgE, or both) is
  known to be present in almost all cases of childhood asthma.  Recent epidemiologic studies have
  indicated that an IgE-mediated reaction may be necessary for the occurrence of almost all cases of
  asthma at any age (Burrows ~et al., 1989).
        Although genetic factors appear to play a major role in the regulation of IgE production
  (Meyers et al., 1987; Hanson et al., J991), several reports have indicated that active smoking
  significantly  increases total serum IgE concentrations and may thus influence the occurrence of
  allergy (Gerrard et al., 1980; Burrows et al., 1981; Zetterstrom et al.,  1981; Taylor et al., 1985).
  Active smokers also have been found to have higher eosinophil counts and increased prevalence of
 eosinophilia when compared with nonsmokers (Kauffmann et al., 1986; Halonen et al., 1982;
 Taylor et al.,  1985).  The physical and chemical similarities between MS and ETS have prompted
 the investigation of a possible role of passive smoking in allergic sensitization in children.
        Weiss and collaborators (1985) first reported a 2.2-fold increased risk of being atopic in
 children of smoking mothers. Martinez and coworkers (1988b) confirmed that children of
 smoking parents were significantly more likely to be atopic than were children of nonsmoking
 parents, and the researchers reported that this association was stronger for male children.  They
 also found a rough dose-response relationship between the number  of cigarettes  smoked by
 parents and the intensity of the skin reactions to a battery of allergens.  Ronchetti and
 collaborators (1990) extended these findings in the same population sample of Martinez and
 coworkers.  They found that total serum IgE levels and eosinophil counts were significantly
 increased in children  of smoking parents, and the effect was related to both maternal and paternal
 smoking.
        It is relevant to note that, due to the so-called "healthy smoker effect," children of  smokers
 should be genetically  less sensitive than children of nonsmokers,  because the latter are likely to
 include a disproportionate number of allergic subjects who are very sensitive to the irritant effects
 of smoke.  As a consequence, the atopy-inducing effects of ETS  may be substantially
 underestimated.
       In summary, there is convincing evidence that both  maternal smoking during pregnancy
and postnatal exposure to ETS alter lung function and structure, increase bronchial
responsiveness, and enhance the process of allergic sensitization.  These changes elicited by
exposure to tobacco products may predispose children to lower respiratory tract illnesses early in
                                            7-9

-------
life and to asthma, lower levels of lung function, and chronic airflow limitation later in life.  Most
of these same effects have been described for active smoking in adults. These smoke-induced
changes are, therefore, known biological mechanisms for the increased prevalence of respiratory
diseases associated with ETS exposure described later in this chapter.
       Exposure to tobacco smoke products during pregnancy and to ETS soon after birth may be
the most important preventable cause of early lung and airway damage leading to both lower
respiratory illness in early childhood and chronic airflow limitation later in life.

7.3.  EFFECT OF PASSIVE SMOKING ON ACUTE RESPIRATORY ILLNESSES IN
      CHILDREN
       A review of the literature that examined the effects of exposure to ETS on the acute
respiratory illness experiences of children was contained in the Surgeon General's report on the
health consequences of involuntary smoking (U.S. DHHS, 1986) and in the report on
environmental tobacco smoke by the NRC (1986).  Table 7-1 shows the studies referenced in these
two reports.
        The Surgeon General's report concluded that "the results of these studies show excess acute
respiratory illness in children of parents who smoke, particularly in children under 2 years of
age," and that "this pattern is evident in studies conducted  with different methodologies and in
different locales" (page 44). It estimated that the increased risk of hospitalization for severe
bronchitis or pneumonia ranged from 20% to 40% during the first year of life. The report stated
 that "young children appear to  be a more susceptible population for the adverse effects of
 involuntary smoking than older children and adults" (page 44). Finally, the report suggested that
 "acute respiratory illnesses during childhood may have long-term effects on lung growth  and
 development, and might increase the susceptibility to  the effects of active smoking and to the
 development of chronic lung disease" (page 44).
        The 1986 NRC report observed that "all the studies that have  examined the incidence of
 respiratory illnesses in children under the age of 1 year have shown a positive association between
 such illnesses and exposure to ETS. The association is very unlikely to have arisen by chance"
 (page 208). It pointed out that "some of the studies have examined the possibility that the
 association is indirect by allowing for confounding factors ... and have concluded that such
 factors do not explain the results. This argues, therefore,  in favor of a causal explanation" (page
 208). The report concluded that "bronchitis, pneumonia, and other lower-respiratory-tract
 illnesses occur  up to twice as often during the first year of life in children who have one or more
 parents who smoke than  in children of nonsmokers" (page 217).
                                             7-10

-------
    Table 7-1.  Studies on respiratory illness referenced in the Surgeon General's and National
    Research Council's reports of 1986
Study
Cameron et al. (1969)
Colley(1971)
Colley (1974)
Dutauetal. (1981)
Fergusson et al. (1981)
Leeder et al. (1976)
Pedreira et al. (1985)
Pullan and Hey (1982)
Rantakallio (1978)
Speizer et al. (1980)
Ware et al. (1984)
No. of
subjects
158
2,205
1,598
892
1,265
2,149
1,144
130
3,644
8,120
8,528
Age of subjects
Children (6 to 9)
Infants
Children (6 to 14)
Infants/children
(0 to 6)
Infants
Infants
Infants
Children (10 to 11)
Infants/children
(0 to 5)
Children (6 to 10)
Children (5 to 9)
Surgeon
General
X
X


X
X
X
X
X
X
X
NRC


X
X
X
X
X

X
X

7.3.1. Recent Studies on Acute Lower Respiratory Illnesses
       Several recent studies not referenced in the Surgeon General's report or in the NRC report
have addressed the relationship between parental smoking and acute lower respiratory illnesses in
children (see Table 7-2).
       Chen and coworkers (1986) studied 1,058 infants out of 1,163 infants born in a given
period in two neighborhoods in Shanghai, People's Republic of China. Information on hospital
admissions from birth to 18  months, smoking habits of household members, parental education,
and social and living conditions was obtained by use of a self-administered questionnaire
completed by the parents when the child reached 18 months of age.  Hospital admissions were
divided into those due to respiratory illness and those from all other conditions. None of the
mothers in the study smoked. There was no statistically significant association between exposure
to ETS and admission to the hospital for any condition other than respiratory illnesses.  Compared
with nonsmoking households, the risk of being admitted to a hospital for respiratory illnesses was
17% higher when one to nine cigarettes were smoked daily by household members (95% C.I. =
                                           7-11

-------
      8!
               >
                                          . i-<
                                         *? o
                                 u

                                  O. a>
                     •all.^11 «
                     TI o -s a o D. sj

                          1,«« § ^
                          H O l-c •-<
                                                     4>
                                                     00
                                                     Ctf

                                                     a
                                                      -
CO
V
CO
CO


g
I
>,


I
o.
CO
2


1

I
o
a
§

3
^

I
£
o.

(M
O
     -I
      3
     is
     o. »
     x €
     » s
     *»v CO
     JO (B
            00 c?^

            ^••TJ P
            II
la-Si
|SS2
o o x-^1-1

P'lSl

!•§:-
ass^
           d
               !£•
§-

°co
HH  •
*C

^-.
e c^


§i
5'g
                                 CN
                                 IS CT\
                               oa\
                               y-< I CT\

                               U -H A
                                                     §
                                                     o
                                                     u
           i—i d

           1-2

           S S


           II
                               • fH __. X 1-d

                               .a .§ 2 a f

                               H&£1
                               <.§ 2 a a
                                   • **  Q

                               ,' Tt 2   fi "O
                               c*-( j^ *-<   C i—i

                               *S 9r "3 ,. . co O
                               "
                                       £

                      s s s s «L
                      3 ^ s 3 .5?
                     PL, S cr d o
                                      co O


                                        "
                                         -2
                                         S
 0)
CM
 O
 co
 0>



1
 u
•»-l

 g>

.2




I
 v

 a

 8

 ^
      *a :
       §

       i
                          55 4J

                          •a S
                          « TJ

                          •as
                          8 c
                          43 «>


                     §11 S3


                     liil;
                     00 O O 00 3
                     V> CM O >rt T3
                               .a
                           *3 .   00
                      d
                      O «)
                      f*t d


                      s8
                      «2.-

                      15
                        oo
                                oo
                                o

       •£ • a> oo

           22
           « Ci
                                d
                                o>


                                U
                              7-12

-------
•o
1


f
o





Is
1

V3j
£>
*c
^
1
a
o
d
O
S
i?
x^ Cj
t| i

•o
(O
^g
*•»
e
o
1
a
o
p-



1
•5
0
<
a> >,
00 +f • £ 9 o

. ^
fl> f^. CNJ
<4H • • • •
*TH i^ > ® ^ cs «•<
O ;« O O ;2 § O
 •»-



>
O
CO
C3
CU
CO
>
o
•8
I
C3
co




o

C3
3
CU
i
A


oo
£2,
cj
gj
U



CO
' 73
5 co ^

ijufiv — j.t iur i]
breast-fed babi
confidence inte
not calculable





























                                                                                      CD


                                                                                      I
                                                                                      00

                                                                                      .S

                                                                                      o
                                                                                      o
                                                                                      §
                                                                                      o
                                                7-13

-------
r
                g

               •^
                C
                O
                o

Observations
                       1
                       1
••2
3

!

I
s
exposure

ssment
ETS
e
                        T»
                        a>
                        w


                        •g


                        ^

                        •3
                        Q,
 52

 S
                                                                  •cf
                                                                                  it
                            O "*
       —

     03 If

     S " o S
                            d
                            o
                                                           ON
                                    s
                              g to «« (S
                             •a "*• * °°-
                              S — g —
                                                           a

                                                            1
                                                                                        

                                                                          I
                                                                          oo
                                                                         .s

                                                                         ^o

                                                                         I
                                                                          «
                                       o


                                      I
                                       +•*
                                       a
                                       8
                              o   -3

                             ifr-s
                                o ,/s
                                                          §s
                                                            &S  2
                                                            oo
                                                                                     £i 0)
                              "3 «»
                              0  ID
                            -a a  oo
                            e.2  «

                            a *3  (a
                                 J3
                                                                                   s



                                                                    •
     si 2
     S-Js
                            CO »H O
       o\
     .8 2
g  g

^
y  §>
Si§

S
M
o
                                                                                    3
                                                                                    a> S
                                                                                   co K
                                                            '•3 v

                                                            .•§ 2
                                                            'a'oo
                                                            en I-.
                                                            O O •
                                                       £ «r S
                                                       •5 S o


                                                       'S :S ^
                                                       o 5 _i

                                                       

                                                                                    4) OO
                                                                                    •O oo
                                                                                    a <^

                                                                                    •< CS
                                                        7-14

-------
•a

 I
 i
t^
s
3
4-*-
i
JO
O




la
3
to
1
I
s
O


S
to •*•*
§1

« I


1

w
o
1
Cv
S



t»
O
<-»
00-3 • Si •
d S CM W? 2 S §
^3 M\ O O O ^™* *^ *"
^•^ v ^» rt +•* c
*•* CX o "^ 5f? _** ^ fl
Cj *3 O« ® *•
O t*H *£3 SH TZ3 o O £
CO
o 1
"^ g) « ^0 ^ 00
W •- •?. r- ° .S
" .*^i ."" .C CO S
|i|'lll
O J3 S O co Q.
g> _
£^ ^3
IJlili
f«
*c
» co •—< co" CS !>
 >
CO —1 •§
™ CD **
co JS .2
p> T>
J £) Q.
T3 73 2
0 C .S

« "> "CD
1 1 « s
list
sip!
a> 3 o 3
t/5 CT 0 «
IH
O
•^
II

"S
CD £3^
.r, 5
II
f»«. n^
•* es
oo .t3
CT\
•
eS
a3
^j
oo
•c
j-ff g-a 's .
j'C tM^1 "-^d "OoS
^•S'e30°cSeo»S.2 w*MS^
HOj3Mwda>ea'25 ofH**-1
J 8 S.-J3 2. =2 c£ a§^ ZwacS

ll^
•sill
•ill3
s^-g-i
- s §1
^73^§
OO.T3 w 0
S-SCM.S
d|
«£3 o
.1 1
a .0
o **
Ec°
d y
'« 2 o d
' "« S ® S
4> CM C > 00
•S o .9 » .d
'•§.11 § "o
O s cr a §
C5
I_H
•2
oo

d
S
w t~.
, »-H
"2
1
•— '
•3

CO
n
                                                                                                                CO
                                                                                                                OJ


                                                                                                                I
                                                                                                                a

                                                                                                                e
                                                                                                                o
                                                                                                                a

                                                                                                                d
                                                                                                                • FH

                                                                                                                42
                                                                                                                1
                                                                                                                d>
                                                                                                                •a
o
o
                                                                                                                o
                                                   7-15

-------
0.6, 2.3) and was 89% higher when more than nine cigarettes were smoked daily by household
members (95% C.I. -1.1, 3.4). The authors controlled for the effects of crowding, chronic
respiratory illness in the family, father's education, type of feeding, and birthweight.
       Chen and coworkers (1988) subsequently studied 2,227 out of 2,315 children born in the
last quarter of 1983 in Chang-Ning District, Shanghai, People's Republic of China.  There were
no smoking mothers in this population. The authors reported a significant linear relationship of
total daily cigarette consumption by family members with incidence density of hospitalization for
respiratory illness and with cumulative incidence of bronchitis and pneumonia in the first 18
months of life.  The relationship was stronger for the 1- to 6-month period than for the 7- to
18-month period: When compared with households whose members did not smoke at home, the
risk of being hospitalized for  respiratory illness during the  1- to 6-month interval was three times
as high (95% C.I. =  1.6, 5.7) in households whose members smoked more than nine cigarettes at
home, whereas comparison of the same two types of household showed that the risk  of being
hospitalized for respiratory illness during the 7- to  18-month interval was only 1.8 times as high
(95% C.I. = 1.0, 3.2) in the smoking household. The relationship also was stronger among
low-birthweight infants.  Results were independent of sex, birthweight, feeding practices, nursery
care, paternal education, family history of chronic respiratory diseases, and use of coal  for
cooking.
       In a different publication based on the same data from the 1988 study, Chen (1989)
reported that the effects of passive smoking were stronger in artificially fed infants  than in
breast-fed infants.  When comparing breast-fed infants of nonsmoking and smoking families, the
risk of being hospitalized for  respiratory illness in the first 18 months of life was 1.6 times as high
for breast-fed infants of smoking families (> 19 cig./day), whereas the same risk was 3.4 times as
high among non-breast-fed infants of smoking families.
       The studies  by Chen (1989) and Chen and coworkers (1986, 1988) were retrospective in
nature and thus not immune to possible biases generated by the fact that the occurrence of the
outcome event may enhance reporting or recall of the conditions considered as risk factors.
However, conclusions are strengthened by  the finding that admissions for nonrespiratory illnesses
were unrelated to passive smoking in the study in which the relationship was assessed (Chen et al.,
1986) and by the fact that the finding  remained significant after adjusting for known
confounders.
       Breese-Hall and coworkers (1984) studied 29 infants hospitalized  with confirmed RSV
bronchiolitis before age 2, 58  controls  hospitalized for acute nonrespiratory conditions, and 58
controls hospitalized for acute lower respiratory illnesses from causes other than RSV. Cases and
controls were matched for age, sex, race, month of admission, and form of payment for
                                           7-16

-------
hospitalization. Information on smoking habits in the family was obtained at the time of each
patient's admission. Cases were 4.8 times as likely as controls (95% C.I. = 1.8, 13.0) to have one or
more household members who smoked five or more cigarettes per day. However, there was no
significant difference in the prevalence of cigarette smoking in the households of subjects with
respiratory illnesses caused by RSV and those not caused by RSV. This was attributable to the
fact that the controls with respiratory illnesses not caused by RSV were also much more likely to
live with smokers of five or more cigarettes per day than were controls with nonrespiratory
illnesses (OR = 2.7, 95% C.I. = 1.3, 5.7).  Little information is given about enrollment and refusals;
thus, it is  not possible to know if selection bias may have influenced the  results. Also, other
possible confounders such as socioeconomic level were not taken into account when matching
cases to controls or when data were analyzed.
        McConnochie and Roghmann (1986a) compared 53 infants drawn from the patient
population of a group practice in Rochester, New York, who had physician-diagnosed
bronchiolitis before age 2 years, with 106 controls from the same practice who did not have lower
respiratory illnesses during the first 2 years of life and who were matched with cases for sex and
age. Parental interviews were conducted when the child had a mean age  of 8.4 years. Parents
were asked about family history of respiratory conditions and allergy, socioeconomic status,
passive smoking, home cooking fuel, home heating methods, and household pets. Passive smoking
was defined as current and former smoking of "at least 20 packs of cigarettes or 12 ounces of
tobacco while living in the home with the subject."  Current and former  smoking was scored
equally, based on the  assumption that the report of either reflected passive smoking in the first
2 years of life. Frequency of paternal smoking was  not increased among children who had
bronchiolitis.  Cases were 2.4 times (95% C.I. =  1.2, 4.8) as likely to have smoking mothers as were
controls.  The association was stronger in families with older siblings (OR = 8.9); however, a
multiplicative test for this interaction did not reach  statistical significance. The authors studied
63% of eligible cases and 34% of eligible controls. Although the reasons  for exclusion from both
groups are detailed, selection bias cannot be excluded completely, and the authors give no
information about maternal smoking habits among excluded subjects.  Also, overreporting of
smoking by parents who were aware  of their child's history of bronchiolitis may have introduced
biases due to differential misclassification. However, the results were consistent across groups
classified according to family history of asthma or allergy, social status, presence of older siblings,
and crowding.
        Ogston and coworkers (1987) conducted a prospective study of 1,565 infants of
primigravidae enrolled antenatally in the Tayside Morbidity and Mortality Study in New Zealand.
Information on the father's smoking  habits and on the mother's  smoking habits during pregnancy
                                            7-17

-------
was obtained at the first antenatal interview and from a postnatal questionnaire.  A summary
record was completed when the child was 1 year of age and included a report of the child's
respiratory illnesses (defined as "infections of the upper or lower respiratory tract") during the
first year of life derived from observations made by health visitors during scheduled visits to see
the child. The authors used a multiple logistic regression to control for the possible  effects of
maternal age, feeding practices, heating type, and father's social class on the relationship between
parental smoking and child health. Of the 588.children of nonsmokers in this sample,  146 (24.8%)
had respiratory illnesses during the first year of life.  Paternal smoking was associated  with a 43%
increase (95% C.I. = 4.7, 96.1)  in the risk of having respiratory illnesses in the first year of life,
and this was independent of maternal smoking. The risk of having a respiratory  illness was 82%
higher (95% C.I. = 2S..6, 264.4) in infants of smoking mothers than  in infants of nonsmoking
parents.  Smoking by both parents did not increase the risk of having respiratory  illnesses beyond
the level observed in infants with smoking mothers and nonsmoking fathers. It is difficult to
compare this study with other reports on the same  issue because the authors could not distinguish
between upper and lower respiratory tract illnesses.
       Anderson and coworkers (1988) performed a case-control study of 102  infants  and young
children hospitalized in Atlanta, Georgia, for lower respiratory tract illnesses before age 2 and 199
age- and sex-matched controls. The unadjusted relative odds of having any family member
smoking cigarettes were 2.0 times as  high (p < 0.05) among cases as among controls (confidence
interval was not calculable from the reported data). The effect disappeared, however,  after
controlling for other factors (prematurity, history of allergy in the child, feeding practices,
number of persons sleeping in the same room with the child, immunization of the child in the last
month) in a multivariable logistic regression analysis.  No information is provided in this report
about maternal and paternal smoking separately, and the number of cigarettes smoked  at home by
each family member was not recorded either.  Also, almost 30% of  all target cases declined
participation in the study, and no information was available on smoking habits in the families of
these children.  No information is given about number of refusals among controls.
       Woodward and collaborators (1990) obtained information about the history of acute
respiratory illnesses in the previous 12 months on 2,125 children aged 18 months  to 3 years whose
parents answered a questionnaire mailed to 4,985 eligible families in Adelaide, Australia.  A
"respiratory score" was calculated from responses to questions regarding 13 different upper and
lower respiratory illnesses.  A total of 1,218 parents (57%) gave further consent for a home
interview.  From this total, parents of 258 cases (children whose respiratory score fell in the top
20%  of scores) and 231 "controls" (children whose scores were within  the bottom 20% of scores)
were interviewed at home.  When compared with controls, cases were twice as likely to have a
                                            7-18

-------
mother who smoked during the first year of life (95% C.I. = 1.3, 3.4).  This effect was
independent of parental history of respiratory illnesses, other smokers in the home, use of group
child care, parental occupation, and level of maternal stress and social support.  The authors found
no differences in the way smokers and nonsmokers perceived or managed acute respiratory
illnesses in their children.  Based on this finding, they ruled out that such differences could
explain their findings.  They also reported that feeding practices strongly modified the effect of
maternal smoking; among breast-fed infants, cases were 1.8  times as likely to have smoking
mothers as were controls (95% C.I. = 1.2, 2.8), whereas among non-breast-fed infants, cases were
11.5 times as likely to have smoking mothers as were controls (95% C.I. = 3.4, 38.5).
       Wright and collaborators (1991) studied the relationship between parental smoking and
incidence of lower respiratory tract  illnesses in the first year of life in a cohort of 847 white
non-Hispanic infants from Tucson,  Arizona, who were enrolled at birth and followed
prospectively.  Lower respiratory illnesses  were diagnosed by the infants' pediatricians. Maternal
and paternal smoking was  ascertained by questionnaire. For verification of smoking habits, the
researchers measured cotinine in umbilical cord serum of a sample of 133 newborns who were
representative of the population as a whole. Cotinine was detectable in umbilical cord sera of all
infants whose mothers reported smoking during pregnancy and in 7 of 100 cord specimens of
infants whose mothers said they had not smoked during pregnancy. There was a strong
relationship between cotinine level at birth and the amount that the mother reported having
smoked during pregnancy.
       Children whose fathers smoked were no more likely  to have a lower respiratory tract
illness in the first year of life than were children of nonsmoking fathers (31.3% vs. 32.2%,
respectively).  The incidence  of lower respiratory tract illnesses was 1.5 times higher (95%
C.I. = 1.1, 2.2) in infants whose mothers smoked as in infants whose mothers were nonsmokers.
This relationship became stronger when mothers who were heavy smokers were separated from
light smokers; 45.0% of children born to mothers who smoked more than 20 cigarettes per day had
a lower respiratory illness, compared with  32.1% of children whose mothers smoked 1 to 19
cigarettes per day and 30.5% of children of nonsmoking mothers (p < 0.05).  The authors tried to
differentiate the effects of maternal smoking during pregnancy from those of postnatal exposure
to ETS but concluded that the amount smoked contributed more to lower respiratory tract illness
rates than did  the time of exposure. The authors also found that maternal smoking had a
significant effect on the incidence of lower respiratory tract illnesses only for the first 6 months
of life; the risk of having a first lower respiratory illness between 6 and 12 months was
independent of maternal smoking habits. A logistic regression showed that the effect of maternal
smoking was independent  of parental childhood respiratory  troubles, season of birth, day-care
                                            7-19

-------
 use, and room sharing. Feeding practices, maternal education, and child's gender were unrelated
 to incidence of lower respiratory illnesses in this sample and were not included in the regression.
 The analysis also showed a significant interaction between maternal smoking and day-care use; the
 effects of maternal smoking were significant when the child did not use day care (OR = 2.7; 95%
 C.I. » 1.2, 5.8) but were weaker and did not reach significance among infants who used day care
 (OR = 1.9; 95% C.I. - 0.9, 4.0).  The authors suggested that day-care use may protect against lower
 respiratory illnesses by reducing exposure to ETS.
        Reese et al. (1992) studied urinary cotinine levels in 491 children, aged  1 month to 17
 years, on admission to hospital.  Children admitted for bronchiolitis had higher urinary cotinine
 levels than a group of children of similar age admitted for nonrespiratory illnesses (p < 0.02). The
 researchers concluded that there are objective data linking passive smoking to hospital admission
 for bronchiolitis in infants.
 7.3.2. Summary and Discussion on Acute Respiratory Illnesses
       Both the literature referenced in the Surgeon General's report (U.S. DHHS, 1986) and the
 NRC report (1986) and the additional, more recent studies considered in this report provide strong
 evidence that children who are exposed to ETS in their home environment are at considerably
 higher risk of having acute lower respiratory tract illnesses than are unexposed children.
 Increased risk associated with ETS exposure has been found in different locales, using different
 methodologies, and in both inpatient and outpatient settings. The effects are biologically plausible
 (see Section 7.2). Several studies also have reported a dose-response relationship between degree
 of exposure (as measured by number of cigarettes smoked in the household) and risk of acute
 respiratory illnesses.  This also supports the existence of a causal explanation for the association.
       The majority of studies found that the effect was stronger among children whose mothers
 smoked than among those whose fathers smoked. This is further evidence in favor of a causal
 explanation, because infants are generally in closer and more frequent contact  with their mothers.
 There are now also fairly convincing data showing that the increased incidence of acute
 respiratory illnesses cannot be attributed exclusively to in utero exposure to maternal smoke.  In
 fact, Chen (1989) and Chen and coworkers (1986, 1988) reported increased risk of acute
 respiratory illnesses in Chinese children living with smoking fathers and in the total absence of
smoking  mothers.  This effect also could be attributed either to in utero exposure to the father's
smoke or to an effect on the father's sperm.  This seems unlikely, however, because no such
effects of parental smoking during pregnancy have been described in similar studies performed in
Western countries. Furthermore, Woodward and coworkers (1990) found that children of smoking
mothers were significantly more prone to acute respiratory illnesses even after  mothers who
                                            7-20

-------
smoked during pregnancy were excluded from the analysis. This clearly suggests the existence of
direct effects of ETS exposure on the young child's respiratory health that are independent of in
utero exposure to tobacco smoke products.
       There is also convincing evidence that the risk is inversely correlated with age; infants
aged 3 months or less are reported to be 3.3 times more likely to have lower respiratory illnesses if
their mothers smoke 20 or more cigarettes per day than are infants of nonsmoking mothers
(Wright et al., 1991). Increases in incidence of 50% to 100% (relative risks of 1.5-2.0) have been
reported in older  infants  and young children.  The evidence for an effect of ETS is less persuasive
for school-age children, although trends go in the same direction as those reported for younger
children. This may be due to a decrease in  illness frequency, to physiological development of the
respiratory tract or immune system with age, or to a decreased  contact between mother and child
with age.
       Reasonable attempts have been made in most studies to adjust for a wide spectrum of
possible confounders. The analyses indicate that the  effects are independent of  race, parental
respiratory symptoms, presence of other siblings, socioeconomic status or parental education,
crowding, maternal age, child's sex, and source of energy for cooking. One study (Graham et al.,
1990) also showed that the effect of ETS exposure on proneness to acute respiratory illnesses in
infancy and early childhood was also independent of several indices of maternal stress, lack of
maternal social support, and family dysfunction. Other factors, such as breastfeeding, decreased
birthweight, and  day-care attendance, have been shown to modify the risk.
       Some sources of bias may have influenced the results, but it is  highly unlikely that they
explain the consistent association between acute lower respiratory illness and ETS exposure. With
one exception (Wright et al., 1991),  all studies relied exclusively on questionnaires or interviews to
assess exposure. Although  questions tend to be very specific, overreporting or more accurate
reporting of smoking habits by parents of affected children is possible, particularly in
case-control and  retrospective studies.  However, such a bias should affect both respiratory and
nonrespiratory outcomes, and at least two studies have shown no association between
nonrespiratory outcomes  and ETS exposure (Chen et  al., 1988;  Breese-Hall et al., 1984).  Selection
bias could not be excluded in some case-control studies, but satisfactory efforts were  made to
avoid this source  of bias  in most studies.

7.4. PASSIVE SMOKING AND ACUTE AND CHRONIC MIDDLE EAR DISEASES
       The Surgeon General's report (U.S.  DHHS, 1986) and the NRC report (1986) reviewed five
studies demonstrating an excess of chronic  middle ear disease in children exposed to parental
cigarette smoke (Table 7-3). Both reports conclude that the data are consistent with increased
rates of chronic ear infections and middle ear effusions in children exposed to ETS at home.
                                            7-21

-------
  Table 7-3.  Studies on middle ear diseases referenced in the Surgeon General's report
  of 1986
Study
Said et al. (1978)
Iversen et al. (1985)
Kraemer et al. (1983)
Black (1985)
Pukander et al. (1985)
No. of subjects
3,290
337
76
450
264
Age of subjects (years)
10-20
0-7
Young children
(unspecified age)
4-9
2-3
7.4.1.  Recent Studies on Acute and Chronic Middle Ear Diseases
       Several recent studies not referenced in the Surgeon General's report or in the NRC report
have addressed the relationship between parental smoking and middle ear illnesses in children
(Table 7-4).
       Fleming and coworkers (1987) examined retrospectively risk factors for the acquisition of
infections of the upper respiratory tract in 575 children less than 5 years of age.  Information on
smoking habits and on upper respiratory tract infections and ear infections in the 2 weeks prior to
interview was  obtained from the children's guardians.  The authors reported a 1.7-fold increase
(p * 0.01) in the risk of having an upper respiratory illness in children of smoking mothers when
compared with children of nonsmoking mothers. This effect was independent of feeding
practices, family income, crowding, day-care attendance, number of siblings aged less than 5
years, child's age, and race.  The authors calculated that 10% of all upper respiratory illnesses in
the population were attributable to maternal smoking, a proportion that was  comparable with that
attributable to day-care attendance. There was no relationship between maternal smoking and
frequency of ear infections in this population sample.
       Willatt (1986) studied 93 children who were the entire group of children admitted to a
Liverpool hospital for tonsillectomy (considered an index of frequent upper  respiratory or ear
infections)  during a 3-month period and 61 age- and sex-matched controls.  The median age was
6.9 years (range 1.8-14.9). Parents were asked about the number of sore throats in the previous 3
months and the smoking habits of all members of the household.  There was  a significant
                                           7-22

-------
 a>
 .3
 •a
 VH
 03
 .1
 S


 1
 •8
 TJ
 d

 I
 rt
 o
 a

 o


 o
 o

.S
xt
 S
 oo
 o
"o
•o
• ^H
a
 cu
 o

1




'. t/t
^ni
1
(U
co
•»*H
- i
l

•  S
I'M CO
5 I


.-.•


"I
'S
6A-
C3
o
i
&
£




52
o
*e
jjj
1 - a
1 00 5 co" £
S OO •> 52 «n «*1 "O
;S .S? •• co jg op Q .-So
O
o"
TT M
".
"^ 2
C- g
_, s
• w «
M oo g
g'il

>,
S
o
o
f~4
E2

«
rt i)
s-g
O ^H Wl
05 & S
all
IH
>. V-
v~i «2 i
-H a>
i "3 oo
•rt 0. 1~4 *t3
5 « vo  *
CS >— 1 g fl>
•R S .g ^
« c- 1> M
2f en - JS
f'J
CU .-i
c a
_, o
•C IH
.a <*-
1 «
oo ^^
ON o
0?
oo
^
rt
tD
o
*s
"2
H
maternal and
paternal
smoking;
small sample








91
« -r
ill
3%
•o a














3

§?









                                                                                                        eu

                                                                                                        I


                                                                                                       .1

                                                                                                        O
 a
 o

I

•S
%-»

 8
                                                        7-23

-------
-o

I
o
u




1
i
s




Is

1
'o>
1
1
i
i

4>
g _
ETS expos
assessmem



•o
•3
°*jj

o
*43
«
1






e»
M
O
*£l

<

aT K3
111!
ills
B » C8 3
00 So 0 M


O
s^*
~, g
•* eo
|| C 
co fsl
d> • M
e-i
si



N
*M
TJ
a
« ^-s
"S «?
 CO C


CM
O
T' eo
CS M»2
" •! S
^ < H
>5 TO CO
O J3 Q.
« — <
O g
•o '•£
« S3
M> CO
•a c
S ""
i «
« g
oo 5
c S
•S 8
CO oo
o
.i
"3
| |
(y o«
0>
(N) C 4-1
^™* c ,_ rt
J, o •§ 2
•^ ob *3 O
10 M e d
DO o o •=!
cs cS o .
•M _^ ^Q J^

VH ^ . ^— H
•« *fl O l
•^ "• « « -C
•-^ »-• e oo i;
-< >..5 ea PQ




Os
oo
Os
^*^
a
o
c

s


.2 T3
ili|llfii§|

aT-S -^

^ *o S «o 4-
| ^.|a|||
I'Sj'OcS ^ ."I »
_.S g « >»tc3-fc<2
2l 1 2 1 § 8 8
i u
,gg JH
rt l«i •*"< CH
mi
2
0>
M
"3
O co
'" g

•o"2 "8
eu > >
> M M -
t- o> o> C
0> eo to o
«5 Ji XI **
•§ ° ° § co
C3 (T\ rtS ^^ *^

T3 T T"! 2
^J M M M "g
S t2 c2 £ S
OO ttn HM MH ^H
^^ s
^^
oo
Os
^,
•a
*j
0>
*0>
a>
H


o -a
| a , •
lllll
£ £ e 5 B
4-. .Q C Q. co

M M
° -i ° o
S? q^
CO ** fO ^"^^
-"o " " 8
"* 2 ^S ^ S, •§
II « .2? II ^"5.
0 1 2 0 1 -3
%
oo
1*
01 ^ co
T3 'g «
»™H Q QJ
del
3
g
"3
(3
If
5. S

C3 ®
4> K
C N
•a s
~ M
o ^C
It
oT
OO
O\

s-~'
•a
d>
5
u.

U
oo
a
e following ]
5

o
(continued































                                              7-24

-------
i

v
a
jg
6






£
i
i*
1
*c
S!
I
a
*••»
a



i-
ot d
S **
« 8
H a
w c8



1
•*»*
d
.3
i
D.
£




^
1
•s ! -§»3 1
•0 jjj 23 ...g'S o oo
^3 rt &) O *^ ^ C3 *2 O ^•T' **^
+3 ^ •!£ *PH ^ "55 O ?5 » *"O

ii
CD « ^
d d t-
a -a CN
•§ -S -'
•§ ° s"
«2 ^^
(^ *J3 2
°"^'

*° 1
1 * .« S f
•I -a .2 g 9
S T3 » tn O.
Ill II
w
d
°2
o
o
>»
c3
.5 "S
w^J

-0 -o

** CO "S
d ^
2 £?-*
|||
P 13 W

"3
4)

d
•,3~
IS
2crj
CO ^H
i-^ -^

t^
Ct
n
2s
« O> 3
fl) ^ WJ
R 03 ^^.
» -g "
«« 5 w
Ji^2
S t3w
•S -3
^ .» eu to

*w ® £ *^ 
CH T^J (j ^*
flj ^^^ ^"^ (Jft -t»
s "i ° g ^
§ 2 1 1 1
'o ^ a S v.
_-,«.« w

d
n O
•3 '§
§1

m
d
is
O
0
S^s
3 U
W^J
I >-,'
1^
v
STJ
o .
v iy
t« ••-<
§1
•g«a
^ £
ro cS
— < O
I
o
^j
e«

S
w
                                  0)
                                  s
                                  a
                                  d
                                  d

                                 .•§
                                 d

                                  §
                                  o
                                  c\
7-25

-------
relationship (p < 0.05) between number of episodes of sore throat and number of cigarettes
smoked by the mother.  The effect was independent of birthweight, sex, child's age, feeding
practices, social class, crowding, and number of sore throats and tonsillectomies in other   ,
household members. The relative odds of having a smoking mother were 2.1 times as  high (95%
C.I. » 1.1, 4.0) in children about to undergo tonsillectomy as in children not undergoing
tonsillectomy.
       Tainio and coworkers (1988) followed 198 healthy newborns from birth to 2.3  years of age.
The investigators recorded physician-diagnosed recurrent otitis media (defined as more than four
episodes of otitis media during the first 2 years or more than four episodes during the second
year).  Parental smoking was more frequent (55%) among the infants with recurrent otitis media
than in the comparison group (33%; p < 0.05).  The authors comment, however, that "parental
smoking was not a risk factor for recurrent otitis media," probably because there was no
significant relationship between parental smoking and recurrent otitis media using definitions of
the latter that differed from the one described above. No distinction was made in this study
between the possible effects of maternal and paternal smoking. In addition, the study sample was
probably too small to obtain reliable risk calculations.
       Reed and Lutz (1988) studied 24 of 70 eligible children who had been seen in a family
practice office for acute otitis media during a period of 4 months and 25 of 70 eligible children
who had been seen for other reasons. Forty-five of these children had tympanograms performed
and had information on household smoke exposure.  Prevalence of an abnormal tympanogram
(indicating the presence of middle ear effusion) was higher among children exposed to smokers at
home (OR - 4.86, 95% C.I. = 1.4, 17.2).  Results were independent of feeding practices, history of
upper respiratory illness in the past month, low socioeconomic status, sex, age, and attendance at a
day-care center.  Only a small fraction of eligible subjects were included in this study, and the
possibility of selection bias as an explanation for the reported results cannot be ruled out.
       Hinton (1989) compared 115 children aged 1 to 12 years (mean = 5 years) admitted to a
British hospital for grommet insertion with 36 children aged 2 to  11 years (mean = 6 years) with
normal ears who were taken from an orthoptic clinic. Prevalence of smoking was significantly
higher in parents of cases than in parents of controls (OR = 2.1, 95% C.I. = 1.0, 4.5). Potential
sources of selection bias or selective misclassification cannot be determined from the data reported
by the author. No effort was made to control for possible confounders.
       Teele and coworkers (1989) studied consecutively enrolled children being followed in two
health centers in Boston from shortly after birth until 7 years of age.  Acute otitis media and
middle ear effusion were diagnosed by the children's pediatricians. Data were analyzed for 877
children observed for at least 1 year, 698 children observed for at least 3 years, and 498 children
                                            7-26

-------
observed until 7 years of age.  A history of parental smoking was obtained when each child
became 2 years old. A parent was considered a smoker if he or she smoked more than one
cigarette per day. The child was considered exposed if either parent was a smoker. The authors
reported that the incidence of acute otitis media during the first year of life was 13% higher in
children of smoking parents when compared with children of nonsmoking parents (p < 0.05), but
statistical significance was no longer present after controlling for alleged confounders (site of
health care, season of birth, birth weight, socioeconomic status, presence and number of siblings,
room sharing, feeding practices, and sibling or parental history of ear infection and allergic
diseases). Several of these variables may not have been confounders if they were not related to
both parental smoking and incidence of acute otitis media. Controlling for risk factors that are
not confounders may result in  overcorrection.  Parental smoking was not associated with an
increased risk for acute otitis media during the first 3 years or 7 years of life.  Likewise, parental
smoking was associated with a significant increase in the number of days with middle ear
effusion, but only during the first year of life (p < 0.009), and the effect was no longer present
after alleged confounders were controlled for.  The authors do not provide information  on
separate risks for maternal and paternal smoking or on the incidence of acute otitis media and
middle ear effusion in children of heavy smokers.
       Takasaka (1990) performed a case-control study on 201 children aged 4 to 8 in Sendai,
Japan. Sixty-seven subjects had otitis media with effusion, and the remaining 134 children were a
control group matched to cases by age, sex, and kindergarten class.  The investigators found no
significant differences in prevalence of exposure to two or more household cigarette smokers
between children with and without otitis media with effusion (no information on either odds
ratios or C.I.s was given). The power of this study may have been too low to determine risk
factors for middle ear effusions reliably.
       Corbo and coworkers (1989) examined  1,615 children aged 6 to 13 years who shared a
bedroom with siblings or parents in Abruzzo, Italy. Parents were asked if the child snored and the
frequency of snoring. Parents were asked about their own smoking habits; they were considered
moderate smokers if the summed total for both parents was fewer than 20 cigarettes per day and
heavy smokers if the summed total was 20 or more cigarettes per day.  Prevalence of habitual
snoring in children increased slightly with the amount of cigarettes smoked by parents; children of
heavy smokers were 1.9 times as likely to be habitual snorers as children in nonsmoking
households (95% C.I. = 1.2, 3.1), whereas children of moderate smokers were 1.8 times as likely to
be habitual snorers as children of nonsmoking parents  (95% C.I. = 1.1, 3.0).  Habitual snorers were
more likely to have had a tonsillectomy, but only if their parents smoked. The authors suggested
                                            7-27

-------
that these results are plausible because adult smokers are also at increased risk of being habitual
snorers.
       Strachan and collaborators (1989) performed tympanograms and collected saliva for
cotinine determinations in 736 children in the third primary class (ages 6i to 7i years) in
Edinburgh, Scotland. Median of salivary cotinine concentrations was 0.19 ng/mL for 405 subjects
living with no smoker, 1.8 ng/mL for 241 subjects living with one smoker, and 4.4  ng/mL for 124
subjects living with two or more smokers. For a given number of smokers in the household, girls
had higher cotinine levels than boys, and children living in rented houses (i.e., of lower
socioeconomic level) had higher cotinine levels than children living in houses owned by their
parents.  The authors found a linear relation between the logarithm of the salivary cotinine
concentration  and the prevalence of middle ear effusion.  The authors calculated odds ratios for
abnormal tympanometry relative to children with undetectable cotinine concentrations, after
adjustment for sex, housing tenure (rented or owned), social class, crowding, gas cooking, and the
presence of damp walls.  The odds ratio for a doubling of salivary cotinine concentration was 1.14
(95% C.I. = 1.03, 1.27).  At a  salivary cotinine concentration of 1 ng/mL, the odds ratio of having
an abnormal tympanogram was 1.7, whereas an odds ratio of 2.3 was calculated for a cotinine level
of 5 ng/mL.  At least one-third of all cases of middle ear effusion may have been attributable to
passive smoking.
       Etzel and coworkers (1992) studied 132 children who attended a day-care facility during
the first 3 years of life. The  investigators measured serum cotinine levels and considered a level
of 2.5 ng/mL  or more to be indicative of exposure to tobacco smoke.  The 87 children with  serum
cotinine above this level had  a significantly (38%) higher rate of new episodes of otitis media with
effusion  during the first 3 years of life than the 45 children with lower or undetectable levels
(incidence density ratio = 1.4, 95% C.I. = 1.2, 1.6).  The authors calculated that 8% of the cases of
otitis media with effusion occurring in this population were attributable to exposure to tobacco
smoke.
7.4.2.  Summary and Discussion of Middle Ear Diseases
       There is some evidence suggesting that the incidence of acute upper respiratory tract
illnesses and acute middle ear infections may be more common in children exposed to ETS.
However, several studies have failed to find any effect.  In addition, the possible role of
confounding factors, the lack of studies showing clear dose-response relationships, and the
absence of a plausible biological mechanism preclude more definitive conclusions.
       Available data provide good evidence demonstrating  a significant increase in the
prevalence of middle ear effusion in children exposed to ETS.  Several studies in which no
                                            7-28

-------
significant association was found between ETS exposure and middle ear effusion were not
specifically designed to test this relationship, and, therefore, either power was insufficient or
assessment of the degree of exposure was inadequate.  Also, Iversen and coworkers (1985), who
assessed middle ear effusion objectively, suggested that the risk associated with passive smoking
increased with age. This may explain the negative results of several studies based on preschool
children; the sample sizes of these studies may have been inadequate to test  for increased risks of  ,
50% or less, as would be expected in children under 6 years of age.  The finding of a log-linear
dose-response relationship between salivary cotinine levels and the prevalence of abnormal
tympanometry in one study (Strachan et al., 1989) adds to the evidence favoring a causal link.
Although not all studies adjusted for possible confounders and selection bias cannot  be excluded
in the case-control studies reviewed, the evidence as a whole suggests that the association is not
likely to be due to chance, bias, or factors related to both ETS exposure and middle  ear effusion.
       The biological mechanisms explaining the association between ETS exposure and middle
ear effusion require further elucidation.  Otitis media with effusion is usually attributed to a loss
of patency of the eustachian tube,  which may be enhanced by upper respiratory infection,
impaired mucociliary function, or  anatomic factors (Strachan et al., 1989).  It is possible that  ,
pharyngeal narrowing by adenoidal tissue (and, consequently, eustachian tube dysfunction) may
be more common in these children. This is suggested by reports of a higher prevalence of
maternal smoking among children  about to undergo or who have undergone tonsijlectomy and by
an increased prevalence of habitual snoring among children of smoking parents.  Impaired
mucociliary clearance has been demonstrated convincingly in smoking adults (U.S. DHHS, 1984).
No data are available on mucociliary transport in children exposed to ETS.  However,  ETS may
affect mucociliary clearance in children as in adults.  If this  were  the case and if normal
mucociliary clearance is required for rapid resolution of otitis media, exposure to ETS could result
in increased prevalence of chronic middle ear effusion.
        The increased prevalence of middle ear effusion attributable to ETS exposure has very
important public health consequences. Middle ear effusion is the  most common reason for
hospitalization of young children for an operation and thus imposes a heavy financial burden to
the health care system (Black, 1984).  There is also evidence suggesting that hearing  loss associated
with middle ear effusion may have long-term consequences  on linguistic and cognitive
development (Maran and Wilson,  1986).
                                            7-29

-------
7.5. EFFECT OF PASSIVE SMOKING ON COUGH, PHLEGM, AND WHEEZING
       Studies addressing the effects of passive smoking on frequency of chronic cough, phlegm,
and wheezing were reviewed both in the Surgeon General's report (U.S. DHHS, 1986) and in the
report by the NRC (1986) (see Table 7-5).
       The Surgeon General's report concluded that children whose parents smoke were found to
have 30% to 80% excess prevalence of chronic cough or phlegm compared with children of
nonsmoking parents.  For wheezing,  the increase in risk varied from none to over sixfold among
the studies reviewed. The report noted that the association with parental smoking was not
statistically significant for all  symptoms in all studies, but added that the majority of studies
showed an  increase in symptom prevalence  with an increase in the number of smoking household
members in the home.  The report stated that the results of some studies could have been
confounded by the child's own smoking habits, but noted that many studies showed a positive
association between parental smoking and symptoms in children at ages before significant
experimentation with cigarettes is prevalent. The report concluded that "chronic cough and
phlegm are more frequent in children whose parents smoke compared  to nonsmokers.  The
implications of chronic respiratory symptoms for respiratory health as an adult are unknown and
deserve further study" (page 107).
       The NRC report concluded that "children of parents who smoke compared with children
of parents who do not smoke show increased prevalence of respiratory symptoms, usually cough
sputum and wheezing.  The odds  ratios for the larger studies, adjusted for the presence of parental
symptoms,  were 1.2-1.8, depending on the symptoms. These findings  imply that ETS exposures
cause respiratory symptoms in some children" (page 216).

7.5.1. Recent Studies on the Effect of Passive Smoking on Cough, Phlegm, and Wheezing
       Several recent studies not  considered either in the NRC report  (1986) or in the Surgeon
General's report (U.S. DHHS,  1986) have addressed the relationship between passive smoking and
respiratory symptoms in children  (Table 7-6).
       McConnochie and Roghmann (1986b) studied 223 of 276 eligible children aged 6 to 10
years without a history of bronchiolitis who were drawn from the patient population of a group
practice in Rochester, New York. Information regarding the child's history of wheezing in the
previous 2 years, socioeconomic status, family history of respiratory illnesses, and smoking in the
household was obtained by questionnaire. Information on breastfeeding was obtained by record
checks and  interviews.  Children whose mothers smoked were more likely to be current wheezers
than were children whose mothers did not smoke (OR = 2.2, 95% C.I. = 1.0, 4.8). Neither paternal
                                          7-30

-------
Table 7-5. Studies on chronic respiratory symptoms referenced in the Surgeon General's and
National Research Council's reports of 1986
Study ,: No. of subjects
Bland et al. (1978)
Charlton (1984)
Colley et al.
(1974)
Dodge (1982)
Ekwo et al. (1983)
Kasuga et al.
(1979)
Lebowitz and
Burrows (1976)
Schenker et al.
(1983)
Schilling et al.
(1977)
Tager et al. (1979)
Ware et al. (1984)
Weiss et al. (1980)
3,105
15,000
2,426
628
1,355
1,937
1,525
4,071
816
444
10,106
650
Age of
subjects
Children/adol.
(12-13)
Children/adol.
(8-19)
Children
(6-14)
Children
(8-10)
Children
(6-12)
Children
(6-11)
Children (< 15)
Children
(5-14)
Children/adol.
(7-16)
Children/adol.
(5-19)
Children
(6-13)
Children (5-9)
Respiratory Surgeon
symptoms General
Cough
Cough
Cough
Wheeze,
phlegm, cough
Cough, wheeze
Wheeze, asthma
Cough, phlegm,
wheeze
Cough, phlegm,
wheeze
Cough, phlegm,
wheeze
Cough, wheeze
Cough, wheeze,
phlegm
Cough, phlegm,
wheeze
X
X
X
X
X
X
X
X
X


X
NRC
X

X
X


X
X
X
X
X
X
                                           7-31

-------
 CO
 a


 g
 "§
 at


 a"
 oo
 ,a

 o.
  •t

 00

 o
 o

 a
 o




 I
 S
 en
 a.

(M
 o
'S
1
 o
 S
 o>

vo
 i
"I
0
3
>
w
g
.0
O




la
•3
8

1

£>
a>
1
t
o

8
l-l
0 C!
a 2
x E
a> w
v*> ">
: co &
V*^ CA
« «




I
*5
ujationstu
Q,
&





i-i
O
S
<
\ 73 „. jf
a> op « c
«- c T3 <:
S3 § t
g a n 2 £ a5 i
S^lsllU
«2 °
oo" bo-jg
S S t3
•^ S o.
r^' "c ° c3
ii S t> 3
04 c5 «£ 2
0 S«
'oo01

||
a> >
^ £
^ a

a>
Ui
•3

IH QJ
rt 9
CL, cr
o
*-H
O ^
«s ?
sg.
oo S
S x
l-i O
25
•2 D5
0 .* J^
ff\ * ^
CS ^j°
•e S"
C3 vo
« oo
« C?\
•2 — ,
o a
ll
^j O
SBS
>>
•2 S • >> *-S
3 S| ^^gs || |^
J | a .-I" a " 1 3 J5 g'rS | •§
!sil5s£ Ililli
£ 2 ^ S **
^"i""'!*
"* .5 o^ § '3
2 ° ••> S -2
c> a ^-^ AI
 ^ c1
ii 3 .2? ''i, 2
o4 a ° °? 8
o^2c,M
ro
V
*3 •*->
B A &
!a 'C -S
111
2
0>
I'M
'3
§152
•sll
OT 35 fi

*3 Q ^
Orfj a

o

O ci
a>
•o S
o> o
rt *
11
3 «
{,) »»H
*O ^>
ro"— <



J
T3
(3 ^_^
ra ^^
OH O
J
> o
j| 'a
** o
11







































                                                                                            8?
                                                                                            a
                                                                                           I
                                                                                           §
                                                                                           1
                                                                                           8
                                                      7-32

-------
!
g
i
                I
3 13 ~w ~rx *?  'm w  O
Ilifllli  i
                          a*
                          -ns
                          O*3
                            S
                                  a
                       _ «

                       g -0
                       .24-
                                                      c«
                                                       oo °
                                                       B g -g

                                                       *
                                                               0
                                                               Q, C
                                                               .«

                                                              Pi
                                                                            0>

                                                                            ff
                                                                            a
                                                                     £

                                                                     S

                                                                     M

               CO

               Al



             o'g
             c » >>
           CN a) JH ca

           11 2 1 5.

           £ a § .s?
           O o C o
                       c2
                        0\

                        OO
                        .
                        «•> ooS
                        • .a
                        O
    S
    o.
                                  «*• £•
                                  S -a B
                                                         w «

                                   119
                                     ® 0
                                       »
                                                                            B

                                                                            O
                                                                            B

                                                                            O
                                                                            U
                                                         ta
             00 .
                                                  1

                                              ««§ « §•
                                               0 OT oo >

                                               S g .S 1
                                              J3 SJ N =3
                                               C "O "> o
                                               IS s*2
                                              5 43 •§ ««
                                              Z o ? o
                                                                •S
                                                       O %
                                                       Q. •"


                                                       ®  "
                                     co
                                     eo
                                    S S
             CO
    « B
    ca B

    S-2

    S to
  2


  1
^-i g

5 .o

(n co
h 0>
ca 3
cu cr
                                          B
                                        a
                                        £

                                       £
                                  3-
                                                      s -a
                                                       
                                                       •- B

                                                       l5-o
                                                                    •s
                                                                    00
                                                              .2 w ^ .a
T3



I



1
U
f-
1
o

1
s
s
           ca

           •O
           v
             •
           si
           s 1
    •s.a

    v^ ^3
    ON ^
                        CN


                        2
                        00
                        ea —



                        >i CO
                        TJ «-i

                        2.a
                        U  .


                        §1
         •a* S)


                                ° si
                                          <0
         0 S "
         2 a^
                                       C^ ^**





                                       jl



                                       12 •"
                                       O rQ

                                       ^* ^
                                       N f



                                       •fl B
                                       5 <*H
                                             IH

                                             >.
                                                        .  a
                                                       2
                                                       "o
                                                               ca *->
                                                               
-------
•a

 I

a
 o
 o
vo


t^-

 CU

' ' "S
. . :-.-.2
ed
&


O

*3
3
cd
CU
§
.S
§
r»
O
A\
ETS exposure
assessment:

•o
.' -i.
:l
' -:M:
.2
f
Q,
£




'i
|

a
CU
« ** -9 2
O O ^ SP"^
«S ** ° cu -5 °
CU *2« [^ ^ — 4 b
O rt g *3 2 2
Z S O « co *O
IH
o
C*4
oo
•*" o-O
-f S.S
-H 43 O
•Z* a
Tf CO
-< § £2
11 *O S
§11
•OT3
S **
9 o
•§ 1
•T "-1 "
eu 2 O
co ra CU
•3^3 S
53 oo o.
>1 0 >»
W 8 43
CM
O
4-» >>
g-°
D. 00
?l|
CM O £
13 fi es
c/o 55 a

t3
"O cu
tt) -a
00 S
^ C^ fe
C3 '" c/3
•a >• ^
rs \o -S
43 S a
o _ o
g^-M
ON 0 O
	 ** Cj ^T*

•
*rrt
,4_i
CU
« ^^
2So
T3 00
a ox










Among English
children whose
parents smoked ^20
cig./day OR = 1.6
(1.2, 2.2) of having
"wheezy chest most
nights"
0
S Jg
u, 1-!
a .S
| 2 §
TO Ti Q
•4-* 03 W
M-a|2
£5ll

'§ 43 "£
§18
111 .
aS-S
o ^
OO-O C rt _
eS G O cu C2
g ^rt o OO c»
O "" C CU *O
? - c§ I .S
'a
1 «
(D
4)
Is?
S ON
O _
lH

"S «
3 ®
-»
T3 ^
e eo
CO O
o
Occasional wheezing
OR = 4.3 (1.1, 16.4)
children of smoking
parents; no effect on
recurrent wheezing


•o
C
igg«
11 S*S
lisi
co o S ?

Parental
questionnaire

2 ^ 1 -9 rt
:rs£-s.§
i-s ail
rt N £.2 £
67 children
yr. hospital]
respiratory
virus bronc
Stockholm,

c3
^f
U
L-(
|_
£c.









Jo
eu "5)O
s§s



a
Respirator
symptoms :
children

Parental
questionnaire
">
e TS
£ c
|«l
43 •-< o
a-o.»»
1,012 schoo
to 7.5 yr. ol
Edinburgh,
00
oo
ON
1— «
Rt
1
•4-*
co








>o •*
•g ^"I
'S " oo
fti s
S'Sis
•r •«':3 S5
.M S c S
-. £ «^
§ ili
£L B •*•! ^5
•O M 43 m
.•3 eu » 0
•S §.sB
















                                                                                                          CU

                                                                                                          S1
                                                                                                          a



                                                                                                         I
                                                                                                          CU
                                                                                                          a
                                                                                                          o

                                                                                                         •o
                                                                                                          CU
                                                                                                          8
                                                           7-34

-------
                    1
                    O
                    a

                    o
                       00
                                  •M eo
                                                                   "S3
                                                           f*o    «j

                                                          •a  a   S>
                                                                         53 « ,*
                                                                         f •§.§
                                                                       — .
                                                                       "O
                                                                       «>
                                                                                            I*

                                                                                           c2
                                                                       i-   2

controing

confounders
                                           3= •*
                                           ON CM

                                           «X A
                       2  a
                     ; TJ  °»
                      JS  e«
                   O.S
 C


1

-3


 l«


 »1

                                    2
                                    S
.§
 3
                                 •a w >>

                                 oo 000

                                 CD C8 S
                                 cu 'H
                                 2; .o •«
                                 « *- c
                                 OH at at
                                                    I*, oo  o



                                                     II  es r-








                                                    oo


                                                    o
                                                    o


                                                    a
                                                    e«


                                                    N

                                                    cu
                                                                                     2
                                                                                     a
                                                                                     c
                                                                                     o
                                                                                     3

                                                                                     CT
                                                    c
                                                    cu
                                                                                                    O
•o
 I




.<»
1
"3
1



•"
%
o
it*
a
*

IH
60 cases of chronic
cough aged <6 yr.;
60 controls; in Salfo
United Kingdom
oT
oo
ON
C-
•a"
eo
"C
«
^
T3 .S
w «
nid *«^
1?
II
33
o .fa
**
ON rt



•3
•4^
CU
'S_,~,
CO ^
co ON



^ 00 |
>> o *** o
t~- C (-) ^H "
— O « . „ j-
S T3 CN iJ" *3
£ e v WBJ -r
•So . op ?
~ cJ "O CU m
jz g Q >j *o
'5'

oo
2
•a
w
a
rt
6


birthweight









                                                                                                                       §
                                                                                                                       a
                                                                                                     CO


                                                                                                    !
                                                                                                     cu
                                                                                                    •«-*
                                                                                                    €g

                                                                                                     cu


                                                                                                    I
                                                                                                                       O
                                                                                                                       u
                                                                                                                      ON
                                                               7-35

-------
smoking nor total household smoking had any influence on the prevalence of wheezing. When the
authors controlled for family history of respiratory allergy, direct effects of maternal smoking on
prevalence of wheezing failed to reach statistical significance.  However, there was a strong
association between maternal smoking and wheezing among children with a positive  family history
of respiratory allergy (OR = 4.5, 95% C.I. = 1.7, 12.0), and the interaction between these terms
was highly significant in multivariable analysis, suggesting the combined importance of both
genetic factors and maternal smoking.
       Park and Kim (1986) studied  3,651 children aged 0 to 14 from a randomized, clustered
sample of households in South Korea (response rate: 89%). A questionnaire was administered to
household members about their smoking habits and respiratory symptoms.  Mothers  answered
questions about the presence of cough in the child in the 3 months prior to interview.  The authors
reported dose-response relationships  between the child's cough and number of smokers in the
family, number of smokers in the same room, number of cigarettes smoked by all family
members, and number of cigarettes smoked by parents. The relationship was present in children
of different ages (less than 5 years, 6 to 11 years, and 12 to 14 years). The authors controlled for
parental education, socioeconomic status, birth rank, parental age, birth interval, number of
family members, and number of siblings. Family members with cough or with morning phlegm
production were  significantly more likely to live  with children with cough. After correcting for
these two factors, chronic cough was 2.4 times as likely in children of families whose members
smoked  1 to 14 cigarettes  per day (95% C.I. = 1.4, 4.3) and 3.2 times as likely in children of
families whose members smoked more than 15 cigarettes per day (95% C.I. =  1.9,  5.5).  However,
effects were more noticeable and only reached statistical significance in children of families
whose adult members did not have chronic cough.
        Bisgaard  and coworkers (1987) studied 5,953 infants of a total of 8,423 eligible newborns
(71%) enrolled in a prospective study.  At the age of 1 year, the child's mother was  interviewed
 regarding episodes of wheeze during the previous year and possible risk factors for  wheezing.
 The risk of wheezing was 2.7 times as high (95% C.I. = 1.8, 4.0) in children whose mothers smoked
 three or more cigarettes per day as in children whose mothers smoked fewer  than three cigarettes
 per day. Results were independent of social status and sex of the child. The authors decided not
 to control for quarter of birth or use of day-care facilities, with the assumption that these factors
 did not modify the relationship between maternal smoking and wheezing. Also, biases could have
 been introduced by the fact that almost one-third of the original sample was not  included in the
 analysis.
        Geller-Bernstein and coworkers (1987) studied 80 children aged 6 to  24 months who had
 been seen as outpatients or inpatients in Israel for wheezing and who had a diagnosis of atopy.
                                            7-36

-------
The children were examined every 6 months during 4 years by a physician. At the end of
assessment, the authors classified children as having "recovered" if they had been symptom-free
for at least 1 (the last) year; otherwise they were classified as "persistent wheezers." "Persistent
wheezers" were more likely to have smoking parents than were "recovered" children (OR = 3.1,
95% C.I. = 1.1, 8.9). This result was independent of changes in IgE levels during the study period.
The authors did not control for the possible confounding effect of parental symptoms.
       Cogswell and coworkers (1987) studied 100 newborns who had at least one parent with a
history of hay fever or asthma.  Ninety-two children were still being followed at 1 year of age and
73 at the age of 5 years. Children were examined periodically and whenever they had signs of
respiratory illness. At the child's first birthday, the number of those who had developed wheezing
was equally distributed between parents who did or did not smoke. By the age of 5 years,
however, 62% of parents who smoked had children who had wheezed compared with 37% in
nonsmoking families (p < 0.05). It is unlikely that these results can be explained by the
confounding effect of parental symptoms, because all parents were allergic by definition. It is
also quite unlikely that preferential withdrawal of nonwheezing children of smoking parents could
have biased the results.
       Toyoshima and coworkers (1987) from Osaka, Japan, followed 48 of 65 wheezy infants
and children less than 3 years old for up to 4 years.  Outcome information  was obtained from
charts or by telephoning the child's mother. Among  18 children  who were still symptomatic 25 to
44 months after their first visit, 17 lived with smokers compared with 13 of 22 children who lived
with smokers and who stopped having symptoms during followup (OR = 11.8, 95% C.I. =
1.3, 105.0).  Results were independent of family history of allergy, feeding practices,  and
disturbances at birth.  Selection bias related to the number of subjects lost  for followup or with
missing information could have influenced the results of this study.
       Tsimoyianis and collaborators (1987) evaluated the effects of exposure to ETS on
respiratory symptoms in a group of 12- to 17-year-old high school athletes (N = 193).  Histories
of smoking by all household members were obtained for all subjects.  Athletes exposed to ETS at
home were more likely to report cough  than were unexposed athletes (p = 0.08). Frequency of
bronchitis, wheeze, and shortness of breath was similar in both groups. A  greater awareness of
the smoking habits of those around them by subjects with cough cannot be excluded as an
explanation of these findings, but this source of bias cannot explain the exposure-response  trends
for ETS and lung function seen in this same sample (see Section 7.8.1).
       Andrae and collaborators (1988) mailed questionnaires to the parents of 5,301 children
aged 6 months to 16 years living in the city of Norrkoping, Sweden. Data were  obtained from
4,990 children (94% response rate). Children with parents who smoked had exercise-induced
                                           7-37

-------
 cough more often than did children of nonsmokers (OR = 1.4, 95% C.I. = 1.1, 1.8). Exposure to
 ETS interacted with living in houses with damage by dampness; children exposed to both had
 more exercise-induced cough and allergic asthma when compared to those exposed to only one or
 neither.  Results of this cross-sectional study may have been biased by preferential reporting of
 symptoms by smoking parents, although a reliability study performed  in a random sample was
 reported to confirm 95% of the answers regarding respiratory symptomatology.  In addition, no
 effort was made to  control for active smoking in older children.
       Somerville and coworkers (1988) enrolled 88% of 8,118 eligible children aged 5 to 11 from
 England and Scotland. Data on the child's respiratory symptoms and parental smoking were
 obtained from a self-administered questionnaire completed by the child's mother.  After
 exclusions for missing data, the proportions of children available ranged from 60.9% to 63.9% of
 all subjects, depending on the variables involved.  Logistic regression analysis was used to control
 for child's age, presence of siblings, one- or two-parent families, paternal employment, social
 class, maternal smoking during pregnancy, overcrowding, maternal education, maternal age,
 triceps skinfold thickness, and birth weight. For Scottish children (who were only  19% of all
 subjects), the authors  found a significant relationship between number of cigarettes smoked at
 home and "chest ever  wheezy" (p < 0.01;  OR not reported). Among English children, there was a
 significant relationship between number of cigarettes smoked at home by mother and father
 together and prevalence of a wheezy or whistling chest most nights (adjusted OR in children
 whose parents smoked 20 cig./day = 1.6; 95% C.I. = 1.2, 2.2).  Attacks  of bronchitis and cough
 during the day or at night were also significantly correlated with number of cigarettes smoked by
 parents in the English sample; odds ratios in children of parents who smoked 20 cigarettes per day
 were  1.4 and 1.3, respectively, but no confidence intervals were reported.  The authors concluded
 that the effect of parental smoking on respiratory symptoms in this age group is small and requires
 a large number of subjects to be detected.
       Rylander and collaborators (1988) from Stockholm, Sweden, studied 67 children aged
 4 to 7 years who had been hospitalized with virologically proven  RSV  infections before age 3.
 Questionnaires  were mailed to parents regarding their smoking habits and the child's history of
 wheezing illnesses after  the initial episode. Children who had subsequent occasional wheezing
 (N » 21) were more likely to have smoking parents than those (N = 24) who had no subsequent
 respiratory symptoms  (OR = 4.3,  95% C.I. = 1.1, 16.4).  However, frequency of parental smoking
 among children who had no subsequent respiratory symptoms was not  significantly different from
that of children who had subsequent recurrent wheezing.  The inconsistency of the results in this
study may be explained  by the small number of subjects involved.
                                           7-38

-------
       Strachan (1988) studied 1,012 of a target sample of 1,095 schoolchildren aged 6.5 to 7.5
years in Edinburgh, Scotland. Parents answered a questionnaire on their smoking habits and on
respiratory symptoms in their children.  There was no relationship between number of smokers in
the household and prevalence of wheezing in the population.  Cough at night (> 3 nights in the'
past month) was more likely to occur in children living with one smoker (OR = 1.6; 95% C.I. =
1.1, 2.6) or two smokers (OR = 2.5; 95% C.I. = 1.5, 4.0) than in children living with nonsmokers.
Occurrence of "chesty colds" in children was also more frequent in households with one  (OR - 1.3;
95% C.I. = 0.9,  1.9) or two smokers (OR = 1.9; 95% C.I. = 1.3, 3.0).
       A subsequent report (Strachan et al., 1990) based on the same population sample studied
the relationship between salivary cotinine levels and respiratory symptomatology in a subset of
770 children (see also Strachan et al. [1989], Section 7.4.1). The authors found no relationship
between cotinine levels and wheezing or frequent night cough.  Frequency of chesty colds was
significantly correlated with quintals of salivary cotinine (p < 0.01).  The authors noted  that
objective markers of recent exposure to ETS may not adequately reflect exposure at some critical
period in the past.  They also noted that there may be  different ways of understanding the concept
of "wheezing" and proposed that this could explain the lack of association between this symptom
and both questionnaire-based and cotinine-based assessment of exposure to ETS in their sample.
       Lewis and coworkers (1989) performed a case-control study of risk factors for chronic
cough in children under 6 years in Salford, United Kingdom. They enrolled 60 children referred
to a pediatric outpatient clinic with cough lasting more than 2 months or frequent episodes of
cough without wheeze. These 60 subjects were compared with controls admitted for routine
surgical procedures. Children with chronic cough were 1.7 times (95% C.I. = 0.8, 3.5) as likely to
live with a smoker as were controls. Because of the small number of subjects and the high
prevalence of parental smoking (> 50%), the power of this study may have been too low to allow
for meaningful conclusions.
       Neuspiel and coworkers (1989) studied 9,670 of 9,953 eligible children enrolled at birth in
Great Britain.  Information on parental smoking was obtained at birth, at age 5 years, and at age
10 years. Outcome data were obtained from maternal  interviews when the children were 10 years
old. Children of smoking mothers had 11% higher risk (95% C.I. = 2%, 21%) of wheezing between
ages 1 and 10 than did children of nonsmoking mothers. An exposure-response relationship was
also present: Cumulative incidence was 5.2% in children whose mothers  were nonsmokers,  6.6% in
children whose mothers smoked 1 to 4 cigarettes per day, 7.5% in children whose mothers smoked
5 to 14 cigarettes per day, 8.1% in children whose mothers smoked 15 to 24 cigarettes per day, and
8.9% in children whose mothers smoked more than 24 cigarettes per day.  The risk also was
increased in children of mothers who did not smoke during pregnancy but were smokers
                                           7-39

-------
thereafter (RR = 2.2, 95% C.I. = 1.2, 3.9).  The association persisted after a logistic regression
model was used to control for the effect of child's sex, child allergy, paternal smoking, parental
allergy, crowding, bedroom dampness, feeding practices, gas cooking, and social status.  The
increase in risk was cut approximately in half but did not disappear when additional corrections
for maternal respiratory symptoms and for a measure of maternal depression were made. Results
of this study may be explained in part by preferential reporting of wheezy illnesses by smoking
mothers. However, it is unlikely that the association between maternal smoking and wheezy
illnesses found in this study can be explained exclusively by uncontrolled sources of bias; there
was a striking exposure-response effect, and the association persisted after controlling for most
known confounders and was independent of maternal smoking  during pregnancy.
       Chan and  collaborators (1989a) studied 134 children aged 7 years out of 216 eligible
infants of under 2,000 g birthweight who were admitted to the  neonatal unit of two hospitals in
London, England. Parents of these 134 children and of 123 control schoolchildren born in the
same period but with normal birthweight completed a self-administered questionnaire on
respiratory illnesses and on social and family history.  At age 7, children whose mothers smoked
were at increased risk of having frequent wheeze independent of their neonatal history (adjusted
OR « 2.7; 95% C.I. = 1.3, 5.5), although the increase only  reached statistical significance for
children of normal birthweight.  Prevalence of frequent cough  was also more likely to occur in
children of smoking mothers (OR = 2.4,  95% C.I. = 1.3, 4.6), and the association was significant
for both cases and controls studied separately.  The authors performed a logistic regression to
control for possible confounders (only the low-birthweight group was included). The relationship
between frequent wheeze and maternal smoking persisted among low-birthweight children after
controlling for family history of asthma, atopy, socioeconomic  status, and use of neonatal oxygen.
The relationship between frequent cough and maternal smoking was no longer significant among
low-birthweight infants after controlling for the same possible  confounders.  For the low-
birthweight group, the authors assessed the reliability of some of the responses to their
questionnaires; there was a high correlation (r = 0.96) between the number of hospitalizations
reported by parents and those documented in the outpatient clinic of the neonatal unit that
followed the infants.  The authors concluded that  misclassification due to parental failure to recall
previous respiratory illnesses in the low-birthweight group was unlikely.
       Krzyzanowski and collaborators (1990) studied a sample of 298 children aged 5 to 15 who
were family members of county employees enrolled in a prospective study. Parents answered a
questionnaire on their smoking habits and on respiratory symptoms in their children.  Indoor
formaldehyde concentrations in the living environment also were measured. Prevalence rates of
chronic bronchitis (as diagnosed by a physician) were significantly higher in children  exposed
                                            7-40

-------
both to ETS and to formaldehyde concentrations of over 60 parts per billion than in children with
one or none of these exposures. The authors also reported that similar effects were not seen in
adults.
       Dijkstra and collaborators (1990) obtained consent for participation in their study for
1,051 of a total of 1,314 (80%) eligible 6- to 12-year-old schoolchildren from a rural area in The
Netherlands. Parents completed a self-administered questionnaire on their smoking habits and on
respiratory symptoms in their children. Complete information was available for 775 children.
When compared to children of nonsmoking households, children exposed to ETS at home were
significantly more likely to have cough on most days for at least 3 months consecutively
(OR = 2.5,  95% C.I. = 1.1, 5,6), wheezy or whistling  sounds in the chest in the last year (OR = 1.9;
95% C.I. =  1.0, 3.5), and attacks of shortness of breath with wheeze in the last year (OR = 2.0; 95%
C.I. = 0.9, 4.2). Exposed children were significantly more likely to have one or more of the above
symptoms than were unexposed children (OR = 2.0; 95% C.I. = 1.2, 3.7).  Results were still
significant  after adjusting for parental respiratory symptoms and for maternal smoking during
pregnancy.  The authors also measured nitrogen dioxide in the homes of all children but found no
association of the latter with respiratory symptoms.
       Mertsola and coworkers (1991) followed prospectively for 3 months 54 patients aged 1 to 6
years from Turku, Finland, who had a history of recurrent attacks of wheezy bronchitis.  The
parents were told to record the symptoms of the child daily and were asked to bring their child to
the hospital emergency room if the child developed signs of an acute respiratory infection.
Incidence of prolonged wheezing  episodes (> 4 days) during followup was significantly more
likely in children exposed to ETS than in  unexposed children (OR = 4.8; 95% C.I. = 1.9, 12.6).
The result was independent of number of siblings, age, sex, medication, and personal history of
allergy.                                                                           ,

7.5.2. Summary and Discussion on Cough, Phlegm, and Wheezing
       Recent studies reviewed in this report that were not included either in the Surgeon
General's report (U.S. DHHS, 1986) or in the NRC report (1986) substantially confirm the
conclusions reached in those two reports.  There is sufficient evidence for the conclusion that ETS
exposure at home is causally associated with respiratory symptoms such as cough, phlegm, or
wheezing in children.
       The evidence is particularly strong for infants and preschool children; in this age range,
most studies have found a significant association between exposure to ETS (and especially to
maternal smoking) and respiratory symptoms in the children, with odds ratios generally ranging
between 1.2 and 2.4. Selection bias may have influenced the results of certain cross-sectional
                                            7-41

-------
studies; retrospective studies also may have been biased by preferential recall of their children's
symptoms by smoking parents.  However, the presence of a causal relationship is strongly
supported by the consistency of the results for different geographic areas (Japan, Korea, People's
Republic of China, Europe, and North America) and by the positive findings in prospective
studies that are less subject to selection and recall  biases.
       In addition, efforts have been made by all researchers to control for possible confounders
and to avoid sources of bias. It is not feasible for each study to take into account all possible
factors that may affect the relationship under study; some of these factors may even be unknown
at present. However, all reviewed studies have controlled for at least some of the best-known
confounders (family history of  respiratory illnesses, parental respiratory  symptoms, socioeconomic
status, crowding, presence of other siblings, home dampness, gas cooking, maternal level of
education, perinatal problems, low birthweight, maternal age, birth rank, and maternal stress, or
depression). Of these possible confounders, a history of respiratory symptoms in parents has been
particularly scrutinized. The NRC report (1986) noted that bias may be  introduced by parents
who have a history of respiratory illnesses for several reasons.  These parents may overstate their
children's symptoms, or their children actually may have more respiratory illnesses and symptoms.
The latter possibility could be the result of intrafamily correlation of susceptibility (referred to as
familial resemblance by Kauffmann and coworkers [1989a]).  Because smokers are  more likely to
have respiratory symptoms, one would expect that controlling for respiratory symptoms in parents
would result in a decrease in statistical significance of the relationship between ETS and
symptoms  in the child.  In fact, most recent studies that have addressed the issue report that
controlling for family history of respiratory symptoms decreases  but does not entirely explain the
increased risk of respiratory symptoms in young children exposed to ETS.  It has been stressed,
however, that the use of these statistical adjustment procedures may induce an underestimation of
the effect of passive smoking; this would indeed be the case if parents with symptoms (and thus
more likely to be smokers) were more prone to report symptoms  in their children than were
parents without symptoms.  Several studies also have found that the effect is independent of
maternal smoking during  pregnancy and cannot be attributed exclusively to intrauterine exposure
to tobacco products (although the latter may potentiate the effects of postnatal exposure to ETS).
        The evidence is significant but less compelling for a relationship between exposure to ETS
and respiratory symptoms in school-age children.  Odds ratios for this age group are usually
between 1.1 and 2.0.  Several studies have shown  that, among school-age children, there are
significant differences in susceptibility to ETS exposure between individuals. There is, in fact,
evidence showing that several factors may amplify the effects of passive smoking:  prematurity, a
family history of allergy, a personal history of respiratory illnesses in early childhood, and being
                                            7-42

-------
exposed to other environmental pollutants such,as formaldehyde.  In addition, long-term exposure
may have more important effects than short-term exposure. One study of 7-year-old children
(Strachan, 1988; Strachan et al., 1990) used both questionnaires regarding smoking habits in the
household and the child's saliva cotinine levels as indices of exposure to ETS. The authors found
a significant increase in the. risk of having frequent cough when the questionnaire was used to
ascertain exposure, but no association between saliva cotinine levels and frequency of cough.  As
the authors remarked, biochemical markers permit characterization of recent tobacco smoke
exposures, but they may not adequately reflect exposure at some critical period in the past.
Recent studies of intraindividual variability of cotinine levels also have suggested that it may be
misleading to assess the validity of questionnaire measures against a single determination of a
biologic marker (Coultas, 1990b; Idle, 1990). It is thus possible that associations evaluated with
salivary cotinine are likely to underestimate the true relationship between passive smoking and
respiratory morbidity (Strachan et al., 1990).
       In the case of older children who may have started experimenting with cigarettes, the
confounding effects of active smoking need to be considered.  Most researchers have been aware
of this problem and have attempted to control for it.  A great difficulty lies in misclassification of
smokers due to underreporting. Young persons may be reluctant to admit smoking cigarettes.   ,
Data are often obtained from parents, who may not be aware of the child's smoking.
       In summary, this report concludes that ETS exposure at home causes increased prevalence
of respiratory symptoms in infants and young children. There is also good  evidence indicating
that passive smoking causes respiratory symptoms in some older children, particularly in children
who have predisposing factors that make them more susceptible to the  effects of ETS.
7.6. EFFECT OF PASSIVE SMOKING ON ASTHMA
       Studies addressing the effects of passive smoking on frequency of asthma were directly
reviewed only in the Surgeon General's report (U.S. DHHS, 1986) and not explicitly in the report
on environmental tobacco smoke by the NRC (1986). The Surgeon General's report concluded
that epidemiologic studies of children had shown no consistent relationship between the report of
a doctor's diagnosis of asthma and exposure to involuntary smoking.  The report pointed out that,
although one study had shown an association between involuntary smoking and asthma
(Gortmaker et al., 1982), others had not (Schenker et al., 1983; Horwood et al.,  1985). This
variability was attributed to differing ages of the children studied, differing exposures,  or
uncontrolled bias. The report also concluded that maternal cigarette smoking may influence the
severity of asthma.  Alteration of nonspecific bronchial responsiveness was proposed as  a
mechanism for this latter effect.
                                           7-43

-------
7.6.1.  Recent Studies on the Effect of Passive Smoking on Asthma in Children
       Several new cross-sectional and longitudinal studies published after the U.S. Surgeon
General's report (U.S. DHHS, 1986) was released have addressed the relationship between
frequency, incidence, and severity of asthma and parental cigarette smoke (Table 7-7).  (Studies
on the relationship between ETS exposure and bronchial responsiveness were reviewed in Section
7.2.4.)
       Burchfield and coworkers (1986) studied 3,482 nonsmoking children and adolescents ages
0 to 19 years out of 4,378 eligible subjects from Tecumseh, Michigan.  Subjects or their parents
(for children aged 15 years or younger) answered questionnaires on past history of asthma and
other respiratory conditions. Information on parental smoking habits was obtained from each
parent. Prevalence rates of asthma were higher among children whose parents both had smoked
during the child's lifetime than among children whose parents had never smoked.  The effect was
stronger and only reached statistical significance for males (OR for boys = 1.7,  95% C.I. = 1.2, 2.5
in boys; OR for girls = 1.2, 95% C.I. = 0.8,  1.9).  Children with one parental smoker were not more
likely to have asthma than was the unexposed reference group. When results were stratified by
parental history of respiratory conditions, there was some reduction in the magnitude of the
parental smoking effects, but results remained significant for asthma in males.  Results were also
independent of age, parental education, family size, a diagnosis of hay fever, and a history of
other allergies. Reporting bias and diagnostic bias  may in  part explain the relationships reported
in this study; smoking parents may be more likely to report asthma in their children, and
physicians may be more prone to diagnose asthma in children of smoking parents.
       D. Evans and coworkers (1987) studied 191 out of 276 children aged 4 to 17 years from
low- income families who were  receiving health care for physician-diagnosed asthma in New
York.  Excluded children were younger and had fewer emergency room visits for asthma than
those with complete data. The authors suggested that the latter subjects had more severe asthma
than the general  community population of low-income children with asthma. Emergency room
visits and hospitalizations for asthma were assessed by reviewing hospital records.  Passive
smoking by  the child was measured by asking one parent if he or she or anyone else in the house
smoked.  Authors did not differentiate between maternal and paternal smoking; no attempt was
made to assess the degree of exposure to cigarette smoke.  Eight children who were active smokers
were excluded. There was a significant correlation between number of emergency room visits and
cigarette smoke exposure  (p = 0.008); the mean frequency (± SD) of annual emergency room visits
observed for children exposed to passive smoking was 3.1 ± 0.4, compared with 1.8 ± 0.3 for
children from nonsmoking households. Passive smoking had no effect  on either the frequency of
days with asthma symptoms or on the annual  frequency of hospitalizations. Results were
                                           7-44

-------
T3
 O

5

1
•S
 I
£
 3

 §
 00
• «—l
^

 1
 M

I
"en
 3
 Q,
CM
 O
 en
 t*
 CO
 O
 £

1
•4-»
 CO
.a
|>

.2
 S
 CO
a
 o.
 CO
&
  •
(^
t^
—
S
£

1
l-l
 t/J
1 1



*§
n
S
I
"Si
3
Q,
O
PH



hi
O
3


Independent
w
c2
^
3
of
^
II
o

o
Prevalence


.S
1
.2
%-»
a



oo
•S
o
onsm
c
«N
OO
>l-x
«
•a
«
2
^
CM
^d
2
BQ

en
*?3 >» CO * CO .M
£ M OO (J N OO
d 2 rt -3 o "5 h
lie IIU*
c?" S §1 S"§
CM to 2 ™ *O ctf d
O In S CX CO Cu CO


oef
cN
""-1 en
II £
. «CM
is?
JD -H


1
d
CO
^ 1.
.£> b.
ll
S CO
a¥
cd en
.S e

• es
>>.s?
o\ -g
"""l *5
O jj"
C t/3
•
e>
-H
en
S
O
O
I*
Emergency




Is
d
1
»— (
o

^
•e
CO
rt
d
2
2
p»<
U
_f
ON

•d
^_i

en
§
>
M
Q
d
!
CO
£>
CO

>,
g
in
i

0?
8
i
a
s^x


T3
A
V)
•frrf
'>


£
1
.0
-l-»
Crt
4>
^
CO

^
•^
o
1
^(
c

^
>.




J^*
00
ON
^-t

"2 -a •«
S d -o d
co 2 co
d g .d S g 2 >«
S CO Q CO ^ CO O| S
d
u- JL
2 |
3 fl H
o *a **
5S £2
.S es 2
.Sd'a
,<3 ^ oo
> o .S
d S •«
o M 2
8*8 1
al?
.252-0
a c« 8
as —
If "s
a «* '•3
« M CO
5.2 S















j^j
U4
O
>*







d
No increase i
•o
§
w
|
^
^
c|
d
.-&
to
cu
Bronchial n




3
d
1
0
-4-*
VO

S)
rt
en
+rf
U
1Q
in
c^
o\

•a"
^4-1
CO
o
d
d
U
b
«
nonasthmatic
en
.y
rt
X
c3
_d
response


b
"3
•o
8
2


2
'I
d
o
*^
i
ijy





r>
I
«
O
PQ
d
*
^
>>




j^*
oo
^

CU
1



2
M
O
S
1















CO
*-*
(U
^
CO
«3
^2









mothers






smoked






























smoked




































                                                                                                         
-------
       t
        03


       §
,2
I

i
      o
      5.
      



                                                                   I

                                                                   00
                                                                   «
                                              d
                                              0

                                              •o
            S
                n»
              n 5
              o C
  2


  1


II
«> K
         e/i
         4-* t-|
         * S3
         •3 •" eS

         I'S ^
         SS2
         m "£ -a

         <2 a-S

                     il
                                       .s «
             -
           '  8
           a.  a

           "3 S §
           d «'*=
                                         1.1
                                          S s
                    OH
           •s-sl
    (

•3 -S *
43 .tS O

°
d

11
         00 .
         Os u,
         ts >.
                                ON -S
                         d T3 2

                         8§S
                         2 |2


                         ••§11
                         O   OT
                         ^ u 0
                         r~ >. 03
                                     •8'
                                     00
                                                   .
                                                   « SJ
                                                     '
  o\
  00

  O\
 Sl§
 JL? CO
 2-c

 S o
                       ea
                                4)

                                d
                                «
                                     en >.
                             ea


                             d>
                             N O*


                             0> ON
                                     7-46

-------
8
r-
trt
C
,2
+*»
I

1
i
1
i
£!
a



s
i s
& I
M »
Cfl CO



TJ
.SJ
1
1
3
Q.
O



O
*-»
<


% t« CO
8 °S ° | 3
lilil

•*-*
1
eo
v«4
.S
en G
CO S
DO--!
g »
» f^
<5 c2
2
CO ^
t3 a
S o
O 43
O. ^
CO IH
*-• »°
S?
£ 2
Q W


s
1
1
^o
1
OT
i-H

•a
4^
.§*
O


-4-*
1

vq1
II
g

.1
o
'S3
PH





"rt
C
u->
O
•*-»
0
I
c
2
U
q^>
f-^

W
N
_g
S


S5
o

>
^o
CIH
O
CO
2
U
Id
cS

O
1
oo
•3



CO
l_l
1
o
1

2
4>
1
"o

c



ON
^


children of
better
educated
mothers
cS
maternal education
whose mothers
smoked ^10 cig./d

.
43








g
O
• £H
«1
en
«
rt
CU







S
1
CM

'o
en
1
4J
I*
3
.SP
ffl
0
0
G
oo
CO
1
G
*

en
"eo
42
I
_C
O
U


43
cf
CO
2
0
00
cN
CN
•a
eo
O
"C
W


cotinine
.a
cotinine in asthmat
^0
'ja
1
2
T-J
§
G
CO
!_i
2
o
*o
urine

^
TJ
«f
5
CO
M
o
CO


CN"
~


.»-«
43

o"
II
O


CO
•4~*
• ^•4
CO




^
oo
0
en

-------
independent of ethnicity and parental employment status.  The association could have been
explained by lower compliance with prescribed treatment of their children's asthma by smoking
parents, but the authors found no significant differences in compliance (as assessed by an index of
asthma self-management activities) between smoking and nonsmoking parents. The authors
estimated that the additional cost for emergency care for asthma was $92  ± $68 per family per
year.
       O'Connor and coworkers (1987) performed bronchial challenges with subfreezing air in
292 subjects 6 to 21 years of age. They were selected from 879 eligible subjects of the same age
who were participating in a longitudinal study on respiratory illnesses in East Boston. An attempt
was made to include as many subjects as possible who reported a history of asthma or wheezing on
standardized questionnaires.  Therefore, the latter group of subjects were overrepresented among
those tested.  The change in FEV^ caused  by subfreezing air was significantly higher in asthmatic
subjects whose mothers smoked at least one cigarette per day than in those whose mothers were
nonsmokers.  This relationship was independent of age, sex, height, personal smoking, paternal
smoking, atopy, and baseline lung function.  There was no relationship between maternal smoking
and response to cold air among nonasthmatics.
       Murray and Morrison (1989) studied 415 nonsmoking children  aged 1 to 17 years
consecutively referred to an allergy clinic in Vancouver, Canada, for asthma or recurrent
wheezing of the chest.  Questionnaires were administered to the parents of all children at the time
of their first visit.  Forced expiratory flows and bronchial reactivity to histamine also were
measured.  An asthma symptom score was calculated for each subject based on the severity of
asthma and the need for medication, as reported by parents. Children  of smoking  mothers had
significantly higher indices of asthma severity (p < 0.01) and significantly lower FEVX (84.4%
predicted vs. 77.3% predicted, p < 0.01) than did children of nonsmoking mothers. They were also
significantly more responsive to histamine than were children of nonsmoking mothers (p = 0.01).
The effect was present in both genders but was stronger for boys than  for girls.  Also, the effect
was stronger for older children (12 to 17 years of age) than  for children 6 years of age or younger.
The authors also reported a positive correlation between length of exposure to ETS and asthma
symptom score. It  is unlikely that these results can be explained by parental overreporting
because the association between passive smoking and severity of symptoms paralleled that between
passive smoking and objective measurements of severity.
       In their previously reviewed report (Section 7.5.1), Krzyzanowski and coworkers (1990)
found that children exposed to ETS and to more than 60 ppb of formaldehyde had significantly
higher prevalence rates of asthma than those  exposed to only one of these contaminants or to none
(OR for the latter comparison = 9.0; 95% C.I. = 2.4, 34.0). No such association was seen among
                                           7-48

-------
adult household members. It is unlikely that this association is attributable to parental
overreporting of asthma because the authors relied on objective measurement of indoor
formaldehyde concentrations.
       Sherman and collaborators (1990) reported on the results of a longitudinal study of
determinants of asthma in a sample of 770 schoolchildren enrolled in East Boston in 1974.
Questionnaires were used to obtain data on respiratory symptoms and illnesses, cigarette smoking
history of parents and children, and  household demographics.  They were administered on entry
and for 11 consecutive years (1978-1988). Parents answered for children aged 9 or less, except for
questions on the child's smoking history. The authors identified risk factors for the onset of
asthma, the occurrence of which antedated the time of first diagnosis of asthma.  There was no
significant relationship between maternal smoking and either prevalence of asthma at the first
survey or incidence of new cases of asthma during followup (sex-adjusted RR = 1.1; 95% C.I. =
0.7, 1.7). The authors considered it unlikely that this finding could be due to exposure levels too
low to increase the risk of asthma. However, no effort was made to assess the relationship
between incidence of asthma and number of cigarettes smoked by parents. Likewise, no effort
was made to determine the possible role of factors known to modify exposure to ETS such as
parental socioeconomic level (Strachan et al., 1989).
       Weitzman and coworkers (1990) studied 4,331 children  aged 0 to 5 years who were part of
the U.S. National Health Interview Survey.  Children were categorized as having asthma if their
parents reported that asthma was current at the time of interview and had been present for more
than 3 months.  Mothers were asked about their smoking habits during and after pregnancy. Odds
of having asthma were 2.1 times as high (95% C.I. = 1.3, 3.3) among children of mothers who
smoked 10 or more cigarettes per day than among children of nonsmoking mothers. The risk of
having asthma was not significantly  increased in children of mothers who smoked fewer than 10
cigarettes per day. Use  of asthma medication was also more frequent among children of mothers
who smoked 10 or more cigarettes per day (OR = 4.1; 95% C.I. = 1.9, 8.9).  Results did not change
significantly after controlling for gender, race,  presence of both parents, family size,  and number
of rooms in the households.  No information was available on parental respiratory symptoms or
socioeconomic status.  The results of this study  could be explained partially by overreporting of
asthma  by smoking mothers.
        Oldigs and collaborators (1991) exposed 11 asthmatic children to ETS and to ambient air
for 1 hour. They found no significant difference in lung function or in bronchial responsiveness
to histamine after ETS exposure when compared with sham exposure.  The study was designed
only to  determine if acute exposures to ETS caused immediate  effects, and it did not assess the
changes induced by chronic exposure to ETS.                                      ,
                                           7-49

-------
       Martinez and coworkers (1992) studied incidence of new cases of asthma in a population
sample of 774 out of 786 eligible children aged 0 to 5 years enrolled in the Tucson study of
chronic obstructive lung disease. At the time of enrollment, the child's parents answered
standardized questionnaires about personal respiratory history and cigarette smoking habits.
Surveys were performed on-an approximately yearly basis, and parents were asked if the child had
been seen by a doctor for asthma in the previous year.  There were 89 (11.5% of the total) new
cases of asthma during followup. Children of mothers with 12 or fewer years of formal education
and who smoked 10 or more cigarettes per day were 2.5 times as likely (95% C.I. = 1.4, 4.6) to
develop asthma as were children of mothers with the same education level who did not smoke or
who smoked fewer than 10 cigarettes per day. This relationship was independent of self-reported
symptoms in parents.  Decrements in lung function paralleled the increase in asthma incidence.
No relationship was observed between maternal smoking and asthma incidence among children of
mothers with more than 12 years of formal education.
       Ehrlich et al. (1992) studied 72 children with acute asthma recruited in the emergency
room; 35 nonacute asthmatic children from an asthma clinic; and 121 control children without
asthma from the emergency room.  They assessed exposure to ETS both by questionnaire and by
measurement of urinary levels of cotinine/creatinine ratios. Smoking by maternal caregiver  was
significantly more prevalent among asthmatic children (OR = 2.0, 95% C.I. = 1.1, 3.4).  This  was
confirmed by a significant difference between groups in prevalence of cotinine to creatinine ratio
of greater or equal to 30 ng/mg (OR = 1.9; 95% C.I. = 1.0, 3.4).  There was no difference in
exposure indices between acute and nonacute asthmatics. The authors concluded that smoking by
a maternal caregiver was a significant risk factor for clinically significant asthma in children.

7.6.2. Summary and Discussion on Asthma
       There is now sufficient evidence to conclude that passive smoking is causally associated
with additional episodes and increased severity of asthma in children who already have the
disease.  Several studies have found that bronchial  responsiveness is more prevalent and more
intense among asthmatic children exposed to maternal smoke. Emergency room visits are more
frequent in children of smoking mothers, and these children also have been found to need more
medication for their asthma than do children of nonsmoking mothers (see Table 7-4).
       A simple bronchospastic effect of cigarette smoke is probably not responsible for the
increased severity of symptoms associated with passive smoking because acute exposure to ETS
has been found to have little immediate effect on lung function parameters and airway
responsiveness in asthmatic children.  Therefore, the mechanisms by which passive smoking
enhances asthma in children who already have the  disease are likely to be similar to those
                                           7-50

-------
 responsible for inducing asthma and entail chronic exposure to relatively hig;h doses of ETS (see
 discussion below). Murray and Morrison (1988) reported that ETS exposure decreased lung
 function and increased medication requirements in asthmatic children only during the cold, wet
 season and not during the dry, hot season in Vancouver, Canada. These seasonal differences may
 be at least partly explained by the finding by Chilmonczyk and collaborators; (1990) that urine
 cotinine levels of children exposed to ETS are significantly higher in winter than in summer.
 These seasonal fluctuations also suggest that the effects of passive smoking on asthma severity are
 reversible and that decreasing exposure to ETS could prevent many asthmatic attacks in affected
 children.
        New evidence available since the Surgeon General's report (U.S. DHHS, 1986) and the
 NRC report (1986) also indicates that passive smoke exposure increases the dumber of new cases
 of asthma among children who have not had previous episodes (see Table 7-7 for results and
 references). Although most studies are based on parental reports of asthma, it is highly unlikely
 that the relationship between asthma and ETS exposure is entirely attributable to reporting bias.
 In fact, concordance in the relationship between ETS exposure and both questionnaires and
 objective  parameters such as lung function or bronchial provocation tests has been reported in
 several  studies. The association is also biologically plausible; the mechanisms that are likely to be
 involved in the relationship between ETS exposure and asthma have been discussed extensively  in
 Section 7.2. The consistency of all the evidence leads to the conclusion that ETS is a risk factor
 for inducing new cases of asthma.  The evidence is suggestive of a causal association but is not
 conclusive.
        Data suggest that levels of exposure required to induce asthma in children are high; in
 fact, most recent and earlier studies that classified children as exposed to ETS if the mother
 smoked one cigarette or more usually failed to find any effect of ETS on asthma prevalence or
 incidence. Furthermore, two recent large studies found an increase in the prevalence (Weitzman
 et al., 1990) or incidence (Martinez et al., 1992)  of asthma only if the mother smoked 10 cigarettes
 or more per day.  It is also important to consider that, for any level of parental smoking, exposure
 to ETS is higher in children belonging to families of a lower socioeconomic level (Strachan et al.,
 1989) and that the relationship of maternal smoking to asthma incidence may be stronger  in such
 families (Martinez et al.,  1992). Concomitant exposure to other pollutants alsio  may enhance the
 effects of  ETS (Krzyzanowski et al., 1990).

7.7.  ETS  EXPOSURE AND SUDDEN INFANT DEATH SYNDROME
                                                                       I
       The relationship between ETS exposure and sudden infant death syndrome (SIDS) was not
addressed  in either the Surgeon General's report (U.S. DHHS, 1986) or in the NRC report (1986).
                                           7-51

-------
Because of the importance of this syndrome as a determinant of infant mortality and because of
the available evidence of an increased risk of SIDS in children of smoking mothers, the issue has
been added to this report (Table 7-8).
       SIDS is the most frequent cause of death in infants aged 1 month to 1 year.
Approximately 2 of every  1,000 live-born infants (more than 5,000 in the United States alone
each year) die suddenly and unexpectedly, usually during sleep, and without significant evidence
of fatal illness at autopsy (CDC, 1989b).  The cause or causes of these deaths are unknown. The
most widely accepted hypotheses suggest that some form of respiratory failure is involved with
most cases of SIDS.
       In 1966, Steele and Langworth (1966) first reported that maternal smoking was associated
with an increased incidence of SIDS. They studied the hospital records of 80 infants who had
died of SIDS in Ontario, Canada, during  1960-1961 and compared them with 157 controls
matched for date of birth, sex, hospital at which the child was  born, and parity of the mother.
Infants of mothers who smoked 1 to 19 cigarettes per day were twice as likely (OR = 2.1; 95%
C.I. « 1.1, 3.8) to die of SIDS as were infants of nonsmoking mothers.  The odds ratio was 3.6
(95% C.I. = 1.7, 7.9) when infants of mothers who smoked 20 or more cigarettes per day were
compared to infants of nonsmoking mothers. The authors reported that the risk of dying of SIDS
was higher in low-birthweight infants whose mothers smoked when compared with
low-birthweight infants whose mothers did  not smoke.  However, they made no effort to control
for other confounders that were related both to maternal smoking and to SIDS, such as maternal
age and socioeconomic status.  In addition, they made no reference to the relative roles of in utero
exposure to tobacco smoke products and  postnatal ETS exposure.
       Naeye and collaborators (1976) studied 59,379 infants born between 1959 and 1966 in
participating hospitals from several U.S.  cities.  After meticulous investigation of clinical and
postmortem material, they identified 125 of these infants (2.3 per 1,000 live births) as having died
of SIDS and compared  them  with 375 infants matched for place of birth, date of delivery,
gestational age, sex, race, and socioeconomic status. Infants of mothers who smoked were more
than 50% more likely (OR =  1.6; 95% C.I. = 1.0, 2.4) to die of SIDS than  were those of mothers
who denied smoking.  When  compared with the latter, infants of mothers who smoked six or more
cigarettes per day were 2.6 times more likely (95% C.I. = 1.7, 4.0) to die  of SIDS. The authors
made no attempt to distinguish between  in utero exposure to tobacco smoke products and ETS
exposure after birth.
       Bergman and Wiesner (1976) selected 100 well-defined cases of SIDS occurring in white
children in King County, Washington. These cases were matched for race, sex, and birth date
with 100 controls. Questionnaires were mailed to the mothers of cases and controls, but only 56
                                            7-52

-------

1
 •o
 I
 i
 ."I
 o
 §
 o

 S
 o

 £
 •s
 CM
 O
 oo
o


-

.,
Ir
***
§J
*




liiiiuiuiisi^ssiii



1
w
o
1
»t






tA
1
»
^
No control for socio-
economic status or

c
| 2
So" —
-• «
||
ii .£
OH O
0 g
g
g

^n •*
maternal age
•o

Si
• *M
II -^»
ll.a
\ ^ C
OO CT\ *^
•S t-' A




Maternal repor
hospital record
birth
|"
^0 —4
0 'w
.11
•o c
•3*
*"8
*!
c S
,« g
t*-4 d
•S*
o v>
00 — 1
^
0

oo
3
^
S
,2 G"
Q> VO
o> o\
oo C,



1
a
U
Ct
'§
•4^
c
O










Controlling for place
of birth, date of
delivery, gestational


<2 '^<2
•^ o o
^ i "*
•» °r •- *~{
i O g O
3 • i*^ •
i ^~* n c^
II
i p^ ^0^
1 O §O
g
0

*n •*
Maternal repor
hospital record
birth


c
II
B'S-
c .
*s ^3
•> >
«« «

,-^
*O
O\
O
• -a • •
•4_»
1
rt
z
age, sex, race, and
socioeconomic status


VO
^
**H
I >,
•S -5.
O 00
a •«























Independent of
maternal education,


c
oo'tH
^ 'G
•* "a
«N 0
ii t3
c4 «£
o *S
be

c >^
O rt
Maternal quest:
naire answered


•-
ll
*** "2
° ji
S ii
88

w
CO
CD
'^
•o
rt
d
S G
a3 °^
CQ O
1
X)
•0
§
n
g
CO
n
V


a
>>
1
4>
•4-^
O
g
IH
fi




S
^o,
5
ca
•8
C3

1
1
w
9
0
^e
^










1
•o


^
_^
^H
T
Tf
-
w
^


1^
<44
equivalent age
controls)


















I
1
§
o
o
Z,



rT
o\
• •*
Tf
II
OH
O




Maternal



g
oo
tM
O
at
0)
U
TT

a?
B^.
0\
•— '
•3
•4***
i
a>

possible confounding
factors













questionnaire


















Controlling for marital
status, maternal age,



f?
rvi
oo
II
Dd
O

a
o
*2
Maternal repor
birth certificati
.—
&
o
ol
I'"'
,d
j3 .
4^
t_l
3
|
o


oo
00
o\
"^

«

-------
•o
CO
O
o
00


r*


I
!
CQ
§










*2
*3
c8
Pi


CO W
O 0
o. 2
% s
4> co
E i
w 3





•o
d>
1
co
opulatioii
OH








0
4*^
<
CO
_ o
Controlling for age.
birthweight, and ra



{f^
o
o
°,
O.
^•^
rr
en
II
prf
O
to

'3
"3 c
S °
VH •*•*
£ M
1 S
2 cr





o ^^
..s-f
1-3"
5? C o>
O <£• ^,
881
K§ s
§§ §
oo —< o
oo
oo
•—<

.
•3
•*7^
Qj

1
(4-1


2 eo
Independent of
birthweight, maten
age, social status,
parity, sex, and typ
of birth
CO
g
• o

>4V M Wj
ri oarf\
ts'^j oT
cf. ° o
0
°°. S r-.
— • «N
II > 1!
BH S DH
OKO
CO
V*
•3
11
"- re
.2 «
5 S
2 cr


C5
CO
•o
CO

VI
_d
CO
^
.^H
oC
CM


o"
OS
O\
"Ct ^*^*
C3 co
c^ 3
•3 'oo
II
oo a
« cs
ffi 0


Independent of
prenatal care,
maternal age,
education, marital
55?
•*•**•
4^5 *^^ ^^
o^ — ; —I cvj
^j ^^ ^^ ^^
°J **? ""1
-* «N >«


^* ^*y
C3 °^
^> _ 2 o
oo 3 CM
0-2 AI
eo

'3'
3 1
C +2
11
W
|
g
O
o
>>
§
s a-
^ »
O Gi
si
— ro
^^
ON
ON
^H
^^
"3
t .
CO
=3
[^
S

— < •«
status, sex, neonata
problems, parity,
birthweight, race,
season of death, am
breastfeeding








































                                               7-54

-------
cases and 86 controls returned them.  Mothers who did not respond tended to be younger and
poorer.  A higher proportion of mothers of SIDS victims smoked cigarettes during pregnancy (61%
vs. 42%). Infants of mothers who smoked after delivery were 2.4 times as likely (95% C.I. = 1.2,
4.8) to die of SIDS as were infants of nonsmoking mothers.  The relationship between postnatal
exposure to ETS and SIDS was significantly stronger and only reached statistical significance for
mothers aged 25 years or less (OR = 4.4; 95% C.I. = 1.7, 11.2). Infants of mothers aged 25 years or
less who smoked 20 or more cigarettes per day were 7.7 times as likely to die of SIDS (95% C.I. =
1.7, 35.4) as were infants of nonsmoking mothers. Effects were independent of maternal
education.  The authors did not try to determine the independent effects of prenatal and postnatal
exposures to maternal smoking on the incidence of SIDS.                       -
       Lewak and coworkers (1979) studied all infants who died during the first year of life and
who were enrolled in a health plan in Oakland, California. Using predefined criteria, they
classified 44 infants (2.3 per 1,000 live births) as having died of SIDS and  compared them with the
rest of the population for several possible risk factors for SIDS. Mothers of  infants  who died of
SIDS were 4.4 times (95% C.I. = 2.1, 9.2) as likely to be smokers as mothers of infants who
survived. Paternal smoking had no significant influence on SIDS frequency.  The authors made no
effort to control for possible confounding factors, nor did they discriminate between the possible
roles of prenatal and postnatal exposure  to tobacco smoke products.
       Malloy and coworkers (1988) linked birth and death certificates to study possible risk
factors for neonatal and postneonatal mortality in over 305,000 singleton white live  births in
Missouri. They identified 372 infants whose deaths were attributed to SIDS (1.2 per 1,000 live
births).  Infants whose mothers smoked were 1.8 times as likely (95% C.I. = 1.4, 2.2) to die of SIDS
than were infants of nonsmoking mothers. This relationship was independent  of maternal marital
status, education level, age, parity, and child's birthweight. There were no data available  that
would have allowed one to differentiate the effects of prenatal and postnatal exposure to tobacco
smoke products.
       Hoffman and collaborators (1988) reported on the results of the National Institute of Child
Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death
Syndrome risk factors.  They studied 800 SIDS cases and 1,600 control infants  collected at six
study centers across the United States. Control infants were matched for age only (N = 800) or for
age, low birthweight, and race (N = 800). SIDS cases  were 3.8 and 3.4 times as likely to have
smoking mothers as the first and second control groups mentioned earlier, respectively (p < 0.005
for both comparisons).  There were no data on prenatal and postnatal exposure to tobacco  smoke
products.
                                            7-55

-------
       Haglund and Cnattingius (1990) examined risk factors for SIDS in a prospective study
based on more than 279,000 Swedish infants who survived the first week of life. SIDS was
reported as the sole cause of death in 190 infants (0.7 per 1,000), and in most cases the diagnosis
was confirmed by the results of an autopsy.  Infants of mothers who smoked one to nine cigarettes
per day were 1.8 times as likely (95% C.I. = 1.2, 2.6) to die of SIDS as were infants of nonsmoking
mothers. Infants of mothers who were heavy smokers had an even higher risk (OR = 2.7; 95%
C.I. = 1.9, 3.9) of dying of SIDS, suggesting an exposure-response  relationship. These findings
were independent of birthweight, maternal age, social situation, parity, sex, and type of birth. No
information was available regarding smoking in the household by either mother or father after the
infant's birth.
       Mitchell  and coworkers (1991) studied SIDS cases occurring in several health districts in
New Zealand between November 1, 1987, and October 31, 1988.  After careful assessment of the
material available from necropsy, 162 infants were classified as having died of SIDS (3.6 per 1,000
live births). These cases were  matched for age with three to four times as many controls. The
researchers interviewed the parents and obtained complete information for 128 cases and 503
controls. Information on maternal smoking during pregnancy (as a yes/no variable) was obtained
from the obstetric records, whereas information on number of cigarettes smoked by the mother in
the 2 weeks preceding the interview was obtained from questionnaires. Mothers of infants who
died of SIDS were 3.3 times as likely (95% C.I. = 2.2, 5.0) to smoke during pregnancy as were
mothers of controls.  The analysis of the relationship between maternal smoking after the child's
birth and frequency of SIDS showed clear evidence of a biological gradient of risk.  Odds ratios
were as follows:  1.9 (95% C.I.  =  1.0, 3.5) for mothers who smoked 1 to 9 cigarettes per day; 2.6
(95% C.I. - 1.5, 4.7) for mothers who smoked 10 to 19 cigarettes per day; and 5.1 (95% C.I. =
2.9, 9.0) for mothers who smoked 20 or more cigarettes per day. The association between
maternal smoking and SIDS frequency was independent of antenatal care, maternal age, maternal
education, marital status, sex, neonatal problems, parity, socioeconomic status, birthweight,
gestational age, race, season of death, sleep position at death, and breastfeeding.
       In summary, there is strong evidence that infants whose mothers smoke are at increased
risk of dying suddenly and unexpectedly during the  first year of life. This relationship is
independent of all other known risk factors for SIDS, including low birthweight and low
gestational age.  The finding that there is a biological gradient of risk extending from  nonsmoking
mothers to those smoking more than 20 cigarettes per day adds to the evidence that exposure to
cigarette smoke products is involved in the sequence of events that result in SIDS.  Available
studies cannot differentiate the possible effects with respect to SIDS of exposure to tobacco smoke
products in utero from those related to passive smoking after birth. As explained earlier (Section
                                           7-56

-------
7.2.2), both human and animal studies show that maternal smoking during pregnancy may modify
and potentiate the effects of postnatal ETS exposure.  The relationship between maternal smoking
and SIDS is independent of low birth weight, which is the most important known effect of
maternal smoking during pregnancy.  In addition, the incidence of SIDS is apparently associated
with days of higher air pollution  levels (Hoppenbrouwers et al., 1981), which could indicate a
direct effect of airborne contaminants.
       In view of the fact that the cause of SIDS is still unknown, it is not possible to assess the
biological plausibility of the increased incidence of SIDS related to ETS exposure. Consequently,
at this time this report is unable to assert whether or not passive smoking is a risk factor for SIDS.

7.8.  PASSIVE SMOKING AND  LUNG FUNCTION IN CHILDREN
       The Surgeon General's report (U.S. DHHS, 1986) reviewed 18 cross-sectional and
longitudinal studies on the effects of ETS exposure on lung function in children (Table 7-9). The
report concluded that "the available data demonstrate that maternal smoking reduces lung function
in young children" (page 54). The hypothesis was proposed that passive smoking during
childhood, by affecting the maximal level of lung function attainable during early adult life, may
increase the subsequent rate of decline of lung function and, thus, increase  the risk of chronic
obstructive lung disease.
       The NRC report (1986) reached similar conclusions after reviewing  12 articles (Table 7-9).
The authors' summary asserted that "estimates of the magnitude of the effect of parental smoking
on FEVj function in children range from 0 to 0.5% decrease per year. This small effect is
unlikely by itself to be clinically  significant. However,  it may reflect pathophysiologic effects of
exposure to ETS in the lungs of the growing child and, as such, may be a factor in the
development of chronic airflow obstruction in later life" (page 215).

7.8.1.  Recent Studies on Passive Smoking and Lung Function in Children
       Studies appearing since the 1986 reports are presented in Table 7-10.
       Lung  function measurements were included in the cross-sectional study by O'Connor and
collaborators (1987) described earlier (Section 7.6.1).  When compared to 97 nonasthmatic children
of nonsmoking mothers (mean age ± SEM = 12.8 ± 0.3  years), 168 nonasthmatic children of
smoking mothers (mean age  ± SEM  = 12.9 ± 0.2 years)  had significantly lower mean percentage
of predicted FEVj (mean ±  SEM = 108.0 ± 1.4 vs.  101.4 ± 1.1, respectively, p < 0.001) and
significantly lower FEF25.75 (103.0 ± 2.3 vs. 88.2 ± 1.5, respectively, p < 0.001). These effects
were independent of personal smoking by the child.
                                           7-57

-------
Table 7-9. Studies on pulmonary function referenced in the Surgeon General's and National
Research Council's reports of 1986
  Study
 No. of
subjects
Age of subjects
Surgeon
General
NRC
  Berkey et al. (1986)           7,834
  Brunekreef et al. (1985)         173
  Burchfield et al. (1986)       3,482
  Chen and Li (1986)             571
  Comstoek et al. (1981)        1,724
  Dodge (1982)                  558
  Ekwo et al. (1983)            1,355
  Ferris et al. (1985)           10,000
  Hasselblad et al. (1981)      16,689
  Kauffmann et al. (1983)       7,818
  Kentner et al. (1984)          1,851
  Lebowitz (1984)                117
  Lebowitz and Burrows          271
  (1976)
  Schilling et al. (1977)            816
  Tager et al. (1979)              444
  Tager et al. (1983)            1,156
  Tashkin et al. (1984)          1,080
  Vedal et al. (1984)            4,000
  Ware etal. (1984)            10,106
  Weiss etal. (1980)              650
  White and Froeb (1980)       2,100
          Children (6 to 10)              X
          Adult women                  X
          Infants/children (0 to 10)        X
          Children/adol. (8 to 16)         X
          Adults                         X
          Children (8 to 10)              X
          Children (6 to 12)              X
          Children/adol. (6 to 13)
          Children (5 to 17)              X
          Adults                         X
          Adults                         X
          Families                       X
          Children/adol. (<16)            X

          Children/adol. (<18)            X
          Children (5 to 19)
          Children (5 to 9)                X
          Children (7 to 17)              X
          Children (6 to 13)              X
          Children (6 to 13)
          Children (5 to 9)                X
          Adults                         X
                                           X
                                           X
                                           X
                                           X
                                           X
                                           X
                                           X

                                           X
                                           X
                                           7-58

-------
I
 o
 ft
•2
 o

I
 DO
 00
 e

2

 I
 CO
•s
 CD
 CO

rS

 §



t
  o
 o
 a
 CD

 4-1



 I
f-

1
I
I
O



rt
(a



S
Is
o,  55
W3 n?

W2
TO
T3
*j
£



B
0
t;
3
^

Independent of
personal smoking
habits
^ As "*
g W +|S ^g -H
ttJ ^^ ^S \f ti ^*^
^S j* OO Clt 'T'J ®® '
S ja "^ "~I o. °>
Iff ^e^
llliJsf



*— 4 CJ
S 0
g'-s


Bu or
97 children (12.8 ± 0.3 yr.)
of smoking mothers;
168 children (12.9 ± 0.2 yr.
of nonsmoking mothers in
Boston, Massachusetts

-3 •
a>
IH
I-

C9^
y o\
O C-

Interaction between
family history of
,
c
o
a-g
>^:
S "
£ S

CO


respiratory illnesses
and passive smoking
for Vmax50% residual

••*
*-*4
i
5
**3



Smoking mot
smoking mot!
(residuals) +3
(p<0.001)



I
maire
IS o
a *2

N
-4_»
fe j^"N
S 00
*ir ^\
jo






































—
Ol
c:



1
co1
1-,
1

s
o
+•*
"8
CO
0
O.
X
CO
CO
S
CO
5
(4

"3
d>
.a
c
.2
O^
S
• w*
H

o
r*
'r.
8
10


CO
W
o
•M
H
CO
Q

X
CO
5
CO
O
a
X
CO
•4-1
§
CO
CO
4-*
,33
15 C/3
3 W




^^^s.
r^
oo

*~H

Independent of sex,
town of origin, age,

§2
, O
co e>
CO ||



[
maire
^3 M
S O
C
Oi co

& §•
1,160 French children
-3
aS
j-
g_
ej^ ,O
9 oo
c3 O\



height, weight, and
family aggregation of
lung function

8
10
UH
O ^^
CJ 0
S3








































T3
Independent of sex,
birthweight, neonatal
respiratory illness, am

co TT
TS 
^ X1"
«? CO 0*
Mean Vraax75
predicted) in
nonexposed 8
CM
0 oo
•52 C
§•1
- !
c C
U, CD
CO *M

2 "3
130 children of low
birthweight at age 7 yr. in
England



"3
CO O
JO\
Q^
U O

treatment



o
0
V
•a


















                                                                                                                 CD


                                                                                                                 %

                                                                                                                 O,

                                                                                                                •4-*

                                                                                                                C

                                                                                                                O
                                                                                                                O
                                                                                                                o
                                                        7-59

-------
      3
Observa

  00 >.
  .S °
O *^S ro
S s S>


"S-a &

                    2 * o
                    Say
         .9*.


         to *T

         i^^

                             '
                            — a rt
                                    •o
                    (U
    S
           30

         «-2
         § t«
                   II
                   C 4-»
                   fli CO


                   1 §

                   Cu or
                            00 «
                            et> el

                            « I 2
                            ••a -
            1
            I
      CIS
          o
                              O -d e
                              *-
          O)
            a>

            3
4)
                      O\
                    on
                    i-

                    I

                                          CT\
                              7-60

-------
       Lebowitz and coworkers (1987) reported on the results of a longitudinal study of
pulmonary function development in Tucson, Arizona. The authors analyzed 1,511 observations
over an average followup period of 8.8 years in 353 subjects aged 5.5 to 25 years.  The last
available lung function value (as residuals after regressing the data with different power functions
of age and height) was used as outcome.  Residuals for vital capacity were significantly higher
among subjects aged 14 years or less at entry whose mothers smoked cigarettes (mean = +3.3 vs.
-1.4 among nonexposed subjects, p < 0.001).  Parental smoking had no direct effect on outcome
FEY], or Vmax50%, but showed significant interactions with personal smoking and parental history
of airway obstructive diseases in their effects on Vmax50%; subjects who had started smoking or
whose parents had airway obstructive diseases and were exposed to ETS had the lowest Vmax50%
residuals at the  end of followup.
       In subsequent reports, Lebowitz and Holberg (1988) and Tager and coworkers (1987)
reanalyzed two  sets of longitudinal pulmonary function data:  the one on which the preceding
study from Tucson,  Arizona, was based (Lebowitz et al.,  1987) and data for children of similar age
from East Boston, Massachusetts (Tager et al., 1983).  The objective was to determine if the
different answers with regard to the effect of  maternal smoking (significant for the Boston study;
no effect for the Tucson study) were due to the use of different statistical tools. Applying the
same multivariable analysis of covariance for both data sets, Lebowitz and Holberg (1988)
confirmed the positive effect of maternal smoking of FEF25_75% with the data from Boston (p <
0.05) and the lack of a significant effect of maternal smoking on Vmax50% with the data from
Tucson, Arizona. A first-order autoregressive model applied by Tager and collaborators (1987) to
both data sets showed effects of maternal smoking on FEVj with the Boston data but not with the
Tucson data. The authors concluded that the most likely factor responsible for the disparate
results was the exposure difference in the two populations.
       Tsimoyianis and collaborators (1987) compared the prevalence of low levels of FEF25_75%
(< 70% of predicted) in athletes exposed and unexposed to ETS (for more information on this
study see Section 7.5.1). Of 132 exposed athletes,  18 (13.6%) had low FEF25_75% compared with  2
of 61 (3.3%) unexposed athletes (OR = 4.7; 95% C.I.= 1.1, 20.8).
       Kauffmann  and collaborators (1989b) assessed familial factors related  to lung function in a
cross-sectional study of 1,160 French children. Levels of lung function (FEVj and FEF25_75%)
were significantly lower in children with mothers who smoked when compared to those whose
mothers were nonsmokers.  The authors reported a loss of 10 mL of FEVj (p < 0.05) and of 15
mL/s of FEF25_75%  (p < 0.01) for every gram of tobacco  smoked per day by the mother.  These
associations were independent of sex, town of origin, age, height, weight, and intrafamilial
aggregation of lung function. There was no effect of paternal smoking on lung function.
                                           7-61

-------
        Chan and coworkers (1989b) performed lung function tests in a cohort of 130 children of
 low birthweight (under 2,000 grams) at 7 years. These authors had previously reported on the
 respiratory outcome of these same children (see Section 7.5.1). Children of low birthweight whose
 mothers smoked had significantly lower values of percentage of predicted Vmax75% than did low-
 birth weight children whose mothers did not smoke (80.7% vs. 91.4%, p < 0.01). This association
 was independent of sex, birthweight, neonatal respiratory illness, and treatment.  As 92% and 79%
 of mothers who smoked when the child was 7 years old were smokers before and during their
 pregnancy, respectively, it was not possible to determine whether the effect of maternal smoking
 was fetal or postnatal.
       The study by Dijkstra and collaborators (1990) has been described earlier (Section 7.5.1).
 The authors studied, together with respiratory symptoms, lung function and its relationship with
 indoor exposures to ETS and nitrogen dioxide in a population of 634 Dutch children 6 to 12 years
 of age.  When compared with unexposed children, children exposed to ETS had significantly lower
 levels of FEVi (-1.8%; 95% C.I. = -0.2, -3.3), FEF25.75%  (-5.2%; 95% C.I. = -1.4, -8.8) and
 Peak Flow (-2.8%; 95% C.I. = -0.6,  -4.8). Adjustment for smoking by the mother when she was
 pregnant with the investigated child removed little of the effect of current ETS exposure on lung
 function. The authors  suggested that this indicated that the associations seen at ages 6 to 12 years
 were not just mirroring harm that was caused when the children  were exposed in utero to tobacco
 smoke components inhaled by the mother.  There was no association between exposure to NO2 and
 lung function.
       A previously mentioned study by Strachan and coworkers (1990) (Section  7.5.1) included
 lung function  measurements in 757 children.  Lung function variables were adjusted for sex,
 height, and housing characteristics. The authors found a significant negative correlation between
 salivary cotinine concentrations and levels of FEF25_75% (p < 0.05) and Vmax75% (p < 0.05). For
 these indices, the difference between adjusted mean values  for the  top and bottom quintiles of
 salivary cotinine was of the order of 7% of the mean value in the children with undetectable
 levels.
       The longitudinal study by Martinez and coworkers (1992) has been  reviewed earlier
 (Section 7.6.1). In addition to their findings on incidence of childhood asthma, these authors
 reported  that, at the end of followup, children of mothers with 12 or fewer years  of formal
education and  who smoked 10 or more cigarettes per day had 15% lower mean values for
percentage of predicted FEF25_75% than did children of mothers of  the same level of education
who were nonsmokers or smoked fewer than 10 cigarettes per day.  Maternal smoking had no
effect on percentage of predicted FEF25_7S% values in children of mothers who had at least some
education beyond high school.  Female children of smoking mothers (£: 10  cig./day) had 7%
                                          7-62

-------
higher vital capacity than did female children of mothers who were nonsmokers or light smokers
(< 10 cig./day), and this was independent of maternal education. All differences were still
significant after controlling for parental history of respiratory disease.

7.8.2. Summary and Discussion on Pulmonary Function in Children
       This report concludes that there is a causal relationship between ETS exposure and
reductions in airflow parameters of lung function (FEV15 FEF25_76%, Vmax50%, or Vmax75%) in
children.  For the population as a whole, these reductions are small relative to the intraindividual
variability of each lung function parameter; for FEF2B_76%, for example, reductions range from
3% to 7% of the levels seen in unexposed children, depending on the study analyzed.  Groups of
particularly susceptible or heavily exposed subjects have larger decrements: Exposed children of
low birthweight, for example, had 12% lower Vmax75% than did children of similar birthweight
who were not exposed to ETS (Chen, 1989).  Likewise, children of less educated mothers who
smoked 10 or more cigarettes per day were shown to have 15% lower mean FEF25_75% than
children of less educated mothers who did  not smoke or smoked fewer than 10 cigarettes per day.
This stronger effect may be explained by Strachan and coworkers' (1989) finding that children of
lower socioeconomic status have higher salivary cotinine levels, for any amount of parental
smoking, than do children of higher socioeconomic status.
       The studies reviewed suggest that a continuum of exposures to tobacco products starting in
fetal life may contribute to the decrements in lung function found in older children.  In fact,
exposure to tobacco smoke products inhaled by the mother during pregnancy may contribute
significantly to these changes, but there is strong  evidence indicating that postnatal exposure to
ETS is an important part of the causal pathway.
       New longitudinal studies have demonstrated that young adults who were exposed earlier in
life to ETS are also more susceptible to the effects of active smoking (Lebowitz et al., 1987). In
addition, Sherrill and collaborators (1990) showed, in a longitudinal study, that children who
entered a longitudinal study with lower levels of lung function still had significantly lower levels
later in  life.  The high degree of tracking shown by these spirometric parameters implies that the
decrements in lung function related  to passive smoking may persist into adulthood.  Although the
subsequent rates of decline in lung function of these subjects have yet to be studied in detail, the
findings by Sherrill and coworkers (1990) support the idea proposed by the Surgeon General's
report (U.S. DHHS, 1986) that, by the mechanisms described above, passive smoking  may increase
the risk of chronic airflow limitation.
                                           7-63

-------
7.9. PASSIVE SMOKING AND RESPIRATORY SYMPTOMS AND LUNG FUNCTION IN
     ADULTS
       Both the NRC report (1986) and the Surgeon General's report (U.S. DHHS, 1986)
extensively reviewed the evidence then available on involuntary smoking and respiratory health in
adults. The Surgeon General's report concluded that healthy adults exposed to ETS may have
small changes on pulmonary function testing but are unlikely to experience clinically significant
deficits in pulmonary function as a result of exposure  to ETS alone.  The report added that the
small magnitude of the effect implied that a previously healthy individual would not develop
chronic lung disease solely on the basis of ETS exposure in adult life. It was suggested that small
changes in lung function may be markers of an irritant response, possibly transient, to the irritants
known to be present in ETS.
       The NRC report concluded that it was difficult to document the extent to which a single
type of exposure like ETS affects lung function. The  report attributed this difficulty to the large
number of factors, including other exposures, that affect lung function over a lifetime.  The
report added that results in adults should be evaluated for possible misclassification of ex-smokers
or occasional smokers as nonsmokers, as well as possible confounding by occupational exposures to
other pollutants. The authors of the report considered it "unlikely that exposure to ETS can cause
much emphysema" (page 212), but that, "as one of many pulmonary insults, ETS may add to the
total burden of environmental factors that become sufficient to cause chronic airway or
parenchyma! disease" (page 212).

7.9.1.  Recent Studies on Passive Smoking and  Adult Respiratory Symptoms and Lung Function
       Six recent studies of respiratory symptoms and lung function in adults are presented in
Table 7-11.
       Svendsen and collaborators (1987) studied longitudinal data from 1,245 married American
men aged 35 to 57 years who reported that they had never smoked. Subjects who had smoking
wives had significantly higher mean levels of exhaled carbon monoxide (7.7 vs. 7.1  ppm,
p < 0.001) but not of serum thiocyanate.  These men also had lower levels of age- and
height-adjusted FEVi (mean difference = 99 mL; 95% C.I. = 5, 192.4 mL).  However, those with
wives who smoked 20 or more cigarettes per day had higher mean adjusted ¥EVt (3,549  mL) than
those with wives who smoked 1 to 19 cigarettes per day (3,412 mL), whereas nonexposed subjects
had mean adjusted FEVj^ of 3,592 mL.
       Kalandidi and coworkers (1987) studied 103  Greek ever-married women aged 40 to 79
who were admitted in 1982 and 1983 to a hospital in Athens with obstructive or mixed type
reduction of pulmonary function, without improvement after bronchodilatatiori.  The women
                                          7-64

-------
                  11
                                o
No dose

response

effect
                           _
                           8-s
                           60 <-.
                                      g „ .3 a G .53 .3
                                      h ^ o- g .,_, *3 a
                                      S 3 8 H i a.»
                                                         4)

                                                         §?
                                                         a
                                              £

                                              "o
                                           	— *f* • *"*

                                               CO CO
           8S

           ga-
      1
       CO
       

I § CO a> I CO .a 00 I g I a (D psipn^ O eo O '2 a. o £ a -CO « 8"8 a CM O ou i! £i « " ^_, CO o *a> CD CO mJS 00 a 9 X — o o oo £-s o ^ q. o £ a CO " « ^° .«|.S •2°-2 p Q, rt on sTJ= a . ^ >» .2 <^ jS C ^o o <« Ifigs tN r\j dJ oo . 00 » 00 < IS •o « P oo ._ o\ !^O .5 OS d ON oo 7-65


-------
 JS
 o
                  43   e

                  00   "

                ,  '& « o



                Mlfi
                  O<1) K p »*J
                  ui o> 55 js
                              s
 I
 I
      o
      o
     •S

     • ^4

      C
             eO
       f  a>



       hJ -^H
» 'S4 C
      II


   c-0

    o|
    v^ fi
    n eoA
   •C^<^

   *o "S,"^


I  I IS

s?  il^
o  >-3 43 •—
 a>
 o
       *


o   .


1
    •
    § I
                      s-a
                      s  s
                    .gS^'S .2
                     rv Q. 
So "2
      o o
      a> o
     •r>co

     O\
     r- vo

                    §
                                     a>
     oo
                     C O
                     ca o

                     N^
      CO


      0>
                    ^
                       00
                                  7-66

-------
denied that they had ever been smokers, and their husbands' smoking habits were compared with
those of 179 ever-married controls of the same age selected from visitors to the hospital. Patients
were 1.9 times more likely to have smoking spouses than were controls (95% C.I. = 1.0, 4.0).
However, odds ratios were higher for women whose spouses smoked 20 or fewer cigarettes per
day (2.5) than for those whose spouses smoked more than 20 cigarettes per day.  The unusually
high number of nonsmoking women hospitalized with chronic lung disease in a 2-year period
suggests that some could have severe asthma unresponsive to bronchodilators and that the results
could in part illustrate exacerbation of symptoms in asthmatic women exposed to ETS.
       Masi and coworkers (1988) mailed questionnaires to 818 subjects aged 15 to 35 who had
previously performed detailed lung function testing and carboxyhemoglobin (COHb)
measurements.  A total of 636 subjects responded to the questionnaire, and 293 denied having
smoked regularly before the date of the  lung function tests.  All but five subjects had COHb
values below 5 grams %.  Questionnaires assessed past and present ETS exposure, both at home
and at work. Indices of cumulative exposure to ETS at home and at work were calculated from
the number of reported smokers on each location, the smoking conditions reported for each area,
and the number of years of exposure. In men, there were significant inverse relationships
between cumulative exposure to ETS in the home and maximal expiratory flows at low lung
volumes. A more detailed analysis showed that in these subjects, exposure before 17 years of age
had the strongest effects on lung function, whereas exposure in the 5 years preceding the lung
function tests had no effect on lung function.  Exposure at work significantly decreased the
diffusing characteristics of  the lung in women.
       Kauffmann and collaborators (1989a) compared the results obtained from a parallel
analysis of the association of passive smoking with respiratory symptoms and lung function in
2,220 American women aged 25 to 69 years  and 3,855 French women aged 25 to 59 years.  Women
were classified according to their personal and current  spouse's smoking habits. After adjusting
for age, city of origin, educational level, and occupational exposure, ever-passive-smokers
(excluding active smokers) had significantly more wheeze than true never-smokers (i.e., never
active and  with nonsmoking spouse) in the U.S. sample (OR of approximately 1.3; C.I. cannot be
calculated). There was a positive trend  for French passive smokers to have more chronic cough
(OR = 1.4) and dyspnea (OR = 1.2), but both results could be due to  chance (95% C.I. = 0.8, 2.4
and 0.9, 1.6, respectively).  In both samples, no significant decrease of lung function was observed
for passive smokers compared with true never-smokers in the whole sample, although FEVj/FVC
values for  ever-passive-smokers tended to be intermediate between those of true never-smokers
and ex-smokers or active smokers. French women aged 40 or older who were passive smokers  had
                                           7-67

-------
significantly lower FVC (p < 0.01) and FEVl (p < 0.01) than did true never-smokers, but no such
effect was seen among American women of the same age.
       Hole and coworkers (1989) studied cardiorespiratory symptoms and mortality in a cohort
of 7,997 subjects aged 45 to 64 and followed for 11 years in urban west Scotland. A self-
administered questionnaire was used in  1972-76 to assess respiratory symptoms and active
smoking by each member of the household.  When compared with true never-smokers (i.e.,
persons who were not active smokers and did not live with an active smoker), passive smokers
were invariably at a higher risk of having each cardiorespiratory symptom examined (including
infected sputum, persistent sputum, and dyspnea), but all 95% confidence intervals for odds ratios
included 1.  FEV^ (adjusted for sex, age, and height) was significantly higher in true never-
smokers than in passive smokers (p < 0.01), but this effect was mainly due to the low adjusted
FEVj of passive smokers with high exposure (i.e., exposed to a cohabitee who smoked >  15
cig./day; mean = 1.83 L) when compared with those with low exposure (mean = 1.89 L) or with no
exposure (mean = 1.88 L).  This study was initiated when there was little concern for the possible
ill effects of passive smoking and is based on self-reports of active smoking by cohabitees.  It is
thus probably  not affected by classification bias due to overreporting of symptoms by smokers.
       Schwartz and Zeger (1990) studied data from a cohort of approximately 100 student nurses
in Los Angeles who kept diaries of acute respiratory symptoms (cough, phlegm, and chest
discomfort)  and for whom data on exposure to passive smoking and air pollution were available.
After controlling for personal smoking,  a smoking  roommate increased the risk of an episode of
phlegm (OR * 1.4; 95% C.I. = 1.1, 1.9) but not of cough. The authors also excluded asthmatics (on
the assumption that medication could bias the results) and found that in this case, the odds ratio of
having phlegm increased to 1.8 (95% C.I. = 1.3, 2.3).  The greater sensitivity of diaries of acute
symptoms such as those used herein, compared with the indices of period prevalence of symptoms
used in other studies, may  have increased  the power of this study.  However, overreporting by
exposed subjects is still a possible source of bias in a study that is solely based on self-report of
symptoms.

7.9.2. Summary and Discussion on Respiratory Symptoms and Lung Function  in Adults
       Recent studies have confirmed the conclusion by the Surgeon General's report
(U.S. DHHS, 1986) that adult nonsmokers exposed to ETS may have small reductions in lung
function (approximately 2.5% lower mean FEVj in the studies by Svendsen et al. [1987] and Hole
et al. [1989]). Using modern statistical tools designed for longitudinal studies, new evidence also
has emerged suggesting that exposure to ETS may increase the frequency of respiratory symptoms
                                           7-68

-------
in adults.  These latter effects are estimated to be 30% to 60% higher in ETS-exposed nonsmokers
compared to unexposed nonsmokers.
       Because active smoking causes significant reductions in lung function and significant
increases in prevalence of respiratory symptoms (U.S. DHHS, 1984), the reported effects of
passive smoking in adults are biologically plausible.  From a quantitative point of view, effects of
passive smoking on lung function are approximately comparable to those reported for light (< 10
cig./day), male active smokers (Camilli et al., 1987). However, because of the self-selection of
smokers and other factors, it is difficult to make direct quantitative comparisons between the
effects of active and passive smoking. The process of self-selection is likely to occur among
smokers by which more susceptible individuals never start smoking or quit smoking early in life
(the "healthy smoker" effect). Therefore, lower lifetime doses may be required to elicit effects
among nonsmokers than among smokers. The different nature of ETS and MS also has been
discussed in previous chapters and must be taken into account when comparing effects of active
and passive smoking.
       Several sources of bias and confounding factors need to be considered in studies of the
effects of single exposures in adults.  Classification bias due to underreporting of active smoking
or past smoking may significantly affect the results of these studies.  Because there is marital
aggregation of smoking (i.e., smokers tend to marry smokers, and nonsmokers are more prone to
marry nonsmokers),  this source of misclassif ication is more probable among spouses of smokers
and may introduce differential biases in some studies. The resulting small overestimation  of
effect may be nevertheless substantial for effects that are particularly subtle, such as those
described for ETS exposure  in adults. In addition, recent public concern with passive smoking
may increase the awareness of respiratory symptoms in exposed subjects, who may be thus more
prone to report symptoms than are unexposed subjects.  Studies using objective measures of lung
function obviously are not affected by the latter type of bias.
       Adults are exposed to multiple sources of potentially harmful substances during their
lifetimes, and it is not always possible to control for the effects of these substances because they
often are unknown or unmeasurable. In general, the majority of these exposures should introduce
nondifferential error to the studies, which would lead to underestimates of the true effects. For
example, a significant nondifferential error may be introduced by ETS exposure during
childhood, which is  known to cause decrements in lung function (see Section 7.7) that may be
carried into adulthood.  ETS exposure during childhood also is known to cause childhood
respiratory diseases (see Sections 7.3, 7.5, and 7.6).  Such childhood respiratory diseases, whatever
the cause, also may be reflected  in decreased respiratory health in adulthood.  These effects have
                                            7-69

-------
not been accounted for in the studies of ETS exposure and lung function in adults, but it is likely
that they would lead to underestimates of the ETS effects in the adult studies.
       Conversely, effects of ETS would be overestimated if a certain noxious exposure were
more likely to occur among ETS-exposed subjects. In this sense, social factors need to be
accurately controlled, because prevalence of smoking is significantly higher among less educated
than among higher educated subjects (Pierce et al., 1989).  Most reviewed studies have controlled
for indices of socioeconomic level in a satisfactory manner. Finally, lifestyles may differ between
spouses of smokers and those of nonsmokers, but it is not possible to determine a priori the effect
of this confounder on the relationship between passive smoking and respiratory health.
       The influence of these factors and sources of bias, together with the subtlety of the
effects, may explain the  inconsistent and sometimes contradictory results of the studies reviewed
in this report. In fact, such variability should be expected, particularly for studies with relatively
low power (i.e., low probability of finding a statistically significant difference when a difference
really exists).  The lack of a dose-response relationship in some studies also may be explained by
the multiplicity of uncontrolled factors that may affect lung function.
       In summary, recent evidence suggests that passive smoking has subtle but statistically
significant effects on the respiratory health  of nonsmoking adults.
                                            7-70

-------
         8. ASSESSMENT OF INCREASED RISK FOR RESPIRATORY ILLNESSES
               IN CHILDREN FROM ENVIRONMENTAL TOBACCO SMOKE

       In the preceding chapter, a review was presented of recently published studies regarding
the association between respiratory illnesses in children and environmental tobacco smoke (ETS)
exposure. The biological plausibility and the possible pathogenetic mechanisms involved in each
group of illnesses included in the chapter also were discussed.  The purpose of this chapter is to
consider the weight of the evidence as a whole, to analyze in detail possible sources of systematic
bias or confounding that may explain the observed associations, and to estimate the population
impact of ETS-associated respiratory illnesses.

8.1.  POSSIBLE ROLE OF CONFOUNDING
       In the review of the available evidence indicating an association (or lack thereof) between
ETS exposure and the different outcomes considered in this report, the possible role of several
confounding factors was analyzed in detail (see Chapter 7).  Such analysis will only be summarized
here.
       •    Other indoor air pollutants (wood smoke, NO2, formaldehyde, etc.) have not been
             found to explain the effects of ETS but may interact with it to increase the risk of
             both respiratory illnesses and decreased lung function in children.
       •    Many of the studies reviewed in this report and in those of the National Research
             Council (NRC,  1986) and the Surgeon General (U.S. DHHS, 1986) used either
             multivariate statSstical methods of analysis or poststratification of the sample to
             control for the possible confounding effects of socioeconomic status. Others
             controlled for this effect by study design. It can be concluded that socioeconomic
             status does not explain the reported effects of ETS on children's health, although
             children belonging to some social groups may be at an increased risk of suffering the
             effects of passive smoking (see also Section 8.3).
        •    The effect of parental symptoms on the association between ETS and child health
             also has been extensively analyzed.  It can be concluded that, although parents with
             symptoms may  be more aware of their children's symptoms than are parents without
             symptoms,  it is unlikely that this fact by itself explains the association. In fact,
             objective parameters of lung function, bronchial responsiveness, and atopy, which
             are not subject to such sources of bias, have been found to be altered in children
             exposed to ETS.
                                             8-1

-------
        •    The effects of passive smoking may be modified by several characteristics of the
             exposed child. Increased risk has been reported in premature infants and infants of
             low birthweight, infants who are not breast-fed, infants who are kept at home with
             smoking mothers and not sent to day-care centers, asthmatic  children, and children
             who are active smokers.
        •    Maternal smoking during pregnancy has significant effects on fetal growth and
             development and may affect lung growth as well as the immunologic system.
             However, reports of important effects of paternal smoking on the child's health and
             studies in which ETS exposure was found to have effects that were independent of
             in utero exposure indicate that maternal smoking during pregnancy does not explain
             the  relation between passive smoking and child health, but modifies the effects of
             ETS.
        In summary, there are no single or combined confounding factors that can explain the
 observed respiratory effects of passive smoking  in children.

 8.2. MISCLASSIFICATION OF EXPOSED AND UNEXPOSED SUBJECTS
        The importance of misclassification of exposed and  unexposed children has not been
 addressed and will be analyzed in detail below.
        Two possible sources of systematic bias related to subject misclassification are considered.
 The first is upward bias from the effect of active smoking in children; the  second is downward
 bias due to misreporting and background exposure.  Both have also been considered in the
 assessment of ETS and  lung cancer in adults. Adjustment for background exposure will be  similar
 to that presented  in Chapter 6, except that data for increased incidence of some ETS-associated
 respiratory diseases show some evidence of thresholds that must also be taken into account.

 8.2.1.  Effect of Active Smoking in Children
       The possibility needs to be considered that some children may be smokers themselves and
 that this may happen more often among children of smoking parents than among those of
 nonsmoking parents. This would bias the  results upwards or against the null effect. This source
 of bias is only applicable to studies of older children; regular active smoking may occur but is rare
 before early adolescence. A study of third graders in Edinburgh, Scotland, by Strachan and
 coworkers (Strachan et al., 1989, see Section 7.4.1, for example) showed that salivary cotinine
 levels compatible  with active smoking were found in 6 of 770 children ages 6-1/2 to 7-1/2 years,
suggesting only a  small  potential for bias.  Consideration should also be given to the fact that some
                                           8-2

-------
of the effects described m Chapter 7 (for example, the increased risks for acute respiratory
illnesses [Section 7.3] and for cough, phlegm, and wheezing [Section 7.5]) have been found to be
stronger in younger children (i.e., those less likely to be active smokers) than in older children.
This observed reduced effect with increasing age may be in part due to an age-related  increase in
misclassification of exposed subjects as "unexposed" (see below), but it is clear that these specific
effects of ETS do not increase  with age, as would be expected if active smoking biased the results
of studies of ETS effects in older children. It can thus be concluded that the association between
respiratory health in children and ETS is  not attributable to active smoking by some  children. It
has been suggested that active  and passive smoking may interact to increase the effects of either
exposure separately (Lebowitz and Holberg, 1988). This interaction is biologically plausible,
because it is likely that active smoking may be more harmful in children whose lungs have been
previously affected by ETS (see Section 7.1).

8.2.2.  Misreporting and Background Exposure
       Various investigators have measured cotinine levels in body fluids in infants  and children
and correlated the results with parental reports of ETS exposure. Coultas and coworkers (1987)
reported that  37% of children  under 5 years of age whose parents were nonsmokers had a salivary
cotinine level greater than  0, compared with 32% of children ages 6 to 12 and with 35% of
children ages  13 to 17. These  authors did not ask parents to report possible sources of ETS
exposure for their children other than their own tobacco consumption.  Strachan and coworkers'
study in 6-1/2- to 7-1/2-year-old children in Scotland (Strachan et al., 1989) showed  that 73% of
children from households with no smokers had detectable  concentrations  of cotinine in saliva,
whereas only  1 in 365 children from households with one or more smokers had no detectable
salivary cotinine.  The assay used by Strachan and coworkers was  10 times more sensitive than that
used by Coultas and coworkers, and this  may explain the larger number of subjects  with
detectable levels in the former study when compared with the latter.
        Greenberg and coworkers (1984)  studied cotinine levels in 32 infants in North  Carolina
 with reported exposure to  tobacco smoke within the previous 24 hours and in 19 unexposed
 infants. All subjects were under 10 months old. Urine samples of all exposed infants contained
 cotinine, whereas all unexposed infants except 2 (11%) had undetectable  urine cotinine or levels
 below those of exposed infants with the  lowest levels of urine cotinine.  This same group of
 researchers reported results for a larger sample (433 infants at a mean age of 18 days)  of the same
 population (Greenberg et al.,  1989). They found that,  of  157 infants who reportedly lived in
 nonsmoking households  and were also not in contact with smokers the previous week, 37 infants
                                             8-3

-------
 (24%) had cotinine in their urine. They concluded that these infants had contact with tobacco
 smoke during the previous week and that this contact was unknown to or was not reported by
 their mothers.
        Greenberg and coworkers (1991) followed 152 of the 433 infants originally enrolled and
 reassessed exposure to ETS (through maternal interviews) and urine cotinine levels when the child
 was 12.3 ± 0.6 months old. They found a significant increase in the prevalence of tobacco smoke
 absorption, indicated by excretion of cotinine, during the first year of life (from 53% at a mean
 age of 3 weeks to 77%).  The interviews showed that this was mainly due to an increased exposure
 to nonhousehold sources of smoke (from 14% to 36%). The proportion of infants who reportedly
 had no contact with smokers but had cotinine in their urine increased from 24% at 3 weeks to 49%
 at 1 year of age.
       These results indicate that studies relying exclusively on parental questionnaires to
 ascertain ETS exposure in children may misclassify many exposed subjects as nonexposed.
 Moreover, the degree of misclassification may increase with the child's age.
       The possible consequences of this misclassification of exposure need to be discussed in
 detail. Nondifferential misclassification (i.e., exposure classification that is incorrect in equal
 proportions of diseased and nondiseased subjects) biases the observed results toward  a conclusion
 of no effect (Rothman, 1986).  The effect of differential misclassification depends on the
 direction in which misclassification occurs. If true ETS exposure is preferentially reported by
 parents of diseased subjects (i.e., there is reporting bias), an excess of disease prevalence would be
 found among  exposed  subjects when compared with unexposed subjects that is unrelated to any
 biological effect of ETS.  The evidence available clearly indicates that this is a very unlikely
 explanation for the reported misclassification of ETS exposure in infants and children. In fact,
 reporting bias cannot explain the substantial increase in "underreporting" of exposure with age.
 The logical explanation is provided by the finding that exposure to nonhousehold smokers
 increases significantly  with age and parallels the increase in  the proportion of subjects who have
 cotinine  in their urine  (Greenberg et al., 1991). There is no  reason to believe that exposure to
 smokers  may occur preferentially among diseased children, and the contrary may be more
 reasonable; the increased awareness of the ill effects of ETS  inhalation may induce parents to limit
 contact between their diseased children and nonhousehold smokers. Thus, the net effect of
misclassification of exposure, both nondifferential and differential, should be a systematic   .
downward bias or bias  toward observing no effect.  A correction for the nondifferential
misclassification bias of background exposure is made in Section 8.3.
                                            8-4

-------
8.3.  ADJUSTMENT FOR BACKGROUND EXPOSURE
       An important conclusion of the previous discussion is that studies based on parental
questionnaires may underestimate the health risk from ETS in children due to underreporting of
ETS exposure. The NRC (1986) report on passive smoking adopted the use of cotinine measures
to correct for misreporting of ETS exposure for lung cancer effects, and this approach was
adapted for use in Chapter 6 of this report. It will also be employed here, with the cotinine ratios,
however, based on exposure data in children rather than in adults. The method is based on several
assumptions:  (1) cotinine concentrations in body fluids of nonsmokers are linearly related to ETS
exposure, (2) the excess risk of respiratory illness in subjects exposed to ETS is linearly related to
the dose of ETS absorbed, (3) the relationship between ambient and absorbed ETS is linear,  and
(4) one cotinine determination may adequately represent average  childhood exposure to ETS.
       As support for assumptions 1 and 2, three recent studies have used body cotinine levels as
biomarkers for ETS exposure in children.  All three have  found significant associations between
cotinine levels and respiratory effects in children. Etzel et al. (1992) found a significant
relationship between serum cotinine levels and otitis media with effusion for children who
attended a day-care facility during the first 3 years of life.  Ehrlich et al. (1992), in a study  that
used questionnaires on maternal caregiver smoking as well as urinary cotinine levels to assess ETS
exposure, found that by either measure ETS exposure was significantly associated with both acute
and nonacute asthma in children.  Furthermore, urinary cotinine  levels in asthmatic children
showed a highly significant correlation with maternal caregiver smoking status. In the third
study, Reese et al. (1992) found urinary cotinine levels significantly (p < 0.02) elevated in children
admitted to the hospital with bronchiolitis compared with a group of similarly aged children
admitted with nonrespiratory illnesses. There was also a highly significant correlation (p < 0.0005)
between urinary cotinine levels and maternal smoking  as determined by questionnaire. Thus, the
evidence suggests that questionnaire ascertainment of childhood exposure to ETS and cotinine
biomarkers in children are highly correlated with each other and  that both correlate with
childhood diseases. This information is used to develop the risk assessment models below.
       While considerable evidence exists for assumptions 1 through 3 (see also Chapter 3), there
is some evidence that assumption 4 may not be entirely warranted, at  least for older children.
Coultas and coworkers (1990b), in a small study of 9 children from 10 homes with at least 1
smoker, reported that there is considerable variability in cotinine levels in body fluids within
individuals exposed to ETS when such levels are  repeatedly measured on different days.
However, Henderson et al. (1989), doing repeated urinary cotinine measures in preschool children,
found stable levels over 4 weeks.  Thus, while the method of adjustment is based on group mean
                                            8-5

-------
body cotinine levels, which apparently reflect household ETS levels well, the Intraindividual
variability, at least in older children, may subject these means to some error.
       Application of the method proposed by the NRC requires some knowledge of Z, the ratio
between the operative mean dose level in the "exposed" group, dE, and the mean dose level in the
"unexposed" group, dN. RR(dE), the relative risk for the group identified as "exposed" compared
with the group identified as "unexposed," is thus given by
                                RR(dE) = (l+Z*/3dN)/(l+/?dN)
(8-1)
where ft is the amount of increase per unit dose and Z > RR(dE) > 1. (The "unexposed" group
actually contains those with background exposure plus those truly unexposed.)
       Several studies are available that could be used for the purpose of estimating Z. Jarvis and
coworkers (1985) studied 569 nonsmoking schoolchildren ages 11 to 16 in Great Britain. The
investigators reported that, when compared with salivary cotinine levels in children of
nonsmoking parents (N = 269), mean levels of salivary cotinine were 3.0 times as high in children
whose father smoked (N = 96), 4.4 times as high in children whose mother smoked, and 7.7 times
as high in children whose parents were both smokers.  Pattishall and  coworkers (1985) reported
that children from homes with smokers (N = 20) had 4.1 times as high mean levels of serum
cotinine as children from nonsmoking families. Black children in the same study, however, had
lower values of Z (2.8) than did white children. Coultas and coworkers (1987) found that, among
600 U.S. children up to age  17 years, mean salivary cotinine levels were between 1.3 and 2.6 times
as high among subjects exposed to one cigarette smoker at home as among unexposed subjects,
and between 2.9 and 3.5 times as high among subjects exposed to two or more smokers at home as
among  subjects not exposed to cigarette smokers at home. Strachan and coworkers (1989) reported
separate results for 6-1/2- to 7-1/2-year-old Scottish children belonging to families living in their
own homes and for those belonging to families living in rented homes.  In the former, geometric
mean salivary cotinine was 6 times as high among subjects exposed to one cigarette smoker at
home as among unexposed subjects and  16 to 17 times as high among subjects exposed to two or
more smokers at home as among unexposed subjects.  For children belonging to families living in
rented  homes, the same ratios  were 3 to  5.5 times and 4 to 7 times, respectively.
       While  these studies show consistent relationships between mean body cotinine levels in
children and home smoker occupancy, there is also a wide variability in the estimated Z ratios,
ranging from  1+ to 17.  These  different estimates may have very important effects on the
background exposure adjustment and, thus, on the calculation of adjusted relative risks for
                                           8-6

-------
different studies (see also Chapter 6). For example, for a study in which the observed relative risk
(RR) is 2.0 but for which the Z ratio is 3, equation 8-1 can be solved for 0dN, which is the
estimated increase in relative risk for the group called "unexposed" but who in fact have been
exposed to  some recent ETS.  Solving, /3dN =1. Thus, the adjusted RR for the group identified as
"unexposed" would be 2, and the adjusted RR for an "exposed" group compared with a truly
unexposed  group would be 1 + (3*1) = 4, i.e., twice the observed risk. For a similar example
(observed RR = 2) but with Z = 5, 0dN = 0.3, the RR for a group identified as "unexposed" in this
case would be 1.3, and the adjusted RR for an "exposed" to a truly unexposed group would be
2.67. Finally, if the observed RR is still 2 but Z = 17, |3dN = 0.07, RR for "unexposed" would be
1.07 and the adjusted RR for exposed children would be 2.13. These results are shown in Table
8-1.
       These calculations show that when use of parental questionnaires significantly
underestimates their children's exposures to other sources of ETS (other than via the parental ETS)
and values of Z are lower (as found in black children by Pattishall and coworkers [1985], and in
children of lower socioeconomic status by Strachan and coworkers [1989]), the "true" RR of
children exposed to ETS may be considerably underestimated. But perhaps the most important
conclusion that may be derived from the above analysis is that exposure to ETS from sources other
than smoking parents may be high enough to constitute a significant risk for their health. This
may be particularly consequential for children of lower socioeconomic levels, whose nutritional
status, crowded conditions at home, and opportunity for contact with biological agents of disease
make them a part of the population that is particularly susceptible to respiratory illnesses during
infancy and childhood.  Available data show that ETS exposure via nonhousehold members in
these children, as measured by cotinine levels in body fluids, may be as much as one-third that of
children exposed to one smoking parent (Z = 3).  In the example presented above (observed
RR = 2), the estimate of the adjusted relative risk is 4 for children of smoking  parents to the truly
unexposed children.  However, using the same assumptions, children of nonsmoking parent? who
are exposed to ETS (at background levels found in some of the studies)  would have twice as high  a
risk of developing the illness under study as children truly unexposed to ETS.
       A cautionary note about the model is appropriate. Table 8-1 shows that, for observed
RR = 2 and Z = 3, the adjusted relative risk is 4.  However, as the observed RR and Z get closer
together* the  behavior of the model becomes erratic. This is shown in Table 8-2.  In fact, the
 model (equation 8-1) becomes undefined if Z is less than or equal to the observed RR, and it
 reaches some stability only as Z becomes at least 30% to 50% greater than the RR.          ,
                                             8-7

-------
 Table 8-1. Adjusted relative risks for "exposed children." Adjusted or background exposure based
 on body cotinine ratios between "exposed" and "unexposed" and equation 8-1

1.0
Observed
1.50
Relative
1.75
Risks
2.00
(RR) 2.50
3.00
1.50
1
-
-
-
-
-
Z Ratio of bodv cotinine levels 7"exoo$fedV"un£xttrtsad'»S
2.00
1
3.00
7.00
-
-
-
3.00
1
2.00
2.80
4.00
10.00
-
',"'1 5,00,
1
1.71
2.15
2.67
4.00
6.00
7.00 JO.OQ , 13.00
1
1.64
2.00
2.40
3.33
4.50
1
1.59
1.91
2.25
3.00
3.86
1
1.57
1.87
2.18
2.86
3.60
17.00
1
1.55
1.84
2.13
2.76
3.43
Table 8-2. Behavior variations in adjusted relative risks from equation 8-1 when the observed
relative risks and Z ratios are close together

Z ratio

1.50
Observed
1.75
Relative
2.00
Risks
2.25
(RR)
2.50
1.50
_

-3.5
-2.0

-1.5

-1.25
1,75
4.50

-
-6.00

-3.38

-2.50
2.00
3.00

7.00
_

-9.00

-5.00
2,25
2.50

4.38
10.00

_.

-12.50
2,50 2.75 \ 3.00 10,00
2.25

3.50
6.00

13.50

-
2.10

3.06
4.67

7.88

17.50
2.00

2.80
4.00

6.00

10.00
1.59

1.91
2.25

2.62

3.00
                                            8-8

-------
       Fortunately, the estimates of Z presented above are appreciably greater than the observed
relative risk estimates seen in Chapter 7, and in the observed range of both RR and Z, the model
yields relatively stable estimates of the adjusted RR.  Furthermore, as discussed in Chapter 6, the
values of RR and Z are expected  to be correlated for each study, i.e., the greater the Z ratio between
exposed and unexposed groups in each study, the greater should be the observed RR and the less the
effect of the (equation 8-1) adjustment.
        If the above model is correct, then exposure of children to ETS other than at home (parental
smoking)  may be an important risk factor for respiratory illness in childhood. On the other hand, it
is also possible that for at least some respiratory illnesses, outside exposure to ETS has relatively little
effect, either because outside exposures in younger children tend to be less than those of older
children or because there may be a threshold of exposure below which certain respiratory effects may
not be expected to occur. For this latter case, equation 8-1 is not an appropriate model, and the
observed  relative risk would be taken to be the true risk.  Both models are addressed in the sections
that follow.

8.4.  ASSESSMENT OF RISK
        Neither the NRC report (1986) nor the Surgeon General's report (U.S. DHHS, 1986)
attempted to assess the population or public health impact of the increased risk of respiratory
disorders in children attributable to ETS exposure. In this section, estimates will be derived for the
number of ETS-attributable lower respiratory tract infections in infants and for the induction and
exacerbation of childhood asthma.  Quantifying the public health impact of other conditions, such as
reduced lung function, coughing, wheezing, and middle ear effusion, is difficult, either because of
the  lack of overt symptoms or because some necessary U.S. population health statistics are not
available. Estimates of sudden infant death syndrome (SIDS) occurrences attributable to ETS will not
 be made  but will be discussed in Section 8.4.3.
        For the following quantitative analyses, estimates will be developed  in terms of ranges. The
 ranges are derived by the use of both threshold and nonthreshold (equation  8-1) models, different
 estimates for population incidence and prevalence, and estimated values of  Z and  RR from studies
 reviewed above. Various differences in design, disease definition, and conduct among these studies
 make them less adaptable to meta-analysis techniques than were the lung cancer studies. To the
 extent that a less rigorous statistical analysis is attempted here, the ranges should reflect that
 uncertainty.
                                              8-9

-------
 8.4.1. Asthma
        From the analysis of studies regarding risk for asthma and ETS exposure, it was concluded
 that passive smoking increases both the number and severity of episodes in asthmatic children.  It was
 further concluded that ETS is a risk factor for new cases among previously asymptomatic children,
 since the evidence is suggestive, but not conclusive, of a causal association (see Section 7.6). Relative
 risks for asthma ranged from 1.0 to 2.5 in the studies analyzed, but methodologies differed
 considerably among studies,  and effects were often found only in children of mothers who smoke
 heavily. Of the four large studies, totaling more than 9,000 children (Burchfield et al., 1986;
 Sherman et al., 1990; Weitzman et al., 1990; Martinez et al., 1991b), three showed statistically
 significant risk estimates ranging from 1.7 to 2.5, with the  two largest ratios, 2.5 (Martinez et al.,
 1991b) and 2.1 (Weitzman et al., 1990), coming from comparisons using children of heavily smoking
 mothers (£: 10 cig./day) as the exposed group. The third study (Burchfield et al., 1986) had OR = 1.7
 for males with two smoking parents, but results  were not significant either for girls or for children
 with one parental smoker.  The fourth study (Sherman et al., 1990) (770 children) did not find an
 effect, but made no  effort to assess the effect of heavy smoking  by parents,  nor was there control for
 socioeconomic status.  Thus,  assigning a range of 1.75 to 2.25 for the estimated relative risk of
 developing asthma for children of mothers who smoke 10 or more cigarettes per day appears
 reasonable and is within the ranges of observed risk.
       The above results suggest two possible scenarios.  One scenario is that relatively heavy
 exposure to ETS is needed  to bring on asthma, i.e., there  is a threshold of exposure below which
 effects will  not occur. Alternatively, lesser exposures may  merely induce fewer effects,  not
 detectable statistically with these study designs.  The choice of scenario does not affect the observed
 relative risk but will affect whether or not an adjustment for background exposure (Z ratio) is
 appropriate.  Under  the first  (threshold) scenario, the estimates of RR = 1.75 to 2.25 need no
 adjustment; under the alternative (nonthreshold) scenario, equation 8-1 applies.
       Considering the nonthreshold model  first, from the  discussion in Section 8.3, it can be
 assumed that values of 3 to 10 may be a reasonable range for estimates of Z (i.e., the ratio of body
 cotinine levels in children whose mothers smoke  heavily to  those of children whose mothers do not
smoke). Lower values of Z would yield significantly larger estimates of asthma cases attributable to
ETS. Based on the above estimates for a range of Z and RR and use of the nonthreshold model, the
estimated range of adjusted relative risks for children of mothers who smoke 10 or more cigarettes
per day would be approximately 1.91 to 6.00 (see Table 8-3). Transforming relative risks to
                                            8-10

-------
O)
§
T3
(U
•8

I

I
en
•c
CO

1






4|
o
fi
1







1-*
^3
T3
o
3
2
"3
1
*






CM
CM'

§
CM



2

04

VO
«


CM
CM





£


k>
relative risl
1 Observed

CO


CO




CO

O

o
*""*


1






1



ine ratio
unexposed)
It
?8i
II x
Ncu
N— '

o
o
vo

"o
^



"o
00
CM'

VO
CM
*— <
F.H


I






(


W
relative risk
1 Adjusted

CO
oq
O

£
0



O*

VO
O
00
o


VO
Q





CO
o



to
H

,


,




'

,





s
O





r-
o



o
II
5

CM
CM
o'

O
0)
0



r-
0*

-*
o'
CM
O


,






1



vo"

-------
attributable risks (Rothman, 1986), 48% to 83% of all cases of asthma among children of mothers
who smoke 10 or more cigarettes per day may be attributable to passive smoking based on
                                        100*(1 -
(8-2)
where ARE is the attributable risk (%) for the exposed population.
       Under the assumptions of the threshold model, RR - 1.75 to 2.25 for children of heavily
smoking mothers, and the ARE - 43% to 56% (see Table 8-3); for children of light-smoking
mothers, RR - 1 and the ARE = 0.
       To calculate the percentage of all cases occurring in a mixed population of exposed and
unexposed individuals that is attributable to exposure (ART), knowledge of the prevalence of
mothers smoking 10 or more cigarettes per day is needed because
                                     ART = ARE*Pi
 (8-3)
where Pr is the proportion of cases that is exposed (Rothman, 1986). It has been reported that
approximately 26% of the population of women of childbearing age smoked in the United States
in 1988 (CDC, 1991b) and in 1990 (CDC, 1992b). For the number of cigarettes smoked, Weitzman
and coworkers (1990), using the 1981 National Health Information Survey (NHIS), found that
approximately 50% of smoking mothers of children ages 0 to 5 years smoke  10 or more cigarettes
per day. The 1990 NHIS reports that 78% of smoking women ages  18 to 44 smoke at least 10
cigarettes per day (data courtesy of Dr. Gary Giovino, CDC). We have used an average of 65% to
derive the estimates in Table 8-3.  Based on these figures and the threshold model, it can thus be
estimated that approximately 7% to 9% of all cases of asthma may be attributable to exposure to
ETS from  mothers who smoke 10 or more cigarettes per day.  Estimates of the prevalence of
asthma among U.S. children less than age 18 vary from 5% to 10% (Clark and Godfrey, 1983) to
3% to 8% (R. Evans et al., 1987), depending on disease definition. This latter paper uses the data
from the 1979-1981 NHIS and derives a population asthma prevalence of 2 million to 5 million.  A
more recent  estimate  from the 1989 NHIS is 3.9 million (U.S. DHHS,  1990b). Use of these
population prevalence figures and the threshold model provides a range of 8,000 to 26,000 as the
annual number of new cases of childhood asthma attributable to mothers who smoke 10 or more
cigarettes per day. The confidence in this estimate  is medium and is dependent on the conclusion
that ETS is a risk factor for asthma induction.
       If the nonthreshold model applies, use of the same prevalence figures leads to a range of
13,000  to 60,000 new cases per year attributable to all ETS exposures  (Table 8-3).
                                          8-12

-------
       While the range of 8,000 to 60,000 is plausible, the existing data are more supportive of
the threshold model, which assumes that rather heavy exposures to ETS are required to induce
asthma in previously asymptomatic children (Section 7.6.2). Thus, the range of 8,000 to 26,000
will be adopted as the more probable range of new cases among children per year attributable to
ETS exposure.
       In view of the increased number and severity of asthmatic episodes also caused by ETS,
the public health impact of ETS on asthmatic children is considerably greater than the range of
estimates for new cases presented above. Shephard (1992), after reviewing several studies,
concludes that ETS exposure (from any source) exacerbates preexisting asthma in approximately
20% of patients. If this figure is correct, up to 1 million asthmatic children could be affected.
Also, in an earlier study, O'Connell and Logan (1974) found that parental smoking aggravated
clinical symptoms of 67% of 265 asthmatic children in the Midwest versus 16% of 137 controls
(p < 0.0001) and that  10% of 400 asthmatic patients (of both smoking and nonsmoking parents)
considered  tobacco smoke a major aggravating factor. D. Evans and coworkers (1987) found that
passive smoking by asthmatic children in New York City (via presence of smokers in  the
household) was associated with a mean annual increase of 1.34 emergency room visits per year for
asthmatic symptoms, an increase of 63% over asthmatic children from nonsmoking households.
Ehrlich et al. (1992), in a study not reviewed by Shephard (1992), found that asthmatics with
clinically significant symptoms had both higher cotinine levels than controls (p = 0.04) and an
OR = 2.0 (p = 0.03) for maternal caregivers who smoke.  Using this estimate of 2.0 with
equation 8-1 and a Z = 3 also leads to an attributable risk fraction, ART, of 20% (equation 8-3).
Multiplying this 20% by the 2 million to 5 million asthmatic children in the United States yields
estimates of 400,000 to 1,000,000 whose condition  is aggravated by exposure to ETS.  Thus,
exposure to ETS in general and especially to parental ETS adversely affects hundreds of thousands
of asthmatic children.

8.4.2.  Lower Respiratory Illness
       From the assessment of available data (see Section 7.3), it was concluded that exposure of
infants and young children to ETS causes an increased incidence  of lower respiratory illness
(LRI).  An examination of the data in the referenced studies of both Tables 7-1 and 7-2 leads to
the conclusion that the observed risk of having LRIs is approximately 1.5 to 2.0 times as high in
young children whose mothers smoke as in those whose mothers do not smoke and that the risk  is
probably higher in infants than in toddlers.
       This estimate  is also consistent with that of the NRC (1986), which estimated a relative risk
of up to 2 for infants who have one or more parents who smoke.  The more recent evidence
                                           8-13

-------
reviewed here strongly suggests that the increased risk due to ETS exposure lasts for at least the
first 18 months and decreases after that. Based on this evidence, this chapter estimates a relative
risk range of 1.5 to 2.0 for infants and children up to 18 months old who have smoking mothers.
It will assume that the increased risk is zero after 18 months.
       Based on these findings, and following equation 8-1 with a range of Z = 3 to 10 and
RR « 1.5 to 2.0, the adjusted relative risk range becomes 1.6 to 4.0, and ARE takes the range 38%
to 75%.  As in the previous section, for equation 8-3, the mixed population attributable risk ART
takes the range 10% to 20%, again based on 1988 and 1990 estimates of approximately 26% women
of childbearing age who smoked (CDC, 1991b, 1992b).  Because the estimated mean number of
cigarettes smoked by these women is approximately 17 to 20 per day (CDC 1991b, 1992b), it is
reasonable  to assume that most children of smoking mothers will be exposed.  Therefore, the
proportion  of cases exposed, Pr, is estimated to be 0.26.
       It has recently been shown that the incidence of LRIs early in life is approximately 30%
(Wright et al., 1991). When the analysis is limited to the first 18 months of life, the population at
risk is approximately 5.5 million children.  A slight modification of the same algorithms described
above yields 150,000 to 300,000 cases of LRIs annually in children under 18 months old
attributable to exposure to ETS generated mostly by smoking mothers.  For RR = 1.5 and Z = 10,
the attributable risk fraction for the exposed population, ARE, is 0.38, and the attributable risk
fraction for the total population, AR, is 0.10.  Assuming 3,7 million children less than 1 year old
and a 30% incidence of LRI, the ETS-attributable population risk is 110,000. In order to get the
incidence rate for the 1.8 million children aged 12 to 18 months, also with 30% incidence, the
110,000 must be subtracted from the 540,000 before multiplying by 0.10.  The product of 43,000
is then added to 110,000 to determine the total annual incidence of 150,000 LRIs. For RR = 2.0
and Z - 3 the total annual incidence is about 300,000.  Approximately 5% of these LRIs require
admission to a hospital (Wright et al., 1989); therefore, it is estimated that 7,500 to 15,000
hospitalizations yearly for LRIs may be attributable to ETS exposure.
       While these estimates may appear large, three factors suggest that they are on the low side.
First, although these estimates are calculated only  for children less than 18 months old, Section 7.3
presents evidence that these ETS-attributed increased risks extend at a decreasing rate up to
3 years of age.  Second, no estimates have been calculated for exposure in a smoking father-
nonsmoking mother household.  Third, these numbers do not take into  account the fact that many
infants and young children have recurrent LRIs, and therefore, more than one episode of such
illnesses may be attributable to ETS in each exposed child.
                                           8-14

-------
8.4.3.  Sudden Infant Death Syndrome
       Because this report concludes that there is an association between maternal smoking and
SIDS but is unable to determine the contribution that ETS makes to that association (see Section
7.7), no estimate of ETS-attributable SIDS deaths will be calculated. The Centers for Disease
Control (CDC, 1991a) provides an estimate of 702 SIDS deaths attributable to maternal smoking,
based on a relative risk of 1.5 for infants of actively smoking mothers.  While this report concurs
with the numbers and the methodology used to determine that estimate, it is unable to apportion
the in utero, lactation, and ETS exposure components of the risk.

8.5.  CONCLUSIONS
       This chapter has attempted to estimate the impact on the U.S. population of ETS exposure
on childhood asthma and lower respiratory tract infections in young children.  For new cases of
asthma in previously asymptomatic children under 18 years of age, we estimate that 8,000 to
26,000 is a probable range of new cases per year that are attributable to ETS exposure from
mothers who smoke at least 10 cigarettes per day. The confidence in this range is medium and is
dependent on the conclusion that ETS is a risk factor for asthma induction.
       While the data are most supportive of a situation in which heavy exposures to ETS are
required to induce new cases of asthma, two other scenarios would lead to larger estimates.  The
first is that even in the  absence of smoking mothers, a child could receive heavy ETS exposure
from other sources.  The second is that lesser ETS exposures induce fewer numbers of new cases,
and the increase is not statistically detectable.  Under this latter (nonthreshold) scenario, the range
of new cases of asthma annually attributable to ETS exposure is 13,000 to 60,000.
       This report concludes that, in addition to inducing new cases of asthma, ETS exposure
increases the number and severity of episodes among this country's 2 million to 5 million
asthmatic children.  This chapter considers exposure to parental smoking to be a major
aggravating factor to approximately 10%, or 200,000,  asthmatic children.  Estimates of the number
of asthmatics whose condition is aggravated  to some degree by ETS exposure are very approximate
but could run well over 1 million.
       This chapter also estimates that 150,000 to 300,000 cases annually of lower respiratory
tract infections in children up to 18  months old are attributable to ETS exposure, most of which
comes from smoking parents (mostly mothers).  These ETS-attributable cases are estimated to
result in 7,500 to 15,000 hospitalizations annually.  Confidence in these estimates is high based on
the conclusion of a causal association and the strong validity of parental smoking as a surrogate of
temporally relevant ETS exposure in infants and young children. Additional cases and
                                           8-15

-------
hospitalizations are expected to occur in children up to 3 years old in decreasing numbers, but this
report makes no further quantitative estimates.
       Infants' exposure to ETS may also be responsible for a portion of the more than 700 deaths
from SIDS attributable to maternal smoking by the CDC (199la), but this report is unable to
determine whether and to what extent these deaths can be attributed specifically to ETS exposure.
       The estimates of population impact presented above are given in ranges and approximate
values to reflect the uncertainty of extrapolating from individual studies to the population.  As
with the lung cancer population impact assessment (Chapter 6), these extrapolations are all based
on human studies conducted at true environmental levels. Therefore, they suffer from none of
the uncertainties associated with either animal-to-human or high-to-low exposure extrapolations.
       In addition to the estimates presented above, ETS exposure in children also leads to
reduced lung function, increased symptoms of respiratory irritation, and increased prevalence  of
middle ear effusion, but this report does not provide estimates  of the population impact of ETS
exposure for these conditions.
                                           8-16

-------
                         ADDENDUM:  PERTINENT NEW STUDIES






       Several pertinent studies on the respiratory health effects of passive smoking have




appeared since the cutoff date for inclusion in this report.  The studies are cited here for the



benefit of anyone who may wish to follow up on these topics.  The studies are briefly described



below, and the authors' conclusions are presented. We do not formally review these studies in this



report, and the citations do not represent a full literature search. These new studies are generally




consistent with this report's conclusions that environmental tobacco smoke (ETS) exposure




increases the risk of lung cancer in nonsmokers and affects the respiratory health of infants.



       Two of the new studies are case-control studies of ETS and lung cancer in U.S. female




nonsmokers (Stockwell et al.,  1992; Brownson et al., 1992).  Stockwell et al. conclude that "long-




term exposure to [ETS] increases the risk of lung cancer in  women who have never smoked."



Similarly, Brownson et al. conclude, "Ours and other recent studies suggest a small but consistent



increased risk of lung cancer from passive smoking."




       In an autopsy study of Greeks who had died of causes other than respiratory diseases,



Trichopoulos et al. (1992) found an increase in "epithelial, possibly precancerous, lesions" in the



lungs of nonsmoking women who were married to smokers.  The authors concluded that their




results "provide support to the body of evidence linking passive smoking to lung cancer.  . . ." In a




fourth study, a case-control study of ETS exposure and lung cancer in  dogs, Reif et al. (1992)



found an association between lung cancer and exposure to a smoker in  the home for breeds with



short- and medium-length noses.  These results are not statistically significant, and the authors



characterize their findings as "inconclusive."



       Finally, Schoendorf and Kiely (1992) conducted a case-control  analysis of sudden infant




death syndrome (SIDS) and maternal smoking status (i.e., maternal smoking both during and after



pregnancy [combined exposure], maternal smoking only after pregnancy [passive exposure], and



no maternal smoking).  These investigators conclude that their data "suggest that both intrauterine



and passive tobacco exposure  are associated with an increased risk of SIDS."




                                          ADD-1

-------
ADDENDUM REFERENCES

Brownson, R.C.; Alavanja, M.C.; Hock, E.T.; Loy, T.S. (1992) Passive smoking and lung cancer in
       nonsmoking women. Am. J. Public Health 82:1525-1530.

Reif, J.S.; Dunn, K.; Ogilvie, G.K.; Harris, C.K. (1992) Passive smoking and canine lung cancer
       risk. Am. J. Epidemiol. 135:234-239.

Schoendorf, K.C.; Kiely, J.L. (1992) Relationship of sudden infant death syndrome to maternal
       smoking during and after pregnancy. Pediatrics 90:905-908.

Stockwell, H.G.; Goldman, A.L.; Lyman, G.H.; Noss, C.I.; Armstrong, A.W.; Pinkham, P.A.;
       Candelora, E.G.; Brusa, M.R. (1992) Environmental tobacco smoke and lung cancer risk in
       nonsmoking women. J. Natl. Cancer Inst. 84:1417-1422.

Trichopoulos, D.; Mollo, F.; Tomatis, L.; Agapitos, E.; Delsedime, L.; Zavitsanos, X.; Kalandidi,
       A.; Katsouyanni, K.; Riboli, E.; Saracci, R. (1992) Active and passive smoking and
       pathological indicators of lung cancer risk in an autopsy study. JAMA 268:1697-1701.
                                         ADD-2

-------
                  APPENDIX A






REVIEWS AND TIER ASSIGNMENTS FOR EPIDEMIOLOGIC




        STUDIES OF ETS AND LUNG CANCER

-------

-------
                 APPENDIX A. REVIEWS AND TIER ASSIGNMENTS FOR
                 EPIDEMIOLOGIC STUDIES OF ETS AND LUNG CANCER

A.l. INTRODUCTION
       This appendix contains material that is used in Section 5.5, entitled Analysis by Tier and
Country. As described in that section, each study is individually reviewed and assigned to one of
four tiers based on its assessed utility for the objective of evaluating the evidence of an
association between environmental tobacco smoke (ETS) exposure and incidence of lung cancer.
The means of constructing study reviews is described in the next section, followed by a
description of the scheme for scoring studies on various items and then assigning the studies to
tiers according to the outcome.  The final section of this appendix contains the individual study
reviews and the tier numbers assigned to them.

A.2. CONSTRUCTION OF INDIVIDUAL STUDY REVIEWS
       Descriptions of the four prospective cohort studies are individualized according to the
requirements of each study.  Reviews of case-control studies follow a structured format,
consisting of three parts:  (1) the author's abstract, which summarizes the most salient features and
conclusions in the author's opinion; (2) a study description based on the contents of a completed
study form designed around principles of good epidemiologic practice and issues  specific to
environmental tobacco smoke; and (3) a section of comments related to evaluation and
interpretation of the study.  The study reviews are used to assign studies to tiers according to the
procedure described in Section A.3.
       The review form for case-control studies shown in Section A.2.1 was completed for each
case-control study in order to systematically extract information about characteristics of interest
for preparation of the reviews.  The form was an aid in treating study reviews uniformly and
noting  omissions or incomplete discussion on issues that may affect the potential for bias or
confounding.
       The study descriptions in Section A.4 were then prepared by following the outline and
information in the completed forms.  Some items included in the form pertain to  characteristics
that would apply to a case-control study on any  topic, i.e., they are "generic items" related to
principles of good epidemiologic investigation; the remaining items tend to identify areas of
potential bias specific to the topic of ETS and lung cancer.
                                           A-l

-------
A.2.1.  Review Form for Case Control Studies
PARTI. GENERAL
       Study name	
       Location	
       Time period (data collection).
       Study objective(s)	
       The source of the primary data set is the current study
                    or a parent study
              containing CS (current)	FS (former)	NS (never-smoker)
       Study uses term "nonsmoker"	or "never-smoker"	to mean
              nonsmoker	
              never-smoker
       "Exposed" to ETS means (preferably in terms of spousal smoking)
       Recall span (how far back in time ETS exposure was measured).
       ETS sources include cigarette
cigar
pipe
                             other
       Describe inclusion of nonsmoking (never-smoking) females not currently married (number
       of cases and controls, assumptions regarding exposure)
                                          A-2

-------
II. DATA COLLECTION (includes NS_
       Inclusion/exclusion criteria
              Cases	
           FS
        CS
unless noted)
              Controls (include matching variables in PART V)_
       Main source of subjects
              Hospital(s) #	
              Community
              Other__	
       Incident cases   Y	
       Control sampling
              Cumulative  	
              Unmatched   	
       Method of collection
              Face-to-face
              Telephone
              Self-admin, ques.
              Medical records
              Vital stat. records
              Other
                     Controls
 N
       Density
       Matched
Cases
Controls
       Collected data verified/corroborated with other sources  Y_
                                                Cases
       Sample size
       (prior to attrition)
              females
                                     N
                                   Controls
       Attrition
       (selection or followup)
             females
             males
                                           A-3

-------
      Source of response
            subject
            proxy
      Exposure sources  NS_
      Age
Childhood
Adulthood
  Spouse
  Parents/in-laws
  Other family/
       live-ins
Workplace
Other
NS        FS
             Distribution
                    _FS_
                    Yes
CS
                                   CS
                            Cases
                                                                   Controls
             Mean
             Standard error
             Standard deviation
             Range

PART III. CLINICAL DATA
       Primary lung cancer verified by
             Histology            	
             Cytology            	
             Radiology/clinical    	
             Death certificate     	
             Tumor registry       	
             Mortality records     	
             Other	    _
              Not verified
                                   NS
            FS
CS
       Airway proximity (no. exp cases/no, cases)
                                          NS
                   FS
                                                                         CS

-------
             Central
             Peripheral
       Tumor type (no. exp cases/no, cases)
             Squamous cell        	
             Small cell
             Adenocarcinoma
             Large cell
             Others or unspecified
PART IV. STATISTICAL ANALYSIS  (includes NS_

       Raw data (for analysis)
             females
              males
unexp

exp

unexp

exp
                                                      Table
                           NS
                                                      Table
                           FS
              Comments (include measure of exposure)    Table

       Unadjusted (crude) analysis

              Estimate      OR _	% CI (	

              Comments                               Table

              Test of       p-value   •••	
               signif.

              Test for       p-value	
               trend

              Comments                               Table

       Adjusted analysis

              Estimate      OR	% CI (
FS
CS
CS
unless noted)
                                        Controls
                                          A-5

-------
              Test of
                signif.
p-value
              Test for
                trend

              Comments •
p-value
                           Table
 PART V. DEPENDENT VARIABLES (potential confounders and effects modifiers considered)
                  In Matching
 Age
 Gender
 Race/ethnicity
 Hospital
 Residence/
  neighborhood
 Housing type
 House/room sizes
 Vital statistics
 Smoking status
 SES
 Medical health
 Menstrual/
  reproductive
 Occupation
 Outdoor air
  pollution
 Cooking habits
 Drinking
 Diet
 Education
 Family history
  of lung cancer
 Other indoor
  smoke/fumes
 Radon
 Lifestyle
 Climate/
  ventilation
           In Analysis
Otherwise
A.3. TIER CLASSIFICATION SCHEME

       The items and study scores used in the algorithm to calculate tier numbers are given in

Table A-l. The items and scoring system in that table and the algorithm for converting the scores
to a tier number are the topics of this section.

       The items displayed in the headings of Table A-l will be described after explanation of

how assignments are calculated from the numbers in that table.  Positive values in the table are
                                          A-6

-------
unfavorable (penalty points); a blank entry means the item was not a problem; negative values are
favorable (bonus points) and occur in a few instances where the study performed well above the
norm indicated by a blank, e.g., FONT, KOO, and HOLE(Coh) each have an entry of "-0.5" under
"Less than 90% confirmation by histology or cytology" in Category C for particularly high
attention given to confirming primary lung cancer in subjects classified as cases. Bonus scores are
always -0.5 and are assigned somewhat sparingly as they have the potential to cancel penalty
scores and thus mask a study weakness.  Parentheses around an entry indicate that the penalty
points were assigned due to  insufficient information (so there is effectively a penalty imposed if
the information needed was not included in the source). The asterisk that occurs under the item
"unsuitable indoor environment" is a marker  that automatically places the study into Tier 4 under
the assignment rule to be described next (the unsuitable environment refers to high levels of coal
smoke in all instances).
       Tier numbers for each study are calculated from the entries in  Table A-l as follows.
Totals are calculated by category and across all items, as shown in Table A-2. If the total for each
category is less than 2.5, then the  tier assignment is determined as follows:
                     Total Score
                     1.75 or less
                     2.00 - 3.75
                     4.00 - 5.75
                     6.00 or greater
Tier
  1
  2
  3
  4
The value 2.5 is designated as a cutoff point for each category.  If a study has one or more
category totals greater than or equal to 2.5, the tier classification is increased by 1 (i.e., 1 is added
to the tier number shown in the above table if any category totals are 2.5 or greater). The three
studies conducted in regions of China where indoor air is heavily polluted with smoke from
burning coal, denoted by an asterisk under item "unsuitable indoor environment," are .placed in
Tier 4 (see reviews in Section A.4 for GENG, LIU, and WUWI). The resultant assignment of
studies to tiers is shown in Table A-2.
       A scheme that attempts to assess utility and to numerically rank studies accordingly, as
done here, has a high degree of subjectivity.  Different analysts would be apt to disagree about
elements of any such approach and the appropriate weights for those elements in assigning studies
to tiers, as suggested above.  One of the difficulties is that the significance of a study "weakness"
is difficult to assess. For example, the use of proxy respondents may be a source of bias, but the
direction and magnitude of bias are unknown for any given study.  Thus, one is faced with rating
studies largely on the basis of one's ability to ascertain what study features are significant and
                                            A-7

-------
Table A-l.  Study scores for tier assignments
  Study
                       Category A
                                        x  Category B
Fanner,
sniokers
Included
Smoking
status
unverified
Exposure
criteria,"^
questionable
Exposure
of
unraarrieds
Exposure
status
unverified
  AKIB
  BROW
  BUFF
  CHAN
  CORR
  FONT
  GAO
  GARF
  GENG
  HUMB
  INOU
  JANE
  KABA
  KALA
  KOO
  LAMT
  LAMW
  LEE
  LIU
  PERS
  SHIM
  SOBU
  SVEN
  TRIG
  WU
  WUWI
  BUTL(Coh)
  GARF(Coh)
  HIRA(Coh)
  HOLE(Coh)
              -0.5
1
0.5
1

0.5
0.5
              -0.5
0.5
                            1
                            1.5
                            2
              1.5
              0.5
              1

              1

              1
                                                        -0.5
(0.5)

(0.5)
0.5

0.5
0.5
                                          -0.5
                                          0.5
                                                       (continued on the following page)
                                        A-8

-------
Table A-l. (continued)
CateaorvC Cateemrv r> 11
Secondary
lung cancers
Study possible
AKIB
BROW
BUFF
CHAN 0.75
CORR
FONT
GAO
GARF
GENG
HUMB
INOU 0.75
JANE
KABA
KALA
KOO
LAMT
LAMW
LEE 0.75
LIU 0.75
PERS
SHIM
SOBU
SVEN
TRIG
WU
WUWI
BUTL(Coh)
GARF(Coh) 0.5
HIRA(Coh) (0.5)
HOLE(Coh) (0.5)
Less than Less than
90% confirm. 90% faee-
histol./cytol. to-face
l 0.5


0.5
-0.5
0.5

0.5
(0.5)

0.5
-0.5

(0.5)
1
0.5
0.5
0.5
1
1
1
0.5
0.5
1 0.5
0.5
-0.5
UnfaJinded
interviews




(0.5)
(0.5)
(0.5)


(0.5)
0.5

(0.5)

(0.5)
0.5


(0.5)
(0.5)
0.5
0.5
0.5
0.5




                                                         (continued on the following page)
                                         A-9

-------
Table A-l. (continued)
                                                               Category F
                                                        >-     (Cohort Only)
                                                     Change in      ',  More than
                                                 '  " smoking ot
                                                     EfS status
Uneven proxy
response
distribution
  More than
  10% proxy
"  respondents
   BUTL(Coh)
   GARF(Coh)
   HIRA(Coh)
   HOLEfCoh
                                                         (continued on the following page)
                                          A-10

-------
Table A-l. (continued)
 Study
 AKIB
 BROW
 BUFF
 CHAN
 CORR
 FONT
 GAO
 GARF
 GENG
 HUMB
 INOU
 JANE
 KABA
 KALA
 KOO
 LAMT
 LAMW
 LEE
 LIU
 PERS
 SHIM
 SOBU
 SVEN
 TRIG
 WU
 WUWI
 BUTL(Coh)
 GARF(Coh)
 HIRA(Coh)
 HOLE(Coh)
                                               Category G
Unsuitable
indoor
environment
 (Case-control only)
Smoking-refated
-disease in
controls ,
                       0.75
                       0.75
                       0.75
Nonincident
cases
included
0.5
(0.5)
                         0.5


                         (0.5)


                         (0.5)
                      0.75
                      0.75
                      0.5
                        (0.5)
                                                        (continued on the following page)
                                        A-ll

-------
Table A-l. (continued)
                                          Category H
                                                               Prob!e»(s)
                                                               with stat methods
Uncontrolled for
other factors
Uncontrolled
for age
  AKIB
  BROW
  BUFF
  CHAN
  CORR
  FONT
  GAO
  GARF
  GENG
  HUMB
  INOU
  JANE
  KABA
  KALA
  KOO
  LAMT
  LAMW
  LEE
  LIU
  PERS
  SHIM
  SOBU
  SVEN
  TRIG
  WU
  WUWI
  BUTL(Coh)
   GARF(Coh)
   HIRA(Coh)
   HOLE(Coh)
                                        A-12

-------
Table A-2. Total scores and tier assignment
Cateaorv
Study A
AKIB
BROW
BUFF
CHAN
CORR
FONT -0.5
GAO
GARF
GENG 1
HUMB 0.5
INOU 1
JANE
KABA 0.5
KALA
KOO
LAMT 0.5
LAMW
LEE
LIU
PERS -0.5
SHIM
SOBU
SVEN
TRIG 1
WU
WUWI 1
BUTL(Coh)
GARF(Coh)
B CD
-0.5 1 0.5
1.5
1.5
2.5 1.25
0.5 0.5
-0.5 -0.5 0.5
1.5 0.5 0.5
1
1
0.5
1 1.25 0.5
0.5
1
0.5 0.5
-0.5

0.5
1.25 0.5
1 1.75
0.5
1
1
1.5
1 0.5
0.5 1.5
0.5 0.5
0.5
1 1.5 0.5
B F G H
1 0.5
1.75 0.5 2.0
1 1.5
0.75 0.75 1.5
0.5 0.5 1.5
0.5 0.5
1.5
1.5 1.25
* 2.5
1.75
1 1.25
0.5 1
1.5

1
1.5
2.5
0.5
* 2.5
0.5
1.25 1.5
0.75 1
0.5
1.5
1
* 1.
0.5 1
1.25
Total
2.5
5.75
4.0
6.75
3.5
0
4.0
3.75
4.5
2.75
6.0
2.0
3.0
1.0
0.5
2.0
3.0
2.25
5.25
0.5
3.75
2.75
2.0
4.0
3.0
3.0
2.0
4.25
Tier
Assign.
2
3
3
4
2
1
3
2
4
2
4
2
2
1
1
2
3
2
4
1
2
2
2
3
2
4
2
3
                                                         (continued on the following page)
                                         A-13

-------
Table A-2.  (continued)



Study
HIRA(Coh)
HOLE(Coh)
	 Catesorv

V S <* ., if % * !••* vf ivyy -- ^ J f f
A i C D E F ^ G H Total
0.5 1 0.5 2.0
1 1.0

ff f/f
Tier
Assign.
••••••••
2
1
*Unsuitable indoor environment

some quantitative construct reflecting an opinion of their relative importance.  Additionally, there
is the possibility of misinterpreting the source or of the omission of needed information from the
source. A further limitation is the inability to include all features of all studies that might affect
one's judgment of it.
       Reservations notwithstanding, the heterogeneity of the ETS studies in objectives and
characteristics of design, data collection, analysis, and interpretation make it worthwhile to
classify studies according to some evaluation of their utility for assessing ETS and lung cancer.
The items used for scoring studies are described in the remainder of this section. The descriptions
are written in the language of case-control studies (references to "cases," "controls," etc.).  Where
cohort studies are evaluated (end of Table A-l), the equivalent concept for cohort studies is
applied under each category heading, with exceptions as noted in the text. An "ideal" is described
for each item, to give the scores a reference point. The ideal applies to the needs of this report,
however, and not to what may have been the ideal for the individual study objectives.
        Very few of the studies were designed and executed with the sole, or even primary,
objective of this report. Consequently, high penalty  scores or an unfavorable tier assignment
indicating limited utility for our objectives should not be interpreted as low study quality relative
to the purpose for which the study was conducted. Comments included on the likely direction of
bias refer to bias of the relative risk estimate.  "Upward bias" is an expected excess in the observed
relative risk above its true (but unknown) value (which is 1.0 if the null hypothesis of no effect is
correct).  "Downward bias"  refers to bias in the opposite direction. "Bias toward the null
hypothesis" is used sometimes in the text. It refers to an influence on the observed relative risk
toward 1.0, the value of the true relative risk when the null hypothesis is correct. When the true
relative risk exceeds 1, "bias toward the null" and "downward bias" are interchangeable.  The
probable magnitude of bias is more difficult to ascertain than the likely direction of bias.  The
                                             A-14

-------
relative values of the penalty scores under items in Table A-l reflect our judgment on this issue.
To determine why a specific study was scored with penalty or bonus points on any particular item,
the reader needs to refer to the review of that study in Section A.4.  A description of items in
Table A-l follows.

Category A: Never-Smoker Status
       •   Inclusion of former smokers. The ideal is for all subjects to be true never-smokers.
           Inclusion of subjects who report themselves as never-smokers but who are actually
           current smokers causes an upward bias in the relative risk (see Section 5.2.2 and
           Appendix B). Inclusion of former smokers may be a source of upward bias by similar
           arguments.  Some degree of  former smoking may be inconsequential depending on
           how much was smoked and the subsequent duration of abstinence, but this
           relationship is not well understood. Penalty points of 0.5 or 1 were assigned to studies
           that allowed some prior smoking because we view it as adding some degree of
           uncertainty compared with exclusive use of never-smokers as subjects.
       •   Verification of smoking status. The ideal  is to implement all means available to verify
           the never-smoking status claimed by subjects. No  studies were penalized on this item,
           but the few studies (i.e., FONT and PERS) that conducted thorough verification were
           given a bonus of -0.5.
Category B:  ETS-Exoosure Criteria
       •   Exposure criteria questionable. The ideal is for a female to be classified as ETS
           exposed according to a measure of duration (e.g., years of spousal smoking) and a
           measure of intensity (e.g., number of cigarettes smoked per day by the spouse). Of
           course, collecting data on measures of exposure is not meaningful unless it enters into
           the analysis.  For the purpose of this report, the objective for case-control studies is to
           differentiate between subjects as sharply as possible on exposure to ETS using spousal
           smoking as an indicator. Knowledge is too limited to know how to accomplish this
           exactly, but extremes wherein the exposed group contains subjects with very little
           exposure or includes only subjects with very high exposure (while all lesser exposed
           subjects are classified as "unexposed") should bias results toward the null hypothesis.
           For cohort studies, GARF(Coh)  was penalized  because the duration of exposure to
           spousal ETS was limited.
       •   Exposure of unmarrieds. Ideally for this report, where the presence or absence of
           spousal smoking is emphasized as the main determinant of ETS exposure because of its
                                           A-15

-------
           high commonality among studies, subjects would be female never-smokers whose
           history of exposure to spousal smoke has been reasonably constant over an extended
           duration (independent of whether a subject may have been married more than once).
           Studies vary in the extent to which this topic is considered and how it is handled, and
           assumptions may need to be considered in view of a country's social practices. For
           example, some studies classify women as unexposed to ETS while unmarried,  which
           may be more reasonable in some cultures than others (e.g., probably more reasonable
           in Greece than in the United States).  Biases resulting from this item are most
           commonly toward the null hypothesis.                                      ,
       •   Verification of exposure status.  The ideal is to verify statements regarding present
           and past exposure to ETS from spousal smoking from other sources. Two studies,
           AKIB and FONT, were given bonus points for extended efforts in  that direction; no
           studies were penalized.

Category C: Lung Cancer Indication
       •   Secondary lung cancers possible.  The ideal is assurance that all cases are accurately
           diagnosed with primary lung cancer and that cases are not included where the lung
           cancer may be secondary to another site.  This item is closely related to the next one,
           which is concerned with the method of diagnosis/confirmation. Bias is toward the
           null hypothesis.
       •   Less than  90% confirmation by histology or cytology.  The ideal is that the original
           diagnosis of lung cancer, or a confirmation of it, is conducted by histology.  No
           penalty points are assigned, however,  if at least 90% of the cases are diagnosed or
           confirmed by histology or cytology. Three studies, FONT, KOO, and HOLE(Coh),
           were given bonus points for extended efforts in diagnostic confirmation.  The
           direction of bias is toward the null hypothesis.

Category P: Interview Type
       •   Less than 90% face-to-face interview. The ideal interviewing technique is face-to-
           face by trained interviewers. The effect on the quality of information from other
           types of data collection is unclear, but telephone interviews and mail-in questionnaires
           probably increase the rate of misclassification of subject information.  The bias is
           toward the null hypothesis if the proportion of interviews by type is the same  for cases
           and controls, and of indeterminate direction otherwise.
                                           A-16

-------
       •   Unblinded (case-control studies only). The ideal is for the interviewer to be unaware
           whether the subject is among the cases or controls and the subject to be unaware of
           the purpose and intended use of the information collected.  Blinding of the
           interviewer is generally not possible in a face-to-face interview.  In face-to-face and
           telephone interviews, potential bias may arise from the investigator's expectations
           regarding the relationship between ETS exposure and lung cancer incidence. The
           potential for bias is probably less with mail-in interviews.

Category E: Proxy Respondents
       •   More than 10% proxy respondents (10% of total for cohort studies and  10% of either
           total cases or total controls for case-control studies). The ideal is for data to be
           supplied by the subject because the subject generally would be expected to be the
           most reliable source. A subject may be either deceased or too ill to participate,
           however, making the use of proxy responses unavoidable if those subjects are to be
           included  in the study (some studies appeared to exclude them).  The direction and
           magnitude of bias from use of proxies is unclear, and may be inconsistent across
           studies.
       •   Uneven distribution between cancer/noncancer subjects.  Ideally, the use of proxies is
           evenly distributed between cases and controls because this might be expected to
           minimize any net bias remaining from the use of proxy responses. The use of proxies
           is often much higher for cases than for controls, as one might expect. The effect of
           proxy distribution on bias is indeterminate.

Category F: Followup (Cohort Studies Only)
       •   Changes in smoking or ETS exposure not addressed.  The ideal is for any changes in
           personal smoking status or exposure to spousal ETS to be  recorded and taken into
           account in the analysis. If a subject begins active smoking during the course of the
           study, it may  lead to upward bias (from arguments like those given for the effect of
           smokers who misreport themselves as never-smokers, as discussed in Section 5.2.2 and
           Appendix B); if the smoking status of the spouse changes, the likely bias would be
           toward the null hypothesis.
       •   More than 10% loss to followup. The ideal, of course, is zero loss to followup. The
           ideal is not achievable in practice, but it seems reasonable to expect  loss to followup
           not to exceed  10%. The bias from loss to followup is indeterminate.  Random loss may
                                           A-17

-------
           have less effect than if subjects who are not followed up have some significant
           characteristics in common.
Category G: Design Issues
           Unsuitable indoor environment.  The ideal indoor air environment contains no
           significant sources of pollution from nontobacco sources that likely contain one or
           more of the known or suspected carcinogens identified in tobacco smoke or would
           otherwise be expected to increase the incidence of lung cancer. The presence of high
           concentrations of indoor smoke from unvented or inadequately vented indoor
           combustion of coal for purposes of warmth or cooking is commonplace in some
           regions of China where studies were conducted. This condition is indicated in some
           studies and has been confirmed from other sources (see reviews in Section A.4 for
           GENG, LIU, and WUWI). It is expected that indoor coal smoke increases the level
           and variability of exposure to many of the same carcinogenic agents that occur in ETS,
           and therefore detection of an incremental increase in lung cancer incidence from ETS
           would be highly unlikely in such a setting.
           Smoking-related disease in controls (case-control studies only). The ideal is for
           controls to be free of any disease related to tobacco smoke. This is an issue in some
           studies where hospital controls are  used. Potential bias is toward the null hypothesis.
           Nonincident cases included (case-control studies only).  The ideal is for all cases to be
           incident (i.e., new cases  that develop during an interval of time). A few studies began
           with prevalent cases and then proceeded with incident cases.  The use of prevalent
           cases may introduce some bias of unknown direction because prevalence is affected by
           survival rate and lung cancer patients generally do not survive for an extended period.
           All studies scored on this item were given one-half point,  which is in parentheses in
           most instances, indicating that information in the source is incomplete.  Interview
           information must be obtained from surviving kin or other proxy subjects as well, but
           that issue is treated separately in  a  following item. Potential bias is of uncertain
           direction.
Category H: Analysis Issues
           Uncontrolled for age. The ideal is to control for age by matching on age in the design
           and then adjusting for age in the analysis of data.  There is no clear formula for
           deciding which variables should be included in a matched analysis, and/or addressed
           in the analysis of the data collected. Age, however, is likely correlated with total
                                           A-18

-------
           exposure for those classified as exposed to ETS and is suspected of playing a role in
           cancer etiology.  The potential bias from age might be significant, but its likely
           direction and magnitude depend in an unknown way on the disparity of age
           distributions between cases and controls.
       •   Uncontrolled for other factors of importance.  This item applies to studies that report
           an increased association of lung cancer with factors other than ETS exposure but do
           not consider further whether these factors may be confounders that should be
           controlled for in the analysis for ETS.  For a variable to be a confounder of ETS,
           exposure to  the variable and to ETS must be correlated (which determines the degree
           of confounding), and the association of the factor with lung cancer must be causal.
           The correlation should be readily calculable from the study data. Conclusions about
           causation may not  be warranted, but one could still make the necessary calculations
           under the assumptions  that they are causative and then report what implications
           causation (if correct) would have for the assessment of ETS.  The expected effect from
           controlling for confounders is  to move the estimated relative risk closer to the true
           value.
       •   Problem(s) with statistical methods. The ideal is that conclusions are drawn from the
           application of statistical methods that are appropriate to the problem and accurately
           interpreted.  One penalty point was assigned studies where we  took issue with the
           statistical methodology or results. The direction of bias is indeterminate, in general, as
           the situations differ between studies.

A.4. INDIVIDUAL STUDY REVIEWS
       This section of Appendix A contains a review  of each epidemiologic study based on the
primary references listed in Table  5-1. Descriptions of the four prospective cohort studies are
individualized according to the requirements of each study—for example,  HIRA(Coh) has a long
history of controversy in the literature, so the main arguments are chronicled and discussed as part
of the review.  As noted previously, reviews of case-control studies follow a structured format,
consisting of three parts: (1) the author's abstract, which summarizes the most salient features and
conclusions in the author's opinion; (2) a study description based on the contents of a completed
study format designed around  principles of good epidemiologic practice and features specific to
ETS; and (3) a section of comments related to evaluation and interpretation of  the study.  The
author's abstract is, of course,  entirely the author's own words; the study description is intended to
portray accurately the reference article vis-a-vis items in the study format, so  the author's words
                                            A-19

-------
are used when possible; the comments section is entirely our own assessment of characteristics
relevant to study interpretation and utility in this report.
       An abstract only is available for the case-control study by Stockwell et al., (1991), referred
to as STOC, which has not appeared in print yet. There is insufficient information on the study to
include it in the main body of this report.  Similarly, an abstract only is available for the second
study of Kabat and Wynder (Kabat, 1990), which is included in an addendum following the
review of their first study, KABA. The data for many of the studies reviewed have been
extracted from a larger, more comprehensive study that includes active smokers.  The subjects and
their data used for investigation of an association between ETS exposure and lung cancer
incidence are referred to as "ETS subjects" and "ETS data," respectively.

A.4.1. AKIB(Tier2)
A.4.1.1.  Author's Abstract
       "A case-control study conducted in Hiroshima and Nagasaki, Japan, revealed a 50%
increased risk of lung cancer among nonsmoking women whose husbands smoked. The risks
tended to increase with amount smoked by the husband, being highest among women who worked
outside the home and whose husbands were heavy smokers, and to decrease with cessation of
exposure. The findings provide incentive for further evaluation of the relationship between
passive smoking and cancer among nonsmokers."

A.4.1.2.  Study Description
       This community-based case-control study was conducted in Hiroshima and Nagasaki,
Japan, in 1982. The data collected on passive smoking are part of a larger investigation of lung
cancer among atomic bomb survivors, the principal objective of which is to evaluate the
interactive roles of cigarette smoking and ionizing radiation. This article reports on married
female never-smokers, an unmatched subset of the data from the whole study.
       The whole study includes a total of 525 primary lung cancer cases diagnosed between 1971
and 1980. Cases were identified from the Hiroshima and Nagasaki Tumor and Tissue Registries
and other records.  Controls were selected from among the cohort members without lung cancer,
two per case in Hiroshima and three per case in Nagasaki.  The controls were individually
matched  to the cases with respect to year of birth (±2 years), city of residence (Hiroshima or
Nagasaki), sex,  biennial medical examinations, and vital status. The majority of cases were
deceased; those cases were matched to decedent controls by year of death (±3 years), in addition
to the other criteria. Controls were selected from causes of death other than cancer and chronic
                                           A-20

-------
respiratory disease.  Face-to-face interviews were conducted for 81% (82%) of the eligible cases
(controls), but 80% to 85% of the interviews for both cases and controls were actually conducted
with the subject's next of kin.  The mean age of cases at diagnosis is 72.1 years (range 36-94) for
males and 70.2 (range 35-95) for females, which is high for lung cancer in Japan.  Fifty-seven
percent of the cases were pathologically confirmed; the remaining 43% were diagnosed by
radiological or clinical findings.
       ETS exposure in adulthood was assessed by spousal smoking status, including the average
number of cigarettes smoked per day, age the spouse started smoking, and, for those who stopped
smoking, the  age at cessation. For childhood exposure, a single question was asked regarding
whether the subject's mother or father or both smoked when the subject was living at home as a
child; responses were obtained for only two-thirds of the subjects. No specific information on
exposure to smoking by other household members' smoking or to smoking in the workplace was
obtained.  ETS exposure data were checked by comparing smoking status with records from
RERF surveys in  1964-68 (self-reported by subjects when they were alive).  Cases and controls
who had never married were excluded.  Of the female cases exposed to spousal smoking, 16% had
squamous or small cell carcinoma, whereas no unexposed cases had those cell types. No
information was provided on location of the carcinomas.
       The number of  female cases exposed to ETS is 73 out of 94 (number exposed/total)
compared with 188 out of 270 female controls (crude odds ratio [OR] is 1.52 [95% confidence
interval [C.I.] = 0.88, 2.63], by our calculations). Application of logistic regression to the whole
study that includes active smokers, gives an adjusted odds ratio of 1.5 (90% C.I. = 1.0, 2.5), similar
to the crude analysis. It is not stated explicitly that matching variables were included in the
logistic regression model. Four additional analyses were conducted on the ETS data alone (i.e.,
without active smokers). The authors stratified exposure by number of cigarettes smoked per day
by husband (0, 1-19, 20-29, 30+) and obtained a marginally significant trend (p = 0.06).  No dose-
response gradient was found in the association between the number of years the husband smoked
cigarettes and the risk of lung cancer in female never-smokers; the odds ratio decreases from
lowest to highest exposure level (2.1, 1.5, and 1.3). Stratified analysis according to recency of
exposure to husband's smoking (unexposed, exposed but not within the past 10 years, and exposed
within the past 10 years) shows a significant upward trend (p = 0.05). Further stratification of
exposed subjects by occupation found that lung cancer risk tends to increase across occupational
categories in the following order:  housewife, white collar worker, blue collar worker. The highest
odds ratio occurred for women who had blue collar jobs and were married to men who smoked
one or more packs of cigarettes  per day, but the number involved was small. It is reported that
                                           A-21

-------
additional analyses of the data indicated that factors for matching in the whole study have little
influence, but the details are omitted.
       Limited histological information is provided. Among cases exposed to spousal smoking,
16% had squamous or small cell cancer, and 84% had adenocarcinoma or large cell cancer. All of
the unexposed cases had adenocarcinoma.
       The authors conclude that there may be a moderate excess in lung cancer risk associated
with passive smoking. The odds ratio for lung cancer among nonsmoking women tends to increase
with amount smoked by their husbands, a trend seen among  housewives, as well as among women
who work outside the home. There was little association with parental smoking or from passive
smoking that had ceased more than 10 years previously.

A.4.1.3.  Comments
       The larger study from which the ETS data are taken  was primarily intended to investigate
the interaction of smoking and ionizing radiation in atomic bomb survivors of Nagasaki and
Hiroshima. The information on passive smoking has been collected posthumously in a large
percentage of the cases, requiring heavy use of proxy responses. The response rate was not high,
however, because some next of kin refused to answer questions about deceased relatives and no
attempt was made to  locate next of kin of some subjects who had died or moved away from
Hiroshima or Nagasaki.  The dependence on proxy respondents raises questions about the validity
of the exposure data for some measures, particularly in childhood, and about detailed information
such as the number of cigarettes smoked per day, duration of smoking habit, and years since
cessation of smoking.  Information on childhood exposure was  obtained for only two-thirds of the
subjects. The omission of data on subjects where the next of kin had refused response or the
subject had moved may be a source of bias. The diagnosis of lung cancer was not pathologically
confirmed in more than 40% of the cases.  Also, it is not clear that the subjects are representative
of the target population. They had been exposed to ionizing radiation to varying  degrees,
whatever implication that may have; they are among the survivors, which may suggest selective
characteristics; and their age distribution is high, ranging from about 35 to 90 years of age with an
average of 70 years or more.
       Only ever-marrieds are included in the ETS subjects, which is helpful in the analysis.
There is some ambiguity in the statistical analyses, however,  in reference to Tables 2 through 6
(the main results).  The tables contain odds ratios that are reported to be the result of logistic
regression with matching.  The details regarding matching in the analysis are not given, but it is
reported that analysis of the crude data and matched logistic  regression give similar values.
                                           A-22

-------
Regarding the analyses for trend, the outcome seems to be sensitive to the measure of exposure
used.  The odds ratios are strictly increasing for stratification by number of cigarettes smoked per
day, but a different pattern emerges when ETS exposure is measured by the number of years the
husband smoked cigarettes.
       In general, the conclusions are presented more strongly than the data warrant. The
assertions are somewhat tenuous that risks tend to increase with amount smoked by the  husband,
are highest among those who work outside the home and whose husbands are heavy smokers, and
decrease with cessation of smoking.  Conversely, whereas little association between ETS exposure
in childhood and lung cancer is reported, relevant information was available for only two-thirds
of the subjects, and its accuracy is questionable because most of that information was provided by
proxies.  Overall, the observed data suggest that ETS exposure may be related to risk of lung
cancer, but there is some potential for misclassification and other sources of bias.  Thus, this study
provides  some useful information  on lung cancer risk in passive smokers, but its interpretation
needs to be conservative, taking into account the atypical characteristics of the subjects and other
concerns described above.

A.4.2. BROW (Tier 3)
A.4.2.1.  Author's Abstract
       "The relation between various risk factors and adenocarcinoma of the lung was evaluated
in a case-control study. Subjects were selected from the Colorado Central Cancer Registry from
1979-82 in the Denver metropolitan area. A total of 102 (50 males and 52 females)
adenocarcinoma case interviews and 131 (65 males and 66 females) control interviews were
completed. The control group consisted of persons  with cancers of the colon and bone marrow.
The risk estimates associated with cigarette smoking were significantly elevated among  males
(OR = 4.49) and females (OR = 3.95) and were found to increase significantly (p < 0.01) with
increasing levels of cigarette smoking for both males and females.  For adenocarcinoma in
females, the age- and smoking-adjusted odds ratios at  different levels of passive smoke exposure
followed an increasing overall trend (p = 0.05). After additional adjustment for potential
confounders, prior cigarette use remained the most  significant predictor of risk of
adenocarcinoma among males and females. Analysis restricted to nonsmoking females revealed a
risk of adenocarcinoma of 1.68 (95% C.I. = 0.39, 2.97)  for passive smoke exposure of 4 or more
hours per day.  Neither sex showed significantly elevated risk for occupational exposures,
although males bordered on significance (OR = 2.23, 95% C.I. = 0.97, 5.12). The results suggest
the need  to develop cell type-specific etiologic hypotheses."
                                           A-23

-------
A.4.2.2.  Study Description
       This study was conducted in Denver, Colorado, to evaluate the role of smoking, passive
smoking, occupation, community air pollution, and socioeconomic status in the etiology of
adenocarcinoma of the lung. Because subjects include active smokers, the data on ETS subjects
are part of a larger data set.
       Cases and controls were drawn from the Colorado Central Cancer Registry. All subjects
were diagnosed with lung adenocarcinoma between 1979 and 1982. Cases are white female
Denver residents of at least 6 months' duration. Controls are of similar description to the cases,
except that they were diagnosed with colon cancer or bone marrow cancer. Controls were
matched on  a group basis to produce the same age and gender composition.  It is not clear if
incident cases were  used and whether control sampling was cumulative or density.
       The  subjects are not matched on smoking  status, so the data on ETS subjects alone are
unmatched for all variables considered in the larger study.  Face-to-face interviews were
conducted, blindly,  on a total of 149 cases and 169 controls, after attrition in selection and follow-
up of 47 cases and 38 controls. The subject was interviewed in 31% of the cases and 61% of the
controls; the remaining interviews were conducted with a friend  or relative.  The mean age of the
female cases (controls) was 64.9 (68.2) years; no further details are provided. Clinical verification
of lung cancer diagnosis was conducted microscopically.
       "Exposed" to ETS is used in two ways, depending on context:  (1) the husband smoked
(presumably "ever-smoked" is intended, rather than "currently  smokes," but that is not explicit);
(2) the subject was in the presence of tobacco smoke, from any source, 4 or more hours per day on
average. Although there are two operational definitions of exposure, neither includes duration of
ETS exposure.  Questions were apparently asked regarding exposure in both childhood and
adulthood, the latter including sources in the home and in the workplace. No indication was
found that the data  collected from subjects were checked for internal consistency or against other
sources. No mention was found regarding the number of unmarried women in the study or what
assumptions may have been made regarding their exposure to ETS when spousal smoking is the
source considered (the first of the definitions given above).
       The  ETS subjects consist of 4 out of 19 (exposed/total) female cases and 7 out of 47
controls, when ETS exposure means the spouse smoked (Definition 1). For exposure from all
sources (Definition 2), the corresponding numbers for cases and controls are 4 out of 19 and 6 out
of 47, respectively.  The crude odds ratio is 1.52 (95% C.I. = 0.39, 5.96) for Definition 1 of ETS
exposure and 1.82 (95% C.I. = 0.45, 7.36) for Definition 2 (data communicated  from first author,
Brownson).  A test for trend using hours per day  as the exposure measure is conducted on the
                                           A-24

-------
whole data set for females including smokers (33 of 52 cases are smokers and 19 of 66 controls are
smokers; the two exposure categories, 4 to 7 and 8 or more hours per day of exposure to passive
smoke, contain a total of only 4 cases  and 6 controls who are nonsmokers, but 19 cases and 7
controls who are smokers). The method of Miettenen is applied with stratification on age and
smoker status (p = 0.05  for trend). The data for never-smokers alone were used in a multiple
logistic regression to compare subjects exposed 0 to 3 hours per day with those exposed from all
sources 4 or more hours per day (Definition 2 of ETS exposure).  Adjustments were made for age,
income, and occupation. The reported odds ratio is 1.68 (95% C.I. = 0.39, 2.97).  (Note:  It appears
that the upper confidence value may be in error. In view of the outcome for the crude odds ratio,
a value about twice what is shown might be anticipated.)
       To summarize the statistical tests and authors' conclusions, no significant risk estimates
were shown when smoking by the spouse was considered as a dichotomous variable.  When the
data for both active smokers and  passive smokers were stratified according to level of passive
smoke exposure, a statistically significant trend in the risk estimates was shown for females
(p = 0.05) after adjustment for age and cigarette smoking.  However, after adjustment by logistic
regression for age, income, occupation, and cigarette smoking, with the two exposure categories
for ETS combined (> 3  and 4+ hours per day), no significant risk was detected.

A.4.2.3.  Comments
       The study is very small when  reduced to the never-smokers alone.  The measure of ETS
exposure used (hours/day from all sources) is not very specific to differentiate exposed from
unexposed persons, particularly exposure 20 to 30 years ago, which may be more relevant than
current exposure. Only 15% of the controls have a husband who smoked; only 13% of ETS
subjects are exposed from any source 4 or more  hours per day.  Thus, the cut-point selected by
the researchers  for general ETS exposure (4+ hours/day) may be too high, resulting in a
substantial amount of exposure in the "unexposed"  group.  For either definition of ETS exposure,
however, the percentage exposed is extremely low.  Details are lacking also in other areas that may
have a bearing (e.g., the treatment of unmarried subjects—whether they were present and, if so,
the assumption made regarding ETS exposure).
       We experienced some difficulty with the statistical analyses.  One of the adjusted
procedures is the trend test.  Perhaps  because the number of ETS subjects is so small, smokers
were included in the analysis and then a method was used to attempt to adjust the effects of their
presence on the outcome. It would be preferable, in our view, to omit the smokers from the
analysis entirely. There are so few ETS subjects in the exposure categories (see above) that it
                                           A-25

-------
 seems highly unlikely that a test for trend would be significant if based on the ETS subjects alone
 (we did not have the number of ETS subjects by exposure group, however, so we were unable to
 conduct the trend test to check the outcome).
        When the two exposure categories were combined and only the ETS subjects used, the
 results were not close to statistically significant (OR is 1.68; 95% C.I. = 0.39, 2.97). We also view
 that result with caution because using the same data for analysis  that were used to determine
 which variables to adjust for may distort the statistical interpretation. There also may be a
 typographical error in the upper confidence limit because the value shown is only about half the
 corresponding  value for the crude odds ratio.
        The remaining analyses are from the crude odds ratio, 1.52 (95% C.I. = 0.39, 5.99) and 1.82
 (95% C.I. = 0.45, 7.36),  which suggests a possible association between ETS exposure and lung
 cancer, although it could easily be ascribed to chance  in view of  the wide confidence intervals.
 The study has a very strict requirement for classification as exposed to ETS (4+ hours per day
 from any source of ETS), which is reflected in only 15% of the controls being designated as
 exposed (40-60% is more typical). This percentage is  only slightly higher than the  12% figure
 based on simply being married to a smoker.  The control subjects thus appear unrepresentative of
 exposure to the target population, or else the classification of subjects exposed is too rigid.  The
 crude odds ratio may be the preferred statistical measure to represent the outcome of the data, but
 care should be  exercised in using the results from this study in conjunction with those of other
 studies.

 A.4.3. BUFF (Tier 3)
 A.4.3.1. Author's Abstract
       "A population-based case-comparison interview study of  lung cancer was conducted from
 1979 to 1982 in six Texas coastal counties—Orange, Jefferson, Chambers, Harris, Galveston, and
 Brazoria—to  evaluate the association of lung cancer with occupational and other environmental
 exposures. Lung cancer mortality rates in these counties consistently have exceeded lung cancer
 mortality rates  observed for Texas and the United States from 1950-69 to 1970-75 for both sexes
 and races (white and nonwhites).
       Histologically and cytologically confirmed incident cases diagnosed during the interval
July 1976 to June 1980 among white male and female residents ages 30 to 79 years were
ascertained from participating hospitals in the six-county area. Both population-based and
decedent comparisons were selected and matched on age, race, sex, region of residence, and  vital
status at time of ascertainment. The exposures of primary interest in the study of lung cancer are
                                           A-26

-------
those associated with occupation (employment in specific industries and occupations) in
conjunction with tobacco, alcohol, diet, and residential exposures."

A.4.3.2.  Study Description
       This population-based case-control study was conducted in six coastal counties of eastern
Texas to evaluate the association of lung cancer with occupational and other environmental
exposures.  Those of primary interest are associated with occupation in conjunction with tobacco,
alcohol, diet, and residential exposures.  The ETS subjects are part of this larger study that
includes active smokers.
       Cases include males and females ascertained from hospital and State records during
1976-80, except for Harris County, which includes only females from 1977-80.  All subjects are
white (including Hispanic) county residents of at least 6 months.  Cases are incident, without
restriction to cell type, and histologically diagnosed to eliminate secondary lung cancers (there is
some inconsistency in the article on whether all diagnoses were by histology or whether some  were
by cytology). Controls were selected from State and Federal records,  group matched on age, sex,
race or ethnicity, county of residence, and vital status. The candidate sample size is estimated in
the report at approximately 1,650, including both sexes, of which just over 700 were lost to
attrition in selection or followup for various reasons.  Face-to-face  interviews were conducted,  a
large number of which were with  next of kin as necessitated by inclusion of decedent cases and
controls.  For example, for females, the number of subject interviews is only 18% for cases
(81/460)  and 24% (116/366) for controls. The  distribution of ages is similar for cases and
controls, based on  groupings of 10-year  intervals.
       "ETS exposed" means having ever lived with a household member who smoked regularly.
Exposure sources include the home environment during childhood and adulthood but exclude the
workplace.  There is no mention of whether data on ETS exposure were cross-checked with other
interview questions or other sources. No indication was found regarding unmarried females in the
sample and how marital status may affect level of exposure to ETS. Some summary information is
provided on the distribution of tumors by cell  type, but totals include smokers, so they are not
reproduced here. The ETS data for females consist of 33 out of 41  (exposed/total) cases and  164
out of 196 controls; for males, the respective figures are 5 out of 11 and 56 out of 90.  For the
exposure definition given above,  the crude  odds ratio reported is 0.78 (95% C.I.  = 0.34, 1.81) for
females (direct calculation from the data yields a value of 0.81; Buffler apparently added 0.5 to all
cells to compensate for inclusion of no subjects in some cells).  Little  difference was found when
female smokers  were categorized  by number of years lived with a household member who smoked.
                                            A-27

-------
 No adjusted statistical analysis is provided to account for variables used in matching for the study
 as a whole, nor is there a test for trend. The authors conclude that no effect of passive smoking is
 indicated for lung cancer.  No attempt is made to evaluate whether exposure to ETS in childhood
 or adulthood is a factor.

 A.4.3.3.  Comments
        The potential relationship between ETS exposure and lung cancer risk was not a principal
 issue in the design of this study.  As described in the abstract,  and more fully in the study
 description above, other potential etiologic factors were of more central concern. There are
 several limitations regarding the study's contribution to the epidemiologic evidence on ETS
 exposure and lung cancer risk.  For example, the interview question on exposure to ETS is not
 very specific. "Having lived with a household member who smoked regularly" does not distinguish
 between exposure in childhood and in adulthood, between substantial and only light exposure, or
 between short-term and long-term exposure. One might expect a high percentage of  persons to
 qualify as "exposed" under such a broad definition, and that is  what the study demonstrates:  84%
 of the controls are classified as exposed.  With such a high percentage, both cases and controls may
 include a number of subjects who have experienced very light  exposure to ETS. Another concern
 in this study is the use of decedent subjects. The majority of both male (86%) and female (82%)
 cases in the study (including smokers) were deceased.  Consequently, a very high percentage of
 interviews was by proxy (82% of cases and 76% of controls).
        This study was conducted in a region with a significantly higher age-adjusted mortality
 rate for lung cancer than for the United States in general.  For all ages combined, the  overall
 excess lung cancer mortality in the Texas study area is approximately 30% to 40% and is
 considerably higher for some age groups, according to the article.  This was the apparent
 motivation for the study, with emphasis on important occupational and industrial exposures for
 residents of the Texas coastal area, including those associated with shipbuilding and repair,
 chemical and petrochemical manufacturing,  petroleum refining, construction, and metal
 industries. If these nonsmoking factors affect the incidence of lung  cancer, then they may be
 confounding the attempt to detect an effect from passive smoking.  Appropriate statistical
 methods need to be applied to adjust the effect of each risk factor for the others.
       Other factors may affect  the ETS analysis also.  Harris County, which is frequently
addressed in the article as distinct from the other five counties, was apparently added  to the study
later (case ascertainment began 1 year later there  and included only females; 10 of the 11 hospitals
that did not participate are in Harris County). Consequently, there are some regional differences
                                           A-28

-------
in the study as well as ethnic and racial differences (white and Hispanic).  Although the authors
took care to match controls on these and other factors, the matching only applies to the whole
study (91% and 97% of male and female cases, respectively, are classified as having smoked
regularly), not to the ETS subject group specifically, and there is no adjustment for these factors
in the analysis.  The unadjusted analysis, the insensitive indicator of ETS exposure, and the large
use of decedent cases and proxy  responses limit the value of this study for assessing any health
effects associated with passive smoking.

A.4.4. BUTL(Coh) (Tier 2)
       This study was undertaken to explore the role of active and passive smoking in Seventh-
Day Adventists in California.  Subjects were participants in a larger prospective cohort study of
factors affecting health in Adventists.
       In 1974, the Adventist Health Study was initiated with the purpose of investigating the
associations  of a number of lifestyle and nutritional factors with morbidity and mortality in
California Seventh-Day Adventists. Registered Adventist households were identified by
contacting the clerks of all 437 California Adventist churches. A basic demographic questionnaire
sent to all households received a  response rate of 58%. In 1976, all subjects aged 25 or older in
1974 were asked to  complete a lifestyle questionnaire that included many demographic, medical,
psychological, and dietary variables.  More than two-thirds of the targeted subjects responded.
From the non-Hispanic whites among these respondents, Butler and his colleagues drew two
cohorts. One consisted of 22,120 spouses married and living together at the time of completion of
the lifestyle questionnaire in 1976 ("spouse-pairs" cohort) and the other of 6,467 individuals
participating in an Adventist Health Smog Study of air pollution and pulmonary disease (the
"ASHMOG" cohort); about two-thirds of the ASHMOG cohort also was included in the spouse-
pairs cohort.
       Subjects received annual  forms for self-reporting of hospitalizations in the past year.
Medical records relating to reported hospitalizations were then reviewed.  Mortality was traced in
four ways:  linkage  with California Death Certificate and National Death  Index Systems, church
clerk notification of deaths entered in church records, and followup of hospitalization history
form responses (or nonresponses).  Underlying and contributing causes of death were obtained
from death certificates.  Death certificates were obtained for all reported  fatalities.
       For the spouse-pairs cohort, subjects were considered  unexposed to ETS if their spouses
were either never-smokers or ex-smokers baptized into the Adventist church—which proscribes
tobacco usage—before marriage.  Those whose spouses were ex-smokers with less than  5 years of
                                           A-29

-------
total smoking also were considered unexposed. All other subjects with ex- and current smoker
spouses were classified as exposed.
       Incidence rates were calculated using person-years. In the spouse-pairs cohort,
age-adjusted lung cancer mortality rates for females married to past or current smokers were
higher than those for female spouses of never-smokers, yielding relative risks of 1.94 and 2.47 for
past and current smokers, respectively. Comparison of wives with ever- versus never-smoking
husbands yielded a relative risk of 2.0. The same age-adjusted relative risk resulted when
analyses  were restricted to the 9,207 never-smoking females included in the spouse pairs.
Virtually identical risk estimates resulted from both Mantel-Haenszel and maximum likelihood
analyses. None of the relative risks was statistically significant at the 5% level.
       In the ASHMOG cohort, the relative risk of lung cancer adjusted for age and past smoking
status among females was 1.16 for women who had lived with a smoker for at least 11 years
compared with women who had not lived with a smoker; no difference was observed for women
who had lived for less than 11 years with a smoker, although this group was only one-tenth as
large as  the others.  A similar pattern  was seen among males  who had lived for at least 11 years
with a smoker, with an adjusted relative risk of 1.17.
       In the spouse-pairs cohort, age-adjusted rates of smoking-related cancers (excluding lung
cancer) were only slightly higher among nonsmoking females married to smokers than among
nonsmokers (relative risk [RR] = 1.06); the relative risk rose  to 1.22 when lung cancers were
included.
        In the ASHMOG cohort, age-adjusted rates using conditional maximum likelihood  analysis
for all smoking-related cancers were higher among males who lived with a smoker (RR = 1.45 for
 1-10 years; 1.74 for 11+ years) or worked with a smoker (RR = 2.62 for 1-10 years; 1.47 for 11+
 years).  Among females, in contrast, only one (at RR = 1.03) of the four exposed categories had a
 higher rate than the nonexposed groups.
        All lifestyle questionnaires were administered anonymously, thus reducing the potential
 for inaccurate responses caused by fear of discovery;  respondents to the special supplemental
 ASHMOG  questionnaire were assured of confidentiality but not anonymity.
         Although causes of death were obtained from death certificates, review of medical records
 revealed histological confirmation in  99% of the primary malignancies reported among the spouse-
 pairs cohort.  Thus, substantial misclassification of lung cancer deaths  is unlikely. Subsequent
 study of patients discharged from 1 of the 11 participating Adventist medical centers over a 6- .
 month period  indicated that under 2% of study participants  failed to report their hospitalizations;
 serious  underascertainment of cases thus also seems unlikely. Losses to followup by study's end
 totaled  only 1.2% of the original study cohort—a very low rate.
                                            A-30

-------
       Comparing the results of the 1976 questionnaire with those of a supplemental
questionnaire given to ASHMOG subjects in 1987, 4.7% of male smokers now reported themselves
as "never-smokers" and 1.4% of never-smokers now reported themselves as nonsmokers.
Concordance of female responses was even higher. This concordance of responses does not
necessarily imply the degree of accuracy of responses, only their reliability.
       Comparison of responses to the 1987 questionnaire by females revealed that about 6% of
those previously classified as not having a smoking spouse now reported having had one; the
converse was also true for 6% of the women.  These data indicate a mild nondifferential
misclassification of exposure, which would push results toward the null.
       Information is available on a large number of variables of possible interest as potential
confounders or risk mediators.  Unfortunately, the modest number of total lung cancer deaths
among females in the spouse-pairs cohort (8) or among both sexes in the ASHMOG cohort (13)
discourages attempts to control for other potential confounders in addition to age in the analyses.
Separate consideration of the association between variables other than passive smoking and age-
adjusted lung cancer mortality among women indicated a high relative risk (RR > 4) for spousal
blue collar occupation.  No other variables produced nearly as strong or consistent an association;
in fact, the only other consistent association was a relative risk of 1.3 to 1.6 for nonrural status.
Unfortunately, no breakdown of blue collar spousal status by exposure groups was presented.
        By virtue of its basic design, the inherent minimization of sources of confounding
provided by its study population and the level of information available regarding potential
confounders, and other sources of bias, the Butler study has many of the key ingredients to
produce convincing results. Unfortunately, this potential goes largely unrealized because of the
low number of outcome events occurring during the followup period, which for the most part
renders stratification or  control for multiple factors simultaneously impractical; even stratification
by several age or exposure levels produces  unstable results.
        Nevertheless, the findings of this study are quite consistent with the hypothesis that ETS
exposure of nonsmokers is associated with  mildly elevated lung cancer, (active) smoking-related
cancer, and ischemic heart disease mortality. Insofar as the study data allow for consideration of
potential misclassification and  confounding effects, neither misclassification nor confounding can
account for the observed association. Because of the limited number of outcome events, several
 possible confounding factors could not be definitively or adequately addressed in the  analyses, and
 the observed associations were not statistically significant; therefore, the study's findings must be
 viewed as suggestive but not of themselves convincing.
                                             A-31

-------
 A.4.S. CHAN (Tier 4)
 A.4.5.1.  Author's Abstract
 (Note:  This study is described in two sources, both of which were used for the description below.
 Chan et al. [1979] is the more complete description, but it contains considerable attention to active
 smoking as a cause of lung cancer.  Chan and Fung [1982] is a condensed version that specifically
 addresses nonsmokers. The abstract given here is for the 1979 article.  No abstract is provided in
 the 1982 source.)
        "Bronchial cancer is a disease of high and increasing annual incidence in Hong Kong,
 especially in women, whose age-specific death rates from this cause are among the highest in  the
 world.  A case-control study of the relationship of bronchial cancer with smoking was carried out
 during 1976-77, taking particular note of the histological type of the tumor. Two hundred and
 eight male and 189 female patients were interviewed, covering about one-half the total number of
 cases of bronchial cancer registered as dead from the disease in Hong Kong during the period of
 the survey. The association with smoking was more evident in males than in females, and in
 squamous and small cell types, as a group, than in adenocarcinoma. Forty-four percent of the
 women with  bronchial cancer were nonsmokers, their predominant tumor being adenocarcinoma,
 and in them no association could be detected with place of residence or occupation.  There was no
 strong evidence of an association with the use of kerosene or gas for cooking; 23 did not use
 kerosene. The cause of the cancer in these nonsmoking women remains unknown."

 A.4.5.2. Study Description
 (Note:  This description is primarily based on Chan et al. [1979]. Chan and Fung [1982] are cited
 when used as a reference.)
        This study is the earliest of four from Hong Kong that consider ETS exposure as a
 potential etiologic factor for lung cancer incidence in nonsmoking women. Here, however, that
 objective is secondary to  evaluation of the relationship of bronchial cancer with active smoking.
        In the whole study, target cases are the lung cancer patients, male and female, in five
 hospitals in Hong Kong during 1976-77 who were willing and able to be interviewed, Controls
 are patients of the same general age groups from the orthopedic wards of the same hospitals as the
 cases. No specific diseases are excluded. Cases are incident and control sampling is density. The
 candidate sample size  is 208 (189) male (female) cases and 204 (189) male (female) controls.
 Attrition from selection of followup is not reported but appears to be high. Subjects were
personally interviewed, when possible. About half of the estimated  number of lung cancer cases
diagnosed in Hong Kong during the study period were  actually interviewed.  Some patients were
                                           A-32

-------
too ill to answer questions, and more than expected were treated elsewhere than in the hospitals
covered. No interviews with next of kin were obtained for the cases interviewed.
       The ETS subjects (never-smokers) alone include 84 (2) female (male) cases and 139 (30)
female (male) controls  The age distribution of the female cases (controls) is, by percentage, as
follows: age less than 40, 7 (5%); ages 40 to 49,  15 (15%); ages 50 to 59, 23 (30%); ages 60 to 69,
23 (22%); and age 70 or more, 32 (28%). Cases with a histological diagnosis were reviewed and
verified by reexamination of the pathological specimens.  In the absence of a histological
specimen, cytological diagnosis was accepted.  In some cases, on histological grounds, secondary
adenocarcinoma was suspected, and a few cases were rejected after detailed examination of the
clinical records. Of the cases, 46 (55%) were diagnosed by histology, 23 (27%) by cytology, and 15
(18%) by radiology and clinical means. Diagnoses by cell type were as follows:  squamous or small
cell, 19 (22%); adenocarcinoma or large cell, 40 (48%); others and unspecified, 25 (30%). Of the
unspecified, 15 had no histological or cytological verification.
        ETS subjects are never-smokers. Classification of a subject as exposed or unexposed to
ETS is based on the response to these questions: (1) If you do not smoke, have you been exposed
to cigarette  smoke from other people at home or at work? (2) Does your husband/wife smoke? (If
"yes," how many cigarettes per day?)  (The first question is included in Chan et al. [1979].  The
second one is from a personal communication of Linda C. Koo.)  No information is reported on
the distribution of tumors by central and peripheral location.
        The ETS data on females based on question 1, above, consists of 50 out of 84
(unexposed/total)  cases and 73 out of 139 controls. The authors state that "this is a rather
subjective approach to the problem."  No statistical estimates are  provided; our calculation of the
crude odds  ratio is 0.75 (95% C.I. = 0.43, 1.30). No clear conclusion is drawn regarding  the
potential relationship between ETS exposure and lung cancer occurrence, but the authors imply
that no connection was found (which the odds ratio and confidence  interval amply support).  The
authors found no particular occupation as being dangerous.  Their findings also do not support air
pollution as a factor, and they provide no strong evidence that cooking with various types of fuel
 is relevant.

 A.4.5.3.  Comments
        Although data on spousal smoking were collected along with an indication of the number
 of cigarettes smoked per day, they are referred to only in the 1982 article," where the  authors note
 without further elaboration that more nonsmoking cases have nonsmoking spouses.  It is reported
 that answers to the question, "Are you exposed to the tobacco smoke of others at home or at
                                            A-33

-------
 work?" gave no indication that other people's smoking was a risk factor for lung cancer in
 nonsmokers, with 40.5% of cases and 47.5% of controls answering yes to this question.  Why the
 data for spousal smoking are not given and analyzed is unknown. The question about general ETS
 exposure combines sources in the household and workplace and refers only to current exposure
 without a measure of duration, which would likely affect any risk associated with passive
 smoking.
        Although it is reported that cases and controls are similar in age, occupation, and other
 characteristics, comparability is questionable. The article cites a criticism of the whole study
 (including smokers) for use of orthopedic patients as controls, on the basis that some patients may
 be hospitalized with smoking-related diseases (e.g., osteoporosis). It was found that the controls
 smoke more than a group representative of the population of Hong Kong.  This would create a
 bias toward negative association. Although these comments refer to smoking habits, they suggest
 the potential for selection bias of controls that may extend to nonsmoking  controls as well.
        It is noted, also, that there are  more cases from Hong Kong Island  than would be expected
 from the population distribution of Hong Kong as a whole, possibly due to more success
 contacting cases in Hong Kong Island than in Kowloon.  The authors caution about reaching any
 conclusion about the distribution of cases within Hong Kong as a whole. The failure to follow up
 on patients who were eventually treated at other hospitals or were too ill to be interviewed is
 itself, of course, a potential source of bias.
        Other differences are apparent between cases and controls. Among nonsmokers, a higher
 percentage of cases than controls (1) are Cantonese (81  vs. 70) or (2) have ever cooked with
 kerosene (73 vs. 60). It is speculated that the Cantonese diet, high in nitrite or nitrate content,
 may be a factor in lung cancer incidence (Chan and Fung, 1982).  More broadly, these
 comparisons between cases and controls indicate differences in ethnic composition, lifestyle, and
 socioeconomic status that are difficult  to assess.
       In summary, ETS subjects are not matched in the design, and an adjusted statistical
 analysis is not conducted. Consequently, potential sources of bias are not controlled. There is
 substantial basis to question the comparability of cases and controls, as described above. Data
 quality is suspect because confirmation of primary lung cancer was limited and cases were missed
 because patients were too ill to be interviewed personally or were eventually treated at another
 hospital.  Also,  the question posed to subjects for classification as exposed  or unexposed to ETS is
 sufficiently general to invite a subjective response. Overall, methodological shortcomings hamper
 the interpretation of this study's results.
       The finding that spousal smoking appears to be more frequent in controls, mentioned in
the 1982 report, is noted to be at variance with the Hirayama study,  which may have motivated
                                           A-34

-------
the authors to conduct this secondary analysis of ETS exposure using their previously collected
data.  Whatever the motivation, the limitations of the original study, which was not designed to
assess passive smoking, limit this study's value for assessing ETS exposure and lung cancer.

A.4.6. CORK (Tier 2)
A.4.6.1.  Author's Abstract
       "Questions about the smoking habits of parents and spouses were asked in a case-control
study involving 1,338 lung cancer patients and 1,393 comparison subjects in Louisiana, United
States. Nonsmokers married to heavy smokers had an increased risk of lung cancer, and so did
subjects whose mothers smoked. There was no association between lung cancer risk and paternal
smoking.  The association with maternal smoking was found only in smokers and persisted after
controlling for variables indicative of active smoking. It is not clear whether the results reflect a
biological effect associated with maternal smoking or the inability to control adequately for ,
confounding factors related to active smoking. This preliminary finding deserves further
investigation."

A.4.6.2.  Study Description
       This study was conducted in Louisiana to investigate the relationship of smoking habits of
parents and spouses to lung cancer occurrence.  Results of the study were published in 1983; some
clarifying details regarding study methodology were supplied in a 1984 paper addressing only  the
effects of active smoking. The accrual period is not stated; cases are probably a mixture of
prevalence and incidence, and controls are cumulatively sampled.  ETS subjects constitute a small
portion of the whole study, which includes active smokers.
       Cases consist of patients diagnosed with primary lung cancer, exclusive of
bronchioalveolar carcinoma, from participating hospitals in several Louisiana parishes (counties),
predominantly in the  southern part of the state. A total of 302 female and 1,036  male cases and
an equal number of controls are included in the whole study. Controls were selected from other
patients, excluding those diagnosed with emphysema, chronic bronchitis or obstructive pulmonary
diseases, or certain cancers (laryngeal, esophageal, oral  cavity, and bladder).  They  were matched
to cases on hospital, age (+ 5 years), sex, and race.  Information about active and passive  smoking
was obtained by interview (presumably face-to-face and unblinded), with responses obtained
from next of kin in 24%  of cases and 11% of controls; no  information  on refusals is provided.
ETS subjects were identified by exclusion of  individuals who had ever smoked or had never been
married, which eliminated 279 female and 1,026 male cases. Removal of subjects with no spousal
                                            A-35

-------
smoking data eliminated one additional female and two male cases, leaving 22 female and 8 male
cases. Similarly, a total of 1,080 men and women were excluded from controls.  No demographic
comparisons are given, either for the whole study or for the ETS subjects alone, nor is the number
of proxy responses provided for the ETS subjects.  Histological confirmation was obtained for
97% of cases in the whole study, including ever-smokers.
       "ETS exposed" is used in two ways, depending on the analysis given: (1) the spouse has
smoked at least 1 pack-year of cigarettes or (2) the spouse currently smokes.  Units of exposure
are pack-years and current consumption is in cigarettes per day for (1) and (2), respectively.  ETS
exposure in childhood means that at least one parent smoked during most of the subject's
childhood.  Types of tobacco smoking other than cigarettes (e.g., cigars and pipes) are referenced
indirectly in regard to interview questions but are not included in the data analysis.  Other sources
of exposure, either at home or in the workplace, are not considered. Never-married women are
excluded from ETS analysis, but no information is given on the number of nonsmoking widows
and divorcees and  how they were handled with regard to ETS exposure.  Adenocarcinoma
accounts for 54% of lung cancers in nonsmoking women, compared with 22% in women who
actively smoke. No further histological breakdowns are provided.
       For the main  analysis of spousal smoking, exposure constitutes 1 or more pack-years of
spousal cigarette consumption. ETS-exposed subjects include  14 (61) of 22 (133) female cases
(controls) and 2 (26) of 8 (180) male cases (controls). These data yield a crude odds ratio of 2.07
(95% C.I. = 0.81, 5.25) for females (confidence interval was calculated by reviewers). Among
females, stratification by 0, 1 to 40, and 41 or more pack-years of exposure yields odds ratios of
1.0, 1.18, and 3.52, respectively, with the highest exposure category being statistically significant
at p < 0.05. No adjusted results are presented.  It is, however,  reported that analyses based on
current daily spousal  cigarette consumption produced very similar results to the pack-year
analyses. In addition, it is reported that neither exclusion of proxy interview data nor restriction
to same-race subjects significantly  alters the results.  Analysis  of parental smoking during
childhood embraces the combined population of smokers  and nonsmokers, adjusting for smoking
status by logistic regression. Maternal smoking is associated with significantly increased estimated
risk of lung cancer (OR = 1.38, p < 0.05) but paternal smoking is not (OR = 0.83).  No association
was noted among nonsmokers alone, but the authors note that small numbers preclude adequate
analysis of this group.
                                           A-36

-------
A.4.6.3.  Comments
       The study entails a major multicentric effort to assemble hospital-, age-, race-, and sex-
matched lung cancer cases and controls from Louisiana hospitals.  Its use of trained local
interviewers familiar with the region's culture increases the probability of obtaining accurate
interview data for the nearly 3,000 subjects involved.  Exclusion of active smokers to assess ETS
exposure, however, exacts a toll on the study's power and validity. Because the initial matching of
cases and controls did not include smoking status, the ETS subjects are unmatched in the analyses
of spousal and parental smoking. This potential problem is not addressed by the authors.  The
lack of any demographic information on cases and controls leaves the comparability of these
groups uncertain.
       The potential problem of misdiagnosis of primary lung cancer is minimized by the;high
rate (97%) of histological case confirmations. Eligibility criteria for controls were intended to
exclude smoking-related diseases.  Some 15% of the controls had cardiovascular disease, however,
which has been associated with both active and passive smoking.  The authors also speculate that
the inclusion of adenocarcinoma, reportedly less smoking-associated than other lung cancers,  may
have diluted the significance of their results, but they do not present analyses using their
extensive histological data to assess this question.
        Restriction  of the spousal smoking analysis to ever-married individuals eliminates
potential bias due to differences between  lifelong single and married individuals. Stratification by
gender controls for any sex-related differences.  Both race and proxy interviews were reported to
have no effect on the spousal smoking results, and the  spousal smoking association was still
observed after division of women into more than and less  than 60 years of age. A small number
of nonsmoking ever-married cases (8 males and 22 females for this study) hampers efforts to
control statistically for other factors; nonetheless, direct adjustment for age and race is needed.
        It is concluded that females married to heavy smokers have an increased risk of lung
cancer.  A significant increase  in risk for nonsmokers was found  from maternal but not from
paternal smoking in childhood. The results for childhood exposure,  however,  use statistical
methods to adjust for the presence of active smokers.  It would be preferable,  in our view, to
remove the data for active smokers prior  to analysis. The potential for bias in all of the analyses,
which could be in either direction and may or may not be of consequence, needs to be kept in
mind when using this study's results.
                                             A-37

-------
 A.4.7. FONT (Tier 1)
 A.4.7.1.  Author's Abstract
        "The association between exposure to ETS and lung cancer in female lifetime never-
 smokers was evaluated using data collected during the first 3 years of an ongoing casercontrol
 study. This large, multicenter, population-based study was designed to minimize some of the
 methodological problems that have been of concern in previous studies of ETS and lung cancer.
 Both a cancer control group and a population control group were selected in order to evaluate
 recall bias. A uniform histopathologic review of diagnostic material was conducted for case
 confirmation and detailed classification. Biochemical determination of current exposure to
 tobacco and screening of multiple sources of information to determine lifetime nonuse were
 employed to minimize misclassification of smokers as nonsmokers.
        A 30% increased risk of lung cancer was associated with exposure to ETS from spouse, and
 a 50% increase was observed for adenocarcinoma of the lung.  A statistically significant positive
 trend in risk was observed as pack-years of exposure from spouse increased, reaching a relative
 risk of 1.7 for pulmonary adenocarcinoma with exposures of 80 or more pack-years.  The
 predominant cell type of the reviewed, eligible lung cancer cases was adenocarcinoma (78%).
 Results were very similar when cases were compared with each control group and when separate
 analyses were conducted for surrogate and personal respondents.  Other adult-life exposures in
 household, occupational, and social settings each were associated with a 40% to 60% increased risk
 of adenocarcinoma of the lung. No association was found between risk of any type of lung cancer
 and childhood exposures from father, mother, or other household members."

 A.4.7.2. Study Description
        This study was initiated in 1985 in five major U.S. metropolitan areas to investigate the
 association between exposure to ETS and lung cancer in female lifetime never-smokers.  The
 study was designed specifically to address this issue and includes only never-smokers.  The results
 reviewed are from an interim report, with the completed study expected to encompass an
 additional 2 years of case accrual.
       Patients were English-, Spanish-, or Chinese-speaking female residents 20 to 79 years  of
 age who have never used tobacco, have no prior history of malignancy, and have
 histopathologically confirmed primary lung cancer. The lung cancers were originally diagnosed at
 participating hospitals in Atlanta, Houston, Los Angeles, New Orleans, and the San Francisco Bay
area, between December 1, 1985, and December 31, 1988. Two control groups were assembled,
one from colon cancer patients and the  other from the general population, with the same general
                                           A-38

-------
eligibility requirements as cases.  The population control group, consisting of women selected
from the general population by random digit dialing and by sampling from Health Care Financing
Administration files, was frequency-matched on age (< 50, 50-59, 60-69, 70+), with two controls
per case. The colon cancer controls were frequency-matched to cases by 10-year age groups and
by race.  The lung cancer group consists of incident cases, but there is no indication whether
density or cumulative sampling was employed for either control group.  Exposure data  were
collected in face-to-face, apparently unblinded, interviews.
       Extensive efforts were made to include only never-smokers.  For cases and colon cancer
controls, medical records were reviewed for tobacco use and physicians were contacted as
necessary.  Eligible cases not previously excluded and all population controls were contacted by
telephone to screen for prior use of tobacco (no more than 100 cigarettes smoked or use of any
tobacco in  any form  for more than 6 months).  Urinary cptinine was bioassayed to eliminate any
misreported current smokers.
       A total of 514 eligible cases were identified, of which  83 were not interviewed  for
unspecified reasons and 2 had urinary cotinine levels consistent with active smoking. Independent
histopathologic review by a pulmonary pathologist  was performed for 84% (359/429) of the lung
cancer cases, resulting in nine exclusions. Only the remaining 420 cases are included in the study.
Colon cancers were not reviewed.  Of 489 (1,105) eligible colon cancer (population) controls, 131
(311) were not interviewed and 7 (14) were excluded for high urinary cotinine.  Proxies were
interviewed for 143 (34%) of the lung cancer cases and 35 (10%) of the colon cancer controls,
whereas no proxies were used for the population controls.
       Cases and the two control groups all have similar age distributions, with the majority of
subjects between 60  and 79 (73%, 74%, and 74% of the cases,  colon, and population groups,
respectively). The proportion of whites is similar across all groups (63-69%), but the control
groups contain a somewhat higher  proportion of blacks and lower proportion of other minorities,
and a little higher percentage of high school graduates (76% and 79% vs. 68%). Cases and controls
are comparable by metropolitan size of adulthood and childhood residences and also by annual
income.
        Four sources of adult ETS  exposure are assessed: smoking by (1) spouse(s) and (2) other
household members  while living with the subject, and reported exposure to ETS in (3)
occupational and (4) social settings. Three sources of possible exposure in childhood (up to 18
years of age) are considered:  smoking by (1) father, (2) mother, or (3) other household member(s)
while living in the subject's home  for at least 6 months. Subjects are characterized as ever- versus
never-exposed with  a subanalysis by tobacco type  (cigarette, pipe, or cigar). Years of  exposure
are also tabulated. In addition, cigarettes per day for spouse and for other household sources and
                                            A-39

-------
 pack-years for spouse(s) are calculated.  No checks on exposure (aside from the cotinine
 screening) are reported.
        Adenocarcinoma is the dominant type of lung cancer among study subjects, representing
 76% (311/409) of all cases included in the study (with the exception of 11 cases with "review
 pending") and also  78% (281/359) of all independently confirmed primary bronchogenic
 carcinomas among  those cases. Other cell types include 12% (48/409) large cell, 7% (27/409)
 squamous cell, 3% (14/409) small cell, and 2% (9/409) other cancers.  No data on airway proximity
 are provided.
        The final study population (for this interim report) consists of 420 lung cancer cases, 351
 colon cancer controls, and 780 population controls. Exposure to spousal smoking from all types of
 tobacco is reported for 294 cases, 231 colon cancer controls, and 492 population controls, yielding
 similar odds ratios (adjusted for age, race, area, income, and education) of 1.28 (95% C.I. = 0.93,
 1.75) and 1.29 (0.99, 1.69) using the respective control groups.  Elevated but statistically
 nonsignificant observed risks are also observed when cigarette,  cigar,  and pipe exposure are
 assessed separately, with either control group. Restriction of analyses to the 281 independently
 reviewed adenocarcinomas results in stronger associations, with adjusted odds ratios of 1.44 (95%
 C.I. = 1.01,  2.05) and 1.47 (1.08, 2.01) for all types of tobacco, and increased odds ratios for each
 type of tobacco as well.
        Odds ratios  were also calculated for ETS exposure from cigarette smoking alone, with the
 two control groups  combined (the individual results using each control group are entirely
 consistent).  For all lung cancer types combined, the adjusted odds ratios are 1.21 (0.96,  1.54) for
 spousal smoking, 1.23 (0.97, 1.56) for other household members, 1.34 (1.03, 1.73) for occupational
 environments, and 1.58 (1.22, 2.04) for social exposure, the last two of which are significant
 (p < 0.05 and 0.01, respectively).  The corresponding odds ratios for adenocarcinoma cases alone
 continue to  be uniformly higher:  1.38 (95% C.I. =  1.04, 1.82), 1.39 (1.05, 1.82), 1.44 (1.06, 1.97),
 and 1.60 (1.19, 2.14). The odds ratio tends to increase over years of exposure for all carcinomas
 combined and for adenocarcinoma alone, although not monotonically (without downturns).  The
 tests for upward trend are all significant or suggestive, with p-values ranging from < 0.001 to 0.07
 (these p-values are one-half those reported, which apply to a trend in either direction).  Finally,
 for spousal smoking measured in pack-years, the upward trend is significant for adenocarcinoma
 alone and for all lung cancers together (p < 0.005 and 0.04, respectively).
       The  authors interpret their findings as evidence of a causal relationship between  ETS
exposure in  adulthood and lung cancer in never-smoking women.  In contrast to adulthood,  ETS
exposure during childhood shows no association with lung cancer,  for  either all cell types
                                           A-40

-------
combined or adenocarcinoma alone. Adjusted odds ratios for childhood exposure tend to be
slightly (but not significantly) below unity for all exposure sources.

A.4.7.3.  Comments
       This study is much larger than any other ETS case-control study.  More than 400
never-smoking female lung cancer cases were enrolled in just over 3 years, in contrast to the 25 to
75 cases typical of most studies, and two control groups were formed, totaling more than 1,200
subjects.  Additionally, the cases and controls are drawn from five widely dispersed metropolitan
centers in the United States, representing a population of approximately 18.5 million people, about
8% of the U.S. population. This characteristic increases the generalizability of the study and
diminishes the potential for bias related to locale.
       Extensive efforts were made to achieve  precision and validity, in evidence throughout the
study. Cases and controls are highly comparable. They are frequency-matched on age and, for
colon cancer controls, on race as well.  The distributions of other demographic variables—annual
income, childhood residence, and adult residence—are quite similar between cases and both
control groups. The control groups contain a little higher (lower)  proportion of blacks (Asians and
Hispanics) and a higher percentage of high school graduates. These differences, however, should
not have influenced the reported associations because all odds ratios are adjusted for race and
education.
       The use of incident cases reduces the potential for selection bias, and the implementation
of two control groups allowed for assessment of potential bias from comparison with cancer
patients or the general population alone.  The similarity of results obtained from the two control
groups suggests little bias from choice  of controls.
       The use of a multistep procedure to eliminate inclusion of former or current smokers
reduces the potential for smoker misclassification as a source of upward bias.  As a further
safeguard, urinary cotinine was bioassayed for  all consenting persons to exclude those likely to be
current smokers. This  is the only published study  we are aware of to implement this precaution.
Attention to histopathology is also very thorough.  Inclusion of only histologically diagnosed
primary carcinoma reduces the likelihood of diagnostic error, which is further reduced by the use
of independent histopathologic review of most  cases by a single pulmonary pathologist.  The
study's histopathologic findings bring out two interesting points.  First, comparison of cell type
diagnoses between hospital and independent reviewers revealed poor concordance for large (56%)
and squamous (67%) cell carcinomas, indicating that cell-type-specific analyses for these cancers
may be misleading,  particularly if all diagnoses are not made by the same pathologist. The
                                            A-41

-------
histopathologic review also resulted in a net increase of adenocarcinomas from 244 to 281, 78% of
the total, a higher proportion than in most but not all other studies. The statistical results were
stronger when limited to cases of adenocarcinoma alone.
       Exposure information was obtained in the most reliable way, by face-to-face interviews
with each interviewer trained and fluent in the subject's primary language. Information for a
substantial proportion of lung cancer cases (34%) was obtained from proxy respondents, but fewer
proxies were required for colon cancer controls (10%), and none  were used for population
controls. The use of proxy respondents raises the possibility of information bias, but their
exclusion reportedly did not alter the study's findings.  The apparent lack of blinding also raises
the possibility of interviewer bias, but it is unlikely that such bias (or recall bias, for that matter)
would focus its effect on adenocarcinoma. Also, the same relationships hold whether the colon
cancer or population controls are used.
       Particular attention is paid to all sources of ETS exposure, which is more informative than
addressing only spousal smoking, with four sources in adulthood  and three in childhood evaluated
both individually and in combination. Additionally, subjects are counted as exposed to the ETS
of a spouse or other household smoker only while living with the source, giving a more accurate
account of exposure than simply determining whether a spouse or household member ever
smoked. Consequently, the measures of ETS exposure are more specific by source, and probably
more accurate, than in most studies.  This reduces bias toward unity in  the odds ratio arising from
poor distinction between exposed and unexposed subjects. Still,  further accuracy might have been
achieved by stipulating  that smoking must occur in the subject's  household or presence, but this is
a minor point.                                                                              .
       Most of the standard risk modifiers,  such as age, race, geographic area, income, and
education, are adjusted  for in all analyses and thus can be ruled out as sources of the observed
results. Although information on diet, occupational exposures, and "other exposures of interest"
were collected, these factors are not addressed in this interim report. Thorough treatment of the
possible impact of these factors presumably will be undertaken after subject accrual is finished
and published in the completed study.
       To summarize, this study was designed specifically and solely to address the topic of ETS
as a potential lung cancer risk to nonsmoking women. Several issues were given special attention,
such as the potential misclassification of smoking status, histopathologic specificity, recall bias,
and source of ETS exposure.  Histopathologic specificity has not  been convincingly demonstrated
in prior studies, and the meaning of "exposed to ETS" has differed widely between studies, even
those addressing spousal smoking only. The  remaining issues are largely related to controlling
potential sources of bias and confounding to enhance validity.  The qualitative rigor and
                                           A-42

-------
completeness of detail in this study is impressive.  In addition, it is quite large, which increases
precision of estimates and power to detect an association, if it exists. Use of dietary,
occupational, and other exposure data in the analyses, along with an additional 2 years of subject
accrual, will make the completed study for which this constitutes an interim report even more
valuable.  As it stands, however, this study is already the largest and most useful case-control
study available.  Its high quality and the reasonable consistency of the evidence across sources of
ETS exposure strongly support an increase in lung cancer incidence associated with passive
smoking.                                               .

A.4.8. GAO(Tier3)
A.4.8.1. Author's Abstract
       "A case-control study involving interviews with 672 female lung cancer patients and 735
population-based controls was conducted to investigate the high rates of lung cancer, notably
adenocarcinoma, among women in Shanghai.  Cigarette smoking was a strong risk factor, but
accounted for only about one-fourth of all newly diagnosed cases of lung cancer. Most patients,
particularly with adenocarcinoma, were lifelong nonsmokers.  The risks of lung cancer were
higher among women reporting tuberculosis and other preexisting lung diseases.  Hormonal factors
were suggested by an increased risk associated with late menopause and by a gradient in the risk
of adenocarcinoma with decreasing menstrual cycle length, with a threefold excess among women
who had shorter cycles. Perhaps most intriguing were associations found  between lung cancer and
measures of exposure to cooking oil vapors.  Risks increased with the number of meals cooked by
either stir frying, deep frying, or boiling; with the frequency of smokiness during cooking; and
with the frequency of eye irritation during cooking.  Use of rapeseed oil, whose volatiles
following high-temperature cooking may be mutagenic, was also reported more often by the
cancer patients. The findings thus confirm that factors other than smoking are responsible for the
high risk of lung cancer among Chinese women and provide clues for further research,  including
the assessment of cooking practices."

A.4.8.2.  Study Description
        This study was undertaken in Shanghai, China, during  1984-86 to explore reasons for the
high rates of lung cancer among women in Shanghai.  Potential etiologic factors associated with
the high occurrence of adenocarcinoma among females in  a population where few women smoke
cigarettes is of particular interest. Several potential risk factors, in addition to exposure to ETS,
                                            A-43

-------
 are investigated.  These are included in the abstract above. Smokers are included in the study as
 well as nonsmokers.
       A special reporting system for lung cancer linked with the area's medical facilities was set
 up for the study period, integrated with the Shanghai Cancer Registry. Incident cases of lung
 cancer occurring among 35- to 69-year-old female residents of urban Shanghai from February
 1984 to February 1986 were interviewed by trained study personnel. Controls were women
 selected from residents of the urban Shanghai community by stratified random sampling designed
 to mimic the age distribution of Registry-reported lung cancer cases during 1980-81. It is not
 clear whether cumulative or density sampling was employed.
       Face-to-face interviews were conducted with 672 cases and  735 controls. No cases refused
 to be interviewed, but 93 died before interview and were  therefore excluded; it is not mentioned
 whether there were any refusals among potential controls. Nonsmokers composed 436 of the cases
 and 605 of the controls. In the total subject population, distribution of age, education, and
 marital status between cases and controls is described as similar, except for a larger proportion of
 controls (32% vs. 20%) in the oldest age group (65-69 years).  The age distribution in the ETS
 population alone is not described.
       ETS exposure is based on living with a smoker.  For general  exposure in childhood or
 adulthood, exposed subjects are those who ever lived with a smoker. For spousal smoking alone,
 however, women are ETS exposed only if they lived with a smoking husband for at least 20 years.
 General ETS exposure sources include all household members but not coworkers. Verification of
 exposure data was not mentioned. Based on the reported exposure criteria, widows  and divorcees
 would have been included in the spousal smoking data set, whereas never-married women would
 have been excluded.
       For ETS subjects, 246 (375) cases (controls) from the total of 672 (735) cases (controls) are
 included in Table II of the article  that lists the number of cases and controls by number of years
 lived  with a smoking husband. Presumably, the 190 cases and 230 controls not included in the
 table are unmarried (or never-married) and do not include women married and living with a
 nonsmoker; no explanation is provided in the article.
       Among nonsmoking women included in.Table II, 189 out of 246 cases and 276 out of 375
 controls had lived with a smoking husband for at least 20 years. These subjects were divided into
exposure categories of 20 to 29, 30 to 39, and 40 or more years for comparison with the
"unexposed" (< 20 years spousal smoking) subjects. The  authors present no unadjusted analyses,
but calculations from their raw data yield an overall odds ratio of 1.2 and stratum-specific odds
ratios of 1.2,  1.3, and  1.1 for 20 to 29, 30 to 39, and 40 or more years of exposure, respectively.
Age-  and education-adjusted odds ratios increase with the number of years exposed:  1.1 (95%
                                           A-44

-------
C.I. = 0.7, 1.8) for 20 to 29 years, 1.3 (0.8, 2.1) for 30 to 39 years, and 1.7 (1.0, 2.9) for 40 or more
years.  The authors report an odds ratio of 2.9 (1.0, 8.9) for squamous and oat cell cancer for 40
years of exposure or less but present no other type-specific results.
       Information on cell type is available for the 542 (81%) study cases diagnosed by histology
or cytology; the rest of the cases  were diagnosed by radiological or other means.  Diagnostic
evidence was reviewed by a team of pathologists and clinicians.  For the lung cancer cases
histologically typed, adenocarcinoma (61%)  greatly predominates, followed by squamous (22%),
small cell (6%), and other (11%) types.  No breakdowns of tumor type are provided for the ETS
group.
       The authors conclude that ETS may account for some, but probably few, of the cancers
among nonsmokers, because there was little or no association with ever having lived with a
smoker.  Among nonsmoking women married to smokers, however, there was an upward trend in
risk associated with increasing years of exposure.  This latter finding is consistent with reports in
other parts of the world. Little evidence was found to implicate the type of fuels used for
cooking in lung cancer risk; occupational factors did not appear  to be important, nor did familial
tendency to lung cancer. Our data suggest,  however,  that prior lung diseases, hormonal  factors,
and cooking practices may be involved.  Most provocative is the association with cooking oil
volatiles, and further investigations are needed to evaluate their  contribution to the high lung
cancer rates among Chinese women in various parts of the world.

A.4.8.3.  Comments
       The number of ETS subjects for analysis is relatively large. Unfortunately,  the study is
unmatched, with  no demographic breakdown of the cases and controls, either for the whole study
or for the ETS subjects alone.  Controls were selected to make their age distribution similar to that
expected for cases in the whole study, but the similarity  may not apply to ETS subjects alone.
Consequently, there is little basis for evaluating the comparability of cases and controls. Age and
education were adjusted for in the analyses, which has some compensatory value.
       The use of direct interview with all subjects without reliance on proxies to gather exposure
information should enhance the  validity of  the exposure comparisons. On the other hand,  the
possible use of unblinded interviewers could have biased results. In light of the lack of  association
noted for passive smoke exposure as a child or adult,  however, it is unlikely that such a  bias
produced the observed association between  spousal smoking and lung cancer. For evaluation of
spousal smoking, the reference group can hardly be classified as "unexposed" to spousal  smoking
because it includes women who lived with a smoking husband for  up to 20 years. The
                                            A-45

-------
investigators probably selected the cutoff level of exposure for their spousal smoking reference
group to balance the numbers in each exposure category, as a practical matter. The reference
group contains an undisclosed number of women who may have been exposed to spousal smoking
for many years,  potentially creating a substantial bias toward the null hypothesis (no association
between ETS exposure and lung cancer).  Consequently, the odds ratios may be biased downwards.
The relative comparison across years of spousal smoking, however, is not affected.  An increasing
trend in the odds ratio was observed, but no statistical test for trend  is cited.  In a similar vein, it
appears that active smokers may have been included in  the data analysis of overall ETS exposure.
That factor, in combination with the use of ever- versus never-exposed classifications without
regard to degree or duration of ETS exposure in the analyses, may have reduced the likelihood of
detecting any positive association that may exist.
       The study appears to have focused on potential risk factors other than ETS.
Unfortunately, the effects of these other factors on the  ETS results were not explored, even
though many of these appeared to be stronger risk factors than passive smoking.  Some factors,
such as  age and education,  were adjusted for in all analyses.  Control for education should in turn
produce a degree of adjustment for factors related to socioeconomic  status (e.g., dwelling size and
quality of diet).
       Overall, the study presents evidence of a mild duration-dependent association between
lung cancer and  spousal smoking that skirts statistical significance. Several sources of
misclassification bias are possible, but most would tend  to bias the odds ratio downward.  The
study was not, however, specifically designed to evaluate the ETS-lung cancer hypothesis.
Information was collected and analyzed on a number of other potential risk factors, but they were
not adjusted for in the analysis.  Coupled with other limitations, this omission  reduces the weight
of the study's results with regard to ETS,  although they support an increase in lung cancer risk
with spousal smoking.

A.4.9. GARF (Case-Control) (Tier 2)
A.4.9.1. Author's Abstract
       "In a case-control study in four hospitals from 1971 to 1981,  134 cases of lung cancer and
402 cases of colon-rectum cancer (the controls) were identified in nonsmoking women. All cases
and controls were confirmed by histologic review of slides, and nonsmoking status and  exposures
were verified by interview. Odds ratios increased with  increasing number of cigarettes smoked by
the husband, particularly for cigarettes smoked at home. The odds ratio for women whose
husbands smoked 20 or more cigarettes at home was 2.11 (95% C.I. = 1.13, 3.95).  A logistic
                                           A-46

-------
regression analysis showed a significant positive trend of increasing risk with increasing exposure
to the husband's smoking at home, controlled for age, hospital, socioeconomic class, and year of
diagnosis. Comparison of women classified by number of hours exposed a day to smoke in the
last five years and in the last 25 years showed no increase in risk of lung cancer."

A.4.9.2.  Study Description
       This study was undertaken in New Jersey and Ohio to investigate the  relationship of
involuntary smoking to primary lung cancer.  All data were collected specifically for this study,
and only nonsmokers were included as subjects. Cases are the lifelong nonsmoking women
histologically diagnosed with primary lung cancer during 1971-81 in four participating New
Jersey and Ohio hospitals. Controls selected from patients with colorectal cancer were matched
3 to 1 to  a case  on hospital and age (±5 years). Subjects were not restricted to incident cases, and
controls were apparently cumulatively sampled. Exposure data were obtained by blinded,
face-to-face interviews with subjects or their relatives.
       A total of 1,175 female lung cancer cases were initially identified from medical records.
Exclusion of women found to be current or former smokers or not to have histologically verified
primary lung cancer eliminated 1,041 of the identified cases, leaving 134 ETS subjects.
Interviews were conducted with patient, spouse, or child in about 75% of the subject population,
whereas the rest were conducted with another relative. The age distributions of  cases and controls
are nearly identical.
       ETS exposure includes pipe and cigar use as well as cigarette smoking. Three sources of
passive smoking are considered, which will be referred to as follows:  "exposure to husband's
smoke" means having a husband or other related cohabitant who smokes more than occasionally,
either (1) anyplace or (2) at home; "general exposure" applies to the smoke of others at home,
work, or otherwise who have smoked more than occasionally during the past (1)5 years or (2) 25
years; and "childhood exposure" refers to experiencing ETS from any source during childhood.
Husband's smoking is quantified as cigarettes  per day and years  smoked; general exposure is given
as average hours per day; and childhood exposure is treated as a dichotomous variable.  Only 57
percent of the cases were women living with a husband at the  time of diagnosis.  No checks on
exposure status are described, and no classification of subjects by marital status was implemented.
Adenocarcinoma (87) predominates among lung cancer cases, followed by large cell (21), small cell
and miscellaneous (15),  and squamous cell cancer (11); no data on airway proximity are provided.
       Ninety of 134 cases were exposed to husband's (or other  relative's) smoking at home,
compared with  245 of 402 controls, giving a crude odds ratio of 1.31 (reported 95% C.I. = 0.99,
                                           A-47

-------
1.73; C.I. calculated by reviewers is 0.87, 1.98). For husband's smoking of 20 or more cigarettes
per day, the highest exposure category, the odds ratio increases to 2.11 (1.13, 3.95).  Husband's
smoking averaged 11.5 cigarettes per day for the exposed subject. For husband's smoking
anyplace, 91 of 134 cases and 254 of 402 controls  were exposed, giving a crude odds ratio of 1.23
(0.94, 1.60). At the highest exposure category, 40 or more cigarettes per day, the odds ratio is 1.99
(1.13, 3.50). Cigar and pipe smoking alone yields odds ratios of 1.17 and 1.13 for husband's
smoking at home and anyplace, respectively. There are statistically  significant trends  for both
husband's smoking at home and for smoking anyplace when measured by cigarettes per day, but
not when evaluated by number of years smoked.  The odds ratio for ETS exposure from husband's
smoke, both total and at home, is calculated by source of interview respondent for the categories
of "self," "husband," "daughter or son," and "other." It is readily apparent that the excess risk is
attributable to "daughter or son," with some contribution from "other." None of the excess risk is
attributable to "self or "husband."
       General smoke exposure also shows an association with lung cancer.  Exposure over the
past 5 and past 25 years yields odds ratios of 1.28  (0.96, 1.70) and 1.13 (0.60, 2.14), respectively.
The odds ratios do not increase with increasing level of exposure, however, and none of the
association's is statistically significant. No association was found between childhood smoke
exposure and lung cancer (OR = 0.9, 0.74-1.12).  When the odds ratio is calculated by  source of
respondent, "other" and "self account for the excess risk when smoking for 5 years is the measure;
for 25 years of smoking, "other" and "daughter or  son" account for the excess risk.
       Stratification by cell type reveals that husband's smoking is much more strongly associated
with squamous cell (OR = 5.00, both for smoking  at home and anyplace) than adenocarcinoma
(corresponding ORs = 1.33 and 1.48);  no association with other cell types was detected.
Stratification by age and socioeconomic status suggests little effect of these variables on  the
results.  The results,  however, appear to be sensitive to whether the  interview data were  obtained
from the subject or a surrogate (offspring, relative, etc.), as noted above.
       A logistic regression analysis including adjustment for age, hospital, socioeconomic status,
and year of diagnosis was  undertaken for passive smoking.  Cigarettes per  day of husband's at-
home smoking is significantly associated with lung cancer, with an estimated relative risk of 1.7 at
exposure of 20 cigarettes per day compared to none.  In contrast, husband's smoking outside the
home is not significantly associated with lung cancer, although the estimated relative risk is 1.26
for 20 cigarettes per day.  General smoke exposure is not significantly associated with lung cancer,
for either the past 5 years or 25 years of exposure. Adjustment for  type of respondent reportedly
had no significant effect on the logistic regression results.
                                            A-48

-------
A.4.9.3.  Comments
       The abundance of nonsmoking cases (134) and controls (402) in this study relative to most
ETS studies gives it above-average statistical power.  Comparability of cases and controls appears
good based on their very similar age distributions, matching on hospital and age, and restriction to
nonsmokers, although the lack of further demographic comparisons means that divergence on
some other factor(s) cannot be ruled out.
       A major difficulty in this study, however, arises from the extensive use of proxy
respondents.  Only 12% (16 of 134) of the case interviews were with the patient. In the stratified
analysis,  it was found that the husband's smoking at home is positively associated with lung cancer
only when the smoking information is provided by a son or a daughter rather than by the patient
or her husband. This leads to several possibilities.  Perhaps the son or daughter claimed that the
patient's  husband smoked when he actually did not, thereby shifting cases from the nonexposed to
exposed category and increasing the odds ratio, or the patient or her husband claimed that the
husband  did not smoke when actually he did, thereby shifting cases from the exposed to
nonexposed category and depressing the odds ratio.  In general, it is thought more likely that true
smokers are misclassified as nonsmokers more often than  true nonsmokers are misclassified as
smokers (see, for example, Lee, 1986, and Machlin et al.,  1989). Also, Machlin indicates that
proxies tend to misclassify smokers no more often than smokers themselves do. Thus, it may be
that the son or daughter data are better than the self or husband data.  Alternatively, the
difference among the reporting sources may be due only to chance; the results in JANE on self or
proxy reports are quite the opposite of those in this paper, with the proxy reports (in this case
including the spouse) leading to lower odds ratios than the self-reports.
       Another possible problem with this study is the use of colon and rectal cancer cases as
controls on the theory that these diseases are not smoking related.  A recent paper, Zahm (1991),
notes that associations have been found between smoking  and these cancers. If these associations
carry over to  passive smoking, they might bias the result downward.
       In general, the detailed results from the stratified  analysis in Table 6 of the paper exhibit
considerable variation, probably caused by chance. Hence, the overall results in Table 5 of the
article, where all the cases and controls are used, may be the most reliable. They indicate an odds
ratio of 1.31 (1.24 after adjustment for smoker misclassification bias in the body of this report)
for exposure to all types of husband's smoking at home.
       The study's exposure assessment methodology is strengthened  by the attempt to maintain
blinding  by not informing interviewers of the study hypothesis or the subjects' disease status.
This is impractical in most studies, but given the use of controls who also have cancer and a high
                                           A-49

-------
proportion of proxy interviews, effective blinding of interviewers and subjects may have been
largely achieved here.  Detailed data on smoke exposure at home as well as elsewhere, including
pipe and cigar smoking, were collected. Pipe and cigar smoking are often not considered in ETS
studies, thus constituting a potential source of exposure misclassification, and smoking at home
should be a more meaningful index of smoke exposure than total smoking. What the authors
termed "husband's smoking" actually includes smoking by related cohabitants as well. Presumably,
this was done both to increase subject numbers (by not excluding unmarried women) and to
enhance detection of passive smoke exposure. However, it could cause some oversight with regard
to classification of ETS exposure (e.g., a widow, living with a nonsmoking sister, whose husband
had been a heavy smoker). Less understandable is the failure to include smoking by unrelated
cohabitants and the inclusion of single women living alone.  Diagnostic misclassification  is
unlikely given the histological verification of all cases and controls.
       Both husband's at-home and total cohabitant smoking are associated with lung cancer, the
association being stronger for at-home smoking.  Both exposures show a statistically significant
general increase in association with level of smoking, with substantial associations only at high
levels. The adjusted association for at-home cohabitant  smoking is much stronger (OR = 1.7;
p = 0.03) than that for smoking outside the home (OR =  1.3; p = 0.13), a pattern consistent with
home smoke exposure rather than some other smoking-related factor as the basis of the observed
results. General ETS exposure, in contrast, was inconsistently related to lung cancer in the
unadjusted analyses, with a stronger association for  exposure within the last 5 years than within
the last 25 (possibly attributable to better recall).  No dose-response  pattern is evident, however,
and no association was found in the adjusted analyses.
       The adjusted analyses include age, hospital, socioeconomic status, and year of diagnosis in
a logistic regression model, along with the passive smoking variable. This adjustment did not
significantly reduce the association between  husband's smoking at home and lung cancer observed
before the adjustment, but it did eliminate any association with  general ETS exposure.  Thus, the
results for husband's smoking at home are probably  not biased due to influences of age,
socioeconomic status, hospital, or temporal variables.  Dietary factors, heating and cooking
practices, and family history of cancer were  not considered as modifying risk; thus, an effect by
one or more of these factors cannot be ruled out.
       The heavy reliance on proxy respondents and their uncertain impact on the analysis leaves
some uncertainty in interpretation.  On the favorable side of this issue,  the authors'  attempt to
blind subjects and interviewers to the study hypothesis lessens the likelihood of potential bias
from proxy response, and no significant effect due to respondent type was found in the adjusted
                                           A-50

-------
analyses. Some of the exposure categories seem vague, but this would tend to reduce the
magnitude of the observed association rather than to give rise to one.  In summary, this study is
suggestive of a dose-dependent association between smoking in the home and lung cancer, with
reservations due to the use of proxies.

A.4.10. GARF(Coh) (Tier 3)
A.4.10.1.  Author's Abstract
       "Lung cancer mortality rates were computed for nonsmokers in the American Cancer
Society's (ACS) prospective study for three 4-year periods from 1960 to  1972 and in the Dorn
study of veterans for three 5-year periods from 1954 to 1969.  There was no  evidence of any trend
in these rates by 5-year age groups or for the total groups.  No time trend was observed in
nonsmokers for cancers of other selected sites except for a decrease in cancer of the uterus.
Compared to nonsmoking women married to nonsmoking husbands, nonsmokers married to
smoking husbands showed very little, if any, increased risk of lung cancer."

A.4.10.2.  Study Description
       This study examines the role of passive smoking in lung cancer among married women in
the United States. It uses data collected in a large prospective study initiated by Cuyler Hammond
of the ACS in 1959. The ACS's objective was to evaluate the association between potential cancer
risk factors and cancer mortality. Although data  were collected on the smoking status of women
and their spouses at the start of the study, Hammond thought the study data should not be used to
estimate lung cancer death rates in relation to amount of passive smoking by  female never-
smokers. Specifically, Hammond notes that the study was not designed for that purpose, and no
special information on the subject was obtained; information was available on the smoking habits
of the husbands of many of the married women in the study, but not on  the smoking habits of the
former husbands of women who were widowed, divorced, separated, or married for a second time.
More important is his statement that women  in America at that time were not generally barred
from public and social gatherings where men were smoking, and working husbands who smoked
generally did much if not most of their smoking away from home (Hammond and Selikoff, 1981).
Similar reservations  are expressed by Garfinkel, who also notes that 13% of the women
nonsmokers who  died of lung cancer in the ACS study reported that they were previously married
and that the classification of their exposure to their husbands' smoking may not be pertinent
(Garfinkel, 1981, p. 1,065).
                                          A-51

-------
       A total of 29 ACS divisions encompassing 25 states took part in the study; participating
counties were in turn selected by division leaders based on feasibility.  Data collection was
undertaken by networks of volunteers set up within participating counties. Recruitment of
subjects and subsequent followup monitoring were undertaken by volunteers who were instructed
to enlist qualifying acquaintances.  Subjects were restricted to persons more than 30 years of age
whose household contained at least one person over 45 years of age.  Illegal immigrants and
persons who were illiterate, institutionalized, or itinerant were excluded. Detailed questionnaires
were distributed to subjects and all members of their household over 35 years of age.  These
questionnaires covered factors such as diet, alcohol consumption, and occupational exposures as
well as smoking habits, but they did not address passive smoke exposure. Volunteers who
recruited subjects were given responsibility for tracing the subject's vital statistics for the next 6
years and contacting living subjects again in 1961,  1963, and 1965 to complete a questionnaire on
changes in smoking habits. Alternate researchers were appointed as necessary to replace
volunteers who moved or quit.  Finally, death certificates  were obtained for subjects reported
deceased; where death due to cancer was indicated, verification was sought from the certifying
physician. Although followup initially ceased with 1965, in 1972 an additional followup was
initiated in 26 of the original 29 ACS divisions and terminated in September 1972.

A.4.10.3. Comments
       The passive smoking study being described was undertaken  by assembling a subcohort of
married women who reported that they had never smoked and whose husbands completed a
questionnaire including smoking habits. This subcohort totaled 176,739 women out of the 375,000
never-smoking women enlisted  by the ACS in 1959. Women Were divided into three exposure
categories based  on their husband's smoking status—nonexposed for never^-smokers, and low
(high) for current smokers of less  (more) than 20.  Wives of former  cigarette smokers and men
who smoked cigars or pipes rather than cigarettes were excluded (Garfinkel, 1984); presumably,
these had already been excluded from the reported total (176,739).  Mortality rates were computed
by 5-year age intervals for unexposed women (i.e., wives of nonsmokers), from which the
expected number of deaths for exposed women was estimated under the hypothesis that spousal
smoking does not affect lung cancer mortality.  The ratio of observed to expected deaths in  the
exposed group provides an age-standardized mortality  ratio.  This mortality ratio is 1.27 (95% C.I.
» 0.85, 1.89) for spousal smoking of under 20 cigarettes per day (low exposure) and 1.10 (0.77,
1.61) for over 20 cigarettes per day (high exposure).
                                           A-52

-------
       In a separate analysis, women healthy at the start of followup were divided into groups
matched on age (5-year grouping), race, education, urban or rural residence, and occupational
exposure of husband to dust, fumes, or vapors.  Each of these matched groups was then
subdivided into zero, low, and high exposure categories. The proportion of observed deaths in
each category was multiplied by the proportion of subjects in the smallest category of the matched
group relative to that category.  This "adjusted" number of deaths was then summed across all
groups with a given exposure and compared with the corresponding value for the unexposed (zero
exposure) category to provide a mortality ratio.  In addition, we conducted a Mantel-Haenszel
analysis of mortality using data supplied by Garfinkel that yielded results similar to the author's
analyses.  Ages 35 to 39 and 70 to 79 were excluded  due to insufficient numbers. After stratifying
by age and correcting for time under study, the calculated lung cancer risk was greater in subjects
whose  husbands smoked, but the predicted risk at low exposure  was greater than at high exposure.
It is notable, however, that the lower risk at higher exposure is entirely attributable to the 50- to
59-year-old age group; otherwise, predicted mortality would be equivalent at the low and high
exposure (see Table C-1 of the report under discussion).
       The original ACS cohort study was a massive undertaking. By using it as the basis of his
cohort, Garfinkel was able to assemble a very large number (more than 170,000) of never-smoking
married women. A cohort of this magnitude attains a number of lung cancer cases ordinarily
feasible only by means of a large case-control study, while avoiding the attendant pitfalls of
potential recall and interviewer bias associated with  case-control studies. There are several
important limitations, however, that make the results of this study difficult to interpret. The ACS
study was not designed to yield a representative sample of the general population.  The sample of
women is older (all at least 35 years of age, two-thirds between  40 and 59 at start of followup),
more educated (only 5.6% were limited to a grade school education), and contains a much smaller
proportion of ethnic minorities (only 6.8% nonwhite) than the general population (Stellman and
Garfinkel, 1986).  Although not representative of the population as a whole, the relative
homogeneity of the subject population does reduce the potential for complications of
interpretation that differences in ethnic or socioeconomic factors or both may pose, and it
increases efficiency by not including subjects belonging to age groups unlikely to experience
significant mortality during followup.  Overall, the study population's unrepresentativeness
strengthens rather than undermines the study's conclusions. It would have been useful, however,
to confirm that exclusion of greatly underrepresented groups, such as nonwhites and persons with
no formal education beyond the eighth grade, had no effect on the results.
       Because the data on smoking habits were collected prospectively, no information on
exposures prior to 1959 was obtained.  Exposure history for the years before 1959 may be as
                                           A-53

-------
important as for the 12 years of followup, however, if lung cancer has a long latency period, such
as 20 years or so. Inclusion of persons whose exposure status may have changed markedly by 1959
could be a biasing influence.  Neither were changes in exposure status during the followup period
considered, despite the availability of data on smoking habits in 1961, 1963, 1965, and 1972.  In
fairness to the author, keep in mind that our comments are directed at evaluation of the study for
its contribution to the issues of passive smoking and lung cancer, although the ACS study was not
designed to assess ETS exposure. The only data collected on ETS exposure are based on the
spouse's current smoking habits at initiation of the study. If the ACS study had been directed at
evaluation of health effects of ETS, these issues would likely have  been taken into consideration
to sharpen the classification of subjects with respect to ETS exposure.  Overall, the likely
consequence of these factors is to reduce the sensitivity of the study to detect an association
between lung cancer and ETS exposure, but the potential for bias in the direction of a false
positive cannot be ruled out.  For example, if wives of smokers are more likely to become active
smokers during followup than wives of nonsmokers, these changes in smoking status could bias
results toward finding a positive association with passive smoking.  (Relevant to this particular
example, the authors state that "very few" subjects reported a change in their smoking status, but
provide no further details. Also, 12 or fewer years is a short exposure to produce lung cancer. It
is thus probable that any bias introduced by active smoking would  be minor; furthermore, the fact
                                                                   i
that a stronger association was observed for low than for high levels of spousal smoking argues
against a confounder associated with spousal smoking. Nevertheless, potential sources of  bias may
be present that influence the study outcome in either direction.)
       During 1959-65, confirmation of primary lung cancer diagnosis was obtained from
physicians for 78% of all cancer cases. Among 203 cases of lung cancer in nonsmoking women
diagnosed by death certificate, confirmation attempts on an unspecified number of these  cases
found  34 misdiagnosed as primary lung cancer, whereas 10 primary lung cancers were discovered
among cancers diagnosed as nonlung on death certificates. Thus, it appears that only about 85%
of the  death certificate diagnoses of primary lung cancer were accurate, while a small percentage
of primaries were misdiagnosed as cancers of other sites. No confirmation of diagnoses was
undertaken during the period after 1965 when nearly two-thirds (119 out of 182, according to
data supplied to reviewers by Garfinkel) of the lung cancer deaths in the ETS study population
were reported.  In light of the misdiagnosis rates found for 1959-65, it is likely that a substantial
percentage of the study's reported primary lung cancers in cases actually arose in other sites,
whereas a substantial percentage of reported cancers of other sites  actually arose in the lung.  The
                                           A-54

-------
resultant errors in subject classification probably bias the results toward no association (i.e., a false
negative conclusion),//a positive association actually exists.
       Loss of subjects to followup is another source of potential bias. A subsequent report on
the ACS cohort (Garfinkel, 1985) states that, whereas more than 98% of the original cohort was
successfully traced through 1965, more than 10% (3 of 29) of the original ACS divisions declined
to participate in the  1971-72 followup effort.  In the study now under review, Garfinkel reports
successful followup of 98.4% through 1965 and 92.8% through 1972, apparently not considering
subjects in the division who declined to participate in the extended followup as losses. It thus
appears that, whereas more than 98% of the original cohort was successfully followed up through
1965, less than 90% of the cohort was targeted for followup through 1972, and losses for this
targeted group approached 7%. Such losses not only reduced the number of observed deaths—
and, hence, the study's power—but introduced the possibility that differential loss to followup
could have distorted the study's results. A greater proportion of losses among exposed subjects
than among unexposed could partially mask a true positive association, whereas greater loss  among
the unexposed could potentially create a spurious association.
       Aside from the issues above, the study controls for  risk modifiers. Subjects were all of the
same gender and marital status, and age was controlled for  in all analyses. Analysis by groups
matched on race, education, residence, and occupation, along with age, produced nearly identical
results as the analyses standardized by age alone, indicating no confounding due to these and
unlikely confounding due to other socioeconomic, occupational,  or geographic factors.
       In summary, this study predicts a weak positive association between spousal smoking at
levels of 1  to 19 cigarettes per day and lung cancer, but only  slight association at higher exposure
levels; neither association is statistically significant. The lack of apparent dose-response pattern
undermines the association, but the confidence intervals of the point estimates for the high- and
low-exposure groups overlap so broadly that the existence of a dose-response relationship cannot
be ruled out entirely. Meaningful interpretation of the results for the issue of ETS exposure and
lung cancer, however,  is limited.  Because the study's objectives  were directed elsewhere, the data
collected on ETS exposure are limited to the status of spousal smoking at the start of the study.
Past history and future changes in status are not well addressed.  There is ample indication that
death certificate diagnoses are not a reliable source for the  selection and classification of subjects.
Although a second 6-year followup period was undertaken to increase the followup period to 12
years, its success was limited by incomplete participation and, perhaps, by organizational
difficulties related to long-term reliance on volunteers (who may relocate, change interests,  lose
contact with the subjects originally enlisted over an extended period, etc.).  Even if the followup
                                            A-55

-------
were entirely successful, however, 12 years of followup without regard to exposure experience is
not a particularly long period to evaluate the lung cancer potential for ETS because the latency
period associated with active smoking may be on the order of 20 years. Although the ACS study
has been an important contribution to its main study objectives, the limited exposure information
and other potential sources of bias for the issue of passive smoking and lung cancer leave its
assessment in question.

A.4.11. GENG (Tier 4)
A.4.11.1. Author's Abstract
       Not included in source.

A.4.11.2. Study Description
       This study was conducted in Tianjin, where China's highest incidence of female lung
cancer occurs, to illustrate the relationship between cigarette smoking and lung cancer in females.
The study explores both active and passive smoking, so the analyses for passive smoking apply to a
subgroup of the larger subject population. The source of the study's subjects and the time over
which they accrued are not specified. Subjects resided in Tianjin for more than 10 years.  The
source of controls is not given, but they consist of females pair-matched with cases on race, age
(±2 years), marital status, and birthplace. It is unclear from the article whether cases were
incident or prevalent and how controls were obtained.  A draft summary description of this study
(Liang and Geng, undated) from Liang indicates,  however, that hospitalized cases (96) were
matched with inpatient  controls and that general population cases (61) were matched with
neighborhood controls.
       The source of the study's exposure data is  not clearly stated, but the draft from Liang
indicates that all identified cases and controls were interviewed.  No information on collection or
verification of smoking or other data is provided.  The  authors state that cases and controls do not
differ significantly in age, education, occupation, race, marital status, birthplace, or residence,
but this refers only to the total study population of 157 cases and 157 controls that includes active
smokers; the same similarity may not hold for the  54 cases and 93 controls used in the passive
smoking analysis.  Tumor types are provided for 85% of the total case population but not
specifically for the passive smoking subpopulation; adenocarcinomas (36.9%) predominate, being
about twice as common  as squamous (22.3%) or small cell (19.7%) tumors. Although nearly 85% of
the total cases were diagnosed histologically or cytologically, it does not appear that verification of
                                           A-56

-------
diagnosis or primary status of tumor was undertaken by the authors, and no information on tumor
distribution is supplied.
       A nonsmoker (which usually means never-smoker) is ETS exposed if the spouse smokes.
Presumably, women  not currently married are excluded from the analysis, although they could
have been included with some assumption  made regarding their exposure status. Information on
dose and duration of exposure was collected but not used  in the passive smoking analysis, and it is
not indicated if cigar or pipe smoke was included.  ETS exposure from parents and colleagues is
reported to have been evaluated. The parental smoking referred to is apparently in adulthood, as
cohabitants in the home, but that is not made explicit. Exposure during childhood was not
specifically addressed.
       Among the ETS subjects, 34 of 54  cases and 41 of 93 controls were exposed.  This yields a
statistically significant crude odds ratio of 2.16 (95% C.I. = 1.03, 4.53) for husband's smoking.  No
analyses adjusted for age or other factors are reported. On a rather confusing note, an odds ratio
of 1.86 is cited twice later, but that value is inconsistent with the odds ratio of 2.16 from the raw
data.  Whether this is an error or the product of an unspecified adjustment by conditional logistic
regression, which the authors employ for other purposes throughout the paper, is unknown.  The
odds ratio increases with the number of cigarettes smoked per day by the husband  and with the
duration of the husband's smoking.  The odds ratios for smoking rates of 1 to 9, 10 to 19, and 20
or more cigarettes per day are 1.4, 2.0, and 2.8, respectively. For 1 to 19, 20 to 39, and 40 or
more years of exposure, the odds ratios are 1.5, 2.2, and 3.3, respectively. No tests for trend are
cited, and the relevant data are not given.  Consideration of ETS exposure from smoking  by
father, mother, or "colleagues" reportedly yielded no results that are "quite significant." No
further details are provided, and it is not clear whether these results consider past smoking status
or apply only to current status.
       The authors conclude that active and passive smoking are the most important risk factors
for female lung cancer in Tianjin.  They attribute 35% to  42% of lung cancer occurring in their
nonsmoking female population to passive smoking. Female lung cancer also is found to be
associated with other factors, such as occupational exposure, with an odds ratio of  3.1 (95%
C.I. = 1.58, 6.02); history of lung disease, with an odds ratio of 2.12 (95% C.I. = 1.23, 3.63); and
cooking with coal, where the odds ratio increases with the duration of exposure from 1.5 to 5.5
(see Table 8 of this reference).
                                           A-57

-------
A.4.11.3.  Comments
       The quality of this study is difficult to assess given the dearth of details supplied by the
authors. Certainly the number of nonsmoking cases and controls included is more substantial than
in some other studies, and the reported association between passive smoking and lung cancer is
statistically significant.  Questions regarding the mechanics of data collection and analysis,
however, remain unanswered.
       Exposure and other data were obtained from hospitalized subjects at bedside and from
others in their homes. Apparently no information was obtained from proxy sources; the number
of cases (or controls) who could not be  interviewed is unspecified. No blinding was employed,
but that may not have been feasible. Despite the reported similarity of the demographic
characteristics of the total case and control populations, dissimilarity cannot be ruled out within
the subgroup used for ETS analyses. Although the whole study, including active smokers, is
matched on several variables, that matching need not apply to the  ETS subjects alone.
       Lack of validation of diagnostic and exposure information may have led  to substantial
misclassification, although the fact that 85% of the lung cancer diagnoses were obtained via
histology or cytology suggests that diagnostic misclassification would not have been extreme.
Lack of consideration of former smoking status is a potential problem.  Inclusion of former
smokers among the nonsmokers, in combination with a tendency for former smokers to marry
smokers, could produce an upward bias in the odds ratios.
       Finally, although the crude odds ratio of 2.16 for passive smoking is statistically
significant, it does not take into account even the most basic potential confounder—age.  For the
larger case-control population (including smokers), occupational exposure (OR = 3.1), history of
lung disease (OR = 2.64), and cooking with coal (OR = 1.54-5.56,  rising with cumulative
exposure) are statistically significant risk factors that the authors claim have joint effects with
smoking, yet the ETS analysis is not adjusted for these likely confounders.  The anomalous odds
ratio of 1.86 given later in the results may have been adjusted for age or other factors, but there is
no way to tell.  Also, the detection of an effect of ETS would be unexpected if the  study area
suffered from high environmental levels of carcinogenic combustion products of coal,  as seen in
LIU and WUWI.  Although the literature contains no studies of Tianjin, Beijing is nearby. Zhao
(1990) reports that mean levels of a urinary indicator of polyaromatic hydrocarbon  exposure
(1-HP) in nonsmoking housewives are  much lower in Beijing than in Shenyang, one of the WUWI
study sites, but Wang (1990) found that indoor air pollution, principally due to coal burning,
sometimes masks the effect of active cigarette smoking.
                                            A-58

-------
       In summary, the study's results are consistent with the hypothesis that passive smoking
increases the risk of lung cancer, but they are not definitive. More detail regarding the mechanics
of the study is needed to assess its general validity.  If warranted, a clearer and more complete
analysis of the study's data regarding passive smoking, including consideration of the information
on dose, duration, and potential confounders already available, would then be useful. For the
current evaluation of epidemiologic evidence on ETS exposure and lung cancer, too many
questions remain about  the design and execution of the study to properly interpret the data and
assess the authors' conclusions.

A.4.12.  HIRA(Coh) (Tier 2)
(Note:  Because of the many publications relating to this study, a different format of presentation
is used.)
       This cohort study and a later case-control study based on it were undertaken to explore the
relationship of passive smoking and other factors with lung cancer in Japanese women.  Subjects
and data used in this study were,  however, drawn from a larger study that was not designed to
investigate passive smoking.
       An exploratory study of mortality determinants targeting adults at least 40 years of age
inhabiting 29 health center districts in Japan was initiated in 1965.  In autumn of 1965, more than
90% of the target population was interviewed to ascertain the status of lifestyle factors that might
affect health (e.g., cigarette smoking, alcohol consumption, and occupation).  Individuals,
including husbands and wives, were interviewed separately. Followup of the interviewees was
conducted using a combination of an annual census of residents and death certificates to monitor
mortality. Mortality, as determined by death certificate, was the outcome variable.  Hirayama
used this study population to examine the potential effect of passive smoking on lung cancer
mortality. In 1981, he reported the results derived from the first 14 years of followup (through
1979) in the British Medical Journal.
       A total of 142,857 women were interviewed in 1965, of whom 91,540 were nonsmokers
whose husbands also had been  interviewed regarding smoking status.  Using their husbands'
smoking status as a surrogate for exposure to ETS, Hirayama calculated lung cancer mortality rates
for comparison of women married to smokers with women married to nonsmokers; rates also were
calculated using various strata of spousal smoking intensity (number of cig./day), as well as age
and occupation.  A total of 346 lung cancer deaths occurred in this cohort during the first 14 years
of followup.
                                           A-59

-------
       After standardization for age and occupation, it was found that women whose husbands
smoked daily had a higher annual rate of lung cancer mortality than did women whose husbands
were nonsmokers or only "occasional" smokers. The rate increased with the level of smoking (e.g.,
8.7/100,000 annually for no or occasional smoking, 14.0 for smoking 1-19 cig./day, and 18.1 for
20+ cig./day). Higher rates and a dose-response pattern were observed in women married to
smokers after stratification on either husband's age or agricultural work status. Mortality due to
two diseases associated with active smoking, emphysema and asthma, was also higher in wives of
smokers and increased with exposure.  Conversely, mortality due to two cancers not linked to
active smoking, cervical and stomach cancer, was no higher in wives of smokers. Consideration of
husbands' drinking habits had no significant impact on mortality for lung cancer or other diseases
mentioned above.
       Further study results appeared in the October 3, 1981, issue of the British Medical Journal.
Among other things, results were presented by husband's age in 10-year intervals instead of 20-
year intervals and for 10 occupational categories instead of 2.  These tabulations revealed a
statistically significant overall association between husbands' smoking and lung cancer mortality
with a dose-response pattern (1.00 RR for nonsmokers plus former smokers, 1.44 RR for medium
smokers, and 1.85 RR for heavy smokers).  Also of interest was a breakdown of lung cancer
mortality and smoking habits in  greater detail for  both husband and wife. Notably, nonsmoking
husbands with smoking wives showed a higher lung cancer mortality rate (RR  = 2.94) than did
those with nonsmoking wives. Because nonsmoking husbands with smoking wives were rather
rare, however, the numbers in this stratum were low (only seven deaths); thus, the observed
association was not statistically significant.
        In 1984, Hirayama published results of an  additional 2 years of followup of his cohort in
Preventive Medicine. The same basic associations reported after 14 years  of followup for spousal
smoking and lung cancer remained after 2 additional years of followup.   Mortality rates increased
with increasing exposure after stratification by age of  husband, occupation, geographical area, and
time period during study; a trend had been reported after stratification for age of wife at start of
study only for ages 40 to 49 and 50 to 59.  It also was reported that the elevation of lung cancer
mortality in nonsmoking women married to smokers was significantly less among women who
consumed green-yellow vegetables daily (e.g., for spousal smoking of 20+ cig./day, the RRs for
disease mortality were 1.63 and 2.38). No such pattern was observed for ischemic heart disease.
In addition, a statistically significant excess of para nasal sinus cancer in nonsmoking wives of
smokers had been observed, which showed an apparent dose-response relationship across four
smoking categories,  culminating in an RR of  3.44 for  spouses of smokers of more than 20
                                            A-60

-------
 cigarettes per day.  That effect dwarfed those related to social class and dietary factors that were
 also examined.
        In 1988, Hirayama reported the results of a case-control study nested within his cohort in
 Environmental Technology Letters. To explore the relationship of women's age at marriage as well
 as husbands' smoking status with lung cancer mortality, lung cancer cases occurring among
 nonsmoking women in the cohort study were contrasted with stomach cancer cases as controls.
 Including only women under 59 years of age at the start of the cohort, the study divided husbands'
 smoking into three categories—none, 1 to 19, and 20 or more cigarettes  per day. Age at marriage
 also was trifurcated in 19 or fewer, 20 to 23, and 24 or more years.  Apparently as a result of
 exclusion of women over the age limit or because of missing data, only  115 cases and 423 controls
 were ultimately compared out of the 200 lung cancers and 854 stomach cancers among the
 nonsmoking female cohort.  Adjusting for woman's age and husband's smoking category resulted
 in odds ratios for lung cancer of 4.95, 1.76, and 1.41 for the respective age-at-marriage groups;
 the first two of these odds ratios were statistically significant.  An additional comparison found
 that among  lung cancer cases, the mean age at first marriage to a smoking husband was nearly
 8 years less  than the mean age at start of smoking for active smokers.
        A greatly expanded nested study was presented in the following  year (Hirayama, 1989).
 The study was designed to explore the potential effect  of dietary habits  on the relationship
 between lung cancer and spousal smoking.  A "baseline" sample of 2,000 nonsmoking wives, aged
 40 to 69 at the start of the cohort study, with known spousal smoking habits was randomly
 selected from the available cohort of 90,458 for comparison with the 194 lung cancer cases
 occurring in equivalent subjects within the cohort.  After determining that the age distributions of
 the case and baseline groups were very similar within smoking categories, the combined
 population was stratified on daily versus less-than-daily consumption for each of five food types
 (green-yellow vegetables, fish, meat, milk, and soybean paste soup), and wives with smoking and
 nonsmoking husbands were contrasted to assess differences in dietary habits.  After adjustment
 for wife's age and husband's occupation, only daily meat consumption was significantly more
 common among wives of smoking husbands, and this was limited to smokers of 20 or more
 cigarettes per day. Calculation of odds ratios for dietary habits resulted  in a "significant" elevation
 only in daily fish consumers (OR = 1.365, 90% C.I. = 1.05, 1.77; Table IV).  A nearly significant
 lowering of the odds ratio was found in daily meat consumers.
       Finally, odds ratios were calculated for lung cancer adjusted by wife's age, husband's
occupation,  and each of the dietary habit categories in succession. A dose-response pattern was
observed between lung cancer and husband's smoking that persisted after adjustment for any of
                                           A-61

-------
the five dietary factors. Odds ratios for the five dietary habit categories ranged from 1.42 to 1.69
for former smokers and smokers of 1 to 19 cigarettes per day and from 1.66 to 1.91 for smokers of
20 or more cigarettes per day compared with nonsmoking husbands.  The observed trend was
highly statistically significant, regardless of which factor was adjusted for in the calculation.

A.4.12.1. Chronology of Controversy
       Publication of Hirayama's initial 14-year followup results in  1981 provoked a sizeable
volume of commentary in the scientific literature. Following the release of updated results in
1983-84, the study attracted little controversy until the latter part of the 1980s, when criticisms
were directed at the study by a  number of authors. This process reached its culmination in
response to the EPA's release for external review of the document Health Effects of  Passive
Smoking: Assessment of Lung  Cancer in Adults and Respiratory  Disorders in Children,  which
placed considerable emphasis on Hirayama's results. An author-by-author, letter-by-letter
consideration of the arguments  regarding Hirayama's work would be dauntingly duplicative and
tedious.  Instead, the most-discussed concerns are highlighted below, followed by an overall
assessment of the study as it stands today.
Chronology of Selected Events Relevant to the Hiravama Cohort Study
Jan. 7, 1981   Results of cohort study are published in British Medical Journal (282:183-185).
Oct. 3, 1981   Comments and letters to the editor by Kornegay  and Kastenbaum (of the U.S.
              Tobacco Institute), Mantel, Harris, and DuMouchel, and MacDonald regarding Jan.
              7 article appear in British Medical Journal, along with the author's reply.
March 3-5    Hirayama presents updated results for his study cohort incorporating an
and July      additional 2 years of followup (for a total of 16 years) to the International Lung
10-15, 1983   Cancer Update Conference in New Orleans and the 5th World Conference on
              Smoking and Health in Winnipeg, Canada.
Dec. 17, 1983 Updated results of the cohort study are published in Lancet.
 1984
 1985
 1987
Results presented in conference of July 1983, and in summary form in Lancet later
that year, are published in full in Preventive Medicine. In addition, Hirayama now
reports a statistically significant increase in brain tumors with husbands' smoking.
In a roundtable discussion published in the same journal, Lee proposes that
misclassification of active smoking status may have biased Hirayama's results.
Another publication of results for the  16-year followup appears in Tokai Journal
of Experimental Clinical Medicine.
Hirayama includes previously published  study data  in a book chapter (Aoki et al.,
1987).
                                            A-62

-------
 1988
 1988
1989
1989
Uberla and Ahlborn publish an article from the Proceedings of the Indoor Ambient
Air Quality Conference in London (which is essentially the same as an earlier
presentation at the 1987 Tokyo International Conference on Indoor Air Quality)
criticizing the Hirayama study on several grounds.  Their primary assertion is that
correction for the cohort's age distribution removes the apparent effect of spousal
smoking.
Hirayama publishes the  results of nested case-control study based on cohort study
data in Environmental Toxicology Letters.  Estimated risk of lung cancer is
reported to increase with earlier age of marriage to smoker.
Layard and Viren publish a paper presented at the Conference on the Present and
Future of Indoor Air Quality in Belgium. Making their own projections  of
expected deaths and estimating losses to followup, they conclude that mortality
rates were anomalously low and followup losses unacceptably high in the Hirayama
study.
Hirayama publishes nested case-control results in Present and  Future of Indoor Air
Quality. Positive association of husband's smoking and lung cancer with  dose-
response pattern is reported after adjustment for dietary variables.
A.4.12.2. Some Major Critical Works
       A basic point raised by MacDonald (1981) and others soon after publication of Hirayama's
initial results concerned the selection of the study's sample population.  It appeared that the
29 health centers included in the study were selected on grounds of convenience rather than to
provide a randomly sampled, representative cross-section of the Japanese population. The
resultant sample might thus be unrepresentative of the Japanese population as a whole.
       Hirayama replied in 1981 that "the satisfactory representativeness [of the study population]
 . . . with regard to demographic and social indices was confirmed after the survey."  He did not,
however, provide supporting data.  MacDonald (1981) contended  that the six prefectures from
which the sample was drawn are relatively industry-heavy.  Hirayama (1983a) presented data
showing  that 40,390 of the cohort's wives were married to agricultural workers, 19,264 to industry
workers, and 31,886 to "others," indicating some overrepresentation of agricultural areas. He later
(1990b) cited quality of incidence data, geographical diversity, and coverage of communities of
both urban and rural character as well as different dominant industries as key selection criteria.
Women aged 70 or more are clearly underrepresented,  composing less than 1% of the study's 40-
and-older nonsmoking female population; this aspect of the study will be addressed later.
       The  key problem arising from an unrepresentative sample is that it may limit
generalizability of results derived from that sample to the population as a whole. In lieu of good
reasons to think that the association between exposure  and disease would be  different in the study
population and the general population, however, the possibility of an unrepresentative sample

                                           A-63

-------
assumes less importance.  Further, in this case, substantial numbers from each major geographical
and occupational element of the general population were included in the sample.  And, as will be
seen in the subsequent discussion, similar patterns of association were observed in a number of
demographic subgroups.
       Misclassification may occur in any  epidemiologic study.  Most of the critical commentary
has focused on potential misclassification of exposure status.  Because the study relies on
interview data to establish smoking status,  misreporting by interviewees may affect accurate
classification of both wives and their husbands' smoking habits.  It has been argued that women
are especially likely to misrepresent their smoking habits because smoking is considered less
socially acceptable for women than for men, particularly in Asian societies. Such misclassification
would tend to reduce the degree of association between passive smoke exposure and its effect(s) if
women in the "exposed" and "unexposed" groups were equally likely to misreport their own
smoking.  One of the most prominent criticisms leveled at the Hirayama study postulates a
differential misclassification of smoking status in women.  Peter Lee (Lehnert, 1984) raised the
argument that if women married to smokers are more likely to be (or to have been) smokers than
women who are married to nonsmokers, and a given percentage of smoking women claim to be
nonsmokers,  then purportedly nonsmoking wives of spousal smokers will include a higher
proportion of active smokers than wives of spousal nonsmokers. This will cause bias in the
direction of a positive association.  Arguments over the probable size of this bias have occurred
with estimated elevations in risk ranging from a few percent to around 50%, depending on
assumptions regarding the extent of misreporting, the risk inherent in active smoking, and the
degree of marital concordance between smokers (Lehnert, 1984; Wald et al., 1986; Lee, 1987a, b).
       Uberla and Ahlborn (1987) raised a number of points regarding the Hirayama study,
including those previously mentioned.  Citing the "severe selection bias by age," the authors report
that the increase in risk with spousal smoking disappears when this bias is corrected for.  The
study population in fact contained a very small proportion of women aged 70 or older (only about
!%)---so small that the rates generated by nonsmoking married women aged 70 or older are too
unstable to provide meaningful results. But by taking the negative results observed in this tiny,
unstable stratum of the cohort and weighting them to "correct" for the underrepresentation of this
age group, the overall association is made to disappear. Such a "correction" is meaningless.  In
addition, Hirayama (1990b) has noted that the authors inappropriately adjusted to the  total female
population rather than to the population of currently married females, and he characterized the
adjustment as "neither of scientific significance nor of creative value."
                                           A-64

-------
       The authors also essentially take Lee's approach to the differential misclassif ication
problem and claim that a modest differential misclassification "leads to risk ratios of around
unity."  As seen previously, this argument is plausible but purely speculative—and potential biases
toward the null are ignored in this and other "corrections." The authors conclude that "the null
hypothesis ... is consistent with the Hirayama data in the same way as is the alternative." But
unless one applies the aforesaid "corrections," the Hirayama data are, in fact,  more consistent with
the hypothesis of association than with the null hypothesis.
       Layard and Viren (1989) estimated "projected" mortality rates for a cohort with the age
and time distribution found in the Hirayama cohort by applying "standard demographic life table
procedures" to year- and age-specific life table data from United Nations and Japanese sources.
They concluded that female all-cause and lung cancer reported rates were only 76% and 85%,
respectively, of projected values. In a separate analysis, the authors also "calculated the numbers
of person-years that would have been observed in the cohort if there had been 100% followup"
from the reported numbers of deaths. The assumptions used in this calculation are unstated. The
authors  then estimated, based on the difference between their person-years for  100% followup
and the  reported person-years, and an assumption that 8 years of observation were lost on average
for each person lost to followup over the 16-year course of the study, that approximately 10% of
the cohort was lost to followup.  Dismissing  other possible causes  of their estimated mortality
deficits, Layard and Viren conclude that "it  is possible that biases exist in the data which might
invalidate an observed relationship between  exposure  to ETS and  mortality."
       Acceptance of Layard and Viren's conclusions must start with acceptance of the validity of
their assumptions and calculations, not all of which are stated explicitly.  Beyond that, their
rejection of alternative explanations for the  difference between projected and reported deaths is
not convincing. For example, random sampling variation and regional variations in death rates are
both dismissed because neither could produce an effect as large as that observed, although the
authors' figures indicate that in combination they could well account for a sizeable portion  of the
difference. Likewise, the effect of admitting only (initially) "healthy" people to  the cohort is
dismissed based on the observation of "still very substantial cohort deficits in the last years  of the
study" without specification of how substantial such deficits were and ignoring the fact that a
pattern in which all-cause mortality is most  affected and cancer mortality least, as their
calculations showed, is the expected pattern  for an effect of selection of healthy individuals.
Finally, to produce a spurious association, a  bias must operate differently on the exposed (smoking
spouse)  and unexposed (nonsmoking spouse) groups, and no evidence is provided that supports
such a pattern.  In fact, Hirayama (1990b) reported an approximately 8%  loss to followup for the
                                            A-65

-------
whole cohort, which did not differ significantly by male smoking status.  Lacking a pattern of
differential loss, the most likely effect of loss to followup is a reduction in the observed
associations due to missing mortality events.  The effect of selecting an abnormally healthy cohort
would in a strict sense limit generalizability of conclusions but would not in itself produce an
exposure-effect association when none actually existed.

A.4.12.3. Critique and Assessment
       Hirayama's cohort is drawn from a study population assembled to explore the associations
between a number of potential health-influencing factors determined via interview and
subsequent mortality.  Thus, the study was not designed to investigate passive smoking and lung
cancer specifically. Most of the weaknesses attributable to Hirayama's study derive from this fact.
       The only indicator of ETS available to Hirayama was self-reported smoking status at time
of baseline interview.  Thus, misclassification of spousal smoking status is possible, and change in
status over time, modifiers of exposure to spousal  smoking, and other sources of ETS exposure
cannot be determined.
       As previously seen, an overrepresentation of current and former active .smokers claiming
to be nonsmokers among wives of tobacco smokers probably biases the association between spousal
smoking  and lung cancer in reported nonsmokers upward.  Even the leading proponent of this
argument, however, states that unless this bias is much stronger than it appears to be in U.S. and
Western populations, it could not account for the major part of the observed results (Lee, 1990).
Lack of information regarding the amount of smoking actually done in the home and in the
presence of the spouse, room size and ventilation, and other exposure-modifying factors must lead
to imprecision in the estimates of exposure via spousal smoking.  This imprecision would make an
actual ETS-lung cancer association more difficult to detect. The fact that spousal smoking
exposure, even if precisely measured, is an imperfect surrogate for total ETS exposure because
workplace and ambient environmental sources are not assessed introduces a similar effect. Both of
these problems would thus introduce a bias toward the null, suggesting that the study's results are
an underestimate of the real association.
       Mortality information was derived from death certificate linkage. It has been contended
that lung cancer is routinely overdiagnosed as a  cause of death on death certificates, thus
undermining the study's credibility. But  the resultant misclassification of cause  of death would
presumably be nondifferential,  and thus bias results toward the null. To cause overestimation of
the association, a greater proportion of women in  the spousal smoking groups than in the
nonsmoking group would have to be falsely diagnosed as having lung cancer.   Because the study
                                           A-66

-------
cohort was made up of nonsmoking women, there would be little reason for such a pattern (unless,
of course, all such cases came from women who falsely reported their initial smoking status or
took up smoking in the course of the study and the misclassification/smoking habit concordance
hypothesized by Lee were actually strongly at work).
       No information is given regarding whether the same interviewers interviewed both
husbands and their wives. Thus, interviewers may not have been blind to spousal smoking
characteristics of  interviewees.  This is likely to have been of little importance, however, because
the outcome—lung cancer mortality—was measured prospectively, and thus did not occur for
some time after exposure had been assessed.  If information bias was to some  extent operant in the
interview, the most likely scenario would find women whose husbands  smoked being probed more
strongly for admission of their own smoking than were women whose husbands did not smoke.
This would tend to reduce underreporting of active smoking in the "exposed" group relative to the
"unexposed" group.  The result would be to lower the observed association between husbands'
smoking and lung cancer mortality.
       Hirayama's cohort includes only married, reportedly nonsmoking women who were at least
40 years of age and "healthy" at the start of the study. In addition, almost all of these women were
under 70 years of age, and agricultural families composed a larger part of the cohort than of the
general  population.  Thus, the cohort does not present a proportionately accurate cross-section of
the Japanese population as a whole.  Nevertheless, there is little obvious reason why a relationship
between spousal smoking and lung cancer mortality found in this cohort should be dismissed on
the grounds that it is not generalizable to the greater Japanese (or other) population.
       The  possibility that confounding by other risk factors explains an observed association
must be considered in any study. For lung cancer, of course, smoking, gender, and age are major
risk determinants. Restriction of comparison groups to same-gender nonsmokers avoids possible
effects due to gender or smoking (but see misclassification discussion regarding smoking status).
Age is only  partially restricted in the study design, so its consideration  in the  analysis is essential.
Hirayama chose to control for husband's age in analyzing the cohort study's results.  All observed
associations persisted after such adjustment.  Spousal ages should be closely correlated,  but direct
adjustment using  the subject's own age rather than the age of their spouse would clearly be
preferable.  One such analysis was supplied (Hirayama,  1983a), and in it a significant association
between spousal smoking and lung cancer mortality persisted.  Furthermore, in analyzing  the
nested case-control studies, adjustment for wife's age was used throughout, which produced
findings that confirmed the results of the cohort study.
                                           A-67

-------
       The potential role of confounding by other factors in the observed results has received
considerable emphasis.  A correlation between smoking and lower socioeconomic status with
concomitant lifestyle and environmental differences could be expected. Among these differences,
particular attention has been paid to the possible effect of dietary factors  (particularly low beta-
carotene intake) and occupational exposures, both of which, some hold, should correlate with
spousal smoking and thus could bring about the observed association even if spousal smoking and
ETS exposure have no  effect.  Yet, neither stratification on daily green-yellow vegetable
consumption—the best available surrogate for  beta carotene intake in the  data—nor on
agricultural versus nonagricultural occupation  of husband eliminated the association between
spousal smoking and lung cancer mortality  in the cohort study.  Similarly, adjustment for
husband's occupation and any of five dietary habit characteristics, along with wife's age, yielded
similar results in the case-control approach. Thus, neither of the major proposed confounders
satisfactorily accounts for the observed results.
       Because the data set does not contain the necessary information to examine effects due to
differences in cooking practices  (such as stir-frying), this cannot be ruled out, although such
practices might be expected to co-vary with some of the dietary factors considered in the analyses.
Similarly, use of coal for cooking or heating cannot be directly assessed, although a degree of
covariance with dietary habits or occupation is likely.
       Husbands' drinking habits were only marginally associated with lung cancer risk; mortality
rates stratified by both drinking  and smoking would have been more useful  (and stratification by
wives' own drinking habits would have been more useful still).
       When lung cancer mortality among wives is stratified by wife's age (in 10-year
increments) and husband's smoking  category, a clear dose-response pattern is seen only in the 40
to 49 and 50 to 59 age strata, whereas a decrease in mortality with spousal smoking is seen in the
70 and older stratum. Given that the latter stratum includes less than 1% of the cohort and very
few deaths, its rates are too unstable to justify much confidence. The dose-response pattern does
become weaker with ascending age strata, however, which has led to conclusions of inconsistency
with an ETS-lung cancer connection and presence of confounding. Hirayama has proposed that
age-related increases in spousal mortality, smoking cessation, and decreased time spent in
husband's proximity during the followup period may account for the observed pattern (Hirayama,
1990a). The proximity effect seems questionable because retirement of older husbands would
eliminate time spent away from the  house at work, but the other arguments  are plausible.
Alternatively, older women recently  married to smokers may be more likely to die from
competing  causes of death that increase with age before passive-smoke cancer develops.
Remarriage, possibly to a spouse whose smoking habits differ from those of the former spouse,
                                            A-68

-------
 also would increase with age and could lead to misclassification of (former) exposure with a bias
 toward the null.  (It is unfortunate that history of former spouses' smoking habits and recency of
 marriage apparently were not obtained in the baseline interview because if the information had
 been collected, the aforementioned problems could have been readily addressed.) Temporal trends
 in some risk modifiers, such as dietary factors, also could play a role.
        Confounding cannot be ruled out entirely in certain instances, but the underlying question
 that must be raised in this regard is the following:  // the spousal smoking group contains a
 disproportionate number of individuals with risk-elevating factors such as poor diet, lack of
 exercise, low socioeconomic status, and occupational hazard exposure, and these factors are
 sufficient to produce an increase in lung cancer mortality relative to the spousal nonsmoking
 group, despite an absence of any real smoking effect, why does this  multitude of risk factors result
 in elevations of established smoking-related diseases  only and no substantial elevation of risk  of
 other causes of mortality (except brain cancer, which encompasses relatively few deaths)?
        In considering the study's results in broader terms, Hirayama's findings are consistent with
 the hypothesis that exposure of nonsmoking women to passive smoke via spousal smoking
 increases risk of lung cancer. The observed association is statistically significant. In addition, the
 persistence of the association after stratification on numerous variables, the observation of a
 parallel association in nonsmoking  husbands of smoking wives, the appearance of associations with
 other smoking-related diseases, the existence of a dose-response pattern in most analyses of strata
 containing adequate numbers, and  the production of  similar conclusions by either cohort or case-
 control approaches argues against attribution of results purely to chance or confounding.
        Possible inclusion  of active, smokers among "nonsmoking" spouses of smokers through
 misclassification bias or differential change in smoking status during followup remains the study's
 greatest weakness. This problem could have been addressed by followup interviews or
 questionnaires coupled with verification of smoking status by alternative means  in a subsample of
 the cohort, and still could be. In addition, losses to followup and failure to use more sophisticated
 survival analysis techniques are weaknesses that probably reduced the study's power.
       Overall, the Hirayama study provides supportive, although not definitive, evidence that
 ETS exposure increases lung cancer risk.

 A.4.13. HOLE(Coh) (Tier 1)
       This prospective cohort  study was undertaken in the towns of Paisley and Renfrew,
Scotland.  The primary objective was to explore the relationship between passive smoking and
cardiorespiratory symptoms and mortality, including  lung cancer.  The towns were selected
                                           A-69

-------
because they are situated in an area with a high incidence of lung cancer.  All persons residing in
these towns between 45 and 64 years of age, inclusive, were visited between 1972 and 1976. Each
person was asked to complete a self-administered questionnaire and to visit a cardiorespiratory
screening center where further interviews were conducted; 80% (15,399 persons) responded.
       Participating households in which at least two "apparently healthy" subjects lived were
included in the study, yielding a study population of 3,960 males and 4,037 females.  Data on
smoking habits were obtained from the questionnaire and verified by interview at the screening
visit. Mortality among subjects was traced  using the Scottish National Health Service Central
Register and General Register offices  (for death certificate linkage), as well as the national cancer
registry system. Results for followup  through  1982 were published in 1984 (Gillis et al., 1984).
The primary results reported here are  for followup through 1985, published in 1989 (Hole et al.,
1989). In addition, the results of unpublished data extending followup through December of 1988
are reported (personal communication from Hole to  A.J. Wells).
       Smoking habits were divided into three categories:  persons who have never smoked,
former smokers, and current smokers. In addition, the number of cigarettes smoked per day was
obtained for current smokers.  Both pipe and cigar smokers were excluded from the group who
had never smoked.  Never-smokers with former or current smokers as cohabitants in their
household were classified as passive smokers; otherwise never-smokers were classified as
"controls."  This classification yielded  1,538 passive smokers and 917 controls for both sexes
combined. The corresponding numbers for females  alone are  1,295 and 489.
       The number of lung cancer deaths among females occurring in the cohort during the
followup period is only six, too small  to yield much  statistical precision. The unpublished data
extending followup through 1988 includes one additional female lung cancer death that occurred
subsequent to 1985.  The crude relative risk is  2.27 (95% C.I. = 0.40, 12.7), which is in the
direction of a positive association between  ETS exposure and lung cancer. The extremely wide
confidence interval is the result of the small number of cancer deaths being compared and
indicates that the data could easily arise when  the true value of the relative risk  is much larger or
smaller than the estimated value. After adjustment  for age and social class, the relative risk is
1.99 (95% C.I. = 0.24, 16.72). Lung cancer incidence was somewhat higher than mortality (10
cases vs. 7 deaths), yielding an adjusted relative risk of 1.39 (95%  C.I. = 0.29, 6.61).  The relative
risks for adjusted mortality (5.30) and incidence (3.54) were higher in males than in females but
were based on even fewer cases (four  deaths, six incident cases).
        Although the observed association could easily occur by chance, it is a useful contribution
to the pool of evidence on lung cancer and passive smoking. Consequently, it is worth noting that
the observed associations are not likely to be attributable to other  factors, because they  persisted
                                            A-70

-------
after control not only for age and gender, but for social class, diastolic blood pressure, serum
cholesterol, and body mass index. Thus, differences in lifestyle or environmental factors such as
diet, housing, and employment between passive-smoking households and nonsmoking households
is an unlikely source of the results.  Specific adjustment for potential occupational exposures or
radon were not carried out, but these variables would presumably co-vary with social class to a
great extent.
       As for other sources of bias, interviewer bias can be discounted because subjects were
"apparently healthy" at interview and supplied smoking information before cardiovascular
screening, and the investigators did not begin determining the passive smoking status of subjects
until 1983 (for the first published study on this cohort).  The extent of loss to followup is not
specified, so one cannot tell whether this was a potential source of problems.  However, linkage
was carried out through two registries for general mortality and an additional registry specifically
designed for cancers. Diagnoses of cancer mortality from death certificates were checked against
cancer registry records for verification, thus reducing potential inaccuracies attendant on use of
death certificates.
       Some data regarding misclassification were collected in an additional questionnaire
administered to a portion of the cohort at some unspecified point in the study. Among controls,
5% said that their household contained a smoker—presumably someone who had not met the
inclusion criteria (e.g., age 45 to 64) for the study.  Thus, a small portion of the control group was
actually currently exposed, which would produce a slight bias toward the null. Differential
misclassification of smokers as never-smokers resulting from concordance of smoking habits
among cohabitants cannot be assessed or ruled out, despite the authors' suggestion that persons
cohabitating with smokers may be more likely to falsely claim to be smokers themselves,
providing a bias toward the null.
       In summary, this study appears well designed and executed, but the number of  ETS-
exposed  subjects is small.  Although the study carries little statistical weight, there are no apparent
methodological problems that would limit its usefulness otherwise.

A.4.14.  HUMB(Tier2)
A.4.14.1. Author's Abstract
       "As part of a population-based case-control study of lung cancer in New Mexico,  we have
collected data on spouses' tobacco-smoking habits and on-the-job exposure to asbestos. The
present analyses include 609 cases and 781  controls with known passive and personal  smoking
status, of whom 28 were lifelong nonsmokers with lung cancer. While no effect of spouse
                                            A-71

-------
cigarette smoking was found among current or former smokers, never smokers married to smokers
had about a twofold increased risk of lung cancer.  Lung cancer risk in never-smokers also
increased with duration of exposure to a smoking spouse, but not with increasing number of
cigarettes smoked per day by the spouse. Our findings are consistent with previous reports of
elevated risk for lung cancer among never-smokers living with a spouse who smokes cigarettes."

A.4.14.2.  Study Description
       This population-based case-control study was conducted through the New Mexico Tumor
Registry during 1980-84. The original purpose was to explain differing lung cancer occurrence in
Hispanic and non-Hispanic whites in  New Mexico. The study questionnaire included questions on
spousal smoking and  on indirect exposure to asbestos through a spouse's job. The current report
describes the risks associated with those exposures in smokers and nonsmokers.  The data on ETS
exposure in nonsmokers  is  extracted from the larger study containing smokers.
       For the whole study,  a total of 724 eligible primary lung cancer patients were identified,
of which 641 were interviewed (89%). About one-half (48%) of the ease interviews were
conducted with the subject.  Information on the remaining subjects was obtained from surrogates,
generally the surviving spouse or a child. Cases were collected in two series, the first consisting of
patients with cancer incident in 1980-82. That group includes all cases less than 50 years of age
and all Hispanics, but not those exclusively. The number of cases was supplemented by a second
series of patients with cancer incident to a 1-year period beginning November 1983. Most of the
controls were selected by random telephone sampling,  but some older subjects were randomly
selected from Medicare participants.  The control group was frequency-matched to the cases for
sex, ethnicity, and 10-year age category, at a ratio of approximately 1.2 controls per case.
Interviews were held for 784 of the 944 eligible controls, with 98% of the responses from subjects.
       The term "never-smoker" means not a cigarette smoker, where the latter is defined to be
someone who has smoked for at least 6 months. The smoker classification is divided further into
current smokers and ex-smokers. The current smoker status includes smokers who have  stopped
within 18 months before the  interview; the ex-smoker status applies if smoking ceased more than
18 months before the interview. Assuming that the minimum 6-month duration of smoking is
intended to apply to current and ex-smokers, never-smokers could have smoked previously for up
to 6 months.
       An  ETS-exposed subject is one ever-married to a spouse who smoked cigarettes,
regardless of the spouse's use of pipes or cigars. No information was obtained on exposure to ETS
from other sources, such as from other household smokers, in the workplace, or from parental
                                          A-72

-------
smoking during childhood.  Measures of ETS exposure from spousal smoking include duration of
exposure (in years) and the average number of cigarettes smoked per day by the spouse. The ETS
subjects (never-smokers) include 20 (4) female (male) cases and 162 (130) controls (the article
reports 8 male cases, the number used in much of the analyses, but 4 of those 8 were found to be
smokers, personal communication from Humble). The age distribution for the female cases
(controls) is as follows: age less than 65, 5 (74); age 65 or more, 15 (88).
       The odds ratio for the crude data on female never-smokers is 1.8 (90% C.I. = 0.6, 5.4) for
spousal smoking of cigarettes only and 2.3 (90% C.I. = 0.9, 6.6) when spousal smoking also
includes use of pipes and cigars. Based on  mean cigarettes per day smoked by the spouse, the
odds ratio of 1.2 at more than 20 cigarettes per day is somewhat lower than the odds ratio of  1.8 at
the lower rate, fewer than 20 cigarettes per day. For duration of exposure, the odds ratio
increases from 1.6 at less than 27 years to 2.1 at 27 or more years. It is reported that adjustment
for age and ethnicity did not alter these results from the crude analysis. A trend test is included
for duration of spousal smoking, but the sample sizes are too small to be meaningful. Application
of logistic regression to adjust for variables gives values very  close to the odds ratios for the crude
analyses shown above for spousal smoking, for use of cigarettes only and also for combined use of
cigarettes, cigars, and pipes.
       The distribution of cases by cell type is given, but only with males and females combined.
The ratios of ETS-exposed cases to the total, by cell type, are as follows:  squamous cell (2/4),
small cell (1/1), adenocarcinoma (either 6/12, 7/12, or 8/12),  and others (either 3/3, 2/3, or 1/3,
depending on correct ratio for adenocarcinoma).
       The authors conclude that the results indicate increased risk from ETS exposure in never-
smokers but not in active smokers.

A.4.14.3. Comments
       This study evaluates smokers as well as nonsmokers for increased risk of lung cancer from
spousal smoking.  Not surprisingly, the number of smokers among the cases far  outweighs the
number of nonsmokers. No evidence of added risk to smokers from passive smoking is found.
Such  an evaluation, however, puts a great deal of faith in the exposure data and the  power of
statistical methods to detect what may be only a marginal increase in risk from ETS  on top of
active smoking.
       Of more central concern to this review is the assessment of lung cancer from ETS exposure
in never-smokers. The ETS  data are taken  from a larger study, so the matching no longer applies,
although the adjustment for those variables (ethnicity and age category) in the analysis is
                                           A-73

-------
 worthwhile. The article suggests that the high rate of proxy response for cases in the original
 study (52%) may be due, at least in part, to inclusion of decedent cases.  That topic is not
 explicitly addressed, however, and controls were not matched to cases on vital status.
 Never-smokers apparently may have a history of smoking, provided it is of less than 6 months'
 duration. Whether any never-smokers actually have a short smoking history is not discussed, but
 the never-smoker classification is  less strict than in most studies.
        The data are evaluated in a number of different ways, consistently yielding an increased
 odds ratio.  The number of cases, however, is too small (15 exposed, 5 unexposed) for the
 observed odds ratio to achieve statistical significance. Similar values of the  odds ratios might be
 observed in a larger study, but, of course, that cannot be assumed.  The study outcome is
 consistent with an association between ETS exposure and lung cancer occurrence.

 A.4.15.  INOU(Tier4)
 A.4.IS.1. Author's Abstract
 (Note:  No abstract was provided; the following was paraphrased from author's discussion.)
        A case-control study on smoking and lung cancer in women was conducted in Kamakura
 and Miura, both in Kanagawa prefecture, Japan. The two cities are distinctly different in social
 environment; the former is a residential community and the latter is a fishing village. After
 stratification on city and age groups, the odds ratio of lung cancer in nonsmoking wives was
 shown to be 1.58 when husbands smoked fewer than 19 cigarettes a day and  3.09 when husbands
 smoked 20 or more cigarettes a day. For comparison, the odds ratio for active smoking is 5.50.
 Although the study size is quite small, it provides additional evidence favoring the passive
 smoking and lung cancer hypothesis.

 A.4.15.2. Study Description
       This study was conducted to assess the roles of active and passive  smoking in the etiology
 of lung cancer in women. It is unclear  how subjects or diagnoses were obtained, but cases are
 women who died of lung cancer in Kamakura or Miura in the time periods 1980-83 and 1973-81,
 respectively.  Controls, consisting of women who died of cerebrovascular disease during the same
 timeframes, are individually matched to cases on year of birth, year of death (±2.5 years), and
 district of residence. It is not clear whether incident cases were used.
       Face-to-face interviews were conducted by public health nurses and  midwives. ETS
subjects consist of the 28 nonsmoking cases and 62 nonsmoking controls remaining after
elimination of 9 cases and 12 controls who were smokers. Husband's smoking status was not
                                           A-74

-------
available for unspecified reasons in a total of 8 cases and 20 controls, but these figures include
smokers as well as nonsmokers.  The exact number of nonsmokers for which spousal smoking
status was available is not specified but can be back-calculated from what is given (see below).
No information is given on the number of proxy respondents, the age distribution of the subjects,
or attempts to confirm diagnoses of primary lung cancer.
       The term  "nonsmoker" is not defined, so it is not clear whether it refers to persons who
never smoked or who do not smoke at present. Nonsmoking women whose husbands smoke at
least five cigarettes per day are classified as exposed to passive smoking. Considerations of
former smoking or marital status, ETS exposure at the workplace or in childhood, and duration of
exposure are not addressed.  No attempts to verify the reliability or validity of the data are
mentioned.
       The number of subjects is not delineated by case versus control and exposed versus
unexposed figures.  They can be determined from the odds ratio and confidence interval,
however, as 18  of 22 (exposed over total) cases and 30 of 47 controls.  For nonsmoking women
with smoking husbands, the crude odds ratio calculated by the reviewers is 2.55 (95% C.I. = 0.74,
8.78). (Note: OR = 2.25 is erroneously reported in the article. The OR  value of 2.55 has been
confirmed by Hirayama.)  When husbands' smoking is divided into  two strata (< 19 cig./day and
20+ cig./day), the odds ratios increase with exposure from 1.16 to 3.35, giving a statistically
significant trend  (p < 0.05).  Age-adjusted odds ratios of 1.39 and 3.16 are reported for the two
strata; adjustment for both age and district  yields corresponding odds ratios of 1.58 and 3.09.
(Note: The first OR value, 1.58, is incorrectly reported in the article as 2.58. The value  1.58 has
been confirmed by Hirayama.)  The authors conclude that, although the study size is quite small,
the results provide more evidence favoring  the hypothesis that passive smoking causes lung cancer.

A.4.15.3.  Comments
       The number of subjects remaining after active smoking and missing data exclusions is
small, guaranteeing poor power and lack of statistical significance in the absence of large odds
ratios. The details on study design are limited.  The source of cases and controls is not mentioned,
for example, and it is unclear whether incident or prevalent cases were used.
       Information regarding quality control and related concerns is equally sparse.  Interviewers
used standardized questionnaires, which would help to promote consistency, but no mention is
made of blinding them to subject background or study question, the absence of which could
introduce interviewer bias (probably in a positive direction). Because cases and controls are stated
to have died during the study period, it is probable that proxy respondents were ^required, but the
                                            A-75

-------
 extent is unknown. In addition, neither duration of ETS exposure from spousal smoking nor
 exposure from other sources, such as other cohabitants, was considered. The resultant inaccuracy
 of exposure assessment probably biases the results toward the null. Lack of information on
 former smoking status or verification of diagnosis may introduce biases of indeterminate
 direction. Except insofar as the district acts as a surrogate for factors related to socioeconomic
 status, no risk modifiers other than age or district of residence were considered. The meaning of
 "nonsmoker" is not given, so treatment of smoking history is unknown, and it is unclear whether
 the accurate and meaningful segregation of never-smoking subjects needed for effective analysis
 was accomplished.
       Although a substantial odds ratio was observed for husband's smoking, these results are
 based on a small sample with too few details provided to assess adequately the study's design and
 execution and its bearing on the evidence, particularly with regard to potential sources of bias.
 The statistical uncertainty of the odds ratios given is reflected in the extremely wide confidence
 intervals shown.  The test for trend does not add any additional information. It is basically a
 restatement of the significant comparison between the heavily exposed group (husband smokes >
 20 cig./day) and the unexposed  group.  Unfortunately, the brevity of the description of this study
 in the source available severely  limits its utility.

 A.4.16. JANE (Tier 2)
 A.4.16.1.  Author's Abstract
       "The relation between passive smoking and lung cancer is of great public health
 importance.  Some previous studies have suggested that exposure to environmental tobacco smoke
 in the household can cause lung cancer, but others have found no effect. Smoking by the  spouse
 has been the most commonly used measure of this exposure.
       In order to determine whether lung cancer is associated with exposure to tobacco smoke
 within the household, we conducted a population-based case-control study of 191 patients with
histologically confirmed primary lung cancer who had never smoked  and an equal number of
persons without lung cancer who had never smoked. Lifetime residential histories including
information on exposure to environmental tobacco smoke were compiled and analyzed.  Exposure
was measured in terms of 'smoker-years,' determined by multiplying the number of years  in each
residence by the number of smokers in the household."
                                          A-76

-------
A.4.16.2.  Study Description
       This study was undertaken in New York State to clarify the role of exposure to tobacco
smoke in the household as a possible cause of lung cancer among nonsmokers. Interviews were
conducted with former smokers as well as never-smokers initially (Varela, 1987), but because
matching was carried out on smoking status, only never-smoking case-control pairs were included
in the analyses for this article.  The study includes both males and females, which are combined in
all of the analyses.  There are 146 (45)  female (male) pairs.
       'Cases are never-smokers aged 20 to 80 years newly diagnosed with lung cancer at 125
referral centers in New York from July 1, 1982, to December 31, 1984. Controls are cumulatively
sampled never-smokers identified from files of the New York Department of Motor Vehicles.
Controls are individually matched to cases on age (± 5  years), gender, and residence.  In addition,
the same interview type (proxy or direct) was used for  controls as for their corresponding cases.
Exposure data were collected face-to-face via standardized questionnaire, and interviewers were
apparently uninformed of the subject's diagnosis.
        From the 439 case-control pairs interviewed, 242 pairs containing former smokers and
6 pairs with a mismatch on the source  of response were excluded. Of the remaining 191 pairs
used in the ETS study, interviews were conducted directly with the subjects in 129 pairs (68%)
and with proxies in 62 pairs (32%) (if a proxy was interviewed for a case, then a proxy was used
for the  matching control as well). No  demographic comparisons were provided for the ETS cases
and controls. For the whole study including smokers, the mean age of cases and controls is nearly
identical (67.0 and 68.1, respectively; Varela, 1987).  Histological verification of diagnosis was
obtained for all but five cases  (for whom only clinical information was available) out  of the initial
population of 439.
        Persons smoking no more than 100 cigarettes over the course of their lifetime  qualified as
never-smokers for this study.  Cigar or pipe smoking was apparently not considered.  Exposure to
ETS was deemed to occur when a smoker lived in the subject's household at any time from
infancy to adulthood. Both total household smoke exposure and spousal smoke exposure were
determined. Preadult (before  21 years of age) and adult exposure were examined separately.
Exposures were computed in units of "smoker-years," the total number of years lived with each
smoker summed over smokers. In addition, pack-years were calculated for spousal smoking.
Workplace exposure also was estimated by smoker-years, whereas exposure in social settings was
estimated subjectively on a scale from 1 to 12 for each decade of life and summed. Exposure data
were not checked, and marital status was not considered in the analyses.  No information on tumor
type or location was provided  for the  never-smoking population.
                                           A-77

-------
       Preadult exposure to 24 or more smoker-years occurred in 52 (29) cases (controls), whereas
82 (94) were exposed to 1 to 24 smoker-years and 57 (68) were unexposed. Odds ratios were
calculated using matched-pairs regression analysis. Preadult passive smoking yielded increasing
odds ratio of 1.09 (95% C.I. = 0.68, 1.73) for 1 to 24 smoker-years and 2.07 (1.16, 3.68) for 25 or
more smoker-years.  The odds ratios for adult exposure are low but also increase—from 0.64
(0.34, 1.21) at 1  to 24 smoker-years to 1.11  (0.56, 2.20) at 75 or more smoker years.  The odds
ratios for lifetime exposure increase from 0.78 (0.36, 1.67) at 1 to 24 smoker-years to 1.80 (0.83,
3.90) at 25 to 99 smoker-years and then dip to 1.13 (0.56, 2.28) at 100 or more smoker-years.
Spousal smoking was not significantly associated with lung cancer.  In fact, when results were
stratified by type of interview, proxy interviews yielded strong and, in  some instances, statistically
significant negative associations for spousal smoking, with odds ratios between 0.20 and 0.68 for
ETS expressed in terms of present or absent, smoker-years, and pack-years of exposure. The
odds ratios for direct interviews, in contrast, range from 0.71 to 1.10 and are uniformly higher
than the odds ratios for corresponding proxy responses.  Workplace exposure to  150 or more
person-years yielded an odds ratio of 0.91 (0.80, 1.04), whereas a social setting exposure score of
20 led  to a statistically  significant decreased odds ratio of 0.59 (0.43, 0.81).
       The  authors conclude that they found a significant adverse effect of relatively high levels
of exposure  to ETS during early life (before age 21). For those who were exposed to 25 or more
smoker-years in their first two decades of life, the risk of lung cancer doubled.  By contrast, the
authors found no adverse effect of exposure to ETS during adulthood, including exposure to a
spouse who smoked.  This lends further support to the observation that  passive smoking may
increase the risk of subsequent lung cancer, and it suggests that it may be particularly important
to protect children and adolescents from this environmental hazard.

A.4.16.3. Comments
       The  number of never-smoking cases is relatively large, resulting in above-average
statistical power for evaluation of ETS effects.  Controls were matched  to cases on smoking status,
as well as the key demographic factors of age, gender, and neighborhood. Comparability of cases
and controls was likely good, as evidenced by the similar mean ages for the total population,
although no  other comparative information is available.  In view of the  use of population-based,
basically healthy controls, it is questionable that any attempted diagnostic blinding would be
effective. The study's  matching on smoking status with subsequent retention of matching and use
of matched-pairs analysis for ETS exposure effectively eliminates potential effects on risk
attributable  to age, gender, or residence, and it makes bias by related factors (such as
                                           A-78

-------
socioeconomic status) less likely.  A rare feature is the use of matching on interview type (i.e.,
proxy or subject direct) to control for bias due to this source.  Comparison of spousal smoking
results for direct and proxy interviews, however, indicates consistently lower estimated risks from
proxies.  This suggests that use of proxy respondents did not merely lead to increased random
misclassification but might have biased the outcome toward a negative association.  The authors
posit that proxies of lung cancer patients may be more likely to underreport exposure than those
of control subjects. Curiously, however, although the authors report that odds ratios "frequently
differed according to type of interview," they do not specify how the odds ratios differed for
exposure other than spousal smoking. Also, the composition of the proxy groups—• relative
proportions of spouses, other relatives, and friends or associates—is never discussed, leaving
unexplored the possibility that misreporting by spouses of cases may lie at the heart of the
observed discrepancy.  It is also interesting that the outcome of self-responses versus proxy
responses in this study is in the opposite direction of the findings in GARF. Diagnostic
misclassification is unlikely, given the histological verification of nearly all cases.
       The restriction of subjects to persons smoking no more than 100 cigarettes in their lifetime
theoretically eliminates active smoking as a source of bias, although no verification  of smoking
status was undertaken. Consideration of potential  sources of ETS exposure is commendably
thorough, and the calculation of total years of  living with smokers, regardless of relation to the
smoker, as an index of household smoke exposure  minimizes the possibility that any source (e.g.,
roommates) is overlooked.  In contrast, the index of exposure in social settings is highly
subjective, and persons more habituated to passive smoke may report a given exposure as less
severe than persons less accustomed to smoke,  thus creating a negative bias.  The proportion of
controls classified as exposed to ETS is 80%, which is high in comparison with other studies. This
suggests that  some exposed controls may have only minor exposure to ETS, making  detection of an
association (if present) less likely. Unlike almost every other ETS study, males and  females are
combined in the analysis and only the joint results are reported.  Because there are 45 (146) pairs
of males (females), the sample sizes are sufficient to warrant reporting odds ratios separately by
sex and to test the hypothesis of no  difference due to gender.
       Lung cancer odds ratios for  adulthood, lifetime, and spousal smoking are consistently well
below  1 for low ETS exposure relative to nonexposure, as if exposure had a protective effect.
Thereafter, however,  the odds ratios associated with increasing levels of exposure are suggestive
of an upward trend in response.  Although we  would not dismiss the occurrence of this outcome as
attributable to chance alone, it is consistent with the baseline  lung cancer mortality  rate in the
control population simply being higher than that of the case population for reasons other than
exposure to spousal smoking.  A pervasive (systematic) negative bias linked with exposure could
                                            A-79

-------
also produce such an effect. Both of these contingencies are necessarily speculative because there
is no evidence in the article to support either, aside from the outcome of the data analysis.
Further fueling the speculation, however, are the markedly lower odds ratios obtained from
surrogate responses, indicative of some source of bias acting unequally on proxy and nonproxy
sources. Also speculative is the idea that using predicted responses from a model that fits the data
poorly might produce such an effect, but that level of detail is beyond the scope of most published
articles, including this one. Some discussion of these issues by the authors, as well as separation of
the analyses by sex, would enhance interpretation of results and facilitate their comparison with
results of other studies on females.
       The authors' finding that exposure during childhood and adolescence appears to influence
subsequent lung cancer risk more than exposure during adulthood raises some interesting
possibilities.  More time may be spent in proximity to a household smoker (particularly the
mother), on average, in childhood than in adulthood. According to data presented by K.M.
Cummings (Roswell Park Memorial Institute, Buffalo, New York) at the Science Advisory Board
meeting on EPA's draft ETS report (U.S. EPA, 1990), on December 4-5, 1990, heavy childhood
exposure is a better surrogate for total lifetime exposure than is spousal exposure.  Also, early
exposure may appear to become a risk, either due to a long latency period for lung cancer or,
perhaps, due to increased susceptibility at an earlier age. The results suggesting an effect from
early exposure but not from spousal smoking are more nearly atypical than reinforced by other
studies, though, and the number of exposure sources considered raises the possibility that the
strength of association seen for  preadult exposure may be due to chance. However, after
elimination of 78 pairs with incomplete marriage or household exposure data, the association
persisted and was strengthened (OR = 2.59), arguing against chance as the major influence.  It is
unclear what role, if any, negative bias due to proxy respondents may have had in the nonspousal
analyses.
       In summary, the findings for preadult exposure are not readily attributable to chance or
confounding, although some role of interviewer bias or other factors such as diet cannot be ruled
out.  No association with lung cancer incidence is observed for spousal smoking. The authors
conclude, however, that, spousal smoking aside, other sources of household ETS exposure support
the conclusion that exposure to  ETS can cause cancer. That conclusion is not unequivocal in our
view.  In general, the odds ratios (aside from preadulthood exposure) tend to be low but trend
upward with exposure, exhibiting more of a patterned response than one might expect to see due
to randomness. This is puzzling because there is no apparent source of bias and the study appears
to have been conducted with considerable forethought and thoroughness. The only exception
                                           A-80

-------
noted is the lack of separate analyses and comparisons of males and females.  These concerns
notwithstanding, the study is a useful addition to the literature on ETS exposure and lung cancer.

A.4.17. KABA(Tier2)
A.4.17.1.  Author's Abstract
       "Among 2,668 patients with newly diagnosed lung cancer interviewed between 1971 and
1980, 134 cases occurred in 'validated' nonsmokers. The proportion of nonsmokers among all
cases was  1.9% (37 of 1,919) for men and 13.0% (97 of 749) for women, giving a sex ratio of 1:2.6.
Kreyberg Type II (mainly adenocarcinoma) was more common among nonsmoking cases,
especially women, than among all lung cancer cases. Comparison of cases with equal numbers of
age-, sex-, race-, and hospital-matched nonsmoking controls showed no differences by religion,
proportion of foreign-born, marital status, residence (urban/rural), alcohol consumption, or
Quetelet's index.  Male cases tended to have higher proportions of professionals and to be more
educated than controls.  No differences in occupation or occupational exposure were seen in men.
Among women, cases were more likely than controls to have worked in a textile-related job (RR =
3.10, 95% C.I. = 1.11, 8.64), but significance of this finding is not clear. Preliminary data on
exposure to passive inhalation of tobacco smoke, available for a subset of cases and controls,
showed no differences except for more frequent exposure among male cases  than controls to
sidestream tobacco smoke at work.  The need for more complete information on exposure to
secondhand tobacco smoke is  discussed."

A.4.17.2. Study Description
        In 1969, the American Health Foundation began interviewing newly  diagnosed lung cancer
patients with cancer at sites potentially related to tobacco use for a case-control study (Wynder
and Stellman, 1977) that is still ongoing. The current article considers the data on lung cancer in
nonsmokers alone  collected from newly diagnosed  lung cancer patients between 1971 and 1980.
Several factors  are of interest: histology, demographic factors, residence, Quetelet's index, alcohol
consumption, previous diseases, occupation and occupational exposures, and  ETS exposure.  The
number of nonsmokers among the cases is small, so the authors consider the  results to be
preliminary.
        The study from which the data on lung cancers in nonsmokers are extracted is a very large
effort that includes tobacco-related cancers at multiple organ sites and includes smokers as well as
nonsmokers.  The  cases are from approximately 20 hospitals in 8 U.S. cities (about one-third from
New York City). With reference to the lung  cancer cases in that study, histologic type of lung
                                           A-81

-------
cancer was determined from pathology reports and discharge summaries. Secondary lung cancer
cases were excluded.  Controls consist of hospital patients with diseases unrelated to tobacco use
who were pair-matched with cases on hospital, age (within 5 years), sex, race (with five
exceptions), date of interview (within 2 years), and nonsmoking status.  Cases appear to be
incident, and control sampling is density. All subjects were interviewed while they were  in the
hospital. The questionnaire for the interviews was expanded in 1976. Questions on exposure to
ETS were not included, however, until an addendum to the questionnaire in 1978, which was then
modified in 1979.
       The term "nonsmoker" applies to subjects who have smoked fewer than one cigarette, pipe,
or cigar per day for a year. The term "never-smoker" is used interchangeably. Independent of the
intended definition, however, subjects whose hospital charts indicated any record of smoking,
even in the remote past, were excluded from the nonsmoker classification.  ETS subjects include
53 (25) females (males), after combined attrition of 22 (9 without primary lung cancer and 13 with
a record of smoking). The age distribution of the female cases (controls) is as follows:  age less
than 50, 12 (15); age 50 to 59, 26 (24); age 60 to 69, 29 (34); age 70 or more, 30 (24).  Histologic
data on lung cancer type are given for female cases:  squamous cell (16), adenocarcinoma (60),
alveolar (12), large cell (4), and unspecified (5).  The authors report that exposed cases did not
differ from the unexposed cases in the distribution of histologic type.
       A person is "ETS exposed" (1) at home, if currently exposed on a regular basis to family
members who smoke, (2) at work, if currently exposed on a regular basis to tobacco smoke at
work, and (3) to spousal smoke, if the spouse smokes.  There are data on 53 cases and their
controls for exposure at home and at  work, but data on only 24 cases and 25 controls for spousal
smoking. This is because of the change in the questionnaire from 1978 to 1979 and because
spousal smoking was only applicable for women currently married. Because nonsmoking status
was a variable for matching, the 53 pairs of cases and controls for analysis of exposure at home or
at work are matched; the data for spousal smoking, however, are technically not matched. There
is no indication at all of an association between ETS exposure and lung cancer for women from
exposure at home, at work, or from spousal smoking.  For ETS exposure at home, there are 16 of
53 (exposed/total) cases and 17 of 53  controls; for exposure at work, the figures are 26 of 53 cases
and 31 of 53 controls; and  for spousal smoking, the data are 13 of 24 cases and 15 of 25 controls.
No statistical calculations are provided for females. From our calculations, the odds ratio  for
spousal smoking is 0.79 (95% C.I. = 0.25, 2.45). (Among male subjects, exposure to ETS in the
workplace was slightly significant, p = 0.05, as reported in the article.)  For other potential risk
factors for lung cancer in women other than passive smoking, it was found that cases were more
likely than controls to have worked in a textile-related job (OR = 3.1; 95% C.I. = 1.1, 8.6), but
                                           A-82

-------
the significance of the finding was not clear.  It also was found that more female cases had a
history of pneumonia compared with controls, but no interpretation could be attached to the
observation.

A.4.17.3. Addendum
       Unpublished preliminary results of a study of ETS and lung cancer in never-smokers
conducted at the American Health Foundation have been reported at two meetings—The
American Public Health Association (APHA) 119th Annual Meeting, Atlanta, Georgia, November
10-14, 1991, and The Toxicology Forum,  1990 Annual Winter Meeting, Washington, D.C.,
February 19-21, 1990.  A completed report for our review was not available at the cutoff date for
inclusion in this document (personal communication with the first author, Dr. G.C. Kabat).
Enclosed below is the abstract for the APHA meeting.

            RISK FACTORS FOR LUNG CANCER IN LIFETIME NONSMOKERS
                             Geoffrey C. Kabat, Ernst L. Wynder

       Risk factors for lung cancer in lifetime nonsmokers (NS) were assessed in a hospital-based
       case-control study carried out between 1983 and 1990.  The study population consisted of
       41 male and 69 female NS cases and 117 male and 187 female NS controls matched on age,
       race, hospital, and date of interview.  Evidence of an effect of exposure to ETS was
       inconsistent.  In males, there was no difference between cases and controls in reported
       exposure to ETS (yes/no) in childhood, in nonsignificant association with exposure in
       childhood (OR = 1.6, 95% C.I.  = 0.9, 2.8), but no association with exposure in adulthood at
       home or at work. Male cases were somewhat more likely to have a smoking spouse (OR =
       1.6, 95% C.I. = 0.7, 3.9), whereas there was no difference in females. Cases and controls
       did not differ in reporting a history of previous respiratory diseases. Female cases were
       more likely to report a history  of radiation treatment (OR = 4.3, 95% C.I. = 1.5, 12.3). In
       females, but not in males, a significant inverse association was  observed between body
       mass index (based on self-reported weight 5 years prior to diagnosis) and lung cancer risk.

 A.4.17.4.  Comments
       Although the study contains more than 2,600 patients, only a small number of nonsmokers
 are available because questions about ETS exposure were not included in the interview until 1978
 and the questions were changed in 1979.  It is not known just how the questionnaire was changed,
                                           A-83

-------
 although the general tenor of the article suggests care in study planning and execution. The
 design for the larger study from which the ETS data are taken is pair-matched on numerous
 factors of potential interest, including "nonsmoking status," which contributes favorably to the
 analysis of ETS data alone.  Cases with secondary tumors were excluded, histological type was
 considered, and all subjects  were personally interviewed.  It appears that only the currently
 married females were included in the question regarding exposure to spousal smoke, which
 alleviates the need to make some approximating assumptions regarding exposure of widows, single
 females, and so forth.
       Two areas that may need to be addressed in the analysis of ETS subjects have to do  with
 the definition of "ETS exposure" and "nonsmoker."  The duration of smoking was comparable  in
 cases and controls, but interview questions regarding exposure to ETS refer only to current
 exposure (this is not explicit in the article but was confirmed by the first author). Any effect
 from reliance on current exposure alone should be a bias toward the null hypothesis.  Also, a
 measure of exposure in units (e.g., number of cigarettes per day or pack-years smoked by spouse)
 would make the question less subjective and help to dichotomize on ETS exposure more sharply.
 Because lung cancer may have a latency period of 20 years or so, exposure in the past, both  in
 terms of duration and intensity, should be more meaningful than current exposure alone.  With
 regard to the definition of nonsmoker, the requirement is less rigid than is often imposed. Ever-
 smokers are included provided they did not smoke more than the equivalent of 1 cigarette per day
 for 1 year (about  18 packs).  It is difficult to know, however, what constitutes a "negligible" level
 of past smoking.  Any bias from  former smoking should inflate the relative risk, but that outcome
 appears unlikely in  this study (RR = 0.74).
       One of the factors of interest  to the investigators is occupation, so cases and controls were
 not matched on that variable. For ETS exposure, occupation could be a confounding factor.
 Among females, the controls contain a higher percentage of professional and skilled workers than
 do the cases (47 to 25) and a lower percentage of housewives (41 to 50). Some differences are also
 apparent in  religious preference between cases and controls that may bear some influence through
 lifestyle or dietary practices. Variables such as these may need to be taken into account in an
adjusted analysis when more data become available.

A.4.18. KALA(Tierl)
A.4.18.1.  Author's Abstract
       "A case-control study was undertaken in Athens to explore the role of passive smoking and
diet in lung  cancer,  by histologic type, in nonsmoking women. Among 160 women with lung
                                           A-84

-------
cancer admitted to one of seven major hospitals in Greater Athens between 1987 and 1989, 154
were interviewed in person; of those interviewed, 91 were lifelong nonsmokers.  Among 160
Identified controls with fractures or other orthopedic conditions, 145 were interviewed in person;
of those interviewed 120 were lifelong nonsmokers.  Marriage of a nonsmoking woman to a
smoker was associated with a relative risk for lung cancer of 2.1 (95% C.I. = 1.1, 4.1); number of
cigarettes smoked daily by the husband and years of exposure to husband's smoking were
positively, but not significantly, related to lung cancer risk.  There was no evidence of any
association with exposure to smoking of other household members, and the association with
exposure to passive smoking at work was small and not statistically significant. Dietary data
collected through a semiquantitative food-frequency questionnaire indicated that high
consumption of fruits was inversely related to the risk of lung cancer (the relative risk between
extreme quartiles was 0.27 (95% C.I. = 0.10, 0.74). Neither vegetables nor any other food group
had an additional protective effect; furthermore, the apparent protective effect of vegetables was
not due to carotenoid vitamin A content and was only partly explained  in terms  of vitamin C.
The associations of lung cancer risk with passive smoking and reduced fruit intake were
independent.  Passive smoking was associated with an increase of the risk of all histologic types of
cancer, although the elevation was more modest for adenocarcinoma."

A.4.18.2.  Study Description
       This study was undertaken in Athens, Greece, in 1987-89. It sought to explore the role of
passive smoking and diet  in the causation of lung cancer in nonsmoking women.  All data used in
the study were collected specifically for that purpose.
       Cases are never-smoking women  hospitalized in one of seven Greater  Athens area
hospitals during an 18-month period of 1987-89 with a definite diagnosis of lung  cancer from
histologic, cytologic,  or bronchoscopic exam. Controls were selected from female never-smoking
patients in the orthopedic ward of the same seven hospitals and an orthopedic hospital.  A control
was interviewed within 1  week of a corresponding case, thus essentially density-sampled but
otherwise unmatched. Cases were not specifically restricted to incident cancers.  All subjects were
interviewed face-to-face by one of five trained interviewers; interviews apparently were
unblinded. A total of 160 lung cancer cases and an equal number of controls  were initially
identified; 6 cases and 12 controls were too ill to interview, whereas 3 controls and no cases
refused to participate.  After exclusion of smokers, 91 cases  and 120 controls  remained.  The age
distributions of the cases  and controls are very similar: for cases (controls), 16.5% (14.2%) were
less than 50 years of age,  19.8 (18.3%) were 50 to 59, 29.7 (25.8%) were 60 to  69, and 34.1 (41.7%)
                                            A-85

-------
 were 70 or older.  Current residence, level of education, occupation (housewife vs. other) and
 marital status were also similarly distributed between cases and controls.  Case diagnosis was
 established by histology (48%), cytology (38%), or bronchoscopy (14%), with exclusion of cancers
 diagnosed as secondary.
        Persons reportedly smoking fewer than 100 cigarettes in their lifetime are classified as
 nonsmokers.  No mention is made of pipe or cigar smoking. Several different sources of ETS
 exposure are considered:  husbands who smoke quantified in terms of years exposed and average
 number of cigarettes smoked per day; household members other than husbands who smoke,
 quantified by the sum of years exposed to each smoker; and coworkers who smoke, measured by
 the number of smokers sharing the "same closed space" as the subject. Presumably, childhood
 exposure is included in the household exposure assessment. For spousal smoking, single women
 are considered unexposed, whereas exposure of widowed or divorced women is based on the
 period when they were married.  No attempts to verify exposure are mentioned.
        For analysis of husband's smoking based on cigarettes per day, 64 out of 90 (exposed/total)
 cases and 70 out of 116 controls gives a crude odds ratio of 1.6 for 90 cases and 116 controls; 64
 cases and 70 controls were exposed.  The authors present results stratified by four exposure
 categories, which indicate no significant association (p = 0.16).  Crude data for husband's smoking
 stratified by five levels of smoking duration (never, < 20, 20-29, 30-39, and 40+ years) yield a
 marginally significant increase in association with increasing duration (p = 0.07), with odds ratios
 of 1.0, 1.3, 1.3, 2.0, and 1.9, respectively.  No statistically significant association was noted for
 ETS exposure from other household members (p = 0.60) or for exposure at work (p = 0.13), but
 the crude odds ratios for these exposures were 1.41 and 1.39, respectively.  Stratification by level
 of intake for each of 16 food and nutrient groups yielded a significant negative (favorable)
 association with cereals (p = 0.04) and a possible association with fruits (p = 0.11).
       Multiple logistic regression was then used to adjust results for age,  education, and
 interviewer.  An adjusted  relative risk estimate of 1.92 (95% C.I. = 1.02, 3.59) was obtained for
 marriage to a smoker.  After adjustment, trends for estimated lung cancer risk showed an increase
 with duration of exposure (average 16% per 10 years) and packs per day (6% per pack), but these
 were not statistically significant.  No trend was observed for ETS in the household or workplace.
 Adjustment for other sources of air pollution had  no  effect on the analyses. Adjustment of
 dietary analyses for age, education, interviewer, and  total energy intake indicated a significant
 decrease in estimated risk between highest and lowest quartiles of consumption of fruit
(RR = 0.33; p = 0.02) and a nearly significant increase with consumption of retinol (RR =1.31;
p « 0.06), whereas beta carotene (RR = 1.01) and other dietary factors had  no significant effect.
Adding fruit consumption to the model for passive smoking increased the adjusted relative risk
                                           A-86

-------
for husband's smoking slightly, from 1.92 to 2.11. Stratification by lung cancer cell type yielded
somewhat lower adjusted estimated relative risks for adenocarcinoma (2.04) than for squamous,
small, and large cell cancer combined (2.58). No adjusted results were presented for other
household or workplace exposure.
       The authors' conclusion is best reflected in their abstract (shown in full above).  Marriage
of a nonsmoking woman to a smoker was associated with a relative risk for lung cancer of 2.1.
Number of cigarettes smoked daily by the husband and years of exposure  to husband's smoking
were positively, but not significantly, related to lung cancer risk. There was no evidence of any
association with exposure to smoking of other household members, and the association with
exposure to passive smoking at work was small and not statistically significant. Dietary data
indicated that high consumption of fruits was inversely related to the risk of lung cancer. Neither
vegetables nor any other food group had an additional protective effect. The associations of lung
cancer risk with passive smoking and reduced fruit intake were independent.  Passive smoking
was associated with an increase of the risk of all  histologic types of cancer, although the elevation
was more modest for adenocarcinoma.
       It is noted that these findings are compatible with the relatively low incidence of lung
cancer in the Greek population—a population with the highest per capita  tobacco consumption in
the world, but with a very high fruit consumption as well.

A.4.18.3. Comments
       This study was generally well designed and executed.  Set up specifically to address passive
smoking and diet as etiological factors in lung cancer,  it  includes sufficient numbers of
nonsmoking women to produce substantive results. Interviews were face-to-face, and no proxies
were used, enhancing accuracy and comparability of responses, whereas the very low rate of
refusal minimizes potential bias  due to volunteer selection.  Cases and controls were  very similar
demographically, were drawn from most of the same hospitals, and were matched temporally on
time of interview, so comparability seems high.  Furthermore, the study hospitals' patient
population accounts for the majority of lung cancer and  trauma patients seen in the  Athens  area,
enhancing generalizability of results. Most lung cancers were histologically or cytologically
confirmed, reducing chances for misclassification of disease status.
        On the  debit side, the apparently unblinded interviews could have been biased (although
what can be accomplished toward that end is limited). Adjustment for interviewer in the analyses
did not affect the results, however, and it is unlikely that all interviewers would share the same
bias.  Determination of what constitutes workplace exposure is vague,  and childhood exposure is
                                            A-87

-------
 not clearly differentiated from adult household exposure; these were notably the passive smoking
 categories, which showed the least association with lung cancer. ETS exposure in the workplace is
 analyzed with regard to trend (Table 2), with levels of exposure represented by "housewife" (zero
 exposure), "minimal," and "some," resulting in a p value of 0.13. Perhaps correctly, the authors
 cautiously note the evidence that ETS exposure is associated with increased risk (referring to
 Table 2 in general, not just exposure at work) but indicate that the differences are not large
 enough to be interpretable without controlling for other factors. An analysis of exposed versus
 unexposed for the workplace may have been useful, especially an adjusted analysis.  Our
 calculation of the crude odds ratio for a comparison of "minimal" and "some" exposure at work is
 1.7, which is suggestive.
       Methodological rigor and thoroughness are  particularly evident in the treatment of other
 factors that may affect risk.  Despite the demographic similarity of cases and controls, the key
 demographic variables of age and education were nevertheless controlled for in the analyses, along
 with interviewer  identity.  The potential effects of air pollution, total energy intake, and other
 dietary factors on lung cancer incidence were examined, and the impact of cancer type was
 evaluated.  An association of husband's smoking with lung cancer yielding an odds ratio of around
 2 persisted with adjustment for those factors.  The authors claim to have taken special effort to
 exclude ex-smokers from misclassification as never-smokers, taking account of this potential
 source of upward bias. No discussion was found, however, of what measures were taken to
 control misclassification of former smokers as never-smokers, beyond interviewing subjects about
 current and former smoking habits.
       In summary, this  study presents evidence of a level- and duration-dependent association
 between husband's smoking and lung cancer in a well-defined and highly comparable group of
 Greek cases and controls. Positive but  nonsignificant relationships with general home or
 workplace passive smoking were observed, and there are indications that additional analysis of
 workplace exposure may  be worthwhile. No effect of air pollution was observed.  With regard to
 dietary factors, the large  number of potential factors considered raises the issue of multiple
 comparisons. Fruit consumption may be a significant factor, but further evidence is needed to
 firmly establish this, particularly in view of the number of dietary factors explored.  Dietary
 factors, however, do not account for the results for ETS exposure in this study. The results
 regarding spousal smoking cannot be readily attributed to bias, and they provide good quantitative
data on the issue of passive smoking and lung cancer.  This well-conducted study makes a
valuable contribution to the evidence on lung  cancer and ETS exposure.
                                           A-88

-------
A.4.19. KATA (No tier assignment is made on this study because the OR is undefined.)
A.4.19.1.  Author's Abstract
       "It is becoming noticeable in Japan that with increased incidence of lung cancer, there has
been an increase in pulmonary carcinoma in women.  Active smoking by women is increasing,
while concern over passive smoking has been intensifying, and the effect of passive smoking on
carcinogenesis has become a social problem.  Regarding this effect, immunological'and public
health reports have appeared in Japan, but there have been few clinical reports, and detailed
analysis of patients has been inadequate.  Lung cancer presents a variegated histological picture,
and presumably there are different carcinogenic factors for different histological types, although
there have also been few reports on this subject.  The effect of passive smoking probably varies
depending on the regional environment and custom, and these factors should also be analyzed and
included in the investigation. The present report describes our findings regarding  the effects of
smoking and familial aggregation of cancer in cases of pulmonary carcinoma in women."

A.4.19.2. Study Description
       This study was undertaken in the Nara Prefecture, Japan, to investigate the effects of
smoking and familial aggregation of cancer in cases of pulmonary carcinoma in women. Active
smokers are included in the  study, from which the nonsmokers are  drawn for analysis. Matching
is retained, however, in the  nonsmokers.
       For the whole study, subjects were drawn from a hospital (presumably the  Nara Prefecture
Medical University Hospital) during an unspecified period of time.  Cases are female patients
with histologically diagnosed lung cancer; controls are female patients  with "nonmalignant"
disease, matched 2 to 1  with cases on age plus or minus 2 years.  It  is not clear if only incident
cases were used and if controls were density sampled. Case diagnoses  were obtained from
histological  exam results, whereas control diagnoses were presumably from medical charts.  Other
information was  collected from apparently unblinded "questioning," with an unspecified degree of
reliance on proxy responses from family  members.
        A total of 25 cases and 50 controls are included in the study; no information on refusals is
provided. Exclusion of active smokers leaves only 17 cases and, with retention of 1:1 matching,
 17 controls.  Mean ages for  the total study population are 67.5 ±  8.8 years (67.6 + 8.5 years) for
cases (controls).  The age distribution of  ETS subjects is not discussed. Nonsmokers are defined
by exclusion of "active smokers," with no delineation between former and current  smokers. ETS
exposure is  defined as exposure to smoking more or less daily through living with  a smoker.
Three periods of ETS exposure are considered: current, past, and childhood, the last for those
                                            A-89

-------
"exposed since early childhood." Clearly these types are not mutually exclusive, although current
sources of exposure are omitted from the "past" exposure category, even if present for a long time.
        ETS exposure is quantified as cigarettes per day smoked times number of years. No
mention is made of cigar or pipe smoking, nor of checks on exposure data. No distinction is made
regarding marital status. Tumors occurring among current passive smokers were mostly
adenocarcinomas (13/17), the remainder (4/17) being squamous or small cell cancers.  Airway
proximity was not specified.  Excluding active smokers, all 17 cases were current passive smokers,
compared with 14 out of 17 controls, for an odds ratio of 1.2, whereas past passive smoking
characterized  16 of 17 cases and 17 of 17 controls,  for an odds ratio of 0.9 (these odds ratios
reflect the substitution of 0.5 for 0 in the exposure categories in which no subjects fall).
Childhood passive smoking was reported in 13 of 15 cases and 7 of 15 controls (apparently all
those for whom information was available), for an  odds ratio of 7.4 (p < 0.1). None of the passive
smoking odds  ratios was statistically significant at the 5% level.  No definite conclusion can be
drawn from the present study, but there is a suggestion that passive smoking is  associated with
development of lung cancer in the Nara region. The effect of passive smoking  that continued to
the present time was especially marked, particularly in  squamous cell carcinoma and small cell
carcinoma.  With adenocarcinoma, an effect of passive  smoking in the past is suspected. Along
with passive smoking, the association of some intrinsic  factor (genetic tendency) to varying
degrees in the different histologic types of lung cancer in women, especially in adenocarcinoma, is
apparent.

A.4.19.3.  Comments
       The  histological diagnosis of all cases, in combination with the apparent involvement of
the researchers in the diagnoses, virtually eliminates the potential pitfall of misclassification of
lung cancer  cases.  It also allows specific breakdowns by cell type. With regard to passive
smoking, however, limitations related to exclusion  of active smokers greatly reduced the study's
potential.
       In their initial analyses, the authors investigate passive smoking without excluding or
stratifying on  active smoking and report statistically significant associations with lung cancer and
combined effects with family history of cancer. This is not a meaningful analysis, because the;
effects of active and passive smoking cannot be separated and passive smoke exposure probably
correlates  strongly with extent of active smoking.  Excluding active smokers greatly reduces the
available numbers  of matched subjects and, in combination with the very high exposure
prevalence among  qualifying controls, makes the differences  between cases and controls (highly
                                           A-90

-------
unstable for all comparisons except for that of childhood exposure. Even here, with an estimated
relative risk of 7.4, the results do not reach the 5% level of statistical significance, notwithstanding
the problem of multiple comparisons.  The authors also conduct cell-type-specific analyses, but
these too fail to yield significant results.  The extraordinarily high proportion of exposed present
and past passive smoking controls is apparently a fluke, because the proportion is not as high in
the total control subject population (or childhood passive smoking controls).  Nevertheless,
exposure was very common among controls. This indicates that the exposure criteria may be too
lax or, alternatively, that the control population included a substantial proportion of persons with
smoking-related diseases (controls  being only stipulated not to have malignant disease).
       In light of the minimal utility of the study's passive smoking analyses, detailed
consideration of design strengths and weaknesses is unwarranted.  Major points not already
mentioned relate to information ascertainment and confounding. Interviews were apparently
unblinded and, especially if conducted by the authors themselves, may thus have been biased
toward uncovering exposure among cases (although the high  prevalence of exposure among
controls as well as cases argues against this).  Furthermore, the extent of proxy interviews,
potentially decreasing accuracy of exposure assessment, is  unclear.
       All subjects are female and, although results are not age adjusted, matching on age was
retained for all analyses. No other risk factors except family history of cancer were considered,
probably due to limited subject numbers, because much information on other factors was
collected. Moreover, family history was  considered only in the nonmeaningful analyses, which
did not differentiate active and passive smokers. Thus, although the problems with numbers and
exposure misclassification probably reduced the study's ability to detect whether an association
exists, information bias and confounding could have biased results either up or down.
       In summary, this study's data are consistent with an association of passive smoking,
particularly childhood exposure, with lung  cancer, but the results are too unstable and subject to
potential bias to carry much weight, and the quantitative results must be viewed with extreme
caution.

A.4.20. KOO(Tier 1)
A.4.20.1. Author's Abstract
       "Lifetime exposures to environmental tobacco smoke from the home  or workplace for 88
"never-smoked" female lung cancer patients and 137 "never-smoked" district controls were
estimated in Hong Kong to assess the  possible causal relationship of passive smoking to lung
cancer risk. When relative risks based on the husband's smoking habits, or lifetime estimates of
                                            A-91

-------
total years, total hours, mean hours/day, or total cigarettes/day, or earlier age of initial exposure,
were combined with years of exposure, there were no apparent increases in relative risk.
However, when the data were segregated by histological type and location of the primary tumor, it
was seen that peripheral tumors in the middle or lower lobes (or less strongly, squamous or small
cell tumors in the middle of lower lobes) had increasing relative risks that might indicate some
association with passive smoking exposure."

A.4.20.2. Study Description
       This study, the second of four from Hong Kong, is based on a secondary data set of
reported female never-smokers.  The parent study from Which the data on ETS subjects were
drawn includes ever-smokers in a matched case-control study of 200 cases and 200 controls (Koo
et al., 1984; also see Koo et al., 1983). Its objective is to assess the role of passive smoking as a
potential etiological factor in the high incidence rate of lung cancer among Chinese females in
Hong Kong.  The current article emphasizes the quantitation of lifetime ETS exposure and the
histological profile of lung cancer in exposed never-smokers.
       In the parent study, cases are  from the wards or outpatient departments of eight hospitals
in Hong Kong during 1981-83.  Controls are healthy subjects from the community, matched on
age (within 5 years), district of residence, and type of housing (public or private). The cases are
incident, and control sampling is density. Attrition due to selection or followup totals 26 (8 too ill
to interview and 18 with secondary lung cancers), leaving 200 cases for interview. Face-to-face
interviews of 1.5 to 2 hours were conducted directly with cases and controls.  There was no
restriction of cases by cell type of lung cancer. The ETS subjects extracted from the parent study
include 88 cases and 137  controls. Of the 88 cases, 83 were confirmed by histology and 5 were
"confirmed malignant." The number  of squamous cell and small cell cases combined is 32 (23 ETS
exposed; 72%); the corresponding figure for adenocarcinoma and large cell combined  is 44 (31
ETS exposed; 70%); 12 cases are of another cell type or otherwise unspecified. For the 86 cases
with available information, tumors were centrally located in 37 (25 ETS exposed; 67%) and
peripherally in 46 (34 ETS exposed; 74%).
       The term "never-smoker" applies to persons who have smoked a total of  fewer than 20
cigarettes. Interview questions regarding exposure to ETS include cigarette and  cigar smoking in
the home during childhood, by the  spouse and other cohabitants in adulthood, and workplace
exposure. "ETS exposed" is technically used in several ways.  For the comparison of exposed with
unexposed ever-marrieds, it means the husband ever smoked in the wife's presence. For measures
of exposure in terms of duration or rate (e.g., total years, hours/day,  total hours, and  cig./day),
                                           A-92

-------
there is some variation.  For example, total years of exposure is derived by adding the years
during which tobacco exposure occurred in the home or workplace. The total hours of exposure
are calculated by multiplying  the average hours per day of exposure by the years of exposure from
each household smoker, or the amount of exposure at each workplace.  The mean hours per day of
exposure are found by adding the hours per day of home and workplace exposures and dividing
this figure by the age of the subject. This figure is intended to approximate the average number
of hours of exposure per day  experienced by the subject, over her lifetime.  Cumulative exposure
is estimated by the total cigarettes smoked by family members, weighted by  years of exposure.
       When data are analyzed on the simple basis of whether a husband ever smoked in the
presence of the wife, the crude and adjusted odds ratios are 1.55 (95%  C.I. = 0.94, 3.08) and 1.64
(95% C.I. = 0.87, 3.09), respectively. The crude analysis applies to ever-marrieds only, which
excludes three subjects. An adjusted analysis uses cigarettes per day smoked by the husband as
the measure of ETS exposure. Conditional logistic regression was applied with stratification on
district of residence, and housing type (public/private); model parameters were included for age,
family history of lung cancer (yes/no),  number of live births, and  number of years since exposure
at home or in the workplace.
       The crude and adjusted methods give very similar odds ratios and confidence intervals,
but the tests for trend differ substantially. The test for trend on the crude data is based on the
Mantel-Haenszel test, using midpoints of the intervals for cigarettes per day smoked by the
husband; the significance value is p = 0.10. The p value for trend  in the adjusted analysis is 0.32.
For analysis of data by other  measures of .exposure, as described above, the estimated odds ratio
ranges between 1.0 and 4.1 across the three levels  of the various measures of ETS exposure for
both the analyses of the crude data and the adjusted analyses by conditional logistic regression,
with two exceptions from analysis of the crude data for hours per  day  of exposure.  The results
are not statistically significant in most cases, because the sample sizes at each exposure level are
small.  The dose-response patterns observed  are clearly sensitive to the measure of ETS exposure
used, with several exhibiting  an apparent peak at a low exposure level. Although the authors
acknowledge that it was troubling to find the lack of a response pattern, no further explanation is
given.
       The authors did not detect a significant trend in the crude  or adjusted odds ratio for the
four lifetime measures of passive smoking (total years, hours, mean hours/day, cig./day).
Although the odds ratio for the intermediate level exposures of hours per day and cigarettes per
day  was significant, the odds ratio at the highest levels of exposure for these two variables fell to a
nonsignificant 1.0 to 1.2. In  fact, the odds ratio for the highest exposure levels for three out of
the four measurements  were  below  all of those with lower exposures and ranged from a very weak
                                           A-93

-------
1.0 to 1.4. On the other hand, most of the crude and adjusted odds ratios were greater than 1.0.
Measurements based on increasing intensity of exposure, defined as increasing years (or hours, or
cig./day) by mean hours per day of exposure, also did not indicate a dose-response relationship.
The analysis of total years of exposure with age of exposure did not suggest that earlier age of
initial exposure and increasing years of exposure led to higher odds ratios.
       It is concluded that when the lung tumors were segregated by histological type and
location, the resulting analyses showed that peripheral tumors in the middle or lower lobes, and
squamous or small cell tumors in the same lobes, exhibited better odds ratio patterns for passive
smoking in terms of consistency, strength, and dose response. The odds ratio for total years,
hours, and hours per day measurements of squamous and small cell lung tumors indicated
consistently elevated risks with increasing exposure.  This pattern was not found for any of the
adjusted odds ratios for adenocarcinoma or large cell lung cancers.
       The cases are divided into two groups histologically, those with squamous cell or small cell
tumors and those with adenocarcinoma or large cell malignancies.  Although none of the crude or
adjusted analyses are found to be significant, it is  concluded that an observed dose-response
pattern seems to be  more apparent in the squamous or small cell group.  With regard to tumor
location, some evidence suggests that peripheral tumors in the middle or lower lobes may be more
common in passive smokers.

A.4.20.3.  Comments
       As described above, the data employed in the  current study were taken from a larger
retrospective study of female lung cancer in  Hong Kong (Koo et al., 1984)  that matched 200 cases
and controls on age, district of residence, and housing type (private or public, an indication of
socioeconomic status).  Attention to detail and accuracy is evident in most aspects of the parent
study.  In particular, considerable effort was put into  attempting to ascertain a better quantitative
measure of exposure than used in preceding studies of ETS.  Records were  apparently verified to
the extent possible to cross-check the accuracy of  information collected, cancers were verified
histologically, and analyses investigated questions related to the histological types and sites of
tumors that may be  related to passive smoking.
       The never-smokers from the parent study, 88  cases and 137 controls, compose the
secondary data set on which  the current article is based.  The matching of the subjects, of course,
is no longer assured, leaving the comparability of the  two groups uncertain. In addition, 60 (27%)
of the subjects are widows, with no information provided on the distribution between cases and
controls. Because spousal smoking is typically the variable on which ETS exposure pivots, this
                                           A-94

-------
may have some bearing on the response. However, an adjustment is made in some analyses for
years since exposure to cigarette smoke ceased.                                      ...,.-
       Some factors in the study itself may be contributing to the variable dose-response patterns.
First, the number of ETS subjects is fairly small. When the subjects are classified into finer
categories of exposure, the statistical variability is greatly increased (total of cases and controls is
typically below 60). Second, questionable measurements of ETS may be causing some distortion.
For instance, in the calculation of total years and total hours of ETS exposure, the years and hours
were not added for simultaneous exposure  to more than one smoker. Pipe smoking and the
cigarette consumption levels of coworkers were excluded from the weighted average of the total
cigarettes per day smoked by each household member. Thus, measurement appears to be based on
the assumption that never-smoking women were exposed to ETS evenly throughout their lives (the
authors claim that only subjects were used for which the exposure  remained relatively regular
during the lifetime, although no mention was found of cases being omitted because of failure to
satisfy this criterion).  Even if this assumption were valid, childhood and adulthood exposures are
mixed  as if the effects of exposure are interchangeable. Interestingly, differences between
exposure in childhood and adulthood is one of the questions addressed in the article.
        Although the  objective is worthy,  the attempt to quantitate exposure more precisely than
previous studies appears to obscure more than to clarify. Some assumptions are not made very
explicit, and their potential implications are not addressed well, which leaves some uneasiness
about the conclusions.  The authors have published at least three articles before this study that
have some bearing on  passive smoking and lung cancer, but their results are not discussed in the
current study, even when the data analyzed are from the same source (Koo et al., 1983, 1984,
1985).  Those articles, one of which  describes the parent study (the 1984 citation), appear to reach
somewhat different conclusions from this study regarding the predominance of histological type
associated with passive smoking. Putting the current study's conclusions within the context of
related prior work would enhance their clarity and  interpretation.
       Considering the reservations described above, the suggestion that the evidence indicates
some association of passive  smoking with the location of tumors is  an overinterpretatipn of the
data.  A weaker conclusion  is warranted, namely, that ETS exposure is associated with increased
lung cancer incidence. What may be of most value in this study is  the analysis based on the
dichotomous classification of cases and controls as exposed or unexposed based on spousal
smoking. Two concerns, however, will be  reiterated.  The ETS data are taken  from a larger study
not matched on smoking status, so they are unmatched.  The study includes 80 widows, without
mention of their distribution between  cases and controls.  In the adjusted analysis, an attempt is
                                           A-95

-------
made to take into account the number of years since last exposure, which would require some
assumption regarding the change of risk relative to cessation of exposure.  Both of these concerns
are mitigated, however, by the similarity of the odds ratios and confidence intervals for the
unadjusted and adjusted analyses.  The care and thoroughness of the study in general make the
results on the odds ratio for exposure to spousal smoke a useful contribution for evaluation with
other study outcomes.

A.4.21. LAMT(Tier2)
A.4.21.1. Author's Abstract
       "In a case-control study in  Hong Kong, 445 cases of Chinese female lung cancer patients
all confirmed pathologically were compared with 445 Chinese female healthy neighborhood
controls matched for age. The predominant histological type was adenocarcinoma (47.2%). The
relative risk in ever-smokers was 3.81 (p < 0.001, 95% C.I. = 2.86, 5.08).  The RRs were
statistically significantly raised for all major cell types with significant trends between RR and
amount of tobacco smoked daily.  Among never-smoking women, RR for passive smoking due to
a smoking husband was 1.65 (p < 0.01, 95% C.I. = 1.16, 2.35),  with a significant trend between RR
and amount smoked daily by the husband.  When broken down by cell types, the numbers were
substantial only for adenocarcinoma (RR = 2.12, p < 0.01, 95% C.I.  = 1.32, 3.39) with a significant
trend between RR and amount smoked daily by the husband.  The results suggest that passive
smoking is a risk factor for lung cancer, particularly adenocarcinoma in Hong Kong Chinese
women who never smoked."

A.4.21.2. Study Description
       This hospital-based case-control study was conducted  in Hong Kong during 1983-86, to
investigate whether smoking is a major risk factor for lung cancer in Hong Kong Chinese women
and, if so, to determine the relationship between smoking and the histological types of lung
cancer. Both active and  passive smoking are of interest. The  ETS subjects constitute only a
subset of the whole study because  it includes active smokers.
       Eligible cases for the whole study are the 445 female patients with pathology-verified lung
cancer admitted  into eight large hospitals in Hong Kong during 1983-86.  Cases were interviewed
in person.  Only a few eligible patients declined or were too ill to cooperate. An equal number of
healthy neighborhood controls were identified and interviewed by density sampling.  Controls
were matched to cases on sex, age  (+5 years), and place of residence.  The cases and controls
include both never-smokers and ever-smokers, but smoking status was not used in matching.
                                           A-96

-------
"Never-smoker" means a person who never smoked as much as one cigarette per day, or its
equivalent, for as long as 1 year.
       A woman is "ETS exposed" if her husband smoked for at least 1 year while they lived
together.  If the husband was an ever-smoker, information on the type of tobacco and amount
usually smoked per day by the husband and the duration of exposure was obtained.  No
information was collected  on ETS exposure from other household members' smoking or smokers at
work.  Single (never-married) women were classified as nonexposed (6.8% and 5.2% in cases and
controls, respectively). The treatment of widowed and divorced subjects is not explicitly
addressed. Age and place  of residence, as well as a series of other demographic variables, are
similar between cases and  controls.
       The distribution of lung cancer by cell type in ETS cases is as follows:  squamous cell, 12
of 27 (number exposed/total); small cell, 6 of 8; adenocarcinoma, 78 of 131; large cell, 7 of 9; and
others  or unspecified, 12 of 24. The corresponding crude odds ratios and 95% confidence
intervals are 0.85 (0.35, 2.06), 3.00 (0.53, 16.90), 2.12 (1.32, 3.39), 3.11 (0.50, 19.54), and 1.08
(0.41, 2.82), respectively.  The odds ratio for all cell types combined is 1.65 (1.16, 2.35), based on
115 of 199 (exposed/total) cases and 152 of 335 controls. The data for all cell types together, and
for adenocarcinoma alone, are both significant at p < 0.01.  No information is available on the
airway proximity of tumors.
       Trend tests were conducted for the amount smoked daily by the husband, categorized in
terms of cigarettes as "nil," 1 to  10, 11 to 20,  and  21 or more. The odds ratios in the three
exposure categories are 2.18, 1.85, and 2.07,. respectively, when all cell types are included.  For
adenocarcinoma alone, the corresponding odds ratios are slightly higher (2.46, 2.29, and 2.89,
respectively). The dose-response relationship does not appear to increase between the lowest dose
and the highest dose, but a test for trend is significant (p < 0.01 for all cell types and p < 0.001 for
adenocarcinoma alone) when the "nil" group is included.  No adjusted analyses are given.
       The authors conclude that the significant  trends observed between relative risk and
amount smoked daily by husband, for all cell types combined and for adenocarcinoma alone,
support the view that the observed association between ETS exposure and lung cancer is likely to
be causal.

A.4.21.3.  Comments
       This study is the fourth of the Hong Kong epidemiologic inquiries into tobacco smoke as a
possible etiological factor in the high rate of lung cancer, particularly adenocarcinoma, among
women. Active smoking was included as well as passive smoking because the previous studies in
                                           A-97

-------
Hong Kong were inconclusive.  According to the authors, this led to the hypothesis that smoking
is not a risk factor for adenocarcinoma in Hong Kong Chinese women. Matching of controls to
cases was conducted for the whole study, including active smokers. It cannot be assumed,
however, that the never-smokers alone, who constitute 45% of the cases and 76% of the controls,
are matched.
       Overall, the study demonstrates care in planning and execution.  The sample size of ETS
subjects is moderately large, providing higher statistical power than the previous Hong Kong
studies. All cases were pathologically confirmed as primary lung cancers, essentially eliminating
the potential for error due to disease misclassification. Odds ratios were calculated by histological
type for comparison. Cases and controls were interviewed personally, apparently with no proxy
respondents and very few refusals, which reduces the potential for response bias. The exclusive
use of incident cases helps to control potential selection bias, and density sampling of controls
contributes to comparability of cases and controls.  For the whole study, including smokers,
healthy controls were matched to cases by sex, age, and neighborhood of residence. The mean and
standard deviation of ages are nearly identical in cases and controls.  According to the authors, a
comparison by other demographic variables showed that, for the whole study, cases and controls
were also comparable in place of birth, duration of stay in Hong Kong, level of education, marital
status, and husband's occupation.  Further attention to detail is evident in the clear definitions of
"never-smoker" and "ETS exposure," essential to accurate classification of subjects  for analysis and
interpretation.  Single women were treated as not exposed to husband's smoking, which  could be a
source of bias because these women may be exposed from other household members. This
possibility was considered,  however, because the article reports that similar results were obtained
when single women were excluded.
       In summary, the crude odds ratios vary between 2.1 and 3.1 for small cell carcinoma,
adenocarcinoma, and large  cell  carcinoma, with adenocarcinoma significant at p <  0.01.  The odds
ratios are consistently elevated at all three intensity levels of spousal smoking, varying between 1.8
and 2.9, with the odds ratio for adenocarcinoma alone somewhat higher than for all cell types
combined.  There is no apparent upward trend, however, from the lowest smoking intensity (1-10
cig./day) to the highest (21+ cig./day). These statistical results are ostensibly suggestive of an
association between ETS exposure and lung cancer incidence, but they are based on only crude
data with cases and controls unmatched, even on ages. Nor are statistical  methods  used  that could
adjust for matching variables, or other factors, in the data analysis (e.g., by stratification or
logistic regression). Although this study was carefully conducted in  most respects, the disregard
for potential confounding effects leaves the authors' conclusion uncertain.
                                           A-98

-------
A.4.22. LAMW(Tier3)
(Note:  This study is part of the thesis of LAM Wah Kit submitted to the University of Hong
Kong for the M.D. degree in 1985, entitled A Clinical and Epidemiological Study of Carcinoma in
Hong Kong.  The description given below is from Chapter 7 of the thesis only, entitled Case-
Control Study of Passive Smoking, Kerosene Stove Usage and Home Incense Burning in Relation to
Lung Cancer in Nonsmoking Females (1981-84), which the author submitted in response to our
request. The abstract below was prepared by the  reviewers, since none was available from the
author.)

A.4.22.1.  Abstract
       The study's objective is to investigate the  hypothesis that an inhaled carcinogen may be
related to the high incidence of centrally situated adenocarcinoma of the lung observed in
nonsmoking female patients. Air pollution is probably not an important factor because it
presumably affects both men and women. Most women in Hong Kong either stay at home or join
the work force in commerce, services, or manufacturing, which are not associated with any known
risk factor for lung cancer. Three etiological activities, all predominantly in  the home, are
considered in this study: passive smoking, kerosene stove cooking, and home incense burning.  No
evidence was found to implicate exposure to kerosene stove fumes or incense burning in centrally
located adenocarcinoma. There is suggestive evidence of an association between ETS exposure
from smoking husbands and occurrence of peripheral (but not central) adenocarcinoma. Why the
location tends to be peripheral  instead of central is speculative.

A.4.22.2.  Study Description
(Note: The details of the study are not complete in the material provided.  Some useful
information, however, is available.)
       The cases are all of the  Chinese female patients admitted to the University Department of
Medicine, Queen Mary Hospital, Hong Kong, between January  1981 and April 1984 with
histologically and/or cytologically confirmed carcinoma of the lung of the four major cell types.
Care was taken  to exclude  patients with secondary carcinoma of the lung; otherwise, all patients
were included.  The controls are Chinese female patients admitted to the orthopedic wards of the
hospital in the period 1982-84, comparable to lung cancer patients in age and social class.  Patients
with pathological fractures due to  smoking-related malignancies or with peripheral  vascular
disease-related orthopedic conditions were excluded.
                                           A-99

-------
       Both cases and controls were patients of the third-class general wards, mostly from the
lower income group. All subjects were interviewed in person. The questions covered dialect
group, occupation, smoking habits, passive smoking, domestic cooking with kerosene, and home
incense burning, in the form of a standardized questionnaire. For very ill patients, or for patients
who spoke a dialect other than Cantonese or Mandarin, the next of kin was interviewed, with the
patient as interpreter. The whole study, including active smokers, contains 161 cases and 185
controls, similar in age (median age is 67.5 [66] for cases [controls]), socioeconomic status (as
measured by occupation and years of schooling), and recent residence. The author considered it
unnecessary to stratify on these or any other variables.
       The ETS subjects consist of 75 (144) cases (controls), including 16(14) never-married
cases (controls). The distribution of cases by cancer cell type is as follows: squamous cell (7),
small cell (3), large cell (5), and adenocarcinoma (60).  Questions related to ETS exposure include
details on each smoker in the home (husband, others, mother, and father), amount smoked per
day, hours of ETS exposure per day, and number of years smoked.  Information about exposure in
the workplace includes size of the workplace, number of coworkers who smoke, exposure
time/day, and number of years of exposure at work.
       Only the data for adenocarcinoma, the predominant cell type observed and the
pathogenesis of interest, are analyzed. The number of cases is 37 out of 60 (exposed/total), and
the number of controls is 64 out of 144, where ETS exposure refers to spousal smoking.  The odds
ratio (calculated by the reviewers) is 2.01 (95% C.I. =  1.09, 3.72). The author divides the cases by
location according to airway proximity, with 18 of 32 (exposed/total) located centrally and 19 of
28 in peripheral regions.  The respective risk ratios are 1.61 and 2.64. Two tests were conducted
for significance, including the Bayesian  risk ratio analysis and a test of the slope for the exposure
parameter in a simple logistic regression model. The significance levels are 0.11 and 0.19,
respectively, for the central location and 0.01 and 0.02, respectively, for peripheral tumors. The
test results differ widely  for total passive smoking (home or workplace).  For the central location,
the respective significance levels are 0.09 and 0.3;  for peripheral locations, the corresponding
values are 0.03 and 0.15.  It is suggested that the different outcomes for the two tests applied to
total passive smoking may be due to a nonlinear logistic dose-response curve or to errors in
assessing the level of exposure due to incomplete information. The apparent association between
passive smoking and peripheral adenocarcinoma (and not central tumors) in the cases was
unexpected. Based on the available raw data, exposure to a smoking spouse, cohabitant, and/or
coworker is associated with an odds ratio of 2.51 (95% C.I. = 1.34, 4.67) for all cell types
combined. The author concludes that there is a suggestion of passive smoking associated with
peripheral adenocarcinoma, particularly passive smoking attributable to smoking husbands.
                                           A-100

-------
Kerosene and incense burning were not found to be associated with adenocarcinoma, either
central or peripheral.

A A.22.3. Comments
       Cases and controls appear to be comparable in age, socioeconomic status, and recent
residence for the whole study (including active smokers), although the study design is not matched
on these or other variables. Some discrepancies between cases and controls are apparent, however,
such as a higher percentage of cases than controls working outside the home  (41% compared with
28%).  The figures for nonsmokers alone (i.e., the ETS subjects) are not given, so comparability is
uncertain for analysis of ETS exposure. Care has been taken to include only primary lung cancer
patients among the cases, essentially eliminating this potential source of bias. Subjects were
personally interviewed, with apparently only a small number of proxy respondents required,
although no figure is given.  The interviews apparently were not blinded, but that may not have
been feasible considering the nature of the questions asked and the use of noncancer patients as
controls. Considerable attention is given to histological type of cancer and the location in terms of
airway proximity.
       The author is particularly interested in the etiology of adenocarcinoma and focuses
discussion on the adenocarcinoma cases to the exclusion of others. Although the raw data
pertaining to other cell types are tabulated, more attention to those types in the analyses would
have been useful. The adenocarcinoma cases are categorized further by central and peripheral
location, which are analyzed separately. Again, a combined analysis  would be useful (the
reviewers calculated the crude odds ratio for the combined data,  which is given above). Although
logistic regression is employed as one of the two statistical tools for analysis, factors that may
differ between cases and controls are not included.  Potential confounding variables need to be
controlled for, by logistic regression, poststratification, or otherwise. To claim that cases and
controls are similar in  potential confounding characteristics does not  alleviate the need to adjust
for them in the analysis, particularly when the ETS data are a subset of the larger data set  to
which reference is made.  Similarly,  in testing three factors for an association with lung cancer
(passive smoking, cooking with kerosene, and burning incense), it would be  useful to conduct an
analysis  that will allow evaluation of the effect of each after adjustment for  the other two.
       The suggestive evidence that passive smoking  is more likely associated with
adenocarcinoma in peripheral rather than central locations may be logical but is weak, especially
considering the lack of analytical rigor. The proportion of ETS-exposed cases of adenocarcinoma
is  18 of 32 (56%) for central locations and 19 of 28 (68%) for peripheral locations.  This difference
                                           A-101

-------
is not statistically significant (p = 0.26 by Fisher's exact test).  Consequently, the "apparent
association" between passive smoking and peripheral adenocarcinoma (and not central tumors) may
well be due to chance alone. There is suggestive evidence in the data that passive smoking may be
associated with lung cancer (OR = 2.01, p < 0.03 for a one-sided test), but that is based only on
the crude odds ratio in unmatched data and needs to be confirmed by a more thorough evaluation
of the data that takes potential confounders into account. Overall, this study provides some
suggestive evidence for an association between passive smoking and lung cancer.  Potential
confounders (including age) have not been controlled for, however, so attribution of the elevated
odds ratio to ETS exposure is uncertain.

A.4.23. LEE (Tier 2)
A.4.23.1. Author's Abstract
       "In the latter part of a large hospital case-control study of the relationship of type of
cigarette smoked to risk of various smoking-associated diseases, patients answered questions on
the smoking habits of their first spouse and on the extent of passive smoke exposure at home, at
work, during travel and during leisure. In an extension of this study an attempt was made  to
obtain smoking habit data directly from the spouses of all lifelong nonsmoking lung cancer cases
and of two lifelong nonsmoking matched controls for each case. The attempt was made regardless
of whether the patients had answered passive smoking questions in the hospital or not.
       Among lifelong nonsmokers, passive smoking was not associated with any significant
increase in risk of lung cancer, chronic bronchitis, ischemic heart disease, or stroke in any
analysis.
       Limitations of past studies on passive smoking are discussed and the need for further
research underlined. From all the available evidence, it appears that any effect of passive smoke
on risk of any of the major diseases that have been associated with active smoking is at most
small, and may not exist at all."

A.4.23.2. Study Description
       This study was undertaken in England, essentially from 1979 to 1983.  Its stated objective
is to investigate the relationship between passive smoking and risk of lung cancer in nonsmokers.
It is an outgrowth, however, of a hospital-based case-control study to assess whether the risk of
cardiorespiratory disease associated with smoking varies by type of cigarette smoked. It was
initiated in 1977 in 10  hospital regions  in England. In 1979, interviewers began gathering
information on passive smoking as  well in four of the regions.  Then in 1982, this case-control
                                           A-102

-------
study of the effects of passive smoking was begun using nonsmoking cases identified by the
ongoing cardiorespiratory effects study. For the new study, spouses of cases and specially selected
controls were interviewed regarding smoking habits. Previously collected data on passive smoke
exposure obtained from patients back to 1979 were used.
        Basically, two substudies were conducted. One used the data obtained directly from
hospitalized cases and controls to address several sources of passive smoke, including spousal
(henceforward the "passive smoking" study); the second substudy used data obtained from the
spouses of cases and controls along with corresponding information from the patients themselves,
when available,  to address spousal smoke exposure only (henceforward the "spousal smoking"
study).  Cases for the passive smoking study were currently married lifelong nonsmokers
diagnosed with lung cancer (of any  cell type), chronic bronchitis, ischemic heart disease, or stroke
in one of four participating hospital regions. Controls were currently married lifelong nonsmoker
inpatients diagnosed with a condition definitely or probably not related to smoking and
individually matched on sex, age, hospital region, and, when possible, hospital ward and time of
interview.  Thus, density sampling was used when possible. For the spousal smoking study,
previously married patients were excluded; the same criteria otherwise applied, except that
controls were now matched on sex, age decade, and—as far as possible—hospital and time of
interview.
        Diagnoses were obtained from medical records. Exposure data were obtained through
apparently unblinded, presumably face-to-face interviews with inpatients and their spouses.  A
total of 3,832 married cases and controls were interviewed regarding passive smoking through
1982; it is unclear how many potential subjects refused or died before interview.  Only 56 of these
were married lung cancer cases meeting the spousal smoking study criteria. Spousal interview data
were obtained for 34 of these cases and 80 controls;  interviews were refused by the remainder.
Although matching of cases and controls was initially carried out, it was not retained in the
analysis, and no  demographic comparison of cases and controls used in the analyses is provided.
Diagnoses were apparently drawn from patients' charts; provisional diagnoses were used where no
final diagnosis was specified, no data on diagnostic technique(s) or histology was presented, and
no diagnostic verification was reported.
       The patient population consists of never-smokers, defined as lifelong nonsmokers, which
presumably excludes cigar and pipe  smokers. Exposure to ETS is approached in several ways.
The primary exposure is that of a spouse smoking manufactured cigarettes at some point over the
course of a marriage. Spousal smoking in the 12 months before interview also was assessed.  In
addition, "regular" exposure to passive smoke in various situations (i.e., at home or work, during
travel or leisure) was assessed.  The first two exposures were quantified in numbers of cigarettes
                                          A-103

-------
smoked per day, the others in terms of "not at all, a little, average, or a lot." Thus, it appears that
cigar and pipe smoking may not have been included in the spousal smoking exposures.
Comparison of individual responses regarding spousal smoking status by patients and their spouses
revealed a high degree of concordance (97%) for smoking during the past 12 months and a
substantial concordance (85%) for smoking during marriage. No other checks on exposure data
were reported.
       The ETS patient data set includes 56 cases and 112 controls who met the initial study
criteria. Not all of these answered each passive exposure question, however, and not all met the
criteria for the spousal interview study.  Similarly, spouses of 34 cases and 80  controls provided
exposure information of  varying completeness.  Thus, the numbers involved in each analysis
varied considerably. For smoking during marriage, data obtained directly from spouses indicated
that for males and females  combined, 24 of 34 lung cancer cases and 51 of 80 controls were
exposed, which yields a crude odds ratio of 1.4 for spousal smoking.  With standardization for age,
an odds ratio of 1.33 (95%  C.I. = 0.50, 3.48) was reported.  Data obtained from qualifying patients,
in contrast, revealed 13 of  29 cases and 27 of 59 controls to be exposed, yielding a crude and
adjusted odds ratio of 1.00 (95% C.I. = 0.41, 2.44). Stratification by gender yielded adjusted odds
ratios from spousal interview data of 1.60 (0.44, 5.78) and 1.01 (0.23, 4.41) for females and males,
respectively, with corresponding odds ratios from patient interview data of 0.75 (0.24, 2.40) and
1.5 (0.37, 6.34).  When spouses identified as smokers  by interview with either source were
classified as exposed, an  odds  ratio of 1.00 (0.37, 2.71) was obtained for female subjects.  For the
larger inpatient passive smoking study population, age-standardized odds ratios for passive smoke
exposure at home, at work, during travel, and  during leisure revealed no consistent associations,
with as many negative as positive relationships observed after adjustment for  both age and
whether still currently married.  The same inconsistency held true for spousal smoking during the
last 12 months and during  the whole marriage.  Adjustment for working in a dusty job reportedly
did not affect the conclusion that passive smoking was not associated with risk.
       Spousal smoking  was slightly negatively associated with chronic bronchitis, ischemic heart
disease, and stroke, whereas a combined ETS exposure index was negatively associated with heart
disease but positively associated with bronchitis and  stroke.
       The author concluded  that the findings appear consistent with the general view, based on
all the available evidence,  that any effect of passive  smoking on risk of lung cancer or other
smoking-associated diseases is at most quite small, if it exists at all. The  marked increases in risk
noted in some studies are more likely to be a result of bias in the study design than of a true
effect of passive smoking.
                                            A-104

-------
A.4.23.3. Comments
       The heart of this study is the spousal interview investigation of lung cancer and spousal
smoking. Only 34 case spouses and 80 control spouses, and even fewer of the corresponding cases
and controls themselves, are included, which gives the study low statistical power.  Because the
study began with hospital inpatient married lifelong nonsmokers, and matching on several key
factors was  employed, good comparability of cases and controls would seem readily achievable.
No case-control demographics are provided, however, and matching is  abandoned in the analyses.
The occurrence of interview refusals and omitted responses (themselves a potential source of
selection and information bias) may have contributed to the decision  to abandon matching, with
the aim of preventing further  substantial reduction in numbers through exclusion of unmatched
subjects.  As a result, the comparability of the cases and controls is uncertain.  At least all are
drawn from the same four hospital areas within a fairly limited timespan, which, in combination
with the other study criteria, reduces  the likelihood of serious noncomparability.
       Numerous opportunities for misclassification  of disease and exposure status are present.
Current working diagnoses are apparently drawn from patient charts  without verification, and
controls are selected from patients with diagnoses judged either probably or definitely not
associated with smoking by unspecified criteria.  This creates considerable potential for
misclassification, both through inaccuracies in diagnoses generally and through inclusion of
smoking-related diseases in the control group particularly, which would produce a downward bias
in results. Exposure misreporting and recall problems would seem least likely where spouses are
interviewed directly about exposure within the past 12 months.  Results for this situation  are not
presented, although they are reportedly similar to those for smoking during marriage.
       The  larger inpatient study elicited smoking data from patients, and only for their first
spouse for patients who had remarried; thus, exposure occurring in subsequent marriages  is not
addressed. In addition, no information on duration or level of smoking in marriage is used in any
of the spousal smoking analyses. The  most likely result of these problems is nondifferential
misclassification resulting in a bias toward the null.  For general estimated home, work, travel, or
leisure exposure  to passive smoke,  rough quantification is attempted by having patients categorize
their exposure as "not at all, a  little, average, or a lot." By necessity, this is a very subjective
evaluation, and people more acclimated to smoke and tolerant of exposure might well tend to
characterize a given amount of exposure as less severe than would a person less tolerant of smoke
who more actively avoids exposure. This tendency would produce a bias toward negative
association.
                                           A-105

-------
       Standardization for age and restriction of cases and controls to currently married lifelong
nonsmokers should control the effects of age, marital status, or active smoking, although
misreporting of current or former active smoking cannot be ruled out entirely. Dusty occupation
reportedly had no effect on the larger inpatient study results. Potential effects of race,
socioeconomic status, diet, cooking habits, or any additional factors were not addressed.
       One might expect  the most accurate reporting of spousal smoke exposure when spouses, are
interviewed directly regarding their own smoking habits, and the most inadvertent
misclassification when patients are queried about the smoking status of their first marital partner
only. Analyses along these lines yielded slightly positive associations with smoking for the former
and negative with  the latter approach.  No consistent pattern of association was seen for other
sources and lung cancer, although high combined exposure scores were associated positively with
chronic bronchitis and stroke and negatively with ischemic heart disease.
       In summary, this study presents equivocal results that neither strongly confirm nor refute;
the hypothesis that passive smoking mildly increases risk of lung cancer.  The quality of the study,
however, is a limitation. The discrepant results for subject-supplied data (OR = 0.75) and spouse-
supplied data (OR = 1.60), varying degrees of completeness of information on subjects, and the
subjective nature of questions regarding ETS exposure limit confidence in the  study's data and, „
consequently, the results of its analysis of those data.

A.4.24.  LIU (Tier 4)
A.4.24.1. Author's Abstract
       "In Xuanwei County, Yunnan Province, lung cancer mortality rates are among the highest
in China in both males and females.  Previous studies have shown a strong association of lung
cancer mortality with indoor air pollution from 'smoky' coal combustion.  In the present case-
control study, 110 newly diagnosed lung cancer patients and 426 controls were matched with
respect to age, sex, occupation (all subjects were farmers), and village of residence (which
provided matching with respect to fuel use).  This design allowed assessment of known and
suspected lung cancer risk factors other than those mentioned above.  Data from males and
females  were analyzed by conditional logistic regression. In females  who do not smoke, the
presence of lung cancer was statistically significantly associated with chronic bronchitis (OR
7.37, 95% C.I. » 2.40, 22.66)  and family history of lung cancer (OR 4.18, 95% C.I. =  1.61, 10.85).
Females' results also suggested an association of lung cancer with duration of cooking food (OR
1.00, 9.18, and 14.70), but not with passive smoking (OR 0.77, 95% C.I. = 0.30, 1.96). In males,
lung cancer was significantly associated with chronic bronchitis (OR 7.32, 95% C.I. = 2.86, 20.18),
                                            A-106

-------
family history of lung cancer (OR 3.78, 95% C.I. = 1.70, 8.42), and personal history of cooking
food (OR 3.36, 95% C.I. = 1.27, 8.88). In males, a dose-response relationship of lung cancer with
smoking index (years of smoking/amount of smoking) was shown by risks of 1.00, 2.61, 2.17, and
4.70."

A.4.24.2. Study Description
       This study was undertaken in Xuanwei County of China's Yunnan Province, a county
whose lung cancer mortality rates are among the country's highest and wherein burning of smoky
coal indoors in unventilated pits is a common practice. The study sought to assess "the influence
of factors other than type of fuel on the occurrence of lung cancer in Xuanwei."
       Cases of newly diagnosed lung cancer occurring among farmers at hospitals and clinics in
Xuanwei between November 1985 and December 1986 were identified as potential study subjects.
Up to five controls were identified for each case, depending on availability after matching on age
(±2 years), gender, and village of residence.  A total of 112 cases were identified, from which 2
were excluded due to unknown addresses.  Of 452 candidate controls, 26 were excluded due to
erroneous questionnaire responses.  All subjects were interviewed face-to-face by trained
personnel using a standardized questionnaire, and blinding extended to both interviewers and
interviewees.
       The final study groups  consist of 54 (56) female (male) cases and 202 (224) female (male)
controls. Mean age is 52 years for both cases and controls, who are also similar in family size,
ethnicity, birthplace, dwelling  type, and type of fuel used (smoky coal, wood). Separate
breakdowns for males and females are not provided.  Very few of the cases (19/110 = 17%) were
histologically or cytologically diagnosed, and no verification of diagnosis  or exclusion of
secondary tumors was undertaken (except to monitor mortality among some of the cases).
       Exposure to ETS was not evaluated for males. Among females, only one subject (a
control) reported ever having smoked, so the ETS population of females effectively consists of
never-smokers. Subjects were classified as exposed to ETS if their household contained at least
one smoker.  Exposure is not quantified, and it is unclear whether former or only current
exposure is intended.  No checks on exposure status or consideration of marital status are
mentioned, and no histological data are presented.
       The proportion of exposed female subjects is 45 out of 54 (176/202) for cases (controls),
yielding a crude odds ratio of 0.74.  A conditional logistic regression analysis adjusted for other
risk factors (presumably the other factors referred to are age-began-cooking and years-of-
                                          A-107

-------
cooking) gives an odds ratio of 0.77 (95% C.I. = 0.30, 1.96).  No further analyses of ETS exposure
are provided.
       Four non-ETS factors are significantly associated with lung cancer among females:  family
history of lung cancer (OR = 4.18; 95% C.I. = 1.61, 10.85), personal history of bronchitis (OR =
7.37; C.I. = 2.40, 22.66), age-began-cooking (OR = 2.44-1.03, but with a reversing and
nonsignificant dose-response), and years-of-cooking (OR = 2.49-2.25, nonsignificant trend).
Among males, significant positive associations were noted for total smoking index, often-cooking-
own-food, family history of lung cancer, and history of chronic bronchitis, whereas age-began-
smoking, years of smoking, and intensity of smoking showed modest but nonsignificant
associations with  lung cancer.
       The authors conclude that "it is quite conceivable that the large amount of air pollutants
inhaled during indoor smoky coal burning in Xuanwei partly overwhelm the carcinogenic effect
of tobacco smoking" and "may also overwhelm the carcinogenic effect of passive smoking." "Our
results disclose important associations of lung cancer with factors other than fuel type and
therefore indicate that those factors must be considered in any comprehensive, quantitative risk
assessment of lung cancer in Xuanwei. Our results also confirm indirectly that smoky coal
pollution is an important determinant of lung cancer in Xuanwei."

A.4.24.3.  Comments
        This modestly sized study was not designed to test for effects  of ETS exposure.  Rather, it
is a hypothesis-generating exercise aimed at covering a broad range of possible risk factors.
Within that context, the study has considerable merit, but as an investigation of ETS it has
numerous flaws.
        Restriction to farmers minimizes concerns with occupation and overall lifestyle, and
control selection, including matching on age, gender, and village, produced demographically
comparable case and control populations for males and females combined despite the enigmatic
exclusion criterion for controls.  It is unknown, however, whether the groups remain comparable
after subdivision into males and females.
        The use of newly diagnosed cases reduces potential selection bias due to inclusion of
prevalent cases, but the heavy reliance (83%) on  clinical and radiological diagnosis and the absence
of independent confirmation or exclusion of secondary tumors introduces a strong potential for
misclassification  of disease and precludes analyses by cell type.  The observation that followup of
a number of lung cancer patients revealed that almost all died within  6 months of diagnosis does
little to confirm diagnostic validity,  contrary to the authors' interpretation.  Such presumably
                                           A-108

-------
 random misclassification would make detection of an existing ETS-lung cancer association more
 difficult.
        Exposure data collection procedures, particularly the exclusive use of face-to-face
 interviews without resort to proxies and the blinding of both interviewers and subjects, are
 laudable.  For ETS, however, the exposure measure used is nonspecific and nonquantitative.
 Complications due to past exposure and differences in degree or duration could distort the
 observed disease-exposure relationship, probably biasing results toward no effect.
        Potential confounding is not adequately addressed in the statistical analysis.  The authors
 are particularly concerned with indoor smoky coal burning due to the known strong correlation
 between smoky coal use and lung cancer mortality in Xuanwei. Wishing to focus their
 investigations on factors other than smoky coal, they matched cases and controls on village,  which
 "provided  effective matching on fuel  type."  But because age and a host of other demographic
 factors, as well as smoky coal  consumption, were comparably distributed in cases and controls (see
 study description),  these factors were not considered further in  the data analysis. This is a serious
 flaw, for pair matching was not retained in the analysis; thus, none of the above factors is
 effectively controlled for. The conditional regression analyses do control for risk factors other
 than those cited above, but exclusion  of age, fuel type (e.g., smoky coal), and degree of exposure
 to fuel  fumes may produce misleading results.  •
        The presence of other significant risk factors for lung cancer makes detection of an effect
 from ETS, if present, less likely.  Masking by the presence of smoky coal and other factors in the
 study environment is probably a factor in the remarkably weak association between active
 smoking and lung cancer among study males (adjusted OR = 1.36).  If even an effect of active
 smoking remains largely obscured under study conditions, it is unlikely that an effect of ETS
 would be detected.  Supporting these concerns are other recent studies  in Xuanwei County that
 have confirmed widespread smoky coal use (e.g., 100% of households in Cheng Guan commune
 before 1958) and serious indoor air pollution with combustion byproducts, including mean indoor
 benzo[a]pyrene (BaP) levels of 9-15 ng/m3 in two communes using smoky coal during fall of 1983
 (Mumford  et al.,  1987). Prior use of smoky coal at age 12 is associated with an OR of 3.7 for lung
 cancer in pair-matched female residents (Chapman et al., 1988). He et al. (1991), who report a
 strong association between indoor BaP and lung cancer, conclude that indoor air  pollution appears
 to be the strongest risk factor for lung cancer in Xuanwei females.
       Overall, this study makes important contributions to  its principal objectives but is not
helpful  in assessing ETS and lung cancer. It is observed, for example, that persons in areas of
Xuanwei with high lung cancer rates (and high smoky coal consumption) may inhale more BaP by
spending 8  hours indoors than by smoking 20 cigarettes.  Due to  such factors, the authors  observe,
                                          A-109

-------
"the effect of passive smoking on lung cancer may depend on local environmental factors and
results obtained in a given region therefore may not be applicable to other regions." Avoidance of
areas atypically rich in competing exposures and careful control of potential confounders and
interactive risk factors must be key objectives in studies of ETS and lung cancer.

A.4.2S. PERS(Tierl)
A.4.25.1. Author's Abstract
       "The relation between passive smoking and lung cancer was examined by means of a case-
control study in a cohort of 27,409 nonsmoking Swedish women identified from questionnaires
mailed in 1961 and 1963.  A total of 77 cases of primary carcinoma of the bronchus or lung were
found in a followup of the cohort through 1980.  A new questionnaire in 1984 provided
information on smoking by study subjects and their spouses  as well as on potential confounding
factors. The study revealed a relative risk of 3.3, constituting a statistically significant increase
(p < 0.05) for squamous cell and small cell carcinomas in women married to smokers and a positive
dose-response relation.  No consistent effect could be seen for other histologic types, indicating
that passive smoking is related primarily to those forms of lung cancer that show the highest
relative risks in smokers."

A.4.25.2. Study Description
       This case-control study, undertaken to explore the role of passive smoking in lung cancer,
is based on cohorts of Swedish women assembled prior to 1963.  Nonsmokers were drawn from
these cohorts  to create matched case and control groups.
       Cases are nonsmoking Swedish women included in the Swedish National Census or Twin
Registry who responded to smoking status questionnaires in 1961-63 and who subsequently
 developed primary lung or bronchial cancer by 1980. Two control groups were cumulatively
 sampled from National Census  or Twin Registry subjects who did not develop lung or bronchial
 cancer.  In group 1,  two controls were matched to each case on year of birth (± 1 year). In
 group 2, two  controls were matched to each case (2:1) on year of birth (± 1 year) and vital status
 in 1980.  Thus, there were 58 cases and 232 controls from the National Census and 34  cases and
 136 controls from the Twin Registry. A  followup questionnaire that included questions on spousal
 and parental smoking habits was distributed to each subject or the next  of kin in 1984. Out of 92
 cases of tracheal, bronchial, lung, or pleural cancer occurring by 1980, 15 cases in which a
 diagnosis of primary cancer of the lung or bronchus was not established were excluded. Exclusion
 of women indicated to be active smokers according to the 1984 questionnaire, or for whom ETS
                                           A-110

-------
exposure information was not available, eliminated a further 10 cases.  Active smoking and lack of
exposure information eliminated 21 of the 368 controls initially assembled. Histological
confirmation was available for 64 of the 77 cases with primary lung or bronchial cancer; 12 cases
were cytologically confirmed, and the remaining case was verified at autopsy.
       Never-smokers are subjects who report that they have never smoked any form of tobacco.
A woman is ETS exposed if she has ever been married to a tobacco smoker; for women married
more than once, only the longest marriage is considered. Exposure to spousal smoking *is
quantified in units of cigarettes per day or packs of pipe tobacco per week; parental smoke
exposure is defined as 0, 1,2, etc. (equal to the number of parents who smoke).  No other sources
of ETS exposure are considered.  Never-smoking status was checked by comparing the responses
to the 1961-63 questionnaires with those obtained in 1984. Data on sources of ETS were not
checked. Never-married  women  were classified  as nonexposed to  spousal smoke; widows and
divorcees were classified according to the smoking status of the former husband with whom they
had lived the longest.  Of the never-smoking cases for whom passive smoking information was
available, squamous and small cell tumors constituted 20 cases, 13 of whom were exposed to
spousal smoke; of the other 47 cases, 20 were exposed to spousal smoke.
       Responses to the ETS questionnaire were available for a total of 81 never-smoking cases
and 347 never-smoking controls.  The 67 cases with primary lung or bronchial cancer constitute
the ETS study subjects. It is not clear how many of the 347 potential controls were employed in
each analysis. Presumably many (up to 4 for each excluded case from the original 81 never-
smoking cases) were not used in the matched analysis, whereas most or all were used in the
unmatched analyses described subsequently.
       A total of 33 of the 67 cases were exposed to spousal smoking.  Among the never-smoking
women, matched analyses indicate that the odds ratio for marriage to a smoker is 3.8 (95% C.I. =
1.1, 16.9) for squamous or small cell cancer compared with control group 1, 3.4 (0.8, 20.1)
compared with control group 2, and 3.3 (1.1, 11.4) compared with  both groups combined.,, .For
other cell types, corresponding odds ratios are 0.7, 0.8, and 0.8, respectively. Subsequent,analyses
abandoned matching and pooled all controls.  For squamous and small cell cancer, high exposure
to spousal smoking (15 or more cig./day or at least one pack of pipe tobacco/week for 30+ years)
is associated with an age-adjusted odds ratio of 6.4 (1.1, 34.7), whereas the lower exposure is
associated with an odds ratio of 1.8 (0.6, 5.3).  The estimated odds  ratios for other types of cancer
are also elevated for the higher exposure, but not at the lower one. Odds ratios adjusted for age
and spousal smoking when at least one parent smokes as well are above 1 (1.9; 95% C.I. = 0.5, 6.2)
for squamous and small cell types but not for other types.
                                          A-lll

-------
        Logistic regression analyses reportedly produced the same results as did the stratified
 analyses.  In addition, occupation, household radon, and urban or rural status had no significant
 effect.  It is notable, however, that for all cancers combined, the odds ratio for radon exposure is
 1.4 (0.4, 5.4), the odds ratio for spousal smoking is 1.2 (0.6, 2.6), and the odds ratio for radon and
 spousal smoking combined is 2.5 (0.8, 8.5). No separate analyses for squamous and small cell
 cancer are provided for radon and other potential confounders.  The authors conclude that
 exposure to ETS is related primarily to the forms of lung cancer that show the highest relative
 risks in smokers. The results are internally consistent.

 A.4.25.3.  Comments
        Although based on cohorts assembled for other purposes, this case-control study was
 specifically designed to investigate passive smoke exposure. Thus, all participants are  ETS
 subjects that are matched. Matching criteria are rather modest—birthdate (± 1 year) for control
 group 1 and birthdate and vital status for control group 2. Because the study targeted  all cases
 detected in the same cohorts from  which matching controls were randomly drawn, good
 comparability of cases and controls is likely.  No demographic comparisons of cases and controls
 for whom ETS information was available—and thus who constituted the analytical subjects—were
 provided to confirm this,  however. Data on active smoking among subjects were collected both at
 the start and after the end of mortality monitoring, providing an opportunity to verify the
 nonsmoking status over time and exclude individuals whose status had changed (apparently those
 reported in 1984 to have smoked daily for at least 2 years were so excluded). Thus, the
 probability of significant misclassification of active smoking status is low.  Data on passive
 smoking were collected only after the end of mortality monitoring and by necessity employed
 proxy respondents extensively, so some misclassification of exposure is likely. Self-administration
 of questionnaires eliminates  interviewer bias as a source of error, making misclassification less
 likely to be systematic, but preferential recall of smoke exposure by  relatives of cancer victims
 could have produced a bias.  Misclassification of disease is unlikely to have been a problem
 because most cases were histologically diagnosed and secondary  lung cancers were excluded.
       Consideration of spousal smoke exposure only in their longest marriage among  women
married more than once means that some of the unexposed group probably had substantial
exposure to spousal smoking, creating a bias toward no association. Classification of all
never-married women as unexposed despite possible smoking by cohabitants creates the same bias.
Few subjects (less than 20%) were single, but the frequency of remarriage is unknown; therefore,
                                           A-112

-------
it is unclear how important this bias might have been.  Lack of consideration of workplace smoke
exposure also may have contributed a bias toward the null hypothesis of no association.
       The authors addressed a number of potential confounders and risk modifiers. Restriction
of subjects to women eliminates potential effects of gender, and age is addressed by retaining
age-matching or, alternatively, adjusting for age in all analyses. Reportedly neither occupation,
radon, nor urban residence had significant confounding effects, which makes confounding by
other factors related to socioeconomic status or lifestyle unlikely, too.  An analysis of parental
smoking controlled for spousal smoking. The authors do, however, present evidence that the odds
ratio for simultaneous exposure to radon and spousal smoke approximately equals the sum of the
separate odds ratios for radon and spousal smoke, consistent with additivity of the effects. But,
perhaps due to limited numbers, they report results only for all cancers combined rather than for
the squamous and small cell subgroup in which the only significant spousal smoking association
was observed.
       In summary, this study reports a consistent, dose-related, and (for high exposure levels)
statistically significant positive association between exposure to spousal tobacco smoke and
squamous and small cell carcinoma of the lung; a positive but nonsignificant association was  also
observed for parental smoke exposure.  No significant associations were observed for other cell
types. The observed associations apparently are not due to confounding by other major risk
factors, although dietary and smoking habits were not directly addressed.  A possible recall bias
cannot be ruled out but seems unlikely given the negative results obtained for cancers other  than
squamous and small cell.  The study provides a useful contribution to investigation of the
relationship between ETS exposure and lung cancer.

A.4.26. SHIM (Tier 2)
A.4.26.1. Author's Abstract
       "A case-control study of Japanese women in Nagoya was conducted to investigate the
significance of passive smoking and other factors in relation to the etiology of female lung cancer.
A total of 90 nonsmoking patients with primary lung cancer and their age- and hospital-matched
female controls were asked to fill in a questionnaire in the hospital.  Elevated RR of lung cancer
was observed for passive smoking from mother (RR = 4.0;  p < 0.05) and from husband's father
(RR = 3.2; p < 0.05).  No association was observed between the risk of lung cancer and smoking of
husband or passive smoke exposure at work. Occupational exposure to iron or other metals also
showed high risk (RR = 4.8; p  < 0.05).  No appreciable differences in food intakes were observed
between cases and controls."
                                           A-113

-------
A.4.26.2. Study Description
       This study was undertaken in Nagoya, Japan, during 1982-85 to investigate the
significance of passive smoking and other factors such as occupational history, domestic heating
system, and dietary habits in the etiology of lung cancer in nonsmoking Japanese women.  All data
were collected specifically for this study, which was limited to never-smokers.
       All subjects were obtained from four hospitals in Nagoya.  Cases are women with primary
lung cancer (of any type) treated in these hospitals between August 1982 and July 1985 who
reported  themselves to be never-smokers and consented to interview.  Controls are women with a
diagnosis other than lung cancer from the same or adjacent wards with controls matched 2:1 with
cases on age (±1 year), hospital, and date of admission. Cases were not restricted to incident
disease, but controls were essentially density-sampled by admission date. Data collection was by
self-administered questionnaire; no attempt at blinding is described. Of 118 female lung cancer
cases treated during the study period, 4 refused to participate in the study and 24 were excluded
as current or former smokers.  Only a single matching control could be found for 17 of the cases.
No other information  on loss of potential controls is provided. There is a total of 90 (163) cases
(controls), with 52 (91) currently married to a smoker. Cases and controls share identical age
ranges (35-81 years) and have nearly identical mean ages (59 years for cases, 58 for controls). All
cases were histologically diagnosed, excluding secondary lung cancers.
       All study subjects are self-reported never-smokers. A number of individual sources of
ETS in the home are considered, including smoking by mother, father, husband, father-in-law,
mother-in-law, offspring, and siblings.  For each of these sources, smoking in the home at any
time constituted exposure.  Workplace exposure was characterized simply as presence or absence;
for other exposures, the number of cigarettes per day was obtained. In addition, data on  length of
marriage, time spent in the same room as the wife,  and total number of cigarettes smoked were
obtained  for husbands.  Exposure data were not checked, and marital status was not considered in
the design or analysis  of the study.  The predominant type of lung cancer is adenocarcinoma
(69 of  90 cases), followed by squamous (13), large cell (4), small cell (3), and adenoid cystic
carcinoma (1).  No data on airway proximity are provided.
       Logistic regression was used to estimate the relative risk  for each source of ETS exposure.
No significant association with lung cancer was noted for smoking by the husband (RR = 1.1),
father  (RR =1.1), husband's mother (RR = 0.8), offspring (RR = 0.8), or siblings (RR = 0.8);
smoking  by the subject's mother (RR = 4.0) and by the husband's father (RR = 3.2), however, are
significant (p < 0.05).  None of eight dietary factors, including green-yellow vegetable and fruit
intake, demonstrated a significant association, nor did type of cooking fuel or frequency of
                                           A-114

-------
cooking oil use.  Occupational history of exposure to iron or other metals shows a moderately
strong but nonsignificant association (RR = 2.8), whereas for use of kerosene, coal, or charcoal
heating there is a mild association (RR = 1.6-1.7).
       Simultaneous stratification by father-in-law's and mother's smoking indicates that the
effects of the two exposures are not additive. Smoking by father-in-law, smoking by mother, and
occupational metal exposure were included simultaneously in a logistic regression model. After
adjusting the effect of each variable for the other two, the relative risk for maternal smoking,
father-in-law's smoking, and metal exposure are 2.1, 3.2 (p < 0.05), and 2.4, respectively. The
authors conclude that the exposure to tobacco smoke from household members (i.e., mother or
husband's father) could be associated with female lung cancer.  Because the precise situation of
passive smoking in the home or other places is still unclear, however, the authors find that further
studies are  needed to clarify the significance of passive smoking in relation to the etiology of lung
cancer in Japanese women.

A.4.26.3. Comments
       This study employs a moderate number of well-matched cases and controls. Their
comparability appears good, as supported by the identical age ranges and similar mean age and
occupational categories for the two groups. A further strength of the study is its lack of reliance
on proxy information with attendant potential for inaccurate recall. Exposure information was
obtained from self-administered questionnaires, which eliminates the possibility of interviewer
bias but  may lead to inaccuracy due to misinterpretation of questions or varying care in their
completion. Such problems with exposure information would tend to mask any actual association.
Lung cancer was histologically diagnosed in all subjects and secondary lung cancers excluded, so
diagnostic accuracy appears good for cases. Control diagnoses, however, were not validated, so
some smoking-related disorders (in addition to the heart conditions noted in 3% of controls) may
be included among the controls, a problem that once again would tend to reduce any observed
association.
       Restriction of subjects to never-smokers maximizes efficiency because effects of passive
smoking would likely be dwarfed by active smoking.  But it is unclear precisely what subjects
were asked about their smoking status.  Were any cut-points regarding past history, duration, or
intensity specified?  Thus, some misclassification of smoking status may have occurred, and if a
greater proportion of persons with smoking family members misreport themselves to be never-
smokers, this would create an upward bias.
                                           A-115

-------
        The authors restrict their assessment of exposure from relatives to at-home smoking,
 which should be more meaningful than total smoking as a potential source of passive smoke
 exposure.  Furthermore, they collected data on smoking habits of all relatives, not just spouses or
 parents, thus reducing the chance of missing an exposure source. On the other hand, there is no
 consideration of total household smoking (all sources combined), cumulative exposure (except for
 husbands), or of pipe or cigar smoking; nor is  there differentiation of current and former
 exposure—all potential sources of exposure misclassification, which would tend to make an
 association more difficult to detect.
        Of the several sources of ETS exposure at home, only the relative risks for smoking by the
 mother and by the father-in-law are suggestive, and both of these are significant (p < 0.05).
 When these sources are considered simultaneously, however, and the effect of each is adjusted for
 the other, smoking by the husband's father remains significant (RR = 3.2; p < 0.05) but the effect
 of mother's smoking is diminished (RR = 2.1)  and is not statistically significant. Exposure from
 the father-in-law is, of course, in adulthood.  There is no evidence of an effect from husband's
 smoking (RR = 1.1), however, and these exposure sources were considered simultaneously so that
 the effect of one could be adjusted for the other. The large number of comparisons (e.g., eight
 groupings of passive smoke exposure, alternative spousal exposure measures, several occupational
 factors, and eight dietary factors) increases the likelihood that an observed relative risk will
 appear to be significant by chance alone (the effect of multiple comparisons).
        Another aspect of the statistical analysis worth noting is that, although cases and controls
 appear well matched on age, hospital, and hospital admission date, these factors are not included
 in an adjusted analysis of the data (aside from  the example  with three sources of exposure
 described above). Consequently, some bias due to these factors is a possibility, although the
 demographic similarities between cases and controls makes a large effect unlikely.
        In summary, this study presents some interesting results.  It finds a strong (adjusted
 RR « 3.2) and statistically significant  association between father-in-law's smoking at home and
 lung cancer and associations for maternal smoking and occupational metal exposure as well. The
 lack of association for any of the other sources of ETS examined could be due to problems with
 exposure assessment and control disease criteria.  Equally, however, given the unclear treatment of
 matching factors in the analysis and the number of variables explored, the few substantial
associations noted might be due to chance, confounding, or  both. Were potential confounders
clearly treated in their analyses,  this study would have made a stronger contribution. As it stands,
the study's data are of moderate utility, providing the number of comparisons and limitations
regarding bias are kept in mind.
                                           A-116

-------
A.4.27. SOBU(Tier2)
A.4.27.1.  Author's Abstract
       "A hospital-based case-control study among nonsmoking women was conducted to clarify
risk factors in nonsmoking females in Japan.  Cases consisted of 144 nonsmoking female lung
cancer patients, and these were compared to 713 nonsmoking female controls. The odds ratios
(95% confidence interval) for use of wood or straw as cooking fuels when subjects were 30 years
old was estimated as 1.77 (1.08, 2.91).  For those whose household members, other than husbands,
had smoked, the odds ratio was estimated as 1.50 (1.01, 2.32). For those whose mothers had
smoked, the odds ratio  was estimated as 1.28  (0.71, 2.31).  Use of heating appliances did not show
an elevated risk. Some points to be noted in this study of low-risk agents for lung cancer are
discussed."

A.4.27.2.  Study Description
       This study was  conducted in Osaka, Japan, to clarify risk factors for lung cancer in
nonsmoking females in Japan. Of interest are the roles of both  active and passive smoking and
other indoor air pollutants, particularly smoke or fumes from sources of indoor cooking and
heating. This article reports only on female nonsmokers in the  study, which is not  matched on
any variables. A very similar article presenting interim results and using slightly fewer subjects
than the one described here is by Sobue and coworkers (1990).
        Cases consist of all newly admitted lung cancer patients in eight Osaka hospitals between
January 1986 and December 1988.  Controls were collected from newly admitted patients in one or
two other wards of the same hospitals during that period.  Almost 90% of the controls were
admitted as cancer patients, about half of whom were diagnosed with breast cancer. Self-
administered questionnaires designed for this study were completed by both cases and controls at
the time of hospital admission. Cases are incident, and control  sampling is density, unmatched
aside from the time of hospital admission (within 1.5 years).  The entire study, including active
smokers and males, consists of 295 (1,079) female  (male) cases and 1,073 (1,369) female (male)
controls.  Nonsmoking females compose 156 cases, of which there was missing information on 12.
The resultant number of ETS subjects is 144 (731) female nonsmoking cases (controls). The age
distribution of the cases (controls)  is as follows: 40 to 49, 20 (238); 50 to 59, 34 (229); 60 to 69, 41
(186); and 70 to 79, 34 (78).  The corresponding percentages are 14 (33), 34 (31), 28 (25), and 24
(11), which indicates that controls  tend to be younger than cases.  Also, the mean age of cases
(controls) is 60 (56).  There was no systematic review of histological diagnosis. All original
diagnoses were confirmed microscopically, however, and  all the pathologists involved in the eight
                                           A-117

-------
participating hospitals were experienced specialists in lung cancer. Thus, the likelihood of
secondary lung cancers among the cases should be small.
       Several sources of ETS exposure are included, all of which occur in the home.  Exposure
in adulthood is expressed by two measures—smoking by the husband and other household
members (the last category consists chiefly of households where the husband's father and/or sons
smoke). Three sources of exposure in childhood are considered—father smokes, mother smokes,
and other household members smoke.  No information is provided on how exposure to spousal
smoking is handled for unmarried women (single, divorced, or separated). The entire complement
of cases and controls is included in the summary data for each of the five sources of exposure
given above. If only married women were included in the study, no mention of it was found.
       The histological data for ETS subjects are not classified by exposure to ETS, but the
percentage of cases by cell type are given:  squamous cell (8), small cell (5), adenocarcinoma (78),
large cell (5), and other (4).  The ETS data on spousal smoking consists of 80 of 144
(exposed/total) cases and 395 of 731 controls, for an odds ratio of 1.13 (95% C.I. = 0.78, 1.63).
(Our calculations give 1.06 [0.74, 1.52].)  The odds ratio for ETS  exposure from other household
members in adulthood is 1.57 (95% C.I. = 1.07,  2.31). (Our calculated values are 1.77 [1.21, 2.58].)
For ETS exposure in childhood by the father, mother, and by other household members, the
respective odds ratios are 0.79 (95% C.I. = 0.52, 1.21), 1.33 (95%  C.I. = 0.74, 2.37), and 1.18
(95% C.I. = 0.76, 1.84). Tests were conducted by the Mantel-Haenszel procedure, with
stratification by age and education (two levels). Analysis by logistic regression, adjusted for age
at time of hospitalization, was conducted for two of the exposure measures described above with
similar outcomes. Based on this evidence, the author concludes that for childhood exposure, a
slight increase of risk was suggested for those with smoking mothers, although statistical
significance was not observed.  For exposure in adulthood, an elevated risk was estimated for
those with smoking household members other than husbands.
       The statistical analysis includes exposure to sources other than ETS, namely, the use of
wood or straw as cooking fuel, the use of heating equipment that pollutes the room with
combustion products, and the use of charcoal foot warmers.  All  exposures considered, including
ETS, are smoke or fumes from products burned indoors. It is concluded that significantly
elevated risks were observed for subjects who had used  wood or straw as cooking fuels at 30 years
of age (OR = 1.89; 95% C.I. = 1.16, 3.06). No elevated risks were found for sources of indoor
heating  (use of kerosene, gas, coal, charcoal, and wood stoves without chimneys). Similarly, no
significance was found for the use of charcoal foot warmers, a practice that was popular until the
1960s.
                                          A-118

-------
A.4.27.3.  Comments
       With 144 cases and 731 controls, the sample size is larger than many of the other
case-control studies on ETS.  Information on cases and controls was obtained by self-administered
questionnaire, which is generally considered less reliable than face-to-face interviews. The
questionnaires were presumably completed by the subjects themselves in all cases, however, which
is preferable to proxy-supplied information. The information supplied was not verified from
other sources, as noted by the authors in reference to testing for biomarkers of exposure to
tobacco smoke (they note that laboratory tests can only detect recent exposure, but they could still
be useful in eliminating current smokers who may misreport themselves as never-smokers).
Although cases and controls were newly diagnosed patients within a short time period in the eight
participating hospitals and were supplied with the same questionnaire, there are still some
questions regarding the comparability of cases and controls and their  representativeness of the
target population.
       Controls tend to be younger than cases:  While mean ages are 56 and 60, respectively, 33%
of controls, compared with 14% of cases, are below the age of 40. Controls also tend to be more
educated than cases, with 69% of controls having completed  10 or more years of education
compared to 52% of cases.  Differences in age and educational level further reflect differences in
lifestyle and socioeconomic status that may affect risk of disease. Also, the controls are
predominantly cancer patients too, almost half with breast cancer, suggesting that the controls may
be a biased sample (as  noted  by the authors).  On  the other hand, exclusion of breast cancer
controls reportedly leaves the results unchanged.  Furthermore, the statistical analysis stratifies on
age and education, so even though cases and controls were not strictly matched on these variables,
the reported results should not be due to confounding by either of these factors.
        Although some of the issues and reservations described above are methodological in nature
and apply  to the study throughout, others are specific to the ETS data alone. For example, one
might expect a question regarding the use of cooking with wood or straw at age 15 and at age 30
to be open to little subjective interpretation or error in recall, presuming that methods of cooking
persisted for several years between  changes within a household.  Although there is some suggestive
evidence of increased lung cancer from ETS exposure, the statistical  evidence may be stronger for
an association between lung cancer and use of wood or straw for cooking at age 30.  Further
support is  provided by the observation that among those who had used wood or straw for cooking
at age 30,  90% had also used those fuels at age 15, suggesting extended exposure in most cases.
The age distribution of those exposed to wood or straw cooking  is not given, but exposure at
                                            A-M9

-------
 30 years of age and before would allow for the long latency expected for lung cancer because 86%
 of the patients are at least 50 years of age.
       The smoke from cooking sources may obscure or distort any impact of ETS exposure
 because the two sources probably contain some of the same carcinogens. The temporal dimension
 of exposure also may be a factor because indoor smoke from cooking may be less common at
 present than 30 years ago in comparison to ETS exposure. Further statistical analysis to adjust the
 effect of ETS exposure for the presence of smoke from cooking might aid interpretation of the
 results in this study.

 A.4.28.  STOC
 A.4.28.1. Author's Abstract
 (Note: This study has not been published. Only the abstract is available, which is given below.)
       "Risk factors for lung cancer among women who  had never smoked cigarettes were
 examined in an ongoing, population-based, case-control  study conducted in Florida. One hundred
 and twenty-four primary carcinomas of the lung and 241 control women who had never smoked
 were  included.  Results suggest that childhood and adult  exposures to environmental tobacco
 smoke may increase the risk of lung  cancer among women who never smoked cigarettes. Having a
 husband who smoked cigarettes resulted in a statistically  significant increase in risk of lung cancer
 among women who had never smoked, with an odds ratio of 1.8 (95% C.I. 1.1, 2.9). A 40%
 increase in  risk was observed among  women with less than 25 years of exposure to a spouse who
 smoked,  when compared with women who reported their spouse had never smoked, with the risk
 increasing to 60% among women exposed 25 years or longer.
       When exposure to tobacco smoke in childhood was considered, the data were less
 consistent.  Having a parent who had smoked during the  respondent's childhood did not increase
 the risk of lung cancer.  However, among those respondents with high levels of exposure to
 parental smoking, an excess risk, although not statistically significant, was observed.  Never-
 smoking  women who accumulated 25 or more exposure years experience a 70% increase in risk
 (OR =* 1.7, 95% C.I. 0.8,  3.6) of lung  cancer compared with women who reported neither parent
 had smoked cigarettes."

 A.4.29. SVEN (Tier 2)
 A.4.29.1. Author's Abstract
       "In a population-based case-control study, the association between female lung cancer and
some possible etiological agents was investigated:  210 incident cases in Stockholm County,
                                         A-120

-------
Sweden, and 209 age-matched population controls were interviewed about their exposure
experiences according to a structured questionnaire.  A strong association between smoking habits
and lung cancer risk was found for all histological subgroups. Relative cancer risk was found for
all histologic subgroups. Relative risk for those who had smoked daily during at least 1  year
ranged between 3.1 for adenocarcinoma to 33.7 for small cell carcinoma in a comparison with
never-smokers. All histological types showed strong dose-response relationships for average daily
cigarette consumption, duration of smoking, and cumulative smoking. There was  no consistent
effect of parental smoking on the lung cancer risk in smokers.  Only 38 cases had never been
regular smokers and the risk estimates for exposure to environmental tobacco smoke were
inconclusive. The high relative risks of small cell and squamous cell carcinoma associated with
smoking may have relative implications for risk assessments regarding passive smoking."

A.4.29.2. Study Description
       This study was undertaken in Stockholm County, Sweden, from 1983 to 1986 to investigate
the association between female lung cancer and some possible etiologic agents, particularly active
and passive smoking.  Because active smoking was an exposure of interest, cases and controls were
not matched on smoking status; thus, the ETS study population is unmatched.
       Cases are  Swedish-speaking women with primary lung cancer from three Stockholm
County hospitals  who were willing and able to be interviewed between September 1983 and
December 1985.  Cases with carcinoid tumors were excluded from the ETS analysis. Both
population and hospital-based control groups were assembled. Population controls were women
randomly selected from the county population register, matched to a case on birthdate and
interviewed between September 1983 and December 1986.  Hospital controls were subjects
originally interviewed as potential lung cancer cases but  subsequently diagnosed with
nonmalignant conditions.  Population controls were enlisted and interviewed as soon as  a case's
diagnosis was confirmed, but because this confirmation took as long as a year after the  interview,
controls were not density sampled.  Unblinded interviews were conducted face-to-face with all
cases (and hospital controls) and 58% of the total population controls; the remainder were
interviewed by telephone.
        After exclusion of 21 potential cases due to initial diagnostic uncertainty,  refusal, or illness
precluding interview, 210 confirmed cases remained. Elimination of  172 ever-smokers and four
subjects with carcinoid or not-microscopically-confirmed tumors left 34 never-smoking cases.
Similarly, 209 population and  191 hospital controls were included in the total study, but a
 combined total of only 174 were never-smokers. The  total case population averaged 62.5 years of
                                           A-121

-------
 age, but no other demographic information regarding cases or controls is provided. All cases used
 in the ETS analyses were histologically or cytologically confirmed primary lung cancers.
        Daily smoking for at least 1 year is the criterion for a smoker; all other persons are
 considered never-smokers.  Pipe and cigar smoking are never specifically addressed. Exposure to
 ETS is calculated for four sources:  mother, father, home, and work.  Having a smoking mother or
 father (at any time during ages 0-9 years) constitutes exposure to that particular source, whereas
 the presence of a smoker at home and work constitutes exposure.  Adulthood and total lifetime
 exposure are considered separately for home and workplace exposure.  Exposure levels are
 arbitrarily scored 1 for nonexposure, 2 for exposure to one source, and 3 for exposure to both
 sources in  trend analyses of never-smokers, where exposures are considered in pairs (i.e., maternal
 and paternal smoking, home and workplace exposure).  No other units of ETS exposure are used.
 Adenocarcinomas constituted 22, squamous cell 5, and small cell 2 of the 34 lung cancers
 occurring among never-smokers in the ETS population; no further histologic details regarding the
 ETS study population are provided.
        To maximize available case numbers, parental smoking was first analyzed among all cases
 and community controls using stratification to adjust for active smoking (cig./day) and age.  A
 risk of 1.8  (95% C.I. = 0.5, 7.0) was estimated for maternal smoking and 0.8 (0.3, 1.4) for paternal
 smoking. A trend analysis in which maternal, paternal only, and no parental smoke exposure were
 scored as 3, 2, and 1, respectively, revealed no indication of trend  (p = 0.9).  Analyses restricted to
 never-smokers used both community and hospital-based controls combined. Among cases
 (controls), for childhood up  through 9 years of age, 3 (5) had smoking mothers, 12 (71) had
 smoking fathers (but not mothers), and 19 (98) were unexposed. This yielded an age-adjusted risk
 estimate of 3.3 for maternal  smoking (with or without paternal smoking) and 0.9 for paternal
 smoking during childhood. Adult exposure at home and at work yielded an estimated risk of 2.1,
 whereas exposure at home or work yielded a risk of 1.2.  For lifetime exposure, the estimated risks
 for exposure as both a child  and adult and as either a child or an adult were 1.9 and 1.4,
 respectively.  None  of these associations were  statistically significant, and no significant trends
 were observed. The authors  conclude that the results pertaining to ETS in the present study were
not conclusive. The small number of never-smokers among the cases could be  one important
reason.  It should be noted, however, that most of the point estimates of relative risk were greater
than unity, which agree with results from previous studies on ETS exposure and with risk
estimates concerning active smoking.
                                          A-122

-------
A.4.29.3. Comments
       This study was undertaken to explore the role of active as well as passive smoking in lung
cancer.  After exclusion of active smokers, the available number of cases is too small to yield,
much statistical power.
       Cases and population-based controls were initially matched on date of birth, but this
matching was abandoned in the ETS analysis; furthermore, unmatched hospital-based controls are
combined with the population-based controls in most analyses to boost available  numbers. The
comparability of these groups is thus unclear, and the authors provide no demographic
comparisons to facilitate assessment of this potential problem. The reported similarity of results
using only population-based controls is reassuring, but no details are provided as to how similar
results actually were.
       Diagnostic misclassification of  cases is unlikely, given the histological or  cytological
confirmation of all  cases and exclusion of secondary cancers. All cases were interviewed face-to-
face, but 42% of controls were interviewed by telephone.  The accuracy of responses may thus be
lower for controls than for cases. In addition, because interviews were not conducted blindly,
inflation of estimated associations through interview bias is possible. A potential bias is also
introduced by the rather large amount  of active smoking required for classification as an ever-
smoker.  This allows considerable active smoking among persons in the never-smoker group, the
effect of which could mask an effect of passive exposure, or, if co-varying positively with passive
smoking, cause overestimation of association.
       The first set of analyses of paternal and maternal smoking includes ever-smokers while
attempting to adjust for active smoking on the basis of average daily cigarette consumption. The
adequacy of this adjustment is questionable given the large estimated risks associated with active
smoking relative to those posited for passive smoking, so the elevated estimated risks for maternal
smoking obtained in these analyses are of questionable validity.
       Restriction  of the analyses to never-smokers similarly produces an elevated odds ratio for
maternal smoking of 3.3, but the numbers involved (three cases and five controls) are so small that
this value is quite unstable. A pattern of  increasing estimated risk with increasing sources of
exposure (at home or at work) as an adult and increasing periods of exposure (in childhood or
adulthood) over the lifetime is suggestive  of an association between lung cancer  and  ETS, but
again small numbers preclude statistical significance of these results.
       Restriction  of the study population to females rules out the possibility of a gender-related
effect.  The likelihood of an ethnicity  effect is reduced by restriction to Swedish-speaking
residents of Stockholm County, and age is reportedly controlled for in all analyses.  No other
                                            A-123

-------
 potential risk modifiers are addressed. For example, marital status is not considered in the
 analyses of spousal smoking, leaving open the possibility that nonsmoking-related differences
 between married and unmarried women contributed to the observed association.  The reported
 similarity of results when only population controls were used instead of hospital and population
 controls combined provides a general argument against bias due to source of controls, although no
 specifics regarding the degree of similarity were supplied.
        In summary, this study presents consistent evidence of associations between lung cancer
 and maternal, home, and workplace passive smoking exposure. Limited numbers preclude
 statistical significance, and interviewer bias or effects due to dietary or other factors cannot be
 ruled out as contributors to the observed results. Bearing these limitations in mind, the study's
 results are inconclusive but (excluding the analyses that include active smokers) do make a useful
 contribution to the pool of information available regarding ETS and lung cancer.

 A.4.30.  TRIG (Tier 3)
 A.4.30.1. Author's Abstract
       "Fifty-one women with lung cancer and 163 other hospital patients were interviewed
 regarding the smoking habits of themselves and their husbands.  Forty of the lung cancer cases
 and 149 of the other patients were nonsmokers. Among the nonsmoking  women, there was a
 statistically significant difference between the cancer cases and the other patients with respect to
 their husbands' smoking habits. Estimates of the relative risk of lung cancer associated with
 having a husband who smokes were 2.4 for a smoker of less than one pack and 3.4 for women
 whose husbands smoked more than one pack of cigarettes per day.  The limitations of the data are
 examined; it is evident that further investigation of this issue is warranted."

 A.4.30.2. Study Description
       This study was undertaken in Athens, Greece, to investigate the relationship of spousal
 smoking and  lung cancer.  All female Caucasian Athenian residents admitted to, one of three  chest
 or cancer hospitals in Athens  and assigned a final diagnosis of lung cancer other than
 adenocarcinoma and alveolar  carcinoma from September 1978 through June  1980 were
 interviewed by a physician. Controls were gathered from nonsmoking female Caucasian Athenian
 patients hospitalized during the same time period in the Athens Orthopedic Hospital. Some
prevalent cases were thus presumably included, so control sampling probably approximated a
density approach but did not strictly conform to one.
                                          A-124

-------
       Diagnostic information was obtained from patients' charts. Exposure information was
obtained by face-to-face unblinded interviews conducted by the same physician for all subjects.
A total of 51 cases and 163 controls were interviewed.  Of these, 11 cases and 14 controls reported
themselves to be active smokers, leaving 40 cases and 149 controls as ETS subjects. No interview
refusals are reported.  Mean age of cases (controls) is 62.8 (62.3) years. Husband's education was
marginally higher in controls than cases, with 63% and 58% of spouses having completed primary
school, respectively. No other demographic comparisons are  reported for the ETS subjects alone.
For the sample population including smokers, factors such as age, duration of marriage,
occupation, education, and urban versus rural residence are all similar for cases and controls,
except once again educational level is slightly higher for controls.  There is no  indication that
verification of diagnosis or exclusion of secondary lung cancers was undertaken in cases. Of the
51 total cases, 14 were diagnosed histologically, 19 cytologically, and 18 by radiological or clinical
means.  No breakdown is given for the ETS subjects alone.
       The study classifies as nonsmokers both reported never-smokers and former smokers who
quit more than 20 years ago. It is not mentioned whether cigar and pipe smoking are considered
as sources of exposure. Nonsmoking women are considered exposed to ETS if they are married to
a man classified as a smoker. The  average number of cigarettes smoked per day by the husband
and the number of years of marriage are used to estimate the total number of cigarettes smoked by
the husband during marriage.  No data on childhood or nonspousal ETS exposure  were collected.
Single women are grouped with women married to a nonsmoker and are thus considered
unexposed. Widowed or divorced women were classified according to their former husband's
smoking status on the assumption that smoking stopped at death or divorce.  No checks of
exposure information are reported.
        For ETS subjects, the number of cases (controls) exposed  over the total is  29 to 40
(78/149). The crude odds ratio calculated by the reviewers is 2.4 (95% C.I. = 1.12, 5.16). The
results presented in the article are all stratified by level of husband's smoking. The odds ratios are
1.8, 2.4, and  3.4 when the husband is a former smoker, smokes 1  to 20 cigarettes per day, and
smokes 20 or more cigarettes per day, respectively.  No confidence intervals are given, but a test
for upward trend was statistically significant (p < 0.02).  When ETS exposure is estimated by total
number of cigarettes smoked during marriage, odds ratios (1.3, 2.5, and 3.0) increase with
cumulative exposure (1-99,  100-299, and 300+ thousand, respectively).  The upward trend remains
statistically significant at p < 0.02.  No analyses adjusted for age or other factors.  With regard to
age and other demographic variables, the authors conclude from the similarity of cases and
controls that it is not necessary to stratify for these variables in the analysis, particularly because
none is significantly associated with smoking in the study.
                                            A-125

-------
       The authors note that this study has obvious limitations and is offered principally to
suggest that further investigation of this issue should be pressed. Most seriously, the numbers of
cases are small.  Nevertheless, the association is in the direction expected if passive smoking is
related to lung cancer, and the outcome is unlikely to be due to chance. Other limitations noted
include the high percentage (35%) of cases lacking cytology and the selection of controls from a
hospital different from those of the cases; it is argued, however, that neither of these appears to
be consequential. The observation is made that it is potentially easier to detect an effect of
passive smoking in the Greek population  than in most Western populations, because in the latter
groups, the overwhelming effects of active smoking, together with the high correlation between
smoking habits of spouses, would tend to confound and conceal the lesser effects of passive
smoking.

A.4.30.3.  Addendum
       In a letter to the editor of Lancet  in 1983, Trichopoulos et al. released a data table derived
from extension of subject collection through December 1982. This nearly doubled the sample size
used in the 1981 publication, yielding 77  nonsmoking cases (102 total)  and 225 smoking controls
(251 total).  The crude odds ratio  calculated by the reviewers is 2.08 (95% C.I. =  1.20, 3.59). The
results for the expanded study show very little change; (estimated) relative risks  when husbands
are former smokers (1-20 cig./day and >  20 cig./day) compared with nonsmokers are 1.95,  1.95,
and 2.54, respectively. The test for upward trend in the dose-response is significant (p = 0.01).
No other analyses are presented.

A.4.30.4.   Comments
       This study was conceived  and undertaken to explore the association of spousal smoking
with lung cancer and does not rely on a preexisting data set.  Thus, the investigators were in a
position to design their selection and data collection to maximize the strength of their findings.
This did not, however, prevent the appearance of some design and analytical flaws.
       Demographics of the total case and control populations are very similar.  All subjects in
the spousal smoking analysis are resident  Athenian nonsmoking women hospitalized in  the same
area of Athens; case and control groups have very similar mean ages, and their husbands are
comparable in education.  Thus, the groups probably have good demographic comparability,
although it would have been helpful if the detailed demographic comparisons were focused on the
nonsmokers alone.  Most of the controls (108 out of 163) were being treated for fractures, a
relatively minor and nonchronic illness compared with lung cancer, which may make them more
                                           A-126

-------
representative of the general community than of hospitalized patients as a whole. This should
reduce the problem of inclusion of smoking-related illnesses in the control group.
       Although the researchers sought to exclude adenocarcinomas and alveolar carcinomas,
presumably considering these would be less smoking related, nearly two-thirds of the cases were
not histologically confirmed, so an indeterminate number of these cell types was probably
included.  More important, the infrequency of histologic confirmation and lack of mechanisms to
verify diagnoses or primary tumor status introduces potential for misclassification.  The likely
effect is a bias toward no association.
       The researchers  clearly devoted considerable thought to the smoking and exposure criteria,
particularly with regard to  changes in smoking and marital status over time.  Single women were,
however,  automatically  classified as unexposed. The authors contend that this is warranted by the
traditional nature of Greek society and report that analyses restricted to married women result in
similar, and still statistically significant, associations, although with somewhat lower estimated
risks. There  is a small reduction in the odds ratios after exclusion of single women, however, and
the restriction of the full analyses and results to married women may have been useful.
        Another issue related to exposure concerns inclusion of former smokers in the study,
provided  they had not smoked for at least 20 years. Active smoking 20 to 30 years before the
onset of lung cancer may be of etiological relevance, however, in view of a long latency period for
lung cancer.  Although  use of the same interviewing physician for  all subjects eliminates the
problem of interobserver variability, it leaves open the potential problem of  interviewer bias in
exposure  assessment, presumably toward a positive association, because the interviews were
apparently conducted unblinded (virtually unavoidable with regard to diagnosis, given that
controls were drawn from orthopedic trauma and rheumatology wards).
        A larger concern, however, is the potential effect of risk factors or modifiers not
addressed in the analysis. The authors contend that the similar distribution of demographic
variables  between cases and controls eliminates the need to consider these variables in the
analyses,  but adjusting  for relevant variables is recommended even in a matched study (see Section
5.4.1).  More convincing is the contention that these variables were not significantly associated
with smoking in these data, although no specifics are included.  The appearance of a statistically
significant trend for ETS exposure measured by either current spousal smoking or cumulative
cigarette  consumption during marriage lends further support to an association between spousal
smoking and increased  lung cancer incidence. Potential factors such as diet, cooking, and heating
practices, however, are not addressed.
        Overall, the issues addressed above would probably produce a conservative bias, resulting
in an underestimate of  the degree of association.  The study's basic design is sound. It provides
                                            A-127

-------
statistically significant evidence of dose-response, and although the limitations described above
should be borne in mind, it provides useful data for assessment of the relationship between ETS
and lung cancer.

A.4.31. WU(Tier2)
A.4.31.1. Author's Abstract
       "A case-control study among white women in Los Angeles County was conducted to
investigate the role of smoking and other factors in the etiology of lung cancer in women. A total
of 149 patients with adenocarcinoma (ADC) and 71 patients with  squamous cell carcinoma (SCC)
of the lung and their age- and sex-matched controls were interviewed. Personal cigarette smoking
accounted for almost all of SCC and about half of ADC in this study population.  Among
nonsmokers, slightly elevated RRs for ADC were observed for passive smoke exposure from
spouse(s) (RR =*  1.2; 95% C.I. =  0.5, 3.3) and at work (RR = 1.3; 95% C.I. = 0.5, 3.3). Childhood
pneumonia (RR  = 2.7; 95% C.I.  =  1.1, 6.7) and childhood exposure to coal burning (RR = 2.3;
95% C.I. = 1.0, 5.5) were additional risk factors for ADC. For both  ADC and SCC, increased risks
were associated with decreased intake of /3-carotene foods but not for total preformed vitamin A
foods and vitamin supplements."

A.4.31.2.  Study Description
       This study was  undertaken in California during 1981 and 1982 to investigate the role of
smoking and other factors in the etiology of lung cancer in women.  These other factors included
prior lung disease, coal heating and cooking, diet, and occupation. Both active and passive
smokers are included; some of the ETS analyses retain active smokers while attempting to adjust
for smoking status.
       Cases are white female English-speaking Los Angeles County residents under 76 years of
age at time of diagnosis with primary adenocarcinoma or squamous cell cancer of the lung
between April 1, 1981, and August 31, 1982. Cases are restricted  to U.S.-, Canadian-, or
European-born individuals with no history of prior cancer other than nonmelanoma skin cancer.
Controls are density sampled, matched individually on  neighborhood and age (±5 years), and
meet all case criteria (except, of course, diagnosis of lung cancer). The L.A. County tumor
registry was used to identify incident cases for inclusion in the study, whereas controls were
recruited house to house. Interviews to obtain exposure data were conducted by telephone with
participating subjects, apparently unblinded.
                                          A-128

-------
       A total of 490 eligible cases were identified; 270 were not interviewed because they were
too ill or had died (190), their physician refused permission to contact them (28), they could not
be located (8), or they refused (44).  Those not interviewed did not differ significantly from those
interviewed with regard to age or their marital, religious, or smoking status as recorded on
registry records.  Refusals eliminated 70 potential controls. The case and control populations had
nearly identical mean ages for adenocarcinoma, 59.7 versus 59.5 years, respectively, and for
squamous cell cancer, 61.4 versus 61.1 years, respectively.  No other demographics are provided.
Histologic diagnoses were obtained for all cases.
       For spousal smoking, exposure constitutes having a spouse who smoked while living with
the subject. For workplace smoke, exposure is based on the opinion of the subject. It is not clear
whether for the lung cancer analyses, parental smoking refers only to adult life (as for spousal and
workplace exposure) or to the childhood and teen years (as was stipulated for coal and preadult
lung disease exposures).  Adult life seems most probable.  Units of exposure for spousal and
parental smoking are cigarettes per day and years of exposure, apparently entered into a regression
model as a combined variable; for occupational exposure, units are in  years of exposure. Exposure
data were apparently not checked, treatment of cigar and pipe smoking is never mentioned, and
no results are reported  for household smoking aside from spouse and parents, although
information on this exposure was collected. Never-married women were excluded from the
spousal smoking analysis, but marital status was not otherwise considered in the analyses. The
only histologic or airway proximity information provided for the ETS subjects is that 29
adenocarcinomas occurred among nonsmokers, 12 of which were bronchoalveolar.
       The total study population includes 220 cases and an equal number of matched controls.
Of the cases, 149 are adenocarcinoma and  71 are squamous cell. Nonsmokers constituted 29 of the
adenocarcinoma cases and 62 of the corresponding controls, while composing 2 of the squamous
cell cases and 30 of the controls. No raw data are presented regarding passive smoking and lung
cancer. Logistic regression analysis of matched pairs was used in all calculations. Results
restricted to nonsmokers are presented only for adenocarcinoma. An estimated relative risk of 1.2
is found for spousal smoking, 1.3 for workplace exposure, and 0.6 for smoking by either parent.
None of these estimates was statistically significant.  Exposure from spouses and at work,
however, shows a dose-response trend with years of exposure, yielding estimated relative risks of
1.0,  1.2, and 2.0, for 0, 1 to 30, and 30 or more years of exposure, respectively.
        Analyses that include active smokers but attempt to adjust for them by including the
number of cigarettes smoked per day and age at start of smoking in a logistic regression model are
presented for both lung cancer types.  For adenocarcinoma, estimated relative risks for maternal,
paternal, spousal, and workplace exposure of 1.7, 1.3, 1.2, and 1.2,  respectively, were obtained.
                                           A-129

-------
For squamous cell cancer, maternal, paternal, spousal, and workplace relative risks are 0.2, 0.9,
1.0, and 2.3, respectively. None of these estimates is statistically significant.
       History of lung disease at least 5 years prior to diagnosis of lung cancer reportedly had no
significant association with lung cancer.  History of lung diseases before age 16 yielded a
significant association for pneumonia (RR = 2.7 [95% C.I. = 1.1, 6.7] for adenocarcinoma and
RR « 2.9 [95% C.I. = 0.5, 17.4] for squamous cell cancer) but not for six other diseases.
       Heating or cooking with coal during the childhood and teenage years is also significantly
associated with lung cancer (RR = 2.3 [95% C.I. = 1.0, 5.5] for adenocarcinoma and RR =1.9
[95% C.I. - 0.5, 6.5]  for squamous cell). Among dietary factors, low beta carotene consumption is
significantly associated with adenocarcinoma (RR = 2.7) and mildly associated with squamous cell
(RR - 1.5). Diets low in dairy products and eggs have similar relative risk values. No significant
associations were noted for vitamin A consumption, occupation, or other health history factors not
previously considered.
       The authors conclude that the etiology of squamous cell carcinoma can be explained almost
entirely by cigarette smoking. Cigarette smoking, however, explains only about half of the
adenocarcinoma cases. On the basis of this study, childhood lung disease and exposure to coal
fires in childhood explain at least another 22% of adenocarcinoma cases.  Passive smoking and
vitamin A may be involved, but more research is needed to clarify their roles in lung cancer
etiology.

A.4.31.3.  Comments
       This study took particular care with its treatment of case and control assembly. Extensive
inclusion criteria extending to both groups, matching not only on age but neighborhood of
residence, and retention of matching through analysis all bode well for comparability of cases and
controls.  The virtually identical mean ages of cases and controls indicate the success of these
efforts. In addition, exclusive use of incident cases reduces the potential for selection  bias, and
density sampling of controls reduces potential problems with temporal variation.  The only real
fault in the treatment of cases and controls is the failure to provide any demographic comparison
other than for age, thus denying concrete confirmation of the expected high case-control
comparability.
       Case diagnoses are likely to be  accurate, because all were histologically diagnosed, making
misclassification unlikely and making cell-type-specific analyses possible.  Although no one
pathologist or team verified these determinations, the authors note that there is generally good
interobserver agreement for the cell types included in this study.  Potentially eligible cases not
                                           A-130

-------
interviewed due to illness, refusal, or other reasons did not differ significantly in demographic or
smoking status from those actually interviewed, again arguing against biased selection.
       No proxy interviews were used, and all subjects were English-speakers, enhancing the
chances of obtaining accurate exposure information. On the other hand, interviews were by
telephone—possibly decreasing accuracy relative to face-to-face interviewing—and apparently
unblinded, thus introducing possible interviewer bias toward positive results.
       Collection of exposure data seems generally adequate, except that treatment of pipe and
cigar smokers is not described. This is coupled with an uncertain definition of parental smoking
and lack of treatment of household smokers other than parents or spouses in the analyses, despite
collection of data on this point. These uncertainties probably translate into nondifferential
exposure misclassification, biasing results toward the null.
       The analyses suffer from the common problem of restricted numbers of nonsmoking
cases—29 for adenocarcinoma and only 2 for squamous cell. Some factors examined are restricted
to nonsmokers alone for adenocarcinoma, but for most analyses, an adjustment for active smoking
by logistic regression modeling was  attempted. The adequacy of such adjustment may be
questionable. For adenocarcinoma,  however, the results for passive smoking were very  similar,
regardless of whether restriction or  adjustment was used. Further, a dose-response pattern was
seen for cumulative years of spousal and workplace exposure among nonsmokers. The results of
the analyses for squamous cell are too unstable to be meaningful, given the paucity of cases.
       The findings of substantial associations between lung cancer (or, at least, adenocarcinoma)
and childhood pneumonia and coal burning are of interest.  It must be borne in mind that seven
adult respiratory diseases (including pneumonia) as well as six other childhood respiratory diseases
were examined, so the possibility that the pneumonia association was an artifact of multiple
comparisons cannot be ruled out. History of hysterectomy and multiparity showed nearly    ;,.
significant associations with adenocarcinoma, but it is not clear how many other health  history
factors also were considered. Coal burning has been associated with lung cancer in several other
studies. Similarly, as in several other  studies, one found an association with low beta carotene
intake, but there was no evidence of a dose-response gradient, and no significant association was
found  for preformed  vitamin A.  The strongest association with a dietary factor was actually that
for low intake of dairy products and eggs, which showed a  consistent dose-response pattern.  The
use of a matched-pair analytical approach controls for effects of age or neighborhood, which also
reduces the likelihood of neighborhood-related factors such as socioeconomic status as major
sources of bias.  Confounding due to active smoking can be ruled out in the passive smoking
results for adenocarcinoma and is not likely  in regard  to other factors given adjustment for this
variable in all analyses. Likewise, the authors report that adjustment for childhood pneumonia,
                                           A-131

-------
coal burning, and beta carotene intake did not alter their results. Strangely, however, no
adjustment for dairy product and egg intake—the dietary factor with the most convincing
association with lung cancer in their data—was carried out.
       Overall, this study's results are consistent with a mild association between spousal  and
workplace ETS exposures and lung adenocarcinoma, although they support no such association for
parental smoking.  In addition, the study raises childhood pneumonia, coal burning during early
life, low intakes of beta carotene, and low intake of dairy products and eggs as potential moderate
risk factors that should be considered by future studies.  The results for squamous cell carcinoma
are uncertain given the small number of nonsmoking cases available, and in all instances,  they lack
statistical  significance due to sample size limitations. Thus,  the study provides useful information
on the relationship of adenocarcinoma of the lung with ETS and a number of other factors;
information regarding squamous cell cancer is of less utility for the objectives of this report.

A.4.32. WUWI (Tier 4)
A.4.32.1.  Author's Abstract
       "A case-control study of lung cancer involving interviews with 965 female patients and
959 controls in Shenyang and Harbin, two industrial cities that have among the highest rates of
lung cancer in China, revealed that cigarette smoking is the  main causal factor and accounted for
about 35% of the tumors among women.  Although  the amount smoked was low (the cases
averaged eight cigarettes per day), the percentage of smokers among women over age 50 in these
cities was nearly double the national average.  Air pollution  from coal burning stoves was
implicated, as risks of lung cancer increased in proportion to years of exposure to Kang and other
heating devices indigenous to the region. In addition, the number of meals cooked by deep frying
and the frequency of smokiness during cooking were associated with risk of lung cancer.  More
cases  than controls reported workplace exposures to coal dust and to smoke from burning fuel.
Elevated risks were observed for smelter workers and decreased risks for textile workers.  Prior
chronic bronchitis/emphysema, pneumonia, and recent tuberculosis contributed significantly to
lung cancer risk, as did  a history of tuberculosis and lung cancer in family members. Higher
intake of  carotene-rich  vegetables was not protective against lung cancer in this population. The
findings were qualitatively similar across the major cell types of lung cancer, except that  the
associations with smoking and  previous lung diseases were stronger for squamous/oat cell cancers
than for adenocarcinoma of the lung."
                                           A-132

-------
A.4.32.2.  Study Description
       The objective of this study was to evaluate the role of potential risk factors for lung
cancer in Harbin and Shenyang, two cities among those with the highest mortality rate for lung
cancer in China. Active smokers are included in the cases, so data on ETS subjects constitute a
subset of the whole study.
       Cases consist of female residents under age 70 newly diagnosed with primary lung cancer
in about 70 participating hospitals in Harbin and Shenyang between 1985 and 1987.  Controls are
female residents randomly selected from the general population of these cities and frequency
matched by 5-year age group to the  age distribution of female lung cancer cases reported in the
cities in 1983.  Trained interviewers collected  information on smoking habits, diet, cooking and
heating practices, and other factors from subjects in face-to-face unblinded interviews.
       A total of 1,049 qualifying cases were  found, including both ever-smokers and
never-smokers, of which 405 were diagnosed by histology, 309 by cytology, and 351 by radiology
or clinical means. (Note: These diagnostic numbers  do not total 1,049. The 351 figure may be
intended to be 251, which would give a total of 965 diagnoses, about the number of cases
interviewed.) Of these,  85 either died prior to interview, refused to participate, or could not be
located. Mean age of participating cases was 55.9 years, whereas that of the 959 controls was 55.4
years.  Nonsmokers compose 417 of  the interviewed  cases and 602 of the controls.
       A smoker is defined as a person who has smoked cigarettes for 6 months or longer, so a
nonsmoker apparently may have smoked for up  to 6 months.  Information on all types of tobacco
products smoked was collected. Sources of  ETS exposure include smoking by any household
cohabitant and smoking by individuals (spouse, mother, and father) over the course of the
subject's lifetime.  Exposure at the workplace is also addressed. ETS exposure in the home is
expressed in terms of cigarettes per day and number of years smoked; no units of measurement
are used for workplace smoking. No checks on exposure data were undertaken. Marital status of
subjects is not discussed. Of the cases with histological or cytological data, adenocarcinomas
compose 310 (41.7%), squamous cell cancers 201 (28.9%), small and oat cell cancers 117 (16.8%),
and large cell or unspecified types 66 (9.5%).  No data on airway proximity or diagnostic
breakdowns limited to nonsmokers are provided.
       Statistical analyses of potential risk factors, including ETS, largely include data on active
smokers and then adjust for the effect due to  smoking by logistic regression, along with  other
potential confounders such as age, education,  and location (Shenyang vs. Harbin). These analyses
indicate no increase in risk from household sources of ETS, with estimated  relative risks of 0.8
(household cohabitants), 0.9  (spouse), 1.0 (mother), and  1.0 (father).  The estimated risk  for
                                           A-133

-------
workplace exposure is nonsignificant (RR = 1.2). Restriction of analyses to ETS subjects alone
(i.e., only the nonsmokers) produced similar results, with estimated relative risks of 0.7 for general
cohabitant, 0.7 for spouse, 0.9 for mother,  1.1 for father, and 1.1 for workplace exposure.  The
ETS exposure from spousal smoking is significantly low (i.e., associated with a decrease in lung
cancer by this analysis, as apparent from the confidence interval; RR = 0.7; 95% C.I. = 0.6, 0.9).
       The smoking-adjusted analyses indicate associations with lung cancer for several types of
heating devices, including kangs (brick beds heated by pipes from the stove or by burners directly
underneath), coal stoves, and heated brick walls or floors. The risk associated with the use of
burning kangs (those heated by stoves underneath) shows an upward trend with years of use,
becoming statistically significant at 21  or more years of use (RR = 1.5; 95% C.I. = 1.1, 2.0).
Significantly elevated risks are also associated with use of heated brick walls or floors (RR = 1.5
[1.1, 2.1] for 1-20 years of use; RR = 1.4 [1.1, 1.9] for > 20 years). Nonsignificant increases in
risk are noted for use of kangs of all types, coal  stoves, and coal burners; nonsignificant
reductions in risk are indicated for noncoal stoves and central heat. Deep-frying cooking at least
twice a month and eye irritation during cooking are both significantly associated with lung cancer,
as are regular intake of animal protein and fresh fruit.  (Note:  Multiple comparisons may be a
factor for the apparent significance of some items, as discussed further in the next section.)
       The authors find no overall association between lung cancer and ETS  exposure.  On the
other hand, coal burning, exposure to cooking oil fumes, and chronic lung disease all may be risk
factors. Consumption of beta carotene shows no evidence of a protective effect. Overall, active
smoking is the major cause of lung cancer among women in the regions sampled.

A.4.32.3.   Comments
       The sample size is impressive, with ETS exposure data available for nearly  1,000 cases
including smokers and more than 400 cases when restricted to nonsmokers, thus providing
substantial statistical power. All subjects are women recruited from two industrial cities in
northeast China, reducing potential for complications due to regional or urban-rural differences.
Nearly all of the hospitals in these cities were involved, all cases occurring in these hospitals were
targeted, and the rate of participation among eligible cases was high; thus  potential for selection
bias is minimized. The effective case recruitment in combination with the use of general
population controls maximizes generalizability of the study's results for northeast China.  It would
have been useful, however, to present the results for the two component study locations
separately. Although coordinated in planning and execution, there are two separate study
                                           A-134

-------
locations, and the sources of heterogeneity between them tends to be obscured when results are
combined.
       Unfortunately, the study's results with regard to ETS are more limited than the strengths
listed above might suggest.  The inclusion of age, education, and city as control variables in all
analyses is laudable, thus eliminating the possible influence of these factors. The attempt to
control for potential sources of confounding that may be causally related to lung cancer by
statistical methods, however, is less certain.  Although some analysis was conducted with  data for
active smokers included, to the authors'  credit they also analyzed data for ETS subjects alone (i.e.,
with the data for active  smokers removed), which is the surest way to control for confounding by
active smoking.  Other potential causes of lung cancer (e.g., air pollution from coal-burning
stoves, smokiness during cooking, and deep-fat frying foods) also need to be taken into account in
an analysis of ETS.  This cannot always be accomplished effectively by statistical methods,
particularly when there  are multiple risk factors to be taken into account that are variable, poorly
measured, and possibly more potent risk factors than ETS may be.
       A case-control study is ideally designed and  executed under conditions where cases and
controls are as comparable as possible aside from the factor of interest, such as ETS exposure.
The presence of other risk factors may tend to  pollute and  obscure, much like the contamination
of a laboratory experiment.  In this same sense, the presence of indoor sources of smoke other
than ETS may contaminate an environment for measuring ETS effects because the non-ETS
smoke likely contains many of the same  carcinogens as ETS, and possibly in much larger
quantities, depending on the relative levels of exposure.  Other factors outside the home,  such as
workplace exposure to coal dust and to smoke from burning fuel that was reported more  often in
cases  than controls, contribute to the potential confounding in a similar way. Consequently, a
credible analysis of ETS requires being able to  adjust for these likely confounding factors
satisfactorily, and the ability to do that depends on precise measures of all exposures as well as the
presence of substantial numbers of subjects for various exposure combinations. That kind of
statistical analysis is not given  in the article, and it does not appear to have been possible, based
on conversations with the authors (Wu-Williams and Blot) and the text of the article: "Despite the
large  size of our study, we were unable to clarify the magnitude of risks due to passive smoking,
recognized as a cause of lung cancer around the world (U.S. DHHS, 1986). Perhaps in this study
population the effects of environmental  tobacco smoke was obscured  by the rather heavy
exposures to pollutants from coal-burning  Kang, other indoor heating sources, and high levels of
neighborhood air pollution (Xu et al., 1989)."
       The potential rate of non-ETS sources of indoor air pollution, particularly coal
combustion, appears exceptionally .strong in the study area. For example, a case-control study of
                                          A-135

-------
primary lung cancer in urban Shenyang residents aged 30-69 in 1985-87 reports that the age,
education, and smoking-adjusted OR for kang use among women ranges from 1.9 to 3.4, the latter
figure being for the higher exposure level (at least 50 years of use). Fully 44% of the controls and
55% of the cases are at the highest exposure level, and only 3% of controls and less than 1% of
cases have no exposure. Benzo[a]pyrene levels in 30 homes sampled during the winter averaged
60 ng/m3, which is 60 times the U.S. recommended limit, and indoor measurements in single and
two-story homes were even higher (Xu et al., 1989).  Abstracts of two papers published in Chinese
indicate that similar conditions exist in Harbin. Sun (1992) found a smoking-adjusted OR for soft
coal use of 2.26 with a highly significant trend for duration of exposure among female residents.
Also, Wang (1989) reports ORs of 10.6 for high coal consumption and 15.2 for "indoor smog
pollution in winter" among females in Harbin. It is noted that winter levels of benzo[a]pyrene are
26.7 times higher in residents' bedrooms than outdoors, suggesting that indoor coal combustion
may even be more of a problem in Harbin than Shenyang.
       The multivariate analysis reported in the article reinforces the viewpoint that any ETS
effect may be dominated by the presence of other risk factors. In that analysis, variables were
allowed to enter a logistic regression model in the  order of their explanatory value (a stepwise
regression exercise in statistical terminology). The order of entry into the model is deep frying,
eye irritation,  pneumonia, household tuberculosis, burning kang, self-reported occupational
exposure to burning fuel, passive smoking,  and heated brick wall or floor. Passive smoking, in
this exercise, is significant (p < 0.05) but in the direction of reducing lung cancer, not
contributing to it.  The 0.05 value, however, is not fully meaningful as a significance level for
ETS, because of the stepwise procedure used (the same data used in the construction of a model is
used for testing variables in the model) and because of the likely confounding between ETS and
other variables.  Note, for example, that passive smoking entered the model ahead of heated  brick
wall or floor, which is highly significant when analyzed alone, whereas passive smoking is not.
       The evidence for association of lung cancer with burning coal and deep-frying foods is
particularly provocative, as it indicates two factors that may play a substantial role in the etiology
of lung cancer in northeast China and, hence, in other areas as well where such practices occur.
The associations noted with other factors are also of interest, but their importance is undermined
by the problem of multiple comparisons.  In the table presenting results for dietary factors, for
example, 26 risk estimates are computed, 4  of which are significant at the 5% significance level
(for a two-sided test, 2.5% level for the test of an effect), only one more significant finding than
expected due to chance alone.
       Being somewhat speculative, the use of cases age 70 and below may be a factor.  Wells
(1988) showed that about one-half of the female passive smoking deaths occur after age  70 for the
                                           A-136

-------
studies included in that reference.  If ETS is a risk for lung cancer and if individual susceptibility
to lung cancer is a factor, some of the stronger risk factors such as coal burning and cooking oil
may have caused lung cancer in the more susceptible subjects before passive smoking had a
chance to exert itself.
       In summary, this large and basically well-executed study observed no significant
association between exposure to ETS from cohabitants, spouse, parents, or workplace and lung
cancer.  Lack of control for a number of other significant risk factors identified in the study
undermines these results, however.  The associations with coal burning for heat and oil frying are
particularly notable. Use of the heating devices most strongly linked with lung cancer is
presumably more common in colder northern regions, whereas stir-frying may be more
widespread in Asian communities, without regard to climate. Thus, this study was exploratory,
designed to generate hypotheses rather than to test the specific hypothesis that ETS exposure is
associated with lung cancer.  It identifies a number of potential  risk factors for consideration in
future studies.  The prevalence of these factors in the study population combined with the lack of
analysis of their association with ETS exposure, however, renders the  results for ETS inconclusive.
                                            A-137

-------

-------
             APPENDIX B






METHOD FOR CORRECTING RELATIVE RISK




    FOR SMOKER MISCLASSIFICATION

-------

-------
               APPENDIX B.  METHOD FOR CORRECTING RELATIVE RISK
                           FOR SMOKER MISCLASSIFICATION

B.I. INTRODUCTION
       The purpose of this appendix is to present the details of the method used in Section 5.2.2.
to correct observed passive smoking relative risks for the systematic upward bias caused by
misclassification of some smokers as never-smokers. The method used is that proposed by A. J.
Wells and W. F. Stewart (Wells, 1990) with minor modifications, including an adjustment for
passive smoking risk to smokers. This appendix covers the following:  the principles of the
method (Section B.2); how the method differs from those previously used by the National
Research Council and P. N. Lee (Section B.3); the data used to calculate the misclassification
factors and other parameters (Section B.4); the mathematical model used to calculate the corrected
relative risks (Section B.5); and a numerical example to show how the method is applied in a
practical case (Section B.6). The results show that the bias due to smoker misclassification is
highly unlikely to be responsible for the increased risks observed in the passive smoking lung
cancer epidemiology studies. Evidence is also presented suggesting that the true downward
corrections for smoker misclassification bias may be even smaller than those developed below and
used in Section 5.2.2. While some of the rates presented below are subject to variability and
argument, attempts are made to provide reasonable  estimates and a defensible methodology.
       There is considerable literature on this topic and a history of controversy regarding the
magnitude of the bias and whether it may explain the observed increase in lung cancer mortality
due to ETS exposure. The NRC report on the health effects of passive smoking (NRC, 1986)
delves into this topic in considerable detail. It concludes that bias  is likely; further, it estimates an
adjustment for the summary relative risk from the combined results for all ETS studies. The NRC
report further concludes that smoker misclassification does not account for the observed passive
smoking risk.  On the other hand, in various publications Lee (1987b, 1988, 1990, 1991a) has
claimed that the smoker misclassification bias is large enough to explain most or all of the
observed passive smoking lung cancer risk.
       Approaches to estimation of misclassification bias have used mathematical modeling with
parameters estimated from a variety of sources that have not always been consistent.  The
procedure described below attempts to rectify some previous sources of misunderstanding on this
topic and utilizes the extensive data sources now available to improve parameter estimates and
tailor refinements to individual populations.
                                            B-l

-------
B.2. PRINCIPLES OF THE WELLS-STEWART METHOD
       The Wells-Stewart method is based on the following principles, the nature and need for
which have largely become apparent from the chronological evolution and disparate approaches to
and results for this problem.
       The parameters are:
       a.  Since the passive smoking epidemiology is essentially concerned entirely with self-
           reported never-smokers, it is necessary to limit the misclassifieds to those who  said
           they never smoked, not simply to nonusers, because the latter would include a
           substantial proportion of self-reported former smokers.
       b.  Use one minus sensitivity or its close relative, false negatives (misclassified  smokers)
           divided by observed positives (self-reported smokers) as the vehicle for transferring
           misclassification  data from cotinine and discordant answer studies to the passive
           smoking studies.  Sensitivity is the term used to describe the fraction correctly
           classified as exposed, namely, true positives divided by true positives plus false
           negatives, but since we are assuming that the true positives and the observed positives
           are the same (no  misclassification of never-smokers as smokers), sensitivity in  this
           case becomes observed positives divided by observed positives  plus false negatives.
           Then one minus sensitivity becomes false negatives divided by observed positives plus
           false  negatives.  Ignoring the false negatives in the denominator introduces  negligible
           error. In any case, do not use specificity (true negatives divided by true negatives plus
           false  positives) or any parameter that uses as its denominator true  or observed
           negatives (self-reported never-smokers).  The reason is that sensitivity is  affected
           much less by smoker prevalence  than parameters based on observed negatives.
       c.  Calculate a correction for each epidemiologic study separately  using a misclassified
           smoker relative risk and a proportion of smokers among subjects and spouses that is
           characteristic of  the timeframe and locale of each study.  Use data from the study
           itself or from another study with the same target population, if possible.
       d.  Use only female  data to correct misclassification of female subjects.
       For the mathematical model, calculate the  corrected risk directly—that is, do  not first
 calculate a bias assuming no  passive risk and then divide the observed risk by that bias  to get a
 corrected risk.
       Subjects found to be misclassified as nonsmokers are categorized according to their self-
 reported smoking status—former or current.  Misclassified current smokers are further classified
 as "regular" or "occasional," according to observed cotinine levels. "Regular" means the  cotinine
 level is above 30% of the self-reported smoker mean; "occasional" applies to the range 10% to 30%.
                                             B-2

-------
Cotinine levels are not informative for misclassified former smokers, who tend to be long-term
abstainers (10+ years, according to Lee [1987b] and Wald et al. [1986]). The two studies with
detailed cotinine levels on female current smokers (Lee, 1986 and Haddow et al., 1986, in Table
B-l) indicate that about 10% of the current smokers are occasionals.

B.3. DIFFERENCES FROM EARLIER WORK
       The Wells-Stewart method differs from the method used by the NRC (1986), which is also
described by Wald et al. (1986), in that the NRC method failed to separate the misclassified
smokers into regular, occasional, and ex-smokers, and failed to account for the effect of smoker
misclassification on active smoker risk. The NRC made an overall correction to the aggregated
passive relative risk using United Kingdom (U.K.) smoking prevalence and risk rather than
making the corrections study-by-study with appropriate smoking prevalences and risk for each
study's time and locale, and it mixed male data with female data in arriving at misclassification
factors.  Their calculated bias of 1.34/1.25 = 1.07, or 7%, for the combined worldwide studies is
substantially higher than the 2% overall bias that would result if the biases in Table 5-7 were
aggregated. The discrepancy is largely due to NRC's use of U.K. parameters for all of the studies
regardless of locale, plus some overestimation of the impact of misclassified occasional and ex-
smokers.
       Lee's methods have evolved over the years in three stages.  In Lee (1987b, 1988), he
improved on the NRC method in that he divided the misclassified smokers into ex-smokers and
current regular and occasional smokers, and he corrected the smoker risk for misclassification.
However, all of the five principles listed above were violated to some degree, resulting in about a
twelvefold overestimation of the bias (Wells, 1992).  The Lee (1990) paper correctly limits
misclassifieds to never-smokers, relates misclassified smokers to smokers, not to never-smokers,
and treats each study separately, but still mixes male input data with female data for use in
calculating bias for females.  Furthermore, his mathematical model  still relies on the assumption
of a passive smoking relative risk of 1.00 (no risk), an assumption that fails at passive risks above
about 1.3 and overstates those biases.  In addition, Lee (1990) has changed from separating the
misclassified smokers into three  groups in favor of the (less useful) overall category of "ever-
smokers." Most recently, Lee (1991a) presented a more complex mathematical model that includes
a term for passive risk, but the method still has the other shortcomings noted for Lee (1990).  A
comparison of the most recent Lee bias estimates with those in Table 5-7 is shown in Table B-2
for the five U.S. studies with the greatest statistical weight. When Lee's inputs are used with the
Wells-Stewart mathematical model, the calculated biases are, if anything, somewhat larger than
when using Lee's most recent model.  Therefore,  the difference between Lee's most recent
                                            B-3

-------
Table B-l. Observed ratios of occasional smokers to current smokers (based on cotinine studies)
Study
Lee (1986)
Coultas
etal. (1988)
Haddow
et al. (1986)
Feyerabend
et al. (1982)3
Jarvis (1987)
Pojer (1984)
Wald et al.
(1984)
Overall
Females , , ] '",
-^ ? ffts
Occl.2 Current Occl./current Qccl
4 72 0.056 12
59
10 64 0.156
7
12
25
13
14 136 0.103 128
Both
Current
176
278

82
90
187
131
944
sexes1
Qccl./eurrent
0.068
0.212

0.085
0.133
0.134
0.099
0.136
JThe "both sexes" data are shown to indicate that the female value of 10.3% is not unduly high.
2Occasional smokers are defined as persons who have cotinine levels in body  fluids that are
 between 10% and 30% of the mean of all self-reported current smokers.
3The Feyerabend et al. (1982) data are for nicotine.
estimates of bias and those shown in Table 5-7 are in practical terms due almost entirely to
differences in input parameters.  The input parameters we have chosen are developed in the next
section, and comparisons with the Lee parameter estimates are shown as footnotes to Table B-2.

B.4. PARAMETER ESTIMATES
       The key input in these calculations is the proportion of misclassified regular current
smokers who claim they have never smoked.  Our definition of misclassified regular current
smokers, first suggested by Lee (1987b), produces a mean cotinine level approximately equal to
that of all self-reported current smokers. Detailed data from  three large cotinine studies have
been assembled for use herein with the cooperation of their principal investigators (Coultas,
Cummings, and Pierce in Table B-3).  The data identify individual nonsmokers with cotinine
values greater than 10% of the mean for self-reported smokers, by sex and self-reported smoking
status (never or former). Data on nonusers are also available from several other studies (the lower
                                            B-4

-------







13
•8
o
£
S
t/3
ea







'
















«
f


Q. *Q
& §
.S fc.
<
rt

so
®
•is
1
§,
r*li
fe,
JS
C8
CK
•O
S
22
«
Is I
T3 ***
Q Cjj
w ^
* Q«
«-« r*
•O\ t£3
3 g
J
*o to


1

,1







pf
&

w
PQ



ft!



<5
M
8
nS



«°

^G
C£
•«<«>




10



m
00
cs


ON
01
*"— '

S
•


f)
CO
1—1


CN
CO

~~i



00

CO

CO


2

o




VO


£;
—^

.^H
•


^.
IN
O
•~"


^
i— i

^



CN

r-
"*
a
o
0
PL,

CO
o




CN
"

CO
*— *

^
•


*o
OO
0
— '


CO
«N
CN
*~!



o

CO
fN
~
2


O

S




^
0

oc
o

s
•


VO
VO
O


>0
c>

^



VO
O
^
o
o
i-H


W
Z

o




oc
"

r-
o
CN

rsl
•


j^
O
r~
-*


^
o
oi
(N
^^



rr
OO

0
CN
CO


I
CJ

                                            a1
                                            Q.

                                            00



                                            |


                                            2
                                            C
                                            o




                                           1
                                            «
                                            o
: Calculated bias is very sensitn
observed never-smokers miscl
4«*
CIS
o
1
%
J»
<
a,
w
e
5
4W
(H
CU
00
•J3
smoker misclassification bias.
w
W
IB
CO
43
x>
iS
CO
*s
tu
0)
J
n
!
5
s
its on smokers.
.'s misclassification factors develi
>
rt
2
5
I
CO
X

•s
#
r^
»— H
•o
•v
2
4)
k>
JS
I
CO
1
lH
CU
CU
I
O
a
9)
t-l
1
«M
"3
CO
a>
2
CU
"3
IH
c2
2
CU
^i
I
CO
1
t-l
^
a>
!
£
as
1
O
CO
2
1
&
CO
1
LH
CU
S
*
o
T
-o
CU
CO
T>
CU
Q.
O
1
CU
•o
2
1
f,
1
•§
cd
-^
_cu ^
"~1 tN
2^
SM
•" Cm
W 0
•S %
•s*
^
>> —<
•° s
T3 rf
a> r-
1 =
12
.3 O
« ^_^
   S
   o
   z

B-5

-------
      0
      ,      •«
      CM     C
      o     §
         ON
cs
.2
3
,0
.S3
•o
(15
00
CD

c2
.^•fc
O
od
^*«<
O
CO
CO
13
^
CO
"b
CO
1-1
rr»
CD
O
CO
1
2
Q.
oo
.s
15
Q
S
CO
CO
'C
u,
CO
1
CO
l-l
fO
?

CJ
*v-*
      s
      CN
                P
             -  o2  2
            •^ ^ •£  o.

            •g -  co  00-
             ^  a  92  a  «
            .a
jg  CO
                   « ^  o
         •!» •*«	U<  S
         8*  o  co  o  S
         r*.  r*  f*  ^  V
         ON

         OO
                     c^TS
          a  "c^
                  w
                     >r>
                  *  S
                  •o  a
            tN
          S?u
                CO  3  co
                     j->  W
                                                             B-6

-------
Table B-3. Misclassification of female current smokers
Self -reported smoking status number

Study
Coultas et al. (1988)2


Cummings (1990)3


Pierce et al. (1987)4


Subtotal


Lee (1986)5


Haddowetal. (1986)5


Haddow et al. (1988)5


Riboli (1991)5'6~U.S.7


Riboli (1991)5-6--East Asia8


Riboli (1991)5'6— Greece9


Total


Proportion misclassified10

Cotinine
level1
10-30
30+
All
10-30
30+
All
10-30
30+
All
10-30
30+
All
10-30
30+
All
10-30
30+
All
10-30
30+
All
10-30
30+
All
10-30
30+
All
10-30
30+
All
10-30
30+
All
10-30%
30+

Never
7
5
387
0
2
225
9
3
232
16
10
844
3
3
333
1
0
174
15
1
1,128
1
0
224
1
1
325
0
0
96
37
15
3,124
24.2%
1.09%
Number
Former
3
8
79
1
0
143
4
3
79
8
11
301
2
2
125
1
1
58
7
1
380
0
0
81
1
0
25
0
0
5
19
15
975
12.4%
1.09%

Current


184


116


167
(67% never)
(48% never)
467


256


64


503


143


77


15


1,525


                                                          (continued on the following page)
                                          B-7

-------
Table B-3. (continued)

 JCotinine levels are in units of percentages of the mean of self-reported smokers for each study;
 30+% are defined as current regular smokers, 10-30% are occasional smokers.
 2Dr. Coultas kindly provided the individual cotinine values for females ages 18+ that were used m
 Table 3 of their paper. The totals differ slightly from the totals in the paper.
 3Dr Cummings kindly provided the cotinine levels for the six misclassified current smokers,
 three males and three females. As noted in the paper, current smokers were recruited during
 only the first half of the study. Therefore, the total equivalent current smokers were estimated
 from the current  smoker/never-smoker ratio from national statistics.
 Individual cotinine levels for the misclassifieds by gender are from a personal communication
 from Petra Macaskill, who now has the basic data for this study.
 5For Lee (1986), Haddow et al. (1986, 1988), and Riboli (1991), no breakdown was given between
 "Never" and "Former."  An estimate was made based on the subtotal distribution. The number ot
 smokers had to be estimated in some cases. The mean for self-reported smokers for Haddow et
 al. (1988) was very low, at 145 ng/mL, because the women were pregnant.
 6Personal communication—individual country data from Riboli et al. (1990).
 7New Orleans, Los Angeles, and Honolulu.
 8China (Shanghai), Hong Kong, and Japan  (Sendai).
  AtHcns
 1&The observed current smokers are assumed to be 90% regular (1,372) and 10% occasional (153)
  smokers  For regular smokers, misclassification as never-smokers is 15/1,372 = 1.09% of
  observed current regulars or 15/(1,372 + 15 + 15) =  1.07% of true current regulars.  For
  occasional smokers, misclassification is 37/153 = 24.2% of observed current occasional or
  377(153 + 37 + 19) = 17 7% of true current occasionals.  For current smokers misclassified as
  former smokers,  the factors are 15/1,372 = 1.09% for observed and 15/1,402 = 1.07% for true
  regular smokers, and 19/153 = 12.4% for observed and  19/209 = 9.1% for true occasionals.


 portion of Table B-3). The proportions of misclassified  smokers who would have said "never"

 versus "former" are estimated using the proportions observed in the first three studies. Data sets

 not differentiating outcomes by sex have not been used.  Also, the large 1987 study by Haddow

 and colleagues has not been used for this purpose on the advice of one of the authors (personal

 communication from G.J. Knight). This study of the effect of current smoking on birthweight

 relied on the cotinine data to distinguish smokers from nonsmokers. The questionnaire data were

 not collected in a  manner that could be equated to the care that would be taken in either their or

 others' passive smoking studies.
        The number of self-reported never- and former smokers with sufficiently high cotinine

 levels to be reclassified as current smokers  is shown by study in Table B-3.  As described above,

 those with cotinine levels in the 10-30% range are considered to be occasional smokers, whereas

 those above 30% are treated as regular smokers.  If it is assumed (Table B-l) that 1,372 (90%) of

 1,525 self-reported current smokers are regular smokers, leaving 153 (10%) as occasionals, then

 the percentage of current regular smokers misclassified as never-smokers totalled over all studies

 in Table B-3 is 15/1,372 or 1.09%. The percentage is almost the same if the number of true, i.e.,
                                             B-8

-------
self-reported plus misclassified current regular, smokers is used. For the occasional smokers only,
the misclassification rate is much higher, about 24% (18%) of observed (true) occasional smokers.
It is possible, however, that the subjects classified as occasional smokers based on cotinine levels
in the range 10-30% may contain some true never-smokers that are just highly exposed to passive
smoke.
       The cutoff points used, namely, 30% of the self-reported current smoker mean cotinine
level to distinguish misclassified regular smokers from occasional smokers and 10% of the self-
reported current smoker mean cotinine level to distinguish occasional smokers from current
nonsmokers, were chosen originally by Lee (1987b). They are justified as follows:  the actual
cotinine levels of the 15 misclassified current smokers in the Never column of Table B-3 whose
levels exceeded 30% of the mean cotinine level for self-reported current smokers in each study
were divided by the mean smoker cotinine level for that study. These values were then averaged
for each study, and a mean for all studies was obtained by weighting each study's mean by the
number of smokers in that study.  The overall mean cotinine level for the misclassified smokers
was 94% of the mean for all of the self-reported smokers because the misclassifieds tended to
concentrate near the bottom of the 30%+ range. A cutoff  of 35% could be justified since the
misclassifieds' mean cotinine level was 99% of the mean for the self-reported smokers, but we
chose to continue with 30% to  be conservative.
       The cutoff between the current nonsmokers and the occasional smokers must be somewhat
arbitrary because there is an overlap between heavily ETS-exposed nonsmokers and very light
current smokers.  Authors who have tried to eliminate all possible smokers from their cohorts have
used lower cutoff points. For example, Coultas et al. (1988), Cummings (1990), and Haddow et al.
(1988), who were trying to eliminate smokers, used cutoffs between 7% and 8%.  However, Pierce
et al. (1987) and Lee (1986), who, as we are, were trying to distinguish smokers from nonsmokers,
used higher cutoffs, 16% and 9%, respectively.  The mean  of the percentages (calculated as above
for the misclassified current regular smokers) that the misclassified occasional smokers' cotinine
levels bear to the mean of the self-reported current smokers is 16% for the seven studies in Table
B-3. This is lower than the midpoint of the 10-30% range, again because the individual values
concentrate at the lower end of the range. If we had used  a 5% cutoff instead  of 10%, the
misclassifieation rate for occasional smokers would have been increased from 24% to about 40%,
but the average of the percentages of current self-reported mean cotinine levels for the
misclassified occasional smokers would have dropped from 16% to 13%. This in turn would
reduce the estimated smokers' relative risk for this group,  and the overall effect on the corrected
risk of never-smokers would be negligible.
                                           B-9

-------
       The studies in Table B-4 provide data on discordant answers, i.e., reported never-smokers
who have called themselves smokers on one or more previous occasions. Based on those data, the
estimated percentage of former smokers misclassified as never-smokers is  11.7% (10.8%) of the
observed (true) number of former smokers.  As mentioned previously, evidence suggests (Wald
et al., 1986; Lee, 1987b) that most former smokers misclassified as never-smokers have been
nonsmokers for an extended period, such as  10+ years, and may have been light smokers on
average.  Accordingly,  we have used a weighted average of the data of Alderson et al. (1985),
Lubin et al. (1984), and Garfinkel and Stellman (1988) for 10+ year abstainers to estimate
misclassified former smoker relative risk, namely, an excess risk that is 9% of current self-
reported smoker excess risk.
       Some confusion and misleading conclusions on smoker misclassification have resulted from
the practice of expressing the number of smokers misclassified as never-smokers as a percentage
of the total number of (either true or observed) never-smokers, rather  than as a percentage of the
number of smokers.  That leads to a higher expected percentage of smokers misclassified as never-
smokers among cases than controls because lung cancer cases are much more likely to have been
smokers than never-smokers.  Some people (Lee,  1988) have interpreted a higher percentage of
observed never-smokers later found to be misclassified smokers among the cases as evidence that
smokers with lung cancer are more apt to claim falsely to be never-smokers than persons without
cancer.  That conclusion, however, appears to  be an artifact of treating the misclassification rate
as a percentage of the number of never-smokers rather than as a percentage of the number of
smokers. The study data summarized in Table B-5 do not support that conclusion. If anything,
they are more supportive of the conclusion that ever-smokers in lung cancer studies may be less
likely to misrepresent themselves as never-smokers than members  of the general public who are
questioned in community surveys.  The 1.0% average misclassification  rate shown in Table B-5 for
the lung cancer cases suggests that estimates such as the 5.7% from the general population studies
(Table B-5) or the equivalent of 3.9% of ever-smokers (Table B-4) that we have used may be
much too high. Further corroboration that the misclassification rates from the community studies
are too high relative to those in the epidemiologic studies is found in the recent lung cancer case-
control study by Fontham et al. (1991), which specifically included in its design a screening by
urinary cotinine levels  to eliminate current smokers from both cases and controls. After
eliminating possible smokers among the self-reported never-smokers by the usual epidemiologic
questionnaire and medical records review techniques, the investigators found by cotinine
measurements that only two probable occasional smokers and no probable regular smokers were
left among the 239 never-smoking  lung cancer cases for which cotinine measurements were made.
Using the procedures herein and assuming 43% ever-smokers among controls and an ever-smoker
                                           B-10

-------
Table B-4. Misclassification of female former smokers reported as never-smokers based on
discordant answers
Reported never-smokers
who reported earlier that
they had smoked1
Study Locate
Kabat and Wynder
(1984)2 U.S.
Controls
Cases
Machlin
et al. (1989) U.S.
Krall et al. (1989)3 Mass.
Britten (1988)4 U.K.
Lee (1987b) U.K.
Akiba et al. (1986) Japan
Overall5
Former
smokers

-------
Table B-5. Misclassification of female lung cancer cases
Source
•••••••••BHHHHMMBMHMMMI
CHAN
Chan et al. (1979)1
KABA
Kabat and Wynder (1984)2
AKIB
Akiba et al. (1986)
PERS
Pershagen et al. (1987)
HUMB
Humble et al. (1987)3
Total
General population4
''"Number of ever-sxaokers
12

652

38

179

223

1,104
1,838
Number Husclassifsecl
1

7

0

2

1

11 (1.0%)
104 (5.7%)
 !Chan sampled five Type I and II never-smokers, one of whom was said by a relative to have
 smoked a few hand-wrapped cigarettes for a year at age 71. The ratio of smoking to nonsmoking
 cases for Types I and II was 44/19, which, multiplied by 5, leads to 12 estimated ever-smokers.
 2Dr. Kabat (personal communication) advised that of 13 misclassifieds, 8 were females, 1 of whom
 used snuff.
 3Of the four misclassifieds found, Dr. Humble (personal communication) has advised that most if
 not all  were males. We have assumed one female.
 ''The general population data are taken from the four nonlung cancer cohorts in Table B-4,
 namely, Machlin et al. (1989), Krall etal. (1989), Britten (1988), and Lee (1987b).
 relative risk of 8, which translates to 10 for misclassified current regular smokers, 2.44 for
 misclassified occasional, and 1.81 for misclassified ex-smokers, there would have been 1,363
 smoker cases, consisting of 1,328 current smokers and 35 occasional smokers to go along with 420
 never-smoking cases. It is seen that a misclassification rate of 0/1,328 = 0.00% for regular
 smokers is well below the 1.09% that we have used from the surveys in Table B-3. For
 occasionals, there would be 20 cases to go along with 239 never-smoking cases, yielding a
 misclassification rate of 2/20 - 10%, which is also well below the 24.2% for occasionals that we
 have used from Table B-3.
        Another indication that the estimates based on community surveys may be too high comes
 from analysis of male data.  The observed percentage of never-smokers is typically much lower
 for males (17% to 35%) than females (41% to 86%).  To correct for smoker misclassification, we
 set up a table analogous to Table B-6 where the number of current and former smokers
                                           B-12

-------
 Table B-6. Deletions from the "never" columns in Tables B-13 and B-16 and corrected elements
Wife's smoking status
Husband's
smoking status
Table B-13
(controls)
Table B-16
(cases)

Never
Ever
Never
Ever
Former
CD
0.00679
0.01275
0.00198
0.00770
QccL
(2) *
0.00194
0.00532
0.00120
0.00365
Regular
(3)
0.00081
0.00219
0.00217
0.00604
Sum1
(4)
0.00953
0.02027
0.00534
0.01739
Observed
never
(5)
0.286
0.242
0.052
0.092
Corrected
never2
#)
0.27647
0.22173
0.04666
0.07461
 2(6) =
 misclassified as never-smokers are subtracted from the reported number of never-smokers.  When
 the misclassification rates generated from community surveys are applied to the male data* the
 outcome is not credible—the number deleted for misclassification exceeds the total number of
 reported never-smokers in 3 of the 11 examples of which we are aware and drives the corrected
 relative risk well below unity in 4 more. This outcome indicates that the misclassification rates
 derived from the community surveys are too high. It is probable that the true smoker
 misclassification bias is on the order of one-fourth to one-half of the values shown in Table 5-7.
       It has also been suggested (Lee, 1991b) that East Asian women misclassify themselves at
 much higher rates than Western women. The data from the International Agency for Research on
 Cancer (Riboli, personal communication) in Table B-3 do not support that claim, however,
 because the East Asia (Hong Kong, Japan, and China) misclassification rate for current regular
 smokers is  1/77 = 1.3%, which is not much different from the overall rate of 1.09%.
       In conclusion, it would appear that the bias introduced by misclassification of smokers as
 never-smokers is not a serious problem. It probably increases observed excess relative risks on a
 worldwide basis by about 1% and for combined U.S. studies by about 3%.

 B.S. MATHEMATICAL MODEL
       The proportion of smokers, mh0, misclassified as never-smokers is estimated separately for
 former smokers (m10), occasional smokers (m20), and regular smokers (m30).  Similarly, the
proportion of current smokers, mhl, misclassified as former smokers is estimated separately for
occasional smokers (m21) and regular smokers (m31).  These estimates are given in Tables B-3 and
B-4. It is assumed that there is no misclassification of true never-smokers as current or former
                                          B-13

-------
smokers or of true former smokers as current smokers.  Also, these misclassification factors are
used for all the studies unless otherwise noted. We suspect that misclassification rates probably
vary from study to study. That variability, however, would tend to cancel out as the individual
study results are combined.
       Let cijk designate the observed distribution of controls (i = 0) and cases (i = 1) by their
smoking status (j = 0,1,2,3) and the smoking status of their husbands (k = 0,1), as illustrated in
Table B-7. Following the notational convention that a dot in the subscript position means
summation on that subscript, then c0.. = Cj.. = 1.
       The observed c^'s are corrected for misclassification of the wife's smoking status by first
specifying a 4 x 4 matrix of distribution (Table B-8), where Phj (h,j = 0,1,2,3) is the probability
that a subject with true smoking status h will also be observed to have smoking status j. The
subscripted notation is shown in Table B-8 for easy reference.  P.. is equal to unity.
       For passive smoking, we are interested only in correcting the ci0k values that are for the
observed never-smokers. It is assumed that the Phj's are the same for cases and controls
(nondifferential misclassification). For given values of wife's subject status  (i) and husband's
smoking status (k), the correction when the wife's observed smoking status is "never" (j = 0) is:
                                                                                       (B-l)
 where C;ok is the corrected form of the element ci0k.  Then the corrected passive risk, RR(c),
 becomes:
                              RR(c) = (C,oi  x
 The values of c0jk in Table B-7 are from prevalence data in the study itself or from a related
 study, from concordance data, and from each study's data on the smoking prevalence of the
 never-smokers' husbands. If necessary, the number of former smokers can be estimated from the
 ever-smokers based on data from nine studies known to us where the percentage of both current
 smokers and former smokers  is known (see Table B-9). These data indicate a time trend in
 nontraditional societies, from 20% former smokers relative to  ever-smokers in 1960 to 45% in
 1985; we estimate an 8-year lag for the traditional societies such as Hong Kong, China, Japan, and
 Greece, based on the data in  Koo et al. (1983) and Sobue et al. (1990).
                                             B-14

-------
Table B-7.  Notation for distribution of reported female lung cancer cases and controls by
husband's smoking status
Wife's observed smoking status (j)
Wife's
subject
status (!)
Control
(i = 0)

Case
(i-D

Husband's
smoking
status (k)
Never (k = 0)
Ever (k = 1)
Total
Never (k = 0)
Ever(k= 1)
Total
Never
( j - 0}
cooo
C001
coo-
C100
C101
C10-
Ex OccL
0*1) 0*2)
C010 C020
C011 C021
C01- C02-
C110 C120
clll C121
cll- C12-
Reg.
0 * 3) Total
C030 C0-0
C03i CQ-I
C03- C0- ( = 1)
C130 cl-0
C131 cl-l
c,, .„,_(•-„
Table B-8. Notation for distribution of subjects by observed and true smoking status
'
Wife's observed
smoking status 0)

Never (j = 0)
Former ( j = 1)
Occl.(j = 2)
Reg- 0 = 3)
Total
Wife's true smoking status (h)

Never Former Occl, Reg.
(h = 0) (h=l) (h = 2) (h-3)
POO PIO P20 P30
P01 Pi! >21 P31
P02 Pl2 P22 P32
PP "D T>
A-J •* 1 1 Jr oa - Jr -ao
"J = U 
-------
Table B-9. Observed ratios of female former smokers to ever-smokers in the U.S., U.K., and
Swedish studies:  populations or controls (numbers or percentage)
Study
Hammond (1966)1
Buffler
etal. (1984)2
Wu et al. (1985)2
Lee (1987b)3
Brownson
et al. (1987)2
Britten (1988)3
Humble
et al. (1987)2
Svensson
et al. (1989)2
Garfinkel and
Stellman (1988)1
Time-
frame
1960
1978
1980
1980
1980
1982
1982
1984
1982
Never-
smokers
78.0%
41%
92
48.3%
47
767
162
120
58.9%
Current
smokers
17.6%
38%
73
33.6%
11
558
63
53
18.7%
Former
smokers
4.4%
21%
55
18.1%
8
320
48
36
22.4%
Ever-
smokers
22.0%
59.0%
128
51.7%
19
878
111
89
41.1%
Former/ever-
smokers
0.20
0.36
0.43
0.35
0.42
0.36
0.43
0.40
0.54
Assumed ratios bv vears (nontraditional societies)4

Year
Ratio
1960 1965
0.20 0.25
1970
0.30
1975 1980
0.35 0.40
1985
0.45

       age distribution of never-smoking cases.
 2Using age distribution of ever-smoking cases.                                ,
 3Smoking status of general population.
 ''Traditional societies (Japan, Greece, China, Hong Kong) are estimated to lag these ratios by
 about 8 years, based on data in Koo et al. (1983) and Sobue et al. (1990). However, because the
 bias for the traditional societies is very low, changes in values of this parameter have little effect.

       To calculate the individual elements, c0jk, of Table B-7, it is necessary to establish
 concordance factors—that is, the cross products in 2 x 2 tables of smoking status of husbands and
 wives by smoking level of the wives. Using data from Sutton (1980), Lee (1987b), Akiba et al.
 (1986), and Hirayama (1984) and the detailed data in Lee (1987b) on never-smokers, current
 smokers, and former smokers, we have calculated that an appropriate average concordance factor
 for current smoking wives and ever-smoking husbands versus never-smoking wives and never-
 smoking husbands is 3.2; for ever-smoking  wives and husbands versus never-smoking wives and
 husbands, it is 2.8, and for former smoking wives and ever-smoking husbands versus never-
                                            B-16

-------
smoking wives and husbands, it is 2.2. These concordance factors can be expected to vary from
study to study, but the effect of the variability should tend to cancel out as the studies are
                                               3        - • -         .     •      .• •  •
aggregated. The element CQQ. and a quantity s0 = JT CQJ. are obtained from smoking prevalence
                                              j=i
data in the study itself, in a related study on the same cohort, or as a last resort from national
statistics.  If national statistics are used, care must be taken to use the rates from an age
distribution that is consistent with the age distribution of the passive smoking cases. The elements
C0j. and c02. + c03. are taken from the  study or are estimated from Table B-9.  The element c02. is
estimated to be 10% of (c02. + c03.); c03. is 90%. The elements CQQQ and cmi are obtained from c00.
and the proportion  of never-smoking controls in the study who are married to either never-
smokers or ever-smokers. The elements COK) and con are obtained by solving the equations
                                                              3               3
coio + con = coi- and (cooo x con)/(cooi x coio) = 2-2-  Terms s^ = £ cojo and s01 = £ c0jl are
                                                             j=i             j=i
obtained from the equations SQQ + sol = s0 and (s01  x CQOO)/(CQQI x SQQ) = 2.8. Then c020 + c030 =
soo ~ coio anc* C02i + C03i = soi ~  con- The values of c020 and c02, are then assumed to be  10% of
C020 + coso anc* C02i + C03i> respectively, and c030 and c031  are assumed to be 90%.
       To obtain the elements for the subject cases (i =  1) in Table B-7, it is necessary first to set
up relative risks for the passively exposed (k = 1)  and not passively exposed (k = 0) wives by
observed smoking status (j = 0,1,2,3). These risks are shown in Table B-10.
       In most instances, the relative risk, RR(e), for female ever-smokers can be obtained from
the study itself or from a related paper (Table B-11). In a few instances, it is necessary to
estimate RR(e) from other "studies similar in time  and locale.  In some papers, a current smoker
risk also is given. We assume (see explanation above) that  the misclassif ied regular smoker risk,
RR(a)3, is equal to the self-reported current smoker risk.  Where only RR(e) is available, RR(a)3
can be assumed to be equal to 1.24 x  RR(e) based on the data in Table B-12.  Because occasional
smokers have mean cotinine levels that are  16% of those of regular smokers, it is assumed that
RR(a)2 - 1 = 0.16(RR(a)3 - 1), and because the former smokers  (j =  1) are  said to be, on average,
long term (Wald et al.,  1986; Lee, 1987b), we have averaged the data of Alderson et al. (1985),
Lubin  et al. (1984), and Garfinkel and Stellman (1988) for the ratio of excess risk of 10+ year
former smokers to the excess risk for  current smokers and  found it to be 9%.  Thus, RR(a), -  1 =
0.09(RR(a)3-l).
                                            B-17

-------
Table B-10. Notation for observed lung cancer relative risks for exposed-(k=l) and nonexposed
(k=0) wives by the wife's smoking status, using average never-smoking wives RR(a)0 as the
reference category
^ ,"•" ,'"•''- WifeTs smoking status
Husband's
smoking status
Never (k=0)
Ever (k=l)
Weighted avg.
active risk
Passive risk1
RR(p)j -
RRjI/RRjO
Never- s
,0 = 0)
RRoo
RR01
RR(a)0= 1.00

RR(p)o
Formet
(j-'l) x
RR10
RRn
RR(a)i

RR(p)l
v ^ fs ^
^,IT_pccL , R-eg.
"DO 1? U
K.K.2Q «-«-30
RR21 RR3i
RR(a)2 RR(a)3

RR(p)2 RR(P)3
Observed passive risk—the ratio of the exposed risk to the unexposed risk in each column.
                                           B-18

-------
Table B-ll.  Prevalences and estimates of lung cancer risk associated with active and passive
smoking
Case-
control
AKIB

BROW6



BUFF

CHAN

CORR

FONT10





GAO

GARF

GENG

HIRA16

HUMB
•
INOU

JANE

£ver-sm
-------
Table B-ll. (continued)
Case-
control
KABA22

KALA



KATA

KOO

LAMT

LAMW

LEE

LIU

PERS

SHIM

SOBU



SVEN

TRIG

WUWI

„ , Ever-smokers
Prev. Crude Prev. of
(%)r RR2 , exposed (%)3
42

17



28

32

24

22

6026

0.05

3711

2111

21



43

10

37

5.90
(4.53, 7.69)
3.32
(2.12, 5.22)


1.21
(0.50, 2.90)
2.77
(1.96, 3.90)
3.77
(2.96, 4.78)
4.12
(2.79, 6.08)
4.6126

*

4.211

2.811

2.81
(2.22, 3.57)


5.97
(4.11,8.67)
2.8 130
(1.69, 4.68)
2.24
(1.92, 2.62)
60

60



82

49

45

56

68

87

43

56

54



66

52

55

Never-smokers
Crude
RR2'4
0.79
(0.30, 2.04)
1.6223
(0.99, 2.65)
1.4123
(0.78,2.55)
*24

1.55
(0.98, 2.44)
1.65
(1.22, 2.22)
2.5125
(1.49,4.23)
1.03
(0.48, 2.20)
0.74
(0.37, 1.48)
1.28
(0.82, 1.98)
1.0828
(0.70, 1.68)
1.0623
(0.79, 1.44)
1.7723
(1.29, 2.43)
1.2629
(0.65, 2.48)
2.0830
(1.31, 3.29)
0.79
(0.64, 0.98)
Adj. ^
RR2>4>*
*

1.92
(1.02, 3.S9)7


*

1.64

*

*

0.75/1. 6027

0.77
(0.35, 1.68)
1.2
(0.7, 2.1)7
*

1.1323
(0.78, 1.63)7
1.5723
(1.07, 2.31)7
1.429

*

0.7

                                                          (continued on the following page)
                                          B-20

-------
 Table B-ll. (continued)

Case-
control
BUTL
(Coh)
GARF
(Coh)
HIRA
(Coh)
HOLE34
(Coh)
Ever-smokers
Prev; Crude
(%)* RR2
1411 4.011
2233 3.5833
16 3.2017
(1.96, 3.90)
56 4.211
-
Prev. of
exposed (%f
*
72
77
73
Never-smokers
Crude
RR2*4
2.4532
*
1.38
(1.03, 1.87)
2.27
(0.40, 12.7)

Adj. ^
RR2*4** ,
2.02
(0.48, 8.S6)7
1.1712
(0.85, 1.61)7
1.61
*
1.99
(0.24, 16.7)7
 Percentage ever-smokers in controls of whole study (or parent study).
 2Parentheses contain 90% confidence limits, unless noted otherwise. Crude ORs and their
  confidence limits were calculated by the reviewers wherever possible. Boldface type indicates
  values used for analysis in text of this report. OR for case-control studies; relative risk (RR) for
  cohort studies. The reference category for active smoking is all never-smoking; for passive
  smoking, it is unexposed never-smokers.
 3Percentage of never-smoking controls exposed to spousal smoking, unless noted otherwise.
  ORs for never-smokers applies to exposure from spousal smoking, unless indicated otherwise.
 Calculated by a statistical method that adjusts for other factors (see Table 5-5).
  Adenocarcinoma only.  Data and OR values communicated from author (Brownson).
 795% confidence interval (C.I.).
 8Exposure to regularly smoking household member. Differs slightly from published value of
  0.78, wherein 0.5 was added to all exposure cells.
 9Excludes bronchioalveolar carcinoma.  Crude OR with bronchioalveolar carcinoma included is
  reported to be 1.77, but raw data for calculation  of confidence interval are not provided.
10The first, second, and third entries are calculated for population controls, colon cancer controls,
  and both control groups combined, respectively.  For adenocarcinoma alone, the corresponding
  ORs, both crude and adjusted, are higher by 0.15 to 0.18.
HFrom other studies  similar in location and time period (see Table 5-7).
12Composite measure formed from categorical data at different exposure levels.
13For GAO, data are  given as (number of years lived with a smoker, adj. OR): (< 20, 1.0), (20-29
  1.1), (30-39,  1.3), (40+,  1.7).
14Estimate for  husband smoking 20 cigarettes per day.
15Crude OR reported in study is 3.05 (95% C.I. = 1.77, 5.30); adjusted OR is 2.6 (95% C.I. = 1.4,
 4.6).
16Case-control study nested in the cohort study of Hirayama. OR for ever-smokers is taken from
 cohort study.  This case-control study is not counted in any summary  results where HIRA(Coh)
 is included.
17Crude OR is  calculated from prospective data in Hirayama (1988).  Adjusted OR for ever-
 smokers given there is 2.67 (no confidence interval).

                                                            (continued on the following page)
                                           B-21

-------
Table B-ll.  (continued)

18OR reported in study is 2.25, in contrast to the value shown that was reconstructed from the
 confidence intervals reported in the study; no reply to inquiry addressed to author had been
 received by press time.
19For Inoue, data are given as (number of cig./day smoked by husband, adj. OR): (< 19, 1.58),
 (20+, 3.09).
20Taken from Rabat (1990) as closest in time and place.
21From subject responses/from proxy responses.
22For second  KABA study (see addendum in study description of KABA), preliminary
 unpublished data and analysis based on ETS exposure in adulthood indicate 68% of
 never-smokers are exposed and OR = 0.90 (90% C.I. = 0.51, 1.58), not dissimilar from the table
 entry shown.
^For the first value, "ETS exposed" means the spouse smokes; for the second value, "ETS
 exposed" means a member of the household other than the spouse smokes.
24Odds ratio is not defined because number of unexposed subjects is 0 for cases or controls.
'"Table entry is for exposure to smoking spouse, cohabitants, and/or coworkers; includes  lung
 cancers of all cell types. The OR for spousal smoking alone is for adenocarcinoma only:
 2.01 (90% C.I. = 1.20, 3.37).
26From Alderson et al.  (1985).
27From subject responses/from spouse responses.
28From crude data estimated to be the following: exposed cases 52, exposed controls 91,
 unexposed cases 38, unexposed controls 72.
29Exposure at home and/or at work.
30Known adenocarcinomas and alveolar carcinomas were excluded, but histological diagnosis was
 not available for many cases. Data are from  Trichopoulos et al. (1983).
31Raw data for WU is from Table  11 of the Surgeon General's report (U.S.  DHHS, 1986). Data
 apply to adenocarcinoma only.
32RR is based on person-years of exposure to spousal smoking. Prevalence in those units is 20%.
33Prevalence is calculated from figures in Hammond (1966) for the age distribution of the cases.
 RR is from U.S. Surgeon General (U.S. DHHS, 1982).
34RR values under never-smoker are for lung  cancer mortality.  For lung cancer incidence, crude
 RR is 1.51 (90% C.I. = 0.41, 5.48) and adjusted RR is 1.39 (95% C.I. = 0.29, 6.61).

 *Data not available.
                                           B-22

-------
Table B-12. Observed ratios of current smoker lung cancer risk to ever-smoker risk for females
Study
Alderson
et al. (1985)
Buffler .
et al. (1984)
Garf inkel and
Stellman
(1988)
Humble et al.
(1985)
Svensson
et al. (1989)
Wu et al.
(1985)
Overall
Exposed cases
plus controls
901
701
832
268
261
317
3,280
Lung
Current
smoker
4.5
7.9
12.7
18.0
8.46
6.5
8.05
cancer RR
Ever-
smoker
4.75
6.9
8.35
13.0
6.10
4.4
6.52
Ratio
Current smoker RR/
ever-sraolcer RR
0.95
1.15
1.52
1.38
1.39
1.48
1.241
lrThe summary ratio of 1.24 is the geometric mean of the individual ratios weighted by the
 exposed cases plus controls in that study.

       The elements RRoo and RR+ C00l)
                                                RR(p)0.
(B-3)

(B-4)
       Various assumptions regarding passive risks can be used for j = 1,2, and 3. We have
assumed, based on the data in Varela (1987), who found that 242 long-term former smokers had
essentially the same passive risk as 197 never-smokers, that the passive risk for former smokers is
the same as for never-smokers, namely, that RR(p)t = RR(p)0. Passive relative risks for female
smokers were taken from seven of the passive smoking studies (Akiba et al., 1986; Brownson et
                                           B-23

-------
al., 1987; Buffler et al., 1984; Humble et al., 1987; Koo et al., 1985; Wu et al., 1985; Hole et al.,
1989). The estimates range from 0.7 to 2.3 with no evident trend with either active smoking risk
or passive smoking risk.  The weighted log mean estimate is 1.25. Since the smokers not exposed
to passive smoke already are exposed to considerable ETS from their own smoking,  it is probable
that the additional ETS from others will have an additive effect rather than a multiplicative
effect. Therefore, we have assumed a difference of 0.25 between the active smoking risks of
passively exposed and nonexposed current smokers such that RR2i - RR2o = RR3i ~ RR30 - 0-25,
and RR2i/RR2o * RR(p)a and RR3i/RR3o = RR(P)S- The values for RR20 and RR30 are derived as
follows:
       RR20 = RR(a)2 - 0.25 c02i/c02., and RR21 = RR20 + 0.25
       RR30 » RR(a)3 - 0.25 C031/c03., and RR31 = RR30 + 0.25.
                                                                               (B-5)

                                                                               (B-6)
The relative risks for former smokers, RRjo and RRn> can t>e obtained by solving the equations
and
       RR(p)1 = RRn/RR10
RR(a)t « [(RRj0 c010)
                                   con)]/(c0,0 + con).
(B-7)

(B-8)
       Crude versions of the elements c^ (i = 1 for cases) are obtained by multiplying each
element c0jk by its respective RRj^. These are then normalized to give the case elements of Table
B-7 by
                            cijk:
                                   cdjkRRjk

                                   j=0 lc=0
                                                                                      (B-9)
       The next step is to set up Table B-8, which is the table of subjects by observed and true
smoking status. This is done by multiplying the observed misclassification rates (Pho/P.j) from
Tables B-3 and B-4 by the appropriate elements from Table B-7. For example, P10 = c0i.(P10/P.j).
An attempt was made to use the true misclassification rates from Tables B-3 and B-4 on the
theory that they would exhibit less variability in being transferred from the cotinine and
discordant answer studies to the passive smoking calculations.  However, the method is laborious
and, as is shown in the Correa example below, does not lead to increased accuracy.
                                           B-24

-------
       The next step is to develop a deletions table to implement Equation B-1 above using the
control and case smoking prevalences in Table B-7 and the distribution in Table B-8. Each
observed element, ci0k, in Table B-7 is multiplied by its appropriate observed misclassification
factor, Ph0 /P.j, where h = j, to yield a deletion element to be subtracted from the appropriate
observed wives' never-smoking-status elements:  CQQQ, CQQJ, c100, and c101, to obtain corrected
elements COOQ, COM, Cioo> an<* CIQI- Thus,
                                         3                 •     . •  -       -
= cooo ~  2J c()jo
            ^
                                                     etc-
(B-10)
Once these corrected never-smoker elements are obtained, the relative risk corrected for smoker
misclassification is obtained from Equation B-2; RR(c)0 = (Ci01 x COQQ)/(CIOQ x GO^), and the
bias becomes RR(p)0 /RR(c)0.

B.6. NUMERICAL EXAMPLE
       Using the Correa et al. (1983) study as an example, the study tells us that 52.8% of the
wives never smoked and that 45.9% of the never-smoking wives were exposed to their spouses'
smoke.  This establishes COQ. as 0.528 and CQQQ and CQQJ as 0.286 and 0.242, respectively. The
quantity s0., the proportion of ever-smokers, by difference is 0.472. From Correa's Table 2 we
find that the former smokers are 35.5% of the ever-smokers.  Thus, the former smokers, c0i.,
become 0.167, and the current smokers (c02. +  c03.) become 0.305.  The current smokers are
divided into current regular smokers at 90% (c03. = 0.275) and current occasional smokers at 10%
(c02. = 0.030). These data are shown in the bottom line of Table B-13.
       Using the concordance factor of 2.8 for ever-smokers versus never-smokers, it is possible
to show as described above that 33.2% of the females in the Correa study would be ever-smoker
wives with smoking husbands (s0i) and that 14.0% would be ever-smoker wives with never-
smoking husbands (SQQ). Similarly, using the concordance factor of 2.2 for former smoking wives
and ever-smoking husbands versus the never-smokers, the former smoking wives married to ever-
smoking husbands (con) would be 10.9% of the total and those married to the never-smoking
husbands (c0i0) would be 5.8%.  Then by difference, exposed current smoking wives (c021 + c031)
would be 22.3%, to be split into 20.1% regular smokers (c031) and 2.2% occasional smokers  (c021),
and the nonexposed current smoking wives (c020 + c030) would be 8.2%, split into 7.4% regular
smokers (c030) and 0.8% occasional smokers (c020). These data now supply all the elements needed
in Table B-13 and the control part of Table B-7.
       The estimate of relative  risk for passive smoking, RR(p)0, for females is 2.07 (Correa et
al.,  1983). The age- and sex-adjusted relative risk for current smoking from a related  paper
                                           B-25

-------
Table B-13.  Observed smoking prevalence among the controls—Correa example
Wife's smoking status
Husband's
smoking status
Never
Ever
All
Never
0.286
0.242
0.528
Former
0.058
0.109
0.167
Occasional
0.008
0.022
0.030
Regular
0.074
0.201
0.275
Alt
0.426
0.574
1.000
(Correa et al., 1984) is 12.6.  The ratio of female smoking crude risk to the average for males and
females is about 80%, indicating an age-adjusted current female risk of about 10. (Note:  This is
different from the current smoker relative risk that would be calculated from the crude ever-
smoker risk of 12.4 used in Table 5-7 [of this report] and  Table B-3. The adjusted risk is used
here simply as an example.)  With these inputs and the weights of controls in the study, the
various exposed and nonexposed relative risks are those shown in Table B-14.  The weighted
average risk for the occasional smokers is calculated as 0.16 (current regular risk — 1) + 1, which
for this example is 0.16 (10 — !) + != 2.44.  The weighted average risk for former smokers is 0.09
(current regular risk  — 1) + 1, which is 0.09 (10 — 1) + 1 = 1.81. The weighted average risks are
split between never-smoking and ever-smoking husbands by using the  passive risks, the
population weights, and Equations B-3, B-4, B-5, B-6, B-7, and B-8.  A crude case prevalence
table is then made up (Table B-15) by multiplying each c^ by its respective RRj^.  This table is
then normalized (Equation B-9) by dividing by 3.653 to yield Table B-16, which is the lower half
of Table B-7 for this example.
       The smoking  status distribution table (Table B-17) is developed, as described above, from
the misclassification factors in Tables B-3 and B-4 and the bottom line of Table B-13. For
example, to arrive at element (h = 3, j = 0), the observed P.3 of 0.275 is multiplied by an observed
misclassification factor of 0.0109 (from Table B-3) to yield 0.003.  To explore the value of using
the true misclassification factors instead of the observed ones, the true  and observed m's were
carried to five decimal places.  An approximation procedure to determine the true smoking
probabilities P0., PlM P2., and P3. was carried through four stages. The resulting total true
distribution of smoking status rounded to three decimal places was essentially identical to the
distribution shown in the bottom line of Table B-17. Similarly, any differences in the individual
elements were very small and beyond the accuracy of the  underlying data. The Correa study was
                                           B-26

-------
Table B-14* Observed relative risks—Correa example
Wife's smoking status
Husband's
smoking status
Never
Ever
Weighted average
Passive risk, RR(p),
Never
0.67
1.39
1.00
2.07
Former
1.07
2.21
1.81
2.07
Occasional
0-2)
2.26
2.51
2.44
1.11
Regular
9.82
10.07
10.00
1.025
Table B-15. Crude case table, prevalence of cases by smoking status—Correa example
Wife's smoking status
Husband's
smoking status
Never
Ever
All
Never
0.192
0.336
0.528
Former
0.062
0.240
0.302
Occasional
0.018
0.055
0.073
Regular
0.726
2.024
2.750
All
0.998
2.655
3.653
Table B-16. Normalized case table, prevalence of cases by smoking status—Correa example
Wife's smoking status
Husband's
smoking status
Never
Ever
All
Never
0.052
0.092
0.144
Former
0.017
0.066
0.083
Occasional
0.005
0.015
0.020
Regular
0.199
0.544
0.743
All
0.273
0.727
1.000
                                          B-27

-------
Table B-17.  Distribution of subjects by observed and true smoking status for wives in Correa
example1
- - - Wife's true ismoking status
Wife's observed
smoking status
Never (j = 0)
Ex (j - 1)
Occasional (j = 2)
Regular (j - 3)
All
Never
' (h*0)
0.499
0
0
0
0.499
Former
0.019
0.160
0
0
0.179
Occasional
0.007
0.004
0.030
0
0.041
Regular

-------
                     APPENDIX C






LUNG CANCER MORTALITY RATES ATTRIBUTABLE TO SPOUSAL




        ETS IN INDIVIDUAL EPIDEMIOLOGIC STUDIES

-------

-------
    APPENDIX C.  LUNG CANCER MORTALITY RATES ATTRIBUTABLE TO SPOUSAL
                     ETS IN INDIVIDUAL EPIDEMIOLOGIC STUDIES

       Many of the epidemiologic studies on lung cancer and environmental tobacco smoke (ETS)
were part of larger investigations that included ever-smokers and never-smokers. For those
studies, the lung cancer mortality rate (LCMR) for all causes,  appropriate to the location and time
period of the study, has been obtained from other sources. Those values and parameter estimates
from the studies are used to partition the excess LCMR from all causes (i.e., the excess after
allowance for baseline sources) into components attributable to ever-smokers (from current and
former smoking) and never-smokers (from exposure to spousal ETS) and to estimate the LCMR in
the subpopulations of interest—unexposed never-smokers (meaning not exposed to spousal
smoking), exposed never-smokers (exposed to spousal smoking), and ever-smokers ("exposed" is
not used to mean exposure to nonspousal ETS, which applies to the whole target population).  The
method is explained in Sections 6.3.1 and 6.3.2.
       Lung cancer mortality rates for the case-accrual periods of case-control studies are
displayed in Table C-l.  For the studies that collected data on both ever-smokers and never-
smokers, the parameter estimates used are shown in Table C-2. The value for the lung cancer
mortality rate is from Table C-l, and the remaining estimates  are from individual study data.  The
rate for the followup period of the study is estimated for HIRA(Coh) and GARF(Coh).  These
values  may not be very "representative" for lung cancer mortality in these two cohort studies
because they extended over several  years, and the LCMRs changed from year to year, particularly
in the United States.  This same difficulty arises in choosing a "representative" year for lung
cancer mortality in the case-control studies, although to a lesser degree. The most extreme
examples are KABA, PERS, INOU, and GARF, with case-accrual periods of 10 years or more.
       The estimates of prevalence of ever-smokers and the percentage of never-smokers exposed
to spousal smoking are the observed proportions in the control group. The extent to which the
control group is representative of the country's population differs between studies; the study
reviews in Appendix A provide more detailed information.  The restriction of cell types among
cases in some studies is another consideration. Active smoking is much more strongly associated
with occurrence of squamous and small cell carcinoma than with large cell carcinoma and
adenocarcinoma. FONT presents evidence that passive smoking is more associated with
adenocarcinoma than with other cell types.  As noted in Table  5-14, some studies excluded
candidate lung cancer cases of specific histopathological types.  This  may produce some bias and
distortion of comparison between studies.  For example, BROW includes only cases of
adenocarcinoma, which should  bias  the relative risk of ever-smokers toward unity, thus
                                          C-l

-------
Table C-l.  Female lung cancer mortality from all causes in case-control-studies1
Study
AKIB
BROW
BUFF
CHAN
CORK3
GAO4
GARF
GENG*
HIRA5
HUMB3
INOU
JANE3
KABA6
KALA6
KATA6
KOO
LAMT6
LAMW
LEE
PERS6
SHIM6
SOBU6
SVEN6
TRIG
WU
WUWI8
Location
Japan
USA
USA
HK
USA
China
USA
China
Japan
USA
Japan
USA
USA
Greece
Japan
HK
HK
HK
Eng/Wal
Sweden
Japan
Japan
Sweden
Greece
USA
China
Case
accrual
1971-80
1979-82
1976-80
1976-77
1979-82
1984-86
1971-81
1983
1965-81
1980-84
1973-83
1982-84
1961-80
1987-89
1984-87
1981-83
1983-86
1981-84
1979-82
1961-80
1982-85
1986-88
1983-85
1978-80
1981-82
1985-87
Begin
5.13
15.68
13^94
23.59
26.0
*
9.45
*
4.46
17.7
5.55
23.7
4.69
6.58
*
22.34
22.75
22.34
16.28
3.71
7.46
7.46
7.72
6.88
17.20
*
Average
6.05
17.29
15.29
23.59
26.0
18.0
13.55
27.8
5.70
17.7
6.53
23.7
13.20
6.586
7.466
22.61
23.46
22.88
17.11
5.09
7.466
7.466
7.726
6.40
18.15
11.6
End
7.08
19.09
17.20
23.59
26.0
*
17.20
*
7.08
*
7.46
*
17.20
6.58
*
22.75
23.69
23.69
17.89
7.56
7.46
7.46
7.72
5.99
19.09
*
Accrual-
lOyrs
average2
4.57
9.49
7.86
19.05
9.49
14.3s
6.87
13.83
4.01
10.55
4.93
9.06
6.61
6.75
4.66
19.82
21.33
20.09
12.60
3.956
5.65
6.36
5.78
5.75
10.14
9.22
Accrual-
20yrs
average2
2.30
4.75
4.38
*
4.75
5.13
*
*
*
5.13
2.95
5.42
4.16
5.836
2.26
*
*
*
8.1
*
4.28
4.93
3.80
5.317
4.96
*
1Rates are per 100,000 per year, standardized to the 1950 world population age distribution. Data
 are drawn from Kurihara et al. (1989), and annual rates for 2-year periods were averaged over
 the years cases were accrued for each study unless otherwise noted.  Where part (or all) of the
 accrual period fell 1 or 2 years outside the years for which rates were available, rates from the
 nearest 2-year period available were assumed to apply to the missing years. U.S. rates are for
 white females only.

                                                             (continued on the following page)
                                             C-2

-------
2The accrual-10 years average is the average for the time period of the same length as the accrual
 period but 10 years previous to it. Similarly, the accrual-20 years value is for the time period 20
 years previous to the accrual period.
3Data for accrual period from 1978-82 rates in IARC (1987b), standardized to  1950 world
 population from Kurihara et al. (1989).  For Correa, weighted average of white and black rates;
 for Humble, weighted average of Hispanic and non-Hispanic white rates.
4Accrual period data for GAO and GENG derived from IARC (1987b) by standardizing to same
 1950 world population used by Kurihara et al. (1989). GAO rates are for 1978-82; GENG, 1981-
 82. For the accrual-10 years value, GAO and GENG are 1973-75 rates standardized to the 1960
 world population from China Map Press (1979). The GAO accrual-20 years value is nonadjusted
 1961 rate from Kaplan and Tsuchitani (1978).
6The nested case-control study of Hirayama (mortality rates for this study also apply to the cohort
 study in which it is nested).
6Where rates for the period were not available in Kurihara et al. (1989), substitutions  were made as
 follows:  Kalandidi from 1984-85 rates; Rabat, 1982-83; Katada, 1982-83; Lam, T., 1984-85;
 Pershagen, 1952-53; Shimizu, 1982-83; Sobue, 1982-83; and Svensson, 1982-83.
7World-standardized rate for 1961-65 from Katsouyanni et al. (1990) (in Greek: translation
 provided by Trichopoulos).
8Accrual period value estimated by multiplying LCMR in Shanghai for period  1978-82
 (standardized to the  1950 world population) by the ratio of LCMRs in  Liaoning and Heilonjiang
 to Shanghai, for the  period 1973-75 (standardized to the 1960 world population). Data are from
 China Map Press (1979).  Value for accrual-10 years is the 1973-75 rate.

*Data not available.
                                           C-3

-------
Table C-2. Parameter values used to partition female lung cancer mortality into component
sources1
Case-control
AKIB
BROW
BUFF
CHAN
CORR
GAO
GARF(Coh)
GENG
HIRA
HIRA(Coh)
HUMB
INOU
KABA
KALA
KOO
LAMT
LAMW
LEE
SOBU
SVEN
TRIG
WU
WUWI
Lung cancer
mortality
6.05
17.29
15.29
23.59
26.00
18.00
7.002
27.80
5.70
5.702
17.70
6.53
13.20
6.58
22.61
23.46
22.88
17.11
7.46
7.72
6.40
18.15
11.60
'^'Ever-sm
Prevalence
21
29
59
26
47
18
33
41
16
16
41
16
42
17
32
24
22
60
21
43
11
58
37
DJK&IT& •*
Relative
2.38
4.30
7.06
3.48
12.40
2.54
3.58
2.77
3.20
3.20
16.30
1.66
5.90
3.32
2.77
3.77
4.12
4.61
2.81
5.97
2.ai
4.38
2.24

- ' Nevejr-Si
Percentage
exposed (%}
70
15
84
47
46
74
72
44
77
77
56
64
60
60
49
45
56
68
54
66
52
60
55
trtokers
Relative
risk
1.50
1.50
0.81
0.74
1.90
1.19
1.15
2.16
1.53
1.37
1.98
2.55
0.74
1.92
1.54
1.64
2.51
1.01
1.13
1.19
2.08
1.31
0.78
*For studies with data on both ever-smokers and never-smokers.  Table entries are
 Tables 5-8, B-ll, and C-l, which contain explanatory footnotes.
2Average of world-standardized rates for location during followup period of study
 et al. (1989).  White female rates used for GARF.
drawn from

from Kurihara
                                           C-4

-------
 attributing too little lung cancer mortality to active smoking and too much to passive smoking and
 background sources.
       Of a more positive nature, there is some advantage to using data from a single study to
 assign attributable fractions to different causes. To estimate the yearly number of lung cancers
 from each cause, the fraction is multiplied by the LCMR for the location and time of the study;
 that figure has to be obtained from sources on vital statistics. As seen in Table C-2, the mortality
 rates from lung cancer vary considerably between and within countries.  For example, the rates
 used for studies  in the United States range between 9 and 26. Applying the lung cancer rate
 suitable to each individual study should provide better estimates for comparison within  a country
 than using a single figure for the whole country for some specific year.
       Despite the reservations described, partitioning the lung cancer mortality for each study
 into components attributable to ever-smoking, spousal ETS, and baseline sources (nontobacco
 smoke and nonspousal ETS) provides a broad overview worth noting.  The calculated values are
 shown in Table C-3.  Estimates of relative risk for exposure to spousal ETS (RR2 in  notation of
 Section 6.3.2) less than 1.0 (see Table 5-9) were replaced by 1.0 to avoid a negative LCMR
 attributable to spousal ETS and the consequent inflation of the LCMR attributable to baseline
 sources and ever-smoking.  Aside from the studies for Hong Kong and China, estimates of lung
 cancer mortality due to background sources cluster  in the interval 1.5 to 5.5 (excluding BROW,
 which is strongly biased), predominantly from 3 to  5. The values for Hong Kong and China,
 however, are much higher, ranging from 7 to 14.5.  The presence of indoor sources of non-ETS
 encountered in some of the studies in China may be a factor, but there is no apparent explanation
 for the outcome  in Hong Kong. Assuming that the  background rate of lung cancer is much higher
 in Hong Kong (and possibly China) as it appears, then the question arises  as to whether  the high
 excess rate relative to  other countries may be attributable to higher exposure to ETS aside from
 spousal smoking  or whether it is more likely due to  other causes. Summary data from the
 10-country collaborative study of ETS exposure to nonsmoking women conducted by the
 International Agency for Research on Cancer (IARC) (Riboli et al., 1990) was kindly submitted to
 us for Hong Kong, Japan (Sendai), and the United States (Los Angeles, New Orleans) from  Drs.
 L.C. Koo, H. Shimizu, A. Wu-Williams, and T.H. Fontham, respectively.  The average
 cotinine/creatinine (ng/mg) levels for nonsmoking women who are not employed and not married
 to a smoker are close for Sendai, Los Angeles, and New Orleans, but they  are several times  higher
for Hong Kong.  Consequently, a high contribution  to background lung cancer mortality from
ETS aside from spousal smoking cannot be eliminated as a factor.
                                           C-3

-------
Table C-3. Female lung cancer mortality rates by attributable source1
s , ,"', „•-//! Baseline
- " sources*
Study
AKIB
BROW
BUFF
CHAN
CORR
GAO
GARF(Coh)
GENG
HIRA(Coh)
HUMS
INOU
KABA
KALA
KOO
LAMT
LAMW
LEE
SOBU
SVEN
TRIG
WU
WUWI
Location
Japan
USA
USA
HK
USA
China
USA
China
Japan
USA
Japan
USA
Greece
HK
HK
HK
Eng./Wales
Japan
Sweden
Greece
USA
China
No. ' '
3.47
8.22
3.34
14.34
2.89
12.36
3.41
10.67
3.28
1.57
2.97
4.32
3.04
11.41
10.94
7.35
5.37
5.05
2.19
3.42
5.17
7.95
% ^
57
48
22
61
11
69
49
38
58
9
45
33
46
50
47
32
31
68>
28
53
28
69
SpQusai smoking
t'//'l'i VOTln- r
" 'NO. %
0.96
0.44
0.00
0.00
0.63
1.42
0.25
3.21
0.78
0.51
2.47
0.00
1.39
2.05
2.39
4.85
0.01
0.28
0.16
1.71
0.40
0.00
16
3
0
0
2
8
4
12
14
3
38
0
21
9
10
21
0
4
2
27
2
0
Ever-smoking "
No. %
1.61
8.63
11.95
9.25
22.47
4.22
3.34
13.92
1.63
15.62
1.09
8.88
2.15
9.14
10.12
10.68
11.73
2.13
5.37
1.27
12.58
3.65
27
50
78
39
86
23
47
50
29
88
17
67
33
40
43
47
69
29
70
20
69
31
 *Rates are per 100,000 per year. Data not available for GARF, JANE, PERS, SHIM, BUTL(Coh),
 and HOLE(Coh).
 2Nonspousal ETS and non-ETS sources.
                                          C-6

-------
       The lung cancer attributable to ever-smoking, spousal smoking, and baseline sources
 depends on the population proportions for those categories as well as the relative risks.  Study
 estimates of the LCMR in each category, in units of lung cancer deaths per 100,000 at risk per
 year, are shown in Table C-4. The last two columns show the ratios of the LCMR and the excess
 LCMR for. exposed never-smokers to ever-smokers. As above, relative risk estimates of less than
 1.0 were set to  1.0 for the calculations. There is considerable variability across study estimates,
 even within the same country, as observed previously in the relative risks for spousal smoking.
       To  summarize,  for studies that included data on ever-smokers, the LCMR for all causes
 was partitioned by attributable source  (Table C-3). Although there is considerable uncertainty in
 the estimates from statistical variability and other sources, the outcomes provide some useful gross
 comparisons. For example, the lung cancer mortality rates from all causes differ markedly
 between countries and  also vary widely between studies within the United States.  The proportion:
 of lung cancers attributable to ever-smoking is very high in the United States, compared with
 some more traditional countries (e.g., Japan and Greece).
       Individual study estimates of the number of lung cancer deaths per year per 100,000 of the
 female population from exposure of never-smokers to spousal ETS are predominantly between 0
 and about 2.5. Estimates of the LCMR attributable to baseline sources (nonspousal ETS and
 nonsmoking causes) are somewhat higher, largely between 2 and 5, except in Hong Kong and
 China, where they range between 7+ and 14. (The U. S. study denoted as BROW has a high value,
 but that should  be upwardly biased because it used only cases of adenocarcinofna, which is not a
 common cell type in smokers.) For reasons discussed in Chapter 5, we would be reluctant to draw
 conclusions about China on the basis of the epidemiologic studies. The evidence from Hong
Kong, however, is very suggestive that the lung cancer rate in women due to baseline sources is
very high.  The extent to which that is attributable to nonsmoking sources of lung cancer and/or
high exposure to nonspousal ETS is not apparent.  The cotinine data for Hong Kong from the
 10-country IARC study (Riboli et al.,  1990) is consistent with excessively high ETS exposure;
therefore, nonspousal ETS may be a factor.
                                           C-7

-------
Table C-4. Lung cancer mortality rates of female ever-smokers (ES) and never-smokers (NS) by
exposure status1
Study
AKIB
BROW
BUFF
CHAN
CORR
GAO
GARF(Coh)
GENG
HIRA(Coh)
HUMB
INOU
KABA
KALA
KOO
LAMT
LAMW
LEE
SOBU
SVEN
TRIG
WU
WUWI
Location
Japan
USA
USA
HK
USA
China
USA
China
Japan
USA
Japan
USA
Greece
HK
HK
HK
Eng/Wal
Japan
Sweden
Greece
USA
China
(I)
Unexposed
3.47
8.21
3.34
14.34
2.89
12.35
3.41
10.66
3.28
1.57
2.96
4.32
3.04
11.41
10.94
7.35
5.36
5.05
2.18
3.41
5.16
7.95
~~ (2)
Exposed
NS*
5.21
12.32
3.34
14.34
5.49
14.70
3.92
23.03
4.49
3.11
7.56
3.78
5.84
17.57
17.94
18.45
5.42
5.70
2.60
7.10
6.77
7.95
ES
11.16
37.99
23.59
49.91
50.70
35.79
13.54
44.62
13.49
39.66
9.80
25.46
15.66
39.98
53.12
55.89
24.91
15.18
14.69
14.99
26.85
17.81
<2) As a
percentage
of (3)
47
32
14
29
11
41
29
52
33
8
77
17
37
44
34
33
22
38
18
47
25
45
(2) - 
-------
     APPENDIX D






STATISTICAL FORMULAE

-------

-------
a
c
b
d
                        APPENDIX D.  STATISTICAL FORMULAE

D.I. CELL FREQUENCIES
       The observed outcome of a case-control study or a cohort study may be depicted in a 2 x 2
table, where a, b, c, and d are cell frequencies.
                                                ETS Exposed
                                                 Yes    No
                              Lung Cancer   Yes
                                Present
                                            No

D.2. CASE-CONTROL STUDIES
       The true (but unknown) odds ratio is estimated by the observed odds ratio (OR),
                                       OR = ad/bc.
A confidence interval on the (true) odds ratio may be calculated from the normal approximation
to the distribution of log(OR), the natural logarithm of OR (Woolf, 1955).  The variance of
log(OR) is estimated by

                            Var(log(OR)) = I/a + 1/b + 1/c + 1/d

and the standard error by its square root,

                               SE(log(OR)) = (Var(log(OR)))*.

Approximate 90% confidence limits are given by

                               log(OR) ±  1.645 SE(log(OR)).

The value 1.645 is replaced by 1.96 for 95% confidence limits and, in general, by Za/2 for
100(1 - a)% confidence limits. The confidence bounds  obtained in this way are sometimes called
logit limits (Breslow and Day, 1980, p. 134).  Significance level (p-value) of a test for effect, i.e.,
H0: (true) odds ratio = 1 against the alternative Ha:  (true) odds ratio > 1, is the area under the
standard normal curve to the right of the value of the test statistic, given by
log(OR)/SE(log(RR)).
                                           D-l

-------
       If the (true) odds ratios are assumed to be equal in k studies, then a pooled estimate is
calculated from
                               log(OR(P))=
where the summations are on i, from 1 to k; OR(P) is the pooled estimate; log(OR)j is the
logarithm of OR from the i^ study; and w{ = (Var(log(OR)i))'1 is the weight of the i& study
(Breslow and Day, 1980).

D.3. COHORT STUDIES
       The true (but unknown) relative risk is estimated by the observed relative risk (RR),

                                    RR = (a/a+c)/(b/b+d).

A confidence interval on the (true) relative risk may be calculated from the normal approximation
to the distribution of log(RR), using the analogue of Woolf's method referred to above (Katz et
al.,  1978).  The variance of log(RR) is estimated by,

                           Var(log(RR)) = c/(a2 + ac) + d/(b2 + bd)

and the standard error by its square root,

                               SE(log(RR)) = (Var(log(RR)))i.

       The remaining calculations follow the description for case-control studies in Section D.2
with "odds ratio" and "OR" replaced by "relative risk" and "RR," respectively.  The pooled estimate
of relative risk from both case-control and cohort studies is calculated  by the same methodology
for pooling estimates from case-control studies or from cohort studies separately, i.e., the
logarithm of each individual estimate is weighted  inversely proportional to its estimated variance
(Kleinbaum et al., 1982).
                                            D-2

-------
                               SELECTED BIBLIOGRAPHY
       Note:  This section includes all references cited in the report as well as additional
references that were reviewed during the preparation of this report. This bibliography is not
intended to be a comprehensive list of all references available on the topic.

Adams, J.D.; O'Mara-Adams, K.J.; Hoffmann, D. (1987) Toxic and carcinogenic agents in
       undiluted mainstream smoke and sidestream smoke of different types of cigarettes.
       Carcinogenesis 8(5):729-731.                                                ,

Aguayo, S.M.; Kane, M.A.; King, T.E.; Schwarz, M.I.; Grauer L.; Miller, Y.E. (1989) Increased
       levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette
       smokers. J. Clin. Invest. 84:1105-1113.

Akiba, S.; Kato, H.; Blot, W.J. (1986) Passive smoking and lung cancer among Japanese women.
       Cancer Res. 46:4804-4807.

Alderson, M.R.; Lee, P.N.; Wang, R. (1985) Risks of lung cancer, chronic bronchitis, ischaemic
       heart disease, and stroke in relation to type of  cigarette smoked. J. Epidemiol. Community
       Health 39:286.

Alfeim, I.; Randahl, T. (1984) Contribution of wood combustion to indoor air pollution as
       measured by mutagenicity in Salmonella  and polycyclic aromatic hydrocarbon
       concentration. Environ. Mol. Mutagen. 6:120-121.

American Academy of Pediatrics, Committee on Environmental Hazards. (1986) Involuntary
       smoking—a hazard to children.  J. Pediatr. 77(5):755.

Ames, B.N. (1983) Dietary carcinogens  and anticarcinogens. Science 221:1256-1264.

Anderson, L.J.; Parker, R.A.; Strikas, R.A.; et al. (1988) Day-care center attendance and
       hospitalization for lower respiratory tract illness. Pediatrics 82:300-308.

Andrae, S.; Axelson, O.; Bjorksten, B.; Fredriksson, M.; Ljellman, N-IM. (1988) Symptoms of
       bronchial hyperreactivity and asthma in relation to environmental factors. Arch. Dis.
       Child. 63:473-478.

Aoki, Y.; et al.  (1987) Smoking and health. Elsevier Science Publishers B.V. (Biomedical Division),
       pp. 483-486.

Arundel, A.;  Sterling, T.; Weinkam, J. (1987) Never-smoker lung cancer risks from exposure to
       particulate tobacco smoke. Environ. Intl. 13:409-426.

Badre, R.; Guillerm, R.; Abran, N.; Bourdin, M.; Dumas, C. (1978) Atmospheric pollution by
       cigarette smoking. Ann. Pharm. Fr. 36:443-452.

Baker, R.R.;  Proctor, C.J. (1990) The origins and properties of environmental tobacco smoke.
        Environ. Int. 16:231 -245.
                                            R-l

-------
Basrur, P.K.; McClure, S.; Zilkey, B. (1978) A comparison of short-term bioassay results with
        carcinogenicity of experimental cigarettes. In: Nieburgs, H.E., ed. Prevention and
        detection of cancer, part 1, v. 2. New York: Marcel Dekker, pp. 2041-2048.

Bellofiore, S.; Eidelman, D.H.; Macklem, P.T.; Martin, J.G. (1989) Effects of elastase-induced
        emphysema on airway responsiveness  to methacholine in rats. J. Appl. Physiol. 66:606-612.

Benner, C.L.; Bayona, J.M.; Caka, P.M.; Tang, H.; Lewis, L.; Eatough, D.J. (1989) Chemical
        composition of environmental tobacco smoke. 2. Particle-phase compounds. Environ. Sci.
        Technol. 23:688-699.

Bergman, A.B.; Wiesner, B.A. (1976) Relationship of passive cigarette smoking to sudden infant
        death syndrome. Pediatrics 58:665-668.

Berkey, C.S.; Ware, J.H.; Dockery, D.W.; Ferris, B.G., Jr.; Speizer, F.E. (1986) Indoor air pollution
        and pulmonary function in preadolescent children. Am, J. Epidemiol. 123:250-260.

Bernfeld, P.; Homburger, F.;  Soto, E.; Pai, K.J. (1979) Cigarette smoke inhalation studies in
        inbred Syrian golden hamsters. J. Natl. Cancer Inst. 63:675-689.

Best, E.W.R.; Josie, G.H.; Walker, C.B. (1961) A Canadian study of mortality in relation to
        smoking habits: A preliminary report. Can. J. Public Health 52:99-106.

Bewley, B.R.; Halil, T.; Snaith, A.H. (1973) Smoking by primary schoolchildren: prevalence and
        associated respiratory symptoms. Br. J. Prev. Soc. Med. 27:150-153.

Billick, I.H.; Baker, P.E.; Colome, S.D. (1988) Simulation of indoor nitrogen dioxide
        concentrations. In: Combustion processes and the quality of the indoor environment.
        Harper, J.P., ed. Transaction of an international conference sponsored by the Air and
        Waste Management Association (TR-15). Niagara Falls, NY.

Bisgaard, H.; Dalgaard, P.; Nyboe, J. (1987) Risk factors for wheezing during infancy: a study of
        5953 infants. Acta Paediatr.  Scand. 76:719-726.

Black, N. (1984) Surgery for glue ear—a modern epidemic? Lancet 1:835-837.

Black, N. (1985) The etiology of glue ear—a case-control study. Int. J.  Pediatr. Otorhinolaryngol.
        9:121-133.

Bland, M.; Bewley, B.R.; Pollard, V.; Banks, N.M. (1978) Effect of children's and parents'
       smoking on respiratory symptoms. Arch. Dis. Child. 53:100-105.

Blot, W.J.; Fraumeni, J.F. (1986) Passive smoking and lung cancer. J. Natl. Cancer Inst.
       77(5):993-999.

Breese-Hall, C.; Hall, J.H.; Gala, C.L.; MaGill, F.B.; Leddy, J.P. (1984) Long-term prospective
       study in children after respiratory syncytial virus infection. J. Pediatr. 105:358-364.

Breslow, N.E.; Day, N.E. (1980) Statistical methods in cancer research,  v. I—The analysis of case-
       control studies. Lyon, France: IARC Sci. Publ. No. 32.
                                           R-2

-------
Breslow, N.E.; Day, N.E. (1987) Statistical methods in cancer research, v. II—The design and
       analysis of cohort studies. Lyon, France: IARC Sci. Publ. No. 82.

Britten, N. (1988) Validity of claims to lifelong nonsmoking at age 36 in a longitudinal study. Int.
       J. Epidemiol. 17(3):525-529.

Bross, I.D.J.; Gibson, R. (1968) Risk of lung cancer in smokers who switch to filter cigarettes.
       Am. J. Public Health 58:1396-1403.

Brown, C.C.; Chu, K. (1987) Use of multistage models to infer stage affected by carcinogenic
       exposure: example of lung cancer and cigarette smoking. J. Chronic Dis. 40(2):171A-179A.

Browne, C.L.;  Keith, C.H.; Allen, R.E. (1980) The effect of filter ventilation on the yield and
       composition of mainstream and sidestream smoke.  Beitr. Tabakforsch. 10:81-90.

Brownson, R.C.; Reif, J.S.; Keefe, T.J.; Ferguson, S.W.; Pritzl, J.A. (1987) Risk factors for
       adenocarcinoma of the lung. Am. J. Epidemiol. 125:25-34.

Brunekreef, B.; Boleij,  J.S.M. (1982) Long-term average suspended particulate concentrations in
       smokers' homes. Int. Arch. Occup. Environ. Health 50:299-302.

Brunekreef, B.; Fischer, P.; Remijn, B.; Van der Lende,  R.; Schouten, J.; Quanjer, P.H. (1985)
       Indoor air pollution and its effects on pulmonary function of adult nonsmoking women.
       III. Passive smoking and pulmonary function. Int. J. Epidemiol. 14:227-230.

Brunnemann, K.D.; Hoffmann, D.; Wynder, E.L.; Gori,  G.B. (1976) Chemical studies on tobacco
       smoke: 37. Determination of tar, nicotine, and carbon  monoxide in cigarette smoke. A
       comparison of international smoking conditions.  In: Wynder,  EX.; Hoffmann, D; Gori,
       G.B., eds. Modifying the risk for the smoker: proceedings of the third world conference on
       smoking and health; June 1975; New York. U.S. Department of Health, Education, and
       Welfare, National Cancer Institute; DHEW Pub. No. (NIH) 76-1221,  pp. 441-449.

Brunnemann, K.D.; Adams, J.D.; Ho, D.P.; Hoffmann D. (1978) The influence of tobacco smoke
       on indoor atmospheres. II. Volatile and tobacco-specific nitrosamines in main and
       sidestream smoke and their contribution to indoor pollution. In: Proceedings of the 4th
       joint conference on sensing of environmental pollutants. Washington, DC: American
       Chemical Society, pp. 876-880.

Brunnemann, K.D.; Kagan, M.R.; Cox, I.E.; Hoffmann, D. (1990) Analysis of 1,3-butadiene and
       other selected gas-phase components in cigarette mainstream and sidestream smoke  by gas
       chromatography—mass selective detection. Carcinogenesis 11(10):1863-1868.

Brunnemann, K.D.; Cox, J.E.; Hoffmann, D. (1992) Analysis  of tobacco-specific N-nitrosamines
       in indoor air. Carcinogenesis (in press).

Buffler, P.A.;  Pickle, L.W.; Mason, T.J.; Contant, C.  (1984) The causes of lung cancer in Texas. In:
       Mizell, M.; Correa, P., eds. Lung cancer: causes and prevention. New York: Verlag Chemie
       International, pp. 83-99.

Burchfield, C.M.; Higgins, M.W.; Keller, J.B.; Howatt, W.F.; Butler, W.J.; Higgins, I.T.T. (1986)
       Passive smoking in childhood: respiratory conditions and pulmonary function in
       Tecumseh, Michigan. Am. Rev. Respir. Dis. 133:966-973.

                                           R-3

-------
Burney, P.G.; Britton, J.R.; Chinn, S.; et al. (1987) Descriptive epidemiology of bronchial
       reactivity in an adult population: results from a community study. Thorax 42:38-44.

Burrows, B.; Halonen, M.; Barbee, R.A.; Lebowitz, M.D. (1981) The relationship of serum
       immunoglobulin E to cigarette smoking. Am. Rev. Respir. Dis. 124:523-525.

Burrows, B.; Knudson, R.J.; Cline, M.G.; Lebowitz, M.D. (1988) A reexamination of risk factors
       for ventilatory impairment. Am. Rev. Respir. Dis. 138:829-836.

Burrows, B.; Martinez, F.D.; Halonen, M.; Barbee, R.A.; Cline, M.G. (1989) Association of asthma
       with serum IgE levels and skin-test reactivity to allergens. N. Engl. J. Med. 320:271-277.

Butler, T.L. (1988) The relationship of passive smoking to various health outcomes among
       Seventh-Day Adventists in California [dissertation]. Los Angeles: University of California
       at Los Angeles.

Butler, WJ. (1990) Comments submitted to EPA on its draft report entitled "Health Effects of
       Passive Smoking: Assessment of Lung Cancer in  Adults and Respiratory Disorders in
       Children," EPA/600/6-90/006A, May 1990.

Butler, WJ. (1991) Supplementary information on confounding and the reported epidemiologic
       association between lung cancer and spousal smoking status (unpublished).

Caddeback, I.E.; Donovan, J.R.; Burg, W.R. (1976) Occupational aspects of passive smoking. Am.
       Ind. Hyg. Assoc. J. 37:263-267.

Cameron, P.; Kostin, J.S.; Oselett, B.; Stacker, R.; Tighe, G.; Winton, J.; Wolfe, J.H.; Zaks, J.M.
       (1969) The health of smokers' and nonsmokers' children.  J. Allergy 43(6):336-341.

Camilli, A.E.; Burrows, B.; Knudson, R.J.;  Lyle, S.K.; Lebowitz, M.D. (1987) Longitudinal
       changes in FEV1 in adults: effects of smoking and smoking cessation. Am. Rev. Respir.
       Dis. 135:794-799.

Cano, J.P.;  Catalin, J.; Badre, R.; Dumas, C.; Viala, A.; Guillerme, R. (1970) Determination de la
       nicotine par chromatographie  en phase gazeuse. II. Applications. Ann. Pharm. Fr.
       28:633-640.

Castro, A.;  Monji,  N. (1986) Dietary nicotine and its significance in studies on tobacco smoking.
       Biochem. Arch. 2:91-97.

CDC. See Centers for Disease Control.

Cederlof, R.; Friberg, L.; Hrubec, Z.; Lorich, U. (1975)  The relationship of smoking and some
       social covariables in mortality and cancer morbidity: a ten-year followup on a probability
       sample of 55,000 Swedish subjects age 18-69, parts 1 and 2. Stockholm, Sweden:
       Department of Environmental Hygiene, Karolinska Institute.

Centers for Disease Control. (1989a) Chronic disease reports: mortality trends—United States,
       1979-1986. MMWR 38:189-191.
                                           R-4

-------
Centers for Disease Control. (1989b) Years of potential life lost before age 65—United States,
       1987. MMWR 38:27-28.

Centers for Disease Control. (1990) The Surgeon General's 1990 report on the health benefits of
       smoking cessation: executive summary. MMWR 39:viii-10.

Centers for Disease Control. (199la) Smoking-attributable mortality and years of potential life
       lost—United States, 1988. MMWR 40:62-71.

Centers for Disease Control. (1991b) Cigarette smoking among adults—United States,  1988.
       MMWR 40:757-765.

Centers for Disease Control (CDC). (1992a) Smoking and health in the Americas: a 1992 report of
       the Surgeon General, in collaboration with the Pan American Health Organization.
       Atlanta, GA: U.S. DHHS, Public Health Service, CDC. DHHS Publication No. (CDC) 92-
       8419.

Centers for Disease Control (CDC). (1992b) Cigarette smoking among adults—United  States, 1990.
       MMWR 41:354-355, 361-362.

Chan, W.C.; Fung, S.C. (1982) Lung cancer in nonsmokers in Hong Kong. In: Grundmann, E., ed.
       Cancer campaign, v. 6, cancer epidemiology. Stuttgart, West Germany: Gustav Fischer
       Verlag, pp. 199-202.

Chan, W.C.; Colbourne, M.J.; Fung, S.C.; Ho, H.C. (1979) Bronchial cancer in Hong Kong, 1976-
       1977. Br. J. Cancer 39:182-192.

Chan, K.N.; Elliman, A.; Bryan, E.; Silverman, M. (1989a) Respiratory symptoms in children of
       low birth weight. Arch. Dis. Child. 64:1294-1304.

Chan, K.M.; Noble-Jamieson, C.M.; Elliman, A.; Bryan, E.M.; Silverman, M. (1989b) Lung
       function in children of low birthweight. Arch. Dis. Child. 64:1284-1293.

Chapman, R.S.; Mumford, J.L.; Harris,  D.B.; Xingzhou, H.; Jiang, W.; Yang, R. (1988) The
       epidemiology of lung cancer in Xuan Wei, China: current progress, issues, and research
       strategies. Arch. Environ. Health 3:180-183.

Charlton, A. (1984) Children's coughs related to parental smoking. Br. Med. J. 288:1647-1649.

Chen, Y. (1989) Synergistic effect of passive smoking  and artificial feeding on hospitalization for
       respiratory illness in early  childhood. Chest 95:1004-1007.

Chen, Y.; Li, W. (1986) The effect of passive smoking on children's pulmonary function in
       Shanghai. Am. J. Public Health 76:515-518.

Chen, Y.; Li, W.;  Yu, S. (1986) Influence of passive smoking on admissions for respiratory illness
       in early childhood. Br. Med. J. 293:303-306.

Chen, M.F.; Kimisuka, G.; Wang,  N.S. (1987) Human fetal lung changes associated with maternal
       smoking during pregnancy. Pediatr. Pulmonol. 3:51-58.
                                           R-5

-------
Chen, Y.; Li, W.; Yu, S.; Qian, W. (1988) Chang-Ning epidemiological study of children's health:
       I. Passive smoking and children's respiratory diseases. Int. J. Epidemic!. 17:348-355.

Chilmonczyk, B.A.; Knight, G.J.; Palomaki, G.E.; Pulkkinen, A.J.; Williams, J.; Haddow, J.E.
       (1990) Environmental tobacco smoke exposure during infancy. Am. J. Public Health
       80:1205-1208.

China Map Press. (1979) Atlas of cancer mortality in the People's Republic of China.

Chortyk, O.T.; Schlotzhauer, W.S. (1989) The contribution of low-tar cigarettes to environmental
       tobacco smoke. J. Anal. Toxicol. 13:129-134.

Clark, T.J.H.; Godfrey, S. (1983) Asthma. 2nd ed. Cambridge, MA: Chapman  and Hall Medical.

Claxton, L.D.; Morin, R.S.; Huges, T.J.; Lewtas, J. (1989) A genotoxic assessment of
       environmental tobacco smoke using bacterial bioassays. Mutat. Res. 222:81-99.

Coghlin, J.; Hammond, S.K.; Gann, P. (1989) Development of epidemiologic tools for measuring
       environmental tobacco smoke exposure. Am. J. Epidemiol.  130:696-704.

Cogswell, J.J.; Mitchel, E.B.; Alexander, J. (1987) Parental smoking, breast feeding, and
       respiratory infection in development of allergic diseases.  Arch. Dis. Child. 62:336-344.

Colley, J.R.T. (1971) Respiratory disease in childhood. Br. Med.  Bull. 27:9-14.

Colley, J.R.T. (1974) Respiratory symptoms in children and parental smoking  and phlegm
       production. Br. Med. J. 2:201-204.

Colley, J.R.T.; Holland, W.W.; Corkhill, R.T. (1974) Influence of passive smoking and parental
       phlegm on pneumonia and bronchitis in early childhood.  Lancet 2:1031-1034.

Collier, A.M.; Goldstein,  G.M.; Shrewsbury, R.P.; Zhang, C.A.; Williams, R.W. (1990) Urine
       cotinine elimination half-life in young children exposed to  sidestream  cigarette smoke. In:
       Indoor air '90: proceedings of the 5th international conference on indoor air quality and
       climate, v. 2, Characteristics of indoor air; July-August. Ottawa, Ontario, Canada: Canada
       Mortgage and Housing Corporation, pp. 195-200.

Collins, M.H.; Moessinger, A.C.;  Kleinerman, J.; Bassi, J.; Rosso, P.; Collins, A.M.; James, L.S.;
       Blanc, W.A. (1985) Fetal lung hypoplasia associated with  maternal smoking: a
       morphometric analysis. Pediatr. Res. 19:408-412.

Comstock, G.W.; Meyer, M.B.; Helsing, K.J.; Tockman, M.S. (1981) The respiratory effects of
       household exposure to tobacco smoke and gas cooking. Am. Rev. Respir. Dis. 124:143-148.

Corbo, G.M.; Fuciarelli, F.; Foresi, A.; De Benedetto, F. (1989) Snoring in children: association
       with respiratory symptoms and passive smoking. Br. Med. J. 299:1491-1494.

Correa, P.; Fontham, E.; Pickle, L.; Lin, Y.; Haenszel, W. (1983)  Passive smoking and lung cancer.
       Lancet 2:595-597.
                                           R-6

-------
Correa, P.; Pickle, L.W.; Fontham, E.; Dalager, N.; Lin, Y.; Haenszel, W.; Johnson, W.D. (1984)
       The causes of lung cancer in Louisiana. In: Mizell, M.; Correa, P., eds. Lung cancer: causes
       and prevention. New York, NY: Verlag Chemie International, pp. 73-82.

Coultas, D.B.; Howard, C.A.; Peake, G.T.; Skipper, B.J.; Samet, J.M. (1987) Salivary cotinine
       levels and involuntary tobacco smoke exposure in children and adults in New Mexico. Am.
       Rev. Respir. Dis. 136:305-309.

Coultas, D.B.; Howard, C.A.; Peake, G.T.; Skipper, B.J.; Samet, J.M. (1988) Discrepancies between
       self-reported and validated cigarette smoking in a community survey of New Mexico
       Hispanics. Am. Rev. Respir. Dis.  137:810-814.

Coultas, D.B.; Peake, G.T.; Samet, J.M. (1989) Questionnaire assessment of lifetime and recent
       exposure to environmental tobacco smoke. Am. J. Epidemiol. 130:338-347.

Coultas, D.B.; Samet, J.M.; McCarthy,  J.F.; Spengler, J.D. (1990a) A personal monitoring study to
       assess workplace exposure  to environmental tobacco smoke.  Am. J. Public Health
       80:988-990.

Coultas, D.B.; Samet, J.M.; McCarthy,  J.F.; Spengler, J.D. (1990b) Variability of measures of
       exposure to environmental tobacco smoke in the home. Am. Rev. Respir. Dis. 142:602-606.

Cummings, K.M. (1990, December 4) Statement to the U.S. Environmental Protection Agency
       Science Advisory Board Indoor Air Quality and Total Human Exposure Committee.
       Environmental Tobacco Smoke Review, Arlington, VA.

Cummings, K.M.; Markello, S.J.; Mahoney, M.C.; Marshall, J.R. (1989) Measurement of lifetime
       exposure to passive  smoke. Am. J. Epidemiol. 130:122-132.

Cummings, K.M.; Markello, S.J.; Mahoney, M.C.; Bhargava, A.K.; et al. (1990) Measurement of
       current exposure to  environmental tobacco smoke. Arch. Environ. Health 45:74-79.

Cutz, E.; Chan, W.; Track, N.S. (1981) Bombesin, calcitonin, and leuenkephalin immunoreactivity
       in endocrine cells of the human lung. Experientia (Basel) 37:765-767.

Dagle, G.E.; McDonald, K.E.; Smith, L.G.; Stevens, D.L., Jr. (1978) Pulmonary carcinogenesis in
       rats given implants of cigarette smoke condensate in beeswax pellets. J. Natl. Cancer Inst.
       61:905-910.

Dalager, N.A.; Pickle, L.W.; Mason, T.J.; Correa, P.; Fontham, E.; Stemhagen,  A.; Buffler, P.A.;
       Ziegler, R.G.; Fraumeni, J.F. (1986) The relation of passive smoking to lung cancer.
       Cancer Res. 46:4808-4811.

Davies, R.F.; Day, T.D. (1969) A study of the comparative carcinogenicity of cigarette and cigar
       smoke condensate on mouse skin. Br. J. Cancer 23:363-368.

Davis, R.A.; Stiles, M.F.; DeBethizy, J.D.; Reynolds, J.H. (1991) Dietary nicotine: a source of
       urinary cotinine. Food Chem. Toxicol. 29(12):821-827.

Day, N.E.; Brown, C.C. (1980) Multistage models and primary prevention of cancer. J. Natl.
       Cancer Inst. 64:977-989.
                                           R-7

-------
 Dean, G.; Lee, P.N.; Todd, G.F.; Wicken, A.J. (1977) Report on a second retrospective study in
        Northeast England. Part I: Factors related to mortality from lung cancer, bronchitis, heart
        disease, and stroke in Cleveland County, with particular emphasis on the relative risks
        associated with smoking filter and plain cigarettes. Research Paper 14. London: Tobacco
        Research Council.

 Deaner, R.M.; Trummer, M.J. (1970) Carcinoma of the lung in women. J. Thorac. Cardiovasc
        Surg. 59:551-554.

 DeMarini, D.M. (1983) Genotoxicity of tobacco smoke and tobacco smoke condensate. Mutat  Res
        114:59-89.                                                          .     ,

 Dijkstra, L.; Houthuijs, D.; Brunekreef, B.; Akkerman, I.; Boleij, J.S.M. (1990) Respiratory health
        effects of  the indoor  environment in a population of Dutch children. Am. Rev. Respir
        Dis. 142:1172-1178.

 Dodge, R. (1982) The effects of indoor pollution on Arizona children. Arch. Environ Health
        37:151-155.

 Doll, R. (1971) The age distribution of cancer. Implication for models of carcinogenesis J R Stat
        Soc. A. 134:133-155.

 Doll, R.; Hill, A.B. (1964a) Mortality in relation to smoking: ten years' observations of British
        doctors. Br. Med. J. i:l399-1410.

 Doll, R.; Hill, A.B. (1964b) Mortality in relation to smoking: ten years' observations of British
        doctors. Br. Med. J. i: 1460-1467.

 Doll, R.; Peto, R. (1976) Mortality in relation to smoking: 20 years' observations on male;British
        doctors. Br. Med. J. ii: 1525-1536.

 Doll, R.; Peto, R. (1978) Cigarette smoking and bronchial carcinoma: dose and time relationships
        among regular smokers and lifelong nonsmokers. J. Epidemiol. Community Health
        32:303-313.

 Doll, R.; Hill, A.B.; Kreyberg, L. (1957) The significance of cell type in relation to the aetiology
        of lung cancer. Br. J.  Cancer  11:43-48.

 Doll, R.; Gray, R.; Hafner, B.; Peto, R. (1980) Mortality in relation to smoking: 22 years'
        observations on female British doctors. Br. Med. J. i:967-971.

 Dontenwill, W.; Chevalier, H.J.; Harke, H.P.; Lafrenz, U.; Reckzeh, G.; Schneider, B. (1973)
       Investigations on the effects of chronic cigarette smoke inhalation in Syrian golden
       hamsters. J. Natl. Cancer Inst. 51:1781-1832.

Dube, M.F.; Green, C.R. (1982) Methods of collection of smoke for analytical purposes.  Recent
       Adv. Tobacco Sci. 8:42-102.

Due, T.V.; Huynh, C.K. (1989) Sidestream tobacco smoke constituents in indoor air modelled in
       an experimental chamber—polycyclic aromatic hydrocarbons.  Environ. Int. 15:57-64.
                                            R-8

-------
Dupont, W.D.; Plummer, W.D. (1990) Power and sample size calculations: a review and computer
       program. In: Controlled clinical trials, v. 11. New York: Elsevier Science Publishing Co.,
       pp.116-128.

Dutau, G.; Enjaume, C.; Petrus, M.; Darcos, P.; Demeurisse, P.; Rochiccioli, P. (1981) Enquete
       epidemiologue sur le tabagisme passif des enfants de 0 a 6 ans. Arch. Fr. Pediatr.
       38:721-725.

Eatough, D.J.; Benner, C.; Mooney, R.L.; Batholomew, D.; Steiner, D.S.; Hansen, L.D.; Lamb,
       J.D.; Lewis, E.A. (1986) Gas and particle phase nicotine in environmental tobacco smoke:
       proceedings of 79th annual meeting of the Air Pollution Control  Association; June;
       Minneapolis, MN. Paper 86-685.

Eatough, D.J.; Benner, C.L.; Bayona, J.M.; Caka, H.; Tang, H.; Lewis, L.; Lamb, J.D.; Lee, M.L.-
       Lewis, E.A.; Hansen, L.D. (1989a) Measurement of toxic and related air pollutants.
       Pittsburgh, PA: Air  Pollution Control Association, pp. 132-139.

Eatough, D.J.; Benner, C.L.; Tang, H.; Landon, V.; Richards, G.; Caka, P.M.; Crawford, F.;
       Lewis, E.A.; Hansen, L.D.; Eatough, N.L. (1989b) The chemical composition of
       environmental tobacco smoke. III. Identification of conservative tracers of environmental
       tobacco smoke. Environ. Int.  15:19-28.

Eatough, D.J.; Caka, P.M.;  Crawford, J.; Braithwaite, S.; Hansen, L.D.; Lewis, E.A. (1990)
       Environmental tobacco smoke in commercial aircraft. In: Indoor air '90: proceedings of the
       5th international conference on indoor air quality and climate, v. 2, Characteristics of
       indoor air; July-August. Ottawa, Ontario, Canada: Canada Mortgage and Housing
       Corporation, pp. 311-316.

Ehrlich, R.; Kattan,  M.; Godbold, J.; Saltzberg, D.S.; Grimm, K.T.; Landrigan, P.J.; Lilienfeld,
       D.E. (1992) Childhood asthma and passive smoking. Urinary cotinine as a biomarker of
       exposure. Am. Rev. Respir. Dis. 145:594-599.

Ekwo, E.; Weinberger, W.M.; Lachenbruch, P.A.; Humtley, W.H. (1983) Relationship of parental
       smoking and gas cooking to respiratory disease in children. Chest 84:662-668.

Elliot, L.P.; Rowe, D.R. (1975) Air quality during public gatherings. J. Air Pollut. Control Assoc.
       25:635-636.

Etzel, R.A.; Greenberg, R.A.; Haley, N.J.; Loda, F.A. (1985) Urinary cotinine excretion in
       neonates exposed to tobacco smoke products in utero. J. Pediatr. 107:146-148.

Etzel, R.A.; Pattishall, E.N.; Haley, N.J.; Fletcher, R.M.; Henderson, F.W. (1992) Passive smoking
       and middle ear effusion among children in day care. Pediatrics 90:228-232.

Eudy, L.W.; Thorne, F.A.;  Heavor, D.L.; Green, C.R.; Ingebrethsen, B.J. (1985) Studies on the
        vapour-phase distribution of environmental nicotine by selected trapping and detection
        methods. Presented at: 39th Tobacco Chemists Research Conference; October; Montreal.

Eudy, L.W.; Thomas, F.A.; Heavner, D.L.; Green, C.R.; Ingebrethsen, B.J. (1986) Studies on the
        vapor-particulate phase distribution of environmental nicotine by selective trapping and
        detection methods:  proceedings of the Air Pollution Control Association 79th annual
        meeting; June; pp. 2-14.

                                            R-9

-------
 Evans, D.; Levison, J.; Feldman, C.H.; et al. (1987) The impact of passive smoking on emergency
        room visits of urban children with asthma. Am. Rev. Respir. Dis. 135:567-572.

 Evans, R.; Mullolly, D.I.; Wilson, R.W.; Gergen, P.J., Rosenberg, H.M.; Grauman, T.S.; Chevarley,
        P.M.; Feinleib, M. (1987) National trends in the morbidity and mortality of asthma in the
        U.S.: prevalence, hospitalization and death from asthma over two decades: 1965-1984.
        Chest 91, June 1987, supplement, pp. 65S-72S.

 Federal Trade Commission. (1990) Tar, nicotine, and carbon monoxide of the smoke of 370
        varieties of domestic cigarettes. Federal Trade Commission, Washington, DC.

 Feinlein, M. (1987) National trends in the morbidity and mortality of asthma in the U.S. Chest
        91(6):655-745.

 Fergusson, D.M.; Horwood L.J.; Shannon, F.T.; Taylor, B. (1981) Paternal smoking and lower
        respiratory illness in the first three years of life. J. Epidemiol. Community Health
        35:180-184.

 Ferris, E.G.; Ware, J.H.; Berkey, C.S.; Dockery, D.W.; Spiro, A.; Speizer, F.E. (1985) Effects of
        passive smoking on health of children. Environ. Health Perspect. 62:289-295.

 Feyerabend, C.; Higenbottam, T.; Russell, M.A.H. (1982) Nicotinic concentrations in urine and
        saliva of smokers and nonsmokers. Br. Med. J. 284:1002-04.

 Fielding, J.E. (1985) Smoking: health effects and  control (part I). N. Engl. J. Med. 313:491.

 Fiore, M.C.; Novotny, T.E.; Pierce, J.P.; Hatziandreu, E.J.; Patel, K.M.; Davis, R.M. (1989)
        Trends in cigarette smoking in the United States: the changing influence of gender and
        race. JAMA 261:49-55.

 First, M.W. (1984) Environmental tobacco smoke measurements: retrospect and prospect. Eur. J.
        Respir. Dis. 65 (Suppl. 133):9-16.

 Fleming, D.W.; Cochi, S.L.; Hightower, A.W.; Broome, C.V. (1987) Childhood upper respiratory
        tract infections: to what degree is incidence affected by day-care attendance? Pediatrics
        79:55-60.

 Floderus, B.; Cederlof, R.; Friberg, L. (1988) Smoking and mortality: a 21-year followup based on
        the Swedish Twin Registry. Int. J. Epidemiol.  17(2):322.

 Fontham, E.T.H.; Correa, P.; Wu-Williams, A.;  Reynolds, P.; Greenberg, R.S.; Buffler, P.A.;
       Chen, V.W.; Boyd, P.; Alterman, T.; Austin, D.F.; Liff, J.; Greenberg, S.D. (1991,
       November) Lung cancer in nonsmoking women: a multicenter case-control study. Cancer
       Epidemiol. Biomarkers Prev. l(l):35-334.

 Fontham, E.T.H.; Correa, P.; Wu-Williams, A.;  Reynolds, P.; Greenberg, R.S.; Buffler, P.A.;
       Chen, V.W.; Boyd, P.; Alterman, T.; Austin, D.F.; Liff, J.; Greenberg, S.D. (1992,
       May/June) Reply. Cancer Epidemiol. Biomarkers Prev. l(l):333-334.

Fraser, G.E.; Beeson, W.L.; Phillips, R.L. (1991) Diet and lung cancer in California Seventh Day
       Adventists. Am. J. Epidemiol. 133:683-693.
                                           R-10

-------
Freedman, D.A.; Navidi, W. (1987a) On the multistage model for carcinogenesis. Tech. Report.
       No. 47, University of California.

Freedman, D.A.; Navidi, W. (198?b) On the risk of lung cancer for ex-smokers. Tech. Report. No.
       135, University of California.

Friedman, G.D.; Petitti, D.B.; Bawol, R.D. (1983) Prevalence and correlates of passive smoking.
       Am. J. Public Health 73:401-406.

Gaffney, M.; Altshuler, B. (1988) Examination of the role of cigarette smoke in lung
       carcinogenesis using multistage models. J. Natl. Cancer Inst. 80:925-931.

Gairola, C. (1982) Genetic effects of fresh cigarette smoke in Saccharomyces cerevisiae. Mutat.
       Res. 102:123-136.

Gao, Y.; Blot, W.J.; Zheng, W.; Ershow, A.G.; Hsu, C.W.; Levin, L.I.; Zhang, R.; Fraumeni, J.F.
       (1987) Lung cancer among Chinese women. Int. J. Cancer 40:604-609.

Garfinkel, L. (1981) Time trends in lung cancer mortality among nonsmokers and a note on
       passive smoking. J. Natl. Cancer Inst. 6:1061-1066.

Garfinkel, L. (1984) Passive smoking and cancer: American experience. Prev. Med. 13:691-697.

Garfinkel, L. (1985) Selection, followup, and analysis in the American Cancer Society prospective
       studies. Presented at a workshop on the selection, followup, and analysis in prospective
       studies held at the Waldorf-Astoria Hotel; October 1983; New York.

Garfinkel,  L.; Silverberg, E. (1991) Lung cancer and smoking trends in the United States over the
       past 25 years. Ca 41:137-145.

Garfinkel,  L.; Stellman, S.D. (1988) Smoking and lung cancer in women: findings in a prospective
       study. Cancer Res. 48:6951-6955.

Garfinkel, L.; Auerbach, O.; Joubert, L. (1985)  Involuntary smoking and lung cancer: a
       case-control study. J. Natl.  Cancer Inst.  75:463-469.

Geller-Bernstein, B.; Kenett, R.; Weisglass, L.; Tsur, S.; Lahav, M.; Levin, S. (1987) Atopic babies
       with wheezy bronchitis. Allergy 42:85-91.

Geng, G.; Liang, Z.H.; Zhang, G.L. (1988) On the relationship between smoking and female lung
       cancer.  In: Smoking and health. Elsevier Science Publishers, pp. 483-486.

Gerrard, J.W.; Helner, D.C.; Ko, C.G.; Mink, J.; Meyers, A.; Dosman, J.A. (1980) Immunoglobulin
        levels in smokers and nonsmokers. Ann. Allergy 44:261-262.

Gillis, C.R.; Hole, D.J.; Hawthorne, V.M.; Boyle, P.  (1984) The effect of environmental tobacco
        smoke in two urban communities in the  west of Scotland. Eur. J. Respir. Dis.
        133(Suppl.):121-126.

 Glantz, S.A.; Parmley, W.W. (1991) Passive smoking and heart disease. Circulation 83:1-12.
                                           R-ll

-------
 Goldstein, G.M.; Collier, A.; Etzel, R.; Lewtas, J.; Haley, N. (1987) Elimination of urinary
        cotinine in children exposed to known levels of side-stream cigarette smoke. In: Seifert,
        H.; Esdorn, M.; Fischer, H.; Ruden, J.; Wegner, eds. Indoor air '87, v. 2. Berlin:
        Oraniendruck GmbH, pp. 61-67.

 Gortmaker, S.L.; Walker, D.K.; Jacobs, F.H.; Ruch-Ross, H. (1982) Parental smoking and the risk
        of childhood asthma. Am. J. Public Health 72:572-579.

 Graham, N.M.H.; Woodward, A.J.; Ryan, P.; Douglas, R.M. (1990) Acute respiratory illness in
        Adelaide children. II. The relationship of maternal stress, social supports, and family
        functioning. Int. J. Epidemiol. 19:937-944.

 Greenberg, R.A.; Haley, N.J.; Etzel, R.A.; Loda, F.A. (1984) Measuring the exposure of infants to
        tobacco smoke. N. Engl. J. Med. 310:1075-1078.

 Greenberg, R.A.; Bauman, K.E.; Glover, L.H.; Strechar, V.J.; Kleinbaum, D.G.; Haley, N.J.;
        Stedman, H.C.; Fowler, M.G.; Loda, F.A. (1989) Ecology of passive smoking by young
        infants. J. Pediatr. 114:774-780.

 Greenberg, R.A.; Bauman, K.E.; Strecher, V.J.; Keyes, L.L.; Glover, L.H.;  Haley, N.J.; Stedman,
        H.C.; Loda, F.A. (1991) Passive smoking during the first year of life. Am. J. Public Health
        81:850-853.

 Greenland, S. (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol.
        Rev. 9:1-30.

 Grimmer, G.; Brune, H.; Dettbarn, G.; Naujack, K.-W.; Mohr, U.; Wenzel-Hartung, R. (1988)
        Contribution of polycyclic aromatic compounds to the carcinogenicity of sidestream smoke
        of cigarettes evaluated by implantation into the lungs of rats. Cancer Lett. 43:173-177.

 Grimsrud, D.T.; Sherman, M.H.; Sonderegger, R.C. (1982) Calculating infiltration: implications
       for a construction quality standard. In: Proceedings of the ASHRAE-DOE Conference on
       the Thermal Performance of the Exterior Envelope of Buildings II; December; Las Vegas,
       NV. New York: ASHRAE, pp. 422-452.

 Grot, R.A.; Clark, R.E. (1979) Air leakage characteristics and weatherization techniques for low-
       income housing. In: Proceedings of the ASHRAE-DOE Conference on the Thermal
       Performance of the Exterior Envelope of Buildings; December;  Orlando, FL. New York:
       ASHRAE, pp. 178-194.

 Guerin, M. (1987) Formation and physicochemical nature of sidestream smoke. In: O'Neill, I.K.;
       Brunnemann, K.D.; Dodet, B.; Hoffmann, D., eds. Environmental carcinogens—selected
       methods of analysis: v. 9, passive smoking. IARC Monographs No. 81. Lyon, France:
       International Agency for Research on Cancer.

Guerin, M.R.; Jenkins, R.A.; Tomkins, B.A. (1992) The chemistry of environmental tobacco
       smoke: composition and measurement. Chelsea, MI: Lewis Publishers.

Gwinn, J.V.; Martinez, F.D.; Wright, A.L.; Ray, C.G.; Taussig, L.M. (1991) Etiology and
       symptomatology of lower respiratory illnesses (LRIs) in the first three years of life. Am.
       Rev. Respir. Dis. 143:A509.
                                          R-12

-------
Haddow, J.E.; Palomaki, G.E.; Knight, G.J. (1986) Use of serum cotinine to assess the accuracy of
       self-reported nonsmoking. Br. Med. J. 293:1306.

Haddow, I.E.; Knight, G.J.; Palomaki, G.E.; Kloza, E.M.; Wald, N.J. (1987) Cigarette
       consumption and serum cotinine in relation to birthweight. Br. J. Obstet. Gynaecol.
       94:678-681.

Haddow, I.E.; Knight, G.J.; Palomaki, G.E.; et al. (1988) Second-trimester serum cotinine levels
       in nonsmokers in relation to birthweight. Am. J. Obstet. Gynecol. 159:481-484.

Haenszel, W.; Taeuber, K.E. (1964) Lung-cancer mortality as related to residence and  smoking
       histories. II. White females. J. Natl. Cancer Inst. 32:803-838.

Haglund, B.; Cnattingius, S. (1990) Cigarette smoking as a risk factor for sudden infant death
       syndrome: a population-based study. Am. J. Public Health 80:29-32.
                                                                                  /      •
Haley, N.J.; Colosimo, S.G.; Axelrad, C.M.; Harris, R.; Sepkovic, D.W. (1989) Biochemical
       validation of self-reported exposure to environmental tobacco smoke. Environ. Res.
       49:127-135.

Halonen, M.; Barbee, R.A.; Lebowitz, M.D.; Burrows, B. (1982) An epidemiologic study of the
       interrelationships of total serum immunoglobulin E, allergy skin-test reactivity, and
       eosinophilia. J. Allergy Clin. Immunol. 69:221-228.

Halonen, M.; Stern, D.; Lyle, S.; Wright, A.; Taussig, L.; Martinez, F.D. (1991) Relationship of
       total serum IgE levels in cord and 9-month sera of infants. Clin. Exp. Allergy  21:235-241.

Hammond, E.C. (1966) Smoking in relation to the death rates of one million men and  women. In:
       Haenszel, W., ed. Epidemiological approaches to the study of cancer and other chronic
       diseases. Washington, DC: National Cancer Institute Monograph No. 19, pp.  127-204.

Hammond, E.G.; Horn, D. (1958a) Smoking and death rates: report on forty-four months of
       followup of 187,783 men. I. Total mortality. JAMA 166:1159-1172.

Hammond, E.G.; Horn, D. (1958b) Smoking and death rates: report on forty-four months of
       followup of 187,783 men. II. Death rates by cause. JAMA 166:1294-1308.

Hammond, S.K.; Leaderer, B.P. (1987) A diffusion monitor to measure exposure to  passive
       smoking. Environ. Sci. Technol. 21:494-497.

Hammond, E.G.; Seidman, H. (1980) Smoking and cancer in the United States. Prev. Med. 9:
        169-173.

Hammond, E.C.; Selikoff, I.J. (1981) Commentary: passive smoking and lung cancer with
       comments on two new papers. Environ. Res. 24:444-452.

Hammond, S.K.; Leaderer, B.P.; Roche, A.C.; Schenker, M. (1987) Collection and analysis of
       nicotine as a marker for environmental tobacco smoke. Atmos. Environ. 21:457-462.

Hammond, S.K.; Smith, T.J.; Woskie, S.R.; Leaderer, B.P.; Bettinger, N. (1988) Markers of
       exposure to diesel exhaust and cigarette smoke in railroad workers. Am. Ind. Hyg. Assoc.
       J. 49:516-522.

                                           R-13

-------
 Hammond, S.K.; Lewtas, J.; Mumford, J.; Henderson, J.; Henderson, F.W. (1989) Exposures to
        environmental tobacco smoke in homes. In: Measurement of toxic and related air
        pollutants. U.S. Environmental Protection Agency/Air and Waste Management Association
        international symposium. Pittsburgh, PA: Air and Waste Management Association,
        pp. 590-595.

 Hammond, S.K.; Gann, P.H.; Coughlin, J.; Tannenbaum, S.R.; Skipper, P.L. (1990) Tobacco
        smoke exposure and carcinogen-hemoglobin adducts. In: Indoor air '90: proceedings of the
        5th international conference on indoor air quality and climate, v. 2, Characteristics of
        indoor air; July-August. Ottawa, Ontario, Canada: Canada Mortgage and Housing
        Corporation, pp. 157-161.

 Hanbury, W.J. (1964) Bronchogenic carcinoma in women. Thorax 19:338-342.

 Hanrahan, J.P.; Tager, I.E.; Segal, M.R.; et al. (1990) Effect of prenatal smoking on infant lung
        function. Am. Rev. Respir. Dis. 141:A282.

 Hanson, B.; McGue, M.; Roitman-Johnson, B.; Segal, N.L.; Bouchard, T.J.; Blumenthal, M.N.
        (1991) Atopic disease and immunoglobulin E in twins reared apart and together. Am. J.
        Hum. Genet. 48:873-879.

 Harmsden, H.; Effenberger, E. (1957) Tobacco smoke in public transportation, dwellings, and
        work rooms. Arch. Hyg. 141:383-400.

 Hasselblad, V.; Humble, C.G.; Graham, M.G.; Anderson, H. (1981) Indoor environmental
        determinants of lung function in children. Am. Rev. Respir. Dis. 123:479-485.

 Hawthorne, V.M.;  Fry, J.S. (1978) Smoking and health: the association between smoking
        behaviour,  total mortality, and cardiorespiratory disease in West Central Scotland. J.
        Epidemiol. Community Health 32:260-266.

 Hawthorne, A.R.; Gammage, D.; Dudney, C.S.; Hingerty, B.E.;  Schuresko,  D.D.; Parzyek, D.C.;
        Womak, D.R.; Morris, S.A.; Westeley, R.R.; White, D.A.; Schrimscher, J.M. (1984) Air
        indoor quality study of forty east Tennessee homes. ORNL 5965. Oak Ridge, TN: Oak
        Ridge National Laboratory, pp. 134.

 He, X-Z.; Chen, W.; Liu, Z-Y.; Chapman, R.S. (1991) An epidemiological study of lung cancer in
        Xuan Wei County, China: current progress. Case-control study on lung cancer and
        cooking fuel. Environ. Health Perspect. 94:9-13.

 Henderson, F.W.; Reid, H.F.; Morris. R.; et al. (1989) Home air nicotine levels and urinary
       cotinine excretion in preschool children. Am. Rev. Respir. Dis. 140:197-201.

 Higgins, C.E.; Jenkins, R.A.; Guerin, M.R. (1987) Organic vapor phase composition of sidestream
       and environmental tobacco smoke from cigarettes. In: Proceedings of the U.S.
       Environmental Protection Agency/Air Pollution Control Association symposium on
       measurement of toxic and related air pollutants, Research Triangle Park, NC, pp.  140-151.

Hill, A.B. (1953)  Observation and experiment. N. Engl. J. Med. 248:995-1001.

Hill, A.B. (1965)  The environment and disease: association or causation? Proc. R. Soc. Med.
       58:295-300.
                                          R-14

-------
Hinds, W.C.; First, M.W. (1975) Concentrations of nicotine and tobacco smoke in public places, N.
       Engl. J. Med. 292:844-845.

Hinton, A.E. (1989) Surgery for otitis media with effusion in children and its relationship to
       parental smoking. J. Laryngol. Otol. 103:559-561.

Hirayama, T. (1967) Smoking in relation to the death rates of 265,118 men and women in Japan.
       Tokyo: National Cancer Center Research Institute.

Hirayama, T. (1975a) Smoking and cancer: a prospective study on cancer epidemiology based on a
       census population in Japan. In: Steinfeld, J.; Griffiths, W.; Ball, K.; et al., eds. Proceedings
       of the 3rd world conference on smoking and health, v. 2, Washington, DC: U.S.
       Department of Health, Education, and Welfare, pp. 65-72.

Hirayama, T. (1975b) Prospective studies on cancer epidemiology based on a census population in
       Japan. In: Bucalossi, P.; Veronesi, U.; Cascinelli, N., eds. Proceedings of the 11th
       international cancer congress; v. 3, Cancer epidemiology, environmental factors; 1974;
       Florence, Italy; Amsterdam: Exerpta Medica, pp. 26-35.

Hirayama, T. (1977) Epidemiology of lung cancer based on population studies. In: National Cancer
       Center Library, ed. Collected papers from the National Cancer Center Research Institute,
       v. 12. Tokyo: National Cancer Center, pp. 452-461.

Hirayama, T. (1978) Prospective studies on cancer epidemiology based on census population in
       Japan. In: Nieburgs, H.E., ed. Prevention and detection of cancer, v. 1, Etiology. New
       York: Marcel Dekker, pp. 1139-1147.                                         ,

Hirayama, T. (198la) Nonsmoking wives of heavy smokers have a higher risk of lung cancer: a
       study from Japan. Br. Med. J. 282:183-185.

Hirayama, T. (1981b) [Letter] Br. Med. J. 283:916-917.

Hirayama, T. (1982) Smoking and cancer in Japan. A prospective study on cancer epidemiology
       based on census population in Japan.  Results of  13 years followup. In: Tominaga, S.; Aoki,
       K., eds. The UICC smoking control workshop; August 1981; Nagoya, Japan. Nagoya:
       University of Nagoya Press, pp. 2-8.

Hirayama, T. (1983a) Passive smoking and lung cancer. Presented at the 5th world conference on
       smoking and health, Winnipeg, Canada.

Hirayama, T. (1983b) Passive smoking and lung cancer:  consistency of association. Lancet
       2:1425-1426.

Hirayama, T. (1984) Cancer mortality in nonsmoking women with smoking husbands based on a
       large-scale cohort study in Japan. Prev. Med. 13:680-690.

Hirayama, T. (1985) A cohort study on cancer in Japan. In: Blot, W.J.; Hirayama, T.; Hoel, D.G.,
       eds. Statistical methods in cancer epidemiology. Hiroshima: Radiation Effects Research
       Foundation, pp. 73-91.

Hirayama, T. (1988) Duration of exposure as a determinant of lung cancer risk in passive smokers.
        Environ. Tech. Lett. 9:731-732.

                                           R-15

-------
 Hirayama, T. (1989) Dietary habits are of limited importance in influencing the lung cancer risk
        among Japanese females who never smoked. In: Bieva, D.J.; Courtois, Y.; Govaerts, M.,
        eds. Present and future of indoor air quality. New York: Elsevier.

 Hirayama, T. (1990a) Passive smoking and cancer: the association between husbands' smoking and
        cancer in the lungs of nonsmoking wives. In: Kaskuga, H., ed. Indoor air quality. Berlin:
        Springer-Verlag.

 Hirayama, T. (1990b) Life-style and mortality; a large-scale census-based cohort study in Japan.
        In: Wahrendorf, J., ed. Contributions to epidemiology and biostatistics. Tokyo: Karger.

 Hoegg, U.R. (1972) Cigarette smoke in closed  spaces. Environ. Health Perspect. 2:117-128.

 Hoffman, H.J.; Damus, K.; Hillman, L.; Krongrad, E. (1988) Risk factors for SIDS. Results of the
        National Institute of Child Health and  Human Development SIDS Cooperative
        Epidemiological Study. Ann. N.Y. Acad. Sci. 533:13-30.

 Hoffmann, D.; Hecht, S.S. (1989) Advances in tobacco carcinogenesis. In: Cooper, C.S.; Grover,
        P.L., eds. Chemical carcinogenesis and mutagenesis. New York: Springer-Verlag, pp. 64-
        102.

 Hoffmann, D.; Wynder, E.L. (1971) A study of tobacco carcinogenesis. XI. Tumor initiators,
        tumor accelerators, and tumor-promoting activity of condensate fractions. Cancer 27:848-
        864.

 Hoffmann, D.; Haley, N.J.; Adams, J.D.; Brunnemann, K.D. (1984) Tobacco sidestream smoke.
        Uptake by nonsmokers. Prev. Med. 13:608-617.

 Hoffmann, D.; Brunnemann, K.D.; Haley, N.J. (1989) Absorption of smoke constituents by
        nonsmokers.  In: Reducing workplace exposures to environmental tobacco smoke.
        EPA/HHS Manual.

 Hole, D.J; Gillis, C.R.; Chopra, C.; Hawthorne, V.M. (1989) Passive smoking and
        cardiorespiratory health in a general population in the west of Scotland. Br. Med. J.
        299:423-427.

 Hopp, R.J.; Bewtra, A.; Nair, N.M.; Townley,  R.G. (1985) The effect of age on methacholine
        response. J. Allergy Clin. Immunol. 76:609-613.

 Hopp, R.J.; Townley, R.G.; Biven, R.E.; Bewtra, A.K.; Nair, N.M. (1990) The presence of airway
        reactivity before the development of asthma. Am. Rev. Respir. Dis. 141:2-8.

 Hoppenbrouwers, T.; Ceeb, M.; Arakawa, K.; Hodgman, J.E. (1981) Seasonal relationship of
       sudden infant death syndrome and environmental pollutants. Am. J. Epidemiol.
        113:623-635.

Horwood, L.J.; Fergusson, D.M.; Shannon, F.T. (1985) Social and familial factors in the
       development of early chilhood asthma.  Pediatrics 75:859-868.

Hulka, B.S.; Wilcosky, T.C.; Griffith, J., eds. (1990) Biological markers in epidemiology. New
       York: Oxford Press.
                                          R-16

-------
Humble, C.G.; Samat, J.M.; Pathak, D.R.; Skipper, B.J. (1985) Cigarette smoking and lung cancer
       in "Hispanic" whites and other whites in New Mexico. Am. J. Public Health 75:145-148.

Humble, C.G.; Samet, J.M.; Pathak, D.R. (1987) Marriage to a smoker and lung cancer risk. Am.
       J. Public Health 77:598-602.

Husgafvel-Pursiainen, K.; Sorsa, M.; Moller, M.; Benestad, C. (1986) Genotoxicity and
       polynuclear aromatic hydrocarbon analysis of environmental tobacco smoke samples from
       restaurants. Mutagenesis 1:287-291.

IARC. See International Agency for Research on Cancer.

Idle, J.R. (1990) Titrating exposure to tobacco smoke using cotinine—a minefield of
       misunderstandings. J. Clin. Epidemiol. 43:313-317.

Ingebrethsen, B.J.; Sears, S.B. (1985) Particle size distribution measurements of sidestream
       cigarette smoke. Presented at: 39th Tobacco Chemists' Research Conference; Montreal,
       Quebec, Canada.

Inoue, R.; Hirayama, T. (1988) Passive smoking and lung cancer in women. In: Smoking and
       health. Elsevier Science Publishers, pp. 283-285.

International Agency for Research on Cancer. (1986) IARC monographs on the evaluation of the
       carcinogenic risk of chemicals to man. v. 38, Tobacco smoking. Lyon, France: World
       Health Organization.

International Agency for Research on Cancer. (1987a) Environmental carcinogens—methods of
       analysis and exposure measurement: v. 9, Passive smoking. O'Neill, I.K.; Brunnemann,
       K.D.; Dodet, B.; Hoffmann, D. eds., Lyon, France: IARC Sci. Publ. No. 81.

International Agency for Research on Cancer. (1987b) Cancer incidence in five continents: v. 5,
       Muir, C.; Waterhouse, J.; Mack, T.; Powell, J.; Whelan, S., eds.  Lyon, France: IARC Sci.
       Pub. No. 88.

Ishizu, Y. (1980) General equation or the estimation of indoor pollution. Environ. Sci. Technol.
       14:1254-1257.

Iversen, M.; Birch, L.; Lundqvist, G.R.; Elbrond, O. (1985) Middle ear effusion and the indoor
       environment. Arch. Environ. Health 40:74-79.

Janerich, D.T.; Thompson, W.D.; Varela, L.R.; et al. (1990) Lung cancer and exposure to tobacco
       smoke  in the household. N. Engl. J. Med. 323:632-636.

Jarvis, M.J.  (1987) Uptake of environmental tobacco smoke. IARC Sci. Publ. 81:43-58.

Jarvis, M.J.  (1989) Application of biochemical intake markers to passive smoking measurement
       and risk estimation. Mutat. Res. 222:101-110.

Jarvis, M.J.; Russell, M.H. (1985) Passive exposure to tobacco smoke. Br. Med. J. 291:1646.
                                           R-17

-------
Jarvis, M.J.; Russell, M.H.; Feyerabend, C. (1983) Absorption of nicotine and carbon dioxide
       from passive smoking under natural conditions of exposure. Thorax 38:829-833.

Jarvis, M.; Tunstall-Pedoe, H.; Feyerabend, C.; Vesey, C.; Kabat, G.C.; Wynder, E.L. (1984) Lung
       cancer in nonsmokers. Cancer 53:1214-1221.

Jarvis, M.J.; Russell, M.A.H.; Feyerabend, C.; Eiser, J.R.; Morgan, M.; Gammage, P.; Gray, E.M.
       (1985) Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative
       sample of nonsmoking children. Br. Med. J. 291:927-929.

Joly, O.G.; Lubin, J.H.; Caraballoso, M. (1983) Dark tobacco and lung cancer in Cuba.  J. Natl.
       Cancer Inst. 70:1033-1039.

Kabat, G.C. (1990) Epidemiologic studies of the relationship between passive smoking  and lung
       cancer. Presented at the 1990 annual winter meeting of the Toxicology Forum in
       Washington, DC.

Kabat, G.C.; Wynder, E.L. (1984) Lung cancer in nonsmokers. Cancer 53:1214-1221.

Kahn, H.A. (1966) The Dorn study of smoking and mortality among U.S. veterans: report on eight
       and one-half years of observation. In: Haenszel, W., ed. Epidemiological approaches to the
       study of cancer and other chronic diseases. Washington, DC: National Cancer Institute
       Monograph No. 19, pp. 1-125.

Kalandidi, A.; Trichopoulos, D.; Hatzakis, A.; Tzannes, S.; Saracci, R.  (1987) Passive smoking and
       chronic obstructive lung disease. Lancet ii: 1325-1326.

Kalandidi, A.; Katsouyanni, K.; Voropoulou, N.; et al. (1990) Passive smoking and diet in the
       etiology of lung cancer among nonsmokers. Cancer Causes Control 1:15-21.

Kaplan, H.S.; Tsuchitani, P.J., eds. (1978) Cancer in China. New York: Alan R. Liss, Inc.

Kasuga, H.; Hasebe, A.; Osaka, F.; Matuski, H. (1979) Respiratory symptoms in school  children
       and the role of passive smoking. Tokai J. Exp. Clin. Med. 4:101-104.

Katada, H.; Mikami, R.; Konishi, M.; Koyama, Y.; Narita, N. (1988) Effect of passive smoking in
       lung cancer development in women in the Nara region. Gan No Rinsho 34(l):21-27.

Katsouyanni, K.; Kogevinas, M.; Dontas, N.; Maisonneuve, P.; Boyle, P.; Trichopoulos, D. (1990)
       Mortality from malignant neoplasms in Greece 1960-1985. Greek Cancer Society, Athens,
       pp. 1-125 [in Greek].

Katz, D.; Baptista, J.; Azen, S.P.;  Pike, M.C. Obtaining confidence intervals for the risk ratio in
       cohort studies. Biometrics 78:469-474.

Kauffmann, F.; Tessier, J.F.; Oriol, P. (1983) Adult passive smoking  in the home environment: a
       risk factor for chronic airflow limitation. Am. J.  Epidemiol. 117:269-280.

Kauffmann, F.; Neukirch, F.; Orobaeff, M.; Marne, M.J.; Claud, J.R.;  Lellouch, J. (1986)
       Eosinophils, smoking, and lung function: an epidemiologic survey among 912 working
       men. Am. Rev. Respir. Dis. 134:1172-1175.
                                          R-18

-------
Kauffmann, F.; Dockery, D.W.; Speizer, F.E.; Ferris, E.G. (1989a) Respiratory symptoms and lung
       function in relation to passive smoking: a comparative study of American and French
       Women. Int. J. Epidemiol. 18:334-344.

Kauffmann, F.; Tager, I.E.; Munoz, A.; Speizer, F.E. (1989b) Familial factors related to lung
       function in children aged 6-10 years: results from the PAARC epidemiologic study. Am. J.
       Epidemiol. 129:1289^1299.

Kentner, M.; Triebig, G.; Weltle, D. (1984) The influence of passive smoking on pulmonary
       function: a study of 1351 office workers. Prev. Med. 13:656-69.

Kleinbaum, D.G.; Kupper, L.L.; Morgenstern, H. (1982) Epidemiologic research. Belmont, CA:
       Lifetime Learning Publications.

Knoth, A.; Bohn,  H.; Schmidt, F. (1983) Passive smoking as a causal factor of bronchial carcinoma
       in female nonsmokers. Med. Klin. 78:66-69.

Koo, L.C. (1988) Dietary habits and lung cancer risk among Chinese females in Hong Kong who
       never smoked. Nutr. Cancer 11:155-172.

Koo, L.C. (1989) Environmental tobacco smoke and lung cancer: is it the smoke or the diet? In:
       Bieva, C.J.; Courtois, Y.; Govaerts, M., eds. Present and future of indoor air quality.
       Excerpta Medica. Amsterdam: Elsevier Science Publishers, pp. 65-75.

Koo, L.C.; Ho, J.H-C.; Saw, D. (1983) Active and passive smoking among female lung cancer
       patients in Hong  Kong. J. Exp. Clin. Cancer Res. 4:367-375.

Koo, L.C.; Ho, J.H-C.; Saw, D. (1984) Is passive smoking an added risk factor for lung cancer in
       Chinese women?  J. Exp. Clin. Cancer Res. 3:277-283.

Koo, L.C.; Ho, J.H-C.; Lee, N. (1985) An analysis of some risk factors for lung cancer in Hong
       Kong. Int. J. Cancer 35:149-155.

Koo, L.C., Ho, J.H.; Saw, D.; Ho, C.Y. (1987) Measurements of passive smoking and estimates of
       lung cancer risk among nonsmoking Chinese females. Int. J. Cancer 39:162-169.

Koo, L.C.; Ho, J.  H-C.; Rylander,  R. (1988) Life-history correlates of environmental tobacco
       smoke: a study on nonsmoking Hong Kong Chinese wives with smoking versus
       nonsmoking husbands. Soc. Sci. Med. 26(7):751-760.

Koutrakis, P.; Fasano, A.M.; Slater, J.L.; Spengler, J.D.; McCarthy, J.F.; Leaderer, B.P. (1989)
       Atmos. Environ.  23:2767-2773.

Koutrakis, P.; Briggs, S.L.K.; Leaderer, B.P. (1992) Source apportionment of indoor aerosols in
       Suffolk and Onandaga Counties, New York. Environ. Sci. Technol. 26:521-527.

Kraemer, M.J.; Richardson, M.A.;  Weiss, N.S.; et al. (1983) Risk factors for persistent middle ear
       effusions:  otitis media, catarrh, cigarette smoke exposure, and atopy. JAMA
       249:1022-1025.

Krall, E.A.; Valadian, I.; Dwyer, J.T.; Gardner, J. (1989) Accuracy of recalled smoking data. Am.
       J. Public Health 79:200.
                                          R-19

-------
Krzyzanowski, M.; Quackenboss, J.J.; Lebowitz, M.D. (1990) Chronic respiratory effects of indoor
       formaldehyde exposure. Environ. Res. 52:117-125.

Kuller, L.H.; Garfinkel, L.; Correa, P.; Haley, N.; Hoffmann, D.; Preston-Martin, S.; Sandier, P.
       (1986) Contribution of passive smoking to respiratory cancer.  Environ. Health Perspect.
       70:57-69.

Kurihara, M.; Aoki, K.; Miller, R.W.; Muir, C.S., eds. (1989) Changing cancer patterns and topics
       in cancer epidemiology. New York: Plenum Press.

Lam, W.K. (1985) A clinical and epidemiological study of carcinoma of lung in Hong Kong
       [doctoral thesis]. Hong Kong: University  of Hong Kong.

Lam, T.H.; Rung, I.T.M.; Wong, C.M.; Lam, W.K.; Kleevens, J.W.L.; Saw, D.; Hsu, C.;
       Seneviratne, S.; Lam, S.Y.; Lo, K.K.; Chan, W.C. (1987) Smoking, passive smoking, and
       histological types in lung cancer in Hong Kong Chinese women. Br. J. Cancer 6:673-678.

Layard, M.W.; Viren, J.R. (1989) Assessing the validity of a Japanese cohort study. Elsevier
       Science Publishers B.V. (Biomedical Division).

Leaderer, B.P. (1988) Measuring exposure to environmental tobacco smoke. Report prepared for
       the U. S. Environmental Protection Agency.

Leaderer, B.P. (1989) Unpublished data.

Leaderer, B. (1990) Assessing exposure to environmental tobacco smoke.  Risk Anal. 10(l):19-26.

Leaderer, B.P.; Cain, W.S.; Isseroff, R.;  Berglund, L.G. (1984) Ventilation requirements in
       buildings II. Particulate matter and  carbon monoxide from cigarette smoking. Atmos.
       Environ. 18:99-106.

Leaderer, B.P.; Koutrakis, P.; Briggs, S.; Rizzuto, J. (1990) Contribution of indoor sources to
       residential aerosol concentrations. In: Indoor air '90: proceedings of the 5th international
       conference on indoor air quality and climate, v. 2, Characteristics of indoor air; July-
       August. Ottawa, Ontario, Canada: Canada Mortgage and Housing Corporation, pp. 269-
       274.

Leaderer, B.P.; Lioy, P.J.; Spengler, J.D. (1992) Assessing exposures to inhaled complex mixtures.
       Environ. Health Perspect. (in press)

Lebowitz, M.D. (1984)  The effects of environmental tobacco smoke exposure and gas stoves on
       daily peak flow rates in asthmatic and nonasthmatic families. Eur. J. Respir. Dig.
       133:190-195.

Lebowitz, M.D.; Burrows, B. (1976) Respiratory symptoms related to smoking habits of family
       adults. Chest 69:49-50.

Lebowitz, M.D.; Holberg, CJ. (1988) Effects of  parental smoking and  other risk factors on the
       development of pulmonary function in children and adolescents. Analysis of two
       longitudinal population studies. Am. J. Epidemiol. 128:589-597.
                                           R-20

-------
Lebowitz, M.D.; Holberg, C.J.; Knudson, R.J.; Burrows, B. (1987) Longitudinal study of
       pulmonary function development in childhood, adolescence, and early adulthood. Am.
       Rev. Respir. Dis. 136:69-75.

Lebowitz, M.D.; Quackenboss, J.J. (1990) The effect of environmental tobacco smoke on
       pulmonary function. Int. Arch. Occup. Environ. Health (Suppl):147-152.

Lebowitz, M.D.; Quackenboss, J.J.; Soczek, M.L.; Kollander, M.; Colome, S. (1989) The new
       standard environmental inventory questionnaire for estimation of indoor concentrations.
       J. Air Pollut. Control Assoc. 39:1411-1419.

Lebret, E.; Boley, J.; Brumekreef, B. (1990) Environmental tobacco smoke in Dutch homes. In:
       Indoor air '90: proceedings of the 5th international conference on indoor air quality and
       climate, v. 2, Characteristics of indoor air, July-August. Ottawa, Ontario, Canada: Canada
       Mortgage and Housing Corporation, pp. 263-268.

Lee, P.N. (1986) Does breathing other people's tobacco smoke cause lung cancer? [Letter] Br. Med.
       J. 293:1503-1504.

Lee, P.N. (1987a) Lung cancer and passive smoking: association an artifact due to misclassification
       of smoking habits. Toxicol. Lett. 35:157-162.
                                                                                      •*
Lee, P.N. (1987b) Passive smoking and lung cancer association: a result of bias? Hum. Toxicol.
       6:517-524.

Lee, P.N. (1988) Misclassification of smoking habits and passive smoking. Berlin: Springer.

Lee, P.N.  (1989) Passive smoking and lung cancer: fact or fiction. In: Bieva, C.J.;  Courtois, Y.;
       Govaerts, M., eds. Present and future of indoor air quality. Excerpta Medica. Amsterdam:
       Elsevier Science Publishers, pp. 119-128.                            .

Lee, P.N. (1990) A detailed review of epidemiological evidence relating environmental tobacco
       smoke (ETS) to the risk of cancer,  heart disease, and other causes of death  in adults who
       have never smoked. Draft 3 of Annex A.

Lee, P.N. (1991a) Correcting meta-analyses of the association of lung cancer in females with
       spouse (or household) exposure for bias due to misclassification of active smoking status.
       Report submitted to U.S. EPA, dated November 29, 1991.

Lee, P.N. (1991b) An estimate of adult mortality in the United States from passive smoking.
       Environ. Int. 17:379-381.

Lee, P.N.; Chamberlain, J.; Alderson, M.R. (1986) Relationship of passive smoking to risk of lung
       cancer and other smoking-associated diseases. Br. J. Cancer 54:97-105.

 Lee, B.L.; Benowitz, N.L.; Jacob P. (1987) Influence on tobacco abstinence on the  disposition
       kinetics and effects of nicotine.  Clin. Pharmacol. Ther. 41:474-479.

 Leeder,  S.R.; Corkhill, R.T.; Irwig, L.M.;  Holland, W.W.; Colley, J.R. (1976) Influence of family
       factors on the incidence of lower respiratory illness during the first year of life, Br. J.
       Prev. Soc. Med. 30:203-212.
                                            R-21

-------
 Lehnert, G. (1984) Roundtable discussion from symposium on medical perspectives on passive
        smoking. Prev. Med. 13:732-733.

 Lewak, R; van den Berg, B.J.; Beckwith, J.B. (1979) Sudden infant death syndrome risk factors.
        Clin. Pediatr. (Phila) 18:404-411.

 Lewis, H.M.; Haeney, M.; Jeacock, J.; Thomas, H. (1989) Chronic cough in a hospital population:
        its  relationship to atopy and defect in host defence. Arch. Dis. Child. 64:1593-1598.

 Lewtas, J.; Claxton, L.; Mumford, J.L. (1987) Human exposure to mutagens from indoor
        combustion sources. In: Seifert, B.; Esdorn, M.; Fischer, M.; Ruden, H.; Wegner, J., eds.
        Indoor air '87, v. 1. Berlin: Oraniendruck GmbH, pp. 473-477.

 Liang, Z-H;  Geng, G.; et al. Effects of smoking and passive smoking on female lung cancer in
        Tianjin area. Tianjin, People's Republic of China: Dept. of Epidemiology, Tianjin Medical
        College.

 Ling, P.I.;  Lofroth, G.; Lewtas, J. (1987) Mutagenic determination  of passive smoking. Toxicol.
        Lett.  35:147-151.

 Liu, Z.; He, X.; Chapman, R.S. (1991) Smoking and other risk factors for lung cancer in Xuanwei,
     -'  China. Int. J. Epidemiol. 20:26-31.

 Lofroth, G.; Zebiihr, Y. (1992) Polychlorinated dibenzo-p-dioxins  (PCDDs) and dibenzofurans
       (PCDFs) in mainstream and sidestream cigarette smoke. Bull. Environ. Contam. Toxicol.
       48:789-794.

 Lofroth, G.; Nilsson, L.; Alfeim, I. (1983) Passive smoking and urban air pollution:
       Salmonella/microsome mutagenicity assay of simultaneously collected indoor and outdoor
       particulate matter. In: Waters, M.D.; Sandhu, S.S.; Lewtas, J.; Claxton, L.; Chernoff, N.;
       Nesnow, S., eds. Short-term bioassays in the analysis of complex environmental mixtures,
       v. 3. New York: Plenum, pp. 515-525.

 Lofroth, G.; Ling, P.I.; Agurell, E. (1988) Public exposure to environmental tobacco smoke.
       Mutat. Res. 202:103-110.

 Lofroth, G.; Burtin, R.; Forehand, L.; Hammond, K.; Selia, R.; Zwiedinger, E.; Lewtas, J. (1989)
       Characterization of genotoxic components of environmental tobacco smoke. Environ. Sci.
       Technol. 23:610-614.

 Lossing, E.H.; Best, E.W.R.; McGregor, J.T.; Josie, G.H.; Walker, C.B.; Delaquis, P.M.; Baker,
       P.M.; McKenzie, A.C. (1966) A Canadian  study of smoking and health. Ottawa, Canada:
       Department of National Health and Welfare.

 Lubin, J.H.; Blot, W.J.; Berrino, F.; Flamant, R.; Gillis, C.R.; Kunze, M.; Schmahl, D.; Visco, G.
       (1984) Modifying risk of developing lung cancer by  changing habits of cigarette smoking.
       Br.  Med. J. 288:1953-1956.

MacDonald, E.J. (1981) [Letter] Br. Med. J. 283:915-916.

Machlin, S.R.; Kleinman, J.C.; Madans, J.H. (1989) Validity of mortality analysis based on
       retrospective smoking information. Stat. Med. 8:997-1009.
                                          R-22

-------
Maclure, M.; Katz, R.B.-A.; Bryant, M.S.; Skipper, P.L.; Tannenbaum, S.R. (1989) Elevated blood
       levels of carcinogens in passive smokers. Am. J. Public Health 79:1381-1384.

Magnusson, C.G.M. (1986) Maternal smoking influences cord serum IgE and IgD levels and
       increases the risk for subsequent infant allergy. J. Allergy Clin. Immunol. 78:898-904.

Makin, J.; Fried, P.A.; Watkinson, B. (1991) A comparison of active and passive smoking during
       pregnancy: long-term effects. Neurotoxicol. Teratol. 13:5-12.

Malloy, M.H.;  Kleinman, J.C.; Land, G.H.; Schramm, W.F. (1988) The association of maternal
       smoking with age and cause of infant death. Am. J. Epidemiol. 128:46-55.

Mantel, N. (1963) Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel
       procedure. J. Am. Stat. Assoc. 58:690-700.

Mantel, N.; Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective
       studies of disease. J. Natl. Cancer  Inst. 22:719-748.

Maran, A.G.D.; Wilson,  J.A. (1986) Glue ear and speech development. Br. Med. J. 293:713-714.

Marbury, M.C.; Hammond, S.K.; Haley, N.J. (1990) Assessing exposure to environmental tobacco
       smoke  in epidemiological studies of acute health effects. In: Indoor air '90: proceedings of
       the 5th international conference on indoor air quality and climate, v. 2, Characteristics of
       indoor air; July-August. Ottawa, Ontario, Canada: Canada Mortgage and Housing
       Corporation, pp. 189-194.

Marchand, L.L.; Wilkens, L.R.; Hankin, J.H.; Haley, N.J. (1991) Dietary patterns of female
       nonsmokers with and without exposure to environmental tobacco smoke. Cancer Causes
       Control 2:11-16.

Martin, T.R.; Bracken, M.B. (1986) Association of low birthweight with passive smoke exposure
       in pregnancy. Am. J. Epidemiol. 124:633-642.

Martinez, F.D.; Morgan, W.J.; Wright, A.L.; Holberg, C.J.; Taussig, L.M. (1988a) Diminished lung
       function as a predisposing factor for wheezing lower respiratory tract illness in infants. N.
       Engl. J. Med. 319:1112-1117.

Martinez, F.D.; Antognoni, G.; Macri, F.; Bonci, E.; Midulla, F.; De Castro, G.; Ronchetti, R.
       (1988b) Parental smoking enhances bronchial responsiveness in nine-year-old children.
       Am. Rev. Respir. Dis. 138:518-523.

Martinez, F.D.; Morgan, W.J.; Wright, A.L.; Holberg, C.; Taussig L.M. (1991) Initial airway
       function is a risk factor for recurrent wheezing respiratory illnesses during the first three
       years of life. Am. Rev. Respir. Dis. 143:312-316.

Martinez, F.D.; Cline, M.; Burrows, B. (1992) Increased incidence of asthma in children of
       smoking mothers. Pediatrics 89:21-26.

Masi, M.A.; Hanley, J.A.; Ernst, P.; Becklake, M.R. (1988) Environmental exposure  to tobacco
       smoke  and lung function in young adults. Am. Rev. Respir. Dis. 138:296-299.
                                           R-23

-------
Mattson, M.E.; Boyd, G.; Byar, D.; Brown, C.; Callahan, J.F.; Cullen, J.W.; Grenblatt, J.; Haley;
       Hammond, N.; J.F.; Lewtas, J.; Reeves, W. (1989) Passive smoking on commercial airline
       flights. JAMA 261:867-872.

McConnochie, K.M.; Roghmann, K.J. (1986a) Parental smoking, presence of older sibling, and
       family history of asthma increase risk of bronchiolitis. Am. J. Dis. Child. 140:806-812.

McConnochie, K.M.; Roghmann, K.J. (1986b) Breast feeding and maternal smoking as predictors
       of wheezing in children age 6 to 10 years. Pediatr. Pulmonol. 2:260-268.

McRae, D.D. (1990) The physical and chemical nature of tobacco smoke. In: Recent advances in
       tobacco science, v. 16: Symposium of the formation and evolution of cigarette smoke. 44th
       Tobacco Chemists Research, Winston-Salem, NC, pp. 233-323.

Mertsola, J.; Ruuskanen, O.; Vanto, T.; Koivikko, A.; Halonen, P. (1991) Recurrent wheezy
       bronchitis and viral respiratory infections. Arch. Dis. Child. 66:124-129.

Meyers, D.A.; Beaty, T.H.; Freidhoff, L.R.; Marsh, D.G. (1987) Inheritance of total serum IgE
       (basal level) in man. Am. J. Hum. Genet. 41:51-62.

Miesner, E.A.; Rudnick, S.N.; Hu, F.; Spengler, J.D.; Preller, L.; Ozkaynak, H.; Nelson, W. (1989)
       Particule and nicotine  sampling in public facilities and offices. J. Air Pollut. Control
       Assoc. 39:1577-1582.

Miller, G.H. (1984) Cancer, passive smoking, and nonemployed and employed wives. West.
       J. Med. 140(4):632-635.

Mitchell, E.A.; Scragg, R.; Stewart, A.W.; et al. (1991) Results from the first year of the New
       Zealand cot death study. N.Z. Med. J. 104:71-6.

Moolgavkar, S.H.; Dewanji, A.; Luebeck, G. (1989) Cigarette smoking and lung cancer: reanalysis
       of the British doctors'  data. J. Am. Cancer Inst. 81(6):415-420.

Moschandreas, D.J. (1981) Exposure  to pollutants and daily time budgets of people. Bull. N.Y.
       Acad. Med. 57:845-859.

Mumford, J.L.; He, X.Z.; Chapman,  R.S.; et al. (1987) Lung cancer and  indoor air pollution in
       Xuanwei, China. Science 235:217-220.

Mumford, J.L.; Lewtas, J.; Burton, R.M.; Henderson, F.W.; Forehand, L.; Allison, J.C.;
       Hammond, S.K. (1989) Assessing environmental tobacco smoke exposure of preschool
       children in homes by monitoring air particles, mutagenicity, and nicotine. In: Measurement
       of toxic and related air pollutants.  U.S. Environmental Protection Agency/Air and Waste
       Management Association international symposium. Pittsburgh, PA: Air and Waste
       Management Association, pp. 606-610.

Muramatsu, M.; Umemura, S.; Okada, T.; Tomita, H. (1984) Estimation of personal exposure to
       tobacco smoke with a newly developed nicotine personal  monitor. Environ. Res.
       35:218-227.
                                          R-24

-------
Murray, A.B.; Morrison, B.J. (1986) The effect of cigarette smoke from the mother on bronchial
       responsiveness and severity of symptoms in children with asthma. J. Allergy Clin,
       Immunol. 77:575-581.

Murray, A.B.; Morrison, B.J. (1988) Passive smoking and the seasonal difference of severity of   *
       asthma in children. Chest 94:701-708.

Murray, A.B.; Morrison, B.J. (1989) Passive smoking by asthmatics: its greater effect on boys than
       on girls and on older than on younger children. Pediatrics 84:451-459.

Naeye, R.L.; Ladis, B.; Drage, J.S. (1976) Sudden infant death syndrome: a prospective study. Am.
       J. Dis. Child.  130:1207-1210.

Nagda, N.; Fortmann, R.; Koontz, M.; Konheim, A. (1990) Investigation of cabin air-quality
       aboard commercial airlines. In: Indoor air '90: proceedings of the 5th international
       conference on indoor air quality and climate, v. 2, Characteristics of indoor air. July-
       August. Ottawa, Ontario, Canada: Canada Mortgage and Housing Corporation,
       pp. 245-250.                                                          .

National Institute for Occupational Safety and Health (NIOSH). (1991) Environmental tobacco
       smoke in the workplace: lung cancer and other health effects. Current Intelligence Bulletin
       54. U.S. Department of Health and Human Services, NIOSH, Cincinnati, OH.

National Research Council, Committee on Indoor Pollutants. (1981) Tobacco smoke. In: Indoor
       pollutants. Washington, DC: National Academy Press, pp. 149-168.

National Research Council. (1986) Environmental tobacco smoke: measuring exposures and
       assessing health effects. Washington, DC: National Academy Press.

National Research Council and Committee on Biological Markers. (1987) Biological markers in
       environmental health research. Environ. Health Perspect. 64:3-9*            ,

Neal, A.D.; Wadden,  R?A.; Rosenberg, S. (1978)  Evaluation of indoor particulate concentrations
       for an urban hospital. Am. Ind. Hyg. Assoc. J. 29:578-582.

Neddenriep, D.; Martinez, F.D.; Morgan, W.J. (1990) Increased specific lung compliance in
       newborns  whose mothers smoked during pregnancy. Am. Rev.  Respir. Dis. 141^282*

Nelson, P.A.; Quant,  F.R.; Sem, G.F. (1982) Experimental measurements of aerosol concentrations
       in offices. Environ. Int. 8:223-227.

Neurath, G.B.; Dunger, M.; Krenz, O.; Orth, D.; Pein, F.G. (1988) Trans-3'-hydroxycotinine—a
       main metabolite in smokers. Klin. Wochenschr. 66(Suppl. 11 ):2-4.

Neuspiel,  D.R.; Rush, D.; Butler, N.; Golding, J.; Bijur, P.E.; Kurzon, M. (1989) Parental smoking
       and post-infancy wheezing in children: a prospective cohort study.  Am. J. Public Health
       79:168-171.

NIOSH. See National Institute for Occupational Safety and Health.
                                           R-25

-------
Nitschke, LA.; Clarke, W.A.; Clarkin, M.E.; Traynmor, G.W.; Wadach, J.B. (1985) Indoor air
       quality infiltration and ventilation in residential buildings. NYSERDA #85-10. Albany,
       NY: New York State Energy Research and Development Authority.

NRC. See National Research Council.

O'Connell, E.J.; Logan, G.B. (1974) Parental smoking in childhood asthma.  Ann. Allergy 32:142-
       145.

O'Connor, G.T.; Sparrow, D.; Weiss, S.T. (1989) The role of allergy and nonspecific airway
       hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. Am.
       Rev. Respir. Dis.  140:225-252.

O'Connor, G.T.; Weiss, S.T.; Tager, I.E.; Speizer, F.E. (1987) The effect of passive smoking on
       pulmonary function and non-specific bronchial responsiveness in a population based
       sample of children and young adults. Am. Rev. Respir. Dis. 135:800-804.

Ogden, M.W.; Maiolo, K.C.; Oldaker, G.B., III; Conrad, F.W., Jr. (1990) Evaluation of methods
       for estimating the contribution of ETS to respirable suspended particles. In: Indoor air '90:
       proceedings of the 5th international conference on indoor air quality and climate, v.  2,
       Characteristics of indoor air; July-August. Ottawa, Ontario, Canada: Canada Mortgage and
       Housing Corporation,  pp. 483-488.

Ogden, M.W.; Nystrom, C.W.; Oldaker, G.B., III; Conrad, F.W., Jr. (1989) Evaluation  of a personal
       passive sampling device for determining exposure to nicotine in environmental tobacco
       smoke. In: Measurement of toxic and related air pollutants. Pittsburgh, PA: Air Pollution
       Control Association, pp. 552-558.

Ogston, S.A.; Florey, C. du V.; Walker, C.M. (1987) Association of infant alimentary and
       respiratory illness with parental smoking and other environmental factors. J. Epidemiol.
       Community Health 41:21-25.

Oldaker,  G.B., III; Conrad, F.W., Jr. (1987) Estimation of the effect of environmental tobacco
       smoke (ETS) on air quality within aircraft cabins  of commercial aircraft. Environ. Sci.
       Technol. 21:994-999.

Oldaker,  G.B.; Ogden, M.W.; Maiolo, K.C.; Conner, J.M.; Conrad, F.W.; DeLuca, P.O. (1990)
       Results from surveys of environmental tobacco smoke in restaurants in Winston-Salem,
       North Carolina. In: Indoor air '90: proceedings of the 5th international conference on
       indoor air quality and climate, v. 2, Characteristics of indoor air; July-August. Ottawa,
       Ontario, Canada: Canada Mortgage and Housing Corporation, pp. 281-285.

Oldigs, M.; Jrres, R.; Magnussen, H. (1991) Acute effects of passive smoking on lung function and
       airway responsiveness in asthmatic  children. Pediatr. Pulmonol. 10:123-131.

Ong, T.M.; Stewart, J.; Whong, W.Z. (1984) A simple in situ mutagenicity test for detection of
       mutagenic air pollutants. Mutat. Res. 139:177-181.

Overpeck, M.D.; Moss, A.J. (1991) Children's exposure to environmental cigarette smoke before
       and after birth. Advance Data from Vital  and Health Statistics of the National Center for
       Health Statistics #202. DHHS Pub.  No. (PHS) 91-1250.
                                           R-26

-------
Park, J.K.; Kim, I.S. (1986) Effect of family smoking on acute respiratory disease in children.
       YonseiMed. 1.27:261-270.

Parker, G.B.; Wilfert, G.L.; Dennis, G.W. (1984) Indoor air quality and infiltration in multifamily
       naval housing. Annual PNWIS/APCA meeting; November; Portland, OR, pp. 1-14.

Pattishall, E.N.; Strope, G.L.; Etzel, R.A.; Helms, R.W.; Haley, N.J.; Denny, F.W. (1985) Serum
       cotinine as a measure of tobacco smoke exposure in children. Am. J. Dis. Child.
       139:1101-1104.

Pedreira, F.A.; Guandolo, V.L.; Feroli, E.J.; Mella, G.W.; Weiss, I.P. (1985) Involuntary smoking
       and incidence of respiratory illness during the first year of life. Pediatrics 75:594-597.

Perera, F.R.; Santella, R.M.; Brenner, D.; Poirier, M.C.; Munshi, A.A.; Fischman, H.K.;  Van
       Ryzin, J. (1987) DNA adducts, protein adducts,  and sister chromatid exchange in cigarette
       smokers and nonsmokers. J. Natl. Cancer Inst. 79:449-456.

Pershagen, G.; Hrubec, Z.; Svensson, C. (1987) Passive smoking and lung cancer in Swedish
       women. Am. J. Epidemiol. 125(1): 17-24.

Peto, R.; Doll, R. (1984) Keynote address: the control of lung cancer. In: Mizell, M.; Correa, P.,
       eds. Lung cancer: causes and prevention. New York: Verlag Chemie International,
       pp. 1-19.

Phillips, R.L.; Garfinkel, L.; Kuzma, J.W.; et al. (1980a) Mortality among California Seventh-Day
       Adventists for selected  cancer sites. J. Natl. Cancer Inst. 65:1097-1107.

Phillips, R.L.; Kuzma, J.W.; Beeson, W.L.; et al. (1980b) Influence of selection versus lifestyle on
       risk of fatal cancer and cardiovascular disease among Seventh-Day Adventists. Am. J.
       Epidemiol. 112:296-314.

Pierce, J.P.; Dwyer, T.; et al. (1987) Cotinine validation of self-reported smoking in commercially
       run community surveys. J. Chronic Dis. 40:68,9-695.

Pierce, J.P.; Fiore, M.C.;  Novotny, T.E.; Hatziandreu, E.J.; Davis, R.M. (1989) Trends in cigarette
       smoking in the United States. Projections to the  year 2000. JAMA 261:61-65.

Pimm, P.E.; Silverman, F.; Shepard, R.J. (1978) Physiological effects of acute passive exposure to
       cigarette smoke. Arch. Environ. Health 33:201-213.

Pojer, R.; Whitfield, J.B.; Poulos, V.; Eckhard, I.F.; Richmond, R.; Hensley, W.J. (1984)
       Carboxyhemoglobin, cotinine, and thiocyanate assay compared for  distinguishing smokers
       from non-smokers. Clin. Chem. 30:1377-1380.

Pukander, J.; Luotonen, J.; Timonen, J.; Karma, P. (1985) Risk factors affecting the occurrence  of
       acute otitis media among 2-3-year old urban children. Acta Otolaryngol. 100:260-265.

Pullan, C.R.; Hey, E.N. (1982)  Wheezing, asthma, and pulmonary dysfunction 10 years after
       infection with respiratory syncytial virus in infancy. Br. Med. J. 284:1665-1669.
                                           R-27

-------
Putnam, D.L.; David, R.M.; Melhorn, J.M.; Dansie, D.R.; Stone, C.J.; Henry, C.J. (1985) Dose-
       responsive increase in sister-chromatid exchanges in bone-marrow cells of mice exposed
       nose-only to whole cigarette smoke. Mutat. Res. 156:181-186.

Quant, F.R.; Nelson, P.A.; Sem, G.J. (1982) Experimental measurements of aerosol concentrations
       in offices. Environ. Int. 8(l-6):249-258.

Rantakallio, P. (1978) Relationship of maternal smoking to morbidity and mortality of the child
       up to the age of five. Acta Paediatr. Scand. 67:621-631.

Redline, S.; Tager, I.E.; Segal, M.R.; Gold, D.; Speizer, F.E.; Weiss, S.T. (1989) The relationship
       between longitudinal changes in pulmonary function and nonspecific airway
       responsiveness in children and young adults. Am. Rev. Respir. Dis. 140:179-184.

Reed, B.D.; Lutz, L.J. (1988) Household smoking exposure—association with middle ear effusions.
       Fam. Med. 20:426-430.

Reese, A.C.; James, I.R.; Landau, L.I.; LeSouef, P.N. (1992) Relationship  between urinary
       cotinine levels and diagnosis in children admitted to hospital. Am. Rev. Respir. Dis.
       146:66-70.

Remmer, H. (1987) Passively inhaled tobacco smoke: a challenge to toxicology and preventive
       medicine. Arch. Toxicol. 61:89-104.

Repace, J.L. (1987) Indoor concentrations of environmental tobacco smoke: models dealing with
       effects of ventilation and room size. In: O'Neill, I.K.; Brunnemann, K.D.; Dodet, B.;
       Hoffmann, D., eds. Environmental carcinogens—selected methods of analysis, v. 9, Passive
       smoking. Chapter 3, IARC Monographs No. 81. Lyon, France: International Agency for
       Research on Cancer.

Repace, J.L. (1989) Workplace restrictions on passive smoking: justification on the basis of cancer
       risk. In: Harper, J.P., ed. Transactions of an international specialty conference—
       Combustion processes and quality  of the indoor environment. Niagara Falls, NY, pp. 333-
       347.

Repace, J.L.; Lowrey, A.H. (1980) Indoor air pollution, tobacco smoke and public health. Science
       208:464-472.

Repace, J.L.; Lowrey, A.H. (1982) Tobacco smoke, ventilation and indoor air quality. Am. Soc.
       Heat Refrig. Air Cond. Eng. Trans. 88:894-914.

Repace, J.L.; Lowrey, A.H. (1985) A quantitative estimate of nonsmokers' lung cancer risk from
       passive smoking. Environ. Int. 11:3-22.

Repace, J.L.; Lowrey, A.H. (1990) Risk assessment methodologies in passive smoking. Risk Anal.
       10(l):27-37.

R.J. Reynolds  Tobacco Company. (1988) New cigarette prototypes that heat instead of burn
       tobacco. Winston-Salem, NC: R.J.  Reynolds Tobacco Co.
                                           R-28

-------
Riboli, E.; Preston-Martin, S.; Saracci, R.; Haley, N.J.; et al. (1990) Exposure of nonsmoking
       women to environmental tobacco smoke: a 10-country collaborative study. Cancer Causes
       Control 1:243-252.

Rickert, W.S.; Kaiserman, M.J.; Collishaw, N.E. (1990) Smoking in the home environment: a
       controlled room study. In: Indoor air '90: proceedings of the 5th International Conference
       on Indoor Air Quality and Climate, v. 2, Characteristics of indoor air; July-August.
       Toronto, Ontario, Canada: Canada Mortgage and Housing Corporation.

Rickert, W.S.; Robinson, J.C.; Collinshaw, N.E. (1984) Yields of tar, nicotine and carbon
       monoxide in the sidestream smoke from  15 brands of Canadian cigarettes. Am. J. Public
       Health 74:228-231.

Rijcken, B.; Schouten, J.P.; Weiss, S.T.; Speizer, F.E.; Van der Lende, R. (1987) The relationship
       of nonspecific bronchial responsiveness to respiratory symptoms in a random population
       sample. Am. Rev. Respir. Dis. 136:62-68.

Rimington, J. (1981) The effect of  filters on the incidence of lung cancer in cigarette smokers.
       Environ. Res. 24:162-166.

Roberts, D.L. (1988) Natural tobacco flavor.  Rec. Advan. Tob. Sci. 14:49-81.

Robins, J.M.; Blebins, D.; Schneiderman, M. (1989) The effective number of cigarettes inhaled
       daily by passive smokers: are epidemiologic and dosimetric estimates consistent?  J. Haz.
       Mat. 21:215-238.

Rogot, E.; Murray, J.L. (1980) Smoking and causes of death among U.S. veterans: 16 years of
       observation. Public Health Rep. 95:213-222.

Ronchetti, R.; Macri, F.; Ciofetta, G.; et al. (1990) Increased serum immunoglobulin E and
       increased prevalence of eosinophilia in 9-year-old children of smoking parents. J. Allergy
       Clin. Immunol. 86:400-407.

Rothman, K.J. (1986) Modern epidemiology. Boston: Little, Brown and Co.

Russell, M.A.H.; Feyerabend, C. (1975) Blood and urinary nicotine in nonsmokers. Lancet
       1:179-181.

Russell, M.A.H.; Jarvis, M.J.; West, R.J. (1986) Use of urinary nicotine concentrations to estimate
       exposure and mortality from passive smoking in non-smokers. Br. J. Addict. 81:275-281.

Rylander, E.; Eriksson, M.; Freyschuss, U. (1988) Risk factors for occasional and recurrent
       wheezing after RSV infection in infancy. Acta Pediatr. Scand. 77:711-715.

Said, G.; Zalokar, J.; Lellouch, J.; Patois, E. (1978) Parental smoking related to adenoidectomy and
       tonsillectomy in children. J. Epidemiol. Community Health 32:97-101.

Samet, J.M.; Tager, I.E.; Speizer, F.E. (1983) The relationship between respiratory illness in
       childhood and chronic air-flow obstruction in adulthood. Am. Rev. Respir. Dis.
       127:508-523.
                                           R-29

-------
Sandier, D.P.; Everson, R.B.; Wilcox, AJ. (1985) Passive smoking in adulthood and cancer risk.
       Am. J. Epidemiol. 121(l):37-48.

Saracci, R. (1989) Passive smoking and cancer risk. IARC report of a panel of experts. Prepared at
       the request of the European School of Oncology through the Europe Against Cancer
       program of the European Economic Community. Lyon, France: IARC.

Saracci, R.; Riboli, E. (1989) Passive smoking and lung cancer: current evidence and ongoing
       studies at the International Agency for Research on Cancer. Mutat. Res. 222:117-127.

Schelesselman, J.J. (1978) Assessing  effects of confounding variables. Am. J. Epidemiol. 108:3-8.

Schelesselman, J.J. (1982) Case-control studies: design, conduct, analysis. New York: Oxford
       University Press.

Schenker, M.B.; Samet, J.M.; Speizer, E.F. (1983) Risk factors for childhood respiratory disease.
       The effect of host factors  and home environment exposures. Am. Rev. Respir. Dis.
       128:1038-1043.

Schenker, M.B.; Samuels, S.J.; Kado, N.Y.; Hammond, S.K.; Smith, T.J.; Woskie, S.R. (1990)
       Markers of exposure to diesel exhaust. Research Publication Number 33. Cambridge, MA:
       Health Effects Institute.

Schilling, R.S.F.; Letai, A.D.; Hui, S.L.; Beck, G.J.; Schoenberg, J.B.; Bouhuys, A. (1977) Lung
       function, respiratory disease, and smoking in families. Am. J. Epidemiol. 106:274-283.

Schwartz, J.; Zeger, S. (1990) Passive smoking, air pollution, and acute respiratory symptoms in a
       diary of student nurses. Am. Rev. Respir. Dis.  141:62-67.,

Seely, J.E.; Zuskin, E.; Bouhuys, A. (1971) Cigarette smoking: objective evidence for lung damage
       in teen-agers. Science 172:741-743.

Seigel, D.G.; Greenhouse, S.W. (1973) Validity in estimating relative risk in case-control studies.  J.
       Chronic Dis. 26:219-226.

Sexton, K.; Spengler, J.D.; Treitman, R.D. (1984) Personal exposure to respirable particulates: a
       case-study in Waterbury, Vermont.  Atmos. Environ. 18:1385-1398.

Sheen, S.J. (1988) Detection of nicotine in foods and plant materials. J. Food Sci. 53:1572-1573.

Shephard, R.J.  (1992) Respiratory irritation from ETS. Arch. Environ. Health 47:(2):123-130.

Shephard, R.J.; Collis, R.; Silverman, F. (1979) "Passive" exposure of asthmatic subjects to
       cigarette smoke. Environ.  Res. 20:392-402.

Sherman, C.B.; Tosteson, T.D.; Tager, I.E.;  Speizer, F.E.; Weiss, S.T. (1990) Early childhood
       predictors of asthma. Am. J. Epidemiol. 132:83-95.

Sherrill, D.; Holberg, C.J.; Lebowitz, M.D. (1990) Differential rates of lung growth as measured
       longitudinally by pulmonary function in children and adolescents. Pediatr. Pulmonol.
       8:145-154.
                                           R-30

-------
Shimizu, H.; Morishita, M.; Mizuno, K.; Masuda, T.; Ogura, Y.; Santo, M.;, Nishimura, M.;
       Kunishima, K.; Karasawa, K.; Nishiwaki, K.; Yamamoto, M.; Hisamichi, S.; Tominaga, S.
       (1988) A case-control study of lung cancer in nonsmoking women. Tohoku J. Exp. Med.
       154:389-397.

Shultz, T.M.; Novotny, T.E.; Rice, D.P. (1991) Quantifying the disease impact of cigarette
       smoking with SAMMEC II Software.  Public Health Rep. 106(3)326-333.

Sidney, S.; Caan, B.; Friedman, G. (1989) Dietary intake of carotene in nonsmokers with and
       without passive smoke at home. Am. J. Epidemiol. 129:1305-1309.

Sims, D.G.; Downham, M.A.P.S.; Gardner, P.S.; Webb, J.K.G.; Weightman, D. (1978) Study of
       8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy.
       Br. Med. J. 1:11-14.

Sobue, T.; Suzuki, R.; Nakayama, N.; Inubuse, C.; Matsuda, M.; Doi, O.; Mori, T.; Furuse, K.;
       Fukuoka, M.; Yasumitsu, T.; Kuwabara, O.; Ichigaya, M.; Kurata, M.; Nakahara, K.;
       Endo, S.; Hattori, S. (1990) Passive  smoking among nonsmoking women and the
       relationship between indoor air pollution and lung cancer incidence—results of a
       multicenter case controlled study. Gan To Rinsho 36(3):329-333.

Somerville, S.M.; Rona, R.J.; Chinn, S. (1988) Passive smoking and respiratory conditions in
       primary school children. J. Epidemiol. Community Health 42:105-110.

Sparrow, D.; O'Connor, G.; Colton, T.; Barry, C.L.; Weiss, S.T. (1987) The relationship of
       nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and
       decreased levels of pulmonary function. The normative aging study.  Am. Rev. Respir. Dis.
       135:1255-1260.

Speizer, F.E.; Ferris, B., Jr.; Bishop, Y.M.;  Spengler, J. (1980) Respiratory disease rates and
       pulmonary function in children associated with NO exposure. Am. Rev. Respir. Dis.
       121:3-10.

Spengler, J.D.; Dockery, D.W.; Turner, W.A.; Wolfson, J.M.; Ferris, E.G. (1981) Long-term
       measurements of respirable sulphates and particles inside and outside homes. Atmos.
       Environ. 15:23-30.

Spengler, J.D.; Treitman, R.D.; Tosteson, T.D.; Mage, D.T.; Soczek, M.L. (1985) Personal
       exposures to respirable particulates  and implications for air pollution epidemiology.
       Environ. Sci. Technol. 19:700-707.

Spitzer, W.O.; Lawrence, V.; Dales, R.; Hill, G.; Archer, M.C.; Clark, P.; Abenhaim, L.; Hardy, J.;
       Sampalis, J.; Pinfold, S.P.; Morgan,  P.P. (1990) Links between passive smoking and disease:
       a best evidence synthesis. A report of the working group on passive smoking. Clin. Invest.
       Med. 13:17-42.

Stahlman,  M.T.; Gray, M.E. (1984) Ontogeny of neuroendocrine cells in human fetal lung. I. An
       electron microscopic study. Lab. Invest. 51:449-463.

Stanton, M.F.; Miller, E.; Wrench, C.; Blackwell, R. (1972) Experimental induction of epidermoid
       carcinoma in the lungs of rats by cigarette smoke condensate. J. Natl. Cancer Inst.
       49:867-877.
                                          R-31

-------
Steele, R.; Langworth, J.T. (1966) The relationship of antenatal and postnatal factors to sudden
       unexpected death in infancy. Can. Med. Assoc. J. 94:1165-1171.

Steenland, K. (1992) Passive smoking and the risk of heart disease. JAMA 267:94-99.

Stellman, S.D.; Garfinkel, L. (1986) Smoking habits and tar levels in a new American Cancer
       Society prospective study of 1.2 million men and women. J. Natl. Cancer Inst.
       76(6):1057-1063.

Sterling, T.D.; Sterling, E.M. (1983) Investigations on the effect of regulating smoking on levels of
       indoor pollution and on the perception of health  and comfort of office workers. Eur. J.
       Respir. Dis. 65 (Suppl. 133): 17-32.

Stockwell, H.G.; Candelora, E.G.; Armstrong, A.W.; Pinkham, P.A. (1991) Environmental tobacco
       smoke and lung cancer in never smoking women. Presented at the annual meeting abstract
       forum: Society for Epidemiologic Research; June; Buffalo, New York.

Strachan, D.P. (1988) Damp housing and childhood asthma: validation of reporting of symptoms.
       Br. Med. J. 297:1223-1226.

Strachan, D.P.; Jarvis, M.J.; Feyerabend, C. (1989) Passive smoking, salivary cotinine
       concentrations, and middle ear effusion in 7 year old children. Br. Med. J. 298:1549-1552.

Strachan, D.P.; Jarvis, M.J.; Feyerabend, C. (1990) The relationship of salivary cotinine to
       respiratory symptoms, spirometry, and exercise-induced bronchospasm in seven-year-old
       children. Am. Rev. Respir. Dis. 142:147-151.

Sun, X-W. (1992) Heating fuels and  respiratory diseases in the risks of female lung cancer. [In
       Chinese with English abstract] Chung Hua Chung Liu Tsa Chih 13(6):413-415.

Sutton, G.C. (1980). Assortive marriage for smoking habits. Ann. Human Biol. 7:449-456.

Svendsen, K.H.; Kuller, L.H.; Martin, M.J.; Ockene, J.K. (1987) Effects of passive smoking in the
       multiple risk intervention trial. Am. J. Epidemiol. 126:783-795.

Svensson, D. (1988) Lung cancer etiology in women [dissertation]. Karolinska Institute, Stockholm,
       Sweden.

Svensson, C.; Pershagen, G.; Klominek, J. (1988) Smoking and passive smoking in relation to  lung
        cancer in women. Department of Epidemiology,  National Institute of Environmental
        Medicine, Stockholm, Sweden.

Svensson, C.; Pershagen, G.; Klominek, J. (1989) Smoking and passive smoking in  relation to  lung
        cancer in women. Acta Oncol. 28:623-629.

Tager, I.E.;  Segal, M.R.; Munoz, A.; Weiss, S.T.; Speizer, F.E. (1987) The effect of maternal
        smoking on the pulmonary function of children and adolescents. Analysis of data from two
        populations. Am. Rev. Respir. Dis. 136:1366-1370.

Tager, I.E.;  Weiss, S.T.; Munoz, A.; Rosner, B.; Speizer,  F.E. (1983) Longitudinal study of the
        effects of maternal smoking  on pulmonary function in children. N. Engl. J. Med.
        309:699-703.

                                           R-32

-------
Tager, I.E.; Weiss, S.T.; Rosner, B.; Speizer, F.E. (1979) Effect of parental cigarette smoking on
       the pulmonary function of children. Am. J. Epidemiol. 110:15-26.

Tainio, V.M.; Savilahti, E.; Salmenpera, L.; Arjomaa, P.; Siimes, M.A.; Perheentupa, J. (1988)
       Risk factors for infantile recurrent otitis media: atopy but not type of feeding. Pediatr.
       Res. 23:509-12.

Takasaka, T. (1990) Incidence, prevalence, and natural history of otitis media in different
       geographic areas and populations. Ann. Otol. Rhinol.  Laryngol. 99:13-14.

Tashkin, D.P.; Clark, V.A.; Simmons, M.; Reems, C.; Coulson, A.H.; Bourque, L.B.; Sayre, J.W.;
       Detels, R.; Rokaw, S. (1984) The UCLA population studies of chronic obstructive
       respiratory disease. VII. Relationship between parental smoking and children's lung
       function. Am. Rev. Respir. Dis. 129:891-897.

Taylor, R.G.; Gross, E.; Joyce, H.; Holland, F.; Pride, N.B. (1985) Smoking, allergy, and the
       differential white blood cell count. Thorax 40:17-22.

Teele, D.W.; Klein, J.O.; Rosner, B. (1989) Epidemiology of otitis media during the first seven
       years of life in children in greater Boston: a prospective,  cohort study. J. Infect. Dis. 160:
       83-94.
Thompson, L.V.; Jenkins, R.A.; Higgins, C.E. (1989) A thermal desorption method for the
       determination of nicotine in indoor environments. Environ. Sci. Technol. 23:429-435.

Toyoshima, K.; Hayashida, M.; Yasunami, J.; Takamatsu, I.; Niwa, H.; Muraoka, T. (1987) Factors
       influencing the prognosis of wheezy infants. J. Asthma 24:267-270.

Trichopoulos, D. (1988) Passive smoking and lung cancer. Scand. J. Soc.  Med. 16:75-79.

Trichopoulos, D.; Kalandidi, A.; Sparros, L. (1983)  Lung cancer and passive smoking: conclusion
       of Greek study. [Letter] Lancet 667-668.

Trichopoulos, D.; Kalandidi, A.; Sparros, L.; MacMahon, B. (1981) Lung cancer and passive
       smoking. Int. J. Cancer 27:1-4.

Tsimoyianis, G.V.; Jacobson, M.S.; Feldman, J.G.; Antonio-Santiago, M.T.; Clutario, B.C.;
       Nussbaum, M.; Shenker, I.R. (1987) Reduction in pulmonary function and increased
       frequency of cough associated with passive smoking in teenage athletes. Pediatrics
       80:32-36.

Tunstall-Pedoe, H.; Woodward, M.; Brown, C.A. (1991) Tea drinking, passive smoking, and serum
       cotinine in the Scottish heart health study.  J. Clin. Epidemiol. 44:1411-1414.

Turk, B.H.; Brown, J.T.; Geisling-Sobotka, K.; Froehlich, D.A.; Grimsrud, D.T.; Harrison, J.;
       Koonce, J.F.; Prill, R.J.; Revzan, K.L. (1987) Indoor air quality and ventilation
       measurements in 38 Pacific Northwest commercial buildings: final report to the Bonneville
       Power Administration, v. 1, Measurement results and interpretation.

Uberla, K.; Ahlborn, W. (1987) Passive smoking and lung cancer; a reanalysis of Hirayama's data.
       In: Proceedings of international conference on indoor air quality. Tokyo: Council for
       Environment and Health, p. 41.

                                           R-33

-------
U.S. Bureau of the Census. (1990)  Statistical abstract of the United States, 1990.

U.S. Department of Health and Human Services (U.S. DHHS). (1982) The health consequences of
       smoking: cancer. A report of the Surgeon General. U.S. DHHS, Public Health Service,
       Washington, DC.

U.S. Department of Health and Human Services. (1983) The health consequences of smoking:
       cardiovascular disease. A report of the Surgeon General. U.S. DHHS, Public Health
       Service, Office of the Assistant Secretary for Health, Office  of Smoking and Health,
       Washington, DC. DHHS Pub. No. (PHS) 84-50204.

U.S. Department of Health and Human Services. (1984) The health consequences of smoking:
       chronic obstructive lung disease. A report of the Surgeon General. U.S. DHHS, Public
       Health Service, Office of the Assistant Secretary for Health,  Office of Smoking and
       Health, Washington, DC. DHHS Pub. No. (PHS) 84-50205.

U.S. Department of Health and Human Services. (1986) The health consequences of involuntary
       smoking. A report of the Surgeon General. U.S. DHHS, Public Health Service, Office of
       the Assistant Secretary for Health, Office of Smoking and Health, Washington, DC. DHHS
       Pub. No. (PHS)  87-8398.

U.S. Department of Health and Human Services. (1989) Reducing the health consequences of
       smoking: 25 years of progress. A report of the Surgeon General. U.S. DHHS, Public Health
       Service, Washington, DC.  DHHS Pub. No. (CDC) 89-8411.

U.S. Department of Health and Human Services. (1990a) The health benefits of smoking cessation.
       A report of the  Surgeon General. U.S. DHHS, Public Health Service, Washington, DC.
       DHHS Pub. No. (CDC) 90-8416.

U.S. Department of Health and Human Services. (1990b) Vital and health statistics: current
       estimates from the national health interview survey, 1989. U.S. DHHS, Public Health
       Service, Washington, DC.

U.S. Department of Health, Education, and Welfare. (1964) Smoking and health.  Report of the
       Advisory Committee to the Surgeon General of the Public Health Service, Washington,
       DC. PHS Pub. No. 1103.

U.S. Department of Health, Education, and Welfare. (1977) Nicotine. NIOSH manual of analytical
       methods, v. 3, 2nd ed. NIOSH, Cincinnati, OH. Publication No. 77-157-C.

U.S. DHEW. See U.S. Department of Health, Education, and  Welfare.

U.S. DHHS. See U.S. Department of Health and Human Services.

U.S. Department of Transportation. (1971) Health aspects of smoking in transport aircraft. U.S.
       Department of Transportation, Washington, DC. Available from: National Technical
       Information Service, Springfield, VA.

U.S. Environmental Protection Agency. (1986a) Guidelines for carcinogen risk assessment. Federal
       Register 51:33992-34003.
                                           R-34

-------
 U.S. Environmental Protection Agency. (1986b) Guidelines for the health risk assessment of
        chemical mixtures. Federal Register 51:34014-34025.

 U.S. Environmental Protection Agency. (1989) Workshop report on EPA guidelines for carcinogen
        risk assessment: use of human evidence. Office of Research and Development, Risk
        Assessment Forum, Washington, DC. EPA/625/3-90/017.

 U.S. Environmental Protection Agency. (1990) Health effects of passive smoking: assessment of
        lung cancer in adults and respiratory disorders in children. Office of Research and
        Development, Office of Health and Environmental Assessment, Washington, DC. External
        Review Draft. EPA/600/6-90/006A.

 U.S. Environmental Protection Agency. (1992) Respiratory health effects of passive smoking: lung
        cancer and other disorders. Office of Research and Development, Office of Health and
        Environmental Assessment, Washington, DC. SAB Review Draft. EPA/600/6-90-006B.

 U.S. EPA. See U.S. Environmental Protection Agency.

 Vainio, H.; Hemminki, K.; Wilbourn, J. (1985) Data on the carcinogenicity of chemicals in the
        IARC Monographs programme. Carcinogenesis 6:1653-1665.

 Varela, L.R. (1987) Assessment of the association between passive smoking and lung cancer.
        [doctoral dissertation]. New Haven, CT: Yale University.

 Vaughan, W.M.; Hammond, S.K. (1990) Impact of designated smoking area. Policy on nicotine
        vapor and particle  concentrations in a modern office  building. J. Air Waste Management
        Assoc. 40:1012-1017.

 Vedal, R.E.; Schenker, M.B.; Samet, J.M.; Speizer, F.E. (1984) Risk factors for childhood
        respiratory disease. Am. Rev. Respir. Dis. 130:187-192.

 Vidic, B.; Ujevic, N.; Shabahang, M.M.; Van de Zande, F. (1989) Differentiation of interstitial
       cells and stromal proteins in the secondary septum of early postnatal rat: effect of maternal
       chronic exposure to whole cigarette smoke. Anat. Rec. 165:165-173.

 Vincent, R.G.; Pickren, J.W.; Lane, W.W.; Bross, I.; Takita, H.; Houten, L.; Gutierrez, A.C.;
       Rzepka, T. (1977) The changing histopathology of lung cancer: a review of 1682 cases
       Cancer 39:1647-1655.

 Vincent, T.N.; Satterfield,  J.V.; Ackerman, L.V. (1965) Carcinoma of the lung in women. Cancer
       18:559-570.

 Vutuc, C. (1984) Quantitative aspects of passive smoking and lung cancer. Prev. Med. 13:698-704.

 Wald, N.J.; Boreham, J.; Bailey, A.; et al. (1984) Urinary cotinine  as a marker of breathing other
       people's tobacco smoke. Lancet 1:230-231.

Wald, N.J.; Ritchie, C. (1984) Validation of studies on lung cancer in nonsmokers married to
       smokers. Lancet 1:1067.
                                          R-35

-------
Wald, N.J.; Nanchahal, K.; Thompson, S.G.; Cuckle, H.S. (1986) Does breathing other people's
       tobacco smoke cause lung cancer? Br. J. Med. 293:1217-1222.

Wall, M.; Johnson, J.; Jacob, P.; Benowitz, N. (1988) Cotinine in the serum, salivia  and urine of
       nonsmokers, passive smokers, and active smokers. Am. J. Public Health 78:699-701.

Wang F-L (1989) Analysis of risk factors for female lung adenocarcinoma in haerbin: indoor air
       pollution. [In Chinese with English abstract] Chung Hua Yu Fang I Hsueh Tsa Chih
       23(5):270-273.

Wang, J-N.; Zhang, Y. (1990) CO and particle pollution of indoor air in Beijing and its elemental
       analysis. Biomed. Environ. Sci. 3(2): 132-138.

Wang N S/ Chen, M.F.; Schraufnagel, D.E. (1984) The cumulative scanning electron microscopic
       changes in baby mouse lungs following prenatal and postnatal exposures to nicotine. J.
       Pathol. 144:89-100.

Ware, J.H.; Dockery, D.W.; Spiro, A., III.; Speizer, F.E.; Ferris, B.G., Jr. (1984) Passive smoking,
       gas cooking,  and respiratory health of children living in six cities. Am. Rev. Respir. Dis.
       129:366-374.

Weber, A.; Fischer, T. (1980) Passive smoking at work. Int. Arch. Occup. Environ.  Health 47:209-
      '221.

Weber, A.; Fischer T.; Grandjean,  A. (1979) Passive smoking in experimental and field conditions.
      ' Environ. Res. 20:205-216.

Weir, J.M.; Dunn, J.E., Jr. (1970) Smoking and mortality: a prospective study. Cancer 25:105-112.

Weiss, S.T.; Tager, I.E.; Speizer, F.E.; Rosner, B. (1980) Persistent wheeze: its relation to
       respiratory illness,  cigarette smoking, and level of pulmonary function in a population
       sample of children. Am. Rev. Respir. Dis. 122:697-707.

Weiss S T/ Tager, I.E.; Munoz, A.; Speizer, F.E. (1985)  The relationship of respiratory infections
        in early childhood  to the occurrence of increased levels of bronchial responsiveness and
        atopy. Am. Rev. Respir. Dis. 131:573-578.

 Weiss, W.; Boucot, K.R.; Seidman, H.; Carnahan, W.J. (1972) Risk of lung cancer according to
        histologic type and cigarette dosage. JAMA 222:799-801.

 Weitzman, M.; Gortmaker, S.; Klein Walker, D.; Sobol, A. (1990) Maternal smoking and childhood
        asthma. Pediatrics  85:505-511.

 Wells, AJ. (1988) An estimate of adult mortality in the United States from passive smoking.
        Environ. Int. 14:249-265.

 Wells, AJ. (1990, December 4) Smoker misclassification does not account for observed passive
        smoking risk for lung cancer. Submission to Indoor Air Quality and Total Human
        Exposure Committee, Science Advisory Board, U.S. Environmental Protection Agency,
        Washington, DC.
                                            R-36

-------
 Wells, A.J. (1991) An estimate of adult mortality in the United States from passive smoking; a
        response to criticism. Environ. Int. 17:382-385.

 Wells, A.J. (1992) An estimate of adult mortality in the United States from passive smoking; a
        further reply. Environ. Int. 18:321-325.

 White, J.R.; Frdeb, H.F. (1980) Small airways dysfunction in nonsmokers chronically exposed to
        tobacco smoke. N. Engl. J. Med. 302:720-723.

 Whittemore, A.S. (1988) Effect of cigarette smoking in epidemiological studies of lung cancer
        Stat. Med. 7:223-238.

 Wigle, D.T.; Collishaw,  N.E.; Kirkbride, J.; Mao, Y. (1987) Deaths in Canada from lung cancer
        due to involuntary smoking. J. Can. Med. Assoc. 136:945-951.

 Willatt, D.J. (1986) Children's sore throats related to parental smoking. Clin. Otolaryneol
        11:317-321.

 Williamson, D.F.; Serdula, M.K.; Kendrick, J.S.; Binkin, N.C. (1989) Comparing the prevalence of
       smoking in pregnant and nonpregnant women, 1985 to 1986. JAMA 261:70-74.

 Woodward, A.; Douglas, R.M.; Graham, N.M.H.; Miles, H. (1990) Acute respiratory illness in
       Adelaide children: breast feeding modifies the effect of passive smoking. J. Epidemiol
       Community Health 44:224-230.

 Wpplcock, A.J.; Peat, J.K.; Leeder, S.R.; Blackburn, C.R.B. (1984) The development of lung
       function in Sydney children: effects of respiratory illnesss and smoking. A ten-year study
       Eur. J. Resp. Dis. 65(Suppl): 1-137.

 Woolcock, A.J.; Peat, J.K.; Salome, C.M.; et al. (1987) Prevalence of bronchial
       hyperresponsiveness and asthma in a rural adult population. Thorax 42:361-368.

 Woolf, B. (1955) On estimating the relationship between blood group and disease Ann Hum
       Genet. 19:251-253.

 Wright, A.L.; Holberg, C.; Martinez, F.D.; Taussig,  L.M. (1991) Relationship of parental smoking
       to wheezing and nonwheezing lower respiratory tract illnesses in infancy. J. Pediatr
       118:207-214.

 Wright, A.L.; Taussig, L.M.; Ray, C.G.; Harrison, H.R.;  Holberg, C.J. (1989) The Tucson's
       children respiratory study. II. Lower respiratory tract illnesses in the first year of life Am
       J. Epidemiol. 129:1232-1246.

 Wu, A.H.; Henderson, B.E.; Pike, M.D.; Yu, M.C. (1985)  Smoking and other risk factors for  lung
       cancer in women. J. Natl. Cancer Inst.  74(4):747-751.

Wu-Williams, A.H.; Samet, J.H. (1990) Environmental tobacco smoke:  exposure-response
       relationships in epidemiologic studies. Risk Anal. 10:1.

Wynder, E.L.; Gottlieb, S.; Wright, G. (1957) A study of tobacco carcinogenesis. IV. Different
       tobacco types. Cancer 10:1206-1209.
                                           R-37

-------
Wynder, E.L.; Hoffmann, D. (1967) Tobacco and tobacco smoke: studies in experimental
       carcinogenesis. New York: Academic Press.

Wynder, E.L.; Mabuchi, K.; Beattie, E.J., Jr. (1970) The epidemiology of lung cancer: recent
       trends. JAMA 213:2221-2228.

Wynder, E.L.; Stellman, S.D. (1977) Comparative epidemiology of tobacco-related cancers. Cancer
       Res. 37:4608-4622.

Xu, Z.Y.; Blot, W.J.; Xiao, H.P.; et al. (1989) Smoking, air pollution, and the high rates of lung
       cancer in Shenyand, China. J. Natl. Cancer Inst. 81:1800.

Yarnell, J.W.; St. Leger, A.S. (1979) Respiratory illness, maternal smoking habit, and lung
       function in children. Br. J. Dis. Chest 73:230-236.

Young, S.; LeSouef, P.N.; Reese, A.C.; Stick, S.M.; Landau, L.I. (1990) Factors predicting cough
       and wheeze in the first 6 months of life. Am. Rev. Respir. Dis. 141:A901.

Zahm, S.H.; Cocco, P.; Blair, A. (1991) Tobacco smoking as a risk factor for colon polyps. Am. J.
      ' Public Health 81:846-849.

Zetterstrom, O.; Osterman, K.; Machado, L.; Johansson, S.G.O. (1981) Another smoking hazard:
       raised serum IgE concentration and increased risk of occupational allergy, Br. Med. J.
       283:1215-1217.

Zhao, Zhen-Hua; Quan, Wen-Yi; Tian, De-Hai (1990) Urinary 1-hydroxypyrene as an indicator
       of human exposure to ambient polycyclic aromatic hydrocarbons in a coal-burning
       environment. Sci. Total Environ. 92:145-154.
                                            R-38
                                                                    *U.S. G.P.O.:1993-751-955

-------

-------

-------